data_1tu2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tu2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.714 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.461 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.3 m -61.55 89.7 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -99.99 163.04 12.61 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.456 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.82 122.41 46.72 Favored 'General case' 0 N--CA 1.525 3.321 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -100.49 98.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.33 65.38 0.07 Allowed 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 113.14 -1.845 . . . . 0.0 114.855 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.8 HD11 ' HB2' ' A' ' 39' ' ' HIS . 15.3 mt -29.52 68.27 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 126.521 1.929 . . . . 0.0 115.543 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.44 59.01 0.4 Allowed Glycine 0 N--CA 1.509 3.539 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.1 p -1.0 54.04 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.33 0 N-CA-C 120.242 3.423 . . . . 0.0 120.242 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.53 -60.19 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.49 14.43 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.962 -1.086 . . . . 0.0 108.151 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.06 -94.86 1.91 Allowed Glycine 0 N--CA 1.512 3.75 0 N-CA-C 115.546 0.978 . . . . 0.0 115.546 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.527 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.9 tp -150.64 -177.13 5.8 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 1.047 HD21 HG23 ' A' ' 36' ' ' VAL . 15.6 mt -74.8 46.73 0.3 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.654 -1.279 . . . . 0.0 111.244 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.599 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.83 165.64 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 118.503 2.779 . . . . 0.0 118.503 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.599 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 5.1 m-30 -102.25 75.35 1.48 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 112.187 -2.279 . . . . 0.0 113.356 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.47 142.47 25.25 Favored Pre-proline 0 N--CA 1.507 2.376 0 O-C-N 121.822 -0.549 . . . . 0.0 111.735 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 20' ' ' LYS . 56.3 Cg_endo -86.43 76.09 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.426 0 N-CA-C 116.359 1.638 . . . . 0.0 116.359 -9.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.73 -44.23 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 1 N-CA-C 122.3 4.185 . . . . 0.0 122.3 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.638 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.62 71.66 1.0 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 122.433 1.111 . . . . 0.0 113.092 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.642 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.11 111.27 7.19 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.152 -1.592 . . . . 0.0 109.107 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.532 ' N ' HD22 ' A' ' 21' ' ' LEU . 52.6 m -87.51 81.5 7.76 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.705 HD11 HD12 ' A' ' 101' ' ' ILE . 4.7 pt -79.7 -177.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.652 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.646 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.69 166.58 10.51 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-N 113.769 -1.559 . . . . 0.0 108.067 179.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.4 Cg_endo -52.18 77.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.571 2.326 0 N-CA-C 116.947 1.864 . . . . 0.0 116.947 174.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.13 -50.48 0.52 Allowed Glycine 1 N--CA 1.522 4.414 0 C-N-CA 119.73 -1.224 . . . . 0.0 115.833 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.655 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.71 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.151 1 N-CA-C 122.104 4.113 . . . . 0.0 122.104 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.461 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.5 m -64.01 35.91 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.012 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 30' ' ' GLU . 59.2 t -51.95 147.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 112.863 -1.971 . . . . 0.0 111.517 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.493 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.9 pt-20 -114.29 154.93 27.12 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 123.934 1.826 . . . . 0.0 115.359 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -107.55 113.86 27.46 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.8 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.79 112.57 25.02 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 120.636 3.569 . . . . 0.0 120.636 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -75.13 84.75 2.35 Favored 'General case' 0 N--CA 1.512 2.645 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.18 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.7 p30 -80.26 -45.14 18.44 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.9 -169.29 3.34 Favored 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 124.661 1.184 . . . . 0.0 109.118 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.047 HG23 HD21 ' A' ' 14' ' ' LEU . 1.6 m 12.82 70.7 0.11 Allowed Pre-proline 0 N--CA 1.521 3.079 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.466 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 58.4 Cg_endo -98.4 177.24 0.41 Allowed 'Trans proline' 0 CA--C 1.569 2.261 0 C-N-CA 123.945 3.096 . . . . 0.0 114.422 -165.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 58.2 Cg_endo -92.41 165.28 25.29 Favored 'Cis proline' 0 N--CA 1.504 2.105 0 N-CA-C 115.402 1.27 . . . . 0.0 115.402 -7.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.8 ' HB2' HD11 ' A' ' 7' ' ' LEU . 17.9 m-70 -118.88 87.44 2.73 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.605 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -103.4 140.29 37.66 Favored 'General case' 0 N--CA 1.516 2.832 0 CA-C-N 122.469 2.395 . . . . 0.0 110.719 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.5 m -118.11 116.25 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 121.419 3.859 . . . . 0.0 121.419 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.957 HG22 ' HB2' ' A' ' 88' ' ' TYR . 14.5 m -75.95 165.35 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.87 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.26 131.02 55.47 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 46' ' ' ALA . 4.1 m-20 -53.47 93.77 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.174 1 N-CA-C 124.148 4.87 . . . . 0.0 124.148 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.98 6.76 43.43 Favored 'General case' 0 CA--C 1.602 2.97 0 N-CA-C 101.23 -3.618 . . . . 0.0 101.23 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 47' ' ' LEU . . . -115.84 -65.57 1.18 Allowed 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 127.526 2.33 . . . . 0.0 112.669 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.639 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.47 9.49 Favored 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.41 151.25 0.74 Allowed Pre-proline 0 N--CA 1.523 3.181 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.0 Cg_endo -42.51 -58.17 1.36 Allowed 'Trans proline' 0 N--CA 1.508 2.359 0 C-N-CA 123.362 2.708 . . . . 0.0 115.102 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.543 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.51 67.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 124.066 1.888 . . . . 0.0 107.062 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.403 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.16 53.5 0.99 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 112.275 -2.239 . . . . 0.0 108.208 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.87 56.89 0.76 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.773 2.508 . . . . 0.0 117.773 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.702 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.51 -48.0 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.13 -30.85 0.16 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.106 -1.622 . . . . 0.0 111.571 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.801 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.16 -28.52 0.1 Allowed 'General case' 0 N--CA 1.509 2.501 0 CA-C-O 122.716 1.246 . . . . 0.0 112.475 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.801 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.81 -27.63 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.2 tptt 65.04 -55.59 0.3 Allowed 'General case' 0 N--CA 1.533 3.691 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -41.68 -28.93 0.16 Allowed 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.87 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.72 -66.71 0.34 Allowed 'General case' 0 CA--C 1.603 3.019 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.823 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.6 p -72.18 98.47 2.15 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.273 1.429 . . . . 0.0 112.765 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.714 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.03 -173.1 3.74 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.815 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.43 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.365 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.815 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 27.1 tt0 105.52 65.99 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 120.292 3.441 . . . . 0.0 120.292 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.987 HD11 ' N ' ' A' ' 64' ' ' LEU . 5.9 mp 38.13 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.605 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 35.2 mt -70.64 82.05 0.6 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.101 -1.624 . . . . 0.0 111.886 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 1.525 ' CE ' HD23 ' B' ' 119' ' ' LEU . 41.9 mmm -79.23 61.97 3.48 Favored 'General case' 0 N--CA 1.511 2.579 0 CA-C-O 126.021 2.82 . . . . 0.0 110.913 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.6 m -112.61 65.98 0.87 Allowed Pre-proline 0 C--N 1.283 -2.287 0 CA-C-N 110.525 -3.034 . . . . 0.0 113.585 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.679 ' CG ' ' OD2' ' B' ' 100' ' ' ASP . 21.9 Cg_endo -52.03 81.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.461 0 C-N-CA 122.945 2.43 . . . . 0.0 114.699 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.64 27.66 Favored Glycine 0 N--CA 1.516 3.973 0 O-C-N 122.177 -0.327 . . . . 0.0 113.637 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.55 156.94 34.76 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 124.321 2.01 . . . . 0.0 116.367 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.8 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -117.05 156.34 27.71 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 119.628 3.195 . . . . 0.0 119.628 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -115.89 147.97 40.5 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-O 116.603 -1.665 . . . . 0.0 107.236 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.466 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.5 143.71 41.91 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 118.383 2.734 . . . . 0.0 118.383 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 84.4 m -119.94 102.54 8.63 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.543 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.4 m -94.73 152.18 18.66 Favored 'General case' 0 N--CA 1.526 3.334 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.92 168.31 8.08 Favored Pre-proline 0 N--CA 1.503 2.184 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.09 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -72.35 -174.74 1.51 Allowed 'Trans proline' 0 CA--C 1.559 1.747 0 C-N-CA 120.994 1.129 . . . . 0.0 111.149 161.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.77 18.96 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 124.41 2.052 . . . . 0.0 107.235 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.13 42.61 0.49 Allowed 'General case' 0 CA--C 1.577 1.984 0 CA-C-N 111.265 -2.698 . . . . 0.0 109.097 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.579 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.27 84.74 9.66 Favored Pre-proline 0 N--CA 1.5 2.032 0 CA-C-N 113.608 -1.633 . . . . 0.0 113.768 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 83' ' ' GLY . 45.9 Cg_endo -79.41 178.68 7.13 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.73 2.287 . . . . 0.0 112.245 172.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.58 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.05 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.91 0 C-N-CA 125.29 1.436 . . . . 0.0 113.333 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.41 125.01 5.63 Favored Glycine 0 N--CA 1.508 3.456 0 N-CA-C 121.76 3.464 . . . . 0.0 121.76 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.65 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 43.9 mt-10 -99.43 61.2 1.18 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.806 ' HB2' HG23 ' A' ' 101' ' ' ILE . 3.0 m-85 -62.07 77.75 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 122.93 1.348 . . . . 0.0 113.013 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.7 m -63.41 135.97 57.31 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.553 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.51 136.52 52.91 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.957 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.61 82.05 8.59 Favored 'General case' 0 N--CA 1.512 2.627 1 N-CA-C 132.634 8.013 . . . . 0.0 132.634 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.706 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.94 82.19 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.438 2 CA-C-N 130.343 5.974 . . . . 0.0 114.313 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.1 tt0 -20.52 -72.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.459 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 36.6 Cg_endo -67.07 -3.43 9.72 Favored 'Trans proline' 0 N--CA 1.511 2.517 0 C-N-CA 122.383 2.056 . . . . 0.0 115.356 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -120.91 -14.13 8.52 Favored 'General case' 0 N--CA 1.511 2.594 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.434 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.25 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.64 -34.16 1.72 Allowed Glycine 1 N--CA 1.521 4.324 0 O-C-N 121.518 -0.739 . . . . 0.0 112.643 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.42 68.44 7.75 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.94 26.63 0.05 OUTLIER Glycine 1 N--CA 1.527 4.71 0 N-CA-C 116.665 1.426 . . . . 0.0 116.665 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.855 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.0 ttt -108.46 43.84 1.19 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 124.524 2.107 . . . . 0.0 113.016 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.96 134.81 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 112.313 -2.221 . . . . 0.0 110.954 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.62 154.9 19.34 Favored Glycine 1 N--CA 1.535 5.289 0 C-N-CA 119.49 -1.338 . . . . 0.0 113.997 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.855 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.1 ttpp -118.61 81.91 1.77 Allowed 'General case' 0 N--CA 1.517 2.912 0 CA-C-N 119.488 1.644 . . . . 0.0 115.226 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.806 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.74 123.31 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 C-N-CA 118.03 -1.468 . . . . 0.0 107.044 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.855 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.9 m -112.65 88.76 2.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.15 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 80' ' ' ALA . 39.1 t -74.06 105.27 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.39 -72.25 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.627 0 O-C-N 126.095 2.122 . . . . 0.0 115.885 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.58 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.484 0 O-C-N 125.526 1.766 . . . . 0.0 113.84 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 24.3 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' TRP . . . . . 0.444 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . 0.424 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 53.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.7 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.4 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 78.4 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' B' ' 27' ' ' LEU . 71.8 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.566 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.2 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 1.353 ' HB ' ' CA ' ' B' ' 34' ' ' VAL 0.389 0.4 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.49 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.436 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.436 ' O ' HG12 ' B' ' 36' ' ' VAL . 28.1 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.7 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.413 HG23 HD12 ' B' ' 247' ' ' ILE . 25.8 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.785 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.652 ' H ' ' HG ' ' B' ' 133' ' ' SER . 32.7 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.435 HG11 ' N ' ' B' ' 46' ' ' PHE . 87.0 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 1.012 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.3 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.471 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.471 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.4 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.563 ' O ' HG21 ' B' ' 68' ' ' VAL . 58.7 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.629 HG12 ' N ' ' B' ' 69' ' ' GLY . 81.4 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.629 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.556 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.559 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.5 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.9 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' PRO . . . . . 0.814 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 17.9 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.814 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 44.3 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.463 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' B' ' 130' ' ' PRO . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.481 ' HA ' HD12 ' B' ' 94' ' ' LEU . 50.0 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.679 ' OD2' ' CG ' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.1 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 1.466 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 18.4 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' GLN . . . . . 0.909 HE22 HG13 ' A' ' 36' ' ' VAL . 11.2 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' TYR . . . . . 0.424 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 23.3 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.498 ' C ' HG13 ' B' ' 114' ' ' VAL . 55.9 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.543 ' O ' HG23 ' B' ' 114' ' ' VAL . 16.7 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 1.578 ' CB ' ' CA ' ' B' ' 115' ' ' ILE 0.521 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 1.49 ' HB ' ' CB ' ' B' ' 116' ' ' VAL 0.463 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.664 ' O ' ' CE ' ' A' ' 66' ' ' MET . 38.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 1.525 HD23 ' CE ' ' A' ' 66' ' ' MET . 81.7 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.8 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.51 ' C ' HG12 ' B' ' 131' ' ' VAL . 13.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 1.012 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.52 0.7 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.9 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' SER . . . . . 0.652 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.7 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . 0.447 ' HG2' HD12 ' B' ' 142' ' ' ILE . 38.2 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . 0.449 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 24.1 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' PRO . . . . . 0.65 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.7 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.449 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . 0.545 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.545 HG22 ' CG ' ' B' ' 139' ' ' ASP 0.453 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . 0.65 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' SER . . . . . 0.488 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.5 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' VAL . . . . . 0.488 HG13 ' C ' ' B' ' 148' ' ' SER 0.387 1.5 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.452 HG12 HG23 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.481 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.6 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.665 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.1 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 1.34 ' HB ' ' CG2' ' B' ' 160' ' ' VAL 0.417 0.8 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' PRO . . . . . 0.444 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.6 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.441 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.8 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . 0.53 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . 0.728 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.7 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.525 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 59.2 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.0 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . 0.721 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.721 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.9 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.448 1.7 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.48 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.1 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.435 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.3 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.645 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 197' ' ' VAL . . . . . 0.645 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.439 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 200' ' ' LYS . . . . . 0.525 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.6 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.457 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.6 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.457 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' ASP . . . . . 0.481 ' O ' HD13 ' B' ' 196' ' ' LEU . 63.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.728 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 40.0 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . 0.403 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.403 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 12.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.5 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.4 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 1.347 ' HB ' ' CA ' ' B' ' 225' ' ' VAL 0.417 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' ASN . . . . . 0.511 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . 0.481 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 22.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.6 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . 0.566 HD13 ' O ' ' B' ' 32' ' ' THR . 15.1 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' ILE . . . . . 0.413 HD12 HG23 ' B' ' 40' ' ' VAL . 18.5 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 40.7 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.716 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.456 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 85.4 m -61.52 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.02 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -100.0 163.01 12.62 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.459 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.75 122.44 46.75 Favored 'General case' 0 N--CA 1.525 3.32 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.4 t -100.57 98.32 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.34 65.4 0.07 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 113.096 -1.865 . . . . 0.0 114.893 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.796 HD11 ' HB2' ' A' ' 39' ' ' HIS . 15.2 mt -29.49 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 126.585 1.954 . . . . 0.0 115.512 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.45 59.09 0.4 Allowed Glycine 0 N--CA 1.51 3.609 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.4 p -1.09 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 120.31 3.448 . . . . 0.0 120.31 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.48 -60.16 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 119.551 3.167 . . . . 0.0 119.551 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.84 22.46 14.44 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 120.956 -1.09 . . . . 0.0 108.209 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.09 -94.85 1.91 Allowed Glycine 0 N--CA 1.511 3.672 0 N-CA-C 115.528 0.971 . . . . 0.0 115.528 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.7 tp -150.54 -177.13 5.79 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 1.034 HD21 HG23 ' A' ' 36' ' ' VAL . 15.7 mt -74.8 46.66 0.3 Allowed 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.627 -1.295 . . . . 0.0 111.247 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.6 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.74 165.73 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 118.575 2.805 . . . . 0.0 118.575 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.6 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 5.1 m-30 -102.34 75.45 1.48 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.384 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.274 4.8 mt-10 -93.48 142.37 25.11 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.781 -0.574 . . . . 0.0 111.806 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 20' ' ' LYS . 55.9 Cg_endo -86.47 76.15 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.389 0 N-CA-C 116.352 1.635 . . . . 0.0 116.352 -9.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.68 -44.17 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.737 1 N-CA-C 122.238 4.162 . . . . 0.0 122.238 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.64 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.68 71.6 0.99 Allowed 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.442 1.115 . . . . 0.0 113.049 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.633 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.1 111.3 7.21 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.178 -1.576 . . . . 0.0 109.098 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.53 ' N ' HD22 ' A' ' 21' ' ' LEU . 54.6 m -87.48 81.38 7.81 Favored 'General case' 0 N--CA 1.514 2.728 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.706 HD11 HD12 ' A' ' 101' ' ' ILE . 4.8 pt -79.68 -177.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.675 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.65 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.72 166.54 10.59 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.104 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.5 Cg_endo -52.18 77.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.288 0 N-CA-C 116.921 1.854 . . . . 0.0 116.921 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.16 -50.44 0.52 Allowed Glycine 1 N--CA 1.522 4.414 0 C-N-CA 119.733 -1.222 . . . . 0.0 115.852 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.647 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.6 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.174 1 N-CA-C 122.101 4.112 . . . . 0.0 122.101 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.6 m -63.99 35.92 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.049 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 30' ' ' GLU . 60.1 t -52.01 147.22 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.501 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.493 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.9 pt-20 -114.26 154.9 27.14 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 123.914 1.816 . . . . 0.0 115.41 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -107.54 113.87 27.47 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.784 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.77 112.54 24.97 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 120.71 3.596 . . . . 0.0 120.71 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -75.2 84.72 2.39 Favored 'General case' 0 N--CA 1.511 2.599 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.18 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.5 p30 -80.18 -45.17 18.54 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.89 -169.29 3.34 Favored 'General case' 0 N--CA 1.508 2.467 0 C-N-CA 124.656 1.183 . . . . 0.0 109.111 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.171 HG13 ' NE2' ' B' ' 104' ' ' GLN . 1.6 m 12.89 70.68 0.11 Allowed Pre-proline 0 N--CA 1.52 3.055 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.153 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 57.7 Cg_endo -98.52 177.26 0.4 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 123.92 3.08 . . . . 0.0 114.324 -165.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.583 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 57.7 Cg_endo -92.44 165.32 25.18 Favored 'Cis proline' 0 N--CA 1.503 2.071 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 -7.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.796 ' HB2' HD11 ' A' ' 7' ' ' LEU . 17.9 m-70 -118.95 87.35 2.72 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.582 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -103.42 140.28 37.68 Favored 'General case' 0 N--CA 1.516 2.857 0 CA-C-N 122.418 2.372 . . . . 0.0 110.685 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.6 m -118.09 116.25 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 121.445 3.868 . . . . 0.0 121.445 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.985 HG22 ' HB2' ' A' ' 88' ' ' TYR . 14.7 m -75.88 165.44 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.873 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.28 130.96 55.5 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 46' ' ' ALA . 4.1 m-20 -53.53 93.82 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.185 1 N-CA-C 124.088 4.847 . . . . 0.0 124.088 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.94 6.74 43.44 Favored 'General case' 0 CA--C 1.602 2.952 0 N-CA-C 101.228 -3.619 . . . . 0.0 101.228 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' HB2' HD13 ' A' ' 47' ' ' LEU . . . -115.88 -65.49 1.18 Allowed 'General case' 0 CA--C 1.573 1.85 0 C-N-CA 127.519 2.328 . . . . 0.0 112.705 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.632 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.48 9.5 Favored 'General case' 0 N--CA 1.52 3.034 0 N-CA-C 118.91 2.93 . . . . 0.0 118.91 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.44 151.24 0.74 Allowed Pre-proline 0 N--CA 1.522 3.151 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.7 Cg_endo -42.42 -58.27 1.31 Allowed 'Trans proline' 0 N--CA 1.509 2.391 0 C-N-CA 123.376 2.717 . . . . 0.0 115.113 170.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.544 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.49 67.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 124.112 1.911 . . . . 0.0 107.04 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.404 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.16 53.49 0.99 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.344 -2.207 . . . . 0.0 108.265 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.81 56.96 0.75 Allowed 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.691 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.57 -47.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.14 -30.84 0.17 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.226 -1.546 . . . . 0.0 111.564 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.801 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.18 -28.53 0.1 Allowed 'General case' 0 N--CA 1.508 2.449 0 CA-C-O 122.77 1.272 . . . . 0.0 112.567 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.801 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.77 -27.58 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.2 tptt 65.01 -55.55 0.3 Allowed 'General case' 0 N--CA 1.533 3.691 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.76 -28.89 0.17 Allowed 'General case' 0 N--CA 1.515 2.818 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.873 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.69 -66.82 0.32 Allowed 'General case' 0 CA--C 1.603 3.013 0 N-CA-C 100.69 -3.819 . . . . 0.0 100.69 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.829 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.14 98.46 2.13 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 125.259 1.424 . . . . 0.0 112.806 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.726 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.1 t60 -90.01 -172.93 3.68 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.837 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.34 155.2 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.353 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.837 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 27.3 tt0 105.41 66.08 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.778 0 N-CA-C 120.285 3.439 . . . . 0.0 120.285 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 1.007 HD11 ' N ' ' A' ' 64' ' ' LEU . 5.9 mp 38.16 84.18 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 120.805 3.632 . . . . 0.0 120.805 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.582 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 36.0 mt -70.59 82.08 0.59 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.225 -1.547 . . . . 0.0 111.876 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.698 ' HE2' ' HG2' ' B' ' 118' ' ' PRO . 42.1 mmm -79.29 62.02 3.54 Favored 'General case' 0 N--CA 1.51 2.536 0 CA-C-O 126.066 2.841 . . . . 0.0 110.945 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.2 m -112.65 65.92 0.87 Allowed Pre-proline 0 C--N 1.283 -2.295 0 CA-C-N 110.482 -3.053 . . . . 0.0 113.601 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -52.0 81.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.444 0 C-N-CA 122.98 2.453 . . . . 0.0 114.698 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.19 6.64 27.56 Favored Glycine 0 N--CA 1.515 3.963 0 O-C-N 122.195 -0.316 . . . . 0.0 113.573 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.4 tt0 -123.59 156.94 34.82 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 124.336 2.017 . . . . 0.0 116.331 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.784 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -117.01 156.32 27.69 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 119.641 3.2 . . . . 0.0 119.641 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.5 t -115.96 148.0 40.56 Favored 'General case' 0 N--CA 1.52 3.043 0 CA-C-O 116.633 -1.651 . . . . 0.0 107.229 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.465 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.55 143.78 41.86 Favored 'General case' 0 N--CA 1.529 3.512 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 87.8 m -119.96 102.57 8.65 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 114.146 -1.388 . . . . 0.0 113.575 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.8 m -94.71 152.19 18.67 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.97 168.29 8.1 Favored Pre-proline 0 N--CA 1.504 2.233 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.114 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.35 -174.81 1.53 Allowed 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 120.989 1.126 . . . . 0.0 111.107 161.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.31 -19.82 18.97 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 124.336 2.017 . . . . 0.0 107.235 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.12 42.68 0.49 Allowed 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 111.285 -2.688 . . . . 0.0 109.097 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.585 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.3 84.79 9.78 Favored Pre-proline 0 N--CA 1.5 2.04 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.794 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 83' ' ' GLY . 44.6 Cg_endo -79.42 178.7 7.11 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.831 2.354 . . . . 0.0 112.23 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.573 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.17 77.73 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.921 0 C-N-CA 125.31 1.444 . . . . 0.0 113.265 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.53 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.44 125.1 5.65 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 121.757 3.463 . . . . 0.0 121.757 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.657 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 44.0 mt-10 -99.49 61.23 1.17 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.826 ' HB2' HG23 ' A' ' 101' ' ' ILE . 3.0 m-85 -62.02 77.77 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.934 1.349 . . . . 0.0 113.049 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.5 136.0 57.27 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.553 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.5 136.57 52.87 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.985 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.76 82.05 8.6 Favored 'General case' 0 N--CA 1.511 2.587 1 N-CA-C 132.586 7.995 . . . . 0.0 132.586 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.83 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.465 2 CA-C-N 130.301 5.955 . . . . 0.0 114.293 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.0 tt0 -20.55 -72.42 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.605 0 N-CA-C 118.502 2.778 . . . . 0.0 118.502 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 36.4 Cg_endo -67.01 -3.54 9.86 Favored 'Trans proline' 0 N--CA 1.511 2.534 0 C-N-CA 122.382 2.055 . . . . 0.0 115.351 176.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -120.82 -14.14 8.56 Favored 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.431 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.37 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 116.625 2.084 . . . . 0.0 116.625 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.59 -33.95 1.74 Allowed Glycine 1 N--CA 1.52 4.291 0 O-C-N 121.57 -0.706 . . . . 0.0 112.682 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.62 68.47 7.98 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.447 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.92 26.71 0.05 OUTLIER Glycine 1 N--CA 1.527 4.7 0 CA-C-N 114.008 -1.451 . . . . 0.0 116.629 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.866 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.0 ttt -108.55 43.9 1.19 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 124.505 2.098 . . . . 0.0 113.071 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.96 134.92 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 112.193 -2.276 . . . . 0.0 110.943 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.61 154.85 19.32 Favored Glycine 1 N--CA 1.536 5.354 0 C-N-CA 119.484 -1.341 . . . . 0.0 113.977 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.844 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.1 ttpp -118.59 81.99 1.78 Allowed 'General case' 0 N--CA 1.518 2.942 0 CA-C-N 119.4 1.6 . . . . 0.0 115.264 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.826 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.74 123.26 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.844 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.9 m -112.62 88.76 2.9 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.187 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 80' ' ' ALA . 39.1 t -74.05 105.21 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.25 -72.36 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 O-C-N 126.039 2.087 . . . . 0.0 115.967 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.573 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.46 0 O-C-N 125.468 1.73 . . . . 0.0 113.819 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.2 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . 0.421 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.2 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.5 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 86.5 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 53.9 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 77.5 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' B' ' 27' ' ' LEU . 71.8 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.563 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.0 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 1.372 ' HB ' ' CG2' ' B' ' 34' ' ' VAL 0.39 0.7 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.492 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.3 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.432 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.432 ' O ' HG12 ' B' ' 36' ' ' VAL . 28.2 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.412 HG23 HD12 ' B' ' 247' ' ' ILE . 25.5 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.778 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.653 ' H ' ' HG ' ' B' ' 133' ' ' SER . 32.6 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.437 HG11 ' N ' ' B' ' 46' ' ' PHE . 87.6 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.979 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.5 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.464 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.464 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.5 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.5 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.566 ' O ' HG21 ' B' ' 68' ' ' VAL . 58.9 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.629 HG12 ' N ' ' B' ' 69' ' ' GLY . 84.1 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.629 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.554 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.0 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' PRO . . . . . 0.783 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 18.7 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.783 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 42.4 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.427 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' B' ' 130' ' ' PRO . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.0 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.478 ' HA ' HD12 ' B' ' 94' ' ' LEU . 50.0 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.2 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 1.153 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 19.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' GLN . . . . . 1.171 ' NE2' HG13 ' A' ' 36' ' ' VAL . 11.3 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.504 ' C ' HG13 ' B' ' 114' ' ' VAL . 56.0 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.542 ' O ' HG23 ' B' ' 114' ' ' VAL . 16.7 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 1.571 ' CB ' ' CA ' ' B' ' 115' ' ' ILE 0.687 0.0 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 1.343 ' HB ' ' CB ' ' B' ' 116' ' ' VAL 0.462 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.698 ' HG2' ' HE2' ' A' ' 66' ' ' MET . 38.2 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 81.8 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.6 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 93.1 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.494 ' C ' HG12 ' B' ' 131' ' ' VAL . 13.6 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.979 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.494 1.1 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' SER . . . . . 0.653 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . 0.424 ' HG2' HD12 ' B' ' 142' ' ' ILE . 38.3 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . 0.448 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 23.7 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' PRO . . . . . 0.65 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.9 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.448 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . 0.539 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.539 HG22 ' CG ' ' B' ' 139' ' ' ASP 0.428 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . 0.65 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' SER . . . . . 0.481 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.7 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' VAL . . . . . 0.481 HG13 ' C ' ' B' ' 148' ' ' SER 0.408 1.4 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.433 HG12 HG23 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.483 HH11 ' HD2' ' B' ' 157' ' ' ARG . 30.4 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.661 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.4 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 1.352 ' HB ' ' CG2' ' B' ' 160' ' ' VAL 0.428 0.9 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' TYR . . . . . 0.4 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 65.6 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.7 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.456 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.7 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . 0.527 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . 0.721 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.3 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.526 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 58.8 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.2 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . 0.716 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.716 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 43.1 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.45 1.5 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.477 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.2 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.429 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.2 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.637 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 197' ' ' VAL . . . . . 0.637 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.409 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 200' ' ' LYS . . . . . 0.526 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.457 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.6 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.457 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' ASP . . . . . 0.475 ' O ' HD13 ' B' ' 196' ' ' LEU . 63.4 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.0 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.5 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.721 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 39.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 1.345 ' HB ' ' CG2' ' B' ' 225' ' ' VAL 0.406 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' ASN . . . . . 0.516 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . 0.481 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.6 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . 0.563 HD13 ' O ' ' B' ' 32' ' ' THR . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' ILE . . . . . 0.412 HD12 HG23 ' B' ' 40' ' ' VAL . 18.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 40.8 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 118.051 -0.976 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.72 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.458 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 79.6 m -61.59 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -99.93 163.02 12.63 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.77 122.34 46.56 Favored 'General case' 0 N--CA 1.525 3.322 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.5 t -100.54 98.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 8' ' ' GLY . 14.0 mmmt -67.39 65.48 0.07 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 113.109 -1.86 . . . . 0.0 114.857 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -29.54 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 126.641 1.976 . . . . 0.0 115.449 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.52 59.02 0.4 Allowed Glycine 0 N--CA 1.51 3.568 0 N-CA-C 106.849 -2.501 . . . . 0.0 106.849 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.2 p -1.15 54.22 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 120.21 3.411 . . . . 0.0 120.21 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.42 -60.19 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.75 22.39 14.56 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 120.917 -1.114 . . . . 0.0 108.193 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.08 -94.77 1.9 Allowed Glycine 0 N--CA 1.511 3.691 0 N-CA-C 115.519 0.968 . . . . 0.0 115.519 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.549 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 47.5 tp -150.63 -177.19 5.83 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 1.074 HD21 HG23 ' A' ' 36' ' ' VAL . 15.8 mt -74.73 46.71 0.3 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.6 -1.312 . . . . 0.0 111.286 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.627 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 7.8 p -113.75 165.64 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 118.53 2.789 . . . . 0.0 118.53 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.627 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 5.1 m-30 -102.21 75.42 1.49 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.363 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.48 142.41 25.16 Favored Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.85 -0.531 . . . . 0.0 111.795 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 20' ' ' LYS . 58.4 Cg_endo -86.43 76.11 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.424 0 N-CA-C 116.365 1.64 . . . . 0.0 116.365 -9.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.7 -44.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 1 N-CA-C 122.319 4.192 . . . . 0.0 122.319 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.627 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.67 71.52 0.99 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 122.484 1.135 . . . . 0.0 113.064 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.652 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.02 111.26 7.11 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.116 -1.615 . . . . 0.0 109.107 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.551 ' N ' HD22 ' A' ' 21' ' ' LEU . 55.1 m -87.52 81.42 7.77 Favored 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.723 HD11 HD12 ' A' ' 101' ' ' ILE . 4.6 pt -79.57 -177.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.72 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.665 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.63 10.43 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.097 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 24.3 Cg_endo -52.33 77.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.287 0 N-CA-C 116.897 1.845 . . . . 0.0 116.897 174.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.17 -50.63 0.51 Allowed Glycine 1 N--CA 1.522 4.382 0 C-N-CA 119.682 -1.247 . . . . 0.0 115.836 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.655 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.56 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 1 N-CA-C 122.115 4.116 . . . . 0.0 122.115 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.458 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.2 m -64.07 35.96 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.018 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 30' ' ' GLU . 58.0 t -51.96 147.19 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 112.849 -1.978 . . . . 0.0 111.513 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.8 pt-20 -114.24 154.89 27.13 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 124.011 1.862 . . . . 0.0 115.368 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -107.51 113.88 27.5 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.786 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.1 tt -100.85 112.52 24.96 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 120.729 3.603 . . . . 0.0 120.729 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -75.16 84.7 2.37 Favored 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.111 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.7 p30 -80.29 -45.09 18.47 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.96 -169.31 3.34 Favored 'General case' 0 N--CA 1.509 2.522 0 C-N-CA 124.569 1.148 . . . . 0.0 109.048 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.237 ' CG1' HE22 ' B' ' 104' ' ' GLN . 1.6 m 12.89 70.61 0.11 Allowed Pre-proline 0 N--CA 1.521 3.11 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.601 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 64.2 Cg_endo -98.35 177.25 0.42 Allowed 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 123.994 3.129 . . . . 0.0 114.441 -165.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 60.9 Cg_endo -92.42 165.3 25.26 Favored 'Cis proline' 0 N--CA 1.503 2.037 0 N-CA-C 115.391 1.266 . . . . 0.0 115.391 -7.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.798 ' HB2' HD11 ' A' ' 7' ' ' LEU . 18.4 m-70 -118.96 87.37 2.72 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.655 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -103.33 140.26 37.66 Favored 'General case' 0 N--CA 1.516 2.868 0 CA-C-N 122.387 2.358 . . . . 0.0 110.675 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.4 m -118.13 116.3 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 121.406 3.854 . . . . 0.0 121.406 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.989 HG22 ' HB2' ' A' ' 88' ' ' TYR . 14.4 m -75.98 165.36 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 102.189 -3.263 . . . . 0.0 102.189 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.88 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.27 131.01 55.48 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 46' ' ' ALA . 4.0 m-20 -53.42 93.73 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.19 1 N-CA-C 124.142 4.867 . . . . 0.0 124.142 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.97 6.72 43.58 Favored 'General case' 0 CA--C 1.602 2.948 0 N-CA-C 101.19 -3.633 . . . . 0.0 101.19 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.8 -65.48 1.18 Allowed 'General case' 0 CA--C 1.574 1.89 0 C-N-CA 127.592 2.357 . . . . 0.0 112.742 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.645 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.7 mp -86.75 66.59 9.53 Favored 'General case' 0 N--CA 1.519 3.023 0 N-CA-C 118.874 2.916 . . . . 0.0 118.874 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.39 151.26 0.75 Allowed Pre-proline 0 N--CA 1.522 3.17 0 N-CA-C 117.487 2.402 . . . . 0.0 117.487 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.1 Cg_endo -42.44 -58.25 1.32 Allowed 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 123.426 2.751 . . . . 0.0 115.088 170.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.54 67.38 0.72 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 124.119 1.914 . . . . 0.0 107.012 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.15 53.53 0.99 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 112.292 -2.231 . . . . 0.0 108.25 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.78 56.93 0.75 Allowed 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 117.8 2.519 . . . . 0.0 117.8 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.682 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.61 -47.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.262 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -41.21 -30.87 0.18 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.082 -1.636 . . . . 0.0 111.587 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.826 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.04 -28.64 0.09 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 122.787 1.279 . . . . 0.0 112.552 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.826 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.72 -27.68 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.462 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.2 tptt 65.13 -55.58 0.31 Allowed 'General case' 0 N--CA 1.533 3.705 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.7 -28.96 0.16 Allowed 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.88 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.4 pp -53.57 -66.9 0.31 Allowed 'General case' 0 CA--C 1.604 3.026 0 N-CA-C 100.688 -3.819 . . . . 0.0 100.688 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.839 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.09 98.47 2.11 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.227 1.411 . . . . 0.0 112.786 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.717 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.0 t60 -90.06 -173.01 3.7 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.823 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.42 155.23 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.823 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 26.5 tt0 105.45 65.97 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 120.315 3.45 . . . . 0.0 120.315 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 1.41 HD22 ' CG ' ' B' ' 118' ' ' PRO . 5.9 mp 38.26 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 120.769 3.618 . . . . 0.0 120.769 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.655 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 35.3 mt -70.67 82.04 0.61 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.166 -1.584 . . . . 0.0 111.876 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.976 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 42.5 mmm -79.16 61.9 3.41 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-O 126.066 2.841 . . . . 0.0 110.962 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.4 m -112.54 65.88 0.84 Allowed Pre-proline 0 N--CA 1.505 2.307 0 CA-C-N 110.482 -3.054 . . . . 0.0 113.597 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -51.87 81.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 122.985 2.457 . . . . 0.0 114.71 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.63 27.66 Favored Glycine 1 N--CA 1.517 4.07 0 O-C-N 122.209 -0.307 . . . . 0.0 113.579 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.488 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.4 tt0 -123.62 156.83 35.1 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 124.404 2.049 . . . . 0.0 116.285 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.786 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -116.87 156.46 27.28 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 119.748 3.24 . . . . 0.0 119.748 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -116.02 147.91 40.72 Favored 'General case' 0 N--CA 1.52 3.029 0 CA-C-O 116.651 -1.642 . . . . 0.0 107.253 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.455 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.51 143.63 42.05 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.448 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 87.6 m -119.84 102.54 8.65 Favored 'General case' 0 N--CA 1.514 2.747 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.632 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 50.2 m -94.76 152.2 18.63 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -107.93 168.33 8.06 Favored Pre-proline 0 N--CA 1.503 2.178 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.124 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.35 -174.85 1.54 Allowed 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 121.021 1.147 . . . . 0.0 111.109 161.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.33 -19.66 19.08 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 124.435 2.064 . . . . 0.0 107.334 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.22 42.71 0.5 Allowed 'General case' 0 CA--C 1.576 1.98 0 CA-C-N 111.187 -2.733 . . . . 0.0 109.045 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.594 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.3 84.68 9.67 Favored Pre-proline 0 N--CA 1.499 2.012 0 CA-C-N 113.675 -1.602 . . . . 0.0 113.761 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 83' ' ' GLY . 53.5 Cg_endo -79.31 178.62 7.23 Favored 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 122.803 2.335 . . . . 0.0 112.304 172.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.585 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.08 77.69 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.92 0 O-C-N 125.018 1.449 . . . . 0.0 113.346 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.37 124.98 5.63 Favored Glycine 0 N--CA 1.508 3.475 0 N-CA-C 121.746 3.459 . . . . 0.0 121.746 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.654 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 44.0 mt-10 -99.46 61.24 1.18 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.831 ' HB2' HG23 ' A' ' 101' ' ' ILE . 3.1 m-85 -62.0 77.8 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.872 1.32 . . . . 0.0 113.052 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.57 135.95 57.18 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.568 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.47 136.49 52.95 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.989 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.64 82.03 8.6 Favored 'General case' 0 N--CA 1.512 2.64 1 N-CA-C 132.637 8.014 . . . . 0.0 132.637 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.1 t -63.9 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.501 2 CA-C-N 130.342 5.974 . . . . 0.0 114.311 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.7 tt0 -20.52 -72.48 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.605 0 N-CA-C 118.468 2.766 . . . . 0.0 118.468 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.59 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 37.6 Cg_endo -66.97 -3.48 9.7 Favored 'Trans proline' 0 N--CA 1.512 2.569 0 C-N-CA 122.39 2.06 . . . . 0.0 115.352 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -120.87 -14.12 8.55 Favored 'General case' 0 N--CA 1.511 2.613 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.451 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.38 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.62 -34.06 1.73 Allowed Glycine 1 N--CA 1.52 4.296 0 O-C-N 121.616 -0.678 . . . . 0.0 112.7 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.56 68.46 7.91 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.86 26.74 0.05 OUTLIER Glycine 1 N--CA 1.526 4.677 0 CA-C-N 114.041 -1.436 . . . . 0.0 116.68 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.843 ' HE2' HD22 ' A' ' 14' ' ' LEU . 1.9 ttt -108.55 43.83 1.19 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 124.406 2.05 . . . . 0.0 112.957 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.99 134.89 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 112.275 -2.239 . . . . 0.0 110.945 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.66 154.85 19.35 Favored Glycine 1 N--CA 1.534 5.212 0 C-N-CA 119.523 -1.323 . . . . 0.0 114.059 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.888 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.1 ttpp -118.56 81.86 1.76 Allowed 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.831 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.63 123.3 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.709 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.888 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 8.0 m -112.63 88.7 2.88 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.185 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 80' ' ' ALA . 39.4 t -74.0 105.17 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.31 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 O-C-N 126.064 2.103 . . . . 0.0 115.933 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.585 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.521 0 O-C-N 125.576 1.798 . . . . 0.0 113.812 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.59 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 22.0 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' TRP . . . . . 0.449 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.0 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . 0.439 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.3 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.499 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 88.7 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 50.9 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 79.5 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' B' ' 27' ' ' LEU . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.575 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.1 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 1.395 ' HB ' ' CA ' ' B' ' 34' ' ' VAL 0.375 0.2 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.481 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.5 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.45 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.45 ' O ' HG12 ' B' ' 36' ' ' VAL . 27.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.414 HG23 HD12 ' B' ' 247' ' ' ILE . 26.1 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.803 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.652 ' H ' ' HG ' ' B' ' 133' ' ' SER . 32.4 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.428 HG11 ' N ' ' B' ' 46' ' ' PHE . 87.9 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 1.021 ' CE1' HG22 ' B' ' 131' ' ' VAL . 51.7 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.493 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.6 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.6 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.493 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.1 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.558 ' O ' HG21 ' B' ' 68' ' ' VAL . 58.1 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.633 HG12 ' N ' ' B' ' 69' ' ' GLY . 79.1 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.633 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.563 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.561 HG21 HD12 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.3 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.1 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' PRO . . . . . 0.908 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 14.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.908 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 46.6 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.513 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' B' ' 130' ' ' PRO . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 74.2 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.491 ' HA ' HD12 ' B' ' 94' ' ' LEU . 49.4 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 17.7 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 1.601 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 17.0 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' GLN . . . . . 1.237 HE22 ' CG1' ' A' ' 36' ' ' VAL . 10.9 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' TYR . . . . . 0.439 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 25.5 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.482 ' C ' HG13 ' B' ' 114' ' ' VAL . 55.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.548 ' O ' HG23 ' B' ' 114' ' ' VAL . 17.2 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 1.531 ' HB ' ' CB ' ' B' ' 115' ' ' ILE 0.54 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.536 HG21 ' C ' ' B' ' 115' ' ' ILE 0.411 0.1 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 1.41 ' CG ' HD22 ' A' ' 64' ' ' LEU . 38.7 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.976 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 81.1 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 57.2 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 90.8 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.576 ' C ' HG12 ' B' ' 131' ' ' VAL . 11.7 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 1.564 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.43 1.6 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.0 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' SER . . . . . 0.652 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . 0.528 ' HG2' HD12 ' B' ' 142' ' ' ILE . 38.9 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . 0.448 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 24.7 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' PRO . . . . . 0.62 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 10.6 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.448 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . 0.558 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.558 HG22 ' CG ' ' B' ' 139' ' ' ASP 0.483 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . 0.62 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.6 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' SER . . . . . 0.493 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.3 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' VAL . . . . . 0.493 HG13 ' C ' ' B' ' 148' ' ' SER 0.335 1.7 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.438 HG12 HG23 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.461 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.661 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.4 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 1.366 ' HB ' ' CA ' ' B' ' 160' ' ' VAL 0.387 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' PRO . . . . . 0.449 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 18.5 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.8 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.426 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 8.4 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . 0.543 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.8 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . 0.742 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.7 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.522 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 59.4 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 64.1 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . 0.735 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.3 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.735 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.6 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.414 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.49 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.0 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.458 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.8 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.671 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 197' ' ' VAL . . . . . 0.671 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.482 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 200' ' ' LYS . . . . . 0.522 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.9 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.6 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.46 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.8 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.46 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' ASP . . . . . 0.499 ' O ' HD13 ' B' ' 196' ' ' LEU . 62.9 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.3 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.2 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.742 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 41.3 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . 0.447 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.447 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 11.2 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 86.4 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 1.396 ' HB ' ' CG1' ' B' ' 225' ' ' VAL 0.385 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.4 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' ASN . . . . . 0.503 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . 0.472 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . 0.575 HD13 ' O ' ' B' ' 32' ' ' THR . 15.0 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' ILE . . . . . 0.414 HD12 HG23 ' B' ' 40' ' ' VAL . 18.9 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 40.5 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.721 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.443 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 70.1 m -61.59 89.67 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.93 163.03 12.62 Favored 'General case' 0 N--CA 1.512 2.653 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.452 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.2 t -107.83 122.43 46.76 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.2 t -100.5 98.39 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.4 mmmt -67.34 65.32 0.07 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 113.086 -1.87 . . . . 0.0 114.888 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 39' ' ' HIS . 14.9 mt -29.47 68.26 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 126.579 1.952 . . . . 0.0 115.459 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.42 59.06 0.4 Allowed Glycine 0 N--CA 1.509 3.552 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 20.3 p -1.12 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.259 0 N-CA-C 120.346 3.462 . . . . 0.0 120.346 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.49 -60.14 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 119.515 3.154 . . . . 0.0 119.515 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.85 22.48 14.43 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.957 -1.09 . . . . 0.0 108.116 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.07 -94.8 1.9 Allowed Glycine 0 N--CA 1.512 3.711 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.576 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.7 tp -150.66 -177.23 5.86 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 1.05 HD21 HG23 ' A' ' 36' ' ' VAL . 15.5 mt -74.72 46.74 0.3 Allowed 'General case' 0 N--CA 1.509 2.516 0 O-C-N 120.7 -1.25 . . . . 0.0 111.236 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.664 HG21 ' N ' ' A' ' 16' ' ' PHE . 7.6 p -113.86 165.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.664 ' N ' HG21 ' A' ' 15' ' ' VAL . 5.3 m-30 -102.12 75.43 1.51 Allowed 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 112.219 -2.264 . . . . 0.0 113.416 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.342 0.6 OUTLIER -93.47 142.39 25.14 Favored Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.853 -0.529 . . . . 0.0 111.746 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 20' ' ' LYS . 46.0 Cg_endo -86.49 76.11 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.466 0 N-CA-C 116.368 1.642 . . . . 0.0 116.368 -9.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.72 -44.22 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.806 1 N-CA-C 122.26 4.17 . . . . 0.0 122.26 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.645 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.65 71.68 1.0 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 122.412 1.101 . . . . 0.0 112.986 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.678 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.14 111.25 7.21 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.148 -1.595 . . . . 0.0 109.159 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.577 ' N ' HD22 ' A' ' 21' ' ' LEU . 47.7 m -87.52 81.53 7.74 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.715 HD11 HD12 ' A' ' 101' ' ' ILE . 4.4 pt -79.71 -177.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 114.75 -1.113 . . . . 0.0 112.699 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.704 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -109.67 166.55 10.58 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.126 179.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 19.9 Cg_endo -52.24 77.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.314 0 N-CA-C 116.833 1.82 . . . . 0.0 116.833 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.13 -50.41 0.52 Allowed Glycine 1 N--CA 1.522 4.42 0 C-N-CA 119.76 -1.209 . . . . 0.0 115.831 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.664 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.71 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 1 N-CA-C 122.11 4.115 . . . . 0.0 122.11 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.443 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 10.8 m -64.03 36.0 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.012 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.527 HG13 ' N ' ' A' ' 30' ' ' GLU . 57.5 t -52.0 147.17 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.566 0 CA-C-N 112.821 -1.991 . . . . 0.0 111.5 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.8 pt-20 -114.19 154.91 27.05 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 123.923 1.82 . . . . 0.0 115.416 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -107.57 113.84 27.42 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.791 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.1 tt -100.72 112.53 24.95 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 120.653 3.575 . . . . 0.0 120.653 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -75.13 84.69 2.35 Favored 'General case' 0 N--CA 1.513 2.689 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.162 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 29.9 p30 -80.27 -45.08 18.54 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 118.935 2.939 . . . . 0.0 118.935 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.95 -169.3 3.34 Favored 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 124.671 1.189 . . . . 0.0 109.077 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.131 HG13 ' NE2' ' B' ' 104' ' ' GLN . 1.6 m 12.79 70.72 0.11 Allowed Pre-proline 0 N--CA 1.52 3.029 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.338 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 55.3 Cg_endo -98.49 177.29 0.4 Allowed 'Trans proline' 0 CA--C 1.568 2.222 0 C-N-CA 123.984 3.123 . . . . 0.0 114.37 -165.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.721 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 52.2 Cg_endo -92.39 165.33 25.33 Favored 'Cis proline' 0 N--CA 1.502 2.029 0 N-CA-C 115.472 1.297 . . . . 0.0 115.472 -7.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.775 ' HB2' HD11 ' A' ' 7' ' ' LEU . 16.5 m-70 -118.96 87.52 2.75 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.712 HD22 ' N ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -103.5 140.23 37.79 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 122.465 2.393 . . . . 0.0 110.663 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.4 m -118.09 116.41 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 121.446 3.869 . . . . 0.0 121.446 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 1.049 HG22 ' HB2' ' A' ' 88' ' ' TYR . 13.0 m -76.07 165.46 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 102.099 -3.297 . . . . 0.0 102.099 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.925 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.32 130.96 55.51 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.45 ' OD1' HD13 ' A' ' 47' ' ' LEU . 4.1 m-20 -53.45 93.82 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.212 1 N-CA-C 124.16 4.874 . . . . 0.0 124.16 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.09 6.8 43.47 Favored 'General case' 0 CA--C 1.602 2.979 0 N-CA-C 101.212 -3.625 . . . . 0.0 101.212 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 47' ' ' LEU . . . -115.9 -65.43 1.19 Allowed 'General case' 0 CA--C 1.574 1.88 0 C-N-CA 127.445 2.298 . . . . 0.0 112.682 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.692 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.4 mp -86.65 66.53 9.51 Favored 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 118.902 2.927 . . . . 0.0 118.902 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.634 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.4 151.28 0.74 Allowed Pre-proline 0 N--CA 1.522 3.145 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 17.3 Cg_endo -42.41 -58.29 1.3 Allowed 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.405 2.736 . . . . 0.0 115.112 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.634 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.46 67.34 0.72 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 124.102 1.906 . . . . 0.0 107.077 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -77.13 53.6 0.99 Allowed 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.312 -2.222 . . . . 0.0 108.272 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 t -115.9 56.99 0.76 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.671 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.63 -47.99 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.256 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.07 -30.88 0.16 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.06 -1.65 . . . . 0.0 111.578 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.795 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.18 -28.53 0.1 Allowed 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 122.755 1.264 . . . . 0.0 112.487 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.795 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.83 -27.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 117.727 2.492 . . . . 0.0 117.727 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.3 tptt 65.05 -55.59 0.3 Allowed 'General case' 0 N--CA 1.533 3.71 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.1 m -41.68 -28.98 0.16 Allowed 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.925 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.2 pp -53.68 -66.82 0.33 Allowed 'General case' 0 CA--C 1.604 3.032 0 N-CA-C 100.71 -3.811 . . . . 0.0 100.71 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.874 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 11.1 p -72.07 98.45 2.1 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 125.259 1.424 . . . . 0.0 112.806 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.743 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.4 t60 -90.08 -173.01 3.7 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.836 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.4 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.836 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 26.0 tt0 105.51 65.97 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 120.303 3.445 . . . . 0.0 120.303 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 1.08 HD11 ' N ' ' A' ' 64' ' ' LEU . 5.6 mp 38.11 84.33 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 120.745 3.609 . . . . 0.0 120.745 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.712 ' N ' HD22 ' A' ' 40' ' ' ASN . 36.5 mt -70.66 82.1 0.61 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.078 -1.639 . . . . 0.0 111.888 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.721 ' SD ' ' HG3' ' A' ' 38' ' ' PRO . 41.0 mmm -79.25 61.93 3.48 Favored 'General case' 0 N--CA 1.51 2.542 0 CA-C-O 126.057 2.837 . . . . 0.0 110.912 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.7 m -112.55 65.92 0.85 Allowed Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 110.543 -3.026 . . . . 0.0 113.621 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -51.95 81.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 122.933 2.422 . . . . 0.0 114.686 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.13 6.73 27.59 Favored Glycine 1 N--CA 1.517 4.036 0 O-C-N 122.251 -0.28 . . . . 0.0 113.541 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.68 156.91 35.02 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 124.374 2.035 . . . . 0.0 116.241 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.791 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.98 156.39 27.55 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 119.681 3.215 . . . . 0.0 119.681 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -116.01 147.96 40.66 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-O 116.678 -1.63 . . . . 0.0 107.215 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.487 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.56 143.79 41.85 Favored 'General case' 0 N--CA 1.53 3.546 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.45 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 73.9 m -119.99 102.62 8.67 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.52 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.0 m -94.78 152.15 18.66 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.91 168.29 8.11 Favored Pre-proline 0 N--CA 1.503 2.181 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.089 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -72.36 -174.83 1.54 Allowed 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 121.023 1.149 . . . . 0.0 111.121 161.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.73 19.0 Favored 'General case' 0 N--CA 1.51 2.535 0 CA-C-O 124.34 2.019 . . . . 0.0 107.237 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.17 42.68 0.49 Allowed 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 111.258 -2.701 . . . . 0.0 109.118 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.58 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.3 84.79 9.78 Favored Pre-proline 0 N--CA 1.5 2.069 0 CA-C-N 113.543 -1.662 . . . . 0.0 113.742 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 38.0 Cg_endo -79.39 178.64 7.18 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 122.817 2.345 . . . . 0.0 112.253 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.574 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.03 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 125.367 1.467 . . . . 0.0 113.24 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.44 125.01 5.63 Favored Glycine 0 N--CA 1.507 3.389 0 N-CA-C 121.787 3.475 . . . . 0.0 121.787 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.66 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 43.8 mt-10 -99.4 61.26 1.19 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.825 ' HB2' HG23 ' A' ' 101' ' ' ILE . 3.1 m-85 -62.05 77.75 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 122.95 1.357 . . . . 0.0 113.033 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.6 m -63.52 136.0 57.25 Favored 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.52 136.5 52.93 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 1.049 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.6 m-85 -84.62 82.02 8.6 Favored 'General case' 0 N--CA 1.51 2.561 1 N-CA-C 132.655 8.02 . . . . 0.0 132.655 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.9 t -63.86 82.11 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.433 2 CA-C-N 130.371 5.987 . . . . 0.0 114.365 179.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.4 tt0 -20.51 -72.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.582 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 31.8 Cg_endo -67.04 -3.45 9.72 Favored 'Trans proline' 0 N--CA 1.51 2.489 0 C-N-CA 122.409 2.073 . . . . 0.0 115.367 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -120.85 -14.22 8.54 Favored 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.473 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.3 79.62 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.742 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.61 -34.03 1.73 Allowed Glycine 1 N--CA 1.522 4.381 0 O-C-N 121.597 -0.689 . . . . 0.0 112.617 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.52 68.46 7.86 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.79 26.8 0.05 OUTLIER Glycine 1 N--CA 1.527 4.731 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.853 ' HE2' HD22 ' A' ' 14' ' ' LEU . 1.8 ttt -108.54 43.85 1.19 Allowed 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 124.485 2.088 . . . . 0.0 113.022 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.97 134.88 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 112.228 -2.26 . . . . 0.0 110.903 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.579 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.71 154.86 19.38 Favored Glycine 1 N--CA 1.536 5.356 0 C-N-CA 119.446 -1.359 . . . . 0.0 113.96 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.839 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.2 ttpp -118.56 81.95 1.77 Allowed 'General case' 0 N--CA 1.517 2.883 0 CA-C-N 119.372 1.586 . . . . 0.0 115.262 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.825 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.71 123.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.667 0 C-N-CA 118.054 -1.458 . . . . 0.0 107.079 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.839 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.1 m -112.68 88.8 2.91 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.124 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 80' ' ' ALA . 38.8 t -74.12 105.27 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.34 -72.28 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 O-C-N 126.101 2.126 . . . . 0.0 115.95 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.574 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.53 0 O-C-N 125.527 1.767 . . . . 0.0 113.81 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' TRP . . . . . 0.458 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . 0.45 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.0 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.2 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 9.9 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 89.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 54.2 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 77.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.464 ' HA ' HD22 ' B' ' 27' ' ' LEU . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.59 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.3 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.483 HG23 HG12 ' B' ' 151' ' ' VAL 0.374 0.1 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.7 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.47 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.47 ' O ' HG12 ' B' ' 36' ' ' VAL . 23.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.416 ' C ' HG11 ' B' ' 40' ' ' VAL . 87.9 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.416 HG11 ' C ' ' B' ' 39' ' ' SER . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.825 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.655 ' H ' ' HG ' ' B' ' 133' ' ' SER . 30.2 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.436 HG11 ' N ' ' B' ' 46' ' ' PHE . 89.4 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 1.141 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.531 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.531 HG22 ' O ' ' B' ' 55' ' ' ASP . 15.2 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 83.3 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.568 ' O ' HG21 ' B' ' 68' ' ' VAL . 55.4 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.658 HG12 ' N ' ' B' ' 69' ' ' GLY . 74.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.658 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.589 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.555 HG21 HD12 ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.2 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' PRO . . . . . 1.047 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 24.7 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 1.047 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 42.5 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.47 ' H ' HG21 ' B' ' 84' ' ' ILE 0.567 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' B' ' 130' ' ' PRO . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' B' ' 94' ' ' LEU . 50.3 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.4 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 1.338 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 17.2 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' GLN . . . . . 1.131 ' NE2' HG13 ' A' ' 36' ' ' VAL . 11.0 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.8 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.476 ' C ' HG13 ' B' ' 114' ' ' VAL . 55.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.581 ' O ' HG23 ' B' ' 114' ' ' VAL . 17.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.555 HD12 HG21 ' B' ' 75' ' ' VAL 0.46 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.532 ' N ' HG21 ' B' ' 115' ' ' ILE 0.255 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 0.7 ' CG ' HD22 ' A' ' 64' ' ' LEU . 36.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.512 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 81.9 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.6 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 85.3 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.506 ' C ' HG12 ' B' ' 131' ' ' VAL . 19.9 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 1.56 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.344 0.5 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' SER . . . . . 0.655 ' HG ' ' H ' ' B' ' 44' ' ' THR . 95.1 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . 0.598 ' HG2' HD12 ' B' ' 142' ' ' ILE . 35.7 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . 0.445 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 25.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' PRO . . . . . 0.525 ' CG ' ' CZ ' ' B' ' 144' ' ' PHE . 18.1 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.445 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . 0.589 ' CG ' ' CG2' ' B' ' 142' ' ' ILE . 44.7 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.598 HD12 ' HG2' ' B' ' 134' ' ' PRO 0.51 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' B' ' 136' ' ' PRO . 81.3 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' SER . . . . . 0.448 ' C ' HG13 ' B' ' 149' ' ' VAL . 69.0 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' VAL . . . . . 1.371 ' HB ' ' CG2' ' B' ' 149' ' ' VAL . 1.3 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.483 HG12 HG23 ' B' ' 34' ' ' VAL . 10.7 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' B' ' 155' ' ' ARG . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' B' ' 157' ' ' ARG . 28.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.683 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.7 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 1.358 ' HB ' ' CA ' ' B' ' 160' ' ' VAL 0.312 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' TYR . . . . . 0.414 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 64.7 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' PRO . . . . . 0.458 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 17.8 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 97.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.434 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.9 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . 0.576 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.9 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . 0.805 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 18.5 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.536 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 61.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.3 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' LYS . . . . . 0.422 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.5 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . 0.758 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.758 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 41.2 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.38 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.482 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 40.8 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.5 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.4 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.726 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 197' ' ' VAL . . . . . 0.726 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 199' ' ' ILE . . . . . 0.534 HG13 ' O ' ' B' ' 199' ' ' ILE 0.519 0.3 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 200' ' ' LYS . . . . . 0.536 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.7 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.6 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.472 ' C ' HG13 ' B' ' 207' ' ' VAL . 60.0 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.472 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.2 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' ASP . . . . . 0.51 ' O ' HD13 ' B' ' 196' ' ' LEU . 63.3 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.0 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.805 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.472 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 18.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.3 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 86.9 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.403 0.1 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.0 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' ASN . . . . . 0.545 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . 0.507 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.7 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . 0.59 HD13 ' O ' ' B' ' 32' ' ' THR . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 19.4 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . 0.427 ' HA ' HD11 ' B' ' 249' ' ' LEU . 41.4 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.711 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.455 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.6 m -61.61 89.7 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.98 162.98 12.64 Favored 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.45 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.0 t -107.68 122.36 46.56 Favored 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.52 98.34 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.41 65.5 0.07 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 113.077 -1.874 . . . . 0.0 114.834 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -29.51 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.96 0 C-N-CA 126.595 1.958 . . . . 0.0 115.534 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.43 59.11 0.4 Allowed Glycine 0 N--CA 1.509 3.557 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.2 p -1.08 54.03 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 120.344 3.461 . . . . 0.0 120.344 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.61 -60.22 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 119.507 3.151 . . . . 0.0 119.507 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.47 14.45 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 120.998 -1.064 . . . . 0.0 108.143 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.09 -94.83 1.9 Allowed Glycine 0 N--CA 1.511 3.69 0 N-CA-C 115.553 0.981 . . . . 0.0 115.553 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 47.1 tp -150.57 -177.16 5.81 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.996 HD21 HG23 ' A' ' 36' ' ' VAL . 15.7 mt -74.68 46.66 0.29 Allowed 'General case' 0 N--CA 1.509 2.478 0 O-C-N 120.608 -1.307 . . . . 0.0 111.296 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.619 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 7.8 p -113.84 165.67 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.619 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 5.1 m-30 -102.24 75.38 1.49 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 112.209 -2.269 . . . . 0.0 113.436 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.42 142.44 25.23 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 121.851 -0.531 . . . . 0.0 111.744 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 20' ' ' LYS . 56.8 Cg_endo -86.4 76.1 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.389 0 N-CA-C 116.382 1.647 . . . . 0.0 116.382 -9.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.7 -44.18 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.812 1 N-CA-C 122.24 4.163 . . . . 0.0 122.24 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.65 71.55 0.99 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.446 1.117 . . . . 0.0 113.052 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.645 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.06 111.27 7.15 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.177 -1.577 . . . . 0.0 109.147 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.522 ' N ' HD22 ' A' ' 21' ' ' LEU . 53.8 m -87.48 81.39 7.81 Favored 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.71 HD11 HD12 ' A' ' 101' ' ' ILE . 4.6 pt -79.7 -177.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.708 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.666 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.69 166.6 10.49 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.078 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.5 Cg_endo -52.3 77.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.569 2.263 0 N-CA-C 116.92 1.854 . . . . 0.0 116.92 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.09 -50.39 0.52 Allowed Glycine 1 N--CA 1.522 4.404 0 C-N-CA 119.727 -1.225 . . . . 0.0 115.859 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.662 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.68 92.11 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.195 1 N-CA-C 122.092 4.108 . . . . 0.0 122.092 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.455 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.3 m -64.12 36.03 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 118.681 2.845 . . . . 0.0 118.681 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.502 HG13 ' N ' ' A' ' 30' ' ' GLU . 59.0 t -51.99 147.2 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 CA-C-N 112.861 -1.972 . . . . 0.0 111.529 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.502 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.8 pt-20 -114.31 154.85 27.29 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 123.936 1.827 . . . . 0.0 115.397 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -107.47 113.9 27.55 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.798 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.78 112.48 24.91 Favored 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 120.759 3.614 . . . . 0.0 120.759 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -75.11 84.75 2.34 Favored 'General case' 0 N--CA 1.511 2.611 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.14 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.5 p30 -80.35 -45.08 18.36 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 118.862 2.912 . . . . 0.0 118.862 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.92 -169.26 3.33 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 124.678 1.191 . . . . 0.0 109.143 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.996 HG23 HD21 ' A' ' 14' ' ' LEU . 1.6 m 12.82 70.7 0.11 Allowed Pre-proline 0 N--CA 1.52 3.038 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.221 ' HG2' ' CZ ' ' B' ' 102' ' ' TYR . 59.5 Cg_endo -98.41 177.26 0.41 Allowed 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 123.953 3.102 . . . . 0.0 114.382 -165.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.623 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 58.9 Cg_endo -92.48 165.22 25.07 Favored 'Cis proline' 0 N--CA 1.503 2.082 0 N-CA-C 115.392 1.266 . . . . 0.0 115.392 -7.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.817 ' HB2' HD11 ' A' ' 7' ' ' LEU . 18.1 m-70 -118.83 87.4 2.72 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 117.377 2.362 . . . . 0.0 117.377 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.618 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -103.4 140.28 37.66 Favored 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 122.429 2.377 . . . . 0.0 110.695 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.4 m -118.1 116.27 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 121.43 3.863 . . . . 0.0 121.43 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.995 HG22 ' HB2' ' A' ' 88' ' ' TYR . 14.4 m -75.9 165.4 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 102.223 -3.251 . . . . 0.0 102.223 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.868 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.28 130.97 55.5 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.436 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.46 93.77 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.188 1 N-CA-C 124.16 4.874 . . . . 0.0 124.16 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.0 6.8 43.34 Favored 'General case' 0 CA--C 1.602 2.965 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' HB2' HD13 ' A' ' 47' ' ' LEU . . . -115.84 -65.63 1.17 Allowed 'General case' 0 CA--C 1.573 1.848 0 C-N-CA 127.537 2.335 . . . . 0.0 112.707 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.633 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.7 mp -86.63 66.58 9.54 Favored 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.38 151.23 0.74 Allowed Pre-proline 0 N--CA 1.523 3.179 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.7 Cg_endo -42.36 -58.26 1.31 Allowed 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 123.398 2.732 . . . . 0.0 115.133 170.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.45 67.36 0.72 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 124.027 1.87 . . . . 0.0 107.067 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.18 53.51 0.99 Allowed 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 112.346 -2.206 . . . . 0.0 108.204 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.87 56.95 0.76 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.701 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.58 -47.91 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 117.252 2.315 . . . . 0.0 117.252 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.08 -30.9 0.16 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.218 -1.551 . . . . 0.0 111.584 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.815 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.16 -28.53 0.1 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 122.696 1.236 . . . . 0.0 112.478 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.815 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.83 -27.64 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.48 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.2 tptt 65.03 -55.54 0.3 Allowed 'General case' 0 N--CA 1.534 3.748 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.77 -28.91 0.17 Allowed 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.868 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.71 -66.76 0.34 Allowed 'General case' 0 CA--C 1.603 2.984 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.819 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.01 98.32 2.05 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 125.356 1.462 . . . . 0.0 112.803 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.731 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.0 -172.97 3.7 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.828 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.39 155.12 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.828 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 27.0 tt0 105.55 65.93 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 120.258 3.429 . . . . 0.0 120.258 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 1.451 HD22 ' CG ' ' B' ' 118' ' ' PRO . 6.0 mp 38.21 84.3 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 120.793 3.627 . . . . 0.0 120.793 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.618 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 35.0 mt -70.76 82.13 0.63 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.137 -1.602 . . . . 0.0 111.818 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 1.422 ' CE ' ' O ' ' B' ' 118' ' ' PRO . 42.3 mmm -79.29 62.0 3.53 Favored 'General case' 0 N--CA 1.512 2.647 0 CA-C-O 126.069 2.842 . . . . 0.0 110.886 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.0 m -112.53 65.89 0.84 Allowed Pre-proline 0 C--N 1.284 -2.259 0 CA-C-N 110.53 -3.032 . . . . 0.0 113.667 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HG2' ' OD2' ' B' ' 100' ' ' ASP . 21.7 Cg_endo -51.91 81.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.466 0 C-N-CA 122.932 2.422 . . . . 0.0 114.696 -177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.08 6.58 27.81 Favored Glycine 1 N--CA 1.516 4.03 0 O-C-N 122.18 -0.325 . . . . 0.0 113.613 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.511 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.56 156.84 34.97 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 124.366 2.031 . . . . 0.0 116.352 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.798 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -116.95 156.38 27.52 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 119.703 3.223 . . . . 0.0 119.703 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -115.95 147.9 40.64 Favored 'General case' 0 N--CA 1.52 3.07 0 CA-C-O 116.711 -1.614 . . . . 0.0 107.192 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.464 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.44 143.67 41.89 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 118.36 2.726 . . . . 0.0 118.36 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.446 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 85.7 m -119.94 102.64 8.7 Favored 'General case' 0 N--CA 1.514 2.772 0 CA-C-N 114.227 -1.351 . . . . 0.0 113.584 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.8 m -94.7 152.2 18.66 Favored 'General case' 0 N--CA 1.526 3.341 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -107.98 168.33 8.04 Favored Pre-proline 0 N--CA 1.504 2.244 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.037 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.36 -174.78 1.52 Allowed 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 121.023 1.149 . . . . 0.0 111.12 161.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.77 18.97 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 124.364 2.03 . . . . 0.0 107.246 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.09 42.55 0.48 Allowed 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 111.24 -2.709 . . . . 0.0 109.067 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.589 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.24 84.81 9.68 Favored Pre-proline 0 N--CA 1.501 2.075 0 CA-C-N 113.658 -1.61 . . . . 0.0 113.768 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 83' ' ' GLY . 47.5 Cg_endo -79.36 178.67 7.16 Favored 'Trans proline' 0 N--CA 1.503 2.085 0 C-N-CA 122.79 2.326 . . . . 0.0 112.276 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.579 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.11 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.86 0 C-N-CA 125.328 1.451 . . . . 0.0 113.291 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.534 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.4 124.92 5.6 Favored Glycine 0 N--CA 1.507 3.393 0 N-CA-C 121.739 3.455 . . . . 0.0 121.739 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.656 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 44.0 mt-10 -99.41 61.31 1.19 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.837 ' HB2' HG23 ' A' ' 101' ' ' ILE . 3.0 m-85 -62.13 77.81 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.906 1.336 . . . . 0.0 113.006 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.8 m -63.46 135.94 57.25 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.568 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.53 136.54 52.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.995 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.71 82.11 8.57 Favored 'General case' 0 N--CA 1.511 2.618 1 N-CA-C 132.562 7.986 . . . . 0.0 132.562 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.94 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.495 2 CA-C-N 130.298 5.953 . . . . 0.0 114.346 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.0 tt0 -20.55 -72.35 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.586 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.42 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 36.8 Cg_endo -67.11 -3.34 9.61 Favored 'Trans proline' 0 N--CA 1.513 2.626 0 C-N-CA 122.359 2.039 . . . . 0.0 115.343 176.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -120.99 -14.12 8.49 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.35 79.71 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.51 -34.03 1.74 Allowed Glycine 1 N--CA 1.522 4.37 0 O-C-N 121.517 -0.739 . . . . 0.0 112.679 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.57 68.44 7.91 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 39.0 26.68 0.05 OUTLIER Glycine 1 N--CA 1.527 4.721 0 CA-C-N 114.018 -1.446 . . . . 0.0 116.573 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.845 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.0 ttt -108.57 43.92 1.18 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 124.52 2.105 . . . . 0.0 112.957 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.0 134.85 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 112.271 -2.24 . . . . 0.0 110.928 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.64 154.87 19.34 Favored Glycine 1 N--CA 1.535 5.295 0 CA-C-N 120.118 1.326 . . . . 0.0 114.039 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.891 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.1 ttpp -118.57 81.91 1.77 Allowed 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 119.405 1.603 . . . . 0.0 115.246 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.837 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.68 123.31 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.737 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.891 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.8 m -112.64 88.73 2.89 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.155 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 80' ' ' ALA . 39.2 t -74.02 105.18 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.25 -72.3 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 O-C-N 126.046 2.091 . . . . 0.0 115.929 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.532 0 O-C-N 125.547 1.78 . . . . 0.0 113.841 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' TRP . . . . . 0.446 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.9 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . 0.426 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.2 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.7 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.4 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 52.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 78.4 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' B' ' 27' ' ' LEU . 72.1 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.569 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.0 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 1.381 ' HB ' ' CA ' ' B' ' 34' ' ' VAL 0.386 0.2 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.488 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.9 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.441 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.441 ' O ' HG12 ' B' ' 36' ' ' VAL . 27.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.413 HG23 HD12 ' B' ' 247' ' ' ILE . 26.0 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.791 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.652 ' H ' ' HG ' ' B' ' 133' ' ' SER . 32.6 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.433 HG11 ' N ' ' B' ' 46' ' ' PHE . 87.5 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 1.028 ' CE1' HG22 ' B' ' 131' ' ' VAL . 51.5 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.5 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.48 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.1 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.48 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.2 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.8 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.561 ' O ' HG21 ' B' ' 68' ' ' VAL . 58.6 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.631 HG12 ' N ' ' B' ' 69' ' ' GLY . 80.7 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.631 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.558 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.532 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.8 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.0 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' PRO . . . . . 0.856 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 17.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.856 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 46.4 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.491 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' B' ' 130' ' ' PRO . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.4 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' B' ' 94' ' ' LEU . 49.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.1 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.1 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 1.221 ' CZ ' ' HG2' ' A' ' 37' ' ' PRO . 17.3 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' GLN . . . . . 0.534 HE22 ' HA ' ' A' ' 36' ' ' VAL . 11.2 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' TYR . . . . . 0.426 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 25.0 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.493 ' C ' HG13 ' B' ' 114' ' ' VAL . 55.7 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.545 ' O ' HG23 ' B' ' 114' ' ' VAL . 16.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 1.478 ' HB ' ' CB ' ' B' ' 115' ' ' ILE 0.526 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.436 HG21 ' C ' ' B' ' 115' ' ' ILE 0.403 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.661 ' C ' ' HE2' ' A' ' 66' ' ' MET . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 1.451 ' CG ' HD22 ' A' ' 64' ' ' LEU . 38.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 81.3 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.8 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 90.0 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.581 ' C ' HG12 ' B' ' 131' ' ' VAL . 12.8 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 1.549 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.511 0.9 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' SER . . . . . 0.652 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . 0.475 ' HG2' HD12 ' B' ' 142' ' ' ILE . 38.3 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . 0.449 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 23.9 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' PRO . . . . . 0.642 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.4 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.449 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . 0.547 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.547 HG22 ' CG ' ' B' ' 139' ' ' ASP 0.469 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . 0.642 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' SER . . . . . 0.495 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.5 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' VAL . . . . . 0.495 HG13 ' C ' ' B' ' 148' ' ' SER 0.361 1.5 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.464 HG12 HG23 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.476 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.6 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.666 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.3 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 1.333 ' HB ' ' CG1' ' B' ' 160' ' ' VAL 0.398 0.6 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.1 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.431 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.9 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . 0.534 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . 0.737 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.2 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.3 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.524 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 58.0 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 64.8 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.9 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . 0.727 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.727 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.7 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.433 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.483 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.1 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.443 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.6 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.655 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 197' ' ' VAL . . . . . 0.655 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.464 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 200' ' ' LYS . . . . . 0.524 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.7 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.458 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.9 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.458 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.8 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' ASP . . . . . 0.488 ' O ' HD13 ' B' ' 196' ' ' LEU . 63.0 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.2 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.737 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 40.3 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . 0.422 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.422 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 12.2 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.3 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.9 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 1.361 ' HB ' ' CG1' ' B' ' 225' ' ' VAL 0.423 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.8 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.6 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' ASN . . . . . 0.51 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . 0.482 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.1 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . 0.569 HD13 ' O ' ' B' ' 32' ' ' THR . 15.0 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' ILE . . . . . 0.413 HD12 HG23 ' B' ' 40' ' ' VAL . 18.7 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 40.8 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.924 -1.036 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.709 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.444 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 69.7 m -61.51 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.963 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.93 163.03 12.63 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.455 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.2 t -107.74 122.43 46.72 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.9 t -100.56 98.37 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.4 mmmt -67.35 65.37 0.07 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.894 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 39' ' ' HIS . 14.9 mt -29.46 68.22 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 126.61 1.964 . . . . 0.0 115.517 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.45 59.01 0.4 Allowed Glycine 0 N--CA 1.51 3.584 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 11' ' ' LYS . 20.3 p -1.13 54.15 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.284 0 N-CA-C 120.32 3.452 . . . . 0.0 120.32 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.51 -60.23 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 119.539 3.163 . . . . 0.0 119.539 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.87 22.62 14.27 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.858 -1.151 . . . . 0.0 108.189 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.2 -94.81 1.89 Allowed Glycine 0 N--CA 1.512 3.721 0 N-CA-C 115.521 0.969 . . . . 0.0 115.521 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.577 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.6 tp -150.56 -177.14 5.8 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 1.036 HD21 HG23 ' A' ' 36' ' ' VAL . 15.4 mt -74.78 46.76 0.3 Allowed 'General case' 0 N--CA 1.509 2.506 0 O-C-N 120.716 -1.24 . . . . 0.0 111.261 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.665 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 7.6 p -113.79 165.59 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 118.464 2.764 . . . . 0.0 118.464 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.665 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 5.3 m-30 -102.22 75.41 1.49 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 112.142 -2.299 . . . . 0.0 113.431 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.343 0.6 OUTLIER -93.46 142.43 25.19 Favored Pre-proline 0 N--CA 1.506 2.347 0 O-C-N 121.805 -0.559 . . . . 0.0 111.754 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' LYS . 46.3 Cg_endo -86.46 76.22 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.39 0 N-CA-C 116.351 1.635 . . . . 0.0 116.351 -9.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.54 -44.17 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.841 1 N-CA-C 122.284 4.179 . . . . 0.0 122.284 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.648 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.61 71.69 1.0 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 122.408 1.099 . . . . 0.0 113.072 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.679 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.19 111.23 7.23 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.237 -1.539 . . . . 0.0 109.1 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.574 ' N ' HD22 ' A' ' 21' ' ' LEU . 46.1 m -87.42 81.41 7.84 Favored 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 101' ' ' ILE . 4.4 pt -79.61 -177.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 CA-C-N 114.772 -1.103 . . . . 0.0 112.719 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.708 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -109.7 166.6 10.49 Favored Pre-proline 0 CA--C 1.566 1.569 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.135 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 19.9 Cg_endo -52.26 77.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.288 0 N-CA-C 116.903 1.847 . . . . 0.0 116.903 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.16 -50.59 0.51 Allowed Glycine 1 N--CA 1.522 4.419 0 C-N-CA 119.753 -1.213 . . . . 0.0 115.834 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.652 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.61 92.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.171 1 N-CA-C 122.227 4.158 . . . . 0.0 122.227 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.444 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.1 m -64.15 36.08 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 30' ' ' GLU . 58.0 t -52.11 147.23 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 CA-C-N 112.878 -1.965 . . . . 0.0 111.475 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.534 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.8 pt-20 -114.28 154.87 27.21 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 123.978 1.847 . . . . 0.0 115.356 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -107.53 113.83 27.41 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.8 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.65 112.49 24.89 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 120.792 3.627 . . . . 0.0 120.792 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -75.12 84.78 2.34 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.164 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 29.7 p30 -80.35 -45.06 18.4 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 118.904 2.928 . . . . 0.0 118.904 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.97 -169.33 3.35 Favored 'General case' 0 N--CA 1.509 2.491 0 C-N-CA 124.596 1.158 . . . . 0.0 109.068 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.05 ' HA ' HE22 ' B' ' 104' ' ' GLN . 1.6 m 12.91 70.62 0.11 Allowed Pre-proline 0 N--CA 1.519 3.01 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.344 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 55.3 Cg_endo -98.43 177.28 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.213 0 C-N-CA 123.908 3.072 . . . . 0.0 114.455 -165.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.72 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 52.3 Cg_endo -92.47 165.29 25.09 Favored 'Cis proline' 0 N--CA 1.503 2.069 0 N-CA-C 115.442 1.285 . . . . 0.0 115.442 -7.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.792 ' HB2' HD11 ' A' ' 7' ' ' LEU . 16.3 m-70 -118.96 87.46 2.74 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.704 HD22 ' N ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -103.37 140.2 37.76 Favored 'General case' 0 N--CA 1.516 2.827 0 CA-C-N 122.395 2.362 . . . . 0.0 110.744 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.3 m -118.11 116.22 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 121.476 3.88 . . . . 0.0 121.476 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.994 HG22 ' HB2' ' A' ' 88' ' ' TYR . 13.3 m -75.87 165.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.907 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.3 130.94 55.51 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.452 ' OD1' HD13 ' A' ' 47' ' ' LEU . 4.2 m-20 -53.4 93.71 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.183 1 N-CA-C 124.2 4.889 . . . . 0.0 124.2 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.98 6.8 43.28 Favored 'General case' 0 CA--C 1.602 2.957 0 N-CA-C 101.23 -3.619 . . . . 0.0 101.23 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB2' HD13 ' A' ' 47' ' ' LEU . . . -115.83 -65.53 1.18 Allowed 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 127.595 2.358 . . . . 0.0 112.704 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.676 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.5 mp -86.72 66.47 9.48 Favored 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 118.966 2.95 . . . . 0.0 118.966 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.43 151.22 0.74 Allowed Pre-proline 0 N--CA 1.522 3.167 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.489 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 17.4 Cg_endo -42.32 -58.31 1.28 Allowed 'Trans proline' 0 N--CA 1.508 2.376 0 C-N-CA 123.408 2.739 . . . . 0.0 115.085 170.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.637 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.48 67.46 0.72 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 124.034 1.873 . . . . 0.0 107.04 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -77.25 53.6 1.02 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 112.333 -2.212 . . . . 0.0 108.331 179.392 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.4 t -115.88 56.96 0.76 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.679 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.57 -47.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.11 -30.87 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.104 -1.622 . . . . 0.0 111.636 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.13 -28.5 0.09 Allowed 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 122.801 1.286 . . . . 0.0 112.561 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.796 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.86 -27.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.477 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.3 tptt 65.15 -55.62 0.31 Allowed 'General case' 0 N--CA 1.533 3.678 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.2 m -41.72 -28.9 0.16 Allowed 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.907 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.2 pp -53.74 -66.71 0.35 Allowed 'General case' 0 CA--C 1.603 3.017 0 N-CA-C 100.723 -3.806 . . . . 0.0 100.723 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.849 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 11.0 p -72.14 98.38 2.12 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.278 1.431 . . . . 0.0 112.816 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.742 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.5 t60 -89.96 -173.01 3.72 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.833 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.39 155.17 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.833 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 26.2 tt0 105.43 66.08 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 120.289 3.44 . . . . 0.0 120.289 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 1.059 HD11 ' N ' ' A' ' 64' ' ' LEU . 5.6 mp 38.1 84.27 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 120.803 3.631 . . . . 0.0 120.803 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.704 ' N ' HD22 ' A' ' 40' ' ' ASN . 36.3 mt -70.68 82.12 0.61 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.144 -1.597 . . . . 0.0 111.88 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 1.107 ' CE ' ' O ' ' B' ' 118' ' ' PRO . 41.4 mmm -79.27 61.92 3.5 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-O 126.096 2.855 . . . . 0.0 110.918 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.9 m -112.52 65.95 0.84 Allowed Pre-proline 0 N--CA 1.505 2.298 0 CA-C-N 110.47 -3.059 . . . . 0.0 113.601 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.824 ' HG3' ' O ' ' B' ' 100' ' ' ASP . 19.3 Cg_endo -51.94 81.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.522 0 C-N-CA 122.979 2.452 . . . . 0.0 114.633 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.09 6.67 27.71 Favored Glycine 1 N--CA 1.516 4.021 0 O-C-N 122.203 -0.31 . . . . 0.0 113.606 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.66 156.82 35.17 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 124.389 2.042 . . . . 0.0 116.332 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.8 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.91 156.34 27.55 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 119.742 3.238 . . . . 0.0 119.742 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -115.9 147.97 40.52 Favored 'General case' 0 N--CA 1.52 3.048 0 CA-C-O 116.643 -1.646 . . . . 0.0 107.264 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.48 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.59 143.76 41.94 Favored 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.441 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 76.1 m -119.95 102.64 8.69 Favored 'General case' 0 N--CA 1.514 2.751 0 CA-C-N 114.221 -1.354 . . . . 0.0 113.525 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.8 m -94.81 152.26 18.56 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -107.97 168.33 8.05 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -72.36 -174.76 1.52 Allowed 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 121.009 1.14 . . . . 0.0 111.115 161.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.34 -19.78 18.98 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 124.301 2.001 . . . . 0.0 107.241 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.16 42.64 0.49 Allowed 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 111.246 -2.706 . . . . 0.0 109.059 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.598 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.3 84.84 9.84 Favored Pre-proline 0 N--CA 1.499 2.023 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.778 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 83' ' ' GLY . 38.0 Cg_endo -79.38 178.6 7.23 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.851 2.367 . . . . 0.0 112.298 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.585 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -15.97 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.889 0 C-N-CA 125.316 1.447 . . . . 0.0 113.262 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.52 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.51 125.08 5.64 Favored Glycine 0 N--CA 1.506 3.365 0 N-CA-C 121.703 3.441 . . . . 0.0 121.703 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.656 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 44.0 mt-10 -99.5 61.18 1.17 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.806 ' HB2' HG23 ' A' ' 101' ' ' ILE . 3.0 m-85 -62.04 77.74 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.873 1.32 . . . . 0.0 113.068 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.4 m -63.36 135.92 57.31 Favored 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.581 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.47 136.55 52.89 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.994 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.6 m-85 -84.63 81.97 8.63 Favored 'General case' 0 N--CA 1.511 2.576 1 N-CA-C 132.625 8.009 . . . . 0.0 132.625 -179.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.7 t -63.84 82.21 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.447 2 CA-C-N 130.434 6.016 . . . . 0.0 114.298 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.5 tt0 -20.61 -72.48 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.61 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.838 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 31.7 Cg_endo -66.88 -3.55 9.71 Favored 'Trans proline' 0 N--CA 1.511 2.547 0 C-N-CA 122.419 2.079 . . . . 0.0 115.372 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -120.88 -14.08 8.54 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.483 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.45 79.75 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.53 -34.03 1.74 Allowed Glycine 1 N--CA 1.521 4.309 0 O-C-N 121.571 -0.706 . . . . 0.0 112.621 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.62 68.54 8.01 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.78 26.78 0.05 OUTLIER Glycine 1 N--CA 1.528 4.787 0 CA-C-N 114.004 -1.453 . . . . 0.0 116.636 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.851 ' HE2' HD22 ' A' ' 14' ' ' LEU . 1.8 ttt -108.53 43.76 1.2 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 124.51 2.1 . . . . 0.0 113.035 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.89 134.89 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 112.216 -2.266 . . . . 0.0 111.007 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.7 154.89 19.38 Favored Glycine 1 N--CA 1.535 5.269 0 C-N-CA 119.486 -1.34 . . . . 0.0 113.986 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.845 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.2 ttpp -118.63 81.96 1.78 Allowed 'General case' 0 N--CA 1.518 2.956 0 CA-C-N 119.404 1.602 . . . . 0.0 115.252 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.806 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.76 123.24 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.845 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.1 m -112.56 88.72 2.89 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.196 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 80' ' ' ALA . 38.8 t -73.97 105.21 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.3 -72.3 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 O-C-N 126.051 2.094 . . . . 0.0 115.888 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.585 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.486 0 O-C-N 125.579 1.799 . . . . 0.0 113.861 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.838 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 24.1 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' TRP . . . . . 0.458 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . 0.45 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.0 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.2 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 89.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 54.2 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 77.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.464 ' HA ' HD22 ' B' ' 27' ' ' LEU . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.59 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.3 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.485 HG23 HG12 ' B' ' 151' ' ' VAL 0.373 0.1 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.6 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.47 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.47 ' O ' HG12 ' B' ' 36' ' ' VAL . 23.7 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.416 ' C ' HG11 ' B' ' 40' ' ' VAL . 87.9 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.416 HG11 ' C ' ' B' ' 39' ' ' SER . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.825 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.654 ' H ' ' HG ' ' B' ' 133' ' ' SER . 30.2 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.436 HG11 ' N ' ' B' ' 46' ' ' PHE . 89.4 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 1.142 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.3 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.531 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.9 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.531 HG22 ' O ' ' B' ' 55' ' ' ASP . 15.1 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 82.9 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.567 ' O ' HG21 ' B' ' 68' ' ' VAL . 55.4 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.658 HG12 ' N ' ' B' ' 69' ' ' GLY . 74.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.658 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.589 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.552 HG21 HD12 ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.2 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' PRO . . . . . 1.049 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 24.8 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 1.049 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 43.0 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . 0.472 ' H ' HG21 ' B' ' 84' ' ' ILE 0.568 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' B' ' 130' ' ' PRO . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' B' ' 94' ' ' LEU . 50.3 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.824 ' O ' ' HG3' ' A' ' 68' ' ' PRO . 24.3 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 1.344 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 17.2 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' GLN . . . . . 1.05 HE22 ' HA ' ' A' ' 36' ' ' VAL . 11.0 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.9 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.475 ' C ' HG13 ' B' ' 114' ' ' VAL . 55.2 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.58 ' O ' HG23 ' B' ' 114' ' ' VAL . 17.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.552 HD12 HG21 ' B' ' 75' ' ' VAL 0.454 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 0.535 ' N ' HG21 ' B' ' 115' ' ' ILE 0.254 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.712 ' C ' ' HE2' ' A' ' 66' ' ' MET . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 1.107 ' O ' ' CE ' ' A' ' 66' ' ' MET . 36.4 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.907 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 81.9 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.5 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 85.3 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.505 ' C ' HG12 ' B' ' 131' ' ' VAL . 19.8 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 1.556 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.348 0.5 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' SER . . . . . 0.654 ' HG ' ' H ' ' B' ' 44' ' ' THR . 95.1 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . 0.598 ' HG2' HD12 ' B' ' 142' ' ' ILE . 35.7 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . 0.444 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 25.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' PRO . . . . . 0.526 ' CG ' ' CZ ' ' B' ' 144' ' ' PHE . 18.2 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.444 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . 0.591 ' CG ' ' CG2' ' B' ' 142' ' ' ILE . 44.7 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.598 HD12 ' HG2' ' B' ' 134' ' ' PRO 0.511 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . 0.526 ' CZ ' ' CG ' ' B' ' 136' ' ' PRO . 81.3 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' SER . . . . . 0.449 ' C ' HG13 ' B' ' 149' ' ' VAL . 69.0 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' VAL . . . . . 1.372 ' HB ' ' CG2' ' B' ' 149' ' ' VAL . 1.3 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.485 HG12 HG23 ' B' ' 34' ' ' VAL . 10.7 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' B' ' 155' ' ' ARG . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' B' ' 157' ' ' ARG . 28.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.683 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.7 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 1.358 ' HB ' ' CA ' ' B' ' 160' ' ' VAL 0.31 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' TYR . . . . . 0.413 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 64.4 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' PRO . . . . . 0.458 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 17.8 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 97.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.434 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.9 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . 0.576 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.9 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . 0.805 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 18.4 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.537 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 61.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.4 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' LYS . . . . . 0.423 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.6 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . 0.759 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.759 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 41.2 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.381 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.483 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 40.8 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.501 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.4 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.726 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 197' ' ' VAL . . . . . 0.726 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 199' ' ' ILE . . . . . 0.537 HG13 ' O ' ' B' ' 199' ' ' ILE 0.52 0.3 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 200' ' ' LYS . . . . . 0.537 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.7 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.6 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.472 ' C ' HG13 ' B' ' 207' ' ' VAL . 60.0 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.472 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.2 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' ASP . . . . . 0.51 ' O ' HD13 ' B' ' 196' ' ' LEU . 63.3 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.805 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 36.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . 0.473 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.473 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 18.3 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.3 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.1 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.402 0.1 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.0 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' ASN . . . . . 0.545 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . 0.507 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.6 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . 0.59 HD13 ' O ' ' B' ' 32' ' ' THR . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 19.4 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . 0.427 ' HA ' HD11 ' B' ' 249' ' ' LEU . 41.4 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.711 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.471 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.5 m -61.53 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.029 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -99.95 163.08 12.6 Favored 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.457 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.83 122.39 46.69 Favored 'General case' 0 N--CA 1.525 3.305 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -100.49 98.38 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.7 mmmt -67.37 65.39 0.07 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 113.121 -1.854 . . . . 0.0 114.847 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.826 HD11 ' HB2' ' A' ' 39' ' ' HIS . 14.6 mt -29.59 68.29 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 126.53 1.932 . . . . 0.0 115.501 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.44 58.98 0.4 Allowed Glycine 0 N--CA 1.509 3.54 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.1 p -1.07 54.24 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 N-CA-C 120.187 3.402 . . . . 0.0 120.187 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.44 -60.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 119.513 3.153 . . . . 0.0 119.513 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.76 22.53 14.42 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.858 -1.151 . . . . 0.0 108.183 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.18 -94.77 1.89 Allowed Glycine 0 N--CA 1.512 3.713 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.484 HD13 ' H ' ' A' ' 14' ' ' LEU . 44.6 tp -150.61 -177.2 5.84 Favored 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 1.022 HD21 HG23 ' A' ' 36' ' ' VAL . 15.2 mt -74.78 46.78 0.3 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 120.638 -1.289 . . . . 0.0 111.279 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.569 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.85 165.68 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 118.596 2.813 . . . . 0.0 118.596 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.569 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 4.9 m-30 -102.23 75.42 1.49 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 112.2 -2.273 . . . . 0.0 113.389 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.308 12.3 mt-10 -93.47 142.43 25.2 Favored Pre-proline 0 N--CA 1.505 2.294 0 O-C-N 121.826 -0.546 . . . . 0.0 111.814 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.41 76.15 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.458 0 N-CA-C 116.328 1.626 . . . . 0.0 116.328 -9.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.59 -44.14 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 1 N-CA-C 122.344 4.201 . . . . 0.0 122.344 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.63 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.62 71.62 1.0 Allowed 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 122.364 1.078 . . . . 0.0 113.025 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.624 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.13 111.31 7.25 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.208 -1.557 . . . . 0.0 109.104 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.503 ' N ' HD22 ' A' ' 21' ' ' LEU . 49.4 m -87.49 81.46 7.78 Favored 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.698 HD11 HD12 ' A' ' 101' ' ' ILE . 5.3 pt -79.78 -177.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.692 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.615 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.66 166.51 10.65 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.198 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.6 Cg_endo -52.2 77.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.3 0 N-CA-C 116.91 1.85 . . . . 0.0 116.91 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.09 -50.44 0.52 Allowed Glycine 1 N--CA 1.523 4.449 0 C-N-CA 119.789 -1.196 . . . . 0.0 115.915 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.674 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.64 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.178 1 N-CA-C 122.151 4.13 . . . . 0.0 122.151 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.471 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.9 m -64.0 35.98 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.027 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 30' ' ' GLU . 63.6 t -52.11 147.21 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 112.906 -1.952 . . . . 0.0 111.418 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' N ' HG13 ' A' ' 29' ' ' VAL . 4.1 pt-20 -114.29 154.93 27.11 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 123.925 1.822 . . . . 0.0 115.324 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -107.53 113.79 27.35 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.801 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.76 112.57 25.0 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 120.758 3.614 . . . . 0.0 120.758 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -75.16 84.72 2.37 Favored 'General case' 0 N--CA 1.511 2.622 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.13 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.23 -45.11 18.55 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.93 -169.38 3.36 Favored 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 124.61 1.164 . . . . 0.0 109.086 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.106 HG13 ' NE2' ' B' ' 104' ' ' GLN . 1.7 m 12.92 70.63 0.11 Allowed Pre-proline 0 N--CA 1.521 3.098 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.45 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.4 177.28 0.41 Allowed 'Trans proline' 0 CA--C 1.569 2.241 0 C-N-CA 123.939 3.093 . . . . 0.0 114.416 -165.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.4 Cg_endo -92.5 165.31 25.0 Favored 'Cis proline' 0 N--CA 1.503 2.068 0 N-CA-C 115.398 1.268 . . . . 0.0 115.398 -7.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.826 ' HB2' HD11 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.89 87.46 2.74 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.587 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 1.0 OUTLIER -103.45 140.22 37.78 Favored 'General case' 0 N--CA 1.515 2.818 0 CA-C-N 122.456 2.389 . . . . 0.0 110.722 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.2 m -118.08 116.31 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.98 HG22 ' HB2' ' A' ' 88' ' ' TYR . 14.8 m -75.95 165.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 102.19 -3.263 . . . . 0.0 102.19 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.856 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.3 130.93 55.51 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.459 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.32 93.77 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.221 1 N-CA-C 124.182 4.882 . . . . 0.0 124.182 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.06 6.74 43.68 Favored 'General case' 0 CA--C 1.602 2.972 0 N-CA-C 101.168 -3.642 . . . . 0.0 101.168 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.8 -65.54 1.18 Allowed 'General case' 0 CA--C 1.573 1.853 0 C-N-CA 127.525 2.33 . . . . 0.0 112.718 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.56 9.53 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 118.915 2.932 . . . . 0.0 118.915 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.46 151.25 0.74 Allowed Pre-proline 0 N--CA 1.522 3.135 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.8 Cg_endo -42.51 -58.2 1.35 Allowed 'Trans proline' 0 N--CA 1.508 2.371 0 C-N-CA 123.438 2.758 . . . . 0.0 115.04 170.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.52 67.43 0.72 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 124.091 1.901 . . . . 0.0 107.072 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.28 53.55 1.02 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.256 -2.247 . . . . 0.0 108.222 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.8 56.94 0.76 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.745 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.58 -47.94 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.184 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.12 -30.85 0.16 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.113 -1.617 . . . . 0.0 111.545 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.793 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.22 -28.54 0.1 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.732 1.253 . . . . 0.0 112.485 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.793 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.82 -27.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.3 tptt 64.93 -55.47 0.3 Allowed 'General case' 0 N--CA 1.533 3.715 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -41.78 -28.86 0.17 Allowed 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.856 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.8 pp -53.74 -66.76 0.33 Allowed 'General case' 0 CA--C 1.604 3.022 0 N-CA-C 100.713 -3.81 . . . . 0.0 100.713 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.789 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.11 98.44 2.11 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 125.268 1.427 . . . . 0.0 112.781 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.72 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.3 t60 -90.05 -173.08 3.73 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.835 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.42 155.15 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.835 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 28.1 tt0 105.5 66.06 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.755 0 N-CA-C 120.313 3.449 . . . . 0.0 120.313 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 1.316 HD22 ' CG ' ' B' ' 118' ' ' PRO . 6.1 mp 38.13 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.511 ' N ' HD22 ' A' ' 40' ' ' ASN . 36.2 mt -70.67 82.08 0.61 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.197 -1.564 . . . . 0.0 111.906 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.965 ' HE1' HD23 ' B' ' 119' ' ' LEU . 41.4 mmm -79.3 62.0 3.53 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 126.051 2.834 . . . . 0.0 110.867 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.4 m -112.58 65.84 0.85 Allowed Pre-proline 0 C--N 1.283 -2.287 0 CA-C-N 110.474 -3.057 . . . . 0.0 113.558 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -51.92 81.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.45 0 C-N-CA 122.959 2.439 . . . . 0.0 114.716 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.66 27.63 Favored Glycine 0 N--CA 1.516 3.991 0 O-C-N 122.131 -0.356 . . . . 0.0 113.603 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.516 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.8 tt0 -123.65 156.92 34.97 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 124.384 2.04 . . . . 0.0 116.273 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.801 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.98 156.37 27.58 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 119.722 3.23 . . . . 0.0 119.722 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -115.93 147.95 40.58 Favored 'General case' 0 N--CA 1.52 3.056 0 CA-C-O 116.636 -1.65 . . . . 0.0 107.194 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.457 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.46 143.74 41.81 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 85.2 m -120.02 102.57 8.63 Favored 'General case' 0 N--CA 1.513 2.719 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.532 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.5 m -94.74 152.22 18.63 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -107.97 168.27 8.13 Favored Pre-proline 0 N--CA 1.502 2.13 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.135 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.33 -174.77 1.51 Allowed 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.006 1.137 . . . . 0.0 111.122 161.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.45 -19.64 19.01 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-O 124.346 2.022 . . . . 0.0 107.216 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.25 42.72 0.5 Allowed 'General case' 0 CA--C 1.576 1.963 0 CA-C-N 111.249 -2.705 . . . . 0.0 109.036 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.583 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.29 84.73 9.68 Favored Pre-proline 0 N--CA 1.5 2.031 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.846 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -79.36 178.68 7.15 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 122.753 2.302 . . . . 0.0 112.226 173.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.583 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.04 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 125.294 1.437 . . . . 0.0 113.3 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.35 125.01 5.64 Favored Glycine 0 N--CA 1.508 3.472 0 N-CA-C 121.777 3.471 . . . . 0.0 121.777 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.662 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 44.0 mt-10 -99.44 61.15 1.18 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.788 ' HB2' HG23 ' A' ' 101' ' ' ILE . 2.8 m-85 -62.06 77.79 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 122.9 1.333 . . . . 0.0 112.984 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.46 135.91 57.23 Favored 'General case' 0 N--CA 1.51 2.561 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.526 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.43 136.51 52.93 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.98 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.64 81.96 8.63 Favored 'General case' 0 N--CA 1.511 2.617 1 N-CA-C 132.611 8.004 . . . . 0.0 132.611 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.758 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.0 t -63.82 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.471 2 CA-C-N 130.384 5.993 . . . . 0.0 114.34 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.6 tt0 -20.5 -72.4 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.62 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 29.6 Cg_endo -67.08 -3.45 9.76 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 122.406 2.071 . . . . 0.0 115.334 176.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -120.93 -14.16 8.51 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.23 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.782 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.58 -34.1 1.73 Allowed Glycine 1 N--CA 1.521 4.304 0 O-C-N 121.516 -0.74 . . . . 0.0 112.628 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.47 68.42 7.79 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.84 26.81 0.05 OUTLIER Glycine 1 N--CA 1.526 4.648 0 N-CA-C 116.616 1.407 . . . . 0.0 116.616 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.871 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.1 ttt -108.55 43.86 1.19 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 124.482 2.087 . . . . 0.0 112.966 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.03 134.88 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 112.233 -2.258 . . . . 0.0 110.973 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.65 154.86 19.34 Favored Glycine 1 N--CA 1.534 5.228 0 C-N-CA 119.525 -1.321 . . . . 0.0 114.032 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.865 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.0 ttpp -118.63 82.0 1.78 Allowed 'General case' 0 N--CA 1.518 2.925 0 CA-C-N 119.474 1.637 . . . . 0.0 115.188 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.788 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.74 123.29 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.865 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.5 m -112.67 88.77 2.9 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.197 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 80' ' ' ALA . 38.3 t -74.05 105.23 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.35 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 O-C-N 126.066 2.104 . . . . 0.0 115.912 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.583 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.438 0 O-C-N 125.478 1.736 . . . . 0.0 113.835 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.28 21.9 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' TRP . . . . . 0.43 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.8 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.308 27.5 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.546 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 52.9 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.537 ' O ' HD13 ' B' ' 243' ' ' LEU . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.403 HG23 HD12 ' B' ' 247' ' ' ILE . 26.5 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.742 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.367 22.0 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.652 ' H ' ' HG ' ' B' ' 133' ' ' SER . 33.0 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.456 HG11 ' N ' ' B' ' 46' ' ' PHE . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.416 ' O ' HG22 ' B' ' 58' ' ' VAL . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.8 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.416 HG22 ' O ' ' B' ' 55' ' ' ASP . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.58 ' O ' HG21 ' B' ' 68' ' ' VAL . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.621 HG12 ' N ' ' B' ' 69' ' ' GLY . 88.0 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.621 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.536 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.421 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.436 HD11 HG23 ' B' ' 149' ' ' VAL . 50.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' PRO . . . . . 0.704 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.1 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.704 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.2 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 94' ' ' LEU . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.5 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 1.45 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 20.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' GLN . . . . . 1.106 ' NE2' HG13 ' A' ' 36' ' ' VAL . 11.9 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.546 ' C ' HG13 ' B' ' 114' ' ' VAL . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.546 HG13 ' C ' ' B' ' 113' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.421 ' CD1' HG21 ' B' ' 75' ' ' VAL 0.592 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 1.316 ' CG ' HD22 ' A' ' 64' ' ' LEU . 36.5 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.965 HD23 ' HE1' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.45 ' C ' HG12 ' B' ' 131' ' ' VAL . 23.9 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.765 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.442 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' SER . . . . . 0.652 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.9 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . 0.429 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 20.9 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' PRO . . . . . 0.677 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.327 23.8 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.429 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . 0.462 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.523 HD11 ' HH ' ' B' ' 147' ' ' TYR 0.316 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . 0.677 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' TYR . . . . . 0.523 ' HH ' HD11 ' B' ' 142' ' ' ILE . 45.3 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' SER . . . . . 0.426 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' VAL . . . . . 0.436 HG23 HD11 ' B' ' 76' ' ' LEU 0.418 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' HIS . . . . . 0.546 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.484 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.526 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' TYR . . . . . 0.403 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 64.1 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' PRO . . . . . 0.43 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 23.0 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.46 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.2 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . 0.495 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . 0.718 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.539 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . 0.687 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.687 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.363 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.445 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.578 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 197' ' ' VAL . . . . . 0.578 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 200' ' ' LYS . . . . . 0.539 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.452 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.452 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' ASP . . . . . 0.433 ' O ' HD13 ' B' ' 196' ' ' LEU . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.718 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 36.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.256 25.7 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.625 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.8 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' ASN . . . . . 0.535 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . 0.52 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 19.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . 0.537 HD13 ' O ' ' B' ' 32' ' ' THR . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' ILE . . . . . 0.403 HD12 HG23 ' B' ' 40' ' ' VAL . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.727 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.473 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 82.1 m -61.63 89.63 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.012 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -99.92 163.03 12.63 Favored 'General case' 0 N--CA 1.511 2.617 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.477 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.79 122.4 46.69 Favored 'General case' 0 N--CA 1.525 3.301 0 N-CA-C 117.179 2.288 . . . . 0.0 117.179 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.49 98.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.6 mmmt -67.36 65.41 0.07 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 113.144 -1.843 . . . . 0.0 114.828 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.816 HD11 ' HB2' ' A' ' 39' ' ' HIS . 14.6 mt -29.48 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 C-N-CA 126.575 1.95 . . . . 0.0 115.508 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.49 59.0 0.4 Allowed Glycine 0 N--CA 1.51 3.62 0 N-CA-C 106.897 -2.481 . . . . 0.0 106.897 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -1.05 54.08 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 120.324 3.453 . . . . 0.0 120.324 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.55 -60.25 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 119.494 3.146 . . . . 0.0 119.494 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.504 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.81 22.53 14.39 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 120.941 -1.099 . . . . 0.0 108.196 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.13 -94.8 1.9 Allowed Glycine 0 N--CA 1.511 3.694 0 N-CA-C 115.511 0.964 . . . . 0.0 115.511 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 14' ' ' LEU . 44.4 tp -150.62 -177.16 5.82 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.984 HD21 HG23 ' A' ' 36' ' ' VAL . 15.2 mt -74.8 46.72 0.3 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 120.677 -1.264 . . . . 0.0 111.271 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.566 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.76 165.69 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 118.578 2.807 . . . . 0.0 118.578 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.566 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 4.9 m-30 -102.26 75.39 1.48 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.364 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.307 12.4 mt-10 -93.45 142.46 25.24 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.81 -0.556 . . . . 0.0 111.746 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.41 76.13 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.459 0 N-CA-C 116.3 1.616 . . . . 0.0 116.3 -9.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.61 -44.19 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.807 1 N-CA-C 122.316 4.191 . . . . 0.0 122.316 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.61 71.62 1.0 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 122.484 1.135 . . . . 0.0 113.061 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.613 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.13 111.28 7.21 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.134 -1.604 . . . . 0.0 109.138 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.501 ' N ' HD22 ' A' ' 21' ' ' LEU . 50.6 m -87.49 81.43 7.79 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.706 HD11 HD12 ' A' ' 101' ' ' ILE . 5.3 pt -79.7 -177.57 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.689 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.619 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.49 10.68 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.133 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.4 Cg_endo -52.16 77.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.314 0 N-CA-C 116.97 1.873 . . . . 0.0 116.97 174.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.19 -50.5 0.51 Allowed Glycine 1 N--CA 1.522 4.403 0 C-N-CA 119.69 -1.243 . . . . 0.0 115.826 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.678 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.66 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.171 1 N-CA-C 122.149 4.129 . . . . 0.0 122.149 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.473 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.7 m -63.98 35.9 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.977 0 N-CA-C 118.726 2.861 . . . . 0.0 118.726 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 30' ' ' GLU . 62.3 t -51.98 147.15 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 112.886 -1.961 . . . . 0.0 111.57 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.486 ' N ' HG13 ' A' ' 29' ' ' VAL . 4.1 pt-20 -114.2 154.9 27.06 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 123.942 1.83 . . . . 0.0 115.442 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.54 113.84 27.43 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.794 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.79 112.49 24.92 Favored 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 120.686 3.587 . . . . 0.0 120.686 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -75.06 84.6 2.31 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.197 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.27 -45.03 18.62 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 118.919 2.933 . . . . 0.0 118.919 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.96 -169.38 3.36 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 124.619 1.167 . . . . 0.0 109.124 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.138 HG11 ' NE2' ' B' ' 104' ' ' GLN . 1.7 m 12.95 70.62 0.11 Allowed Pre-proline 0 N--CA 1.521 3.076 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.475 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.37 177.33 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.224 0 C-N-CA 123.941 3.094 . . . . 0.0 114.395 -165.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.3 Cg_endo -92.38 165.28 25.37 Favored 'Cis proline' 0 N--CA 1.504 2.104 0 N-CA-C 115.453 1.29 . . . . 0.0 115.453 -7.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.816 ' HB2' HD11 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.83 87.41 2.73 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 117.346 2.35 . . . . 0.0 117.346 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.578 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -103.44 140.25 37.73 Favored 'General case' 0 N--CA 1.516 2.863 0 CA-C-N 122.494 2.406 . . . . 0.0 110.681 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.1 m -118.11 116.26 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 121.386 3.847 . . . . 0.0 121.386 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.984 HG22 ' HB2' ' A' ' 88' ' ' TYR . 15.0 m -75.89 165.35 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 102.238 -3.245 . . . . 0.0 102.238 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.859 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.3 131.02 55.47 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.473 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.53 93.87 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.163 1 N-CA-C 124.149 4.87 . . . . 0.0 124.149 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.08 6.84 43.3 Favored 'General case' 0 CA--C 1.601 2.94 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.85 -65.5 1.18 Allowed 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 127.612 2.365 . . . . 0.0 112.753 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.9 mp -86.78 66.64 9.55 Favored 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 118.885 2.92 . . . . 0.0 118.885 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.48 151.22 0.73 Allowed Pre-proline 0 N--CA 1.522 3.137 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.7 Cg_endo -42.47 -58.24 1.33 Allowed 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 123.403 2.736 . . . . 0.0 115.079 170.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.45 67.34 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 124.063 1.887 . . . . 0.0 107.084 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.06 53.39 0.96 Allowed 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.296 -2.229 . . . . 0.0 108.266 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.77 56.89 0.76 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.846 2.535 . . . . 0.0 117.846 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.745 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.49 -48.04 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.171 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.04 -30.93 0.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.098 -1.626 . . . . 0.0 111.584 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.804 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.08 -28.61 0.09 Allowed 'General case' 0 N--CA 1.509 2.501 0 CA-C-O 122.68 1.229 . . . . 0.0 112.524 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.804 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.81 -27.48 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.807 ' HE2' ' OE1' ' B' ' 189' ' ' GLU . 12.3 tptt 65.08 -55.64 0.3 Allowed 'General case' 0 N--CA 1.532 3.66 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.7 m -41.67 -28.93 0.16 Allowed 'General case' 0 N--CA 1.513 2.715 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.859 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.8 pp -53.69 -66.8 0.33 Allowed 'General case' 0 CA--C 1.604 3.038 0 N-CA-C 100.673 -3.825 . . . . 0.0 100.673 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.765 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.16 98.47 2.14 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.248 1.419 . . . . 0.0 112.78 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.717 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.07 -173.05 3.72 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.829 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.39 155.18 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.829 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 28.2 tt0 105.44 66.11 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 N-CA-C 120.281 3.437 . . . . 0.0 120.281 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.965 HD11 ' N ' ' A' ' 64' ' ' LEU . 6.1 mp 38.13 84.23 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 120.789 3.626 . . . . 0.0 120.789 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 40' ' ' ASN . 36.2 mt -70.6 81.99 0.6 Allowed 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.051 -1.655 . . . . 0.0 111.88 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 1.357 ' CE ' ' HA ' ' B' ' 119' ' ' LEU . 41.2 mmm -79.18 61.94 3.44 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 126.052 2.834 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.489 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.0 m -112.55 65.94 0.85 Allowed Pre-proline 0 C--N 1.284 -2.277 0 CA-C-N 110.465 -3.061 . . . . 0.0 113.662 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -52.05 81.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.463 0 C-N-CA 123.001 2.468 . . . . 0.0 114.642 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.06 6.73 27.73 Favored Glycine 1 N--CA 1.516 4.007 0 O-C-N 122.115 -0.366 . . . . 0.0 113.619 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 36.0 tt0 -123.61 156.85 35.02 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 124.36 2.029 . . . . 0.0 116.326 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.794 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.96 156.37 27.55 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -115.95 147.89 40.67 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-O 116.518 -1.706 . . . . 0.0 107.247 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.442 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.45 143.76 41.77 Favored 'General case' 0 N--CA 1.529 3.511 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 84.0 m -119.95 102.52 8.61 Favored 'General case' 0 N--CA 1.514 2.769 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.546 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.7 m -94.8 152.24 18.58 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.9 168.33 8.05 Favored Pre-proline 0 N--CA 1.504 2.268 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.076 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.35 -174.84 1.54 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 121.058 1.172 . . . . 0.0 111.073 161.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.36 -19.74 18.99 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 124.289 1.995 . . . . 0.0 107.173 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.15 42.66 0.49 Allowed 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 111.286 -2.688 . . . . 0.0 109.132 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.592 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.34 84.83 9.9 Favored Pre-proline 0 N--CA 1.499 2.011 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.723 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.8 Cg_endo -79.45 178.59 7.22 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.83 2.354 . . . . 0.0 112.303 172.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.569 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.03 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 125.432 1.493 . . . . 0.0 113.243 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.541 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.33 124.99 5.63 Favored Glycine 0 N--CA 1.507 3.38 0 N-CA-C 121.792 3.477 . . . . 0.0 121.792 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.655 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 44.0 mt-10 -99.46 61.23 1.18 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.813 ' HB2' HG23 ' A' ' 101' ' ' ILE . 2.8 m-85 -62.13 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.924 1.345 . . . . 0.0 112.969 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.8 m -63.42 135.95 57.28 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.538 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.53 136.53 52.91 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.984 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.69 82.11 8.57 Favored 'General case' 0 N--CA 1.512 2.672 1 N-CA-C 132.536 7.976 . . . . 0.0 132.536 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.0 t -63.91 82.21 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.495 2 CA-C-N 130.343 5.974 . . . . 0.0 114.324 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.5 tt0 -20.6 -72.42 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.6 0 N-CA-C 118.518 2.784 . . . . 0.0 118.518 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.55 ' O ' ' CD2' ' B' ' 3' ' ' PHE . 29.5 Cg_endo -67.04 -3.41 9.65 Favored 'Trans proline' 0 N--CA 1.51 2.473 0 C-N-CA 122.361 2.04 . . . . 0.0 115.383 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -120.85 -14.18 8.54 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.415 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.35 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.55 -33.94 1.74 Allowed Glycine 1 N--CA 1.521 4.343 0 O-C-N 121.491 -0.756 . . . . 0.0 112.645 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.6 68.51 7.98 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.9 26.74 0.05 OUTLIER Glycine 1 N--CA 1.528 4.774 0 CA-C-N 114.0 -1.455 . . . . 0.0 116.631 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.895 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.1 ttm -108.63 43.9 1.19 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 124.539 2.114 . . . . 0.0 112.973 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.02 134.87 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 112.209 -2.269 . . . . 0.0 110.916 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.538 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.62 154.88 19.33 Favored Glycine 1 N--CA 1.536 5.36 0 C-N-CA 119.468 -1.349 . . . . 0.0 114.023 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.909 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.0 ttpp -118.63 81.95 1.77 Allowed 'General case' 0 N--CA 1.516 2.863 0 CA-C-N 119.408 1.604 . . . . 0.0 115.238 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.813 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.66 123.22 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.731 0 C-N-CA 118.061 -1.456 . . . . 0.0 107.087 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.909 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.5 m -112.59 88.74 2.89 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.177 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 80' ' ' ALA . 38.2 t -74.08 105.15 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.16 -72.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 O-C-N 126.112 2.133 . . . . 0.0 115.93 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.569 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.534 0 O-C-N 125.555 1.785 . . . . 0.0 113.796 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.281 22.0 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.55 ' CD2' ' O ' ' A' ' 91' ' ' PRO . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' TRP . . . . . 0.429 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.7 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.31 27.8 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.548 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 53.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.537 ' O ' HD13 ' B' ' 243' ' ' LEU . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.403 HG23 HD12 ' B' ' 247' ' ' ILE . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.742 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.368 22.4 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.652 ' H ' ' HG ' ' B' ' 133' ' ' SER . 33.0 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.457 HG11 ' N ' ' B' ' 46' ' ' PHE . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.764 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.417 ' O ' HG22 ' B' ' 58' ' ' VAL . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.417 HG22 ' O ' ' B' ' 55' ' ' ASP . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.58 ' O ' HG21 ' B' ' 68' ' ' VAL . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.621 HG12 ' N ' ' B' ' 69' ' ' GLY . 88.0 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.621 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.536 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.421 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.437 HD11 HG23 ' B' ' 149' ' ' VAL . 50.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' PRO . . . . . 0.704 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.704 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.2 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.3 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 94' ' ' LEU . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.7 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 1.475 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 20.7 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' GLN . . . . . 1.138 ' NE2' HG11 ' A' ' 36' ' ' VAL . 11.9 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.546 ' C ' HG13 ' B' ' 114' ' ' VAL . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.546 HG13 ' C ' ' B' ' 113' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.421 ' CD1' HG21 ' B' ' 75' ' ' VAL 0.592 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 1.278 ' O ' ' HE2' ' A' ' 66' ' ' MET . 36.4 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 1.357 ' HA ' ' CE ' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.45 ' C ' HG12 ' B' ' 131' ' ' VAL . 24.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.764 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.442 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' SER . . . . . 0.652 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . 0.429 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 20.8 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' PRO . . . . . 0.677 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.328 23.8 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.429 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . 0.462 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.523 HD11 ' HH ' ' B' ' 147' ' ' TYR 0.317 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . 0.677 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' TYR . . . . . 0.523 ' HH ' HD11 ' B' ' 142' ' ' ILE . 45.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' SER . . . . . 0.426 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' VAL . . . . . 0.437 HG23 HD11 ' B' ' 76' ' ' LEU 0.418 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' HIS . . . . . 0.548 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.484 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.0 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.525 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' TYR . . . . . 0.403 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 64.3 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' PRO . . . . . 0.429 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 23.0 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.46 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.1 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . 0.495 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . 0.719 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.54 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . 0.687 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.687 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' GLU . . . . . 0.807 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.363 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.444 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.578 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 197' ' ' VAL . . . . . 0.578 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 200' ' ' LYS . . . . . 0.54 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.8 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.452 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.452 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' ASP . . . . . 0.433 ' O ' HD13 ' B' ' 196' ' ' LEU . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.719 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.256 25.9 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.627 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' ASN . . . . . 0.537 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 19.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . 0.537 HD13 ' O ' ' B' ' 32' ' ' THR . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' ILE . . . . . 0.403 HD12 HG23 ' B' ' 40' ' ' VAL . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.727 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 82.5 m -61.65 89.68 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.022 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.95 163.01 12.63 Favored 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.72 122.41 46.68 Favored 'General case' 0 N--CA 1.526 3.326 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.5 t -100.57 98.36 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.7 mmmt -67.27 65.33 0.07 Allowed 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 113.144 -1.844 . . . . 0.0 114.9 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.814 HD11 ' HB2' ' A' ' 39' ' ' HIS . 14.7 mt -29.45 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 126.539 1.935 . . . . 0.0 115.531 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.48 59.04 0.4 Allowed Glycine 0 N--CA 1.51 3.576 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -0.95 54.0 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.61 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.84 22.57 14.34 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 120.956 -1.09 . . . . 0.0 108.154 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.22 -94.82 1.89 Allowed Glycine 0 N--CA 1.512 3.715 0 N-CA-C 115.499 0.96 . . . . 0.0 115.499 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.481 HD13 ' H ' ' A' ' 14' ' ' LEU . 44.6 tp -150.59 -177.14 5.8 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.999 HD21 HG23 ' A' ' 36' ' ' VAL . 15.1 mt -74.77 46.65 0.3 Allowed 'General case' 0 N--CA 1.509 2.499 0 O-C-N 120.641 -1.287 . . . . 0.0 111.264 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.78 165.6 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.561 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 4.9 m-30 -102.17 75.43 1.5 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 112.263 -2.244 . . . . 0.0 113.423 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.307 12.4 mt-10 -93.51 142.43 25.18 Favored Pre-proline 0 N--CA 1.506 2.333 0 O-C-N 121.822 -0.549 . . . . 0.0 111.778 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.5 76.22 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.431 0 N-CA-C 116.4 1.654 . . . . 0.0 116.4 -9.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.63 -44.22 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.795 1 N-CA-C 122.319 4.192 . . . . 0.0 122.319 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.631 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.56 71.65 1.0 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 122.388 1.09 . . . . 0.0 113.066 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.614 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.1 111.2 7.13 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.131 -1.606 . . . . 0.0 109.099 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.5 ' N ' HD22 ' A' ' 21' ' ' LEU . 49.7 m -87.46 81.42 7.81 Favored 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.696 HD11 HD12 ' A' ' 101' ' ' ILE . 5.3 pt -79.72 -177.55 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.626 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.619 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.68 166.55 10.58 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-N 113.78 -1.554 . . . . 0.0 108.122 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.4 Cg_endo -52.22 77.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.318 0 N-CA-C 116.866 1.833 . . . . 0.0 116.866 174.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.07 -50.51 0.52 Allowed Glycine 1 N--CA 1.522 4.428 0 C-N-CA 119.717 -1.23 . . . . 0.0 115.879 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.684 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.73 92.11 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.184 1 N-CA-C 122.19 4.144 . . . . 0.0 122.19 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.477 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.9 m -64.1 36.07 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.019 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 30' ' ' GLU . 62.8 t -52.11 147.17 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 CA-C-N 112.853 -1.976 . . . . 0.0 111.51 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' N ' HG13 ' A' ' 29' ' ' VAL . 4.1 pt-20 -114.2 154.88 27.11 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 123.916 1.817 . . . . 0.0 115.38 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.52 113.81 27.39 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.779 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.67 112.6 25.02 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -75.17 84.74 2.37 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.159 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.33 -45.11 18.36 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.92 -169.25 3.33 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 124.662 1.185 . . . . 0.0 109.109 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.999 HG23 HD21 ' A' ' 14' ' ' LEU . 1.7 m 12.75 70.69 0.11 Allowed Pre-proline 0 N--CA 1.52 3.066 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.229 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.44 177.24 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.219 0 C-N-CA 123.99 3.127 . . . . 0.0 114.424 -165.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.6 Cg_endo -92.44 165.31 25.18 Favored 'Cis proline' 0 N--CA 1.503 2.048 0 N-CA-C 115.399 1.269 . . . . 0.0 115.399 -7.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.814 ' HB2' HD11 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.9 87.43 2.73 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.586 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -103.36 140.35 37.55 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 122.482 2.401 . . . . 0.0 110.664 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.0 m -118.12 116.24 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 121.438 3.866 . . . . 0.0 121.438 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.977 HG22 ' HB2' ' A' ' 88' ' ' TYR . 15.0 m -75.92 165.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 102.258 -3.238 . . . . 0.0 102.258 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.861 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.32 130.97 55.51 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.472 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.41 93.78 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.168 1 N-CA-C 124.111 4.856 . . . . 0.0 124.111 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.07 6.8 43.47 Favored 'General case' 0 CA--C 1.602 2.967 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.81 -65.55 1.18 Allowed 'General case' 0 CA--C 1.574 1.889 0 C-N-CA 127.549 2.339 . . . . 0.0 112.723 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.6 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.71 66.45 9.47 Favored 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.37 151.27 0.75 Allowed Pre-proline 0 N--CA 1.523 3.182 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.8 Cg_endo -42.47 -58.28 1.32 Allowed 'Trans proline' 0 N--CA 1.507 2.324 0 C-N-CA 123.385 2.724 . . . . 0.0 115.079 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.43 67.4 0.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 124.069 1.89 . . . . 0.0 107.038 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.2 53.51 1.0 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 112.275 -2.239 . . . . 0.0 108.249 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.85 56.91 0.76 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.741 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.63 -47.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.244 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.17 -30.83 0.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.174 -1.579 . . . . 0.0 111.558 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.806 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.13 -28.59 0.1 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 122.693 1.235 . . . . 0.0 112.498 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.806 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.8 -27.57 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.639 ' HE2' ' OE1' ' B' ' 189' ' ' GLU . 12.3 tptt 65.06 -55.58 0.3 Allowed 'General case' 0 N--CA 1.532 3.632 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -41.68 -28.93 0.16 Allowed 'General case' 0 N--CA 1.515 2.785 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.861 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.8 pp -53.68 -66.79 0.33 Allowed 'General case' 0 CA--C 1.603 2.999 0 N-CA-C 100.711 -3.811 . . . . 0.0 100.711 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.776 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.14 98.39 2.12 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 125.33 1.452 . . . . 0.0 112.789 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.721 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -89.99 -173.0 3.71 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.827 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.37 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.827 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 28.0 tt0 105.45 65.9 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 120.346 3.462 . . . . 0.0 120.346 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 1.396 HD22 ' CG ' ' B' ' 118' ' ' PRO . 6.0 mp 38.24 84.26 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 120.762 3.616 . . . . 0.0 120.762 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 40' ' ' ASN . 36.2 mt -70.65 82.04 0.6 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.18 -1.575 . . . . 0.0 111.812 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.962 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 41.2 mmm -79.28 62.0 3.52 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 126.158 2.885 . . . . 0.0 110.94 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.7 m -112.62 65.94 0.87 Allowed Pre-proline 0 N--CA 1.504 2.267 0 CA-C-N 110.486 -3.052 . . . . 0.0 113.577 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -51.98 81.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.987 2.458 . . . . 0.0 114.674 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.18 6.56 27.65 Favored Glycine 1 N--CA 1.516 4.028 0 O-C-N 122.209 -0.307 . . . . 0.0 113.604 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.491 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.9 tt0 -123.54 156.82 34.95 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 124.324 2.011 . . . . 0.0 116.368 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.779 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.82 156.35 27.42 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 119.694 3.22 . . . . 0.0 119.694 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -116.0 147.91 40.71 Favored 'General case' 0 N--CA 1.518 2.951 0 CA-C-O 116.59 -1.671 . . . . 0.0 107.222 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.442 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.49 143.62 42.03 Favored 'General case' 0 N--CA 1.529 3.515 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.423 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 84.5 m -119.89 102.56 8.65 Favored 'General case' 0 N--CA 1.515 2.8 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.569 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.1 m -94.73 152.26 18.6 Favored 'General case' 0 N--CA 1.524 3.246 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -107.96 168.4 7.95 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.068 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.41 -174.77 1.53 Allowed 'Trans proline' 0 CA--C 1.558 1.708 0 C-N-CA 121.012 1.141 . . . . 0.0 111.116 161.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.38 -19.75 18.97 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 124.34 2.019 . . . . 0.0 107.222 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.17 42.63 0.49 Allowed 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 111.195 -2.729 . . . . 0.0 109.106 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.593 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.18 84.75 9.51 Favored Pre-proline 0 N--CA 1.5 2.028 0 CA-C-N 113.603 -1.635 . . . . 0.0 113.841 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -79.4 178.68 7.13 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.77 2.313 . . . . 0.0 112.354 172.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.569 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.11 77.75 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 C-N-CA 125.367 1.467 . . . . 0.0 113.244 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.535 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.4 125.03 5.64 Favored Glycine 0 N--CA 1.508 3.487 0 N-CA-C 121.694 3.438 . . . . 0.0 121.694 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.653 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 43.8 mt-10 -99.49 61.26 1.17 Allowed 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.809 ' HB2' HG23 ' A' ' 101' ' ' ILE . 2.8 m-85 -62.1 77.69 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 122.884 1.326 . . . . 0.0 113.07 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.8 m -63.29 135.89 57.33 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.49 136.58 52.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.977 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.7 82.05 8.59 Favored 'General case' 0 N--CA 1.511 2.607 1 N-CA-C 132.617 8.006 . . . . 0.0 132.617 -179.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.1 t -63.93 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.499 2 CA-C-N 130.355 5.98 . . . . 0.0 114.295 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.5 tt0 -20.53 -72.44 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.565 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.562 ' O ' ' CD2' ' B' ' 3' ' ' PHE . 29.5 Cg_endo -66.98 -3.51 9.79 Favored 'Trans proline' 0 N--CA 1.511 2.548 0 C-N-CA 122.467 2.112 . . . . 0.0 115.363 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -120.86 -14.16 8.54 Favored 'General case' 0 N--CA 1.51 2.565 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.402 ' O ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -25.34 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.52 -34.0 1.74 Allowed Glycine 1 N--CA 1.52 4.292 0 O-C-N 121.534 -0.729 . . . . 0.0 112.735 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.59 68.41 7.93 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.93 26.73 0.05 OUTLIER Glycine 1 N--CA 1.527 4.733 0 CA-C-N 114.035 -1.439 . . . . 0.0 116.605 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.888 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.1 ttt -108.51 43.81 1.19 Allowed 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 124.406 2.05 . . . . 0.0 113.0 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.01 134.85 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 112.247 -2.251 . . . . 0.0 110.968 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.534 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.68 154.87 19.36 Favored Glycine 1 N--CA 1.535 5.24 0 C-N-CA 119.435 -1.364 . . . . 0.0 114.013 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.904 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.0 ttpp -118.58 81.97 1.77 Allowed 'General case' 0 N--CA 1.517 2.907 0 CA-C-N 119.405 1.602 . . . . 0.0 115.242 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.809 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.75 123.28 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.743 0 C-N-CA 118.0 -1.48 . . . . 0.0 107.026 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.904 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.5 m -112.57 88.75 2.9 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.228 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 80' ' ' ALA . 38.3 t -74.01 105.19 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.26 -72.37 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.643 0 O-C-N 126.121 2.138 . . . . 0.0 115.885 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.569 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.48 0 O-C-N 125.43 1.706 . . . . 0.0 113.889 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.281 21.7 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 91' ' ' PRO . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' TRP . . . . . 0.429 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.7 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.31 27.6 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.547 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 52.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.537 ' O ' HD13 ' B' ' 243' ' ' LEU . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.404 HG23 HD12 ' B' ' 247' ' ' ILE . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.741 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.369 22.0 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.652 ' H ' ' HG ' ' B' ' 133' ' ' SER . 33.1 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.456 HG11 ' N ' ' B' ' 46' ' ' PHE . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.763 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.415 ' O ' HG22 ' B' ' 58' ' ' VAL . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.415 HG22 ' O ' ' B' ' 55' ' ' ASP . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.579 ' O ' HG21 ' B' ' 68' ' ' VAL . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.621 HG12 ' N ' ' B' ' 69' ' ' GLY . 87.8 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.621 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.536 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.437 HD11 HG23 ' B' ' 149' ' ' VAL . 50.2 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' PRO . . . . . 0.704 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.0 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.704 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.3 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 94' ' ' LEU . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.6 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 1.229 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 20.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' GLN . . . . . 0.967 HE22 ' CG1' ' A' ' 36' ' ' VAL . 11.9 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.546 ' C ' HG13 ' B' ' 114' ' ' VAL . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.546 HG13 ' C ' ' B' ' 113' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.42 ' CD1' HG21 ' B' ' 75' ' ' VAL 0.591 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 1.396 ' CG ' HD22 ' A' ' 64' ' ' LEU . 36.5 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.962 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 93.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.45 ' C ' HG12 ' B' ' 131' ' ' VAL . 24.1 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.763 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.441 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' SER . . . . . 0.652 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.9 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . 0.428 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 20.8 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' PRO . . . . . 0.679 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.328 23.5 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.428 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . 0.461 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.524 HD11 ' HH ' ' B' ' 147' ' ' TYR 0.316 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . 0.679 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' TYR . . . . . 0.524 ' HH ' HD11 ' B' ' 142' ' ' ILE . 45.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' SER . . . . . 0.426 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' VAL . . . . . 0.437 HG23 HD11 ' B' ' 76' ' ' LEU 0.417 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' HIS . . . . . 0.547 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.483 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.524 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' TYR . . . . . 0.403 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 64.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' PRO . . . . . 0.429 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 22.9 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.46 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.1 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . 0.494 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . 0.717 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 18.9 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.539 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . 0.686 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.686 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' GLU . . . . . 0.639 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.362 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.445 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.577 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 197' ' ' VAL . . . . . 0.577 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 200' ' ' LYS . . . . . 0.539 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.7 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.452 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.452 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' ASP . . . . . 0.433 ' O ' HD13 ' B' ' 196' ' ' LEU . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.717 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.257 25.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.627 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' ASN . . . . . 0.536 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . 0.521 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.0 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . 0.537 HD13 ' O ' ' B' ' 32' ' ' THR . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' ILE . . . . . 0.404 HD12 HG23 ' B' ' 40' ' ' VAL . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLU . . . . . 0.708 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.466 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 91.2 m -61.63 89.73 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.975 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -100.01 162.97 12.64 Favored 'General case' 0 N--CA 1.513 2.683 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.8 t -107.71 122.49 46.83 Favored 'General case' 0 N--CA 1.526 3.331 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.0 t -100.62 98.38 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.46 65.53 0.08 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.834 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.802 HD11 ' HB2' ' A' ' 39' ' ' HIS . 15.0 mt -29.67 68.27 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.996 0 C-N-CA 126.54 1.936 . . . . 0.0 115.493 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.46 59.1 0.4 Allowed Glycine 0 N--CA 1.51 3.583 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -1.13 54.15 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.256 0 N-CA-C 120.282 3.438 . . . . 0.0 120.282 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.44 -60.15 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 119.538 3.162 . . . . 0.0 119.538 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.508 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.5 14.42 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.931 -1.106 . . . . 0.0 108.164 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.11 -94.83 1.9 Allowed Glycine 0 N--CA 1.512 3.75 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.3 tp -150.62 -177.16 5.81 Favored 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 36' ' ' VAL . 15.8 mt -74.73 46.7 0.3 Allowed 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.67 -1.269 . . . . 0.0 111.3 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.602 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.74 165.66 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.602 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 5.1 m-30 -102.22 75.35 1.49 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.402 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.283 7.4 mt-10 -93.46 142.46 25.24 Favored Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 121.825 -0.547 . . . . 0.0 111.753 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 20' ' ' LYS . 53.9 Cg_endo -86.46 76.14 0.09 OUTLIER 'Cis proline' 0 CA--C 1.571 2.364 0 N-CA-C 116.353 1.636 . . . . 0.0 116.353 -9.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.74 -44.26 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 1 N-CA-C 122.241 4.163 . . . . 0.0 122.241 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.636 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.58 71.59 1.0 Allowed 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 122.413 1.101 . . . . 0.0 113.1 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.634 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.16 111.31 7.27 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.199 -1.563 . . . . 0.0 109.111 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.526 ' N ' HD22 ' A' ' 21' ' ' LEU . 55.9 m -87.52 81.47 7.76 Favored 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.684 HD11 HD12 ' A' ' 101' ' ' ILE . 4.9 pt -79.66 -177.55 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.742 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.639 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.51 10.66 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 113.887 -1.506 . . . . 0.0 108.115 179.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.0 Cg_endo -52.12 77.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.304 0 N-CA-C 116.934 1.859 . . . . 0.0 116.934 174.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.11 -50.45 0.52 Allowed Glycine 1 N--CA 1.522 4.423 0 C-N-CA 119.706 -1.235 . . . . 0.0 115.857 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.655 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.65 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.167 1 N-CA-C 122.08 4.104 . . . . 0.0 122.08 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.466 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 12.6 m -64.09 35.96 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 30' ' ' GLU . 60.4 t -51.96 147.21 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 112.862 -1.972 . . . . 0.0 111.51 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.497 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.9 pt-20 -114.3 154.86 27.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 123.92 1.819 . . . . 0.0 115.35 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.46 113.8 27.38 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.781 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.69 112.5 24.91 Favored 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 120.728 3.603 . . . . 0.0 120.728 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -75.17 84.73 2.38 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.156 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.6 p30 -80.31 -44.97 18.64 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -150.01 -169.34 3.35 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 124.643 1.177 . . . . 0.0 109.097 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.035 HG23 HD21 ' A' ' 14' ' ' LEU . 1.7 m 12.81 70.69 0.11 Allowed Pre-proline 0 N--CA 1.52 3.046 0 N-CA-C 117.168 2.285 . . . . 0.0 117.168 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 1.557 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 56.3 Cg_endo -98.41 177.19 0.42 Allowed 'Trans proline' 0 CA--C 1.569 2.263 0 C-N-CA 124.041 3.161 . . . . 0.0 114.372 -165.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 56.5 Cg_endo -92.45 165.24 25.16 Favored 'Cis proline' 0 N--CA 1.503 2.063 0 N-CA-C 115.399 1.269 . . . . 0.0 115.399 -7.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.802 ' HB2' HD11 ' A' ' 7' ' ' LEU . 17.5 m-70 -118.88 87.44 2.73 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.55 HD22 ' N ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -103.34 140.27 37.65 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 122.421 2.373 . . . . 0.0 110.716 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.9 m -118.16 116.31 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 121.431 3.863 . . . . 0.0 121.431 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.962 HG22 ' HB2' ' A' ' 88' ' ' TYR . 14.7 m -75.98 165.4 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.858 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.26 130.89 55.52 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.4 93.71 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.208 1 N-CA-C 124.205 4.891 . . . . 0.0 124.205 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.94 6.7 43.57 Favored 'General case' 0 CA--C 1.602 2.959 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB2' HD13 ' A' ' 47' ' ' LEU . . . -115.81 -65.54 1.18 Allowed 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 127.501 2.32 . . . . 0.0 112.668 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.619 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.62 66.46 9.49 Favored 'General case' 0 N--CA 1.518 2.949 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.36 151.28 0.75 Allowed Pre-proline 0 N--CA 1.522 3.158 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.6 Cg_endo -42.51 -58.3 1.32 Allowed 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 123.389 2.726 . . . . 0.0 115.025 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.51 67.47 0.72 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 124.15 1.928 . . . . 0.0 107.056 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.2 53.5 1.0 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 112.267 -2.242 . . . . 0.0 108.219 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.82 56.81 0.76 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.693 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.46 -48.01 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.13 -30.85 0.17 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.127 -1.608 . . . . 0.0 111.606 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.12 -28.6 0.1 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.649 1.214 . . . . 0.0 112.461 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.792 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.76 -27.7 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.479 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.2 tptt 65.14 -55.57 0.31 Allowed 'General case' 0 N--CA 1.534 3.752 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -41.69 -28.94 0.16 Allowed 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.858 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.6 pp -53.68 -66.82 0.32 Allowed 'General case' 0 CA--C 1.604 3.035 0 N-CA-C 100.697 -3.816 . . . . 0.0 100.697 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.812 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.9 p -72.06 98.42 2.09 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 125.267 1.427 . . . . 0.0 112.814 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.713 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.1 t60 -90.02 -173.03 3.72 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.829 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.42 155.2 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.317 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.829 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 27.1 tt0 105.43 66.02 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 120.309 3.448 . . . . 0.0 120.309 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 1.006 HD22 ' HG3' ' B' ' 118' ' ' PRO . 6.0 mp 38.19 84.25 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 120.748 3.61 . . . . 0.0 120.748 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.437 ' N ' ' ND2' ' A' ' 40' ' ' ASN . 36.3 mt -70.66 82.04 0.61 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.145 -1.597 . . . . 0.0 111.865 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.93 ' CE ' ' HA ' ' B' ' 119' ' ' LEU . 42.2 mmm -79.21 61.94 3.46 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 126.074 2.845 . . . . 0.0 110.965 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.9 m -112.53 65.96 0.85 Allowed Pre-proline 0 C--N 1.284 -2.262 0 CA-C-N 110.464 -3.062 . . . . 0.0 113.601 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.682 ' HB2' ' OD2' ' B' ' 100' ' ' ASP . 21.3 Cg_endo -51.98 81.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.507 0 C-N-CA 122.964 2.442 . . . . 0.0 114.675 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.17 6.69 27.55 Favored Glycine 1 N--CA 1.517 4.056 0 O-C-N 122.238 -0.289 . . . . 0.0 113.513 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.8 tt0 -123.61 156.8 35.11 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 124.34 2.019 . . . . 0.0 116.349 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.781 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.83 156.37 27.4 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 119.716 3.228 . . . . 0.0 119.716 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.7 t -116.06 147.88 40.8 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-O 116.682 -1.628 . . . . 0.0 107.199 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.455 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.45 143.72 41.83 Favored 'General case' 0 N--CA 1.529 3.503 0 N-CA-C 118.347 2.721 . . . . 0.0 118.347 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 91.3 m -119.88 102.62 8.7 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.517 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.7 m -94.85 152.22 18.57 Favored 'General case' 0 N--CA 1.525 3.297 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -107.95 168.28 8.12 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -72.27 -174.8 1.51 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 121.03 1.153 . . . . 0.0 111.157 161.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.35 -19.76 18.99 Favored 'General case' 0 N--CA 1.509 2.504 0 CA-C-O 124.384 2.04 . . . . 0.0 107.286 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.14 42.72 0.49 Allowed 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 111.225 -2.716 . . . . 0.0 109.111 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.585 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.38 84.74 9.88 Favored Pre-proline 0 N--CA 1.499 2.008 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.809 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 83' ' ' GLY . 42.4 Cg_endo -79.39 178.63 7.2 Favored 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 122.753 2.302 . . . . 0.0 112.275 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.577 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -15.99 77.69 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 125.348 1.459 . . . . 0.0 113.264 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.537 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.43 125.01 5.63 Favored Glycine 0 N--CA 1.507 3.417 0 N-CA-C 121.74 3.456 . . . . 0.0 121.74 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.656 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 43.9 mt-10 -99.51 61.25 1.17 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.817 ' HB2' HG23 ' A' ' 101' ' ' ILE . 2.9 m-85 -62.05 77.79 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 122.904 1.335 . . . . 0.0 113.032 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 99' ' ' GLY . 7.2 m -63.42 135.95 57.29 Favored 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.555 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.53 136.51 52.92 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.962 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.64 82.07 8.58 Favored 'General case' 0 N--CA 1.512 2.672 1 N-CA-C 132.559 7.985 . . . . 0.0 132.559 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.6 t -63.85 82.23 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.498 2 CA-C-N 130.329 5.968 . . . . 0.0 114.314 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.1 tt0 -20.57 -72.45 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.56 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 35.6 Cg_endo -67.04 -3.43 9.69 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.326 2.017 . . . . 0.0 115.401 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -120.84 -14.12 8.56 Favored 'General case' 0 N--CA 1.511 2.585 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.409 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.23 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.53 -33.91 1.75 Allowed Glycine 1 N--CA 1.52 4.266 0 O-C-N 121.535 -0.728 . . . . 0.0 112.657 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.64 68.42 7.98 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.92 26.7 0.05 OUTLIER Glycine 1 N--CA 1.526 4.636 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.843 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.0 ttt -108.5 43.87 1.19 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 124.559 2.123 . . . . 0.0 113.023 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.94 134.91 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 112.19 -2.277 . . . . 0.0 110.902 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.7 154.88 19.38 Favored Glycine 1 N--CA 1.536 5.347 0 C-N-CA 119.489 -1.339 . . . . 0.0 113.978 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.841 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.1 ttpp -118.7 82.0 1.78 Allowed 'General case' 0 N--CA 1.518 2.94 0 CA-C-N 119.371 1.585 . . . . 0.0 115.192 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.817 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.69 123.33 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.841 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 8.4 m -112.7 88.75 2.9 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.193 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 80' ' ' ALA . 39.2 t -73.98 105.21 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.35 -72.26 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 O-C-N 126.132 2.145 . . . . 0.0 115.942 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.577 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.486 0 O-C-N 125.49 1.744 . . . . 0.0 113.811 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' TRP . . . . . 0.44 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.9 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . 0.407 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 62.6 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.6 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.441 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 56.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.5 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 55.5 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' B' ' 27' ' ' LEU . 71.5 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' THR . . . . . 0.559 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.1 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 1.376 ' HB ' ' CG2' ' B' ' 34' ' ' VAL 0.399 1.4 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.6 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.425 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.425 ' O ' HG12 ' B' ' 36' ' ' VAL . 28.0 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.411 HG23 HD12 ' B' ' 247' ' ' ILE . 25.8 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.771 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.653 ' H ' ' HG ' ' B' ' 133' ' ' SER . 32.5 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.441 HG11 ' N ' ' B' ' 46' ' ' PHE . 86.9 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.953 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.4 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.453 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.9 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.3 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.453 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.8 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.8 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.568 ' O ' HG21 ' B' ' 68' ' ' VAL . 58.9 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.628 HG12 ' N ' ' B' ' 69' ' ' GLY . 86.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.628 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' LEU . . . . . 0.551 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.2 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.9 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' PRO . . . . . 0.761 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 19.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.761 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 44.1 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.384 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 37.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 72.6 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.474 ' HA ' HD12 ' B' ' 94' ' ' LEU . 50.4 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.8 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.682 ' OD2' ' HB2' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 1.557 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 19.1 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' GLN . . . . . 0.897 HE22 ' CG1' ' A' ' 36' ' ' VAL . 11.1 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' TYR . . . . . 0.407 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 23.9 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.513 ' C ' HG13 ' B' ' 114' ' ' VAL . 56.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.54 ' O ' HG23 ' B' ' 114' ' ' VAL . 16.5 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.524 ' CD1' HG21 ' B' ' 75' ' ' VAL 0.727 0.0 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' VAL . . . . . 1.575 ' HB ' ' CB ' ' B' ' 116' ' ' VAL 0.68 0.1 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' PRO . . . . . 1.006 ' HG3' HD22 ' A' ' 64' ' ' LEU . 38.0 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . 0.93 ' HA ' ' CE ' ' A' ' 66' ' ' MET . 82.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.5 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 94.4 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.471 ' C ' HG12 ' B' ' 131' ' ' VAL . 15.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.953 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.5 1.5 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' SER . . . . . 0.653 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ASN . . . . . 0.446 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 23.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' PRO . . . . . 0.641 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 13.0 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' ALA . . . . . 0.446 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' ASP . . . . . 0.541 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.541 HG22 ' CG ' ' B' ' 139' ' ' ASP 0.393 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' PHE . . . . . 0.641 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.0 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' SER . . . . . 0.471 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.6 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' VAL . . . . . 0.471 HG13 ' C ' ' B' ' 148' ' ' SER 0.426 1.2 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' HIS . . . . . 0.441 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.418 HG12 HG23 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.463 ' NH2' ' HB2' ' B' ' 169' ' ' ASN . 29.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.666 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.2 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 1.355 ' HB ' ' CG2' ' B' ' 160' ' ' VAL 0.457 1.3 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' TYR . . . . . 0.4 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 63.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' PRO . . . . . 0.44 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 20.2 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.8 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' LEU . . . . . 0.521 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' TYR . . . . . 0.718 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.6 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.529 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 58.5 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.8 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' ILE . . . . . 0.709 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.1 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' ALA . . . . . 0.709 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 43.8 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.444 0.9 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.472 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.3 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.419 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.2 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . 0.625 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 197' ' ' VAL . . . . . 0.625 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.366 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 200' ' ' LYS . . . . . 0.529 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 81.0 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.456 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.4 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.456 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.8 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' ASP . . . . . 0.468 ' O ' HD13 ' B' ' 196' ' ' LEU . 63.5 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.718 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 39.1 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 88.3 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.9 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' VAL . . . . . 1.392 ' HB ' ' CG2' ' B' ' 225' ' ' VAL 0.391 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.6 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' ASN . . . . . 0.501 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.4 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . 0.475 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 22.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.6 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . 0.559 HD13 ' O ' ' B' ' 32' ' ' THR . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' ILE . . . . . 0.411 HD12 HG23 ' B' ' 40' ' ' VAL . 18.2 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.0 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 118.159 -0.924 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.714 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.461 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.3 m -61.55 89.7 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -99.99 163.04 12.61 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.456 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.82 122.41 46.72 Favored 'General case' 0 N--CA 1.525 3.321 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -100.49 98.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.33 65.38 0.07 Allowed 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 113.14 -1.845 . . . . 0.0 114.855 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.8 HD11 ' HB2' ' A' ' 39' ' ' HIS . 15.3 mt -29.52 68.27 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 126.521 1.929 . . . . 0.0 115.543 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.44 59.01 0.4 Allowed Glycine 0 N--CA 1.509 3.539 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.1 p -1.0 54.04 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.33 0 N-CA-C 120.242 3.423 . . . . 0.0 120.242 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.53 -60.19 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.49 14.43 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.962 -1.086 . . . . 0.0 108.151 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.06 -94.86 1.91 Allowed Glycine 0 N--CA 1.512 3.75 0 N-CA-C 115.546 0.978 . . . . 0.0 115.546 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.527 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.9 tp -150.64 -177.13 5.8 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 1.047 HD21 HG23 ' A' ' 36' ' ' VAL . 15.6 mt -74.8 46.73 0.3 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.654 -1.279 . . . . 0.0 111.244 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.599 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.83 165.64 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 118.503 2.779 . . . . 0.0 118.503 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.599 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 5.1 m-30 -102.25 75.35 1.48 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 112.187 -2.279 . . . . 0.0 113.356 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.47 142.47 25.25 Favored Pre-proline 0 N--CA 1.507 2.376 0 O-C-N 121.822 -0.549 . . . . 0.0 111.735 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 20' ' ' LYS . 56.3 Cg_endo -86.43 76.09 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.426 0 N-CA-C 116.359 1.638 . . . . 0.0 116.359 -9.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.73 -44.23 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 1 N-CA-C 122.3 4.185 . . . . 0.0 122.3 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.638 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.62 71.66 1.0 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 122.433 1.111 . . . . 0.0 113.092 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.642 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.11 111.27 7.19 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.152 -1.592 . . . . 0.0 109.107 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.532 ' N ' HD22 ' A' ' 21' ' ' LEU . 52.6 m -87.51 81.5 7.76 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.705 HD11 HD12 ' A' ' 101' ' ' ILE . 4.7 pt -79.7 -177.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.652 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.646 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.69 166.58 10.51 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-N 113.769 -1.559 . . . . 0.0 108.067 179.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.4 Cg_endo -52.18 77.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.571 2.326 0 N-CA-C 116.947 1.864 . . . . 0.0 116.947 174.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.13 -50.48 0.52 Allowed Glycine 1 N--CA 1.522 4.414 0 C-N-CA 119.73 -1.224 . . . . 0.0 115.833 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.655 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.71 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.151 1 N-CA-C 122.104 4.113 . . . . 0.0 122.104 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.461 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.5 m -64.01 35.91 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.012 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 30' ' ' GLU . 59.2 t -51.95 147.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 112.863 -1.971 . . . . 0.0 111.517 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.493 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.9 pt-20 -114.29 154.93 27.12 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 123.934 1.826 . . . . 0.0 115.359 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -107.55 113.86 27.46 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.8 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.79 112.57 25.02 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 120.636 3.569 . . . . 0.0 120.636 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -75.13 84.75 2.35 Favored 'General case' 0 N--CA 1.512 2.645 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.18 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.7 p30 -80.26 -45.14 18.44 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.9 -169.29 3.34 Favored 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 124.661 1.184 . . . . 0.0 109.118 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.047 HG23 HD21 ' A' ' 14' ' ' LEU . 1.6 m 12.82 70.7 0.11 Allowed Pre-proline 0 N--CA 1.521 3.079 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.466 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 58.4 Cg_endo -98.4 177.24 0.41 Allowed 'Trans proline' 0 CA--C 1.569 2.261 0 C-N-CA 123.945 3.096 . . . . 0.0 114.422 -165.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 58.2 Cg_endo -92.41 165.28 25.29 Favored 'Cis proline' 0 N--CA 1.504 2.105 0 N-CA-C 115.402 1.27 . . . . 0.0 115.402 -7.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.8 ' HB2' HD11 ' A' ' 7' ' ' LEU . 17.9 m-70 -118.88 87.44 2.73 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.605 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -103.4 140.29 37.66 Favored 'General case' 0 N--CA 1.516 2.832 0 CA-C-N 122.469 2.395 . . . . 0.0 110.719 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.5 m -118.11 116.25 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 121.419 3.859 . . . . 0.0 121.419 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.957 HG22 ' HB2' ' A' ' 88' ' ' TYR . 14.5 m -75.95 165.35 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.87 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.26 131.02 55.47 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 46' ' ' ALA . 4.1 m-20 -53.47 93.77 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.174 1 N-CA-C 124.148 4.87 . . . . 0.0 124.148 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.98 6.76 43.43 Favored 'General case' 0 CA--C 1.602 2.97 0 N-CA-C 101.23 -3.618 . . . . 0.0 101.23 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 47' ' ' LEU . . . -115.84 -65.57 1.18 Allowed 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 127.526 2.33 . . . . 0.0 112.669 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.639 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.47 9.49 Favored 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.41 151.25 0.74 Allowed Pre-proline 0 N--CA 1.523 3.181 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.0 Cg_endo -42.51 -58.17 1.36 Allowed 'Trans proline' 0 N--CA 1.508 2.359 0 C-N-CA 123.362 2.708 . . . . 0.0 115.102 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.543 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.51 67.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 124.066 1.888 . . . . 0.0 107.062 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.403 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.16 53.5 0.99 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 112.275 -2.239 . . . . 0.0 108.208 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.87 56.89 0.76 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.773 2.508 . . . . 0.0 117.773 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.702 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.51 -48.0 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.13 -30.85 0.16 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.106 -1.622 . . . . 0.0 111.571 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.801 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.16 -28.52 0.1 Allowed 'General case' 0 N--CA 1.509 2.501 0 CA-C-O 122.716 1.246 . . . . 0.0 112.475 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.801 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.81 -27.63 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.2 tptt 65.04 -55.59 0.3 Allowed 'General case' 0 N--CA 1.533 3.691 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -41.68 -28.93 0.16 Allowed 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.87 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.72 -66.71 0.34 Allowed 'General case' 0 CA--C 1.603 3.019 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.823 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.6 p -72.18 98.47 2.15 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.273 1.429 . . . . 0.0 112.765 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.714 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.03 -173.1 3.74 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.815 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.43 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.365 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.815 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 27.1 tt0 105.52 65.99 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 120.292 3.441 . . . . 0.0 120.292 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.987 HD11 ' N ' ' A' ' 64' ' ' LEU . 5.9 mp 38.13 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.605 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 35.2 mt -70.64 82.05 0.6 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.101 -1.624 . . . . 0.0 111.886 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 1.525 ' CE ' HD23 ' B' ' 119' ' ' LEU . 41.9 mmm -79.23 61.97 3.48 Favored 'General case' 0 N--CA 1.511 2.579 0 CA-C-O 126.021 2.82 . . . . 0.0 110.913 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.6 m -112.61 65.98 0.87 Allowed Pre-proline 0 C--N 1.283 -2.287 0 CA-C-N 110.525 -3.034 . . . . 0.0 113.585 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.679 ' CG ' ' OD2' ' B' ' 100' ' ' ASP . 21.9 Cg_endo -52.03 81.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.461 0 C-N-CA 122.945 2.43 . . . . 0.0 114.699 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.64 27.66 Favored Glycine 0 N--CA 1.516 3.973 0 O-C-N 122.177 -0.327 . . . . 0.0 113.637 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.55 156.94 34.76 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 124.321 2.01 . . . . 0.0 116.367 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.8 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -117.05 156.34 27.71 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 119.628 3.195 . . . . 0.0 119.628 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -115.89 147.97 40.5 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-O 116.603 -1.665 . . . . 0.0 107.236 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.466 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.5 143.71 41.91 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 118.383 2.734 . . . . 0.0 118.383 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 84.4 m -119.94 102.54 8.63 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.543 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.4 m -94.73 152.18 18.66 Favored 'General case' 0 N--CA 1.526 3.334 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.92 168.31 8.08 Favored Pre-proline 0 N--CA 1.503 2.184 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.09 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -72.35 -174.74 1.51 Allowed 'Trans proline' 0 CA--C 1.559 1.747 0 C-N-CA 120.994 1.129 . . . . 0.0 111.149 161.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.77 18.96 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 124.41 2.052 . . . . 0.0 107.235 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.13 42.61 0.49 Allowed 'General case' 0 CA--C 1.577 1.984 0 CA-C-N 111.265 -2.698 . . . . 0.0 109.097 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.579 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.27 84.74 9.66 Favored Pre-proline 0 N--CA 1.5 2.032 0 CA-C-N 113.608 -1.633 . . . . 0.0 113.768 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 83' ' ' GLY . 45.9 Cg_endo -79.41 178.68 7.13 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.73 2.287 . . . . 0.0 112.245 172.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.58 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.05 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.91 0 C-N-CA 125.29 1.436 . . . . 0.0 113.333 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.41 125.01 5.63 Favored Glycine 0 N--CA 1.508 3.456 0 N-CA-C 121.76 3.464 . . . . 0.0 121.76 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.65 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 43.9 mt-10 -99.43 61.2 1.18 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.806 ' HB2' HG23 ' A' ' 101' ' ' ILE . 3.0 m-85 -62.07 77.75 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 122.93 1.348 . . . . 0.0 113.013 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.7 m -63.41 135.97 57.31 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.553 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.51 136.52 52.91 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.957 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.61 82.05 8.59 Favored 'General case' 0 N--CA 1.512 2.627 1 N-CA-C 132.634 8.013 . . . . 0.0 132.634 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.706 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.94 82.19 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.438 2 CA-C-N 130.343 5.974 . . . . 0.0 114.313 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.1 tt0 -20.52 -72.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.459 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 36.6 Cg_endo -67.07 -3.43 9.72 Favored 'Trans proline' 0 N--CA 1.511 2.517 0 C-N-CA 122.383 2.056 . . . . 0.0 115.356 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -120.91 -14.13 8.52 Favored 'General case' 0 N--CA 1.511 2.594 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.434 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.25 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.64 -34.16 1.72 Allowed Glycine 1 N--CA 1.521 4.324 0 O-C-N 121.518 -0.739 . . . . 0.0 112.643 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.42 68.44 7.75 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.94 26.63 0.05 OUTLIER Glycine 1 N--CA 1.527 4.71 0 N-CA-C 116.665 1.426 . . . . 0.0 116.665 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.855 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.0 ttt -108.46 43.84 1.19 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 124.524 2.107 . . . . 0.0 113.016 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.96 134.81 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 112.313 -2.221 . . . . 0.0 110.954 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.62 154.9 19.34 Favored Glycine 1 N--CA 1.535 5.289 0 C-N-CA 119.49 -1.338 . . . . 0.0 113.997 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.855 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.1 ttpp -118.61 81.91 1.77 Allowed 'General case' 0 N--CA 1.517 2.912 0 CA-C-N 119.488 1.644 . . . . 0.0 115.226 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.806 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.74 123.31 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 C-N-CA 118.03 -1.468 . . . . 0.0 107.044 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.855 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.9 m -112.65 88.76 2.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.15 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 80' ' ' ALA . 39.1 t -74.06 105.27 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.39 -72.25 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.627 0 O-C-N 126.095 2.122 . . . . 0.0 115.885 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.58 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.484 0 O-C-N 125.526 1.766 . . . . 0.0 113.84 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 24.3 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' TRP . . . . . 0.444 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.424 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 53.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.7 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.4 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.606 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 52.8 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.43 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 78.4 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' B' ' 27' ' ' LEU . 71.8 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.566 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.2 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 1.353 ' HB ' ' CA ' ' B' ' 34' ' ' VAL 0.389 0.4 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.49 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.436 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.436 ' O ' HG12 ' B' ' 36' ' ' VAL . 28.1 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.7 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.413 HG23 HD12 ' B' ' 247' ' ' ILE . 25.8 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.785 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.652 ' H ' ' HG ' ' B' ' 133' ' ' SER . 32.7 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.435 HG11 ' N ' ' B' ' 46' ' ' PHE . 87.0 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 1.012 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.3 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.471 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.471 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.4 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.563 ' O ' HG21 ' B' ' 68' ' ' VAL . 58.7 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.629 HG12 ' N ' ' B' ' 69' ' ' GLY . 81.4 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.629 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.556 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.559 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.5 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.9 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 0.814 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 17.9 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.814 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 44.3 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.463 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' B' ' 130' ' ' PRO . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.481 ' HA ' HD12 ' B' ' 94' ' ' LEU . 50.0 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.679 ' OD2' ' CG ' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.1 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 1.466 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 18.4 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' GLN . . . . . 0.909 HE22 HG13 ' A' ' 36' ' ' VAL . 11.2 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.424 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 23.3 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.498 ' C ' HG13 ' B' ' 114' ' ' VAL . 55.9 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.543 ' O ' HG23 ' B' ' 114' ' ' VAL . 16.7 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 1.578 ' CB ' ' CA ' ' B' ' 115' ' ' ILE 0.521 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 1.49 ' HB ' ' CB ' ' B' ' 116' ' ' VAL 0.463 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.664 ' O ' ' CE ' ' A' ' 66' ' ' MET . 38.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 1.525 HD23 ' CE ' ' A' ' 66' ' ' MET . 81.7 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.8 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.51 ' C ' HG12 ' B' ' 131' ' ' VAL . 13.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 1.012 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.52 0.7 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.9 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.652 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.7 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . 0.447 ' HG2' HD12 ' B' ' 142' ' ' ILE . 38.2 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.449 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 24.1 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' PRO . . . . . 0.65 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.7 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.449 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.545 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.545 HG22 ' CG ' ' B' ' 139' ' ' ASP 0.453 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . 0.65 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' SER . . . . . 0.488 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.5 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' VAL . . . . . 0.488 HG13 ' C ' ' B' ' 148' ' ' SER 0.387 1.5 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.452 HG12 HG23 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.481 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.6 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.665 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.1 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 1.34 ' HB ' ' CG2' ' B' ' 160' ' ' VAL 0.417 0.8 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' PRO . . . . . 0.444 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.6 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.441 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.8 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . 0.53 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . 0.728 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.7 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.525 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 59.2 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.0 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.721 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.721 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.9 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.448 1.7 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.48 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.1 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.435 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.3 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.645 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' VAL . . . . . 0.645 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.439 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' LYS . . . . . 0.525 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.6 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.457 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.6 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.457 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' ASP . . . . . 0.481 ' O ' HD13 ' B' ' 196' ' ' LEU . 63.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.728 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 40.0 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . 0.403 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.403 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 12.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.5 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.4 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 1.347 ' HB ' ' CA ' ' B' ' 225' ' ' VAL 0.417 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' ASN . . . . . 0.511 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . 0.481 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 22.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.6 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . 0.566 HD13 ' O ' ' B' ' 32' ' ' THR . 15.1 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' ILE . . . . . 0.413 HD12 HG23 ' B' ' 40' ' ' VAL . 18.5 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 40.7 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' HEC . . . . . 0.606 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.716 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.456 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 85.4 m -61.52 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.02 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -100.0 163.01 12.62 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.459 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.75 122.44 46.75 Favored 'General case' 0 N--CA 1.525 3.32 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.4 t -100.57 98.32 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.34 65.4 0.07 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 113.096 -1.865 . . . . 0.0 114.893 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.796 HD11 ' HB2' ' A' ' 39' ' ' HIS . 15.2 mt -29.49 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 126.585 1.954 . . . . 0.0 115.512 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.45 59.09 0.4 Allowed Glycine 0 N--CA 1.51 3.609 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.4 p -1.09 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 120.31 3.448 . . . . 0.0 120.31 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.48 -60.16 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 119.551 3.167 . . . . 0.0 119.551 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.84 22.46 14.44 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 120.956 -1.09 . . . . 0.0 108.209 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.09 -94.85 1.91 Allowed Glycine 0 N--CA 1.511 3.672 0 N-CA-C 115.528 0.971 . . . . 0.0 115.528 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.7 tp -150.54 -177.13 5.79 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 1.034 HD21 HG23 ' A' ' 36' ' ' VAL . 15.7 mt -74.8 46.66 0.3 Allowed 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.627 -1.295 . . . . 0.0 111.247 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.6 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.74 165.73 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 118.575 2.805 . . . . 0.0 118.575 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.6 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 5.1 m-30 -102.34 75.45 1.48 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.384 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.274 4.8 mt-10 -93.48 142.37 25.11 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.781 -0.574 . . . . 0.0 111.806 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 20' ' ' LYS . 55.9 Cg_endo -86.47 76.15 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.389 0 N-CA-C 116.352 1.635 . . . . 0.0 116.352 -9.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.68 -44.17 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.737 1 N-CA-C 122.238 4.162 . . . . 0.0 122.238 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.64 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.68 71.6 0.99 Allowed 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.442 1.115 . . . . 0.0 113.049 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.633 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.1 111.3 7.21 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.178 -1.576 . . . . 0.0 109.098 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.53 ' N ' HD22 ' A' ' 21' ' ' LEU . 54.6 m -87.48 81.38 7.81 Favored 'General case' 0 N--CA 1.514 2.728 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.706 HD11 HD12 ' A' ' 101' ' ' ILE . 4.8 pt -79.68 -177.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.675 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.65 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.72 166.54 10.59 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.104 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.5 Cg_endo -52.18 77.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.288 0 N-CA-C 116.921 1.854 . . . . 0.0 116.921 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.16 -50.44 0.52 Allowed Glycine 1 N--CA 1.522 4.414 0 C-N-CA 119.733 -1.222 . . . . 0.0 115.852 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.647 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.6 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.174 1 N-CA-C 122.101 4.112 . . . . 0.0 122.101 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.6 m -63.99 35.92 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.049 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 30' ' ' GLU . 60.1 t -52.01 147.22 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.501 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.493 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.9 pt-20 -114.26 154.9 27.14 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 123.914 1.816 . . . . 0.0 115.41 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -107.54 113.87 27.47 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.784 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.77 112.54 24.97 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 120.71 3.596 . . . . 0.0 120.71 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -75.2 84.72 2.39 Favored 'General case' 0 N--CA 1.511 2.599 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.18 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.5 p30 -80.18 -45.17 18.54 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.89 -169.29 3.34 Favored 'General case' 0 N--CA 1.508 2.467 0 C-N-CA 124.656 1.183 . . . . 0.0 109.111 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.171 HG13 ' NE2' ' B' ' 104' ' ' GLN . 1.6 m 12.89 70.68 0.11 Allowed Pre-proline 0 N--CA 1.52 3.055 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.153 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 57.7 Cg_endo -98.52 177.26 0.4 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 123.92 3.08 . . . . 0.0 114.324 -165.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.583 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 57.7 Cg_endo -92.44 165.32 25.18 Favored 'Cis proline' 0 N--CA 1.503 2.071 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 -7.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.796 ' HB2' HD11 ' A' ' 7' ' ' LEU . 17.9 m-70 -118.95 87.35 2.72 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.582 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -103.42 140.28 37.68 Favored 'General case' 0 N--CA 1.516 2.857 0 CA-C-N 122.418 2.372 . . . . 0.0 110.685 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.6 m -118.09 116.25 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 121.445 3.868 . . . . 0.0 121.445 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.985 HG22 ' HB2' ' A' ' 88' ' ' TYR . 14.7 m -75.88 165.44 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.873 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.28 130.96 55.5 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 46' ' ' ALA . 4.1 m-20 -53.53 93.82 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.185 1 N-CA-C 124.088 4.847 . . . . 0.0 124.088 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.94 6.74 43.44 Favored 'General case' 0 CA--C 1.602 2.952 0 N-CA-C 101.228 -3.619 . . . . 0.0 101.228 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' HB2' HD13 ' A' ' 47' ' ' LEU . . . -115.88 -65.49 1.18 Allowed 'General case' 0 CA--C 1.573 1.85 0 C-N-CA 127.519 2.328 . . . . 0.0 112.705 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.632 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.48 9.5 Favored 'General case' 0 N--CA 1.52 3.034 0 N-CA-C 118.91 2.93 . . . . 0.0 118.91 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.44 151.24 0.74 Allowed Pre-proline 0 N--CA 1.522 3.151 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.7 Cg_endo -42.42 -58.27 1.31 Allowed 'Trans proline' 0 N--CA 1.509 2.391 0 C-N-CA 123.376 2.717 . . . . 0.0 115.113 170.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.544 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.49 67.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 124.112 1.911 . . . . 0.0 107.04 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.404 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.16 53.49 0.99 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.344 -2.207 . . . . 0.0 108.265 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.81 56.96 0.75 Allowed 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.691 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.57 -47.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.14 -30.84 0.17 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.226 -1.546 . . . . 0.0 111.564 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.801 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.18 -28.53 0.1 Allowed 'General case' 0 N--CA 1.508 2.449 0 CA-C-O 122.77 1.272 . . . . 0.0 112.567 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.801 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.77 -27.58 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.2 tptt 65.01 -55.55 0.3 Allowed 'General case' 0 N--CA 1.533 3.691 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.76 -28.89 0.17 Allowed 'General case' 0 N--CA 1.515 2.818 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.873 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.69 -66.82 0.32 Allowed 'General case' 0 CA--C 1.603 3.013 0 N-CA-C 100.69 -3.819 . . . . 0.0 100.69 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.829 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.14 98.46 2.13 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 125.259 1.424 . . . . 0.0 112.806 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.726 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.1 t60 -90.01 -172.93 3.68 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.837 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.34 155.2 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.353 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.837 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 27.3 tt0 105.41 66.08 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.778 0 N-CA-C 120.285 3.439 . . . . 0.0 120.285 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 1.176 HD21 ' CZ ' ' B' ' 1' ' ' TYR . 5.9 mp 38.16 84.18 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 120.805 3.632 . . . . 0.0 120.805 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.582 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 36.0 mt -70.59 82.08 0.59 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.225 -1.547 . . . . 0.0 111.876 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.698 ' HE2' ' HG2' ' B' ' 118' ' ' PRO . 42.1 mmm -79.29 62.02 3.54 Favored 'General case' 0 N--CA 1.51 2.536 0 CA-C-O 126.066 2.841 . . . . 0.0 110.945 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.2 m -112.65 65.92 0.87 Allowed Pre-proline 0 C--N 1.283 -2.295 0 CA-C-N 110.482 -3.053 . . . . 0.0 113.601 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -52.0 81.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.444 0 C-N-CA 122.98 2.453 . . . . 0.0 114.698 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.19 6.64 27.56 Favored Glycine 0 N--CA 1.515 3.963 0 O-C-N 122.195 -0.316 . . . . 0.0 113.573 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.4 tt0 -123.59 156.94 34.82 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 124.336 2.017 . . . . 0.0 116.331 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.784 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -117.01 156.32 27.69 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 119.641 3.2 . . . . 0.0 119.641 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.5 t -115.96 148.0 40.56 Favored 'General case' 0 N--CA 1.52 3.043 0 CA-C-O 116.633 -1.651 . . . . 0.0 107.229 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.465 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.55 143.78 41.86 Favored 'General case' 0 N--CA 1.529 3.512 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 87.8 m -119.96 102.57 8.65 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 114.146 -1.388 . . . . 0.0 113.575 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.8 m -94.71 152.19 18.67 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.97 168.29 8.1 Favored Pre-proline 0 N--CA 1.504 2.233 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.114 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.35 -174.81 1.53 Allowed 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 120.989 1.126 . . . . 0.0 111.107 161.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.31 -19.82 18.97 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 124.336 2.017 . . . . 0.0 107.235 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.12 42.68 0.49 Allowed 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 111.285 -2.688 . . . . 0.0 109.097 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.585 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.3 84.79 9.78 Favored Pre-proline 0 N--CA 1.5 2.04 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.794 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 83' ' ' GLY . 44.6 Cg_endo -79.42 178.7 7.11 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.831 2.354 . . . . 0.0 112.23 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.573 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.17 77.73 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.921 0 C-N-CA 125.31 1.444 . . . . 0.0 113.265 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.53 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.44 125.1 5.65 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 121.757 3.463 . . . . 0.0 121.757 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.657 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 44.0 mt-10 -99.49 61.23 1.17 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.826 ' HB2' HG23 ' A' ' 101' ' ' ILE . 3.0 m-85 -62.02 77.77 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.934 1.349 . . . . 0.0 113.049 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.5 136.0 57.27 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.553 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.5 136.57 52.87 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.985 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.76 82.05 8.6 Favored 'General case' 0 N--CA 1.511 2.587 1 N-CA-C 132.586 7.995 . . . . 0.0 132.586 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.83 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.465 2 CA-C-N 130.301 5.955 . . . . 0.0 114.293 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.0 tt0 -20.55 -72.42 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.605 0 N-CA-C 118.502 2.778 . . . . 0.0 118.502 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 36.4 Cg_endo -67.01 -3.54 9.86 Favored 'Trans proline' 0 N--CA 1.511 2.534 0 C-N-CA 122.382 2.055 . . . . 0.0 115.351 176.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -120.82 -14.14 8.56 Favored 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.431 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.37 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 116.625 2.084 . . . . 0.0 116.625 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.59 -33.95 1.74 Allowed Glycine 1 N--CA 1.52 4.291 0 O-C-N 121.57 -0.706 . . . . 0.0 112.682 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.62 68.47 7.98 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.447 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.92 26.71 0.05 OUTLIER Glycine 1 N--CA 1.527 4.7 0 CA-C-N 114.008 -1.451 . . . . 0.0 116.629 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.866 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.0 ttt -108.55 43.9 1.19 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 124.505 2.098 . . . . 0.0 113.071 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.96 134.92 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 112.193 -2.276 . . . . 0.0 110.943 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.61 154.85 19.32 Favored Glycine 1 N--CA 1.536 5.354 0 C-N-CA 119.484 -1.341 . . . . 0.0 113.977 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.844 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.1 ttpp -118.59 81.99 1.78 Allowed 'General case' 0 N--CA 1.518 2.942 0 CA-C-N 119.4 1.6 . . . . 0.0 115.264 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.826 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.74 123.26 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.844 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.9 m -112.62 88.76 2.9 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.187 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 80' ' ' ALA . 39.1 t -74.05 105.21 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.25 -72.36 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 O-C-N 126.039 2.087 . . . . 0.0 115.967 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.573 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.46 0 O-C-N 125.468 1.73 . . . . 0.0 113.819 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.176 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 60.5 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.2 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.421 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.2 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.5 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 86.5 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.606 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 53.9 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.43 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 77.5 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' B' ' 27' ' ' LEU . 71.8 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.563 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.0 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 1.372 ' HB ' ' CG2' ' B' ' 34' ' ' VAL 0.39 0.7 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.492 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.3 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.432 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.432 ' O ' HG12 ' B' ' 36' ' ' VAL . 28.2 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.412 HG23 HD12 ' B' ' 247' ' ' ILE . 25.5 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.778 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.653 ' H ' ' HG ' ' B' ' 133' ' ' SER . 32.6 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.437 HG11 ' N ' ' B' ' 46' ' ' PHE . 87.6 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.979 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.5 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.464 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.464 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.5 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.5 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.566 ' O ' HG21 ' B' ' 68' ' ' VAL . 58.9 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.629 HG12 ' N ' ' B' ' 69' ' ' GLY . 84.1 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.629 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.554 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.549 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.0 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 0.783 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 18.7 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.783 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 42.4 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.427 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' B' ' 130' ' ' PRO . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.0 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.478 ' HA ' HD12 ' B' ' 94' ' ' LEU . 50.0 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.2 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 1.153 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 19.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' GLN . . . . . 1.171 ' NE2' HG13 ' A' ' 36' ' ' VAL . 11.3 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.504 ' C ' HG13 ' B' ' 114' ' ' VAL . 56.0 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.542 ' O ' HG23 ' B' ' 114' ' ' VAL . 16.7 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 1.571 ' CB ' ' CA ' ' B' ' 115' ' ' ILE 0.687 0.0 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 1.343 ' HB ' ' CB ' ' B' ' 116' ' ' VAL 0.462 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.698 ' HG2' ' HE2' ' A' ' 66' ' ' MET . 38.2 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 81.8 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.6 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 93.1 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.494 ' C ' HG12 ' B' ' 131' ' ' VAL . 13.6 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.979 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.494 1.1 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.653 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . 0.424 ' HG2' HD12 ' B' ' 142' ' ' ILE . 38.3 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.448 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 23.7 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' PRO . . . . . 0.65 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.9 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.448 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.539 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.539 HG22 ' CG ' ' B' ' 139' ' ' ASP 0.428 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . 0.65 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' SER . . . . . 0.481 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.7 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' VAL . . . . . 0.481 HG13 ' C ' ' B' ' 148' ' ' SER 0.408 1.4 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.433 HG12 HG23 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.483 HH11 ' HD2' ' B' ' 157' ' ' ARG . 30.4 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.661 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.4 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 1.352 ' HB ' ' CG2' ' B' ' 160' ' ' VAL 0.428 0.9 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' TYR . . . . . 0.4 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 65.6 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.7 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.456 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.7 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . 0.527 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . 0.721 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.3 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.526 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 58.8 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.2 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.716 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.716 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 43.1 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.45 1.5 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.477 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.2 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.429 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.2 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.637 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' VAL . . . . . 0.637 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.409 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' LYS . . . . . 0.526 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.457 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.6 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.457 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' ASP . . . . . 0.475 ' O ' HD13 ' B' ' 196' ' ' LEU . 63.4 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.0 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.5 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.721 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 39.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 1.345 ' HB ' ' CG2' ' B' ' 225' ' ' VAL 0.406 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' ASN . . . . . 0.516 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . 0.481 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.6 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . 0.563 HD13 ' O ' ' B' ' 32' ' ' THR . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' ILE . . . . . 0.412 HD12 HG23 ' B' ' 40' ' ' VAL . 18.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 40.8 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 118.051 -0.976 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' HEC . . . . . 0.606 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.72 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.458 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 79.6 m -61.59 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -99.93 163.02 12.63 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.77 122.34 46.56 Favored 'General case' 0 N--CA 1.525 3.322 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.5 t -100.54 98.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 8' ' ' GLY . 14.0 mmmt -67.39 65.48 0.07 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 113.109 -1.86 . . . . 0.0 114.857 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -29.54 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 126.641 1.976 . . . . 0.0 115.449 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.52 59.02 0.4 Allowed Glycine 0 N--CA 1.51 3.568 0 N-CA-C 106.849 -2.501 . . . . 0.0 106.849 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.2 p -1.15 54.22 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 120.21 3.411 . . . . 0.0 120.21 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.42 -60.19 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.75 22.39 14.56 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 120.917 -1.114 . . . . 0.0 108.193 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.08 -94.77 1.9 Allowed Glycine 0 N--CA 1.511 3.691 0 N-CA-C 115.519 0.968 . . . . 0.0 115.519 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.549 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 47.5 tp -150.63 -177.19 5.83 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 1.074 HD21 HG23 ' A' ' 36' ' ' VAL . 15.8 mt -74.73 46.71 0.3 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.6 -1.312 . . . . 0.0 111.286 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.627 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 7.8 p -113.75 165.64 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 118.53 2.789 . . . . 0.0 118.53 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.627 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 5.1 m-30 -102.21 75.42 1.49 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.363 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.48 142.41 25.16 Favored Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.85 -0.531 . . . . 0.0 111.795 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 20' ' ' LYS . 58.4 Cg_endo -86.43 76.11 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.424 0 N-CA-C 116.365 1.64 . . . . 0.0 116.365 -9.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.7 -44.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 1 N-CA-C 122.319 4.192 . . . . 0.0 122.319 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.627 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.67 71.52 0.99 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 122.484 1.135 . . . . 0.0 113.064 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.652 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.02 111.26 7.11 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.116 -1.615 . . . . 0.0 109.107 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.551 ' N ' HD22 ' A' ' 21' ' ' LEU . 55.1 m -87.52 81.42 7.77 Favored 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.723 HD11 HD12 ' A' ' 101' ' ' ILE . 4.6 pt -79.57 -177.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.72 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.665 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.63 10.43 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.097 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 24.3 Cg_endo -52.33 77.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.287 0 N-CA-C 116.897 1.845 . . . . 0.0 116.897 174.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.17 -50.63 0.51 Allowed Glycine 1 N--CA 1.522 4.382 0 C-N-CA 119.682 -1.247 . . . . 0.0 115.836 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.655 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.56 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 1 N-CA-C 122.115 4.116 . . . . 0.0 122.115 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.458 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.2 m -64.07 35.96 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.018 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.495 HG13 ' N ' ' A' ' 30' ' ' GLU . 58.0 t -51.96 147.19 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 112.849 -1.978 . . . . 0.0 111.513 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.8 pt-20 -114.24 154.89 27.13 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 124.011 1.862 . . . . 0.0 115.368 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -107.51 113.88 27.5 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.786 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.1 tt -100.85 112.52 24.96 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 120.729 3.603 . . . . 0.0 120.729 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -75.16 84.7 2.37 Favored 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.111 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.7 p30 -80.29 -45.09 18.47 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.96 -169.31 3.34 Favored 'General case' 0 N--CA 1.509 2.522 0 C-N-CA 124.569 1.148 . . . . 0.0 109.048 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.237 ' CG1' HE22 ' B' ' 104' ' ' GLN . 1.6 m 12.89 70.61 0.11 Allowed Pre-proline 0 N--CA 1.521 3.11 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.601 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 64.2 Cg_endo -98.35 177.25 0.42 Allowed 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 123.994 3.129 . . . . 0.0 114.441 -165.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 60.9 Cg_endo -92.42 165.3 25.26 Favored 'Cis proline' 0 N--CA 1.503 2.037 0 N-CA-C 115.391 1.266 . . . . 0.0 115.391 -7.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.798 ' HB2' HD11 ' A' ' 7' ' ' LEU . 18.4 m-70 -118.96 87.37 2.72 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.655 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -103.33 140.26 37.66 Favored 'General case' 0 N--CA 1.516 2.868 0 CA-C-N 122.387 2.358 . . . . 0.0 110.675 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.4 m -118.13 116.3 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 121.406 3.854 . . . . 0.0 121.406 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.989 HG22 ' HB2' ' A' ' 88' ' ' TYR . 14.4 m -75.98 165.36 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 102.189 -3.263 . . . . 0.0 102.189 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.88 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.27 131.01 55.48 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 46' ' ' ALA . 4.0 m-20 -53.42 93.73 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.19 1 N-CA-C 124.142 4.867 . . . . 0.0 124.142 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.97 6.72 43.58 Favored 'General case' 0 CA--C 1.602 2.948 0 N-CA-C 101.19 -3.633 . . . . 0.0 101.19 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.8 -65.48 1.18 Allowed 'General case' 0 CA--C 1.574 1.89 0 C-N-CA 127.592 2.357 . . . . 0.0 112.742 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.645 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.7 mp -86.75 66.59 9.53 Favored 'General case' 0 N--CA 1.519 3.023 0 N-CA-C 118.874 2.916 . . . . 0.0 118.874 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.39 151.26 0.75 Allowed Pre-proline 0 N--CA 1.522 3.17 0 N-CA-C 117.487 2.402 . . . . 0.0 117.487 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.1 Cg_endo -42.44 -58.25 1.32 Allowed 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 123.426 2.751 . . . . 0.0 115.088 170.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.54 67.38 0.72 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 124.119 1.914 . . . . 0.0 107.012 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.15 53.53 0.99 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 112.292 -2.231 . . . . 0.0 108.25 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.78 56.93 0.75 Allowed 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 117.8 2.519 . . . . 0.0 117.8 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.682 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.61 -47.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.262 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -41.21 -30.87 0.18 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.082 -1.636 . . . . 0.0 111.587 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.826 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.04 -28.64 0.09 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 122.787 1.279 . . . . 0.0 112.552 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.826 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.72 -27.68 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.462 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.2 tptt 65.13 -55.58 0.31 Allowed 'General case' 0 N--CA 1.533 3.705 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.7 -28.96 0.16 Allowed 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.88 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.4 pp -53.57 -66.9 0.31 Allowed 'General case' 0 CA--C 1.604 3.026 0 N-CA-C 100.688 -3.819 . . . . 0.0 100.688 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.839 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.09 98.47 2.11 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.227 1.411 . . . . 0.0 112.786 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.717 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.0 t60 -90.06 -173.01 3.7 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.823 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.42 155.23 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.823 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 26.5 tt0 105.45 65.97 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 120.315 3.45 . . . . 0.0 120.315 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 1.634 HD21 ' CE1' ' B' ' 1' ' ' TYR . 5.9 mp 38.26 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 120.769 3.618 . . . . 0.0 120.769 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.655 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 35.3 mt -70.67 82.04 0.61 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.166 -1.584 . . . . 0.0 111.876 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.976 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 42.5 mmm -79.16 61.9 3.41 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-O 126.066 2.841 . . . . 0.0 110.962 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.4 m -112.54 65.88 0.84 Allowed Pre-proline 0 N--CA 1.505 2.307 0 CA-C-N 110.482 -3.054 . . . . 0.0 113.597 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -51.87 81.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 122.985 2.457 . . . . 0.0 114.71 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.63 27.66 Favored Glycine 1 N--CA 1.517 4.07 0 O-C-N 122.209 -0.307 . . . . 0.0 113.579 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.488 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.4 tt0 -123.62 156.83 35.1 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 124.404 2.049 . . . . 0.0 116.285 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.786 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -116.87 156.46 27.28 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 119.748 3.24 . . . . 0.0 119.748 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -116.02 147.91 40.72 Favored 'General case' 0 N--CA 1.52 3.029 0 CA-C-O 116.651 -1.642 . . . . 0.0 107.253 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.455 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.51 143.63 42.05 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.448 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 87.6 m -119.84 102.54 8.65 Favored 'General case' 0 N--CA 1.514 2.747 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.632 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 50.2 m -94.76 152.2 18.63 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -107.93 168.33 8.06 Favored Pre-proline 0 N--CA 1.503 2.178 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.124 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.35 -174.85 1.54 Allowed 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 121.021 1.147 . . . . 0.0 111.109 161.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.33 -19.66 19.08 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 124.435 2.064 . . . . 0.0 107.334 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.22 42.71 0.5 Allowed 'General case' 0 CA--C 1.576 1.98 0 CA-C-N 111.187 -2.733 . . . . 0.0 109.045 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.594 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.3 84.68 9.67 Favored Pre-proline 0 N--CA 1.499 2.012 0 CA-C-N 113.675 -1.602 . . . . 0.0 113.761 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 83' ' ' GLY . 53.5 Cg_endo -79.31 178.62 7.23 Favored 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 122.803 2.335 . . . . 0.0 112.304 172.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.585 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.08 77.69 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.92 0 O-C-N 125.018 1.449 . . . . 0.0 113.346 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.37 124.98 5.63 Favored Glycine 0 N--CA 1.508 3.475 0 N-CA-C 121.746 3.459 . . . . 0.0 121.746 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.654 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 44.0 mt-10 -99.46 61.24 1.18 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.831 ' HB2' HG23 ' A' ' 101' ' ' ILE . 3.1 m-85 -62.0 77.8 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.872 1.32 . . . . 0.0 113.052 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.57 135.95 57.18 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.568 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.47 136.49 52.95 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.989 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.64 82.03 8.6 Favored 'General case' 0 N--CA 1.512 2.64 1 N-CA-C 132.637 8.014 . . . . 0.0 132.637 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.1 t -63.9 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.501 2 CA-C-N 130.342 5.974 . . . . 0.0 114.311 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.7 tt0 -20.52 -72.48 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.605 0 N-CA-C 118.468 2.766 . . . . 0.0 118.468 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.59 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 37.6 Cg_endo -66.97 -3.48 9.7 Favored 'Trans proline' 0 N--CA 1.512 2.569 0 C-N-CA 122.39 2.06 . . . . 0.0 115.352 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -120.87 -14.12 8.55 Favored 'General case' 0 N--CA 1.511 2.613 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.451 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.38 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.62 -34.06 1.73 Allowed Glycine 1 N--CA 1.52 4.296 0 O-C-N 121.616 -0.678 . . . . 0.0 112.7 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.56 68.46 7.91 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.86 26.74 0.05 OUTLIER Glycine 1 N--CA 1.526 4.677 0 CA-C-N 114.041 -1.436 . . . . 0.0 116.68 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.843 ' HE2' HD22 ' A' ' 14' ' ' LEU . 1.9 ttt -108.55 43.83 1.19 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 124.406 2.05 . . . . 0.0 112.957 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.99 134.89 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 112.275 -2.239 . . . . 0.0 110.945 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.66 154.85 19.35 Favored Glycine 1 N--CA 1.534 5.212 0 C-N-CA 119.523 -1.323 . . . . 0.0 114.059 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.888 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.1 ttpp -118.56 81.86 1.76 Allowed 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.831 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.63 123.3 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.709 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.888 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 8.0 m -112.63 88.7 2.88 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.185 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 80' ' ' ALA . 39.4 t -74.0 105.17 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.31 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 O-C-N 126.064 2.103 . . . . 0.0 115.933 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.585 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.521 0 O-C-N 125.576 1.798 . . . . 0.0 113.812 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.634 ' CE1' HD21 ' A' ' 64' ' ' LEU . 60.9 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.59 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 22.0 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' TRP . . . . . 0.449 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.0 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.439 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.3 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.499 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 88.7 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 50.9 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.43 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 79.5 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' B' ' 27' ' ' LEU . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.575 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.1 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 1.395 ' HB ' ' CA ' ' B' ' 34' ' ' VAL 0.375 0.2 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.481 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.5 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.45 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.45 ' O ' HG12 ' B' ' 36' ' ' VAL . 27.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.414 HG23 HD12 ' B' ' 247' ' ' ILE . 26.1 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.803 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.652 ' H ' ' HG ' ' B' ' 133' ' ' SER . 32.4 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.428 HG11 ' N ' ' B' ' 46' ' ' PHE . 87.9 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 1.021 ' CE1' HG22 ' B' ' 131' ' ' VAL . 51.7 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.493 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.6 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.6 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.493 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.1 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.558 ' O ' HG21 ' B' ' 68' ' ' VAL . 58.1 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.633 HG12 ' N ' ' B' ' 69' ' ' GLY . 79.1 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.633 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.563 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.561 HG21 HD12 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.3 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.1 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 0.908 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 14.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.908 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 46.6 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.513 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' B' ' 130' ' ' PRO . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 74.2 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.491 ' HA ' HD12 ' B' ' 94' ' ' LEU . 49.4 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 17.7 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 1.601 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 17.0 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' GLN . . . . . 1.237 HE22 ' CG1' ' A' ' 36' ' ' VAL . 10.9 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.439 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 25.5 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.482 ' C ' HG13 ' B' ' 114' ' ' VAL . 55.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.548 ' O ' HG23 ' B' ' 114' ' ' VAL . 17.2 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 1.531 ' HB ' ' CB ' ' B' ' 115' ' ' ILE 0.54 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.536 HG21 ' C ' ' B' ' 115' ' ' ILE 0.411 0.1 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 1.41 ' CG ' HD22 ' A' ' 64' ' ' LEU . 38.7 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.976 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 81.1 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 57.2 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 90.8 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.576 ' C ' HG12 ' B' ' 131' ' ' VAL . 11.7 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 1.564 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.43 1.6 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.0 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.652 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . 0.528 ' HG2' HD12 ' B' ' 142' ' ' ILE . 38.9 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.448 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 24.7 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' PRO . . . . . 0.62 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 10.6 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.448 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.558 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.558 HG22 ' CG ' ' B' ' 139' ' ' ASP 0.483 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . 0.62 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.6 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' SER . . . . . 0.493 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.3 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' VAL . . . . . 0.493 HG13 ' C ' ' B' ' 148' ' ' SER 0.335 1.7 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.438 HG12 HG23 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.461 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.661 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.4 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 1.366 ' HB ' ' CA ' ' B' ' 160' ' ' VAL 0.387 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' PRO . . . . . 0.449 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 18.5 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.8 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.426 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 8.4 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . 0.543 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.8 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . 0.742 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.7 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.522 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 59.4 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 64.1 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.735 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.3 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.735 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.6 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.414 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.49 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.0 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.458 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.8 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.671 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' VAL . . . . . 0.671 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.482 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' LYS . . . . . 0.522 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.9 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.6 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.46 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.8 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.46 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' ASP . . . . . 0.499 ' O ' HD13 ' B' ' 196' ' ' LEU . 62.9 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.3 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.2 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.742 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 41.3 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . 0.447 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.447 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 11.2 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 86.4 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 1.396 ' HB ' ' CG1' ' B' ' 225' ' ' VAL 0.385 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.4 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' ASN . . . . . 0.503 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . 0.472 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . 0.575 HD13 ' O ' ' B' ' 32' ' ' THR . 15.0 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' ILE . . . . . 0.414 HD12 HG23 ' B' ' 40' ' ' VAL . 18.9 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 40.5 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' HEC . . . . . 0.607 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.721 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.443 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 70.1 m -61.59 89.67 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.93 163.03 12.62 Favored 'General case' 0 N--CA 1.512 2.653 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.452 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.2 t -107.83 122.43 46.76 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.2 t -100.5 98.39 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.4 mmmt -67.34 65.32 0.07 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 113.086 -1.87 . . . . 0.0 114.888 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 39' ' ' HIS . 14.9 mt -29.47 68.26 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 126.579 1.952 . . . . 0.0 115.459 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.42 59.06 0.4 Allowed Glycine 0 N--CA 1.509 3.552 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 20.3 p -1.12 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.259 0 N-CA-C 120.346 3.462 . . . . 0.0 120.346 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.49 -60.14 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 119.515 3.154 . . . . 0.0 119.515 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.85 22.48 14.43 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.957 -1.09 . . . . 0.0 108.116 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.07 -94.8 1.9 Allowed Glycine 0 N--CA 1.512 3.711 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.576 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.7 tp -150.66 -177.23 5.86 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 1.05 HD21 HG23 ' A' ' 36' ' ' VAL . 15.5 mt -74.72 46.74 0.3 Allowed 'General case' 0 N--CA 1.509 2.516 0 O-C-N 120.7 -1.25 . . . . 0.0 111.236 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.664 HG21 ' N ' ' A' ' 16' ' ' PHE . 7.6 p -113.86 165.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.664 ' N ' HG21 ' A' ' 15' ' ' VAL . 5.3 m-30 -102.12 75.43 1.51 Allowed 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 112.219 -2.264 . . . . 0.0 113.416 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.342 0.6 OUTLIER -93.47 142.39 25.14 Favored Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.853 -0.529 . . . . 0.0 111.746 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 20' ' ' LYS . 46.0 Cg_endo -86.49 76.11 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.466 0 N-CA-C 116.368 1.642 . . . . 0.0 116.368 -9.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.72 -44.22 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.806 1 N-CA-C 122.26 4.17 . . . . 0.0 122.26 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.645 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.65 71.68 1.0 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 122.412 1.101 . . . . 0.0 112.986 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.678 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.14 111.25 7.21 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.148 -1.595 . . . . 0.0 109.159 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.577 ' N ' HD22 ' A' ' 21' ' ' LEU . 47.7 m -87.52 81.53 7.74 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.715 HD11 HD12 ' A' ' 101' ' ' ILE . 4.4 pt -79.71 -177.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 114.75 -1.113 . . . . 0.0 112.699 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.704 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -109.67 166.55 10.58 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.126 179.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 19.9 Cg_endo -52.24 77.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.314 0 N-CA-C 116.833 1.82 . . . . 0.0 116.833 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.13 -50.41 0.52 Allowed Glycine 1 N--CA 1.522 4.42 0 C-N-CA 119.76 -1.209 . . . . 0.0 115.831 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.664 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.71 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 1 N-CA-C 122.11 4.115 . . . . 0.0 122.11 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.443 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 10.8 m -64.03 36.0 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.012 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.527 HG13 ' N ' ' A' ' 30' ' ' GLU . 57.5 t -52.0 147.17 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.566 0 CA-C-N 112.821 -1.991 . . . . 0.0 111.5 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.8 pt-20 -114.19 154.91 27.05 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 123.923 1.82 . . . . 0.0 115.416 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -107.57 113.84 27.42 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.791 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.1 tt -100.72 112.53 24.95 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 120.653 3.575 . . . . 0.0 120.653 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -75.13 84.69 2.35 Favored 'General case' 0 N--CA 1.513 2.689 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.162 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 29.9 p30 -80.27 -45.08 18.54 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 118.935 2.939 . . . . 0.0 118.935 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.95 -169.3 3.34 Favored 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 124.671 1.189 . . . . 0.0 109.077 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.131 HG13 ' NE2' ' B' ' 104' ' ' GLN . 1.6 m 12.79 70.72 0.11 Allowed Pre-proline 0 N--CA 1.52 3.029 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.338 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 55.3 Cg_endo -98.49 177.29 0.4 Allowed 'Trans proline' 0 CA--C 1.568 2.222 0 C-N-CA 123.984 3.123 . . . . 0.0 114.37 -165.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.721 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 52.2 Cg_endo -92.39 165.33 25.33 Favored 'Cis proline' 0 N--CA 1.502 2.029 0 N-CA-C 115.472 1.297 . . . . 0.0 115.472 -7.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.775 ' HB2' HD11 ' A' ' 7' ' ' LEU . 16.5 m-70 -118.96 87.52 2.75 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.712 HD22 ' N ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -103.5 140.23 37.79 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 122.465 2.393 . . . . 0.0 110.663 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.4 m -118.09 116.41 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 121.446 3.869 . . . . 0.0 121.446 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 1.049 HG22 ' HB2' ' A' ' 88' ' ' TYR . 13.0 m -76.07 165.46 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 102.099 -3.297 . . . . 0.0 102.099 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.925 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.32 130.96 55.51 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' OD1' HD13 ' A' ' 47' ' ' LEU . 4.1 m-20 -53.45 93.82 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.212 1 N-CA-C 124.16 4.874 . . . . 0.0 124.16 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.09 6.8 43.47 Favored 'General case' 0 CA--C 1.602 2.979 0 N-CA-C 101.212 -3.625 . . . . 0.0 101.212 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 47' ' ' LEU . . . -115.9 -65.43 1.19 Allowed 'General case' 0 CA--C 1.574 1.88 0 C-N-CA 127.445 2.298 . . . . 0.0 112.682 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.692 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.4 mp -86.65 66.53 9.51 Favored 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 118.902 2.927 . . . . 0.0 118.902 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.634 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.4 151.28 0.74 Allowed Pre-proline 0 N--CA 1.522 3.145 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 17.3 Cg_endo -42.41 -58.29 1.3 Allowed 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.405 2.736 . . . . 0.0 115.112 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.634 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.46 67.34 0.72 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 124.102 1.906 . . . . 0.0 107.077 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -77.13 53.6 0.99 Allowed 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.312 -2.222 . . . . 0.0 108.272 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 t -115.9 56.99 0.76 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.671 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.63 -47.99 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.256 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.07 -30.88 0.16 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.06 -1.65 . . . . 0.0 111.578 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.795 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.18 -28.53 0.1 Allowed 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 122.755 1.264 . . . . 0.0 112.487 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.795 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.83 -27.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 117.727 2.492 . . . . 0.0 117.727 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.3 tptt 65.05 -55.59 0.3 Allowed 'General case' 0 N--CA 1.533 3.71 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.1 m -41.68 -28.98 0.16 Allowed 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.925 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.2 pp -53.68 -66.82 0.33 Allowed 'General case' 0 CA--C 1.604 3.032 0 N-CA-C 100.71 -3.811 . . . . 0.0 100.71 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.874 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 11.1 p -72.07 98.45 2.1 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 125.259 1.424 . . . . 0.0 112.806 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.743 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.4 t60 -90.08 -173.01 3.7 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.836 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.4 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.836 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 26.0 tt0 105.51 65.97 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 120.303 3.445 . . . . 0.0 120.303 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 1.08 HD11 ' N ' ' A' ' 64' ' ' LEU . 5.6 mp 38.11 84.33 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 120.745 3.609 . . . . 0.0 120.745 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.712 ' N ' HD22 ' A' ' 40' ' ' ASN . 36.5 mt -70.66 82.1 0.61 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.078 -1.639 . . . . 0.0 111.888 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.721 ' SD ' ' HG3' ' A' ' 38' ' ' PRO . 41.0 mmm -79.25 61.93 3.48 Favored 'General case' 0 N--CA 1.51 2.542 0 CA-C-O 126.057 2.837 . . . . 0.0 110.912 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.7 m -112.55 65.92 0.85 Allowed Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 110.543 -3.026 . . . . 0.0 113.621 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -51.95 81.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 122.933 2.422 . . . . 0.0 114.686 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.13 6.73 27.59 Favored Glycine 1 N--CA 1.517 4.036 0 O-C-N 122.251 -0.28 . . . . 0.0 113.541 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.68 156.91 35.02 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 124.374 2.035 . . . . 0.0 116.241 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.791 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.98 156.39 27.55 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 119.681 3.215 . . . . 0.0 119.681 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -116.01 147.96 40.66 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-O 116.678 -1.63 . . . . 0.0 107.215 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.487 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.56 143.79 41.85 Favored 'General case' 0 N--CA 1.53 3.546 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.45 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 73.9 m -119.99 102.62 8.67 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.52 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.0 m -94.78 152.15 18.66 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.91 168.29 8.11 Favored Pre-proline 0 N--CA 1.503 2.181 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.089 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -72.36 -174.83 1.54 Allowed 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 121.023 1.149 . . . . 0.0 111.121 161.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.73 19.0 Favored 'General case' 0 N--CA 1.51 2.535 0 CA-C-O 124.34 2.019 . . . . 0.0 107.237 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.17 42.68 0.49 Allowed 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 111.258 -2.701 . . . . 0.0 109.118 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.58 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.3 84.79 9.78 Favored Pre-proline 0 N--CA 1.5 2.069 0 CA-C-N 113.543 -1.662 . . . . 0.0 113.742 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 38.0 Cg_endo -79.39 178.64 7.18 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 122.817 2.345 . . . . 0.0 112.253 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.574 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.03 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 125.367 1.467 . . . . 0.0 113.24 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.44 125.01 5.63 Favored Glycine 0 N--CA 1.507 3.389 0 N-CA-C 121.787 3.475 . . . . 0.0 121.787 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.66 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 43.8 mt-10 -99.4 61.26 1.19 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.825 ' HB2' HG23 ' A' ' 101' ' ' ILE . 3.1 m-85 -62.05 77.75 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 122.95 1.357 . . . . 0.0 113.033 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.6 m -63.52 136.0 57.25 Favored 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.52 136.5 52.93 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 1.049 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.6 m-85 -84.62 82.02 8.6 Favored 'General case' 0 N--CA 1.51 2.561 1 N-CA-C 132.655 8.02 . . . . 0.0 132.655 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.9 t -63.86 82.11 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.433 2 CA-C-N 130.371 5.987 . . . . 0.0 114.365 179.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.4 tt0 -20.51 -72.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.582 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 31.8 Cg_endo -67.04 -3.45 9.72 Favored 'Trans proline' 0 N--CA 1.51 2.489 0 C-N-CA 122.409 2.073 . . . . 0.0 115.367 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -120.85 -14.22 8.54 Favored 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.473 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.3 79.62 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.742 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.61 -34.03 1.73 Allowed Glycine 1 N--CA 1.522 4.381 0 O-C-N 121.597 -0.689 . . . . 0.0 112.617 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.52 68.46 7.86 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.79 26.8 0.05 OUTLIER Glycine 1 N--CA 1.527 4.731 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.853 ' HE2' HD22 ' A' ' 14' ' ' LEU . 1.8 ttt -108.54 43.85 1.19 Allowed 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 124.485 2.088 . . . . 0.0 113.022 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.97 134.88 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 112.228 -2.26 . . . . 0.0 110.903 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.579 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.71 154.86 19.38 Favored Glycine 1 N--CA 1.536 5.356 0 C-N-CA 119.446 -1.359 . . . . 0.0 113.96 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.839 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.2 ttpp -118.56 81.95 1.77 Allowed 'General case' 0 N--CA 1.517 2.883 0 CA-C-N 119.372 1.586 . . . . 0.0 115.262 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.825 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.71 123.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.667 0 C-N-CA 118.054 -1.458 . . . . 0.0 107.079 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.839 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.1 m -112.68 88.8 2.91 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.124 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 80' ' ' ALA . 38.8 t -74.12 105.27 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.34 -72.28 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 O-C-N 126.101 2.126 . . . . 0.0 115.95 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.574 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.53 0 O-C-N 125.527 1.767 . . . . 0.0 113.81 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.433 ' H1 ' ' N ' ' B' ' 1' ' ' TYR . 60.5 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' TRP . . . . . 0.458 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.45 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.0 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.2 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 9.9 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 89.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 54.2 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.43 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 77.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.464 ' HA ' HD22 ' B' ' 27' ' ' LEU . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.59 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.3 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.483 HG23 HG12 ' B' ' 151' ' ' VAL 0.374 0.1 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.7 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.47 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.47 ' O ' HG12 ' B' ' 36' ' ' VAL . 23.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.416 ' C ' HG11 ' B' ' 40' ' ' VAL . 87.9 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.416 HG11 ' C ' ' B' ' 39' ' ' SER . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.825 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.655 ' H ' ' HG ' ' B' ' 133' ' ' SER . 30.2 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.436 HG11 ' N ' ' B' ' 46' ' ' PHE . 89.4 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 1.141 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.531 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.531 HG22 ' O ' ' B' ' 55' ' ' ASP . 15.2 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 83.3 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.568 ' O ' HG21 ' B' ' 68' ' ' VAL . 55.4 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.658 HG12 ' N ' ' B' ' 69' ' ' GLY . 74.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.658 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.589 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.555 HG21 HD12 ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.2 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 1.047 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 24.7 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 1.047 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 42.5 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.47 ' H ' HG21 ' B' ' 84' ' ' ILE 0.567 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' B' ' 130' ' ' PRO . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' B' ' 94' ' ' LEU . 50.3 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.4 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 1.338 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 17.2 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' GLN . . . . . 1.131 ' NE2' HG13 ' A' ' 36' ' ' VAL . 11.0 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.8 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.476 ' C ' HG13 ' B' ' 114' ' ' VAL . 55.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.581 ' O ' HG23 ' B' ' 114' ' ' VAL . 17.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.555 HD12 HG21 ' B' ' 75' ' ' VAL 0.46 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.532 ' N ' HG21 ' B' ' 115' ' ' ILE 0.255 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 0.7 ' CG ' HD22 ' A' ' 64' ' ' LEU . 36.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.512 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 81.9 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.6 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 85.3 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.506 ' C ' HG12 ' B' ' 131' ' ' VAL . 19.9 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 1.56 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.344 0.5 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.655 ' HG ' ' H ' ' B' ' 44' ' ' THR . 95.1 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . 0.598 ' HG2' HD12 ' B' ' 142' ' ' ILE . 35.7 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.445 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 25.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' PRO . . . . . 0.525 ' CG ' ' CZ ' ' B' ' 144' ' ' PHE . 18.1 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.445 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.589 ' CG ' ' CG2' ' B' ' 142' ' ' ILE . 44.7 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.598 HD12 ' HG2' ' B' ' 134' ' ' PRO 0.51 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' B' ' 136' ' ' PRO . 81.3 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' SER . . . . . 0.448 ' C ' HG13 ' B' ' 149' ' ' VAL . 69.0 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' VAL . . . . . 1.371 ' HB ' ' CG2' ' B' ' 149' ' ' VAL . 1.3 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.483 HG12 HG23 ' B' ' 34' ' ' VAL . 10.7 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . 0.427 ' O ' ' HG2' ' B' ' 155' ' ' ARG . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' B' ' 157' ' ' ARG . 28.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.683 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.7 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 1.358 ' HB ' ' CA ' ' B' ' 160' ' ' VAL 0.312 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' TYR . . . . . 0.414 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 64.7 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' PRO . . . . . 0.458 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 17.8 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 97.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.434 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.9 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . 0.576 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.9 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . 0.805 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 18.5 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.536 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 61.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.3 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' LYS . . . . . 0.422 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.5 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.758 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.758 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 41.2 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.38 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.482 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 40.8 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.5 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.4 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.726 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' VAL . . . . . 0.726 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' ILE . . . . . 0.534 HG13 ' O ' ' B' ' 199' ' ' ILE 0.519 0.3 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' LYS . . . . . 0.536 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.7 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.6 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.472 ' C ' HG13 ' B' ' 207' ' ' VAL . 60.0 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.472 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.2 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' ASP . . . . . 0.51 ' O ' HD13 ' B' ' 196' ' ' LEU . 63.3 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.0 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.805 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.472 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 18.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.3 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 86.9 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.403 0.1 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.0 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' ASN . . . . . 0.545 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . 0.507 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.7 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . 0.59 HD13 ' O ' ' B' ' 32' ' ' THR . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 19.4 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . 0.427 ' HA ' HD11 ' B' ' 249' ' ' LEU . 41.4 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' HEC . . . . . 0.608 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.711 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.455 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.6 m -61.61 89.7 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.98 162.98 12.64 Favored 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.45 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.0 t -107.68 122.36 46.56 Favored 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.52 98.34 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.41 65.5 0.07 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 113.077 -1.874 . . . . 0.0 114.834 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.817 HD11 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -29.51 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.96 0 C-N-CA 126.595 1.958 . . . . 0.0 115.534 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.43 59.11 0.4 Allowed Glycine 0 N--CA 1.509 3.557 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.2 p -1.08 54.03 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 120.344 3.461 . . . . 0.0 120.344 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.61 -60.22 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 119.507 3.151 . . . . 0.0 119.507 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.47 14.45 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 120.998 -1.064 . . . . 0.0 108.143 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.09 -94.83 1.9 Allowed Glycine 0 N--CA 1.511 3.69 0 N-CA-C 115.553 0.981 . . . . 0.0 115.553 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 47.1 tp -150.57 -177.16 5.81 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.996 HD21 HG23 ' A' ' 36' ' ' VAL . 15.7 mt -74.68 46.66 0.29 Allowed 'General case' 0 N--CA 1.509 2.478 0 O-C-N 120.608 -1.307 . . . . 0.0 111.296 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.619 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 7.8 p -113.84 165.67 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.619 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 5.1 m-30 -102.24 75.38 1.49 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 112.209 -2.269 . . . . 0.0 113.436 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.42 142.44 25.23 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 121.851 -0.531 . . . . 0.0 111.744 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 20' ' ' LYS . 56.8 Cg_endo -86.4 76.1 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.389 0 N-CA-C 116.382 1.647 . . . . 0.0 116.382 -9.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.7 -44.18 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.812 1 N-CA-C 122.24 4.163 . . . . 0.0 122.24 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.65 71.55 0.99 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.446 1.117 . . . . 0.0 113.052 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.645 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.06 111.27 7.15 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.177 -1.577 . . . . 0.0 109.147 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.522 ' N ' HD22 ' A' ' 21' ' ' LEU . 53.8 m -87.48 81.39 7.81 Favored 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.71 HD11 HD12 ' A' ' 101' ' ' ILE . 4.6 pt -79.7 -177.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.708 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.666 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.69 166.6 10.49 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.078 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.5 Cg_endo -52.3 77.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.569 2.263 0 N-CA-C 116.92 1.854 . . . . 0.0 116.92 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.09 -50.39 0.52 Allowed Glycine 1 N--CA 1.522 4.404 0 C-N-CA 119.727 -1.225 . . . . 0.0 115.859 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.662 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.68 92.11 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.195 1 N-CA-C 122.092 4.108 . . . . 0.0 122.092 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.455 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.3 m -64.12 36.03 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 118.681 2.845 . . . . 0.0 118.681 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.502 HG13 ' N ' ' A' ' 30' ' ' GLU . 59.0 t -51.99 147.2 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 CA-C-N 112.861 -1.972 . . . . 0.0 111.529 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.502 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.8 pt-20 -114.31 154.85 27.29 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 123.936 1.827 . . . . 0.0 115.397 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -107.47 113.9 27.55 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.798 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.78 112.48 24.91 Favored 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 120.759 3.614 . . . . 0.0 120.759 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -75.11 84.75 2.34 Favored 'General case' 0 N--CA 1.511 2.611 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.14 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.5 p30 -80.35 -45.08 18.36 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 118.862 2.912 . . . . 0.0 118.862 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.92 -169.26 3.33 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 124.678 1.191 . . . . 0.0 109.143 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.996 HG23 HD21 ' A' ' 14' ' ' LEU . 1.6 m 12.82 70.7 0.11 Allowed Pre-proline 0 N--CA 1.52 3.038 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.221 ' HG2' ' CZ ' ' B' ' 102' ' ' TYR . 59.5 Cg_endo -98.41 177.26 0.41 Allowed 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 123.953 3.102 . . . . 0.0 114.382 -165.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.623 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 58.9 Cg_endo -92.48 165.22 25.07 Favored 'Cis proline' 0 N--CA 1.503 2.082 0 N-CA-C 115.392 1.266 . . . . 0.0 115.392 -7.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.817 ' HB2' HD11 ' A' ' 7' ' ' LEU . 18.1 m-70 -118.83 87.4 2.72 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 117.377 2.362 . . . . 0.0 117.377 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.618 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -103.4 140.28 37.66 Favored 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 122.429 2.377 . . . . 0.0 110.695 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.4 m -118.1 116.27 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 121.43 3.863 . . . . 0.0 121.43 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.995 HG22 ' HB2' ' A' ' 88' ' ' TYR . 14.4 m -75.9 165.4 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 102.223 -3.251 . . . . 0.0 102.223 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.868 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.28 130.97 55.5 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.436 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.46 93.77 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.188 1 N-CA-C 124.16 4.874 . . . . 0.0 124.16 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.0 6.8 43.34 Favored 'General case' 0 CA--C 1.602 2.965 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' HB2' HD13 ' A' ' 47' ' ' LEU . . . -115.84 -65.63 1.17 Allowed 'General case' 0 CA--C 1.573 1.848 0 C-N-CA 127.537 2.335 . . . . 0.0 112.707 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.633 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.7 mp -86.63 66.58 9.54 Favored 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.38 151.23 0.74 Allowed Pre-proline 0 N--CA 1.523 3.179 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.459 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.7 Cg_endo -42.36 -58.26 1.31 Allowed 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 123.398 2.732 . . . . 0.0 115.133 170.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.45 67.36 0.72 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 124.027 1.87 . . . . 0.0 107.067 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.18 53.51 0.99 Allowed 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 112.346 -2.206 . . . . 0.0 108.204 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.87 56.95 0.76 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.701 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.58 -47.91 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 117.252 2.315 . . . . 0.0 117.252 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.08 -30.9 0.16 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.218 -1.551 . . . . 0.0 111.584 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.815 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.16 -28.53 0.1 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 122.696 1.236 . . . . 0.0 112.478 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.815 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.83 -27.64 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.2 tptt 65.03 -55.54 0.3 Allowed 'General case' 0 N--CA 1.534 3.748 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.77 -28.91 0.17 Allowed 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.868 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.71 -66.76 0.34 Allowed 'General case' 0 CA--C 1.603 2.984 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.819 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.01 98.32 2.05 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 125.356 1.462 . . . . 0.0 112.803 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.731 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.0 -172.97 3.7 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.828 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.39 155.12 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.828 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 27.0 tt0 105.55 65.93 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 120.258 3.429 . . . . 0.0 120.258 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 1.451 HD22 ' CG ' ' B' ' 118' ' ' PRO . 6.0 mp 38.21 84.3 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 120.793 3.627 . . . . 0.0 120.793 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.618 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 35.0 mt -70.76 82.13 0.63 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.137 -1.602 . . . . 0.0 111.818 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 1.422 ' CE ' ' O ' ' B' ' 118' ' ' PRO . 42.3 mmm -79.29 62.0 3.53 Favored 'General case' 0 N--CA 1.512 2.647 0 CA-C-O 126.069 2.842 . . . . 0.0 110.886 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.0 m -112.53 65.89 0.84 Allowed Pre-proline 0 C--N 1.284 -2.259 0 CA-C-N 110.53 -3.032 . . . . 0.0 113.667 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HG2' ' OD2' ' B' ' 100' ' ' ASP . 21.7 Cg_endo -51.91 81.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.466 0 C-N-CA 122.932 2.422 . . . . 0.0 114.696 -177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.08 6.58 27.81 Favored Glycine 1 N--CA 1.516 4.03 0 O-C-N 122.18 -0.325 . . . . 0.0 113.613 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.511 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.56 156.84 34.97 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 124.366 2.031 . . . . 0.0 116.352 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.798 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -116.95 156.38 27.52 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 119.703 3.223 . . . . 0.0 119.703 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -115.95 147.9 40.64 Favored 'General case' 0 N--CA 1.52 3.07 0 CA-C-O 116.711 -1.614 . . . . 0.0 107.192 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.464 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.44 143.67 41.89 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 118.36 2.726 . . . . 0.0 118.36 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.446 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 85.7 m -119.94 102.64 8.7 Favored 'General case' 0 N--CA 1.514 2.772 0 CA-C-N 114.227 -1.351 . . . . 0.0 113.584 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.8 m -94.7 152.2 18.66 Favored 'General case' 0 N--CA 1.526 3.341 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -107.98 168.33 8.04 Favored Pre-proline 0 N--CA 1.504 2.244 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.037 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.36 -174.78 1.52 Allowed 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 121.023 1.149 . . . . 0.0 111.12 161.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.77 18.97 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 124.364 2.03 . . . . 0.0 107.246 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.09 42.55 0.48 Allowed 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 111.24 -2.709 . . . . 0.0 109.067 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.589 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.24 84.81 9.68 Favored Pre-proline 0 N--CA 1.501 2.075 0 CA-C-N 113.658 -1.61 . . . . 0.0 113.768 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 83' ' ' GLY . 47.5 Cg_endo -79.36 178.67 7.16 Favored 'Trans proline' 0 N--CA 1.503 2.085 0 C-N-CA 122.79 2.326 . . . . 0.0 112.276 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.579 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.11 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.86 0 C-N-CA 125.328 1.451 . . . . 0.0 113.291 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.534 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.4 124.92 5.6 Favored Glycine 0 N--CA 1.507 3.393 0 N-CA-C 121.739 3.455 . . . . 0.0 121.739 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.656 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 44.0 mt-10 -99.41 61.31 1.19 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.837 ' HB2' HG23 ' A' ' 101' ' ' ILE . 3.0 m-85 -62.13 77.81 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.906 1.336 . . . . 0.0 113.006 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.8 m -63.46 135.94 57.25 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.568 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.53 136.54 52.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.995 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.71 82.11 8.57 Favored 'General case' 0 N--CA 1.511 2.618 1 N-CA-C 132.562 7.986 . . . . 0.0 132.562 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.94 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.495 2 CA-C-N 130.298 5.953 . . . . 0.0 114.346 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.0 tt0 -20.55 -72.35 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.586 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.42 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 36.8 Cg_endo -67.11 -3.34 9.61 Favored 'Trans proline' 0 N--CA 1.513 2.626 0 C-N-CA 122.359 2.039 . . . . 0.0 115.343 176.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -120.99 -14.12 8.49 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.35 79.71 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.51 -34.03 1.74 Allowed Glycine 1 N--CA 1.522 4.37 0 O-C-N 121.517 -0.739 . . . . 0.0 112.679 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.57 68.44 7.91 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 39.0 26.68 0.05 OUTLIER Glycine 1 N--CA 1.527 4.721 0 CA-C-N 114.018 -1.446 . . . . 0.0 116.573 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.845 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.0 ttt -108.57 43.92 1.18 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 124.52 2.105 . . . . 0.0 112.957 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.0 134.85 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 112.271 -2.24 . . . . 0.0 110.928 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.64 154.87 19.34 Favored Glycine 1 N--CA 1.535 5.295 0 CA-C-N 120.118 1.326 . . . . 0.0 114.039 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.891 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.1 ttpp -118.57 81.91 1.77 Allowed 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 119.405 1.603 . . . . 0.0 115.246 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.837 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.68 123.31 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.737 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.891 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.8 m -112.64 88.73 2.89 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.155 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 80' ' ' ALA . 39.2 t -74.02 105.18 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.25 -72.3 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 O-C-N 126.046 2.091 . . . . 0.0 115.929 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.532 0 O-C-N 125.547 1.78 . . . . 0.0 113.841 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.203 ' CE1' HD21 ' A' ' 64' ' ' LEU . 60.9 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' TRP . . . . . 0.446 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.9 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.426 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.2 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.7 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.4 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 52.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.43 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 78.4 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.421 ' HA ' HD22 ' B' ' 27' ' ' LEU . 72.1 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.569 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.0 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 1.381 ' HB ' ' CA ' ' B' ' 34' ' ' VAL 0.386 0.2 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.488 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.9 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.441 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.441 ' O ' HG12 ' B' ' 36' ' ' VAL . 27.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.413 HG23 HD12 ' B' ' 247' ' ' ILE . 26.0 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.791 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.652 ' H ' ' HG ' ' B' ' 133' ' ' SER . 32.6 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.433 HG11 ' N ' ' B' ' 46' ' ' PHE . 87.5 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 1.028 ' CE1' HG22 ' B' ' 131' ' ' VAL . 51.5 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.5 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.48 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.1 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.48 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.2 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.8 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.561 ' O ' HG21 ' B' ' 68' ' ' VAL . 58.6 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.631 HG12 ' N ' ' B' ' 69' ' ' GLY . 80.7 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.631 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.558 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.532 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.8 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.0 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 0.856 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 17.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.856 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 46.4 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.491 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' B' ' 130' ' ' PRO . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.4 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.484 ' HA ' HD12 ' B' ' 94' ' ' LEU . 49.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.1 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.1 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 1.221 ' CZ ' ' HG2' ' A' ' 37' ' ' PRO . 17.3 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' GLN . . . . . 0.534 HE22 ' HA ' ' A' ' 36' ' ' VAL . 11.2 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.426 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 25.0 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.493 ' C ' HG13 ' B' ' 114' ' ' VAL . 55.7 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.545 ' O ' HG23 ' B' ' 114' ' ' VAL . 16.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 1.478 ' HB ' ' CB ' ' B' ' 115' ' ' ILE 0.526 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.436 HG21 ' C ' ' B' ' 115' ' ' ILE 0.403 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.661 ' C ' ' HE2' ' A' ' 66' ' ' MET . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 1.451 ' CG ' HD22 ' A' ' 64' ' ' LEU . 38.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 81.3 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.8 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 90.0 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.581 ' C ' HG12 ' B' ' 131' ' ' VAL . 12.8 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 1.549 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.511 0.9 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.652 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . 0.475 ' HG2' HD12 ' B' ' 142' ' ' ILE . 38.3 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.449 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 23.9 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' PRO . . . . . 0.642 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.4 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.449 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.547 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.547 HG22 ' CG ' ' B' ' 139' ' ' ASP 0.469 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . 0.642 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' SER . . . . . 0.495 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.5 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' VAL . . . . . 0.495 HG13 ' C ' ' B' ' 148' ' ' SER 0.361 1.5 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.464 HG12 HG23 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.476 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.6 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.666 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.3 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 1.333 ' HB ' ' CG1' ' B' ' 160' ' ' VAL 0.398 0.6 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.1 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.431 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.9 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . 0.534 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . 0.737 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.2 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.3 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.524 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 58.0 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 64.8 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.9 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.727 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.727 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.7 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.433 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.483 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.1 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.443 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.6 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.655 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' VAL . . . . . 0.655 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.464 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' LYS . . . . . 0.524 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.7 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.458 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.9 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.458 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.8 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' ASP . . . . . 0.488 ' O ' HD13 ' B' ' 196' ' ' LEU . 63.0 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.2 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.737 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 40.3 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . 0.422 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.422 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 12.2 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.3 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.9 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 1.361 ' HB ' ' CG1' ' B' ' 225' ' ' VAL 0.423 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.8 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.6 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' ASN . . . . . 0.51 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . 0.482 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.1 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . 0.569 HD13 ' O ' ' B' ' 32' ' ' THR . 15.0 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' ILE . . . . . 0.413 HD12 HG23 ' B' ' 40' ' ' VAL . 18.7 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 40.8 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.924 -1.036 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' HEC . . . . . 0.607 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.709 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.444 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 69.7 m -61.51 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.963 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.93 163.03 12.63 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.455 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.2 t -107.74 122.43 46.72 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.9 t -100.56 98.37 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.4 mmmt -67.35 65.37 0.07 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.894 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 39' ' ' HIS . 14.9 mt -29.46 68.22 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 126.61 1.964 . . . . 0.0 115.517 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.45 59.01 0.4 Allowed Glycine 0 N--CA 1.51 3.584 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 11' ' ' LYS . 20.3 p -1.13 54.15 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.284 0 N-CA-C 120.32 3.452 . . . . 0.0 120.32 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.51 -60.23 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 119.539 3.163 . . . . 0.0 119.539 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.87 22.62 14.27 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.858 -1.151 . . . . 0.0 108.189 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.2 -94.81 1.89 Allowed Glycine 0 N--CA 1.512 3.721 0 N-CA-C 115.521 0.969 . . . . 0.0 115.521 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.577 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.6 tp -150.56 -177.14 5.8 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 1.036 HD21 HG23 ' A' ' 36' ' ' VAL . 15.4 mt -74.78 46.76 0.3 Allowed 'General case' 0 N--CA 1.509 2.506 0 O-C-N 120.716 -1.24 . . . . 0.0 111.261 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.665 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 7.6 p -113.79 165.59 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 118.464 2.764 . . . . 0.0 118.464 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.665 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 5.3 m-30 -102.22 75.41 1.49 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 112.142 -2.299 . . . . 0.0 113.431 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.343 0.6 OUTLIER -93.46 142.43 25.19 Favored Pre-proline 0 N--CA 1.506 2.347 0 O-C-N 121.805 -0.559 . . . . 0.0 111.754 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' LYS . 46.3 Cg_endo -86.46 76.22 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.39 0 N-CA-C 116.351 1.635 . . . . 0.0 116.351 -9.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.54 -44.17 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.841 1 N-CA-C 122.284 4.179 . . . . 0.0 122.284 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.648 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.61 71.69 1.0 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 122.408 1.099 . . . . 0.0 113.072 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.679 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.19 111.23 7.23 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.237 -1.539 . . . . 0.0 109.1 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.574 ' N ' HD22 ' A' ' 21' ' ' LEU . 46.1 m -87.42 81.41 7.84 Favored 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.713 HD11 HD12 ' A' ' 101' ' ' ILE . 4.4 pt -79.61 -177.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 CA-C-N 114.772 -1.103 . . . . 0.0 112.719 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.708 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -109.7 166.6 10.49 Favored Pre-proline 0 CA--C 1.566 1.569 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.135 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 19.9 Cg_endo -52.26 77.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.288 0 N-CA-C 116.903 1.847 . . . . 0.0 116.903 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.16 -50.59 0.51 Allowed Glycine 1 N--CA 1.522 4.419 0 C-N-CA 119.753 -1.213 . . . . 0.0 115.834 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.652 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.61 92.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.171 1 N-CA-C 122.227 4.158 . . . . 0.0 122.227 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.444 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.1 m -64.15 36.08 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 30' ' ' GLU . 58.0 t -52.11 147.23 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 CA-C-N 112.878 -1.965 . . . . 0.0 111.475 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.534 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.8 pt-20 -114.28 154.87 27.21 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 123.978 1.847 . . . . 0.0 115.356 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -107.53 113.83 27.41 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.8 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.65 112.49 24.89 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 120.792 3.627 . . . . 0.0 120.792 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -75.12 84.78 2.34 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.164 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 29.7 p30 -80.35 -45.06 18.4 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 118.904 2.928 . . . . 0.0 118.904 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.97 -169.33 3.35 Favored 'General case' 0 N--CA 1.509 2.491 0 C-N-CA 124.596 1.158 . . . . 0.0 109.068 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.05 ' HA ' HE22 ' B' ' 104' ' ' GLN . 1.6 m 12.91 70.62 0.11 Allowed Pre-proline 0 N--CA 1.519 3.01 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.344 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 55.3 Cg_endo -98.43 177.28 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.213 0 C-N-CA 123.908 3.072 . . . . 0.0 114.455 -165.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.72 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 52.3 Cg_endo -92.47 165.29 25.09 Favored 'Cis proline' 0 N--CA 1.503 2.069 0 N-CA-C 115.442 1.285 . . . . 0.0 115.442 -7.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.792 ' HB2' HD11 ' A' ' 7' ' ' LEU . 16.3 m-70 -118.96 87.46 2.74 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.704 HD22 ' N ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -103.37 140.2 37.76 Favored 'General case' 0 N--CA 1.516 2.827 0 CA-C-N 122.395 2.362 . . . . 0.0 110.744 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.3 m -118.11 116.22 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 121.476 3.88 . . . . 0.0 121.476 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.994 HG22 ' HB2' ' A' ' 88' ' ' TYR . 13.3 m -75.87 165.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.907 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.3 130.94 55.51 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.452 ' OD1' HD13 ' A' ' 47' ' ' LEU . 4.2 m-20 -53.4 93.71 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.183 1 N-CA-C 124.2 4.889 . . . . 0.0 124.2 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.98 6.8 43.28 Favored 'General case' 0 CA--C 1.602 2.957 0 N-CA-C 101.23 -3.619 . . . . 0.0 101.23 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB2' HD13 ' A' ' 47' ' ' LEU . . . -115.83 -65.53 1.18 Allowed 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 127.595 2.358 . . . . 0.0 112.704 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.676 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.5 mp -86.72 66.47 9.48 Favored 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 118.966 2.95 . . . . 0.0 118.966 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.43 151.22 0.74 Allowed Pre-proline 0 N--CA 1.522 3.167 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.489 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 17.4 Cg_endo -42.32 -58.31 1.28 Allowed 'Trans proline' 0 N--CA 1.508 2.376 0 C-N-CA 123.408 2.739 . . . . 0.0 115.085 170.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.637 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.48 67.46 0.72 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 124.034 1.873 . . . . 0.0 107.04 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -77.25 53.6 1.02 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 112.333 -2.212 . . . . 0.0 108.331 179.392 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.4 t -115.88 56.96 0.76 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.679 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.57 -47.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.11 -30.87 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.104 -1.622 . . . . 0.0 111.636 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.13 -28.5 0.09 Allowed 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 122.801 1.286 . . . . 0.0 112.561 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.796 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.86 -27.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.3 tptt 65.15 -55.62 0.31 Allowed 'General case' 0 N--CA 1.533 3.678 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.2 m -41.72 -28.9 0.16 Allowed 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.907 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.2 pp -53.74 -66.71 0.35 Allowed 'General case' 0 CA--C 1.603 3.017 0 N-CA-C 100.723 -3.806 . . . . 0.0 100.723 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.849 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 11.0 p -72.14 98.38 2.12 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.278 1.431 . . . . 0.0 112.816 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.742 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.5 t60 -89.96 -173.01 3.72 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.833 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.39 155.17 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.833 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 26.2 tt0 105.43 66.08 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 120.289 3.44 . . . . 0.0 120.289 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 1.164 HD21 ' CE1' ' B' ' 1' ' ' TYR . 5.6 mp 38.1 84.27 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 120.803 3.631 . . . . 0.0 120.803 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.704 ' N ' HD22 ' A' ' 40' ' ' ASN . 36.3 mt -70.68 82.12 0.61 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.144 -1.597 . . . . 0.0 111.88 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 1.107 ' CE ' ' O ' ' B' ' 118' ' ' PRO . 41.4 mmm -79.27 61.92 3.5 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-O 126.096 2.855 . . . . 0.0 110.918 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.9 m -112.52 65.95 0.84 Allowed Pre-proline 0 N--CA 1.505 2.298 0 CA-C-N 110.47 -3.059 . . . . 0.0 113.601 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.824 ' HG3' ' O ' ' B' ' 100' ' ' ASP . 19.3 Cg_endo -51.94 81.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.522 0 C-N-CA 122.979 2.452 . . . . 0.0 114.633 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.09 6.67 27.71 Favored Glycine 1 N--CA 1.516 4.021 0 O-C-N 122.203 -0.31 . . . . 0.0 113.606 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.66 156.82 35.17 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 124.389 2.042 . . . . 0.0 116.332 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.8 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.91 156.34 27.55 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 119.742 3.238 . . . . 0.0 119.742 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -115.9 147.97 40.52 Favored 'General case' 0 N--CA 1.52 3.048 0 CA-C-O 116.643 -1.646 . . . . 0.0 107.264 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.48 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.59 143.76 41.94 Favored 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.441 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 76.1 m -119.95 102.64 8.69 Favored 'General case' 0 N--CA 1.514 2.751 0 CA-C-N 114.221 -1.354 . . . . 0.0 113.525 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.8 m -94.81 152.26 18.56 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -107.97 168.33 8.05 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -72.36 -174.76 1.52 Allowed 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 121.009 1.14 . . . . 0.0 111.115 161.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.34 -19.78 18.98 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 124.301 2.001 . . . . 0.0 107.241 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.16 42.64 0.49 Allowed 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 111.246 -2.706 . . . . 0.0 109.059 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.598 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.3 84.84 9.84 Favored Pre-proline 0 N--CA 1.499 2.023 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.778 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 83' ' ' GLY . 38.0 Cg_endo -79.38 178.6 7.23 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.851 2.367 . . . . 0.0 112.298 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.585 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -15.97 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.889 0 C-N-CA 125.316 1.447 . . . . 0.0 113.262 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.52 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.51 125.08 5.64 Favored Glycine 0 N--CA 1.506 3.365 0 N-CA-C 121.703 3.441 . . . . 0.0 121.703 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.656 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 44.0 mt-10 -99.5 61.18 1.17 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.806 ' HB2' HG23 ' A' ' 101' ' ' ILE . 3.0 m-85 -62.04 77.74 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.873 1.32 . . . . 0.0 113.068 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.4 m -63.36 135.92 57.31 Favored 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.581 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.47 136.55 52.89 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.994 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.6 m-85 -84.63 81.97 8.63 Favored 'General case' 0 N--CA 1.511 2.576 1 N-CA-C 132.625 8.009 . . . . 0.0 132.625 -179.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.7 t -63.84 82.21 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.447 2 CA-C-N 130.434 6.016 . . . . 0.0 114.298 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.5 tt0 -20.61 -72.48 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.61 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.838 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 31.7 Cg_endo -66.88 -3.55 9.71 Favored 'Trans proline' 0 N--CA 1.511 2.547 0 C-N-CA 122.419 2.079 . . . . 0.0 115.372 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -120.88 -14.08 8.54 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.483 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.45 79.75 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.53 -34.03 1.74 Allowed Glycine 1 N--CA 1.521 4.309 0 O-C-N 121.571 -0.706 . . . . 0.0 112.621 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.62 68.54 8.01 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.78 26.78 0.05 OUTLIER Glycine 1 N--CA 1.528 4.787 0 CA-C-N 114.004 -1.453 . . . . 0.0 116.636 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.851 ' HE2' HD22 ' A' ' 14' ' ' LEU . 1.8 ttt -108.53 43.76 1.2 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 124.51 2.1 . . . . 0.0 113.035 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.89 134.89 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 112.216 -2.266 . . . . 0.0 111.007 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.7 154.89 19.38 Favored Glycine 1 N--CA 1.535 5.269 0 C-N-CA 119.486 -1.34 . . . . 0.0 113.986 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.845 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.2 ttpp -118.63 81.96 1.78 Allowed 'General case' 0 N--CA 1.518 2.956 0 CA-C-N 119.404 1.602 . . . . 0.0 115.252 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.806 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.76 123.24 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.845 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.1 m -112.56 88.72 2.89 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.196 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 80' ' ' ALA . 38.8 t -73.97 105.21 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.3 -72.3 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 O-C-N 126.051 2.094 . . . . 0.0 115.888 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.585 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.486 0 O-C-N 125.579 1.799 . . . . 0.0 113.861 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.424 ' H1 ' ' N ' ' B' ' 1' ' ' TYR . 60.6 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.838 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 24.1 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' TRP . . . . . 0.458 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.45 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.0 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.2 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 89.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 54.2 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.43 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 77.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.464 ' HA ' HD22 ' B' ' 27' ' ' LEU . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.59 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.3 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.485 HG23 HG12 ' B' ' 151' ' ' VAL 0.373 0.1 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.6 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.47 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.47 ' O ' HG12 ' B' ' 36' ' ' VAL . 23.7 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.416 ' C ' HG11 ' B' ' 40' ' ' VAL . 87.9 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.416 HG11 ' C ' ' B' ' 39' ' ' SER . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.825 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.654 ' H ' ' HG ' ' B' ' 133' ' ' SER . 30.2 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.436 HG11 ' N ' ' B' ' 46' ' ' PHE . 89.4 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 1.142 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.3 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.531 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.9 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.531 HG22 ' O ' ' B' ' 55' ' ' ASP . 15.1 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 82.9 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.567 ' O ' HG21 ' B' ' 68' ' ' VAL . 55.4 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.658 HG12 ' N ' ' B' ' 69' ' ' GLY . 74.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.658 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.589 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.552 HG21 HD12 ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.2 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 1.049 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 24.8 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 1.049 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 43.0 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . 0.472 ' H ' HG21 ' B' ' 84' ' ' ILE 0.568 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' B' ' 130' ' ' PRO . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' B' ' 94' ' ' LEU . 50.3 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.824 ' O ' ' HG3' ' A' ' 68' ' ' PRO . 24.3 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 1.344 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 17.2 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' GLN . . . . . 1.05 HE22 ' HA ' ' A' ' 36' ' ' VAL . 11.0 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.9 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.475 ' C ' HG13 ' B' ' 114' ' ' VAL . 55.2 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.58 ' O ' HG23 ' B' ' 114' ' ' VAL . 17.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.552 HD12 HG21 ' B' ' 75' ' ' VAL 0.454 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 0.535 ' N ' HG21 ' B' ' 115' ' ' ILE 0.254 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.712 ' C ' ' HE2' ' A' ' 66' ' ' MET . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 1.107 ' O ' ' CE ' ' A' ' 66' ' ' MET . 36.4 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.907 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 81.9 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.5 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 85.3 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.505 ' C ' HG12 ' B' ' 131' ' ' VAL . 19.8 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 1.556 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.348 0.5 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.654 ' HG ' ' H ' ' B' ' 44' ' ' THR . 95.1 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . 0.598 ' HG2' HD12 ' B' ' 142' ' ' ILE . 35.7 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.444 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 25.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' PRO . . . . . 0.526 ' CG ' ' CZ ' ' B' ' 144' ' ' PHE . 18.2 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.444 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.591 ' CG ' ' CG2' ' B' ' 142' ' ' ILE . 44.7 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.598 HD12 ' HG2' ' B' ' 134' ' ' PRO 0.511 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . 0.526 ' CZ ' ' CG ' ' B' ' 136' ' ' PRO . 81.3 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' SER . . . . . 0.449 ' C ' HG13 ' B' ' 149' ' ' VAL . 69.0 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' VAL . . . . . 1.372 ' HB ' ' CG2' ' B' ' 149' ' ' VAL . 1.3 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.485 HG12 HG23 ' B' ' 34' ' ' VAL . 10.7 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' B' ' 155' ' ' ARG . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' B' ' 157' ' ' ARG . 28.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.683 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.7 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 1.358 ' HB ' ' CA ' ' B' ' 160' ' ' VAL 0.31 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' TYR . . . . . 0.413 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 64.4 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' PRO . . . . . 0.458 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 17.8 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 97.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.434 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.9 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . 0.576 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.9 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . 0.805 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 18.4 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.537 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 61.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.4 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' LYS . . . . . 0.423 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.6 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.759 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.759 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 41.2 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.381 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.483 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 40.8 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.501 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.4 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.726 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' VAL . . . . . 0.726 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' ILE . . . . . 0.537 HG13 ' O ' ' B' ' 199' ' ' ILE 0.52 0.3 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' LYS . . . . . 0.537 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.7 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.6 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.472 ' C ' HG13 ' B' ' 207' ' ' VAL . 60.0 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.472 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.2 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' ASP . . . . . 0.51 ' O ' HD13 ' B' ' 196' ' ' LEU . 63.3 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.805 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 36.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . 0.473 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.473 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 18.3 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.3 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.1 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.402 0.1 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.0 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' ASN . . . . . 0.545 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . 0.507 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.6 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . 0.59 HD13 ' O ' ' B' ' 32' ' ' THR . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 19.4 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . 0.427 ' HA ' HD11 ' B' ' 249' ' ' LEU . 41.4 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' HEC . . . . . 0.608 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.711 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.471 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.5 m -61.53 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.029 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -99.95 163.08 12.6 Favored 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.457 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.83 122.39 46.69 Favored 'General case' 0 N--CA 1.525 3.305 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -100.49 98.38 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.7 mmmt -67.37 65.39 0.07 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 113.121 -1.854 . . . . 0.0 114.847 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.826 HD11 ' HB2' ' A' ' 39' ' ' HIS . 14.6 mt -29.59 68.29 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 126.53 1.932 . . . . 0.0 115.501 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.44 58.98 0.4 Allowed Glycine 0 N--CA 1.509 3.54 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.1 p -1.07 54.24 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 N-CA-C 120.187 3.402 . . . . 0.0 120.187 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.44 -60.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 119.513 3.153 . . . . 0.0 119.513 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' NZ ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.76 22.53 14.42 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.858 -1.151 . . . . 0.0 108.183 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.18 -94.77 1.89 Allowed Glycine 0 N--CA 1.512 3.713 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.484 HD13 ' H ' ' A' ' 14' ' ' LEU . 44.6 tp -150.61 -177.2 5.84 Favored 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 1.022 HD21 HG23 ' A' ' 36' ' ' VAL . 15.2 mt -74.78 46.78 0.3 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 120.638 -1.289 . . . . 0.0 111.279 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.569 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.85 165.68 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 118.596 2.813 . . . . 0.0 118.596 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.569 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 4.9 m-30 -102.23 75.42 1.49 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 112.2 -2.273 . . . . 0.0 113.389 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.308 12.3 mt-10 -93.47 142.43 25.2 Favored Pre-proline 0 N--CA 1.505 2.294 0 O-C-N 121.826 -0.546 . . . . 0.0 111.814 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.41 76.15 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.458 0 N-CA-C 116.328 1.626 . . . . 0.0 116.328 -9.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.59 -44.14 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 1 N-CA-C 122.344 4.201 . . . . 0.0 122.344 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.63 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.62 71.62 1.0 Allowed 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 122.364 1.078 . . . . 0.0 113.025 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.624 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.13 111.31 7.25 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.208 -1.557 . . . . 0.0 109.104 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.503 ' N ' HD22 ' A' ' 21' ' ' LEU . 49.4 m -87.49 81.46 7.78 Favored 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.698 HD11 HD12 ' A' ' 101' ' ' ILE . 5.3 pt -79.78 -177.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.692 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.615 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.66 166.51 10.65 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.198 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.6 Cg_endo -52.2 77.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.3 0 N-CA-C 116.91 1.85 . . . . 0.0 116.91 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.09 -50.44 0.52 Allowed Glycine 1 N--CA 1.523 4.449 0 C-N-CA 119.789 -1.196 . . . . 0.0 115.915 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.674 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.64 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.178 1 N-CA-C 122.151 4.13 . . . . 0.0 122.151 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.9 m -64.0 35.98 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.027 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 30' ' ' GLU . 63.6 t -52.11 147.21 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 112.906 -1.952 . . . . 0.0 111.418 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' N ' HG13 ' A' ' 29' ' ' VAL . 4.1 pt-20 -114.29 154.93 27.11 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 123.925 1.822 . . . . 0.0 115.324 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -107.53 113.79 27.35 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.801 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.76 112.57 25.0 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 120.758 3.614 . . . . 0.0 120.758 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -75.16 84.72 2.37 Favored 'General case' 0 N--CA 1.511 2.622 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.13 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.23 -45.11 18.55 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.93 -169.38 3.36 Favored 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 124.61 1.164 . . . . 0.0 109.086 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.106 HG13 ' NE2' ' B' ' 104' ' ' GLN . 1.7 m 12.92 70.63 0.11 Allowed Pre-proline 0 N--CA 1.521 3.098 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.45 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.4 177.28 0.41 Allowed 'Trans proline' 0 CA--C 1.569 2.241 0 C-N-CA 123.939 3.093 . . . . 0.0 114.416 -165.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.4 Cg_endo -92.5 165.31 25.0 Favored 'Cis proline' 0 N--CA 1.503 2.068 0 N-CA-C 115.398 1.268 . . . . 0.0 115.398 -7.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.826 ' HB2' HD11 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.89 87.46 2.74 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.587 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 1.0 OUTLIER -103.45 140.22 37.78 Favored 'General case' 0 N--CA 1.515 2.818 0 CA-C-N 122.456 2.389 . . . . 0.0 110.722 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.2 m -118.08 116.31 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.98 HG22 ' HB2' ' A' ' 88' ' ' TYR . 14.8 m -75.95 165.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 102.19 -3.263 . . . . 0.0 102.19 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.856 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.3 130.93 55.51 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.459 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.32 93.77 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.221 1 N-CA-C 124.182 4.882 . . . . 0.0 124.182 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.06 6.74 43.68 Favored 'General case' 0 CA--C 1.602 2.972 0 N-CA-C 101.168 -3.642 . . . . 0.0 101.168 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.8 -65.54 1.18 Allowed 'General case' 0 CA--C 1.573 1.853 0 C-N-CA 127.525 2.33 . . . . 0.0 112.718 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.56 9.53 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 118.915 2.932 . . . . 0.0 118.915 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.46 151.25 0.74 Allowed Pre-proline 0 N--CA 1.522 3.135 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.8 Cg_endo -42.51 -58.2 1.35 Allowed 'Trans proline' 0 N--CA 1.508 2.371 0 C-N-CA 123.438 2.758 . . . . 0.0 115.04 170.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.52 67.43 0.72 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 124.091 1.901 . . . . 0.0 107.072 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.28 53.55 1.02 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.256 -2.247 . . . . 0.0 108.222 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.8 56.94 0.76 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.745 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.58 -47.94 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.184 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.12 -30.85 0.16 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.113 -1.617 . . . . 0.0 111.545 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.793 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.22 -28.54 0.1 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.732 1.253 . . . . 0.0 112.485 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.793 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.82 -27.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.3 tptt 64.93 -55.47 0.3 Allowed 'General case' 0 N--CA 1.533 3.715 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -41.78 -28.86 0.17 Allowed 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.856 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.8 pp -53.74 -66.76 0.33 Allowed 'General case' 0 CA--C 1.604 3.022 0 N-CA-C 100.713 -3.81 . . . . 0.0 100.713 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.789 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.11 98.44 2.11 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 125.268 1.427 . . . . 0.0 112.781 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.72 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.3 t60 -90.05 -173.08 3.73 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.835 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.42 155.15 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.835 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 28.1 tt0 105.5 66.06 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.755 0 N-CA-C 120.313 3.449 . . . . 0.0 120.313 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 1.316 HD22 ' CG ' ' B' ' 118' ' ' PRO . 6.1 mp 38.13 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' N ' HD22 ' A' ' 40' ' ' ASN . 36.2 mt -70.67 82.08 0.61 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.197 -1.564 . . . . 0.0 111.906 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.965 ' HE1' HD23 ' B' ' 119' ' ' LEU . 41.4 mmm -79.3 62.0 3.53 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 126.051 2.834 . . . . 0.0 110.867 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.4 m -112.58 65.84 0.85 Allowed Pre-proline 0 C--N 1.283 -2.287 0 CA-C-N 110.474 -3.057 . . . . 0.0 113.558 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -51.92 81.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.45 0 C-N-CA 122.959 2.439 . . . . 0.0 114.716 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.66 27.63 Favored Glycine 0 N--CA 1.516 3.991 0 O-C-N 122.131 -0.356 . . . . 0.0 113.603 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.516 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.8 tt0 -123.65 156.92 34.97 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 124.384 2.04 . . . . 0.0 116.273 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.801 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.98 156.37 27.58 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 119.722 3.23 . . . . 0.0 119.722 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -115.93 147.95 40.58 Favored 'General case' 0 N--CA 1.52 3.056 0 CA-C-O 116.636 -1.65 . . . . 0.0 107.194 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.457 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.46 143.74 41.81 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 85.2 m -120.02 102.57 8.63 Favored 'General case' 0 N--CA 1.513 2.719 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.532 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.5 m -94.74 152.22 18.63 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -107.97 168.27 8.13 Favored Pre-proline 0 N--CA 1.502 2.13 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.135 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.33 -174.77 1.51 Allowed 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.006 1.137 . . . . 0.0 111.122 161.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.45 -19.64 19.01 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-O 124.346 2.022 . . . . 0.0 107.216 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.25 42.72 0.5 Allowed 'General case' 0 CA--C 1.576 1.963 0 CA-C-N 111.249 -2.705 . . . . 0.0 109.036 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.583 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.29 84.73 9.68 Favored Pre-proline 0 N--CA 1.5 2.031 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.846 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -79.36 178.68 7.15 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 122.753 2.302 . . . . 0.0 112.226 173.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.583 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.04 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 125.294 1.437 . . . . 0.0 113.3 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.35 125.01 5.64 Favored Glycine 0 N--CA 1.508 3.472 0 N-CA-C 121.777 3.471 . . . . 0.0 121.777 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.662 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 44.0 mt-10 -99.44 61.15 1.18 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.788 ' HB2' HG23 ' A' ' 101' ' ' ILE . 2.8 m-85 -62.06 77.79 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 122.9 1.333 . . . . 0.0 112.984 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.46 135.91 57.23 Favored 'General case' 0 N--CA 1.51 2.561 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.526 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.43 136.51 52.93 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.98 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.64 81.96 8.63 Favored 'General case' 0 N--CA 1.511 2.617 1 N-CA-C 132.611 8.004 . . . . 0.0 132.611 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.758 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.0 t -63.82 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.471 2 CA-C-N 130.384 5.993 . . . . 0.0 114.34 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.6 tt0 -20.5 -72.4 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.62 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 29.6 Cg_endo -67.08 -3.45 9.76 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 122.406 2.071 . . . . 0.0 115.334 176.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -120.93 -14.16 8.51 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.23 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.782 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.58 -34.1 1.73 Allowed Glycine 1 N--CA 1.521 4.304 0 O-C-N 121.516 -0.74 . . . . 0.0 112.628 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.47 68.42 7.79 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.84 26.81 0.05 OUTLIER Glycine 1 N--CA 1.526 4.648 0 N-CA-C 116.616 1.407 . . . . 0.0 116.616 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.871 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.1 ttt -108.55 43.86 1.19 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 124.482 2.087 . . . . 0.0 112.966 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.03 134.88 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 112.233 -2.258 . . . . 0.0 110.973 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.65 154.86 19.34 Favored Glycine 1 N--CA 1.534 5.228 0 C-N-CA 119.525 -1.321 . . . . 0.0 114.032 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.865 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.0 ttpp -118.63 82.0 1.78 Allowed 'General case' 0 N--CA 1.518 2.925 0 CA-C-N 119.474 1.637 . . . . 0.0 115.188 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.788 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.74 123.29 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.865 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.5 m -112.67 88.77 2.9 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.197 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 80' ' ' ALA . 38.3 t -74.05 105.23 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.35 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 O-C-N 126.066 2.104 . . . . 0.0 115.912 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.583 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.438 0 O-C-N 125.478 1.736 . . . . 0.0 113.835 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.888 ' CE1' HD21 ' A' ' 64' ' ' LEU . 61.0 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.28 21.9 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' TRP . . . . . 0.43 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.8 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.308 27.5 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.546 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 52.9 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.611 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.429 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.537 ' O ' HD13 ' B' ' 243' ' ' LEU . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.403 HG23 HD12 ' B' ' 247' ' ' ILE . 26.5 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.742 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.367 22.0 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.652 ' H ' ' HG ' ' B' ' 133' ' ' SER . 33.0 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.456 HG11 ' N ' ' B' ' 46' ' ' PHE . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.765 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.416 ' O ' HG22 ' B' ' 58' ' ' VAL . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.8 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.416 HG22 ' O ' ' B' ' 55' ' ' ASP . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.58 ' O ' HG21 ' B' ' 68' ' ' VAL . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.621 HG12 ' N ' ' B' ' 69' ' ' GLY . 88.0 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.621 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.536 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.421 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.436 HD11 HG23 ' B' ' 149' ' ' VAL . 50.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 0.704 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.1 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.704 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.2 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 94' ' ' LEU . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.5 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 1.45 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 20.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' GLN . . . . . 1.106 ' NE2' HG13 ' A' ' 36' ' ' VAL . 11.9 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.546 ' C ' HG13 ' B' ' 114' ' ' VAL . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.546 HG13 ' C ' ' B' ' 113' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.421 ' CD1' HG21 ' B' ' 75' ' ' VAL 0.592 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 1.316 ' CG ' HD22 ' A' ' 64' ' ' LEU . 36.5 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.965 HD23 ' HE1' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.45 ' C ' HG12 ' B' ' 131' ' ' VAL . 23.9 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.765 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.442 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.652 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.9 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.429 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 20.9 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' PRO . . . . . 0.677 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.327 23.8 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.429 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.462 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.523 HD11 ' HH ' ' B' ' 147' ' ' TYR 0.316 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . 0.677 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' TYR . . . . . 0.523 ' HH ' HD11 ' B' ' 142' ' ' ILE . 45.3 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' SER . . . . . 0.426 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' VAL . . . . . 0.436 HG23 HD11 ' B' ' 76' ' ' LEU 0.418 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' HIS . . . . . 0.546 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.484 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.526 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' TYR . . . . . 0.403 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 64.1 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' PRO . . . . . 0.43 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 23.0 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.46 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.2 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . 0.495 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . 0.718 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.539 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.687 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.687 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.363 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.445 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.578 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' VAL . . . . . 0.578 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' LYS . . . . . 0.539 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.452 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.452 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' ASP . . . . . 0.433 ' O ' HD13 ' B' ' 196' ' ' LEU . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.718 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 36.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.256 25.7 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.625 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.8 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' ASN . . . . . 0.535 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . 0.52 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 19.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . 0.537 HD13 ' O ' ' B' ' 32' ' ' THR . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' ILE . . . . . 0.403 HD12 HG23 ' B' ' 40' ' ' VAL . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' HEC . . . . . 0.611 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.727 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.473 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 82.1 m -61.63 89.63 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.012 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -99.92 163.03 12.63 Favored 'General case' 0 N--CA 1.511 2.617 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.477 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.79 122.4 46.69 Favored 'General case' 0 N--CA 1.525 3.301 0 N-CA-C 117.179 2.288 . . . . 0.0 117.179 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.49 98.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.6 mmmt -67.36 65.41 0.07 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 113.144 -1.843 . . . . 0.0 114.828 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.816 HD11 ' HB2' ' A' ' 39' ' ' HIS . 14.6 mt -29.48 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 C-N-CA 126.575 1.95 . . . . 0.0 115.508 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.49 59.0 0.4 Allowed Glycine 0 N--CA 1.51 3.62 0 N-CA-C 106.897 -2.481 . . . . 0.0 106.897 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -1.05 54.08 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 120.324 3.453 . . . . 0.0 120.324 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.55 -60.25 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 119.494 3.146 . . . . 0.0 119.494 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.504 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.81 22.53 14.39 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 120.941 -1.099 . . . . 0.0 108.196 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.13 -94.8 1.9 Allowed Glycine 0 N--CA 1.511 3.694 0 N-CA-C 115.511 0.964 . . . . 0.0 115.511 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 14' ' ' LEU . 44.4 tp -150.62 -177.16 5.82 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.984 HD21 HG23 ' A' ' 36' ' ' VAL . 15.2 mt -74.8 46.72 0.3 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 120.677 -1.264 . . . . 0.0 111.271 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.566 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.76 165.69 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 118.578 2.807 . . . . 0.0 118.578 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.566 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 4.9 m-30 -102.26 75.39 1.48 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.364 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.307 12.4 mt-10 -93.45 142.46 25.24 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.81 -0.556 . . . . 0.0 111.746 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.41 76.13 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.459 0 N-CA-C 116.3 1.616 . . . . 0.0 116.3 -9.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.61 -44.19 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.807 1 N-CA-C 122.316 4.191 . . . . 0.0 122.316 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.61 71.62 1.0 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 122.484 1.135 . . . . 0.0 113.061 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.613 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.13 111.28 7.21 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.134 -1.604 . . . . 0.0 109.138 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.501 ' N ' HD22 ' A' ' 21' ' ' LEU . 50.6 m -87.49 81.43 7.79 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.706 HD11 HD12 ' A' ' 101' ' ' ILE . 5.3 pt -79.7 -177.57 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.689 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.619 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.49 10.68 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.133 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.4 Cg_endo -52.16 77.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.314 0 N-CA-C 116.97 1.873 . . . . 0.0 116.97 174.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.19 -50.5 0.51 Allowed Glycine 1 N--CA 1.522 4.403 0 C-N-CA 119.69 -1.243 . . . . 0.0 115.826 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.678 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.66 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.171 1 N-CA-C 122.149 4.129 . . . . 0.0 122.149 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.473 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.7 m -63.98 35.9 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.977 0 N-CA-C 118.726 2.861 . . . . 0.0 118.726 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 30' ' ' GLU . 62.3 t -51.98 147.15 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 112.886 -1.961 . . . . 0.0 111.57 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.486 ' N ' HG13 ' A' ' 29' ' ' VAL . 4.1 pt-20 -114.2 154.9 27.06 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 123.942 1.83 . . . . 0.0 115.442 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.54 113.84 27.43 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.794 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.79 112.49 24.92 Favored 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 120.686 3.587 . . . . 0.0 120.686 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -75.06 84.6 2.31 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.197 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.27 -45.03 18.62 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 118.919 2.933 . . . . 0.0 118.919 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.96 -169.38 3.36 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 124.619 1.167 . . . . 0.0 109.124 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.138 HG11 ' NE2' ' B' ' 104' ' ' GLN . 1.7 m 12.95 70.62 0.11 Allowed Pre-proline 0 N--CA 1.521 3.076 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.475 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.37 177.33 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.224 0 C-N-CA 123.941 3.094 . . . . 0.0 114.395 -165.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.3 Cg_endo -92.38 165.28 25.37 Favored 'Cis proline' 0 N--CA 1.504 2.104 0 N-CA-C 115.453 1.29 . . . . 0.0 115.453 -7.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.816 ' HB2' HD11 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.83 87.41 2.73 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 117.346 2.35 . . . . 0.0 117.346 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.578 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -103.44 140.25 37.73 Favored 'General case' 0 N--CA 1.516 2.863 0 CA-C-N 122.494 2.406 . . . . 0.0 110.681 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.1 m -118.11 116.26 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 121.386 3.847 . . . . 0.0 121.386 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.984 HG22 ' HB2' ' A' ' 88' ' ' TYR . 15.0 m -75.89 165.35 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 102.238 -3.245 . . . . 0.0 102.238 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.859 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.3 131.02 55.47 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.473 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.53 93.87 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.163 1 N-CA-C 124.149 4.87 . . . . 0.0 124.149 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.08 6.84 43.3 Favored 'General case' 0 CA--C 1.601 2.94 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.451 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.85 -65.5 1.18 Allowed 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 127.612 2.365 . . . . 0.0 112.753 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.9 mp -86.78 66.64 9.55 Favored 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 118.885 2.92 . . . . 0.0 118.885 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.48 151.22 0.73 Allowed Pre-proline 0 N--CA 1.522 3.137 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.7 Cg_endo -42.47 -58.24 1.33 Allowed 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 123.403 2.736 . . . . 0.0 115.079 170.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.45 67.34 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 124.063 1.887 . . . . 0.0 107.084 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.06 53.39 0.96 Allowed 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.296 -2.229 . . . . 0.0 108.266 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.77 56.89 0.76 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.846 2.535 . . . . 0.0 117.846 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.745 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.49 -48.04 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.171 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.04 -30.93 0.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.098 -1.626 . . . . 0.0 111.584 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.804 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.08 -28.61 0.09 Allowed 'General case' 0 N--CA 1.509 2.501 0 CA-C-O 122.68 1.229 . . . . 0.0 112.524 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.804 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.81 -27.48 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.807 ' HE2' ' OE1' ' B' ' 189' ' ' GLU . 12.3 tptt 65.08 -55.64 0.3 Allowed 'General case' 0 N--CA 1.532 3.66 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.7 m -41.67 -28.93 0.16 Allowed 'General case' 0 N--CA 1.513 2.715 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.859 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.8 pp -53.69 -66.8 0.33 Allowed 'General case' 0 CA--C 1.604 3.038 0 N-CA-C 100.673 -3.825 . . . . 0.0 100.673 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.765 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.16 98.47 2.14 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.248 1.419 . . . . 0.0 112.78 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.717 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.07 -173.05 3.72 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.829 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.39 155.18 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.829 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 28.2 tt0 105.44 66.11 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 N-CA-C 120.281 3.437 . . . . 0.0 120.281 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 1.07 HD21 ' CE1' ' B' ' 1' ' ' TYR . 6.1 mp 38.13 84.23 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 120.789 3.626 . . . . 0.0 120.789 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 40' ' ' ASN . 36.2 mt -70.6 81.99 0.6 Allowed 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.051 -1.655 . . . . 0.0 111.88 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 1.357 ' CE ' ' HA ' ' B' ' 119' ' ' LEU . 41.2 mmm -79.18 61.94 3.44 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 126.052 2.834 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.489 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.0 m -112.55 65.94 0.85 Allowed Pre-proline 0 C--N 1.284 -2.277 0 CA-C-N 110.465 -3.061 . . . . 0.0 113.662 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -52.05 81.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.463 0 C-N-CA 123.001 2.468 . . . . 0.0 114.642 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.06 6.73 27.73 Favored Glycine 1 N--CA 1.516 4.007 0 O-C-N 122.115 -0.366 . . . . 0.0 113.619 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 36.0 tt0 -123.61 156.85 35.02 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 124.36 2.029 . . . . 0.0 116.326 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.794 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.96 156.37 27.55 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -115.95 147.89 40.67 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-O 116.518 -1.706 . . . . 0.0 107.247 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.442 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.45 143.76 41.77 Favored 'General case' 0 N--CA 1.529 3.511 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 84.0 m -119.95 102.52 8.61 Favored 'General case' 0 N--CA 1.514 2.769 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.546 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.7 m -94.8 152.24 18.58 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -107.9 168.33 8.05 Favored Pre-proline 0 N--CA 1.504 2.268 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.076 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.35 -174.84 1.54 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 121.058 1.172 . . . . 0.0 111.073 161.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.36 -19.74 18.99 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 124.289 1.995 . . . . 0.0 107.173 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.15 42.66 0.49 Allowed 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 111.286 -2.688 . . . . 0.0 109.132 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.592 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.34 84.83 9.9 Favored Pre-proline 0 N--CA 1.499 2.011 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.723 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.8 Cg_endo -79.45 178.59 7.22 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.83 2.354 . . . . 0.0 112.303 172.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.569 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.03 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 125.432 1.493 . . . . 0.0 113.243 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.541 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.33 124.99 5.63 Favored Glycine 0 N--CA 1.507 3.38 0 N-CA-C 121.792 3.477 . . . . 0.0 121.792 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.655 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 44.0 mt-10 -99.46 61.23 1.18 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.813 ' HB2' HG23 ' A' ' 101' ' ' ILE . 2.8 m-85 -62.13 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.924 1.345 . . . . 0.0 112.969 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.8 m -63.42 135.95 57.28 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.538 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.53 136.53 52.91 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.984 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.69 82.11 8.57 Favored 'General case' 0 N--CA 1.512 2.672 1 N-CA-C 132.536 7.976 . . . . 0.0 132.536 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.0 t -63.91 82.21 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.495 2 CA-C-N 130.343 5.974 . . . . 0.0 114.324 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.5 tt0 -20.6 -72.42 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.6 0 N-CA-C 118.518 2.784 . . . . 0.0 118.518 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.55 ' O ' ' CD2' ' B' ' 3' ' ' PHE . 29.5 Cg_endo -67.04 -3.41 9.65 Favored 'Trans proline' 0 N--CA 1.51 2.473 0 C-N-CA 122.361 2.04 . . . . 0.0 115.383 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -120.85 -14.18 8.54 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.415 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.35 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.55 -33.94 1.74 Allowed Glycine 1 N--CA 1.521 4.343 0 O-C-N 121.491 -0.756 . . . . 0.0 112.645 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.6 68.51 7.98 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.9 26.74 0.05 OUTLIER Glycine 1 N--CA 1.528 4.774 0 CA-C-N 114.0 -1.455 . . . . 0.0 116.631 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.895 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.1 ttm -108.63 43.9 1.19 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 124.539 2.114 . . . . 0.0 112.973 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.02 134.87 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 112.209 -2.269 . . . . 0.0 110.916 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.538 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.62 154.88 19.33 Favored Glycine 1 N--CA 1.536 5.36 0 C-N-CA 119.468 -1.349 . . . . 0.0 114.023 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.909 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.0 ttpp -118.63 81.95 1.77 Allowed 'General case' 0 N--CA 1.516 2.863 0 CA-C-N 119.408 1.604 . . . . 0.0 115.238 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.813 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.66 123.22 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.731 0 C-N-CA 118.061 -1.456 . . . . 0.0 107.087 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.909 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.5 m -112.59 88.74 2.89 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.177 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 80' ' ' ALA . 38.2 t -74.08 105.15 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.16 -72.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 O-C-N 126.112 2.133 . . . . 0.0 115.93 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.569 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.534 0 O-C-N 125.555 1.785 . . . . 0.0 113.796 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.07 ' CE1' HD21 ' A' ' 64' ' ' LEU . 61.1 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.281 22.0 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.55 ' CD2' ' O ' ' A' ' 91' ' ' PRO . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' TRP . . . . . 0.429 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.7 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.31 27.8 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.548 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 53.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.611 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.429 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.537 ' O ' HD13 ' B' ' 243' ' ' LEU . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.403 HG23 HD12 ' B' ' 247' ' ' ILE . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.742 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.368 22.4 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.652 ' H ' ' HG ' ' B' ' 133' ' ' SER . 33.0 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.457 HG11 ' N ' ' B' ' 46' ' ' PHE . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.764 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.417 ' O ' HG22 ' B' ' 58' ' ' VAL . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.417 HG22 ' O ' ' B' ' 55' ' ' ASP . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.58 ' O ' HG21 ' B' ' 68' ' ' VAL . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.621 HG12 ' N ' ' B' ' 69' ' ' GLY . 88.0 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.621 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.536 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.421 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.437 HD11 HG23 ' B' ' 149' ' ' VAL . 50.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 0.704 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.704 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.2 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.3 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 94' ' ' LEU . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.7 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 1.475 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 20.7 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' GLN . . . . . 1.138 ' NE2' HG11 ' A' ' 36' ' ' VAL . 11.9 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.546 ' C ' HG13 ' B' ' 114' ' ' VAL . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.546 HG13 ' C ' ' B' ' 113' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.421 ' CD1' HG21 ' B' ' 75' ' ' VAL 0.592 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 1.278 ' O ' ' HE2' ' A' ' 66' ' ' MET . 36.4 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 1.357 ' HA ' ' CE ' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.45 ' C ' HG12 ' B' ' 131' ' ' VAL . 24.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.764 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.442 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.652 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.429 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 20.8 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' PRO . . . . . 0.677 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.328 23.8 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.429 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.462 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.523 HD11 ' HH ' ' B' ' 147' ' ' TYR 0.317 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . 0.677 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' TYR . . . . . 0.523 ' HH ' HD11 ' B' ' 142' ' ' ILE . 45.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' SER . . . . . 0.426 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' VAL . . . . . 0.437 HG23 HD11 ' B' ' 76' ' ' LEU 0.418 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' HIS . . . . . 0.548 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.484 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.0 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.525 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' TYR . . . . . 0.403 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 64.3 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' PRO . . . . . 0.429 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 23.0 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.46 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.1 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . 0.495 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . 0.719 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.54 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.687 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.687 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' GLU . . . . . 0.807 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.363 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.444 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.578 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' VAL . . . . . 0.578 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' LYS . . . . . 0.54 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.8 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.452 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.452 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' ASP . . . . . 0.433 ' O ' HD13 ' B' ' 196' ' ' LEU . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.719 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.256 25.9 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.627 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' ASN . . . . . 0.537 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 19.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . 0.537 HD13 ' O ' ' B' ' 32' ' ' THR . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' ILE . . . . . 0.403 HD12 HG23 ' B' ' 40' ' ' VAL . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' HEC . . . . . 0.611 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.727 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 82.5 m -61.65 89.68 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.022 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.95 163.01 12.63 Favored 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.72 122.41 46.68 Favored 'General case' 0 N--CA 1.526 3.326 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.5 t -100.57 98.36 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.7 mmmt -67.27 65.33 0.07 Allowed 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 113.144 -1.844 . . . . 0.0 114.9 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.814 HD11 ' HB2' ' A' ' 39' ' ' HIS . 14.7 mt -29.45 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 126.539 1.935 . . . . 0.0 115.531 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.48 59.04 0.4 Allowed Glycine 0 N--CA 1.51 3.576 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -0.95 54.0 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.61 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.84 22.57 14.34 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 120.956 -1.09 . . . . 0.0 108.154 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.22 -94.82 1.89 Allowed Glycine 0 N--CA 1.512 3.715 0 N-CA-C 115.499 0.96 . . . . 0.0 115.499 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.481 HD13 ' H ' ' A' ' 14' ' ' LEU . 44.6 tp -150.59 -177.14 5.8 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.999 HD21 HG23 ' A' ' 36' ' ' VAL . 15.1 mt -74.77 46.65 0.3 Allowed 'General case' 0 N--CA 1.509 2.499 0 O-C-N 120.641 -1.287 . . . . 0.0 111.264 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.78 165.6 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.561 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 4.9 m-30 -102.17 75.43 1.5 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 112.263 -2.244 . . . . 0.0 113.423 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.307 12.4 mt-10 -93.51 142.43 25.18 Favored Pre-proline 0 N--CA 1.506 2.333 0 O-C-N 121.822 -0.549 . . . . 0.0 111.778 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.5 76.22 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.431 0 N-CA-C 116.4 1.654 . . . . 0.0 116.4 -9.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.63 -44.22 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.795 1 N-CA-C 122.319 4.192 . . . . 0.0 122.319 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.631 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.56 71.65 1.0 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 122.388 1.09 . . . . 0.0 113.066 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.614 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.1 111.2 7.13 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.131 -1.606 . . . . 0.0 109.099 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.5 ' N ' HD22 ' A' ' 21' ' ' LEU . 49.7 m -87.46 81.42 7.81 Favored 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.696 HD11 HD12 ' A' ' 101' ' ' ILE . 5.3 pt -79.72 -177.55 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.626 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.619 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.68 166.55 10.58 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-N 113.78 -1.554 . . . . 0.0 108.122 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.4 Cg_endo -52.22 77.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.318 0 N-CA-C 116.866 1.833 . . . . 0.0 116.866 174.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.07 -50.51 0.52 Allowed Glycine 1 N--CA 1.522 4.428 0 C-N-CA 119.717 -1.23 . . . . 0.0 115.879 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.684 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.73 92.11 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.184 1 N-CA-C 122.19 4.144 . . . . 0.0 122.19 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.477 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 11.9 m -64.1 36.07 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.019 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 30' ' ' GLU . 62.8 t -52.11 147.17 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 CA-C-N 112.853 -1.976 . . . . 0.0 111.51 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' N ' HG13 ' A' ' 29' ' ' VAL . 4.1 pt-20 -114.2 154.88 27.11 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 123.916 1.817 . . . . 0.0 115.38 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.52 113.81 27.39 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.779 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.67 112.6 25.02 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -75.17 84.74 2.37 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.159 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.33 -45.11 18.36 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.92 -169.25 3.33 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 124.662 1.185 . . . . 0.0 109.109 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.999 HG23 HD21 ' A' ' 14' ' ' LEU . 1.7 m 12.75 70.69 0.11 Allowed Pre-proline 0 N--CA 1.52 3.066 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.229 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.44 177.24 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.219 0 C-N-CA 123.99 3.127 . . . . 0.0 114.424 -165.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.6 Cg_endo -92.44 165.31 25.18 Favored 'Cis proline' 0 N--CA 1.503 2.048 0 N-CA-C 115.399 1.269 . . . . 0.0 115.399 -7.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.814 ' HB2' HD11 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.9 87.43 2.73 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.586 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -103.36 140.35 37.55 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 122.482 2.401 . . . . 0.0 110.664 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.0 m -118.12 116.24 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 121.438 3.866 . . . . 0.0 121.438 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.977 HG22 ' HB2' ' A' ' 88' ' ' TYR . 15.0 m -75.92 165.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 102.258 -3.238 . . . . 0.0 102.258 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.861 ' CB ' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.32 130.97 55.51 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.472 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.41 93.78 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.168 1 N-CA-C 124.111 4.856 . . . . 0.0 124.111 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.07 6.8 43.47 Favored 'General case' 0 CA--C 1.602 2.967 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.81 -65.55 1.18 Allowed 'General case' 0 CA--C 1.574 1.889 0 C-N-CA 127.549 2.339 . . . . 0.0 112.723 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.6 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.71 66.45 9.47 Favored 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.37 151.27 0.75 Allowed Pre-proline 0 N--CA 1.523 3.182 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.8 Cg_endo -42.47 -58.28 1.32 Allowed 'Trans proline' 0 N--CA 1.507 2.324 0 C-N-CA 123.385 2.724 . . . . 0.0 115.079 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.43 67.4 0.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 124.069 1.89 . . . . 0.0 107.038 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.2 53.51 1.0 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 112.275 -2.239 . . . . 0.0 108.249 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.85 56.91 0.76 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.741 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.63 -47.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.244 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.17 -30.83 0.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.174 -1.579 . . . . 0.0 111.558 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.806 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.13 -28.59 0.1 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 122.693 1.235 . . . . 0.0 112.498 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.806 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.8 -27.57 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.639 ' HE2' ' OE1' ' B' ' 189' ' ' GLU . 12.3 tptt 65.06 -55.58 0.3 Allowed 'General case' 0 N--CA 1.532 3.632 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -41.68 -28.93 0.16 Allowed 'General case' 0 N--CA 1.515 2.785 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.861 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.8 pp -53.68 -66.79 0.33 Allowed 'General case' 0 CA--C 1.603 2.999 0 N-CA-C 100.711 -3.811 . . . . 0.0 100.711 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.776 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.14 98.39 2.12 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 125.33 1.452 . . . . 0.0 112.789 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.721 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -89.99 -173.0 3.71 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.827 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.37 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.827 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 28.0 tt0 105.45 65.9 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 120.346 3.462 . . . . 0.0 120.346 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 1.396 HD22 ' CG ' ' B' ' 118' ' ' PRO . 6.0 mp 38.24 84.26 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 120.762 3.616 . . . . 0.0 120.762 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 40' ' ' ASN . 36.2 mt -70.65 82.04 0.6 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.18 -1.575 . . . . 0.0 111.812 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.962 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 41.2 mmm -79.28 62.0 3.52 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 126.158 2.885 . . . . 0.0 110.94 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.7 m -112.62 65.94 0.87 Allowed Pre-proline 0 N--CA 1.504 2.267 0 CA-C-N 110.486 -3.052 . . . . 0.0 113.577 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -51.98 81.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.987 2.458 . . . . 0.0 114.674 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.18 6.56 27.65 Favored Glycine 1 N--CA 1.516 4.028 0 O-C-N 122.209 -0.307 . . . . 0.0 113.604 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.491 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.9 tt0 -123.54 156.82 34.95 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 124.324 2.011 . . . . 0.0 116.368 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.779 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.82 156.35 27.42 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 119.694 3.22 . . . . 0.0 119.694 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -116.0 147.91 40.71 Favored 'General case' 0 N--CA 1.518 2.951 0 CA-C-O 116.59 -1.671 . . . . 0.0 107.222 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.442 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.49 143.62 42.03 Favored 'General case' 0 N--CA 1.529 3.515 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.423 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 84.5 m -119.89 102.56 8.65 Favored 'General case' 0 N--CA 1.515 2.8 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.569 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.1 m -94.73 152.26 18.6 Favored 'General case' 0 N--CA 1.524 3.246 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -107.96 168.4 7.95 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.068 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.41 -174.77 1.53 Allowed 'Trans proline' 0 CA--C 1.558 1.708 0 C-N-CA 121.012 1.141 . . . . 0.0 111.116 161.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.38 -19.75 18.97 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 124.34 2.019 . . . . 0.0 107.222 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.17 42.63 0.49 Allowed 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 111.195 -2.729 . . . . 0.0 109.106 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.593 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.18 84.75 9.51 Favored Pre-proline 0 N--CA 1.5 2.028 0 CA-C-N 113.603 -1.635 . . . . 0.0 113.841 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -79.4 178.68 7.13 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.77 2.313 . . . . 0.0 112.354 172.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.569 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.11 77.75 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 C-N-CA 125.367 1.467 . . . . 0.0 113.244 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.535 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.4 125.03 5.64 Favored Glycine 0 N--CA 1.508 3.487 0 N-CA-C 121.694 3.438 . . . . 0.0 121.694 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.653 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 43.8 mt-10 -99.49 61.26 1.17 Allowed 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.809 ' HB2' HG23 ' A' ' 101' ' ' ILE . 2.8 m-85 -62.1 77.69 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 122.884 1.326 . . . . 0.0 113.07 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 99' ' ' GLY . 6.8 m -63.29 135.89 57.33 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.49 136.58 52.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.977 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.7 82.05 8.59 Favored 'General case' 0 N--CA 1.511 2.607 1 N-CA-C 132.617 8.006 . . . . 0.0 132.617 -179.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.773 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.1 t -63.93 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.499 2 CA-C-N 130.355 5.98 . . . . 0.0 114.295 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.5 tt0 -20.53 -72.44 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.565 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.562 ' O ' ' CD2' ' B' ' 3' ' ' PHE . 29.5 Cg_endo -66.98 -3.51 9.79 Favored 'Trans proline' 0 N--CA 1.511 2.548 0 C-N-CA 122.467 2.112 . . . . 0.0 115.363 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -120.86 -14.16 8.54 Favored 'General case' 0 N--CA 1.51 2.565 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.402 ' O ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -25.34 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.52 -34.0 1.74 Allowed Glycine 1 N--CA 1.52 4.292 0 O-C-N 121.534 -0.729 . . . . 0.0 112.735 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.59 68.41 7.93 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.93 26.73 0.05 OUTLIER Glycine 1 N--CA 1.527 4.733 0 CA-C-N 114.035 -1.439 . . . . 0.0 116.605 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.888 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.1 ttt -108.51 43.81 1.19 Allowed 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 124.406 2.05 . . . . 0.0 113.0 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.01 134.85 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 112.247 -2.251 . . . . 0.0 110.968 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.534 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.68 154.87 19.36 Favored Glycine 1 N--CA 1.535 5.24 0 C-N-CA 119.435 -1.364 . . . . 0.0 114.013 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.904 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.0 ttpp -118.58 81.97 1.77 Allowed 'General case' 0 N--CA 1.517 2.907 0 CA-C-N 119.405 1.602 . . . . 0.0 115.242 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.809 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.75 123.28 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.743 0 C-N-CA 118.0 -1.48 . . . . 0.0 107.026 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.904 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 7.5 m -112.57 88.75 2.9 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.228 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 80' ' ' ALA . 38.3 t -74.01 105.19 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.26 -72.37 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.643 0 O-C-N 126.121 2.138 . . . . 0.0 115.885 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.569 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.48 0 O-C-N 125.43 1.706 . . . . 0.0 113.889 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.349 ' CE1' HD21 ' A' ' 64' ' ' LEU . 61.1 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.281 21.7 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 91' ' ' PRO . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' TRP . . . . . 0.429 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.7 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.31 27.6 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.547 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 52.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.611 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.429 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.537 ' O ' HD13 ' B' ' 243' ' ' LEU . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.404 HG23 HD12 ' B' ' 247' ' ' ILE . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.741 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.369 22.0 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.652 ' H ' ' HG ' ' B' ' 133' ' ' SER . 33.1 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.456 HG11 ' N ' ' B' ' 46' ' ' PHE . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.763 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.415 ' O ' HG22 ' B' ' 58' ' ' VAL . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.415 HG22 ' O ' ' B' ' 55' ' ' ASP . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.579 ' O ' HG21 ' B' ' 68' ' ' VAL . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.621 HG12 ' N ' ' B' ' 69' ' ' GLY . 87.8 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.621 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.536 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.437 HD11 HG23 ' B' ' 149' ' ' VAL . 50.2 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 0.704 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.0 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.704 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.3 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 94' ' ' LEU . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.6 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 1.229 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 20.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' GLN . . . . . 0.967 HE22 ' CG1' ' A' ' 36' ' ' VAL . 11.9 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.546 ' C ' HG13 ' B' ' 114' ' ' VAL . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.546 HG13 ' C ' ' B' ' 113' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.42 ' CD1' HG21 ' B' ' 75' ' ' VAL 0.591 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 1.396 ' CG ' HD22 ' A' ' 64' ' ' LEU . 36.5 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.962 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 93.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.45 ' C ' HG12 ' B' ' 131' ' ' VAL . 24.1 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.763 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.441 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.652 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.9 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.428 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 20.8 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' PRO . . . . . 0.679 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.328 23.5 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.428 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.461 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.524 HD11 ' HH ' ' B' ' 147' ' ' TYR 0.316 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . 0.679 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' TYR . . . . . 0.524 ' HH ' HD11 ' B' ' 142' ' ' ILE . 45.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' SER . . . . . 0.426 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' VAL . . . . . 0.437 HG23 HD11 ' B' ' 76' ' ' LEU 0.417 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' HIS . . . . . 0.547 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.483 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.524 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' TYR . . . . . 0.403 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 64.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' PRO . . . . . 0.429 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 22.9 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.46 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.1 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . 0.494 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . 0.717 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 18.9 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.539 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.686 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.686 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' GLU . . . . . 0.639 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.362 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.445 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.577 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' VAL . . . . . 0.577 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' LYS . . . . . 0.539 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.7 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.452 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.452 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' ASP . . . . . 0.433 ' O ' HD13 ' B' ' 196' ' ' LEU . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.717 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.257 25.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.627 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' ASN . . . . . 0.536 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . 0.521 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.0 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . 0.537 HD13 ' O ' ' B' ' 32' ' ' THR . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' ILE . . . . . 0.404 HD12 HG23 ' B' ' 40' ' ' VAL . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' HEC . . . . . 0.611 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.708 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.466 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 91.2 m -61.63 89.73 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.975 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -100.01 162.97 12.64 Favored 'General case' 0 N--CA 1.513 2.683 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.8 t -107.71 122.49 46.83 Favored 'General case' 0 N--CA 1.526 3.331 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.0 t -100.62 98.38 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.46 65.53 0.08 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.834 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.802 HD11 ' HB2' ' A' ' 39' ' ' HIS . 15.0 mt -29.67 68.27 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.996 0 C-N-CA 126.54 1.936 . . . . 0.0 115.493 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.46 59.1 0.4 Allowed Glycine 0 N--CA 1.51 3.583 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -1.13 54.15 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.256 0 N-CA-C 120.282 3.438 . . . . 0.0 120.282 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.44 -60.15 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 119.538 3.162 . . . . 0.0 119.538 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.508 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.5 14.42 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.931 -1.106 . . . . 0.0 108.164 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.11 -94.83 1.9 Allowed Glycine 0 N--CA 1.512 3.75 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.3 tp -150.62 -177.16 5.81 Favored 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 36' ' ' VAL . 15.8 mt -74.73 46.7 0.3 Allowed 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.67 -1.269 . . . . 0.0 111.3 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.602 ' CG2' ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.74 165.66 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.602 ' N ' ' CG2' ' A' ' 15' ' ' VAL . 5.1 m-30 -102.22 75.35 1.49 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.402 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.283 7.4 mt-10 -93.46 142.46 25.24 Favored Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 121.825 -0.547 . . . . 0.0 111.753 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 20' ' ' LYS . 53.9 Cg_endo -86.46 76.14 0.09 OUTLIER 'Cis proline' 0 CA--C 1.571 2.364 0 N-CA-C 116.353 1.636 . . . . 0.0 116.353 -9.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.74 -44.26 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 1 N-CA-C 122.241 4.163 . . . . 0.0 122.241 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.636 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.58 71.59 1.0 Allowed 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 122.413 1.101 . . . . 0.0 113.1 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.634 ' C ' ' CD2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -72.16 111.31 7.27 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.199 -1.563 . . . . 0.0 109.111 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.526 ' N ' HD22 ' A' ' 21' ' ' LEU . 55.9 m -87.52 81.47 7.76 Favored 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.684 HD11 HD12 ' A' ' 101' ' ' ILE . 4.9 pt -79.66 -177.55 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.742 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.639 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.51 10.66 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 113.887 -1.506 . . . . 0.0 108.115 179.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.0 Cg_endo -52.12 77.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.304 0 N-CA-C 116.934 1.859 . . . . 0.0 116.934 174.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.11 -50.45 0.52 Allowed Glycine 1 N--CA 1.522 4.423 0 C-N-CA 119.706 -1.235 . . . . 0.0 115.857 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.655 ' CG ' ' H3 ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.65 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.167 1 N-CA-C 122.08 4.104 . . . . 0.0 122.08 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.466 ' HB ' ' OG1' ' A' ' 2' ' ' THR . 12.6 m -64.09 35.96 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.497 HG13 ' N ' ' A' ' 30' ' ' GLU . 60.4 t -51.96 147.21 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 112.862 -1.972 . . . . 0.0 111.51 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.497 ' N ' HG13 ' A' ' 29' ' ' VAL . 3.9 pt-20 -114.3 154.86 27.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 123.92 1.819 . . . . 0.0 115.35 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.46 113.8 27.38 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.781 ' CB ' ' HG ' ' A' ' 71' ' ' SER . 7.0 tt -100.69 112.5 24.91 Favored 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 120.728 3.603 . . . . 0.0 120.728 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -75.17 84.73 2.38 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.156 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.6 p30 -80.31 -44.97 18.64 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -150.01 -169.34 3.35 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 124.643 1.177 . . . . 0.0 109.097 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.035 HG23 HD21 ' A' ' 14' ' ' LEU . 1.7 m 12.81 70.69 0.11 Allowed Pre-proline 0 N--CA 1.52 3.046 0 N-CA-C 117.168 2.285 . . . . 0.0 117.168 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 1.557 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 56.3 Cg_endo -98.41 177.19 0.42 Allowed 'Trans proline' 0 CA--C 1.569 2.263 0 C-N-CA 124.041 3.161 . . . . 0.0 114.372 -165.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 56.5 Cg_endo -92.45 165.24 25.16 Favored 'Cis proline' 0 N--CA 1.503 2.063 0 N-CA-C 115.399 1.269 . . . . 0.0 115.399 -7.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.802 ' HB2' HD11 ' A' ' 7' ' ' LEU . 17.5 m-70 -118.88 87.44 2.73 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.55 HD22 ' N ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -103.34 140.27 37.65 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 122.421 2.373 . . . . 0.0 110.716 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.9 m -118.16 116.31 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 121.431 3.863 . . . . 0.0 121.431 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.962 HG22 ' HB2' ' A' ' 88' ' ' TYR . 14.7 m -75.98 165.4 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.858 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.26 130.89 55.52 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.449 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.4 93.71 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.208 1 N-CA-C 124.205 4.891 . . . . 0.0 124.205 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.94 6.7 43.57 Favored 'General case' 0 CA--C 1.602 2.959 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB2' HD13 ' A' ' 47' ' ' LEU . . . -115.81 -65.54 1.18 Allowed 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 127.501 2.32 . . . . 0.0 112.668 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.619 ' CD1' ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.62 66.46 9.49 Favored 'General case' 0 N--CA 1.518 2.949 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.36 151.28 0.75 Allowed Pre-proline 0 N--CA 1.522 3.158 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.6 Cg_endo -42.51 -58.3 1.32 Allowed 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 123.389 2.726 . . . . 0.0 115.025 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.51 67.47 0.72 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 124.15 1.928 . . . . 0.0 107.056 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.2 53.5 1.0 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 112.267 -2.242 . . . . 0.0 108.219 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.82 56.81 0.76 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.693 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -24.46 -48.01 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.13 -30.85 0.17 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.127 -1.608 . . . . 0.0 111.606 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 56' ' ' ALA . 2.9 pp -41.12 -28.6 0.1 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.649 1.214 . . . . 0.0 112.461 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.792 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -166.76 -27.7 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.479 ' H ' HD23 ' A' ' 59' ' ' LEU . 12.2 tptt 65.14 -55.57 0.31 Allowed 'General case' 0 N--CA 1.534 3.752 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -41.69 -28.94 0.16 Allowed 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.858 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.6 pp -53.68 -66.82 0.32 Allowed 'General case' 0 CA--C 1.604 3.035 0 N-CA-C 100.697 -3.816 . . . . 0.0 100.697 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.812 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.9 p -72.06 98.42 2.09 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 125.267 1.427 . . . . 0.0 112.814 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.713 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.1 t60 -90.02 -173.03 3.72 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.829 ' HZ1' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 152.42 155.2 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.317 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.829 ' HB2' ' HZ1' ' A' ' 62' ' ' LYS . 27.1 tt0 105.43 66.02 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 120.309 3.448 . . . . 0.0 120.309 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 1.343 HD21 ' CE1' ' B' ' 1' ' ' TYR . 6.0 mp 38.19 84.25 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 120.748 3.61 . . . . 0.0 120.748 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.437 ' N ' ' ND2' ' A' ' 40' ' ' ASN . 36.3 mt -70.66 82.04 0.61 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.145 -1.597 . . . . 0.0 111.865 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.93 ' CE ' ' HA ' ' B' ' 119' ' ' LEU . 42.2 mmm -79.21 61.94 3.46 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 126.074 2.845 . . . . 0.0 110.965 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.9 m -112.53 65.96 0.85 Allowed Pre-proline 0 C--N 1.284 -2.262 0 CA-C-N 110.464 -3.062 . . . . 0.0 113.601 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.682 ' HB2' ' OD2' ' B' ' 100' ' ' ASP . 21.3 Cg_endo -51.98 81.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.507 0 C-N-CA 122.964 2.442 . . . . 0.0 114.675 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.17 6.69 27.55 Favored Glycine 1 N--CA 1.517 4.056 0 O-C-N 122.238 -0.289 . . . . 0.0 113.513 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.8 tt0 -123.61 156.8 35.11 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 124.34 2.019 . . . . 0.0 116.349 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.781 ' HG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.83 156.37 27.4 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 119.716 3.228 . . . . 0.0 119.716 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.7 t -116.06 147.88 40.8 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-O 116.682 -1.628 . . . . 0.0 107.199 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.455 ' HG ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 m -111.45 143.72 41.83 Favored 'General case' 0 N--CA 1.529 3.503 0 N-CA-C 118.347 2.721 . . . . 0.0 118.347 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 91.3 m -119.88 102.62 8.7 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.517 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.7 m -94.85 152.22 18.57 Favored 'General case' 0 N--CA 1.525 3.297 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -107.95 168.28 8.12 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -72.27 -174.8 1.51 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 121.03 1.153 . . . . 0.0 111.157 161.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.35 -19.76 18.99 Favored 'General case' 0 N--CA 1.509 2.504 0 CA-C-O 124.384 2.04 . . . . 0.0 107.286 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.14 42.72 0.49 Allowed 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 111.225 -2.716 . . . . 0.0 109.111 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.585 ' O ' HG13 ' A' ' 103' ' ' VAL . . . -114.38 84.74 9.88 Favored Pre-proline 0 N--CA 1.499 2.008 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.809 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 83' ' ' GLY . 42.4 Cg_endo -79.39 178.63 7.2 Favored 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 122.753 2.302 . . . . 0.0 112.275 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.577 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -15.99 77.69 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 125.348 1.459 . . . . 0.0 113.264 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.537 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.43 125.01 5.63 Favored Glycine 0 N--CA 1.507 3.417 0 N-CA-C 121.74 3.456 . . . . 0.0 121.74 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.656 ' CG ' ' HZ3' ' A' ' 100' ' ' LYS . 43.9 mt-10 -99.51 61.25 1.17 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.817 ' HB2' HG23 ' A' ' 101' ' ' ILE . 2.9 m-85 -62.05 77.79 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 122.904 1.335 . . . . 0.0 113.032 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 99' ' ' GLY . 7.2 m -63.42 135.95 57.29 Favored 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.555 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.53 136.51 52.92 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.962 ' HB2' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.64 82.07 8.58 Favored 'General case' 0 N--CA 1.512 2.672 1 N-CA-C 132.559 7.985 . . . . 0.0 132.559 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.6 t -63.85 82.23 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.498 2 CA-C-N 130.329 5.968 . . . . 0.0 114.314 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.1 tt0 -20.57 -72.45 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.56 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 35.6 Cg_endo -67.04 -3.43 9.69 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.326 2.017 . . . . 0.0 115.401 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -120.84 -14.12 8.56 Favored 'General case' 0 N--CA 1.511 2.585 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.409 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.23 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.53 -33.91 1.75 Allowed Glycine 1 N--CA 1.52 4.266 0 O-C-N 121.535 -0.728 . . . . 0.0 112.657 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.64 68.42 7.98 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.92 26.7 0.05 OUTLIER Glycine 1 N--CA 1.526 4.636 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.843 ' HE2' HD22 ' A' ' 14' ' ' LEU . 2.0 ttt -108.5 43.87 1.19 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 124.559 2.123 . . . . 0.0 113.023 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.94 134.91 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 112.19 -2.277 . . . . 0.0 110.902 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.7 154.88 19.38 Favored Glycine 1 N--CA 1.536 5.347 0 C-N-CA 119.489 -1.339 . . . . 0.0 113.978 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.841 ' HZ1' ' HG1' ' A' ' 102' ' ' THR . 24.1 ttpp -118.7 82.0 1.78 Allowed 'General case' 0 N--CA 1.518 2.94 0 CA-C-N 119.371 1.585 . . . . 0.0 115.192 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.817 HG23 ' HB2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -55.69 123.33 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.841 ' HG1' ' HZ1' ' A' ' 100' ' ' LYS . 8.4 m -112.7 88.75 2.9 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.193 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 80' ' ' ALA . 39.2 t -73.98 105.21 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.35 -72.26 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 O-C-N 126.132 2.145 . . . . 0.0 115.942 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.577 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.486 0 O-C-N 125.49 1.744 . . . . 0.0 113.811 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.343 ' CE1' HD21 ' A' ' 64' ' ' LEU . 60.8 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' TRP . . . . . 0.44 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.9 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.407 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 62.6 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.6 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.441 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 56.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.5 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 55.5 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' CYS . . . . . 0.43 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 77.0 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' B' ' 27' ' ' LEU . 71.5 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' THR . . . . . 0.559 ' O ' HD13 ' B' ' 243' ' ' LEU . 19.1 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 1.376 ' HB ' ' CG2' ' B' ' 34' ' ' VAL 0.399 1.4 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.6 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.425 HG12 ' O ' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.425 ' O ' HG12 ' B' ' 36' ' ' VAL . 28.0 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.411 HG23 HD12 ' B' ' 247' ' ' ILE . 25.8 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.771 ' N ' HD23 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.653 ' H ' ' HG ' ' B' ' 133' ' ' SER . 32.5 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.441 HG11 ' N ' ' B' ' 46' ' ' PHE . 86.9 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.953 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.4 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 61.1 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.453 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.9 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.3 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.453 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.8 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.8 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.568 ' O ' HG21 ' B' ' 68' ' ' VAL . 58.9 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.628 HG12 ' N ' ' B' ' 69' ' ' GLY . 86.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.628 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' LEU . . . . . 0.551 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.2 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.9 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 0.761 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 19.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.761 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 44.1 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.384 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 37.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 72.6 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.474 ' HA ' HD12 ' B' ' 94' ' ' LEU . 50.4 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.8 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.682 ' OD2' ' HB2' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 1.557 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 19.1 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' GLN . . . . . 0.897 HE22 ' CG1' ' A' ' 36' ' ' VAL . 11.1 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' TYR . . . . . 0.407 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 23.9 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.513 ' C ' HG13 ' B' ' 114' ' ' VAL . 56.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.54 ' O ' HG23 ' B' ' 114' ' ' VAL . 16.5 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.524 ' CD1' HG21 ' B' ' 75' ' ' VAL 0.727 0.0 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . 1.575 ' HB ' ' CB ' ' B' ' 116' ' ' VAL 0.68 0.1 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . 1.006 ' HG3' HD22 ' A' ' 64' ' ' LEU . 38.0 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . 0.93 ' HA ' ' CE ' ' A' ' 66' ' ' MET . 82.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.5 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 94.4 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.471 ' C ' HG12 ' B' ' 131' ' ' VAL . 15.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.953 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.5 1.5 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' SER . . . . . 0.653 ' HG ' ' H ' ' B' ' 44' ' ' THR . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.446 ' OD1' ' HB1' ' B' ' 137' ' ' ALA . 23.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' PRO . . . . . 0.641 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 13.0 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' ALA . . . . . 0.446 ' HB1' ' OD1' ' B' ' 135' ' ' ASN . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASP . . . . . 0.541 ' CG ' HG22 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.541 HG22 ' CG ' ' B' ' 139' ' ' ASP 0.393 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' PHE . . . . . 0.641 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.0 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' SER . . . . . 0.471 ' C ' HG13 ' B' ' 149' ' ' VAL . 68.6 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' VAL . . . . . 0.471 HG13 ' C ' ' B' ' 148' ' ' SER 0.426 1.2 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' HIS . . . . . 0.441 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.418 HG12 HG23 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.463 ' NH2' ' HB2' ' B' ' 169' ' ' ASN . 29.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.666 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.2 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 1.355 ' HB ' ' CG2' ' B' ' 160' ' ' VAL 0.457 1.3 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' TYR . . . . . 0.4 ' HB3' ' HD2' ' B' ' 162' ' ' PRO . 63.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' PRO . . . . . 0.44 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 20.2 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.8 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . 0.521 ' C ' HD22 ' B' ' 171' ' ' LEU . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' TYR . . . . . 0.718 ' HH ' ' HG3' ' B' ' 212' ' ' PRO . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.6 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.529 ' HB3' ' CE ' ' B' ' 200' ' ' LYS . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 58.5 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.8 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' ILE . . . . . 0.709 HG23 ' N ' ' B' ' 184' ' ' ALA . 2.1 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' ALA . . . . . 0.709 ' N ' HG23 ' B' ' 183' ' ' ILE . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 43.8 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.444 0.9 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.472 ' HZ3' HG22 ' B' ' 183' ' ' ILE . 41.3 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.419 ' C ' HD11 ' B' ' 196' ' ' LEU . 18.2 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . 0.625 HD23 ' N ' ' B' ' 197' ' ' VAL . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' VAL . . . . . 0.625 ' N ' HD23 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.366 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' LYS . . . . . 0.529 ' CE ' ' HB3' ' B' ' 176' ' ' ALA . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 81.0 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.456 ' C ' HG13 ' B' ' 207' ' ' VAL . 59.4 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.456 HG13 ' C ' ' B' ' 206' ' ' VAL . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.8 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' ASP . . . . . 0.468 ' O ' HD13 ' B' ' 196' ' ' LEU . 63.5 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.718 ' HG3' ' HH ' ' B' ' 172' ' ' TYR . 39.1 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 88.3 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.9 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' VAL . . . . . 1.392 ' HB ' ' CG2' ' B' ' 225' ' ' VAL 0.391 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.6 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' ASN . . . . . 0.501 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.4 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . 0.475 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 22.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.6 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . 0.559 HD13 ' O ' ' B' ' 32' ' ' THR . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' ILE . . . . . 0.411 HD12 HG23 ' B' ' 40' ' ' VAL . 18.2 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.0 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 118.159 -0.924 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' HEC . . . . . 0.608 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.3 m -61.55 89.7 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -99.99 163.04 12.61 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.47 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.82 122.41 46.72 Favored 'General case' 0 N--CA 1.525 3.321 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -100.49 98.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.33 65.38 0.07 Allowed 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 113.14 -1.845 . . . . 0.0 114.855 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.3 mt -29.52 68.27 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 126.521 1.929 . . . . 0.0 115.543 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.44 59.01 0.4 Allowed Glycine 0 N--CA 1.509 3.539 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.1 p -1.0 54.04 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.33 0 N-CA-C 120.242 3.423 . . . . 0.0 120.242 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.53 -60.19 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.49 14.43 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.962 -1.086 . . . . 0.0 108.151 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.06 -94.86 1.91 Allowed Glycine 0 N--CA 1.512 3.75 0 N-CA-C 115.546 0.978 . . . . 0.0 115.546 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.553 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.9 tp -150.64 -177.13 5.8 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.557 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.6 mt -74.8 46.73 0.3 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.654 -1.279 . . . . 0.0 111.244 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.655 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.83 165.64 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 118.503 2.779 . . . . 0.0 118.503 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.655 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.25 75.35 1.48 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 112.187 -2.279 . . . . 0.0 113.356 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.47 142.47 25.25 Favored Pre-proline 0 N--CA 1.507 2.376 0 O-C-N 121.822 -0.549 . . . . 0.0 111.735 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 20' ' ' LYS . 56.3 Cg_endo -86.43 76.09 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.426 0 N-CA-C 116.359 1.638 . . . . 0.0 116.359 -9.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.73 -44.23 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 1 N-CA-C 122.3 4.185 . . . . 0.0 122.3 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.638 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.62 71.66 1.0 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 122.433 1.111 . . . . 0.0 113.092 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.808 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.11 111.27 7.19 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.152 -1.592 . . . . 0.0 109.107 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.524 ' N ' HD23 ' A' ' 21' ' ' LEU . 52.6 m -87.51 81.5 7.76 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.808 HG23 HD22 ' A' ' 21' ' ' LEU . 4.7 pt -79.7 -177.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.652 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.646 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.69 166.58 10.51 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-N 113.769 -1.559 . . . . 0.0 108.067 179.455 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.4 Cg_endo -52.18 77.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.571 2.326 0 N-CA-C 116.947 1.864 . . . . 0.0 116.947 174.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.13 -50.48 0.52 Allowed Glycine 1 N--CA 1.522 4.414 0 C-N-CA 119.73 -1.224 . . . . 0.0 115.833 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.71 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.151 1 N-CA-C 122.104 4.113 . . . . 0.0 122.104 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 28' ' ' THR . 11.5 m -64.01 35.91 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.012 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.95 147.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 112.863 -1.971 . . . . 0.0 111.517 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.9 pt-20 -114.29 154.93 27.12 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 123.934 1.826 . . . . 0.0 115.359 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.415 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.6 m-85 -107.55 113.86 27.46 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.79 112.57 25.02 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 120.636 3.569 . . . . 0.0 120.636 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -75.13 84.75 2.35 Favored 'General case' 0 N--CA 1.512 2.645 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.18 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.7 p30 -80.26 -45.14 18.44 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.9 -169.29 3.34 Favored 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 124.661 1.184 . . . . 0.0 109.118 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.62 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.6 m 12.82 70.7 0.11 Allowed Pre-proline 0 N--CA 1.521 3.079 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.458 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 58.4 Cg_endo -98.4 177.24 0.41 Allowed 'Trans proline' 0 CA--C 1.569 2.261 0 C-N-CA 123.945 3.096 . . . . 0.0 114.422 -165.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.602 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 58.2 Cg_endo -92.41 165.28 25.29 Favored 'Cis proline' 0 N--CA 1.504 2.105 0 N-CA-C 115.402 1.27 . . . . 0.0 115.402 -7.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.818 ' HB2' HD13 ' A' ' 7' ' ' LEU . 17.9 m-70 -118.88 87.44 2.73 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.615 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -103.4 140.29 37.66 Favored 'General case' 0 N--CA 1.516 2.832 0 CA-C-N 122.469 2.395 . . . . 0.0 110.719 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.498 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.5 m -118.11 116.25 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 121.419 3.859 . . . . 0.0 121.419 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.567 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.5 m -75.95 165.35 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.033 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.26 131.02 55.47 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.436 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.47 93.77 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.174 1 N-CA-C 124.148 4.87 . . . . 0.0 124.148 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.98 6.76 43.43 Favored 'General case' 0 CA--C 1.602 2.97 0 N-CA-C 101.23 -3.618 . . . . 0.0 101.23 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.84 -65.57 1.18 Allowed 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 127.526 2.33 . . . . 0.0 112.669 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.681 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.47 9.49 Favored 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.41 151.25 0.74 Allowed Pre-proline 0 N--CA 1.523 3.181 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.0 Cg_endo -42.51 -58.17 1.36 Allowed 'Trans proline' 0 N--CA 1.508 2.359 0 C-N-CA 123.362 2.708 . . . . 0.0 115.102 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.543 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.51 67.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 124.066 1.888 . . . . 0.0 107.062 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.16 53.5 0.99 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 112.275 -2.239 . . . . 0.0 108.208 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.87 56.89 0.76 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.773 2.508 . . . . 0.0 117.773 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.672 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.51 -48.0 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.13 -30.85 0.16 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.106 -1.622 . . . . 0.0 111.571 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.514 HD12 ' C ' ' A' ' 55' ' ' LEU . 2.9 pp -41.16 -28.52 0.1 Allowed 'General case' 0 N--CA 1.509 2.501 0 CA-C-O 122.716 1.246 . . . . 0.0 112.475 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.497 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.81 -27.63 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.466 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.04 -55.59 0.3 Allowed 'General case' 0 N--CA 1.533 3.691 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -41.68 -28.93 0.16 Allowed 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.033 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.72 -66.71 0.34 Allowed 'General case' 0 CA--C 1.603 3.019 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.806 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.6 p -72.18 98.47 2.15 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.273 1.429 . . . . 0.0 112.765 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.669 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.03 -173.1 3.74 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.669 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.43 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.365 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.591 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.1 tt0 105.52 65.99 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 120.292 3.441 . . . . 0.0 120.292 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.778 HD12 ' H ' ' A' ' 64' ' ' LEU . 5.9 mp 38.13 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.615 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 35.2 mt -70.64 82.05 0.6 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.101 -1.624 . . . . 0.0 111.886 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . 1.312 ' CE ' ' CD2' ' B' ' 119' ' ' LEU . 41.9 mmm -79.23 61.97 3.48 Favored 'General case' 0 N--CA 1.511 2.579 0 CA-C-O 126.021 2.82 . . . . 0.0 110.913 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.6 m -112.61 65.98 0.87 Allowed Pre-proline 0 C--N 1.283 -2.287 0 CA-C-N 110.525 -3.034 . . . . 0.0 113.585 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.679 ' CG ' ' OD2' ' B' ' 100' ' ' ASP . 21.9 Cg_endo -52.03 81.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.461 0 C-N-CA 122.945 2.43 . . . . 0.0 114.699 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.64 27.66 Favored Glycine 0 N--CA 1.516 3.973 0 O-C-N 122.177 -0.327 . . . . 0.0 113.637 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.55 156.94 34.76 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 124.321 2.01 . . . . 0.0 116.367 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -117.05 156.34 27.71 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 119.628 3.195 . . . . 0.0 119.628 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -115.89 147.97 40.5 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-O 116.603 -1.665 . . . . 0.0 107.236 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.5 143.71 41.91 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 118.383 2.734 . . . . 0.0 118.383 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.4 m -119.94 102.54 8.63 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.543 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.451 ' OG1' HG23 ' A' ' 28' ' ' THR . 48.4 m -94.73 152.18 18.66 Favored 'General case' 0 N--CA 1.526 3.334 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.429 ' N ' HG22 ' A' ' 75' ' ' THR . 90.3 m-85 -107.92 168.31 8.08 Favored Pre-proline 0 N--CA 1.503 2.184 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.09 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -72.35 -174.74 1.51 Allowed 'Trans proline' 0 CA--C 1.559 1.747 0 C-N-CA 120.994 1.129 . . . . 0.0 111.149 161.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.77 18.96 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 124.41 2.052 . . . . 0.0 107.235 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.13 42.61 0.49 Allowed 'General case' 0 CA--C 1.577 1.984 0 CA-C-N 111.265 -2.698 . . . . 0.0 109.097 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.27 84.74 9.66 Favored Pre-proline 0 N--CA 1.5 2.032 0 CA-C-N 113.608 -1.633 . . . . 0.0 113.768 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 83' ' ' GLY . 45.9 Cg_endo -79.41 178.68 7.13 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.73 2.287 . . . . 0.0 112.245 172.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.6 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.05 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.91 0 C-N-CA 125.29 1.436 . . . . 0.0 113.333 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.529 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.41 125.01 5.63 Favored Glycine 0 N--CA 1.508 3.456 0 N-CA-C 121.76 3.464 . . . . 0.0 121.76 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.9 mt-10 -99.43 61.2 1.18 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.529 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.07 77.75 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 122.93 1.348 . . . . 0.0 113.013 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.7 m -63.41 135.97 57.31 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.555 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.51 136.52 52.91 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.567 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.61 82.05 8.59 Favored 'General case' 0 N--CA 1.512 2.627 1 N-CA-C 132.634 8.013 . . . . 0.0 132.634 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.94 82.19 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.438 2 CA-C-N 130.343 5.974 . . . . 0.0 114.313 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.1 tt0 -20.52 -72.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.459 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 36.6 Cg_endo -67.07 -3.43 9.72 Favored 'Trans proline' 0 N--CA 1.511 2.517 0 C-N-CA 122.383 2.056 . . . . 0.0 115.356 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -120.91 -14.13 8.52 Favored 'General case' 0 N--CA 1.511 2.594 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.466 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.25 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.64 -34.16 1.72 Allowed Glycine 1 N--CA 1.521 4.324 0 O-C-N 121.518 -0.739 . . . . 0.0 112.643 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.42 68.44 7.75 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.94 26.63 0.05 OUTLIER Glycine 1 N--CA 1.527 4.71 0 N-CA-C 116.665 1.426 . . . . 0.0 116.665 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.558 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.46 43.84 1.19 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 124.524 2.107 . . . . 0.0 113.016 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.96 134.81 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 112.313 -2.221 . . . . 0.0 110.954 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.62 154.9 19.34 Favored Glycine 1 N--CA 1.535 5.289 0 C-N-CA 119.49 -1.338 . . . . 0.0 113.997 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.61 81.91 1.77 Allowed 'General case' 0 N--CA 1.517 2.912 0 CA-C-N 119.488 1.644 . . . . 0.0 115.226 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.463 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.74 123.31 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 C-N-CA 118.03 -1.468 . . . . 0.0 107.044 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.9 m -112.65 88.76 2.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.15 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.442 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.1 t -74.06 105.27 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.39 -72.25 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.627 0 O-C-N 126.095 2.122 . . . . 0.0 115.885 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.6 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.484 0 O-C-N 125.526 1.766 . . . . 0.0 113.84 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 24.3 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' TRP . . . . . 0.455 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' GLN . . . . . 0.447 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.449 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 53.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.7 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.4 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 78.4 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.698 HG13 HG22 ' B' ' 50' ' ' VAL 0.389 0.4 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.49 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.7 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 25.8 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.605 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.7 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.0 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.963 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.3 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.698 HG22 HG13 ' B' ' 34' ' ' VAL . 61.3 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.403 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.403 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.4 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.424 HG12 ' N ' ' B' ' 69' ' ' GLY . 81.4 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.424 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.519 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.591 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.5 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.9 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' PRO . . . . . 0.825 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 17.9 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.825 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 44.3 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.52 HG22 HG11 ' B' ' 114' ' ' VAL 0.463 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.679 ' OD2' ' CG ' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.1 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 1.458 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 18.4 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' GLN . . . . . 0.62 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.6 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' TYR . . . . . 0.447 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 23.3 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.9 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.52 HG11 HG22 ' B' ' 84' ' ' ILE . 16.7 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 1.578 ' CB ' ' CA ' ' B' ' 115' ' ' ILE 0.521 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.444 ' N ' HG23 ' B' ' 115' ' ' ILE 0.463 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.664 ' O ' ' CE ' ' A' ' 66' ' ' MET . 38.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 1.312 ' CD2' ' CE ' ' A' ' 66' ' ' MET . 81.7 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.8 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.494 ' C ' HG12 ' B' ' 131' ' ' VAL . 13.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.963 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.52 0.7 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.9 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.7 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' PRO . . . . . 0.659 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.7 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 139' ' ' ASP . . . . . 0.636 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.636 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.453 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' PHE . . . . . 0.659 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.5 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.387 1.5 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 150' ' ' HIS . . . . . 0.449 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.61 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.485 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.6 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' GLN . . . . . 0.665 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.1 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.417 0.8 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 162' ' ' PRO . . . . . 0.455 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.6 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.44 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 63.5 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.675 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 172' ' ' TYR . . . . . 0.675 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.7 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.402 HG22 ' N ' ' B' ' 178' ' ' GLY . 59.2 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.402 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.0 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 182' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.401 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.9 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.448 1.7 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.812 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.439 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.6 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 213' ' ' ALA . . . . . 0.43 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.43 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 12.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.4 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.417 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' ASN . . . . . 0.511 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.481 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 22.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.6 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.1 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.5 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.55 HD22 HD11 ' B' ' 142' ' ' ILE . 40.7 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.596 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 85.4 m -61.52 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.02 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -100.0 163.01 12.62 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.467 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.75 122.44 46.75 Favored 'General case' 0 N--CA 1.525 3.32 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.4 t -100.57 98.32 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.34 65.4 0.07 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 113.096 -1.865 . . . . 0.0 114.893 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.2 mt -29.49 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 126.585 1.954 . . . . 0.0 115.512 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.45 59.09 0.4 Allowed Glycine 0 N--CA 1.51 3.609 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.4 p -1.09 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 120.31 3.448 . . . . 0.0 120.31 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.48 -60.16 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 119.551 3.167 . . . . 0.0 119.551 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.84 22.46 14.44 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 120.956 -1.09 . . . . 0.0 108.209 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.09 -94.85 1.91 Allowed Glycine 0 N--CA 1.511 3.672 0 N-CA-C 115.528 0.971 . . . . 0.0 115.528 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.543 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.7 tp -150.54 -177.13 5.79 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.558 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.7 mt -74.8 46.66 0.3 Allowed 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.627 -1.295 . . . . 0.0 111.247 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.672 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.74 165.73 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 118.575 2.805 . . . . 0.0 118.575 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.672 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.34 75.45 1.48 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.384 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.274 4.8 mt-10 -93.48 142.37 25.11 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.781 -0.574 . . . . 0.0 111.806 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 20' ' ' LYS . 55.9 Cg_endo -86.47 76.15 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.389 0 N-CA-C 116.352 1.635 . . . . 0.0 116.352 -9.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.68 -44.17 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.737 1 N-CA-C 122.238 4.162 . . . . 0.0 122.238 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.64 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.68 71.6 0.99 Allowed 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.442 1.115 . . . . 0.0 113.049 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.793 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.1 111.3 7.21 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.178 -1.576 . . . . 0.0 109.098 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.522 ' N ' HD23 ' A' ' 21' ' ' LEU . 54.6 m -87.48 81.38 7.81 Favored 'General case' 0 N--CA 1.514 2.728 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.793 HG23 HD22 ' A' ' 21' ' ' LEU . 4.8 pt -79.68 -177.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.675 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.652 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.72 166.54 10.59 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.104 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.5 Cg_endo -52.18 77.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.288 0 N-CA-C 116.921 1.854 . . . . 0.0 116.921 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.16 -50.44 0.52 Allowed Glycine 1 N--CA 1.522 4.414 0 C-N-CA 119.733 -1.222 . . . . 0.0 115.852 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.6 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.174 1 N-CA-C 122.101 4.112 . . . . 0.0 122.101 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 28' ' ' THR . 11.6 m -63.99 35.92 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.049 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.01 147.22 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.501 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.9 pt-20 -114.26 154.9 27.14 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 123.914 1.816 . . . . 0.0 115.41 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.402 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.4 m-85 -107.54 113.87 27.47 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.77 112.54 24.97 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 120.71 3.596 . . . . 0.0 120.71 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -75.2 84.72 2.39 Favored 'General case' 0 N--CA 1.511 2.599 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.18 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.5 p30 -80.18 -45.17 18.54 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.89 -169.29 3.34 Favored 'General case' 0 N--CA 1.508 2.467 0 C-N-CA 124.656 1.183 . . . . 0.0 109.111 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.069 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.6 m 12.89 70.68 0.11 Allowed Pre-proline 0 N--CA 1.52 3.055 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.169 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 57.7 Cg_endo -98.52 177.26 0.4 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 123.92 3.08 . . . . 0.0 114.324 -165.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 57.7 Cg_endo -92.44 165.32 25.18 Favored 'Cis proline' 0 N--CA 1.503 2.071 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 -7.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.81 ' HB2' HD13 ' A' ' 7' ' ' LEU . 17.9 m-70 -118.95 87.35 2.72 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.65 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -103.42 140.28 37.68 Favored 'General case' 0 N--CA 1.516 2.857 0 CA-C-N 122.418 2.372 . . . . 0.0 110.685 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.6 m -118.09 116.25 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 121.445 3.868 . . . . 0.0 121.445 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.564 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.7 m -75.88 165.44 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.033 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.28 130.96 55.5 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 46' ' ' ALA . 4.1 m-20 -53.53 93.82 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.185 1 N-CA-C 124.088 4.847 . . . . 0.0 124.088 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.94 6.74 43.44 Favored 'General case' 0 CA--C 1.602 2.952 0 N-CA-C 101.228 -3.619 . . . . 0.0 101.228 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.88 -65.49 1.18 Allowed 'General case' 0 CA--C 1.573 1.85 0 C-N-CA 127.519 2.328 . . . . 0.0 112.705 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.676 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.48 9.5 Favored 'General case' 0 N--CA 1.52 3.034 0 N-CA-C 118.91 2.93 . . . . 0.0 118.91 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.44 151.24 0.74 Allowed Pre-proline 0 N--CA 1.522 3.151 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.7 Cg_endo -42.42 -58.27 1.31 Allowed 'Trans proline' 0 N--CA 1.509 2.391 0 C-N-CA 123.376 2.717 . . . . 0.0 115.113 170.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.544 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.49 67.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 124.112 1.911 . . . . 0.0 107.04 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.16 53.49 0.99 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.344 -2.207 . . . . 0.0 108.265 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.81 56.96 0.75 Allowed 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.68 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.57 -47.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.14 -30.84 0.17 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.226 -1.546 . . . . 0.0 111.564 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.507 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.18 -28.53 0.1 Allowed 'General case' 0 N--CA 1.508 2.449 0 CA-C-O 122.77 1.272 . . . . 0.0 112.567 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.499 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.77 -27.58 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.01 -55.55 0.3 Allowed 'General case' 0 N--CA 1.533 3.691 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.76 -28.89 0.17 Allowed 'General case' 0 N--CA 1.515 2.818 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.033 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.69 -66.82 0.32 Allowed 'General case' 0 CA--C 1.603 3.013 0 N-CA-C 100.69 -3.819 . . . . 0.0 100.69 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.812 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.14 98.46 2.13 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 125.259 1.424 . . . . 0.0 112.806 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.691 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.1 t60 -90.01 -172.93 3.68 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.691 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.34 155.2 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.353 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.598 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.3 tt0 105.41 66.08 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.778 0 N-CA-C 120.285 3.439 . . . . 0.0 120.285 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.795 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.9 mp 38.16 84.18 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 120.805 3.632 . . . . 0.0 120.805 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.65 ' N ' HD21 ' A' ' 40' ' ' ASN . 36.0 mt -70.59 82.08 0.59 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.225 -1.547 . . . . 0.0 111.876 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.582 ' SD ' ' HG3' ' A' ' 38' ' ' PRO . 42.1 mmm -79.29 62.02 3.54 Favored 'General case' 0 N--CA 1.51 2.536 0 CA-C-O 126.066 2.841 . . . . 0.0 110.945 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.2 m -112.65 65.92 0.87 Allowed Pre-proline 0 C--N 1.283 -2.295 0 CA-C-N 110.482 -3.053 . . . . 0.0 113.601 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -52.0 81.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.444 0 C-N-CA 122.98 2.453 . . . . 0.0 114.698 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.19 6.64 27.56 Favored Glycine 0 N--CA 1.515 3.963 0 O-C-N 122.195 -0.316 . . . . 0.0 113.573 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.4 tt0 -123.59 156.94 34.82 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 124.336 2.017 . . . . 0.0 116.331 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.439 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -117.01 156.32 27.69 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 119.641 3.2 . . . . 0.0 119.641 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.5 t -115.96 148.0 40.56 Favored 'General case' 0 N--CA 1.52 3.043 0 CA-C-O 116.633 -1.651 . . . . 0.0 107.229 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.55 143.78 41.86 Favored 'General case' 0 N--CA 1.529 3.512 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.8 m -119.96 102.57 8.65 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 114.146 -1.388 . . . . 0.0 113.575 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 28' ' ' THR . 48.8 m -94.71 152.19 18.67 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.422 ' N ' HG22 ' A' ' 75' ' ' THR . 90.3 m-85 -107.97 168.29 8.1 Favored Pre-proline 0 N--CA 1.504 2.233 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.114 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.35 -174.81 1.53 Allowed 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 120.989 1.126 . . . . 0.0 111.107 161.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.31 -19.82 18.97 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 124.336 2.017 . . . . 0.0 107.235 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.12 42.68 0.49 Allowed 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 111.285 -2.688 . . . . 0.0 109.097 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.79 9.78 Favored Pre-proline 0 N--CA 1.5 2.04 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.794 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 83' ' ' GLY . 44.6 Cg_endo -79.42 178.7 7.11 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.831 2.354 . . . . 0.0 112.23 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.593 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.17 77.73 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.921 0 C-N-CA 125.31 1.444 . . . . 0.0 113.265 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.44 125.1 5.65 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 121.757 3.463 . . . . 0.0 121.757 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.49 61.23 1.17 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.536 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.02 77.77 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.934 1.349 . . . . 0.0 113.049 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.5 136.0 57.27 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.557 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.5 136.57 52.87 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.564 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.76 82.05 8.6 Favored 'General case' 0 N--CA 1.511 2.587 1 N-CA-C 132.586 7.995 . . . . 0.0 132.586 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.83 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.465 2 CA-C-N 130.301 5.955 . . . . 0.0 114.293 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.0 tt0 -20.55 -72.42 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.605 0 N-CA-C 118.502 2.778 . . . . 0.0 118.502 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 36.4 Cg_endo -67.01 -3.54 9.86 Favored 'Trans proline' 0 N--CA 1.511 2.534 0 C-N-CA 122.382 2.055 . . . . 0.0 115.351 176.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -120.82 -14.14 8.56 Favored 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.446 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.37 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 116.625 2.084 . . . . 0.0 116.625 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.59 -33.95 1.74 Allowed Glycine 1 N--CA 1.52 4.291 0 O-C-N 121.57 -0.706 . . . . 0.0 112.682 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.62 68.47 7.98 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.92 26.71 0.05 OUTLIER Glycine 1 N--CA 1.527 4.7 0 CA-C-N 114.008 -1.451 . . . . 0.0 116.629 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.559 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.55 43.9 1.19 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 124.505 2.098 . . . . 0.0 113.071 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.96 134.92 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 112.193 -2.276 . . . . 0.0 110.943 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.61 154.85 19.32 Favored Glycine 1 N--CA 1.536 5.354 0 C-N-CA 119.484 -1.341 . . . . 0.0 113.977 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.59 81.99 1.78 Allowed 'General case' 0 N--CA 1.518 2.942 0 CA-C-N 119.4 1.6 . . . . 0.0 115.264 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.74 123.26 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.9 m -112.62 88.76 2.9 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.187 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.454 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.1 t -74.05 105.21 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.25 -72.36 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 O-C-N 126.039 2.087 . . . . 0.0 115.967 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.593 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.46 0 O-C-N 125.468 1.73 . . . . 0.0 113.819 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' TRP . . . . . 0.452 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.2 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' GLN . . . . . 0.442 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.2 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.464 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 51.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.5 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 86.5 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 53.9 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 77.5 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.0 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.67 HG13 HG22 ' B' ' 50' ' ' VAL 0.39 0.7 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.3 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 25.5 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.599 HD22 ' N ' ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.6 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.6 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.99 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.5 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.67 HG22 HG13 ' B' ' 34' ' ' VAL . 61.2 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.5 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.422 HG12 ' N ' ' B' ' 69' ' ' GLY . 84.1 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.422 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.517 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.575 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.0 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' PRO . . . . . 0.8 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 18.7 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.8 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 42.4 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.561 HG22 HG11 ' B' ' 114' ' ' VAL 0.427 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.0 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.2 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 1.169 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 19.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' GLN . . . . . 1.069 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.6 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 56.0 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.561 HG11 HG22 ' B' ' 84' ' ' ILE . 16.7 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 1.571 ' CA ' ' CB ' ' B' ' 115' ' ' ILE 0.687 0.0 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.462 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.414 ' HG2' ' CE ' ' A' ' 66' ' ' MET . 38.2 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 81.8 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.6 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 93.1 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.42 ' C ' HG12 ' B' ' 131' ' ' VAL . 13.6 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.99 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.494 1.1 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' PRO . . . . . 0.66 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.9 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 139' ' ' ASP . . . . . 0.643 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.643 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.428 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' PHE . . . . . 0.66 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.7 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.408 1.4 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' HIS . . . . . 0.464 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.616 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.477 HH11 ' HD2' ' B' ' 157' ' ' ARG . 30.4 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 159' ' ' GLN . . . . . 0.661 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.4 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.428 0.9 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 162' ' ' PRO . . . . . 0.452 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.7 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 63.0 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.67 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 172' ' ' TYR . . . . . 0.67 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.3 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.402 HG22 ' N ' ' B' ' 178' ' ' GLY . 58.8 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.402 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.2 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 43.1 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.45 1.5 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.804 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.409 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.0 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.5 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 213' ' ' ALA . . . . . 0.415 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.415 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 13.0 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.406 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' ASN . . . . . 0.516 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.481 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.6 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.503 HD22 HD11 ' B' ' 142' ' ' ILE . 40.8 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 118.051 -0.976 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.472 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 79.6 m -61.59 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -99.93 163.02 12.63 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.77 122.34 46.56 Favored 'General case' 0 N--CA 1.525 3.322 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.5 t -100.54 98.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 8' ' ' GLY . 14.0 mmmt -67.39 65.48 0.07 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 113.109 -1.86 . . . . 0.0 114.857 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -29.54 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 126.641 1.976 . . . . 0.0 115.449 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.52 59.02 0.4 Allowed Glycine 0 N--CA 1.51 3.568 0 N-CA-C 106.849 -2.501 . . . . 0.0 106.849 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.2 p -1.15 54.22 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 120.21 3.411 . . . . 0.0 120.21 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.42 -60.19 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.75 22.39 14.56 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 120.917 -1.114 . . . . 0.0 108.193 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.08 -94.77 1.9 Allowed Glycine 0 N--CA 1.511 3.691 0 N-CA-C 115.519 0.968 . . . . 0.0 115.519 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.573 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 47.5 tp -150.63 -177.19 5.83 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.573 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 15.8 mt -74.73 46.71 0.3 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.6 -1.312 . . . . 0.0 111.286 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.693 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.8 p -113.75 165.64 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 118.53 2.789 . . . . 0.0 118.53 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.693 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.21 75.42 1.49 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.363 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.48 142.41 25.16 Favored Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.85 -0.531 . . . . 0.0 111.795 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 20' ' ' LYS . 58.4 Cg_endo -86.43 76.11 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.424 0 N-CA-C 116.365 1.64 . . . . 0.0 116.365 -9.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.7 -44.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 1 N-CA-C 122.319 4.192 . . . . 0.0 122.319 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.627 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.67 71.52 0.99 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 122.484 1.135 . . . . 0.0 113.064 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.817 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.02 111.26 7.11 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.116 -1.615 . . . . 0.0 109.107 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.542 ' N ' HD23 ' A' ' 21' ' ' LEU . 55.1 m -87.52 81.42 7.77 Favored 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.817 HG23 HD22 ' A' ' 21' ' ' LEU . 4.6 pt -79.57 -177.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.72 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.67 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.63 10.43 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.097 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 24.3 Cg_endo -52.33 77.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.287 0 N-CA-C 116.897 1.845 . . . . 0.0 116.897 174.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.17 -50.63 0.51 Allowed Glycine 1 N--CA 1.522 4.382 0 C-N-CA 119.682 -1.247 . . . . 0.0 115.836 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.56 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 1 N-CA-C 122.115 4.116 . . . . 0.0 122.115 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 28' ' ' THR . 11.2 m -64.07 35.96 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.018 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -51.96 147.19 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 112.849 -1.978 . . . . 0.0 111.513 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.24 154.89 27.13 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 124.011 1.862 . . . . 0.0 115.368 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.416 ' HB3' HD11 ' A' ' 7' ' ' LEU . 56.7 m-85 -107.51 113.88 27.5 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.585 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.1 tt -100.85 112.52 24.96 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 120.729 3.603 . . . . 0.0 120.729 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -75.16 84.7 2.37 Favored 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.111 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.7 p30 -80.29 -45.09 18.47 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.96 -169.31 3.34 Favored 'General case' 0 N--CA 1.509 2.522 0 C-N-CA 124.569 1.148 . . . . 0.0 109.048 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.243 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.6 m 12.89 70.61 0.11 Allowed Pre-proline 0 N--CA 1.521 3.11 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.608 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 64.2 Cg_endo -98.35 177.25 0.42 Allowed 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 123.994 3.129 . . . . 0.0 114.441 -165.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 60.9 Cg_endo -92.42 165.3 25.26 Favored 'Cis proline' 0 N--CA 1.503 2.037 0 N-CA-C 115.391 1.266 . . . . 0.0 115.391 -7.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.8 ' HB2' HD13 ' A' ' 7' ' ' LEU . 18.4 m-70 -118.96 87.37 2.72 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.754 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -103.33 140.26 37.66 Favored 'General case' 0 N--CA 1.516 2.868 0 CA-C-N 122.387 2.358 . . . . 0.0 110.675 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.4 m -118.13 116.3 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 121.406 3.854 . . . . 0.0 121.406 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.554 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.4 m -75.98 165.36 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 102.189 -3.263 . . . . 0.0 102.189 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.045 ' HB2' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.27 131.01 55.48 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.0 m-20 -53.42 93.73 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.19 1 N-CA-C 124.142 4.867 . . . . 0.0 124.142 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.97 6.72 43.58 Favored 'General case' 0 CA--C 1.602 2.948 0 N-CA-C 101.19 -3.633 . . . . 0.0 101.19 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.8 -65.48 1.18 Allowed 'General case' 0 CA--C 1.574 1.89 0 C-N-CA 127.592 2.357 . . . . 0.0 112.742 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.705 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.7 mp -86.75 66.59 9.53 Favored 'General case' 0 N--CA 1.519 3.023 0 N-CA-C 118.874 2.916 . . . . 0.0 118.874 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.39 151.26 0.75 Allowed Pre-proline 0 N--CA 1.522 3.17 0 N-CA-C 117.487 2.402 . . . . 0.0 117.487 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.1 Cg_endo -42.44 -58.25 1.32 Allowed 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 123.426 2.751 . . . . 0.0 115.088 170.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.54 67.38 0.72 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 124.119 1.914 . . . . 0.0 107.012 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.15 53.53 0.99 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 112.292 -2.231 . . . . 0.0 108.25 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.78 56.93 0.75 Allowed 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 117.8 2.519 . . . . 0.0 117.8 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.661 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.61 -47.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.262 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -41.21 -30.87 0.18 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.082 -1.636 . . . . 0.0 111.587 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.526 HD12 ' C ' ' A' ' 55' ' ' LEU . 2.9 pp -41.04 -28.64 0.09 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 122.787 1.279 . . . . 0.0 112.552 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.502 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.72 -27.68 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.481 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.13 -55.58 0.31 Allowed 'General case' 0 N--CA 1.533 3.705 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.7 -28.96 0.16 Allowed 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.045 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.4 pp -53.57 -66.9 0.31 Allowed 'General case' 0 CA--C 1.604 3.026 0 N-CA-C 100.688 -3.819 . . . . 0.0 100.688 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.851 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.09 98.47 2.11 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.227 1.411 . . . . 0.0 112.786 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.698 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.0 t60 -90.06 -173.01 3.7 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.698 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.42 155.23 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 26.5 tt0 105.45 65.97 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 120.315 3.45 . . . . 0.0 120.315 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.282 HD23 ' CG ' ' B' ' 118' ' ' PRO . 5.9 mp 38.26 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 120.769 3.618 . . . . 0.0 120.769 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.754 ' N ' HD21 ' A' ' 40' ' ' ASN . 35.3 mt -70.67 82.04 0.61 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.166 -1.584 . . . . 0.0 111.876 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . 1.022 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 42.5 mmm -79.16 61.9 3.41 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-O 126.066 2.841 . . . . 0.0 110.962 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.4 m -112.54 65.88 0.84 Allowed Pre-proline 0 N--CA 1.505 2.307 0 CA-C-N 110.482 -3.054 . . . . 0.0 113.597 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -51.87 81.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 122.985 2.457 . . . . 0.0 114.71 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.63 27.66 Favored Glycine 1 N--CA 1.517 4.07 0 O-C-N 122.209 -0.307 . . . . 0.0 113.579 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.4 tt0 -123.62 156.83 35.1 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 124.404 2.049 . . . . 0.0 116.285 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.437 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -116.87 156.46 27.28 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 119.748 3.24 . . . . 0.0 119.748 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -116.02 147.91 40.72 Favored 'General case' 0 N--CA 1.52 3.029 0 CA-C-O 116.651 -1.642 . . . . 0.0 107.253 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.51 143.63 42.05 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.6 m -119.84 102.54 8.65 Favored 'General case' 0 N--CA 1.514 2.747 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.632 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.452 ' OG1' HG23 ' A' ' 28' ' ' THR . 50.2 m -94.76 152.2 18.63 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.416 ' N ' HG22 ' A' ' 75' ' ' THR . 90.7 m-85 -107.93 168.33 8.06 Favored Pre-proline 0 N--CA 1.503 2.178 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.124 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.35 -174.85 1.54 Allowed 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 121.021 1.147 . . . . 0.0 111.109 161.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.33 -19.66 19.08 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 124.435 2.064 . . . . 0.0 107.334 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.22 42.71 0.5 Allowed 'General case' 0 CA--C 1.576 1.98 0 CA-C-N 111.187 -2.733 . . . . 0.0 109.045 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.68 9.67 Favored Pre-proline 0 N--CA 1.499 2.012 0 CA-C-N 113.675 -1.602 . . . . 0.0 113.761 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 83' ' ' GLY . 53.5 Cg_endo -79.31 178.62 7.23 Favored 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 122.803 2.335 . . . . 0.0 112.304 172.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.606 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.08 77.69 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.92 0 O-C-N 125.018 1.449 . . . . 0.0 113.346 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.37 124.98 5.63 Favored Glycine 0 N--CA 1.508 3.475 0 N-CA-C 121.746 3.459 . . . . 0.0 121.746 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.46 61.24 1.18 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.526 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.1 m-85 -62.0 77.8 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.872 1.32 . . . . 0.0 113.052 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.57 135.95 57.18 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.47 136.49 52.95 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.554 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.64 82.03 8.6 Favored 'General case' 0 N--CA 1.512 2.64 1 N-CA-C 132.637 8.014 . . . . 0.0 132.637 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.1 t -63.9 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.501 2 CA-C-N 130.342 5.974 . . . . 0.0 114.311 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.7 tt0 -20.52 -72.48 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.605 0 N-CA-C 118.468 2.766 . . . . 0.0 118.468 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.59 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 37.6 Cg_endo -66.97 -3.48 9.7 Favored 'Trans proline' 0 N--CA 1.512 2.569 0 C-N-CA 122.39 2.06 . . . . 0.0 115.352 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -120.87 -14.12 8.55 Favored 'General case' 0 N--CA 1.511 2.613 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.477 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.38 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.62 -34.06 1.73 Allowed Glycine 1 N--CA 1.52 4.296 0 O-C-N 121.616 -0.678 . . . . 0.0 112.7 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.56 68.46 7.91 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.86 26.74 0.05 OUTLIER Glycine 1 N--CA 1.526 4.677 0 CA-C-N 114.041 -1.436 . . . . 0.0 116.68 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.559 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 1.9 ttt -108.55 43.83 1.19 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 124.406 2.05 . . . . 0.0 112.957 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.99 134.89 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 112.275 -2.239 . . . . 0.0 110.945 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.66 154.85 19.35 Favored Glycine 1 N--CA 1.534 5.212 0 C-N-CA 119.523 -1.323 . . . . 0.0 114.059 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.56 81.86 1.76 Allowed 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.63 123.3 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.709 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.0 m -112.63 88.7 2.88 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.185 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.444 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.4 t -74.0 105.17 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.31 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 O-C-N 126.064 2.103 . . . . 0.0 115.933 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.606 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.521 0 O-C-N 125.576 1.798 . . . . 0.0 113.812 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.59 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 22.0 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' TRP . . . . . 0.462 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.0 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' GLN . . . . . 0.459 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.3 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.499 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 88.7 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 50.9 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 79.5 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.1 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.783 HG13 HG22 ' B' ' 50' ' ' VAL 0.375 0.2 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.481 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.5 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.408 HG13 ' HD2' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.408 ' HD2' HG13 ' B' ' 36' ' ' VAL . 27.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.625 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.4 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.9 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 1.027 ' CE1' HG22 ' B' ' 131' ' ' VAL . 51.7 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.783 HG22 HG13 ' B' ' 34' ' ' VAL . 61.4 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.421 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.6 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.6 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.421 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.1 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.426 HG12 ' N ' ' B' ' 69' ' ' GLY . 79.1 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.426 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.526 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.507 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.3 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.1 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' PRO . . . . . 0.914 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 14.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.914 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 46.6 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.513 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 74.2 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.4 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 17.7 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 1.608 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 17.0 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' GLN . . . . . 1.243 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.7 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' TYR . . . . . 0.459 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 25.5 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.507 HD11 HG23 ' B' ' 75' ' ' VAL 0.54 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.466 ' N ' HG23 ' B' ' 115' ' ' ILE 0.411 0.1 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 1.282 ' CG ' HD23 ' A' ' 64' ' ' LEU . 38.7 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 1.022 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 81.1 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 57.2 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 90.8 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.481 ' C ' HG12 ' B' ' 131' ' ' VAL . 11.7 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 1.564 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.43 1.6 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.0 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' PRO . . . . . 0.623 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 10.6 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 139' ' ' ASP . . . . . 0.607 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.66 HD11 HD22 ' B' ' 249' ' ' LEU 0.483 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' PHE . . . . . 0.623 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.6 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.3 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 149' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' B' ' 149' ' ' VAL 0.335 1.7 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.581 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.471 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' GLN . . . . . 0.661 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.4 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.387 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 162' ' ' PRO . . . . . 0.462 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 18.5 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.8 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.44 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 62.3 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.692 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.8 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 172' ' ' TYR . . . . . 0.692 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.7 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.408 HG22 ' N ' ' B' ' 178' ' ' GLY . 59.4 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.408 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 64.1 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 182' ' ' LYS . . . . . 0.411 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.411 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.3 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.6 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.414 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.84 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 199' ' ' ILE . . . . . 0.46 ' O ' HG13 ' B' ' 199' ' ' ILE 0.482 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.6 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.3 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.2 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 213' ' ' ALA . . . . . 0.465 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.465 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 11.2 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 86.4 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.385 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.4 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' ASN . . . . . 0.503 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.472 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.0 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.9 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.66 HD22 HD11 ' B' ' 142' ' ' ILE . 40.5 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.596 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.453 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 70.1 m -61.59 89.67 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.93 163.03 12.62 Favored 'General case' 0 N--CA 1.512 2.653 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.455 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.2 t -107.83 122.43 46.76 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.2 t -100.5 98.39 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.4 mmmt -67.34 65.32 0.07 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 113.086 -1.87 . . . . 0.0 114.888 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.806 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.9 mt -29.47 68.26 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 126.579 1.952 . . . . 0.0 115.459 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.42 59.06 0.4 Allowed Glycine 0 N--CA 1.509 3.552 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 20.3 p -1.12 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.259 0 N-CA-C 120.346 3.462 . . . . 0.0 120.346 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.49 -60.14 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 119.515 3.154 . . . . 0.0 119.515 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.85 22.48 14.43 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.957 -1.09 . . . . 0.0 108.116 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.07 -94.8 1.9 Allowed Glycine 0 N--CA 1.512 3.711 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.594 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.7 tp -150.66 -177.23 5.86 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.597 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.5 mt -74.72 46.74 0.3 Allowed 'General case' 0 N--CA 1.509 2.516 0 O-C-N 120.7 -1.25 . . . . 0.0 111.236 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.732 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.6 p -113.86 165.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.732 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.3 m-30 -102.12 75.43 1.51 Allowed 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 112.219 -2.264 . . . . 0.0 113.416 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.342 0.6 OUTLIER -93.47 142.39 25.14 Favored Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.853 -0.529 . . . . 0.0 111.746 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 20' ' ' LYS . 46.0 Cg_endo -86.49 76.11 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.466 0 N-CA-C 116.368 1.642 . . . . 0.0 116.368 -9.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.72 -44.22 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.806 1 N-CA-C 122.26 4.17 . . . . 0.0 122.26 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.645 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.65 71.68 1.0 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 122.412 1.101 . . . . 0.0 112.986 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.847 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.14 111.25 7.21 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.148 -1.595 . . . . 0.0 109.159 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.576 ' N ' HD23 ' A' ' 21' ' ' LEU . 47.7 m -87.52 81.53 7.74 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.847 HG23 HD22 ' A' ' 21' ' ' LEU . 4.4 pt -79.71 -177.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 114.75 -1.113 . . . . 0.0 112.699 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.705 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -109.67 166.55 10.58 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.126 179.388 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 19.9 Cg_endo -52.24 77.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.314 0 N-CA-C 116.833 1.82 . . . . 0.0 116.833 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.13 -50.41 0.52 Allowed Glycine 1 N--CA 1.522 4.42 0 C-N-CA 119.76 -1.209 . . . . 0.0 115.831 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.556 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.71 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 1 N-CA-C 122.11 4.115 . . . . 0.0 122.11 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 28' ' ' THR . 10.8 m -64.03 36.0 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.012 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.5 t -52.0 147.17 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.566 0 CA-C-N 112.821 -1.991 . . . . 0.0 111.5 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.19 154.91 27.05 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 123.923 1.82 . . . . 0.0 115.416 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.433 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.9 m-85 -107.57 113.84 27.42 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.1 tt -100.72 112.53 24.95 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 120.653 3.575 . . . . 0.0 120.653 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -75.13 84.69 2.35 Favored 'General case' 0 N--CA 1.513 2.689 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.162 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 29.9 p30 -80.27 -45.08 18.54 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 118.935 2.939 . . . . 0.0 118.935 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.95 -169.3 3.34 Favored 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 124.671 1.189 . . . . 0.0 109.077 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.105 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.6 m 12.79 70.72 0.11 Allowed Pre-proline 0 N--CA 1.52 3.029 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.344 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 55.3 Cg_endo -98.49 177.29 0.4 Allowed 'Trans proline' 0 CA--C 1.568 2.222 0 C-N-CA 123.984 3.123 . . . . 0.0 114.37 -165.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.717 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 52.2 Cg_endo -92.39 165.33 25.33 Favored 'Cis proline' 0 N--CA 1.502 2.029 0 N-CA-C 115.472 1.297 . . . . 0.0 115.472 -7.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.806 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.5 m-70 -118.96 87.52 2.75 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.963 HD22 ' HA ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -103.5 140.23 37.79 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 122.465 2.393 . . . . 0.0 110.663 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 6.4 m -118.09 116.41 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 121.446 3.869 . . . . 0.0 121.446 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.577 HG22 ' CB ' ' A' ' 88' ' ' TYR . 13.0 m -76.07 165.46 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 102.099 -3.297 . . . . 0.0 102.099 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.066 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.32 130.96 55.51 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.443 ' OD1' HD13 ' A' ' 47' ' ' LEU . 4.1 m-20 -53.45 93.82 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.212 1 N-CA-C 124.16 4.874 . . . . 0.0 124.16 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.09 6.8 43.47 Favored 'General case' 0 CA--C 1.602 2.979 0 N-CA-C 101.212 -3.625 . . . . 0.0 101.212 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.439 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -115.9 -65.43 1.19 Allowed 'General case' 0 CA--C 1.574 1.88 0 C-N-CA 127.445 2.298 . . . . 0.0 112.682 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.4 mp -86.65 66.53 9.51 Favored 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 118.902 2.927 . . . . 0.0 118.902 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.634 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.4 151.28 0.74 Allowed Pre-proline 0 N--CA 1.522 3.145 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 17.3 Cg_endo -42.41 -58.29 1.3 Allowed 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.405 2.736 . . . . 0.0 115.112 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.634 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.46 67.34 0.72 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 124.102 1.906 . . . . 0.0 107.077 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -77.13 53.6 0.99 Allowed 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.312 -2.222 . . . . 0.0 108.272 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 t -115.9 56.99 0.76 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.664 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.63 -47.99 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.256 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.07 -30.88 0.16 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.06 -1.65 . . . . 0.0 111.578 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 55' ' ' LEU . 2.9 pp -41.18 -28.53 0.1 Allowed 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 122.755 1.264 . . . . 0.0 112.487 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.83 -27.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 117.727 2.492 . . . . 0.0 117.727 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.479 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.3 tptt 65.05 -55.59 0.3 Allowed 'General case' 0 N--CA 1.533 3.71 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.1 m -41.68 -28.98 0.16 Allowed 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.066 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.2 pp -53.68 -66.82 0.33 Allowed 'General case' 0 CA--C 1.604 3.032 0 N-CA-C 100.71 -3.811 . . . . 0.0 100.71 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.862 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 11.1 p -72.07 98.45 2.1 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 125.259 1.424 . . . . 0.0 112.806 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.706 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.4 t60 -90.08 -173.01 3.7 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.706 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.4 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.591 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 26.0 tt0 105.51 65.97 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 120.303 3.445 . . . . 0.0 120.303 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.963 ' HA ' HD22 ' A' ' 40' ' ' ASN . 5.6 mp 38.11 84.33 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 120.745 3.609 . . . . 0.0 120.745 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 65' ' ' LEU . 36.5 mt -70.66 82.1 0.61 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.078 -1.639 . . . . 0.0 111.888 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.856 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 41.0 mmm -79.25 61.93 3.48 Favored 'General case' 0 N--CA 1.51 2.542 0 CA-C-O 126.057 2.837 . . . . 0.0 110.912 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.7 m -112.55 65.92 0.85 Allowed Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 110.543 -3.026 . . . . 0.0 113.621 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -51.95 81.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 122.933 2.422 . . . . 0.0 114.686 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.13 6.73 27.59 Favored Glycine 1 N--CA 1.517 4.036 0 O-C-N 122.251 -0.28 . . . . 0.0 113.541 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.68 156.91 35.02 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 124.374 2.035 . . . . 0.0 116.241 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.455 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.98 156.39 27.55 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 119.681 3.215 . . . . 0.0 119.681 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -116.01 147.96 40.66 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-O 116.678 -1.63 . . . . 0.0 107.215 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.56 143.79 41.85 Favored 'General case' 0 N--CA 1.53 3.546 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.9 m -119.99 102.62 8.67 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.52 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.439 ' OG1' HG23 ' A' ' 28' ' ' THR . 49.0 m -94.78 152.15 18.66 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.424 ' N ' HG22 ' A' ' 75' ' ' THR . 89.4 m-85 -107.91 168.29 8.11 Favored Pre-proline 0 N--CA 1.503 2.181 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.089 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -72.36 -174.83 1.54 Allowed 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 121.023 1.149 . . . . 0.0 111.121 161.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.73 19.0 Favored 'General case' 0 N--CA 1.51 2.535 0 CA-C-O 124.34 2.019 . . . . 0.0 107.237 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.17 42.68 0.49 Allowed 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 111.258 -2.701 . . . . 0.0 109.118 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.79 9.78 Favored Pre-proline 0 N--CA 1.5 2.069 0 CA-C-N 113.543 -1.662 . . . . 0.0 113.742 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 38.0 Cg_endo -79.39 178.64 7.18 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 122.817 2.345 . . . . 0.0 112.253 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.594 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.03 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 125.367 1.467 . . . . 0.0 113.24 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.44 125.01 5.63 Favored Glycine 0 N--CA 1.507 3.389 0 N-CA-C 121.787 3.475 . . . . 0.0 121.787 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.8 mt-10 -99.4 61.26 1.19 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.516 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.1 m-85 -62.05 77.75 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 122.95 1.357 . . . . 0.0 113.033 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.6 m -63.52 136.0 57.25 Favored 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.582 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.52 136.5 52.93 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.577 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.6 m-85 -84.62 82.02 8.6 Favored 'General case' 0 N--CA 1.51 2.561 1 N-CA-C 132.655 8.02 . . . . 0.0 132.655 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.9 t -63.86 82.11 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.433 2 CA-C-N 130.371 5.987 . . . . 0.0 114.365 179.651 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.4 tt0 -20.51 -72.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.582 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.43 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 31.8 Cg_endo -67.04 -3.45 9.72 Favored 'Trans proline' 0 N--CA 1.51 2.489 0 C-N-CA 122.409 2.073 . . . . 0.0 115.367 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -120.85 -14.22 8.54 Favored 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.49 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.3 79.62 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.742 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.61 -34.03 1.73 Allowed Glycine 1 N--CA 1.522 4.381 0 O-C-N 121.597 -0.689 . . . . 0.0 112.617 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.52 68.46 7.86 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.79 26.8 0.05 OUTLIER Glycine 1 N--CA 1.527 4.731 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.563 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 1.8 ttt -108.54 43.85 1.19 Allowed 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 124.485 2.088 . . . . 0.0 113.022 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.97 134.88 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 112.228 -2.26 . . . . 0.0 110.903 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.71 154.86 19.38 Favored Glycine 1 N--CA 1.536 5.356 0 C-N-CA 119.446 -1.359 . . . . 0.0 113.96 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.2 ttpp -118.56 81.95 1.77 Allowed 'General case' 0 N--CA 1.517 2.883 0 CA-C-N 119.372 1.586 . . . . 0.0 115.262 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.71 123.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.667 0 C-N-CA 118.054 -1.458 . . . . 0.0 107.079 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -112.68 88.8 2.91 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.124 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.453 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.8 t -74.12 105.27 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.34 -72.28 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 O-C-N 126.101 2.126 . . . . 0.0 115.95 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.594 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.53 0 O-C-N 125.527 1.767 . . . . 0.0 113.81 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' TRP . . . . . 0.474 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' GLN . . . . . 0.471 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.0 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.2 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 9.9 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 89.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 54.2 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 77.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.3 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.839 HG13 HG22 ' B' ' 50' ' ' VAL 0.374 0.1 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.7 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.457 HG13 ' HD2' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.457 ' HD2' HG13 ' B' ' 36' ' ' VAL . 23.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.9 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.667 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 30.2 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 1.118 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.839 HG22 HG13 ' B' ' 34' ' ' VAL . 62.0 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.449 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.449 HG22 ' O ' ' B' ' 55' ' ' ASP . 15.2 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 83.3 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.452 HG12 ' N ' ' B' ' 69' ' ' GLY . 74.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.452 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.555 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.415 HG23 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.2 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' PRO . . . . . 1.049 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 24.7 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 1.049 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 42.5 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.567 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 94' ' ' LEU . 50.3 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.4 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 1.344 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 17.2 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' GLN . . . . . 1.105 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.8 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.8 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.507 HG23 ' N ' ' B' ' 116' ' ' VAL 0.46 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.507 ' N ' HG23 ' B' ' 115' ' ' ILE 0.255 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.614 ' CG ' HD23 ' A' ' 64' ' ' LEU . 36.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.856 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 81.9 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.6 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 85.3 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.508 ' C ' HG12 ' B' ' 131' ' ' VAL . 19.9 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 1.56 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.344 0.5 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' B' ' 142' ' ' ILE . 35.7 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' PRO . . . . . 0.525 ' CG ' ' CZ ' ' B' ' 144' ' ' PHE . 18.1 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 139' ' ' ASP . . . . . 0.589 ' CG ' ' CG2' ' B' ' 142' ' ' ILE . 44.7 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.737 HD11 HD22 ' B' ' 249' ' ' LEU 0.51 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' B' ' 136' ' ' PRO . 81.3 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 69.0 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' B' ' 149' ' ' VAL . 1.3 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.627 HG11 ' CG2' ' B' ' 34' ' ' VAL . 10.7 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 155' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' B' ' 155' ' ' ARG . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' B' ' 157' ' ' ARG . 28.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' GLN . . . . . 0.683 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.7 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.312 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 162' ' ' PRO . . . . . 0.474 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 17.8 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 97.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.442 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 62.2 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.725 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.9 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 172' ' ' TYR . . . . . 0.725 ' N ' HD23 ' B' ' 171' ' ' LEU . 18.5 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.436 HG22 ' N ' ' B' ' 178' ' ' GLY . 61.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.436 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.3 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 182' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.5 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.428 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 41.2 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.38 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.903 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 199' ' ' ILE . . . . . 0.639 HG13 ' O ' ' B' ' 199' ' ' ILE 0.519 0.3 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.6 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.2 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.0 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' ALA . . . . . 0.488 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 18.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.3 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 86.9 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.403 0.1 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.0 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' B' ' 231' ' ' LEU . 84.2 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' ASN . . . . . 0.545 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.507 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.7 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 19.4 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.737 HD22 HD11 ' B' ' 142' ' ' ILE . 41.4 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.47 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.6 m -61.61 89.7 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.98 162.98 12.64 Favored 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.452 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.0 t -107.68 122.36 46.56 Favored 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.52 98.34 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.41 65.5 0.07 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 113.077 -1.874 . . . . 0.0 114.834 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.804 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -29.51 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.96 0 C-N-CA 126.595 1.958 . . . . 0.0 115.534 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.43 59.11 0.4 Allowed Glycine 0 N--CA 1.509 3.557 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.2 p -1.08 54.03 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 120.344 3.461 . . . . 0.0 120.344 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.61 -60.22 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 119.507 3.151 . . . . 0.0 119.507 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.508 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.47 14.45 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 120.998 -1.064 . . . . 0.0 108.143 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.09 -94.83 1.9 Allowed Glycine 0 N--CA 1.511 3.69 0 N-CA-C 115.553 0.981 . . . . 0.0 115.553 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.556 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 47.1 tp -150.57 -177.16 5.81 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.556 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 15.7 mt -74.68 46.66 0.29 Allowed 'General case' 0 N--CA 1.509 2.478 0 O-C-N 120.608 -1.307 . . . . 0.0 111.296 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.681 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.8 p -113.84 165.67 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.681 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.24 75.38 1.49 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 112.209 -2.269 . . . . 0.0 113.436 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.42 142.44 25.23 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 121.851 -0.531 . . . . 0.0 111.744 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 20' ' ' LYS . 56.8 Cg_endo -86.4 76.1 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.389 0 N-CA-C 116.382 1.647 . . . . 0.0 116.382 -9.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.7 -44.18 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.812 1 N-CA-C 122.24 4.163 . . . . 0.0 122.24 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.65 71.55 0.99 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.446 1.117 . . . . 0.0 113.052 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.841 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.06 111.27 7.15 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.177 -1.577 . . . . 0.0 109.147 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.515 ' N ' HD23 ' A' ' 21' ' ' LEU . 53.8 m -87.48 81.39 7.81 Favored 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.841 HG23 HD22 ' A' ' 21' ' ' LEU . 4.6 pt -79.7 -177.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.708 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.666 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.69 166.6 10.49 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.078 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.5 Cg_endo -52.3 77.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.569 2.263 0 N-CA-C 116.92 1.854 . . . . 0.0 116.92 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.09 -50.39 0.52 Allowed Glycine 1 N--CA 1.522 4.404 0 C-N-CA 119.727 -1.225 . . . . 0.0 115.859 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.68 92.11 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.195 1 N-CA-C 122.092 4.108 . . . . 0.0 122.092 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 28' ' ' THR . 11.3 m -64.12 36.03 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 118.681 2.845 . . . . 0.0 118.681 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.99 147.2 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 CA-C-N 112.861 -1.972 . . . . 0.0 111.529 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.31 154.85 27.29 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 123.936 1.827 . . . . 0.0 115.397 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -107.47 113.9 27.55 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.78 112.48 24.91 Favored 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 120.759 3.614 . . . . 0.0 120.759 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -75.11 84.75 2.34 Favored 'General case' 0 N--CA 1.511 2.611 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.14 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.5 p30 -80.35 -45.08 18.36 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 118.862 2.912 . . . . 0.0 118.862 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.92 -169.26 3.33 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 124.678 1.191 . . . . 0.0 109.143 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HA ' HE22 ' B' ' 104' ' ' GLN . 1.6 m 12.82 70.7 0.11 Allowed Pre-proline 0 N--CA 1.52 3.038 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.221 ' HG2' ' CZ ' ' B' ' 102' ' ' TYR . 59.5 Cg_endo -98.41 177.26 0.41 Allowed 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 123.953 3.102 . . . . 0.0 114.382 -165.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.619 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 58.9 Cg_endo -92.48 165.22 25.07 Favored 'Cis proline' 0 N--CA 1.503 2.082 0 N-CA-C 115.392 1.266 . . . . 0.0 115.392 -7.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.804 ' HB2' HD13 ' A' ' 7' ' ' LEU . 18.1 m-70 -118.83 87.4 2.72 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 117.377 2.362 . . . . 0.0 117.377 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.673 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -103.4 140.28 37.66 Favored 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 122.429 2.377 . . . . 0.0 110.695 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.499 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.4 m -118.1 116.27 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 121.43 3.863 . . . . 0.0 121.43 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.4 m -75.9 165.4 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 102.223 -3.251 . . . . 0.0 102.223 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.022 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.28 130.97 55.5 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.46 93.77 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.188 1 N-CA-C 124.16 4.874 . . . . 0.0 124.16 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.0 6.8 43.34 Favored 'General case' 0 CA--C 1.602 2.965 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.84 -65.63 1.17 Allowed 'General case' 0 CA--C 1.573 1.848 0 C-N-CA 127.537 2.335 . . . . 0.0 112.707 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.684 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.7 mp -86.63 66.58 9.54 Favored 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.38 151.23 0.74 Allowed Pre-proline 0 N--CA 1.523 3.179 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.7 Cg_endo -42.36 -58.26 1.31 Allowed 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 123.398 2.732 . . . . 0.0 115.133 170.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.45 67.36 0.72 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 124.027 1.87 . . . . 0.0 107.067 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.18 53.51 0.99 Allowed 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 112.346 -2.206 . . . . 0.0 108.204 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.87 56.95 0.76 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.671 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.58 -47.91 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 117.252 2.315 . . . . 0.0 117.252 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.08 -30.9 0.16 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.218 -1.551 . . . . 0.0 111.584 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 55' ' ' LEU . 2.9 pp -41.16 -28.53 0.1 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 122.696 1.236 . . . . 0.0 112.478 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.505 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.83 -27.64 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.48 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.03 -55.54 0.3 Allowed 'General case' 0 N--CA 1.534 3.748 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.77 -28.91 0.17 Allowed 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.022 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.71 -66.76 0.34 Allowed 'General case' 0 CA--C 1.603 2.984 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.831 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.01 98.32 2.05 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 125.356 1.462 . . . . 0.0 112.803 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.694 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.0 -172.97 3.7 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.694 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.39 155.12 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.59 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.0 tt0 105.55 65.93 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 120.258 3.429 . . . . 0.0 120.258 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.584 HD23 ' CG ' ' B' ' 118' ' ' PRO . 6.0 mp 38.21 84.3 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 120.793 3.627 . . . . 0.0 120.793 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.673 ' N ' HD21 ' A' ' 40' ' ' ASN . 35.0 mt -70.76 82.13 0.63 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.137 -1.602 . . . . 0.0 111.818 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . 1.422 ' CE ' ' O ' ' B' ' 118' ' ' PRO . 42.3 mmm -79.29 62.0 3.53 Favored 'General case' 0 N--CA 1.512 2.647 0 CA-C-O 126.069 2.842 . . . . 0.0 110.886 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.0 m -112.53 65.89 0.84 Allowed Pre-proline 0 C--N 1.284 -2.259 0 CA-C-N 110.53 -3.032 . . . . 0.0 113.667 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HG2' ' OD2' ' B' ' 100' ' ' ASP . 21.7 Cg_endo -51.91 81.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.466 0 C-N-CA 122.932 2.422 . . . . 0.0 114.696 -177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.08 6.58 27.81 Favored Glycine 1 N--CA 1.516 4.03 0 O-C-N 122.18 -0.325 . . . . 0.0 113.613 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.56 156.84 34.97 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 124.366 2.031 . . . . 0.0 116.352 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.438 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -116.95 156.38 27.52 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 119.703 3.223 . . . . 0.0 119.703 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -115.95 147.9 40.64 Favored 'General case' 0 N--CA 1.52 3.07 0 CA-C-O 116.711 -1.614 . . . . 0.0 107.192 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.44 143.67 41.89 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 118.36 2.726 . . . . 0.0 118.36 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.7 m -119.94 102.64 8.7 Favored 'General case' 0 N--CA 1.514 2.772 0 CA-C-N 114.227 -1.351 . . . . 0.0 113.584 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.455 ' OG1' HG23 ' A' ' 28' ' ' THR . 48.8 m -94.7 152.2 18.66 Favored 'General case' 0 N--CA 1.526 3.341 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' N ' HG22 ' A' ' 75' ' ' THR . 90.7 m-85 -107.98 168.33 8.04 Favored Pre-proline 0 N--CA 1.504 2.244 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.037 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.36 -174.78 1.52 Allowed 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 121.023 1.149 . . . . 0.0 111.12 161.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.77 18.97 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 124.364 2.03 . . . . 0.0 107.246 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.09 42.55 0.48 Allowed 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 111.24 -2.709 . . . . 0.0 109.067 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.24 84.81 9.68 Favored Pre-proline 0 N--CA 1.501 2.075 0 CA-C-N 113.658 -1.61 . . . . 0.0 113.768 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 83' ' ' GLY . 47.5 Cg_endo -79.36 178.67 7.16 Favored 'Trans proline' 0 N--CA 1.503 2.085 0 C-N-CA 122.79 2.326 . . . . 0.0 112.276 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.598 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.11 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.86 0 C-N-CA 125.328 1.451 . . . . 0.0 113.291 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.539 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.4 124.92 5.6 Favored Glycine 0 N--CA 1.507 3.393 0 N-CA-C 121.739 3.455 . . . . 0.0 121.739 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.41 61.31 1.19 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.539 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.13 77.81 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.906 1.336 . . . . 0.0 113.006 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.8 m -63.46 135.94 57.25 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.53 136.54 52.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.568 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.71 82.11 8.57 Favored 'General case' 0 N--CA 1.511 2.618 1 N-CA-C 132.562 7.986 . . . . 0.0 132.562 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.94 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.495 2 CA-C-N 130.298 5.953 . . . . 0.0 114.346 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.0 tt0 -20.55 -72.35 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.586 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.417 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 36.8 Cg_endo -67.11 -3.34 9.61 Favored 'Trans proline' 0 N--CA 1.513 2.626 0 C-N-CA 122.359 2.039 . . . . 0.0 115.343 176.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -120.99 -14.12 8.49 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.458 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.35 79.71 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.51 -34.03 1.74 Allowed Glycine 1 N--CA 1.522 4.37 0 O-C-N 121.517 -0.739 . . . . 0.0 112.679 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.57 68.44 7.91 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 39.0 26.68 0.05 OUTLIER Glycine 1 N--CA 1.527 4.721 0 CA-C-N 114.018 -1.446 . . . . 0.0 116.573 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.567 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.57 43.92 1.18 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 124.52 2.105 . . . . 0.0 112.957 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.0 134.85 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 112.271 -2.24 . . . . 0.0 110.928 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.64 154.87 19.34 Favored Glycine 1 N--CA 1.535 5.295 0 CA-C-N 120.118 1.326 . . . . 0.0 114.039 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.57 81.91 1.77 Allowed 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 119.405 1.603 . . . . 0.0 115.246 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.68 123.31 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.737 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.8 m -112.64 88.73 2.89 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.155 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.446 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.2 t -74.02 105.18 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.25 -72.3 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 O-C-N 126.046 2.091 . . . . 0.0 115.929 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.598 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.532 0 O-C-N 125.547 1.78 . . . . 0.0 113.841 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' TRP . . . . . 0.458 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.9 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' GLN . . . . . 0.448 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.2 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.413 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 55.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.7 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.4 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 52.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 78.4 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.0 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.738 HG13 HG22 ' B' ' 50' ' ' VAL 0.386 0.2 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.488 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.9 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.613 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.6 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.5 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.974 ' CE1' HG22 ' B' ' 131' ' ' VAL . 51.5 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.738 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.5 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.411 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.1 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.411 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.2 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.8 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.424 HG12 ' N ' ' B' ' 69' ' ' GLY . 80.7 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.424 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.522 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.514 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.8 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.0 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' PRO . . . . . 0.859 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 17.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.859 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 46.4 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.478 HG22 HG11 ' B' ' 114' ' ' VAL 0.491 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.4 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.1 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.544 ' OD2' ' HG2' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.1 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 1.221 ' CZ ' ' HG2' ' A' ' 37' ' ' PRO . 17.3 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' GLN . . . . . 0.58 HE22 ' HA ' ' A' ' 36' ' ' VAL . 11.2 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' TYR . . . . . 0.448 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 25.0 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.7 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.478 HG11 HG22 ' B' ' 84' ' ' ILE . 16.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.514 HD11 HG23 ' B' ' 75' ' ' VAL 0.526 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.433 ' N ' HG23 ' B' ' 115' ' ' ILE 0.403 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.667 ' C ' ' HE1' ' A' ' 66' ' ' MET . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 1.584 ' CG ' HD23 ' A' ' 64' ' ' LEU . 38.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 66' ' ' MET . 81.3 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.8 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 90.0 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.521 ' C ' HG12 ' B' ' 131' ' ' VAL . 12.8 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 1.549 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.511 0.9 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' PRO . . . . . 0.647 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.4 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 139' ' ' ASP . . . . . 0.626 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.626 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.469 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' PHE . . . . . 0.647 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.5 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.361 1.5 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' HIS . . . . . 0.413 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.6 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.623 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.475 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.6 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' GLN . . . . . 0.666 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.3 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.398 0.6 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 162' ' ' PRO . . . . . 0.458 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.1 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.443 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 62.7 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.681 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 172' ' ' TYR . . . . . 0.681 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.2 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.3 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.405 HG22 ' N ' ' B' ' 178' ' ' GLY . 58.0 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.405 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 64.8 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.9 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 182' ' ' LYS . . . . . 0.406 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.406 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.7 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.433 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.822 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 199' ' ' ILE . . . . . 0.4 ' O ' HG13 ' B' ' 199' ' ' ILE 0.464 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.7 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.9 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.8 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.2 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 213' ' ' ALA . . . . . 0.443 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.443 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 12.2 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.3 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.9 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.423 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.8 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.6 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 234' ' ' ASN . . . . . 0.51 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.482 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.1 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.0 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.7 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.597 HD22 HD11 ' B' ' 142' ' ' ILE . 40.8 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.924 -1.036 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.455 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 69.7 m -61.51 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.963 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.408 ' HD2' HD11 ' A' ' 21' ' ' LEU . 10.8 m-85 -99.93 163.03 12.63 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.46 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.2 t -107.74 122.43 46.72 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.9 t -100.56 98.37 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.4 mmmt -67.35 65.37 0.07 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.894 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.807 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.9 mt -29.46 68.22 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 126.61 1.964 . . . . 0.0 115.517 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.45 59.01 0.4 Allowed Glycine 0 N--CA 1.51 3.584 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 11' ' ' LYS . 20.3 p -1.13 54.15 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.284 0 N-CA-C 120.32 3.452 . . . . 0.0 120.32 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.51 -60.23 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 119.539 3.163 . . . . 0.0 119.539 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.87 22.62 14.27 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.858 -1.151 . . . . 0.0 108.189 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.2 -94.81 1.89 Allowed Glycine 0 N--CA 1.512 3.721 0 N-CA-C 115.521 0.969 . . . . 0.0 115.521 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.6 tp -150.56 -177.14 5.8 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.597 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 15.4 mt -74.78 46.76 0.3 Allowed 'General case' 0 N--CA 1.509 2.506 0 O-C-N 120.716 -1.24 . . . . 0.0 111.261 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.727 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.6 p -113.79 165.59 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 118.464 2.764 . . . . 0.0 118.464 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.727 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.3 m-30 -102.22 75.41 1.49 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 112.142 -2.299 . . . . 0.0 113.431 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.343 0.6 OUTLIER -93.46 142.43 25.19 Favored Pre-proline 0 N--CA 1.506 2.347 0 O-C-N 121.805 -0.559 . . . . 0.0 111.754 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' LYS . 46.3 Cg_endo -86.46 76.22 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.39 0 N-CA-C 116.351 1.635 . . . . 0.0 116.351 -9.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.54 -44.17 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.841 1 N-CA-C 122.284 4.179 . . . . 0.0 122.284 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.648 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.61 71.69 1.0 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 122.408 1.099 . . . . 0.0 113.072 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.865 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.19 111.23 7.23 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.237 -1.539 . . . . 0.0 109.1 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.572 ' N ' HD23 ' A' ' 21' ' ' LEU . 46.1 m -87.42 81.41 7.84 Favored 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.865 HG23 HD22 ' A' ' 21' ' ' LEU . 4.4 pt -79.61 -177.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 CA-C-N 114.772 -1.103 . . . . 0.0 112.719 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.706 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -109.7 166.6 10.49 Favored Pre-proline 0 CA--C 1.566 1.569 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.135 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 19.9 Cg_endo -52.26 77.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.288 0 N-CA-C 116.903 1.847 . . . . 0.0 116.903 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.16 -50.59 0.51 Allowed Glycine 1 N--CA 1.522 4.419 0 C-N-CA 119.753 -1.213 . . . . 0.0 115.834 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.61 92.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.171 1 N-CA-C 122.227 4.158 . . . . 0.0 122.227 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 28' ' ' THR . 11.1 m -64.15 36.08 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -52.11 147.23 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 CA-C-N 112.878 -1.965 . . . . 0.0 111.475 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.28 154.87 27.21 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 123.978 1.847 . . . . 0.0 115.356 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.418 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.9 m-85 -107.53 113.83 27.41 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.65 112.49 24.89 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 120.792 3.627 . . . . 0.0 120.792 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -75.12 84.78 2.34 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.164 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 29.7 p30 -80.35 -45.06 18.4 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 118.904 2.928 . . . . 0.0 118.904 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.97 -169.33 3.35 Favored 'General case' 0 N--CA 1.509 2.491 0 C-N-CA 124.596 1.158 . . . . 0.0 109.068 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.815 ' HA ' ' OE1' ' B' ' 104' ' ' GLN . 1.6 m 12.91 70.62 0.11 Allowed Pre-proline 0 N--CA 1.519 3.01 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.328 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 55.3 Cg_endo -98.43 177.28 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.213 0 C-N-CA 123.908 3.072 . . . . 0.0 114.455 -165.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.713 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 52.3 Cg_endo -92.47 165.29 25.09 Favored 'Cis proline' 0 N--CA 1.503 2.069 0 N-CA-C 115.442 1.285 . . . . 0.0 115.442 -7.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.807 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.3 m-70 -118.96 87.46 2.74 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.729 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -103.37 140.2 37.76 Favored 'General case' 0 N--CA 1.516 2.827 0 CA-C-N 122.395 2.362 . . . . 0.0 110.744 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.5 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.3 m -118.11 116.22 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 121.476 3.88 . . . . 0.0 121.476 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.566 HG22 ' CB ' ' A' ' 88' ' ' TYR . 13.3 m -75.87 165.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.049 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.3 130.94 55.51 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.444 ' OD1' HD13 ' A' ' 47' ' ' LEU . 4.2 m-20 -53.4 93.71 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.183 1 N-CA-C 124.2 4.889 . . . . 0.0 124.2 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.98 6.8 43.28 Favored 'General case' 0 CA--C 1.602 2.957 0 N-CA-C 101.23 -3.619 . . . . 0.0 101.23 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -115.83 -65.53 1.18 Allowed 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 127.595 2.358 . . . . 0.0 112.704 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.5 mp -86.72 66.47 9.48 Favored 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 118.966 2.95 . . . . 0.0 118.966 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.43 151.22 0.74 Allowed Pre-proline 0 N--CA 1.522 3.167 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.505 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 17.4 Cg_endo -42.32 -58.31 1.28 Allowed 'Trans proline' 0 N--CA 1.508 2.376 0 C-N-CA 123.408 2.739 . . . . 0.0 115.085 170.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.637 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.48 67.46 0.72 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 124.034 1.873 . . . . 0.0 107.04 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -77.25 53.6 1.02 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 112.333 -2.212 . . . . 0.0 108.331 179.392 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.4 t -115.88 56.96 0.76 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.658 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.57 -47.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.11 -30.87 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.104 -1.622 . . . . 0.0 111.636 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 55' ' ' LEU . 2.9 pp -41.13 -28.5 0.09 Allowed 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 122.801 1.286 . . . . 0.0 112.561 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.86 -27.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.48 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.3 tptt 65.15 -55.62 0.31 Allowed 'General case' 0 N--CA 1.533 3.678 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.2 m -41.72 -28.9 0.16 Allowed 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.049 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.2 pp -53.74 -66.71 0.35 Allowed 'General case' 0 CA--C 1.603 3.017 0 N-CA-C 100.723 -3.806 . . . . 0.0 100.723 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.861 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 11.0 p -72.14 98.38 2.12 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.278 1.431 . . . . 0.0 112.816 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.702 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.5 t60 -89.96 -173.01 3.72 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.702 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.39 155.17 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.584 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 26.2 tt0 105.43 66.08 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 120.289 3.44 . . . . 0.0 120.289 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.855 HD12 ' H ' ' A' ' 64' ' ' LEU . 5.6 mp 38.1 84.27 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 120.803 3.631 . . . . 0.0 120.803 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.729 ' N ' HD21 ' A' ' 40' ' ' ASN . 36.3 mt -70.68 82.12 0.61 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.144 -1.597 . . . . 0.0 111.88 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . 1.27 ' HE2' ' O ' ' B' ' 118' ' ' PRO . 41.4 mmm -79.27 61.92 3.5 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-O 126.096 2.855 . . . . 0.0 110.918 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.524 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.9 m -112.52 65.95 0.84 Allowed Pre-proline 0 N--CA 1.505 2.298 0 CA-C-N 110.47 -3.059 . . . . 0.0 113.601 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.86 ' HG3' ' O ' ' B' ' 100' ' ' ASP . 19.3 Cg_endo -51.94 81.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.522 0 C-N-CA 122.979 2.452 . . . . 0.0 114.633 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.09 6.67 27.71 Favored Glycine 1 N--CA 1.516 4.021 0 O-C-N 122.203 -0.31 . . . . 0.0 113.606 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.66 156.82 35.17 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 124.389 2.042 . . . . 0.0 116.332 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.451 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.91 156.34 27.55 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 119.742 3.238 . . . . 0.0 119.742 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -115.9 147.97 40.52 Favored 'General case' 0 N--CA 1.52 3.048 0 CA-C-O 116.643 -1.646 . . . . 0.0 107.264 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.59 143.76 41.94 Favored 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 76.1 m -119.95 102.64 8.69 Favored 'General case' 0 N--CA 1.514 2.751 0 CA-C-N 114.221 -1.354 . . . . 0.0 113.525 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.443 ' OG1' HG23 ' A' ' 28' ' ' THR . 49.8 m -94.81 152.26 18.56 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.429 ' N ' HG22 ' A' ' 75' ' ' THR . 89.8 m-85 -107.97 168.33 8.05 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.067 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -72.36 -174.76 1.52 Allowed 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 121.009 1.14 . . . . 0.0 111.115 161.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.34 -19.78 18.98 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 124.301 2.001 . . . . 0.0 107.241 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.16 42.64 0.49 Allowed 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 111.246 -2.706 . . . . 0.0 109.059 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.84 9.84 Favored Pre-proline 0 N--CA 1.499 2.023 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.778 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 83' ' ' GLY . 38.0 Cg_endo -79.38 178.6 7.23 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.851 2.367 . . . . 0.0 112.298 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.604 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -15.97 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.889 0 C-N-CA 125.316 1.447 . . . . 0.0 113.262 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.51 125.08 5.64 Favored Glycine 0 N--CA 1.506 3.365 0 N-CA-C 121.703 3.441 . . . . 0.0 121.703 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.5 61.18 1.17 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.525 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.04 77.74 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.873 1.32 . . . . 0.0 113.068 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.4 m -63.36 135.92 57.31 Favored 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.583 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.47 136.55 52.89 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.566 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.6 m-85 -84.63 81.97 8.63 Favored 'General case' 0 N--CA 1.511 2.576 1 N-CA-C 132.625 8.009 . . . . 0.0 132.625 -179.33 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.7 t -63.84 82.21 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.447 2 CA-C-N 130.434 6.016 . . . . 0.0 114.298 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.5 tt0 -20.61 -72.48 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.61 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.838 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 31.7 Cg_endo -66.88 -3.55 9.71 Favored 'Trans proline' 0 N--CA 1.511 2.547 0 C-N-CA 122.419 2.079 . . . . 0.0 115.372 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -120.88 -14.08 8.54 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.501 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.45 79.75 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.53 -34.03 1.74 Allowed Glycine 1 N--CA 1.521 4.309 0 O-C-N 121.571 -0.706 . . . . 0.0 112.621 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.62 68.54 8.01 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.78 26.78 0.05 OUTLIER Glycine 1 N--CA 1.528 4.787 0 CA-C-N 114.004 -1.453 . . . . 0.0 116.636 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.573 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 1.8 ttt -108.53 43.76 1.2 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 124.51 2.1 . . . . 0.0 113.035 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.89 134.89 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 112.216 -2.266 . . . . 0.0 111.007 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.7 154.89 19.38 Favored Glycine 1 N--CA 1.535 5.269 0 C-N-CA 119.486 -1.34 . . . . 0.0 113.986 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.2 ttpp -118.63 81.96 1.78 Allowed 'General case' 0 N--CA 1.518 2.956 0 CA-C-N 119.404 1.602 . . . . 0.0 115.252 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.76 123.24 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -112.56 88.72 2.89 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.196 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.449 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.8 t -73.97 105.21 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.3 -72.3 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 O-C-N 126.051 2.094 . . . . 0.0 115.888 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.486 0 O-C-N 125.579 1.799 . . . . 0.0 113.861 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.838 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 24.1 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' TRP . . . . . 0.474 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' GLN . . . . . 0.471 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.0 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.2 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 89.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 54.2 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 77.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.3 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.84 HG13 HG22 ' B' ' 50' ' ' VAL 0.373 0.1 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.6 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.458 HG13 ' HD2' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.458 ' HD2' HG13 ' B' ' 36' ' ' VAL . 23.7 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.9 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.668 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 30.2 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 1.112 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.3 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.84 HG22 HG13 ' B' ' 34' ' ' VAL . 62.0 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.449 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.9 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.449 HG22 ' O ' ' B' ' 55' ' ' ASP . 15.1 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 82.9 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.452 HG12 ' N ' ' B' ' 69' ' ' GLY . 74.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.452 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.555 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.416 HG23 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.2 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' PRO . . . . . 1.052 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 24.8 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 1.052 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 43.0 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.568 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 94' ' ' LEU . 50.3 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.86 ' O ' ' HG3' ' A' ' 68' ' ' PRO . 24.3 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 1.328 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 17.2 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' GLN . . . . . 0.815 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 1.8 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.9 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.2 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.513 HG23 ' N ' ' B' ' 116' ' ' VAL 0.454 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 116' ' ' VAL . . . . . 0.513 ' N ' HG23 ' B' ' 115' ' ' ILE 0.254 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.576 ' C ' ' HE1' ' A' ' 66' ' ' MET . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 1.27 ' O ' ' HE2' ' A' ' 66' ' ' MET . 36.4 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.917 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 81.9 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.5 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 85.3 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.515 ' C ' HG12 ' B' ' 131' ' ' VAL . 19.8 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 1.556 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.348 0.5 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' B' ' 142' ' ' ILE . 35.7 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' PRO . . . . . 0.526 ' CG ' ' CZ ' ' B' ' 144' ' ' PHE . 18.2 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 139' ' ' ASP . . . . . 0.591 ' CG ' ' CG2' ' B' ' 142' ' ' ILE . 44.7 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.739 HD11 HD22 ' B' ' 249' ' ' LEU 0.511 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' PHE . . . . . 0.526 ' CZ ' ' CG ' ' B' ' 136' ' ' PRO . 81.3 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 69.0 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' B' ' 149' ' ' VAL . 1.3 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.627 HG11 ' CG2' ' B' ' 34' ' ' VAL . 10.7 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 155' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' B' ' 155' ' ' ARG . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.458 HH11 ' HD2' ' B' ' 157' ' ' ARG . 28.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 159' ' ' GLN . . . . . 0.683 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.7 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.31 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 162' ' ' PRO . . . . . 0.474 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 17.8 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 97.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.442 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 62.2 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.725 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.9 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 172' ' ' TYR . . . . . 0.725 ' N ' HD23 ' B' ' 171' ' ' LEU . 18.4 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.436 HG22 ' N ' ' B' ' 178' ' ' GLY . 61.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.436 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.4 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 182' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.6 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 183' ' ' ILE . . . . . 0.429 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 41.2 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.381 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.904 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 199' ' ' ILE . . . . . 0.642 HG13 ' O ' ' B' ' 199' ' ' ILE 0.52 0.3 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.6 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.2 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' ALA . . . . . 0.488 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 18.3 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.3 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.1 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.402 0.1 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.0 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' B' ' 231' ' ' LEU . 84.2 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 234' ' ' ASN . . . . . 0.545 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.507 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.6 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 19.4 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.739 HD22 HD11 ' B' ' 142' ' ' ILE . 41.4 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.605 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.488 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.5 m -61.53 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.029 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -99.95 163.08 12.6 Favored 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.83 122.39 46.69 Favored 'General case' 0 N--CA 1.525 3.305 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -100.49 98.38 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.7 mmmt -67.37 65.39 0.07 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 113.121 -1.854 . . . . 0.0 114.847 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.826 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.6 mt -29.59 68.29 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 126.53 1.932 . . . . 0.0 115.501 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.44 58.98 0.4 Allowed Glycine 0 N--CA 1.509 3.54 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.1 p -1.07 54.24 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 N-CA-C 120.187 3.402 . . . . 0.0 120.187 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.44 -60.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 119.513 3.153 . . . . 0.0 119.513 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.76 22.53 14.42 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.858 -1.151 . . . . 0.0 108.183 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.18 -94.77 1.89 Allowed Glycine 0 N--CA 1.512 3.713 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 44.6 tp -150.61 -177.2 5.84 Favored 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.532 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.2 mt -74.78 46.78 0.3 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 120.638 -1.289 . . . . 0.0 111.279 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.624 HG22 ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.85 165.68 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 118.596 2.813 . . . . 0.0 118.596 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.624 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.9 m-30 -102.23 75.42 1.49 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 112.2 -2.273 . . . . 0.0 113.389 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.308 12.3 mt-10 -93.47 142.43 25.2 Favored Pre-proline 0 N--CA 1.505 2.294 0 O-C-N 121.826 -0.546 . . . . 0.0 111.814 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.41 76.15 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.458 0 N-CA-C 116.328 1.626 . . . . 0.0 116.328 -9.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.59 -44.14 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 1 N-CA-C 122.344 4.201 . . . . 0.0 122.344 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.63 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.62 71.62 1.0 Allowed 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 122.364 1.078 . . . . 0.0 113.025 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.787 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.13 111.31 7.25 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.208 -1.557 . . . . 0.0 109.104 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.488 ' N ' HD23 ' A' ' 21' ' ' LEU . 49.4 m -87.49 81.46 7.78 Favored 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.787 HG23 HD22 ' A' ' 21' ' ' LEU . 5.3 pt -79.78 -177.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.692 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.613 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.66 166.51 10.65 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.198 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.6 Cg_endo -52.2 77.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.3 0 N-CA-C 116.91 1.85 . . . . 0.0 116.91 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.09 -50.44 0.52 Allowed Glycine 1 N--CA 1.523 4.449 0 C-N-CA 119.789 -1.196 . . . . 0.0 115.915 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.555 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.64 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.178 1 N-CA-C 122.151 4.13 . . . . 0.0 122.151 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 28' ' ' THR . 11.9 m -64.0 35.98 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.027 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.11 147.21 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 112.906 -1.952 . . . . 0.0 111.418 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 4.1 pt-20 -114.29 154.93 27.11 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 123.925 1.822 . . . . 0.0 115.324 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -107.53 113.79 27.35 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.76 112.57 25.0 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 120.758 3.614 . . . . 0.0 120.758 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -75.16 84.72 2.37 Favored 'General case' 0 N--CA 1.511 2.622 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.13 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.23 -45.11 18.55 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.553 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.93 -169.38 3.36 Favored 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 124.61 1.164 . . . . 0.0 109.086 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.845 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.7 m 12.92 70.63 0.11 Allowed Pre-proline 0 N--CA 1.521 3.098 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.454 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.4 177.28 0.41 Allowed 'Trans proline' 0 CA--C 1.569 2.241 0 C-N-CA 123.939 3.093 . . . . 0.0 114.416 -165.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.4 Cg_endo -92.5 165.31 25.0 Favored 'Cis proline' 0 N--CA 1.503 2.068 0 N-CA-C 115.398 1.268 . . . . 0.0 115.398 -7.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.826 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.89 87.46 2.74 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.64 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 1.0 OUTLIER -103.45 140.22 37.78 Favored 'General case' 0 N--CA 1.515 2.818 0 CA-C-N 122.456 2.389 . . . . 0.0 110.722 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 41' ' ' VAL . 7.2 m -118.08 116.31 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.564 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.8 m -75.95 165.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 102.19 -3.263 . . . . 0.0 102.19 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.03 ' HB2' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.3 130.93 55.51 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.32 93.77 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.221 1 N-CA-C 124.182 4.882 . . . . 0.0 124.182 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.4 ' C ' ' HB2' ' A' ' 51' ' ' LYS . . . -91.06 6.74 43.68 Favored 'General case' 0 CA--C 1.602 2.972 0 N-CA-C 101.168 -3.642 . . . . 0.0 101.168 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.8 -65.54 1.18 Allowed 'General case' 0 CA--C 1.573 1.853 0 C-N-CA 127.525 2.33 . . . . 0.0 112.718 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.56 9.53 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 118.915 2.932 . . . . 0.0 118.915 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.46 151.25 0.74 Allowed Pre-proline 0 N--CA 1.522 3.135 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.497 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.8 Cg_endo -42.51 -58.2 1.35 Allowed 'Trans proline' 0 N--CA 1.508 2.371 0 C-N-CA 123.438 2.758 . . . . 0.0 115.04 170.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.52 67.43 0.72 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 124.091 1.901 . . . . 0.0 107.072 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.412 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.28 53.55 1.02 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.256 -2.247 . . . . 0.0 108.222 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.8 56.94 0.76 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.7 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.58 -47.94 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.184 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.12 -30.85 0.16 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.113 -1.617 . . . . 0.0 111.545 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.548 ' HG ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 pp -41.22 -28.54 0.1 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.732 1.253 . . . . 0.0 112.485 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.489 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.82 -27.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.3 tptt 64.93 -55.47 0.3 Allowed 'General case' 0 N--CA 1.533 3.715 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -41.78 -28.86 0.17 Allowed 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.03 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.8 pp -53.74 -66.76 0.33 Allowed 'General case' 0 CA--C 1.604 3.022 0 N-CA-C 100.713 -3.81 . . . . 0.0 100.713 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.756 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.11 98.44 2.11 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 125.268 1.427 . . . . 0.0 112.781 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.671 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.3 t60 -90.05 -173.08 3.73 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.671 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.42 155.15 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 28.1 tt0 105.5 66.06 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.755 0 N-CA-C 120.313 3.449 . . . . 0.0 120.313 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.246 HD23 ' CG ' ' B' ' 118' ' ' PRO . 6.1 mp 38.13 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.518 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 36.2 mt -70.67 82.08 0.61 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.197 -1.564 . . . . 0.0 111.906 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.663 ' HE2' HD23 ' B' ' 119' ' ' LEU . 41.4 mmm -79.3 62.0 3.53 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 126.051 2.834 . . . . 0.0 110.867 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.4 m -112.58 65.84 0.85 Allowed Pre-proline 0 C--N 1.283 -2.287 0 CA-C-N 110.474 -3.057 . . . . 0.0 113.558 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HG2' ' OD2' ' B' ' 100' ' ' ASP . 19.5 Cg_endo -51.92 81.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.45 0 C-N-CA 122.959 2.439 . . . . 0.0 114.716 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.66 27.63 Favored Glycine 0 N--CA 1.516 3.991 0 O-C-N 122.131 -0.356 . . . . 0.0 113.603 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.8 tt0 -123.65 156.92 34.97 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 124.384 2.04 . . . . 0.0 116.273 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.435 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.98 156.37 27.58 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 119.722 3.23 . . . . 0.0 119.722 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -115.93 147.95 40.58 Favored 'General case' 0 N--CA 1.52 3.056 0 CA-C-O 116.636 -1.65 . . . . 0.0 107.194 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.46 143.74 41.81 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.2 m -120.02 102.57 8.63 Favored 'General case' 0 N--CA 1.513 2.719 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.532 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.457 ' OG1' HG23 ' A' ' 28' ' ' THR . 44.5 m -94.74 152.22 18.63 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.452 ' N ' HG22 ' A' ' 75' ' ' THR . 89.2 m-85 -107.97 168.27 8.13 Favored Pre-proline 0 N--CA 1.502 2.13 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.135 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.33 -174.77 1.51 Allowed 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.006 1.137 . . . . 0.0 111.122 161.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.45 -19.64 19.01 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-O 124.346 2.022 . . . . 0.0 107.216 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.25 42.72 0.5 Allowed 'General case' 0 CA--C 1.576 1.963 0 CA-C-N 111.249 -2.705 . . . . 0.0 109.036 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.29 84.73 9.68 Favored Pre-proline 0 N--CA 1.5 2.031 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.846 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -79.36 178.68 7.15 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 122.753 2.302 . . . . 0.0 112.226 173.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.604 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.04 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 125.294 1.437 . . . . 0.0 113.3 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.549 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.35 125.01 5.64 Favored Glycine 0 N--CA 1.508 3.472 0 N-CA-C 121.777 3.471 . . . . 0.0 121.777 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.44 61.15 1.18 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.549 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.8 m-85 -62.06 77.79 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 122.9 1.333 . . . . 0.0 112.984 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 6.9 m -63.46 135.91 57.23 Favored 'General case' 0 N--CA 1.51 2.561 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.526 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.43 136.51 52.93 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.564 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.64 81.96 8.63 Favored 'General case' 0 N--CA 1.511 2.617 1 N-CA-C 132.611 8.004 . . . . 0.0 132.611 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.0 t -63.82 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.471 2 CA-C-N 130.384 5.993 . . . . 0.0 114.34 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.6 tt0 -20.5 -72.4 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.62 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 29.6 Cg_endo -67.08 -3.45 9.76 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 122.406 2.071 . . . . 0.0 115.334 176.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -120.93 -14.16 8.51 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.442 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.23 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.782 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.58 -34.1 1.73 Allowed Glycine 1 N--CA 1.521 4.304 0 O-C-N 121.516 -0.74 . . . . 0.0 112.628 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.47 68.42 7.79 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.84 26.81 0.05 OUTLIER Glycine 1 N--CA 1.526 4.648 0 N-CA-C 116.616 1.407 . . . . 0.0 116.616 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.586 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.1 ttt -108.55 43.86 1.19 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 124.482 2.087 . . . . 0.0 112.966 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.03 134.88 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 112.233 -2.258 . . . . 0.0 110.973 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.65 154.86 19.34 Favored Glycine 1 N--CA 1.534 5.228 0 C-N-CA 119.525 -1.321 . . . . 0.0 114.032 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 ttpp -118.63 82.0 1.78 Allowed 'General case' 0 N--CA 1.518 2.925 0 CA-C-N 119.474 1.637 . . . . 0.0 115.188 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.74 123.29 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.5 m -112.67 88.77 2.9 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.197 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.3 t -74.05 105.23 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.35 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 O-C-N 126.066 2.104 . . . . 0.0 115.912 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.438 0 O-C-N 125.478 1.736 . . . . 0.0 113.835 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.28 21.9 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' TRP . . . . . 0.437 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.8 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.308 27.5 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.406 ' HE ' ' CE1' ' B' ' 150' ' ' HIS . 52.9 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.638 HG22 HG11 ' B' ' 151' ' ' VAL 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.5 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.557 HD22 ' N ' ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.367 22.0 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 33.0 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.786 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.411 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.8 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.418 HG12 ' N ' ' B' ' 69' ' ' GLY . 88.0 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.418 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.506 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 50.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' PRO . . . . . 0.719 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.1 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.719 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.2 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.512 HG22 HG11 ' B' ' 114' ' ' VAL 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' B' ' 130' ' ' PRO . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.5 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 68' ' ' PRO . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 1.454 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 20.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' GLN . . . . . 0.845 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.6 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.512 HG11 HG22 ' B' ' 84' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . 0.592 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 1.246 ' CG ' HD23 ' A' ' 64' ' ' LEU . 36.5 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.663 HD23 ' HE2' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.466 ' HB3' HD21 ' B' ' 94' ' ' LEU . 23.9 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.786 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.442 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' PRO . . . . . 0.691 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.327 23.8 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 139' ' ' ASP . . . . . 0.556 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.556 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.316 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' PHE . . . . . 0.691 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.418 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 150' ' ' HIS . . . . . 0.406 ' CE1' ' HE ' ' B' ' 14' ' ' ARG . 82.0 m-70 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.638 HG11 HG22 ' B' ' 34' ' ' VAL . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.501 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.526 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 162' ' ' PRO . . . . . 0.437 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 23.0 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.2 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.635 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 172' ' ' TYR . . . . . 0.635 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.363 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.739 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.256 25.7 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.625 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.8 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' ASN . . . . . 0.535 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.52 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 19.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.593 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 82.1 m -61.63 89.63 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.012 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -99.92 163.03 12.63 Favored 'General case' 0 N--CA 1.511 2.617 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.79 122.4 46.69 Favored 'General case' 0 N--CA 1.525 3.301 0 N-CA-C 117.179 2.288 . . . . 0.0 117.179 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.49 98.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.6 mmmt -67.36 65.41 0.07 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 113.144 -1.843 . . . . 0.0 114.828 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.846 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.6 mt -29.48 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 C-N-CA 126.575 1.95 . . . . 0.0 115.508 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.49 59.0 0.4 Allowed Glycine 0 N--CA 1.51 3.62 0 N-CA-C 106.897 -2.481 . . . . 0.0 106.897 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -1.05 54.08 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 120.324 3.453 . . . . 0.0 120.324 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.55 -60.25 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 119.494 3.146 . . . . 0.0 119.494 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.504 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.81 22.53 14.39 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 120.941 -1.099 . . . . 0.0 108.196 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.13 -94.8 1.9 Allowed Glycine 0 N--CA 1.511 3.694 0 N-CA-C 115.511 0.964 . . . . 0.0 115.511 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.496 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 44.4 tp -150.62 -177.16 5.82 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.531 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.2 mt -74.8 46.72 0.3 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 120.677 -1.264 . . . . 0.0 111.271 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.629 HG22 ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.76 165.69 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 118.578 2.807 . . . . 0.0 118.578 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.629 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.9 m-30 -102.26 75.39 1.48 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.364 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.307 12.4 mt-10 -93.45 142.46 25.24 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.81 -0.556 . . . . 0.0 111.746 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.41 76.13 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.459 0 N-CA-C 116.3 1.616 . . . . 0.0 116.3 -9.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.61 -44.19 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.807 1 N-CA-C 122.316 4.191 . . . . 0.0 122.316 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.61 71.62 1.0 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 122.484 1.135 . . . . 0.0 113.061 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.788 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.13 111.28 7.21 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.134 -1.604 . . . . 0.0 109.138 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.489 ' N ' HD23 ' A' ' 21' ' ' LEU . 50.6 m -87.49 81.43 7.79 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.788 HG23 HD22 ' A' ' 21' ' ' LEU . 5.3 pt -79.7 -177.57 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.689 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.623 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.49 10.68 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.133 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.4 Cg_endo -52.16 77.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.314 0 N-CA-C 116.97 1.873 . . . . 0.0 116.97 174.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.19 -50.5 0.51 Allowed Glycine 1 N--CA 1.522 4.403 0 C-N-CA 119.69 -1.243 . . . . 0.0 115.826 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.66 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.171 1 N-CA-C 122.149 4.129 . . . . 0.0 122.149 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 28' ' ' THR . 11.7 m -63.98 35.9 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.977 0 N-CA-C 118.726 2.861 . . . . 0.0 118.726 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.3 t -51.98 147.15 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 112.886 -1.961 . . . . 0.0 111.57 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 4.1 pt-20 -114.2 154.9 27.06 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 123.942 1.83 . . . . 0.0 115.442 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.54 113.84 27.43 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.56 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.79 112.49 24.92 Favored 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 120.686 3.587 . . . . 0.0 120.686 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -75.06 84.6 2.31 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.197 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.27 -45.03 18.62 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 118.919 2.933 . . . . 0.0 118.919 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.96 -169.38 3.36 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 124.619 1.167 . . . . 0.0 109.124 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.871 ' HA ' ' CE2' ' B' ' 102' ' ' TYR . 1.7 m 12.95 70.62 0.11 Allowed Pre-proline 0 N--CA 1.521 3.076 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.489 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.37 177.33 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.224 0 C-N-CA 123.941 3.094 . . . . 0.0 114.395 -165.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.3 Cg_endo -92.38 165.28 25.37 Favored 'Cis proline' 0 N--CA 1.504 2.104 0 N-CA-C 115.453 1.29 . . . . 0.0 115.453 -7.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.846 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.83 87.41 2.73 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 117.346 2.35 . . . . 0.0 117.346 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.707 HD21 ' N ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -103.44 140.25 37.73 Favored 'General case' 0 N--CA 1.516 2.863 0 CA-C-N 122.494 2.406 . . . . 0.0 110.681 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.1 m -118.11 116.26 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 121.386 3.847 . . . . 0.0 121.386 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.566 HG22 ' CB ' ' A' ' 88' ' ' TYR . 15.0 m -75.89 165.35 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 102.238 -3.245 . . . . 0.0 102.238 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.061 ' HB2' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.3 131.02 55.47 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.481 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.53 93.87 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.163 1 N-CA-C 124.149 4.87 . . . . 0.0 124.149 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.08 6.84 43.3 Favored 'General case' 0 CA--C 1.601 2.94 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.85 -65.5 1.18 Allowed 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 127.612 2.365 . . . . 0.0 112.753 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.9 mp -86.78 66.64 9.55 Favored 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 118.885 2.92 . . . . 0.0 118.885 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.48 151.22 0.73 Allowed Pre-proline 0 N--CA 1.522 3.137 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.7 Cg_endo -42.47 -58.24 1.33 Allowed 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 123.403 2.736 . . . . 0.0 115.079 170.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.45 67.34 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 124.063 1.887 . . . . 0.0 107.084 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.8 OUTLIER -77.06 53.39 0.96 Allowed 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.296 -2.229 . . . . 0.0 108.266 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.77 56.89 0.76 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.846 2.535 . . . . 0.0 117.846 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.709 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.49 -48.04 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.171 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.04 -30.93 0.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.098 -1.626 . . . . 0.0 111.584 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.551 ' HG ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 pp -41.08 -28.61 0.09 Allowed 'General case' 0 N--CA 1.509 2.501 0 CA-C-O 122.68 1.229 . . . . 0.0 112.524 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.81 -27.48 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.798 ' HE2' ' OE1' ' B' ' 189' ' ' GLU . 12.3 tptt 65.08 -55.64 0.3 Allowed 'General case' 0 N--CA 1.532 3.66 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.7 m -41.67 -28.93 0.16 Allowed 'General case' 0 N--CA 1.513 2.715 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.061 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.8 pp -53.69 -66.8 0.33 Allowed 'General case' 0 CA--C 1.604 3.038 0 N-CA-C 100.673 -3.825 . . . . 0.0 100.673 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.761 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.16 98.47 2.14 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.248 1.419 . . . . 0.0 112.78 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.685 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.07 -173.05 3.72 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.685 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.39 155.18 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 28.2 tt0 105.44 66.11 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 N-CA-C 120.281 3.437 . . . . 0.0 120.281 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.733 HD12 ' H ' ' A' ' 64' ' ' LEU . 6.1 mp 38.13 84.23 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 120.789 3.626 . . . . 0.0 120.789 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 65' ' ' LEU . 36.2 mt -70.6 81.99 0.6 Allowed 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.051 -1.655 . . . . 0.0 111.88 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . 1.374 ' CE ' ' HA ' ' B' ' 119' ' ' LEU . 41.2 mmm -79.18 61.94 3.44 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 126.052 2.834 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.0 m -112.55 65.94 0.85 Allowed Pre-proline 0 C--N 1.284 -2.277 0 CA-C-N 110.465 -3.061 . . . . 0.0 113.662 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -52.05 81.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.463 0 C-N-CA 123.001 2.468 . . . . 0.0 114.642 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.06 6.73 27.73 Favored Glycine 1 N--CA 1.516 4.007 0 O-C-N 122.115 -0.366 . . . . 0.0 113.619 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.502 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 36.0 tt0 -123.61 156.85 35.02 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 124.36 2.029 . . . . 0.0 116.326 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.434 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.96 156.37 27.55 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -115.95 147.89 40.67 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-O 116.518 -1.706 . . . . 0.0 107.247 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.45 143.76 41.77 Favored 'General case' 0 N--CA 1.529 3.511 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.0 m -119.95 102.52 8.61 Favored 'General case' 0 N--CA 1.514 2.769 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.546 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.463 ' OG1' HG23 ' A' ' 28' ' ' THR . 44.7 m -94.8 152.24 18.58 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.461 ' N ' HG22 ' A' ' 75' ' ' THR . 89.1 m-85 -107.9 168.33 8.05 Favored Pre-proline 0 N--CA 1.504 2.268 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.076 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.35 -174.84 1.54 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 121.058 1.172 . . . . 0.0 111.073 161.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.36 -19.74 18.99 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 124.289 1.995 . . . . 0.0 107.173 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.15 42.66 0.49 Allowed 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 111.286 -2.688 . . . . 0.0 109.132 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.34 84.83 9.9 Favored Pre-proline 0 N--CA 1.499 2.011 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.723 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.8 Cg_endo -79.45 178.59 7.22 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.83 2.354 . . . . 0.0 112.303 172.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.589 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.03 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 125.432 1.493 . . . . 0.0 113.243 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.546 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.33 124.99 5.63 Favored Glycine 0 N--CA 1.507 3.38 0 N-CA-C 121.792 3.477 . . . . 0.0 121.792 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.46 61.23 1.18 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.546 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.8 m-85 -62.13 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.924 1.345 . . . . 0.0 112.969 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 6.8 m -63.42 135.95 57.28 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.539 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.53 136.53 52.91 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.566 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.69 82.11 8.57 Favored 'General case' 0 N--CA 1.512 2.672 1 N-CA-C 132.536 7.976 . . . . 0.0 132.536 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.0 t -63.91 82.21 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.495 2 CA-C-N 130.343 5.974 . . . . 0.0 114.324 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.5 tt0 -20.6 -72.42 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.6 0 N-CA-C 118.518 2.784 . . . . 0.0 118.518 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.55 ' O ' ' CD2' ' B' ' 3' ' ' PHE . 29.5 Cg_endo -67.04 -3.41 9.65 Favored 'Trans proline' 0 N--CA 1.51 2.473 0 C-N-CA 122.361 2.04 . . . . 0.0 115.383 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -120.85 -14.18 8.54 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.457 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.35 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.55 -33.94 1.74 Allowed Glycine 1 N--CA 1.521 4.343 0 O-C-N 121.491 -0.756 . . . . 0.0 112.645 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.6 68.51 7.98 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.9 26.74 0.05 OUTLIER Glycine 1 N--CA 1.528 4.774 0 CA-C-N 114.0 -1.455 . . . . 0.0 116.631 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.605 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.1 ttm -108.63 43.9 1.19 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 124.539 2.114 . . . . 0.0 112.973 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.02 134.87 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 112.209 -2.269 . . . . 0.0 110.916 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.539 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.62 154.88 19.33 Favored Glycine 1 N--CA 1.536 5.36 0 C-N-CA 119.468 -1.349 . . . . 0.0 114.023 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 ttpp -118.63 81.95 1.77 Allowed 'General case' 0 N--CA 1.516 2.863 0 CA-C-N 119.408 1.604 . . . . 0.0 115.238 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.66 123.22 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.731 0 C-N-CA 118.061 -1.456 . . . . 0.0 107.087 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.5 m -112.59 88.74 2.89 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.177 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.47 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.2 t -74.08 105.15 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.16 -72.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 O-C-N 126.112 2.133 . . . . 0.0 115.93 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.589 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.534 0 O-C-N 125.555 1.785 . . . . 0.0 113.796 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.281 22.0 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.55 ' CD2' ' O ' ' A' ' 91' ' ' PRO . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.7 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.31 27.8 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.405 ' HE ' ' CE1' ' B' ' 150' ' ' HIS . 53.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.638 HG22 HG11 ' B' ' 151' ' ' VAL 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.557 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.368 22.4 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 33.0 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.785 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.411 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.418 HG12 ' N ' ' B' ' 69' ' ' GLY . 88.0 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.418 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.506 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 50.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' PRO . . . . . 0.72 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.72 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.2 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.512 HG22 HG11 ' B' ' 114' ' ' VAL 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.3 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' B' ' 130' ' ' PRO . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.7 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 1.489 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 20.7 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' GLN . . . . . 0.854 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.6 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.512 HG11 HG22 ' B' ' 84' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . 0.592 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 1.23 ' O ' ' HE1' ' A' ' 66' ' ' MET . 36.4 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 1.374 ' HA ' ' CE ' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.467 ' HB3' HD21 ' B' ' 94' ' ' LEU . 24.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.442 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' PRO . . . . . 0.693 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.328 23.8 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 139' ' ' ASP . . . . . 0.556 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.556 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.317 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 144' ' ' PHE . . . . . 0.693 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.418 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 150' ' ' HIS . . . . . 0.405 ' CE1' ' HE ' ' B' ' 14' ' ' ARG . 82.0 m-70 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.638 HG11 HG22 ' B' ' 34' ' ' VAL . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.503 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.0 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.525 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 162' ' ' PRO . . . . . 0.436 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 23.0 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.1 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.635 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 172' ' ' TYR . . . . . 0.635 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 189' ' ' GLU . . . . . 0.798 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.363 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.739 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.8 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.256 25.9 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.627 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' ASN . . . . . 0.537 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 19.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.493 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 82.5 m -61.65 89.68 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.022 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.95 163.01 12.63 Favored 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.462 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.72 122.41 46.68 Favored 'General case' 0 N--CA 1.526 3.326 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.5 t -100.57 98.36 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.7 mmmt -67.27 65.33 0.07 Allowed 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 113.144 -1.844 . . . . 0.0 114.9 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.833 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.7 mt -29.45 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 126.539 1.935 . . . . 0.0 115.531 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.48 59.04 0.4 Allowed Glycine 0 N--CA 1.51 3.576 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -0.95 54.0 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.61 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.84 22.57 14.34 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 120.956 -1.09 . . . . 0.0 108.154 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.22 -94.82 1.89 Allowed Glycine 0 N--CA 1.512 3.715 0 N-CA-C 115.499 0.96 . . . . 0.0 115.499 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.499 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 44.6 tp -150.59 -177.14 5.8 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.1 mt -74.77 46.65 0.3 Allowed 'General case' 0 N--CA 1.509 2.499 0 O-C-N 120.641 -1.287 . . . . 0.0 111.264 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.78 165.6 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.621 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.9 m-30 -102.17 75.43 1.5 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 112.263 -2.244 . . . . 0.0 113.423 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.307 12.4 mt-10 -93.51 142.43 25.18 Favored Pre-proline 0 N--CA 1.506 2.333 0 O-C-N 121.822 -0.549 . . . . 0.0 111.778 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.5 76.22 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.431 0 N-CA-C 116.4 1.654 . . . . 0.0 116.4 -9.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.63 -44.22 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.795 1 N-CA-C 122.319 4.192 . . . . 0.0 122.319 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.631 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.56 71.65 1.0 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 122.388 1.09 . . . . 0.0 113.066 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.804 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.1 111.2 7.13 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.131 -1.606 . . . . 0.0 109.099 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.485 ' N ' HD23 ' A' ' 21' ' ' LEU . 49.7 m -87.46 81.42 7.81 Favored 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.804 HG23 HD22 ' A' ' 21' ' ' LEU . 5.3 pt -79.72 -177.55 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.626 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.623 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.68 166.55 10.58 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-N 113.78 -1.554 . . . . 0.0 108.122 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.4 Cg_endo -52.22 77.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.318 0 N-CA-C 116.866 1.833 . . . . 0.0 116.866 174.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.07 -50.51 0.52 Allowed Glycine 1 N--CA 1.522 4.428 0 C-N-CA 119.717 -1.23 . . . . 0.0 115.879 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.563 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.73 92.11 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.184 1 N-CA-C 122.19 4.144 . . . . 0.0 122.19 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 28' ' ' THR . 11.9 m -64.1 36.07 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.019 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.8 t -52.11 147.17 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 CA-C-N 112.853 -1.976 . . . . 0.0 111.51 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 4.1 pt-20 -114.2 154.88 27.11 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 123.916 1.817 . . . . 0.0 115.38 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.52 113.81 27.39 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.554 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.67 112.6 25.02 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -75.17 84.74 2.37 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.159 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.33 -45.11 18.36 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.92 -169.25 3.33 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 124.662 1.185 . . . . 0.0 109.109 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.921 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.7 m 12.75 70.69 0.11 Allowed Pre-proline 0 N--CA 1.52 3.066 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.235 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.44 177.24 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.219 0 C-N-CA 123.99 3.127 . . . . 0.0 114.424 -165.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.6 Cg_endo -92.44 165.31 25.18 Favored 'Cis proline' 0 N--CA 1.503 2.048 0 N-CA-C 115.399 1.269 . . . . 0.0 115.399 -7.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.833 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.9 87.43 2.73 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -103.36 140.35 37.55 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 122.482 2.401 . . . . 0.0 110.664 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 41' ' ' VAL . 7.0 m -118.12 116.24 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 121.438 3.866 . . . . 0.0 121.438 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.562 HG22 ' CB ' ' A' ' 88' ' ' TYR . 15.0 m -75.92 165.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 102.258 -3.238 . . . . 0.0 102.258 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.046 ' HB2' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.32 130.97 55.51 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.483 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.41 93.78 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.168 1 N-CA-C 124.111 4.856 . . . . 0.0 124.111 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.07 6.8 43.47 Favored 'General case' 0 CA--C 1.602 2.967 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.81 -65.55 1.18 Allowed 'General case' 0 CA--C 1.574 1.889 0 C-N-CA 127.549 2.339 . . . . 0.0 112.723 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.71 66.45 9.47 Favored 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.37 151.27 0.75 Allowed Pre-proline 0 N--CA 1.523 3.182 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.8 Cg_endo -42.47 -58.28 1.32 Allowed 'Trans proline' 0 N--CA 1.507 2.324 0 C-N-CA 123.385 2.724 . . . . 0.0 115.079 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.43 67.4 0.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 124.069 1.89 . . . . 0.0 107.038 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.2 53.51 1.0 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 112.275 -2.239 . . . . 0.0 108.249 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.85 56.91 0.76 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.712 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.63 -47.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.244 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.17 -30.83 0.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.174 -1.579 . . . . 0.0 111.558 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.547 ' HG ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 pp -41.13 -28.59 0.1 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 122.693 1.235 . . . . 0.0 112.498 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.489 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.8 -27.57 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.628 ' HE2' ' OE1' ' B' ' 189' ' ' GLU . 12.3 tptt 65.06 -55.58 0.3 Allowed 'General case' 0 N--CA 1.532 3.632 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -41.68 -28.93 0.16 Allowed 'General case' 0 N--CA 1.515 2.785 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.046 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.8 pp -53.68 -66.79 0.33 Allowed 'General case' 0 CA--C 1.603 2.999 0 N-CA-C 100.711 -3.811 . . . . 0.0 100.711 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.762 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.14 98.39 2.12 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 125.33 1.452 . . . . 0.0 112.789 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.686 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -89.99 -173.0 3.71 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.686 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.37 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.611 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 28.0 tt0 105.45 65.9 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 120.346 3.462 . . . . 0.0 120.346 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.2 HD23 ' CG ' ' B' ' 118' ' ' PRO . 6.0 mp 38.24 84.26 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 120.762 3.616 . . . . 0.0 120.762 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.495 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 36.2 mt -70.65 82.04 0.6 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.18 -1.575 . . . . 0.0 111.812 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.904 ' HE3' HD23 ' B' ' 119' ' ' LEU . 41.2 mmm -79.28 62.0 3.52 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 126.158 2.885 . . . . 0.0 110.94 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.7 m -112.62 65.94 0.87 Allowed Pre-proline 0 N--CA 1.504 2.267 0 CA-C-N 110.486 -3.052 . . . . 0.0 113.577 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -51.98 81.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.987 2.458 . . . . 0.0 114.674 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.18 6.56 27.65 Favored Glycine 1 N--CA 1.516 4.028 0 O-C-N 122.209 -0.307 . . . . 0.0 113.604 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.9 tt0 -123.54 156.82 34.95 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 124.324 2.011 . . . . 0.0 116.368 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.82 156.35 27.42 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 119.694 3.22 . . . . 0.0 119.694 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -116.0 147.91 40.71 Favored 'General case' 0 N--CA 1.518 2.951 0 CA-C-O 116.59 -1.671 . . . . 0.0 107.222 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.49 143.62 42.03 Favored 'General case' 0 N--CA 1.529 3.515 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.5 m -119.89 102.56 8.65 Favored 'General case' 0 N--CA 1.515 2.8 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.569 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 76' ' ' PHE . 44.1 m -94.73 152.26 18.6 Favored 'General case' 0 N--CA 1.524 3.246 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.465 ' N ' HG22 ' A' ' 75' ' ' THR . 89.2 m-85 -107.96 168.4 7.95 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.068 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.41 -174.77 1.53 Allowed 'Trans proline' 0 CA--C 1.558 1.708 0 C-N-CA 121.012 1.141 . . . . 0.0 111.116 161.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.38 -19.75 18.97 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 124.34 2.019 . . . . 0.0 107.222 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.17 42.63 0.49 Allowed 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 111.195 -2.729 . . . . 0.0 109.106 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.18 84.75 9.51 Favored Pre-proline 0 N--CA 1.5 2.028 0 CA-C-N 113.603 -1.635 . . . . 0.0 113.841 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -79.4 178.68 7.13 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.77 2.313 . . . . 0.0 112.354 172.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.588 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.11 77.75 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 C-N-CA 125.367 1.467 . . . . 0.0 113.244 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.54 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.4 125.03 5.64 Favored Glycine 0 N--CA 1.508 3.487 0 N-CA-C 121.694 3.438 . . . . 0.0 121.694 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.8 mt-10 -99.49 61.26 1.17 Allowed 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.54 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.8 m-85 -62.1 77.69 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 122.884 1.326 . . . . 0.0 113.07 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 6.8 m -63.29 135.89 57.33 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.536 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.49 136.58 52.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.562 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.7 82.05 8.59 Favored 'General case' 0 N--CA 1.511 2.607 1 N-CA-C 132.617 8.006 . . . . 0.0 132.617 -179.334 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.1 t -63.93 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.499 2 CA-C-N 130.355 5.98 . . . . 0.0 114.295 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.5 tt0 -20.53 -72.44 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.565 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.562 ' O ' ' CD2' ' B' ' 3' ' ' PHE . 29.5 Cg_endo -66.98 -3.51 9.79 Favored 'Trans proline' 0 N--CA 1.511 2.548 0 C-N-CA 122.467 2.112 . . . . 0.0 115.363 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -120.86 -14.16 8.54 Favored 'General case' 0 N--CA 1.51 2.565 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.34 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.52 -34.0 1.74 Allowed Glycine 1 N--CA 1.52 4.292 0 O-C-N 121.534 -0.729 . . . . 0.0 112.735 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.59 68.41 7.93 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.93 26.73 0.05 OUTLIER Glycine 1 N--CA 1.527 4.733 0 CA-C-N 114.035 -1.439 . . . . 0.0 116.605 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.603 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.1 ttt -108.51 43.81 1.19 Allowed 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 124.406 2.05 . . . . 0.0 113.0 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.01 134.85 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 112.247 -2.251 . . . . 0.0 110.968 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.536 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.68 154.87 19.36 Favored Glycine 1 N--CA 1.535 5.24 0 C-N-CA 119.435 -1.364 . . . . 0.0 114.013 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 ttpp -118.58 81.97 1.77 Allowed 'General case' 0 N--CA 1.517 2.907 0 CA-C-N 119.405 1.602 . . . . 0.0 115.242 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.75 123.28 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.743 0 C-N-CA 118.0 -1.48 . . . . 0.0 107.026 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.5 m -112.57 88.75 2.9 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.228 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.471 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.3 t -74.01 105.19 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.26 -72.37 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.643 0 O-C-N 126.121 2.138 . . . . 0.0 115.885 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.588 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.48 0 O-C-N 125.43 1.706 . . . . 0.0 113.889 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.281 21.7 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 91' ' ' PRO . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' TRP . . . . . 0.437 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.7 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.31 27.6 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.408 ' HE ' ' CE1' ' B' ' 150' ' ' HIS . 52.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.638 HG22 HG11 ' B' ' 151' ' ' VAL 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.557 HD22 ' N ' ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.369 22.0 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 33.1 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.783 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.41 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.418 HG12 ' N ' ' B' ' 69' ' ' GLY . 87.8 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.418 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.505 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 50.2 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' PRO . . . . . 0.719 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.0 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.719 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.3 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.511 HG22 HG11 ' B' ' 114' ' ' VAL 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' B' ' 130' ' ' PRO . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.6 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 1.235 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 20.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' GLN . . . . . 0.921 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.6 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.511 HG11 HG22 ' B' ' 84' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . 0.591 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 1.2 ' CG ' HD23 ' A' ' 64' ' ' LEU . 36.5 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.904 HD23 ' HE3' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 93.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.467 ' HB3' HD21 ' B' ' 94' ' ' LEU . 24.1 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.783 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.441 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' PRO . . . . . 0.693 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.328 23.5 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 139' ' ' ASP . . . . . 0.556 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.556 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.316 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' PHE . . . . . 0.693 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.417 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 150' ' ' HIS . . . . . 0.408 ' CE1' ' HE ' ' B' ' 14' ' ' ARG . 82.0 m-70 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.638 HG11 HG22 ' B' ' 34' ' ' VAL . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.502 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.524 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 162' ' ' PRO . . . . . 0.437 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 22.9 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.1 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.634 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 172' ' ' TYR . . . . . 0.634 ' N ' HD23 ' B' ' 171' ' ' LEU . 18.9 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 189' ' ' GLU . . . . . 0.628 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.362 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.739 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.7 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.257 25.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.627 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 234' ' ' ASN . . . . . 0.536 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.521 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.0 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.48 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 91.2 m -61.63 89.73 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.975 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -100.01 162.97 12.64 Favored 'General case' 0 N--CA 1.513 2.683 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.462 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.8 t -107.71 122.49 46.83 Favored 'General case' 0 N--CA 1.526 3.331 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.0 t -100.62 98.38 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.46 65.53 0.08 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.834 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.0 mt -29.67 68.27 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.996 0 C-N-CA 126.54 1.936 . . . . 0.0 115.493 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.46 59.1 0.4 Allowed Glycine 0 N--CA 1.51 3.583 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -1.13 54.15 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.256 0 N-CA-C 120.282 3.438 . . . . 0.0 120.282 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.44 -60.15 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 119.538 3.162 . . . . 0.0 119.538 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.508 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.5 14.42 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.931 -1.106 . . . . 0.0 108.164 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.11 -94.83 1.9 Allowed Glycine 0 N--CA 1.512 3.75 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.3 tp -150.62 -177.16 5.81 Favored 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.554 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.8 mt -74.73 46.7 0.3 Allowed 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.67 -1.269 . . . . 0.0 111.3 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.665 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.74 165.66 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.665 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.22 75.35 1.49 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.402 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.283 7.4 mt-10 -93.46 142.46 25.24 Favored Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 121.825 -0.547 . . . . 0.0 111.753 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 20' ' ' LYS . 53.9 Cg_endo -86.46 76.14 0.09 OUTLIER 'Cis proline' 0 CA--C 1.571 2.364 0 N-CA-C 116.353 1.636 . . . . 0.0 116.353 -9.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.74 -44.26 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 1 N-CA-C 122.241 4.163 . . . . 0.0 122.241 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.636 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.58 71.59 1.0 Allowed 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 122.413 1.101 . . . . 0.0 113.1 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.8 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.16 111.31 7.27 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.199 -1.563 . . . . 0.0 109.111 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.516 ' N ' HD23 ' A' ' 21' ' ' LEU . 55.9 m -87.52 81.47 7.76 Favored 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.8 HG23 HD22 ' A' ' 21' ' ' LEU . 4.9 pt -79.66 -177.55 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.742 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.643 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.51 10.66 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 113.887 -1.506 . . . . 0.0 108.115 179.397 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.0 Cg_endo -52.12 77.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.304 0 N-CA-C 116.934 1.859 . . . . 0.0 116.934 174.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.11 -50.45 0.52 Allowed Glycine 1 N--CA 1.522 4.423 0 C-N-CA 119.706 -1.235 . . . . 0.0 115.857 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.65 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.167 1 N-CA-C 122.08 4.104 . . . . 0.0 122.08 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 28' ' ' THR . 12.6 m -64.09 35.96 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.96 147.21 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 112.862 -1.972 . . . . 0.0 111.51 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.9 pt-20 -114.3 154.86 27.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 123.92 1.819 . . . . 0.0 115.35 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.404 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.7 m-85 -107.46 113.8 27.38 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.69 112.5 24.91 Favored 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 120.728 3.603 . . . . 0.0 120.728 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -75.17 84.73 2.38 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.156 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.6 p30 -80.31 -44.97 18.64 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -150.01 -169.34 3.35 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 124.643 1.177 . . . . 0.0 109.097 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.959 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.7 m 12.81 70.69 0.11 Allowed Pre-proline 0 N--CA 1.52 3.046 0 N-CA-C 117.168 2.285 . . . . 0.0 117.168 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.561 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 56.3 Cg_endo -98.41 177.19 0.42 Allowed 'Trans proline' 0 CA--C 1.569 2.263 0 C-N-CA 124.041 3.161 . . . . 0.0 114.372 -165.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 56.5 Cg_endo -92.45 165.24 25.16 Favored 'Cis proline' 0 N--CA 1.503 2.063 0 N-CA-C 115.399 1.269 . . . . 0.0 115.399 -7.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.825 ' HB2' HD13 ' A' ' 7' ' ' LEU . 17.5 m-70 -118.88 87.44 2.73 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.993 HD22 ' HA ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -103.34 140.27 37.65 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 122.421 2.373 . . . . 0.0 110.716 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.497 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.9 m -118.16 116.31 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 121.431 3.863 . . . . 0.0 121.431 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.558 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.7 m -75.98 165.4 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.027 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.26 130.89 55.52 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.4 93.71 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.208 1 N-CA-C 124.205 4.891 . . . . 0.0 124.205 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.94 6.7 43.57 Favored 'General case' 0 CA--C 1.602 2.959 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.81 -65.54 1.18 Allowed 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 127.501 2.32 . . . . 0.0 112.668 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.677 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.62 66.46 9.49 Favored 'General case' 0 N--CA 1.518 2.949 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.36 151.28 0.75 Allowed Pre-proline 0 N--CA 1.522 3.158 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.6 Cg_endo -42.51 -58.3 1.32 Allowed 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 123.389 2.726 . . . . 0.0 115.025 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.51 67.47 0.72 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 124.15 1.928 . . . . 0.0 107.056 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.2 53.5 1.0 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 112.267 -2.242 . . . . 0.0 108.219 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.82 56.81 0.76 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.675 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.46 -48.01 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.13 -30.85 0.17 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.127 -1.608 . . . . 0.0 111.606 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.12 -28.6 0.1 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.649 1.214 . . . . 0.0 112.461 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.76 -27.7 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.14 -55.57 0.31 Allowed 'General case' 0 N--CA 1.534 3.752 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -41.69 -28.94 0.16 Allowed 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.027 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.6 pp -53.68 -66.82 0.32 Allowed 'General case' 0 CA--C 1.604 3.035 0 N-CA-C 100.697 -3.816 . . . . 0.0 100.697 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.802 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.9 p -72.06 98.42 2.09 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 125.267 1.427 . . . . 0.0 112.814 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.673 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.1 t60 -90.02 -173.03 3.72 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.673 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.42 155.2 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.317 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.597 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.1 tt0 105.43 66.02 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 120.309 3.448 . . . . 0.0 120.309 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.993 ' HA ' HD22 ' A' ' 40' ' ' ASN . 6.0 mp 38.19 84.25 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 120.748 3.61 . . . . 0.0 120.748 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.3 mt -70.66 82.04 0.61 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.145 -1.597 . . . . 0.0 111.865 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.982 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 42.2 mmm -79.21 61.94 3.46 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 126.074 2.845 . . . . 0.0 110.965 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.9 m -112.53 65.96 0.85 Allowed Pre-proline 0 C--N 1.284 -2.262 0 CA-C-N 110.464 -3.062 . . . . 0.0 113.601 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.695 ' HB2' ' OD2' ' B' ' 100' ' ' ASP . 21.3 Cg_endo -51.98 81.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.507 0 C-N-CA 122.964 2.442 . . . . 0.0 114.675 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.17 6.69 27.55 Favored Glycine 1 N--CA 1.517 4.056 0 O-C-N 122.238 -0.289 . . . . 0.0 113.513 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.8 tt0 -123.61 156.8 35.11 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 124.34 2.019 . . . . 0.0 116.349 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.439 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.83 156.37 27.4 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 119.716 3.228 . . . . 0.0 119.716 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.7 t -116.06 147.88 40.8 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-O 116.682 -1.628 . . . . 0.0 107.199 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.45 143.72 41.83 Favored 'General case' 0 N--CA 1.529 3.503 0 N-CA-C 118.347 2.721 . . . . 0.0 118.347 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.3 m -119.88 102.62 8.7 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.517 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 28' ' ' THR . 51.7 m -94.85 152.22 18.57 Favored 'General case' 0 N--CA 1.525 3.297 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' N ' HG22 ' A' ' 75' ' ' THR . 90.0 m-85 -107.95 168.28 8.12 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.059 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -72.27 -174.8 1.51 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 121.03 1.153 . . . . 0.0 111.157 161.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.35 -19.76 18.99 Favored 'General case' 0 N--CA 1.509 2.504 0 CA-C-O 124.384 2.04 . . . . 0.0 107.286 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.14 42.72 0.49 Allowed 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 111.225 -2.716 . . . . 0.0 109.111 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.38 84.74 9.88 Favored Pre-proline 0 N--CA 1.499 2.008 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.809 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 83' ' ' GLY . 42.4 Cg_endo -79.39 178.63 7.2 Favored 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 122.753 2.302 . . . . 0.0 112.275 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.596 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -15.99 77.69 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 125.348 1.459 . . . . 0.0 113.264 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.544 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.43 125.01 5.63 Favored Glycine 0 N--CA 1.507 3.417 0 N-CA-C 121.74 3.456 . . . . 0.0 121.74 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.9 mt-10 -99.51 61.25 1.17 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.544 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.9 m-85 -62.05 77.79 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 122.904 1.335 . . . . 0.0 113.032 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 7.2 m -63.42 135.95 57.29 Favored 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.53 136.51 52.92 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.558 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.64 82.07 8.58 Favored 'General case' 0 N--CA 1.512 2.672 1 N-CA-C 132.559 7.985 . . . . 0.0 132.559 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.711 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.6 t -63.85 82.23 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.498 2 CA-C-N 130.329 5.968 . . . . 0.0 114.314 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.1 tt0 -20.57 -72.45 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.56 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.406 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 35.6 Cg_endo -67.04 -3.43 9.69 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.326 2.017 . . . . 0.0 115.401 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -120.84 -14.12 8.56 Favored 'General case' 0 N--CA 1.511 2.585 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.23 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.53 -33.91 1.75 Allowed Glycine 1 N--CA 1.52 4.266 0 O-C-N 121.535 -0.728 . . . . 0.0 112.657 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.64 68.42 7.98 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.92 26.7 0.05 OUTLIER Glycine 1 N--CA 1.526 4.636 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.581 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.5 43.87 1.19 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 124.559 2.123 . . . . 0.0 113.023 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.94 134.91 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 112.19 -2.277 . . . . 0.0 110.902 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.7 154.88 19.38 Favored Glycine 1 N--CA 1.536 5.347 0 C-N-CA 119.489 -1.339 . . . . 0.0 113.978 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.7 82.0 1.78 Allowed 'General case' 0 N--CA 1.518 2.94 0 CA-C-N 119.371 1.585 . . . . 0.0 115.192 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.473 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.69 123.33 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.4 m -112.7 88.75 2.9 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.193 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.456 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.2 t -73.98 105.21 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.35 -72.26 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 O-C-N 126.132 2.145 . . . . 0.0 115.942 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.596 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.486 0 O-C-N 125.49 1.744 . . . . 0.0 113.811 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' TRP . . . . . 0.45 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.9 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' GLN . . . . . 0.429 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 62.6 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.6 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.442 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 56.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.5 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 55.5 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.5 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.1 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.63 HG22 HG11 ' B' ' 151' ' ' VAL 0.399 1.4 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.6 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 25.8 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.591 HD22 ' N ' ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.5 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 86.9 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.969 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.4 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.582 HG22 HG13 ' B' ' 34' ' ' VAL . 61.1 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.3 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.8 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.421 HG12 ' N ' ' B' ' 69' ' ' GLY . 86.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.421 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' LEU . . . . . 0.515 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.505 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.2 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.9 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' PRO . . . . . 0.779 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 19.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.779 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 44.1 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ILE . . . . . 0.58 HG22 HG11 ' B' ' 114' ' ' VAL 0.384 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 37.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 72.6 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 50.4 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.8 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.695 ' OD2' ' HB2' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 1.561 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 19.1 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' GLN . . . . . 0.959 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.6 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 23.9 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 56.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.58 HG11 HG22 ' B' ' 84' ' ' ILE . 16.5 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.505 HD11 HG23 ' B' ' 75' ' ' VAL 0.727 0.0 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.68 0.1 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' PRO . . . . . 0.839 ' CG ' HD23 ' A' ' 64' ' ' LEU . 38.0 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.982 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 82.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.5 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 94.4 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.969 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.5 1.5 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' PRO . . . . . 0.653 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 13.0 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 139' ' ' ASP . . . . . 0.629 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.629 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.393 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' PHE . . . . . 0.653 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.0 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.6 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.426 1.2 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 150' ' ' HIS . . . . . 0.442 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.63 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.495 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' GLN . . . . . 0.666 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.2 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.457 1.3 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 162' ' ' PRO . . . . . 0.45 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 20.2 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.461 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 64.3 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' LEU . . . . . 0.664 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 172' ' ' TYR . . . . . 0.664 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.6 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.4 HG22 ' N ' ' B' ' 178' ' ' GLY . 58.5 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.4 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.8 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.1 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 43.8 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.444 0.9 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.791 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.366 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 81.0 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.8 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 88.3 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.9 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.391 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.6 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' ASN . . . . . 0.501 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.4 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' ASN . . . . . 0.475 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 22.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.6 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.2 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 249' ' ' LEU . . . . . 0.436 HD22 HD11 ' B' ' 142' ' ' ILE . 41.0 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 118.159 -0.924 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.3 m -61.55 89.7 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -99.99 163.04 12.61 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.47 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.82 122.41 46.72 Favored 'General case' 0 N--CA 1.525 3.321 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -100.49 98.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.33 65.38 0.07 Allowed 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 113.14 -1.845 . . . . 0.0 114.855 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.3 mt -29.52 68.27 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 126.521 1.929 . . . . 0.0 115.543 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.44 59.01 0.4 Allowed Glycine 0 N--CA 1.509 3.539 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.1 p -1.0 54.04 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.33 0 N-CA-C 120.242 3.423 . . . . 0.0 120.242 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.53 -60.19 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.49 14.43 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.962 -1.086 . . . . 0.0 108.151 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.06 -94.86 1.91 Allowed Glycine 0 N--CA 1.512 3.75 0 N-CA-C 115.546 0.978 . . . . 0.0 115.546 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.553 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.9 tp -150.64 -177.13 5.8 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.557 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.6 mt -74.8 46.73 0.3 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.654 -1.279 . . . . 0.0 111.244 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.655 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.83 165.64 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 118.503 2.779 . . . . 0.0 118.503 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.655 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.25 75.35 1.48 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 112.187 -2.279 . . . . 0.0 113.356 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.47 142.47 25.25 Favored Pre-proline 0 N--CA 1.507 2.376 0 O-C-N 121.822 -0.549 . . . . 0.0 111.735 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 20' ' ' LYS . 56.3 Cg_endo -86.43 76.09 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.426 0 N-CA-C 116.359 1.638 . . . . 0.0 116.359 -9.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.73 -44.23 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 1 N-CA-C 122.3 4.185 . . . . 0.0 122.3 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.638 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.62 71.66 1.0 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 122.433 1.111 . . . . 0.0 113.092 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.808 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.11 111.27 7.19 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.152 -1.592 . . . . 0.0 109.107 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.524 ' N ' HD23 ' A' ' 21' ' ' LEU . 52.6 m -87.51 81.5 7.76 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.808 HG23 HD22 ' A' ' 21' ' ' LEU . 4.7 pt -79.7 -177.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.652 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.646 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.69 166.58 10.51 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-N 113.769 -1.559 . . . . 0.0 108.067 179.455 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.4 Cg_endo -52.18 77.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.571 2.326 0 N-CA-C 116.947 1.864 . . . . 0.0 116.947 174.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.13 -50.48 0.52 Allowed Glycine 1 N--CA 1.522 4.414 0 C-N-CA 119.73 -1.224 . . . . 0.0 115.833 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.71 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.151 1 N-CA-C 122.104 4.113 . . . . 0.0 122.104 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 28' ' ' THR . 11.5 m -64.01 35.91 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.012 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.95 147.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 112.863 -1.971 . . . . 0.0 111.517 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.9 pt-20 -114.29 154.93 27.12 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 123.934 1.826 . . . . 0.0 115.359 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.415 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.6 m-85 -107.55 113.86 27.46 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.79 112.57 25.02 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 120.636 3.569 . . . . 0.0 120.636 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -75.13 84.75 2.35 Favored 'General case' 0 N--CA 1.512 2.645 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.18 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.7 p30 -80.26 -45.14 18.44 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.9 -169.29 3.34 Favored 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 124.661 1.184 . . . . 0.0 109.118 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.62 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.6 m 12.82 70.7 0.11 Allowed Pre-proline 0 N--CA 1.521 3.079 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.458 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 58.4 Cg_endo -98.4 177.24 0.41 Allowed 'Trans proline' 0 CA--C 1.569 2.261 0 C-N-CA 123.945 3.096 . . . . 0.0 114.422 -165.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.602 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 58.2 Cg_endo -92.41 165.28 25.29 Favored 'Cis proline' 0 N--CA 1.504 2.105 0 N-CA-C 115.402 1.27 . . . . 0.0 115.402 -7.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.818 ' HB2' HD13 ' A' ' 7' ' ' LEU . 17.9 m-70 -118.88 87.44 2.73 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.615 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -103.4 140.29 37.66 Favored 'General case' 0 N--CA 1.516 2.832 0 CA-C-N 122.469 2.395 . . . . 0.0 110.719 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.498 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.5 m -118.11 116.25 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 121.419 3.859 . . . . 0.0 121.419 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.567 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.5 m -75.95 165.35 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.033 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.26 131.02 55.47 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.436 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.47 93.77 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.174 1 N-CA-C 124.148 4.87 . . . . 0.0 124.148 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.98 6.76 43.43 Favored 'General case' 0 CA--C 1.602 2.97 0 N-CA-C 101.23 -3.618 . . . . 0.0 101.23 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.84 -65.57 1.18 Allowed 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 127.526 2.33 . . . . 0.0 112.669 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.681 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.47 9.49 Favored 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.41 151.25 0.74 Allowed Pre-proline 0 N--CA 1.523 3.181 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.0 Cg_endo -42.51 -58.17 1.36 Allowed 'Trans proline' 0 N--CA 1.508 2.359 0 C-N-CA 123.362 2.708 . . . . 0.0 115.102 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.543 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.51 67.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 124.066 1.888 . . . . 0.0 107.062 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.16 53.5 0.99 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 112.275 -2.239 . . . . 0.0 108.208 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.87 56.89 0.76 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.773 2.508 . . . . 0.0 117.773 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.672 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.51 -48.0 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.13 -30.85 0.16 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.106 -1.622 . . . . 0.0 111.571 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.514 HD12 ' C ' ' A' ' 55' ' ' LEU . 2.9 pp -41.16 -28.52 0.1 Allowed 'General case' 0 N--CA 1.509 2.501 0 CA-C-O 122.716 1.246 . . . . 0.0 112.475 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.497 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.81 -27.63 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.466 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.04 -55.59 0.3 Allowed 'General case' 0 N--CA 1.533 3.691 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -41.68 -28.93 0.16 Allowed 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.033 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.72 -66.71 0.34 Allowed 'General case' 0 CA--C 1.603 3.019 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.806 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.6 p -72.18 98.47 2.15 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.273 1.429 . . . . 0.0 112.765 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.669 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.03 -173.1 3.74 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.669 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.43 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.365 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.591 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.1 tt0 105.52 65.99 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 120.292 3.441 . . . . 0.0 120.292 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.778 HD12 ' H ' ' A' ' 64' ' ' LEU . 5.9 mp 38.13 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.615 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 35.2 mt -70.64 82.05 0.6 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.101 -1.624 . . . . 0.0 111.886 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 1.312 ' CE ' ' CD2' ' B' ' 119' ' ' LEU . 41.9 mmm -79.23 61.97 3.48 Favored 'General case' 0 N--CA 1.511 2.579 0 CA-C-O 126.021 2.82 . . . . 0.0 110.913 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.6 m -112.61 65.98 0.87 Allowed Pre-proline 0 C--N 1.283 -2.287 0 CA-C-N 110.525 -3.034 . . . . 0.0 113.585 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.679 ' CG ' ' OD2' ' B' ' 100' ' ' ASP . 21.9 Cg_endo -52.03 81.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.461 0 C-N-CA 122.945 2.43 . . . . 0.0 114.699 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.64 27.66 Favored Glycine 0 N--CA 1.516 3.973 0 O-C-N 122.177 -0.327 . . . . 0.0 113.637 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.55 156.94 34.76 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 124.321 2.01 . . . . 0.0 116.367 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -117.05 156.34 27.71 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 119.628 3.195 . . . . 0.0 119.628 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -115.89 147.97 40.5 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-O 116.603 -1.665 . . . . 0.0 107.236 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.5 143.71 41.91 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 118.383 2.734 . . . . 0.0 118.383 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.4 m -119.94 102.54 8.63 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.543 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.451 ' OG1' HG23 ' A' ' 28' ' ' THR . 48.4 m -94.73 152.18 18.66 Favored 'General case' 0 N--CA 1.526 3.334 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.429 ' N ' HG22 ' A' ' 75' ' ' THR . 90.3 m-85 -107.92 168.31 8.08 Favored Pre-proline 0 N--CA 1.503 2.184 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.09 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -72.35 -174.74 1.51 Allowed 'Trans proline' 0 CA--C 1.559 1.747 0 C-N-CA 120.994 1.129 . . . . 0.0 111.149 161.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.77 18.96 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 124.41 2.052 . . . . 0.0 107.235 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.13 42.61 0.49 Allowed 'General case' 0 CA--C 1.577 1.984 0 CA-C-N 111.265 -2.698 . . . . 0.0 109.097 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.27 84.74 9.66 Favored Pre-proline 0 N--CA 1.5 2.032 0 CA-C-N 113.608 -1.633 . . . . 0.0 113.768 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 83' ' ' GLY . 45.9 Cg_endo -79.41 178.68 7.13 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.73 2.287 . . . . 0.0 112.245 172.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.6 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.05 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.91 0 C-N-CA 125.29 1.436 . . . . 0.0 113.333 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.529 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.41 125.01 5.63 Favored Glycine 0 N--CA 1.508 3.456 0 N-CA-C 121.76 3.464 . . . . 0.0 121.76 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.9 mt-10 -99.43 61.2 1.18 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.529 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.07 77.75 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 122.93 1.348 . . . . 0.0 113.013 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.7 m -63.41 135.97 57.31 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.555 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.51 136.52 52.91 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.567 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.61 82.05 8.59 Favored 'General case' 0 N--CA 1.512 2.627 1 N-CA-C 132.634 8.013 . . . . 0.0 132.634 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.94 82.19 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.438 2 CA-C-N 130.343 5.974 . . . . 0.0 114.313 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.1 tt0 -20.52 -72.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.459 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 36.6 Cg_endo -67.07 -3.43 9.72 Favored 'Trans proline' 0 N--CA 1.511 2.517 0 C-N-CA 122.383 2.056 . . . . 0.0 115.356 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -120.91 -14.13 8.52 Favored 'General case' 0 N--CA 1.511 2.594 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.466 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.25 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.64 -34.16 1.72 Allowed Glycine 1 N--CA 1.521 4.324 0 O-C-N 121.518 -0.739 . . . . 0.0 112.643 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.42 68.44 7.75 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.94 26.63 0.05 OUTLIER Glycine 1 N--CA 1.527 4.71 0 N-CA-C 116.665 1.426 . . . . 0.0 116.665 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.558 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.46 43.84 1.19 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 124.524 2.107 . . . . 0.0 113.016 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.96 134.81 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 112.313 -2.221 . . . . 0.0 110.954 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.62 154.9 19.34 Favored Glycine 1 N--CA 1.535 5.289 0 C-N-CA 119.49 -1.338 . . . . 0.0 113.997 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.61 81.91 1.77 Allowed 'General case' 0 N--CA 1.517 2.912 0 CA-C-N 119.488 1.644 . . . . 0.0 115.226 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.463 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.74 123.31 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 C-N-CA 118.03 -1.468 . . . . 0.0 107.044 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.9 m -112.65 88.76 2.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.15 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.442 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.1 t -74.06 105.27 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.39 -72.25 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.627 0 O-C-N 126.095 2.122 . . . . 0.0 115.885 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.6 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.484 0 O-C-N 125.526 1.766 . . . . 0.0 113.84 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 24.3 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' TRP . . . . . 0.455 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.447 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.449 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 53.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.7 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.4 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.606 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 52.8 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.528 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 78.4 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.698 HG13 HG22 ' B' ' 50' ' ' VAL 0.389 0.4 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.49 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.7 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 25.8 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.605 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.7 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.0 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.963 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.3 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.698 HG22 HG13 ' B' ' 34' ' ' VAL . 61.3 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.403 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.403 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.4 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.424 HG12 ' N ' ' B' ' 69' ' ' GLY . 81.4 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.424 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.519 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.591 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.5 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.9 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 0.825 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 17.9 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.825 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 44.3 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.52 HG22 HG11 ' B' ' 114' ' ' VAL 0.463 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.679 ' OD2' ' CG ' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.1 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 1.458 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 18.4 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' GLN . . . . . 0.62 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.6 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.447 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 23.3 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.9 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.52 HG11 HG22 ' B' ' 84' ' ' ILE . 16.7 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 1.578 ' CB ' ' CA ' ' B' ' 115' ' ' ILE 0.521 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.444 ' N ' HG23 ' B' ' 115' ' ' ILE 0.463 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.664 ' O ' ' CE ' ' A' ' 66' ' ' MET . 38.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 1.312 ' CD2' ' CE ' ' A' ' 66' ' ' MET . 81.7 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.8 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.494 ' C ' HG12 ' B' ' 131' ' ' VAL . 13.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.963 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.52 0.7 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.9 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.7 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' PRO . . . . . 0.659 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.7 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.636 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.636 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.453 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' PHE . . . . . 0.659 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.5 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.387 1.5 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' HIS . . . . . 0.449 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.61 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.485 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.6 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.665 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.1 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.417 0.8 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' PRO . . . . . 0.455 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.6 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.44 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 63.5 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.675 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' TYR . . . . . 0.675 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.7 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.402 HG22 ' N ' ' B' ' 178' ' ' GLY . 59.2 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.402 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.0 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.401 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.9 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.448 1.7 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.812 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.439 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.6 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' ALA . . . . . 0.43 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.43 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 12.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.4 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.417 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' ASN . . . . . 0.511 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.481 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 22.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.6 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.1 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.5 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.55 HD22 HD11 ' B' ' 142' ' ' ILE . 40.7 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 255' ' ' HEC . . . . . 0.606 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.596 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 85.4 m -61.52 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.02 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -100.0 163.01 12.62 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.467 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.75 122.44 46.75 Favored 'General case' 0 N--CA 1.525 3.32 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.4 t -100.57 98.32 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.34 65.4 0.07 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 113.096 -1.865 . . . . 0.0 114.893 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.2 mt -29.49 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 126.585 1.954 . . . . 0.0 115.512 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.45 59.09 0.4 Allowed Glycine 0 N--CA 1.51 3.609 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.4 p -1.09 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 120.31 3.448 . . . . 0.0 120.31 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.48 -60.16 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 119.551 3.167 . . . . 0.0 119.551 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.84 22.46 14.44 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 120.956 -1.09 . . . . 0.0 108.209 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.09 -94.85 1.91 Allowed Glycine 0 N--CA 1.511 3.672 0 N-CA-C 115.528 0.971 . . . . 0.0 115.528 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.543 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.7 tp -150.54 -177.13 5.79 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.558 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.7 mt -74.8 46.66 0.3 Allowed 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.627 -1.295 . . . . 0.0 111.247 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.672 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.74 165.73 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 118.575 2.805 . . . . 0.0 118.575 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.672 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.34 75.45 1.48 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.384 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.274 4.8 mt-10 -93.48 142.37 25.11 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.781 -0.574 . . . . 0.0 111.806 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 20' ' ' LYS . 55.9 Cg_endo -86.47 76.15 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.389 0 N-CA-C 116.352 1.635 . . . . 0.0 116.352 -9.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.68 -44.17 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.737 1 N-CA-C 122.238 4.162 . . . . 0.0 122.238 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.64 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.68 71.6 0.99 Allowed 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.442 1.115 . . . . 0.0 113.049 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.793 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.1 111.3 7.21 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.178 -1.576 . . . . 0.0 109.098 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.522 ' N ' HD23 ' A' ' 21' ' ' LEU . 54.6 m -87.48 81.38 7.81 Favored 'General case' 0 N--CA 1.514 2.728 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.793 HG23 HD22 ' A' ' 21' ' ' LEU . 4.8 pt -79.68 -177.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.675 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.652 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.72 166.54 10.59 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.104 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.5 Cg_endo -52.18 77.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.288 0 N-CA-C 116.921 1.854 . . . . 0.0 116.921 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.16 -50.44 0.52 Allowed Glycine 1 N--CA 1.522 4.414 0 C-N-CA 119.733 -1.222 . . . . 0.0 115.852 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.6 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.174 1 N-CA-C 122.101 4.112 . . . . 0.0 122.101 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 28' ' ' THR . 11.6 m -63.99 35.92 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.049 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.01 147.22 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.501 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.9 pt-20 -114.26 154.9 27.14 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 123.914 1.816 . . . . 0.0 115.41 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.402 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.4 m-85 -107.54 113.87 27.47 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.77 112.54 24.97 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 120.71 3.596 . . . . 0.0 120.71 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -75.2 84.72 2.39 Favored 'General case' 0 N--CA 1.511 2.599 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.18 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.5 p30 -80.18 -45.17 18.54 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.89 -169.29 3.34 Favored 'General case' 0 N--CA 1.508 2.467 0 C-N-CA 124.656 1.183 . . . . 0.0 109.111 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.069 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.6 m 12.89 70.68 0.11 Allowed Pre-proline 0 N--CA 1.52 3.055 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.169 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 57.7 Cg_endo -98.52 177.26 0.4 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 123.92 3.08 . . . . 0.0 114.324 -165.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 57.7 Cg_endo -92.44 165.32 25.18 Favored 'Cis proline' 0 N--CA 1.503 2.071 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 -7.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.81 ' HB2' HD13 ' A' ' 7' ' ' LEU . 17.9 m-70 -118.95 87.35 2.72 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.65 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -103.42 140.28 37.68 Favored 'General case' 0 N--CA 1.516 2.857 0 CA-C-N 122.418 2.372 . . . . 0.0 110.685 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.6 m -118.09 116.25 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 121.445 3.868 . . . . 0.0 121.445 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.564 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.7 m -75.88 165.44 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.033 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.28 130.96 55.5 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 46' ' ' ALA . 4.1 m-20 -53.53 93.82 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.185 1 N-CA-C 124.088 4.847 . . . . 0.0 124.088 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.94 6.74 43.44 Favored 'General case' 0 CA--C 1.602 2.952 0 N-CA-C 101.228 -3.619 . . . . 0.0 101.228 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.88 -65.49 1.18 Allowed 'General case' 0 CA--C 1.573 1.85 0 C-N-CA 127.519 2.328 . . . . 0.0 112.705 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.48 9.5 Favored 'General case' 0 N--CA 1.52 3.034 0 N-CA-C 118.91 2.93 . . . . 0.0 118.91 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.44 151.24 0.74 Allowed Pre-proline 0 N--CA 1.522 3.151 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.7 Cg_endo -42.42 -58.27 1.31 Allowed 'Trans proline' 0 N--CA 1.509 2.391 0 C-N-CA 123.376 2.717 . . . . 0.0 115.113 170.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.544 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.49 67.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 124.112 1.911 . . . . 0.0 107.04 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.16 53.49 0.99 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.344 -2.207 . . . . 0.0 108.265 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.81 56.96 0.75 Allowed 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.68 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.57 -47.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.14 -30.84 0.17 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.226 -1.546 . . . . 0.0 111.564 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 55' ' ' LEU . 2.9 pp -41.18 -28.53 0.1 Allowed 'General case' 0 N--CA 1.508 2.449 0 CA-C-O 122.77 1.272 . . . . 0.0 112.567 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.77 -27.58 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.01 -55.55 0.3 Allowed 'General case' 0 N--CA 1.533 3.691 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.76 -28.89 0.17 Allowed 'General case' 0 N--CA 1.515 2.818 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.033 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.69 -66.82 0.32 Allowed 'General case' 0 CA--C 1.603 3.013 0 N-CA-C 100.69 -3.819 . . . . 0.0 100.69 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.812 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.14 98.46 2.13 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 125.259 1.424 . . . . 0.0 112.806 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.691 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.1 t60 -90.01 -172.93 3.68 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.691 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.34 155.2 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.353 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.598 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.3 tt0 105.41 66.08 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.778 0 N-CA-C 120.285 3.439 . . . . 0.0 120.285 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.154 HD21 ' CZ ' ' B' ' 1' ' ' TYR . 5.9 mp 38.16 84.18 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 120.805 3.632 . . . . 0.0 120.805 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.65 ' N ' HD21 ' A' ' 40' ' ' ASN . 36.0 mt -70.59 82.08 0.59 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.225 -1.547 . . . . 0.0 111.876 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.582 ' SD ' ' HG3' ' A' ' 38' ' ' PRO . 42.1 mmm -79.29 62.02 3.54 Favored 'General case' 0 N--CA 1.51 2.536 0 CA-C-O 126.066 2.841 . . . . 0.0 110.945 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.2 m -112.65 65.92 0.87 Allowed Pre-proline 0 C--N 1.283 -2.295 0 CA-C-N 110.482 -3.053 . . . . 0.0 113.601 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -52.0 81.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.444 0 C-N-CA 122.98 2.453 . . . . 0.0 114.698 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.19 6.64 27.56 Favored Glycine 0 N--CA 1.515 3.963 0 O-C-N 122.195 -0.316 . . . . 0.0 113.573 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.4 tt0 -123.59 156.94 34.82 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 124.336 2.017 . . . . 0.0 116.331 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.439 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -117.01 156.32 27.69 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 119.641 3.2 . . . . 0.0 119.641 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.5 t -115.96 148.0 40.56 Favored 'General case' 0 N--CA 1.52 3.043 0 CA-C-O 116.633 -1.651 . . . . 0.0 107.229 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.55 143.78 41.86 Favored 'General case' 0 N--CA 1.529 3.512 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.8 m -119.96 102.57 8.65 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 114.146 -1.388 . . . . 0.0 113.575 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 28' ' ' THR . 48.8 m -94.71 152.19 18.67 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.422 ' N ' HG22 ' A' ' 75' ' ' THR . 90.3 m-85 -107.97 168.29 8.1 Favored Pre-proline 0 N--CA 1.504 2.233 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.114 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.35 -174.81 1.53 Allowed 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 120.989 1.126 . . . . 0.0 111.107 161.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.31 -19.82 18.97 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 124.336 2.017 . . . . 0.0 107.235 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.12 42.68 0.49 Allowed 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 111.285 -2.688 . . . . 0.0 109.097 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.79 9.78 Favored Pre-proline 0 N--CA 1.5 2.04 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.794 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 83' ' ' GLY . 44.6 Cg_endo -79.42 178.7 7.11 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.831 2.354 . . . . 0.0 112.23 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.593 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.17 77.73 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.921 0 C-N-CA 125.31 1.444 . . . . 0.0 113.265 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.44 125.1 5.65 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 121.757 3.463 . . . . 0.0 121.757 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.49 61.23 1.17 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.536 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.02 77.77 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.934 1.349 . . . . 0.0 113.049 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.5 136.0 57.27 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.557 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.5 136.57 52.87 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.564 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.76 82.05 8.6 Favored 'General case' 0 N--CA 1.511 2.587 1 N-CA-C 132.586 7.995 . . . . 0.0 132.586 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.83 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.465 2 CA-C-N 130.301 5.955 . . . . 0.0 114.293 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.0 tt0 -20.55 -72.42 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.605 0 N-CA-C 118.502 2.778 . . . . 0.0 118.502 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 36.4 Cg_endo -67.01 -3.54 9.86 Favored 'Trans proline' 0 N--CA 1.511 2.534 0 C-N-CA 122.382 2.055 . . . . 0.0 115.351 176.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -120.82 -14.14 8.56 Favored 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.446 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.37 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 116.625 2.084 . . . . 0.0 116.625 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.59 -33.95 1.74 Allowed Glycine 1 N--CA 1.52 4.291 0 O-C-N 121.57 -0.706 . . . . 0.0 112.682 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.62 68.47 7.98 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.92 26.71 0.05 OUTLIER Glycine 1 N--CA 1.527 4.7 0 CA-C-N 114.008 -1.451 . . . . 0.0 116.629 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.559 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.55 43.9 1.19 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 124.505 2.098 . . . . 0.0 113.071 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.96 134.92 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 112.193 -2.276 . . . . 0.0 110.943 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.61 154.85 19.32 Favored Glycine 1 N--CA 1.536 5.354 0 C-N-CA 119.484 -1.341 . . . . 0.0 113.977 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.59 81.99 1.78 Allowed 'General case' 0 N--CA 1.518 2.942 0 CA-C-N 119.4 1.6 . . . . 0.0 115.264 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.74 123.26 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.9 m -112.62 88.76 2.9 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.187 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.454 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.1 t -74.05 105.21 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.25 -72.36 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 O-C-N 126.039 2.087 . . . . 0.0 115.967 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.593 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.46 0 O-C-N 125.468 1.73 . . . . 0.0 113.819 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.154 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 60.5 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' TRP . . . . . 0.452 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.2 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.442 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.2 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.464 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 51.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.5 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 86.5 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.606 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 53.9 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.529 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 77.5 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.0 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.67 HG13 HG22 ' B' ' 50' ' ' VAL 0.39 0.7 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.492 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.3 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 25.5 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.599 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.6 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.6 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.99 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.5 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.67 HG22 HG13 ' B' ' 34' ' ' VAL . 61.2 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.5 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.422 HG12 ' N ' ' B' ' 69' ' ' GLY . 84.1 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.422 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.517 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.575 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.0 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 0.8 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 18.7 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.8 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 42.4 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.561 HG22 HG11 ' B' ' 114' ' ' VAL 0.427 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.0 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.2 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 1.169 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 19.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' GLN . . . . . 1.069 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.6 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 56.0 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.561 HG11 HG22 ' B' ' 84' ' ' ILE . 16.7 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 1.571 ' CB ' ' CA ' ' B' ' 115' ' ' ILE 0.687 0.0 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.462 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.414 ' HG2' ' CE ' ' A' ' 66' ' ' MET . 38.2 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 81.8 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.6 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 93.1 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.42 ' C ' HG12 ' B' ' 131' ' ' VAL . 13.6 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.99 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.494 1.1 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' PRO . . . . . 0.66 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.9 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.643 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.643 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.428 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' PHE . . . . . 0.66 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.7 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.408 1.4 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' HIS . . . . . 0.464 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.616 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.477 HH11 ' HD2' ' B' ' 157' ' ' ARG . 30.4 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.661 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.4 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.428 0.9 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' PRO . . . . . 0.452 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.7 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 63.0 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.67 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' TYR . . . . . 0.67 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.3 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.402 HG22 ' N ' ' B' ' 178' ' ' GLY . 58.8 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.402 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.2 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 43.1 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.45 1.5 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.804 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.409 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.0 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.5 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' ALA . . . . . 0.415 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.415 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 13.0 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.406 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' ASN . . . . . 0.516 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.481 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.6 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.503 HD22 HD11 ' B' ' 142' ' ' ILE . 40.8 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 118.051 -0.976 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 255' ' ' HEC . . . . . 0.606 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.472 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 79.6 m -61.59 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -99.93 163.02 12.63 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.77 122.34 46.56 Favored 'General case' 0 N--CA 1.525 3.322 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.5 t -100.54 98.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 8' ' ' GLY . 14.0 mmmt -67.39 65.48 0.07 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 113.109 -1.86 . . . . 0.0 114.857 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -29.54 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 126.641 1.976 . . . . 0.0 115.449 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.52 59.02 0.4 Allowed Glycine 0 N--CA 1.51 3.568 0 N-CA-C 106.849 -2.501 . . . . 0.0 106.849 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.2 p -1.15 54.22 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 120.21 3.411 . . . . 0.0 120.21 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.42 -60.19 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.75 22.39 14.56 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 120.917 -1.114 . . . . 0.0 108.193 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.08 -94.77 1.9 Allowed Glycine 0 N--CA 1.511 3.691 0 N-CA-C 115.519 0.968 . . . . 0.0 115.519 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.573 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 47.5 tp -150.63 -177.19 5.83 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.573 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 15.8 mt -74.73 46.71 0.3 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.6 -1.312 . . . . 0.0 111.286 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.693 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.8 p -113.75 165.64 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 118.53 2.789 . . . . 0.0 118.53 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.693 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.21 75.42 1.49 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.363 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.48 142.41 25.16 Favored Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.85 -0.531 . . . . 0.0 111.795 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 20' ' ' LYS . 58.4 Cg_endo -86.43 76.11 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.424 0 N-CA-C 116.365 1.64 . . . . 0.0 116.365 -9.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.7 -44.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 1 N-CA-C 122.319 4.192 . . . . 0.0 122.319 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.627 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.67 71.52 0.99 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 122.484 1.135 . . . . 0.0 113.064 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.817 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.02 111.26 7.11 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.116 -1.615 . . . . 0.0 109.107 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.542 ' N ' HD23 ' A' ' 21' ' ' LEU . 55.1 m -87.52 81.42 7.77 Favored 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.817 HG23 HD22 ' A' ' 21' ' ' LEU . 4.6 pt -79.57 -177.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.72 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.67 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.63 10.43 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.097 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 24.3 Cg_endo -52.33 77.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.287 0 N-CA-C 116.897 1.845 . . . . 0.0 116.897 174.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.17 -50.63 0.51 Allowed Glycine 1 N--CA 1.522 4.382 0 C-N-CA 119.682 -1.247 . . . . 0.0 115.836 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.56 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 1 N-CA-C 122.115 4.116 . . . . 0.0 122.115 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 28' ' ' THR . 11.2 m -64.07 35.96 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.018 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -51.96 147.19 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 112.849 -1.978 . . . . 0.0 111.513 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.24 154.89 27.13 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 124.011 1.862 . . . . 0.0 115.368 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.416 ' HB3' HD11 ' A' ' 7' ' ' LEU . 56.7 m-85 -107.51 113.88 27.5 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.585 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.1 tt -100.85 112.52 24.96 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 120.729 3.603 . . . . 0.0 120.729 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -75.16 84.7 2.37 Favored 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.111 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.7 p30 -80.29 -45.09 18.47 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.96 -169.31 3.34 Favored 'General case' 0 N--CA 1.509 2.522 0 C-N-CA 124.569 1.148 . . . . 0.0 109.048 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.243 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.6 m 12.89 70.61 0.11 Allowed Pre-proline 0 N--CA 1.521 3.11 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.608 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 64.2 Cg_endo -98.35 177.25 0.42 Allowed 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 123.994 3.129 . . . . 0.0 114.441 -165.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 60.9 Cg_endo -92.42 165.3 25.26 Favored 'Cis proline' 0 N--CA 1.503 2.037 0 N-CA-C 115.391 1.266 . . . . 0.0 115.391 -7.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.8 ' HB2' HD13 ' A' ' 7' ' ' LEU . 18.4 m-70 -118.96 87.37 2.72 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.754 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -103.33 140.26 37.66 Favored 'General case' 0 N--CA 1.516 2.868 0 CA-C-N 122.387 2.358 . . . . 0.0 110.675 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.4 m -118.13 116.3 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 121.406 3.854 . . . . 0.0 121.406 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.554 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.4 m -75.98 165.36 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 102.189 -3.263 . . . . 0.0 102.189 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.045 ' HB2' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.27 131.01 55.48 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.0 m-20 -53.42 93.73 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.19 1 N-CA-C 124.142 4.867 . . . . 0.0 124.142 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.97 6.72 43.58 Favored 'General case' 0 CA--C 1.602 2.948 0 N-CA-C 101.19 -3.633 . . . . 0.0 101.19 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.8 -65.48 1.18 Allowed 'General case' 0 CA--C 1.574 1.89 0 C-N-CA 127.592 2.357 . . . . 0.0 112.742 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.705 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.7 mp -86.75 66.59 9.53 Favored 'General case' 0 N--CA 1.519 3.023 0 N-CA-C 118.874 2.916 . . . . 0.0 118.874 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.39 151.26 0.75 Allowed Pre-proline 0 N--CA 1.522 3.17 0 N-CA-C 117.487 2.402 . . . . 0.0 117.487 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.1 Cg_endo -42.44 -58.25 1.32 Allowed 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 123.426 2.751 . . . . 0.0 115.088 170.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.54 67.38 0.72 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 124.119 1.914 . . . . 0.0 107.012 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.15 53.53 0.99 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 112.292 -2.231 . . . . 0.0 108.25 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.78 56.93 0.75 Allowed 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 117.8 2.519 . . . . 0.0 117.8 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.661 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.61 -47.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.262 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -41.21 -30.87 0.18 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.082 -1.636 . . . . 0.0 111.587 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.526 HD12 ' C ' ' A' ' 55' ' ' LEU . 2.9 pp -41.04 -28.64 0.09 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 122.787 1.279 . . . . 0.0 112.552 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.502 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.72 -27.68 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.481 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.13 -55.58 0.31 Allowed 'General case' 0 N--CA 1.533 3.705 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.7 -28.96 0.16 Allowed 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.045 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.4 pp -53.57 -66.9 0.31 Allowed 'General case' 0 CA--C 1.604 3.026 0 N-CA-C 100.688 -3.819 . . . . 0.0 100.688 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.851 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.09 98.47 2.11 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.227 1.411 . . . . 0.0 112.786 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.698 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.0 t60 -90.06 -173.01 3.7 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.698 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.42 155.23 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 26.5 tt0 105.45 65.97 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 120.315 3.45 . . . . 0.0 120.315 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.532 HD21 ' CE1' ' B' ' 1' ' ' TYR . 5.9 mp 38.26 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 120.769 3.618 . . . . 0.0 120.769 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.754 ' N ' HD21 ' A' ' 40' ' ' ASN . 35.3 mt -70.67 82.04 0.61 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.166 -1.584 . . . . 0.0 111.876 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . 1.022 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 42.5 mmm -79.16 61.9 3.41 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-O 126.066 2.841 . . . . 0.0 110.962 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.4 m -112.54 65.88 0.84 Allowed Pre-proline 0 N--CA 1.505 2.307 0 CA-C-N 110.482 -3.054 . . . . 0.0 113.597 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -51.87 81.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 122.985 2.457 . . . . 0.0 114.71 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.63 27.66 Favored Glycine 1 N--CA 1.517 4.07 0 O-C-N 122.209 -0.307 . . . . 0.0 113.579 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.4 tt0 -123.62 156.83 35.1 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 124.404 2.049 . . . . 0.0 116.285 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.437 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -116.87 156.46 27.28 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 119.748 3.24 . . . . 0.0 119.748 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -116.02 147.91 40.72 Favored 'General case' 0 N--CA 1.52 3.029 0 CA-C-O 116.651 -1.642 . . . . 0.0 107.253 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.51 143.63 42.05 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.6 m -119.84 102.54 8.65 Favored 'General case' 0 N--CA 1.514 2.747 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.632 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.452 ' OG1' HG23 ' A' ' 28' ' ' THR . 50.2 m -94.76 152.2 18.63 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.416 ' N ' HG22 ' A' ' 75' ' ' THR . 90.7 m-85 -107.93 168.33 8.06 Favored Pre-proline 0 N--CA 1.503 2.178 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.124 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.35 -174.85 1.54 Allowed 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 121.021 1.147 . . . . 0.0 111.109 161.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.33 -19.66 19.08 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 124.435 2.064 . . . . 0.0 107.334 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.22 42.71 0.5 Allowed 'General case' 0 CA--C 1.576 1.98 0 CA-C-N 111.187 -2.733 . . . . 0.0 109.045 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.68 9.67 Favored Pre-proline 0 N--CA 1.499 2.012 0 CA-C-N 113.675 -1.602 . . . . 0.0 113.761 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 83' ' ' GLY . 53.5 Cg_endo -79.31 178.62 7.23 Favored 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 122.803 2.335 . . . . 0.0 112.304 172.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.606 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.08 77.69 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.92 0 O-C-N 125.018 1.449 . . . . 0.0 113.346 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.37 124.98 5.63 Favored Glycine 0 N--CA 1.508 3.475 0 N-CA-C 121.746 3.459 . . . . 0.0 121.746 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.46 61.24 1.18 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.1 m-85 -62.0 77.8 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.872 1.32 . . . . 0.0 113.052 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.57 135.95 57.18 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.47 136.49 52.95 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.554 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.64 82.03 8.6 Favored 'General case' 0 N--CA 1.512 2.64 1 N-CA-C 132.637 8.014 . . . . 0.0 132.637 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.1 t -63.9 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.501 2 CA-C-N 130.342 5.974 . . . . 0.0 114.311 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.7 tt0 -20.52 -72.48 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.605 0 N-CA-C 118.468 2.766 . . . . 0.0 118.468 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.59 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 37.6 Cg_endo -66.97 -3.48 9.7 Favored 'Trans proline' 0 N--CA 1.512 2.569 0 C-N-CA 122.39 2.06 . . . . 0.0 115.352 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -120.87 -14.12 8.55 Favored 'General case' 0 N--CA 1.511 2.613 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.477 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.38 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.62 -34.06 1.73 Allowed Glycine 1 N--CA 1.52 4.296 0 O-C-N 121.616 -0.678 . . . . 0.0 112.7 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.56 68.46 7.91 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.86 26.74 0.05 OUTLIER Glycine 1 N--CA 1.526 4.677 0 CA-C-N 114.041 -1.436 . . . . 0.0 116.68 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.559 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 1.9 ttt -108.55 43.83 1.19 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 124.406 2.05 . . . . 0.0 112.957 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.99 134.89 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 112.275 -2.239 . . . . 0.0 110.945 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.66 154.85 19.35 Favored Glycine 1 N--CA 1.534 5.212 0 C-N-CA 119.523 -1.323 . . . . 0.0 114.059 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.56 81.86 1.76 Allowed 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.63 123.3 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.709 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.0 m -112.63 88.7 2.88 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.185 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.444 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.4 t -74.0 105.17 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.31 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 O-C-N 126.064 2.103 . . . . 0.0 115.933 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.606 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.521 0 O-C-N 125.576 1.798 . . . . 0.0 113.812 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.532 ' CE1' HD21 ' A' ' 64' ' ' LEU . 60.9 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.59 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 22.0 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' TRP . . . . . 0.462 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.0 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.459 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.3 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.499 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 88.7 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 50.9 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.529 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 79.5 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.1 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.783 HG13 HG22 ' B' ' 50' ' ' VAL 0.375 0.2 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.481 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.5 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.408 HG13 ' HD2' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.408 ' HD2' HG13 ' B' ' 36' ' ' VAL . 27.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.625 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.4 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.9 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 1.027 ' CE1' HG22 ' B' ' 131' ' ' VAL . 51.7 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.783 HG22 HG13 ' B' ' 34' ' ' VAL . 61.4 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.421 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.6 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.6 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.421 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.1 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.426 HG12 ' N ' ' B' ' 69' ' ' GLY . 79.1 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.426 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.526 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.507 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.3 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.1 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 0.914 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 14.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.914 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 46.6 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.513 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 74.2 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.4 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 17.7 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 1.608 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 17.0 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' GLN . . . . . 1.243 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.7 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.459 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 25.5 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.507 HD11 HG23 ' B' ' 75' ' ' VAL 0.54 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.466 ' N ' HG23 ' B' ' 115' ' ' ILE 0.411 0.1 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 1.282 ' CG ' HD23 ' A' ' 64' ' ' LEU . 38.7 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 1.022 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 81.1 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 57.2 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 90.8 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.481 ' C ' HG12 ' B' ' 131' ' ' VAL . 11.7 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 1.564 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.43 1.6 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.0 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' PRO . . . . . 0.623 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 10.6 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.607 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.66 HD11 HD22 ' B' ' 249' ' ' LEU 0.483 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' PHE . . . . . 0.623 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.6 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.3 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' B' ' 149' ' ' VAL 0.335 1.7 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.581 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.471 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.661 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.4 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.387 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' PRO . . . . . 0.462 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 18.5 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.8 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.44 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 62.3 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.692 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.8 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 172' ' ' TYR . . . . . 0.692 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.7 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.408 HG22 ' N ' ' B' ' 178' ' ' GLY . 59.4 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.408 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 64.1 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' LYS . . . . . 0.411 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.411 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.3 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.6 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.414 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.84 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 199' ' ' ILE . . . . . 0.46 ' O ' HG13 ' B' ' 199' ' ' ILE 0.482 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.6 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.3 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.2 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' ALA . . . . . 0.465 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.465 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 11.2 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 86.4 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.385 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.4 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' ASN . . . . . 0.503 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.472 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.0 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.9 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.66 HD22 HD11 ' B' ' 142' ' ' ILE . 40.5 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 255' ' ' HEC . . . . . 0.607 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.596 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.453 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 70.1 m -61.59 89.67 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.93 163.03 12.62 Favored 'General case' 0 N--CA 1.512 2.653 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.455 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.2 t -107.83 122.43 46.76 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.2 t -100.5 98.39 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.4 mmmt -67.34 65.32 0.07 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 113.086 -1.87 . . . . 0.0 114.888 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.806 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.9 mt -29.47 68.26 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 126.579 1.952 . . . . 0.0 115.459 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.42 59.06 0.4 Allowed Glycine 0 N--CA 1.509 3.552 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 20.3 p -1.12 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.259 0 N-CA-C 120.346 3.462 . . . . 0.0 120.346 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.49 -60.14 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 119.515 3.154 . . . . 0.0 119.515 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.85 22.48 14.43 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.957 -1.09 . . . . 0.0 108.116 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.07 -94.8 1.9 Allowed Glycine 0 N--CA 1.512 3.711 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.594 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.7 tp -150.66 -177.23 5.86 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.597 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.5 mt -74.72 46.74 0.3 Allowed 'General case' 0 N--CA 1.509 2.516 0 O-C-N 120.7 -1.25 . . . . 0.0 111.236 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.732 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.6 p -113.86 165.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.732 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.3 m-30 -102.12 75.43 1.51 Allowed 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 112.219 -2.264 . . . . 0.0 113.416 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.342 0.6 OUTLIER -93.47 142.39 25.14 Favored Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.853 -0.529 . . . . 0.0 111.746 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 20' ' ' LYS . 46.0 Cg_endo -86.49 76.11 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.466 0 N-CA-C 116.368 1.642 . . . . 0.0 116.368 -9.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.72 -44.22 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.806 1 N-CA-C 122.26 4.17 . . . . 0.0 122.26 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.645 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.65 71.68 1.0 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 122.412 1.101 . . . . 0.0 112.986 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.847 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.14 111.25 7.21 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.148 -1.595 . . . . 0.0 109.159 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.576 ' N ' HD23 ' A' ' 21' ' ' LEU . 47.7 m -87.52 81.53 7.74 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.847 HG23 HD22 ' A' ' 21' ' ' LEU . 4.4 pt -79.71 -177.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 114.75 -1.113 . . . . 0.0 112.699 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.705 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -109.67 166.55 10.58 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.126 179.388 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 19.9 Cg_endo -52.24 77.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.314 0 N-CA-C 116.833 1.82 . . . . 0.0 116.833 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.13 -50.41 0.52 Allowed Glycine 1 N--CA 1.522 4.42 0 C-N-CA 119.76 -1.209 . . . . 0.0 115.831 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.556 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.71 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 1 N-CA-C 122.11 4.115 . . . . 0.0 122.11 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 28' ' ' THR . 10.8 m -64.03 36.0 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.012 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.5 t -52.0 147.17 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.566 0 CA-C-N 112.821 -1.991 . . . . 0.0 111.5 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.19 154.91 27.05 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 123.923 1.82 . . . . 0.0 115.416 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.433 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.9 m-85 -107.57 113.84 27.42 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.1 tt -100.72 112.53 24.95 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 120.653 3.575 . . . . 0.0 120.653 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -75.13 84.69 2.35 Favored 'General case' 0 N--CA 1.513 2.689 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.162 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 29.9 p30 -80.27 -45.08 18.54 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 118.935 2.939 . . . . 0.0 118.935 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.95 -169.3 3.34 Favored 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 124.671 1.189 . . . . 0.0 109.077 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.105 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.6 m 12.79 70.72 0.11 Allowed Pre-proline 0 N--CA 1.52 3.029 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.344 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 55.3 Cg_endo -98.49 177.29 0.4 Allowed 'Trans proline' 0 CA--C 1.568 2.222 0 C-N-CA 123.984 3.123 . . . . 0.0 114.37 -165.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.717 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 52.2 Cg_endo -92.39 165.33 25.33 Favored 'Cis proline' 0 N--CA 1.502 2.029 0 N-CA-C 115.472 1.297 . . . . 0.0 115.472 -7.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.806 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.5 m-70 -118.96 87.52 2.75 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.963 HD22 ' HA ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -103.5 140.23 37.79 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 122.465 2.393 . . . . 0.0 110.663 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 6.4 m -118.09 116.41 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 121.446 3.869 . . . . 0.0 121.446 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.577 HG22 ' CB ' ' A' ' 88' ' ' TYR . 13.0 m -76.07 165.46 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 102.099 -3.297 . . . . 0.0 102.099 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.066 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.32 130.96 55.51 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.443 ' OD1' HD13 ' A' ' 47' ' ' LEU . 4.1 m-20 -53.45 93.82 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.212 1 N-CA-C 124.16 4.874 . . . . 0.0 124.16 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.09 6.8 43.47 Favored 'General case' 0 CA--C 1.602 2.979 0 N-CA-C 101.212 -3.625 . . . . 0.0 101.212 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.439 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -115.9 -65.43 1.19 Allowed 'General case' 0 CA--C 1.574 1.88 0 C-N-CA 127.445 2.298 . . . . 0.0 112.682 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.4 mp -86.65 66.53 9.51 Favored 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 118.902 2.927 . . . . 0.0 118.902 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.634 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.4 151.28 0.74 Allowed Pre-proline 0 N--CA 1.522 3.145 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 17.3 Cg_endo -42.41 -58.29 1.3 Allowed 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.405 2.736 . . . . 0.0 115.112 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.634 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.46 67.34 0.72 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 124.102 1.906 . . . . 0.0 107.077 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -77.13 53.6 0.99 Allowed 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.312 -2.222 . . . . 0.0 108.272 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 t -115.9 56.99 0.76 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.664 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.63 -47.99 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.256 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.07 -30.88 0.16 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.06 -1.65 . . . . 0.0 111.578 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 55' ' ' LEU . 2.9 pp -41.18 -28.53 0.1 Allowed 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 122.755 1.264 . . . . 0.0 112.487 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.83 -27.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 117.727 2.492 . . . . 0.0 117.727 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.479 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.3 tptt 65.05 -55.59 0.3 Allowed 'General case' 0 N--CA 1.533 3.71 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.1 m -41.68 -28.98 0.16 Allowed 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.066 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.2 pp -53.68 -66.82 0.33 Allowed 'General case' 0 CA--C 1.604 3.032 0 N-CA-C 100.71 -3.811 . . . . 0.0 100.71 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.862 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 11.1 p -72.07 98.45 2.1 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 125.259 1.424 . . . . 0.0 112.806 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.706 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.4 t60 -90.08 -173.01 3.7 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.706 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.4 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.591 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 26.0 tt0 105.51 65.97 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 120.303 3.445 . . . . 0.0 120.303 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.119 HD21 ' CE1' ' B' ' 1' ' ' TYR . 5.6 mp 38.11 84.33 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 120.745 3.609 . . . . 0.0 120.745 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 65' ' ' LEU . 36.5 mt -70.66 82.1 0.61 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.078 -1.639 . . . . 0.0 111.888 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.856 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 41.0 mmm -79.25 61.93 3.48 Favored 'General case' 0 N--CA 1.51 2.542 0 CA-C-O 126.057 2.837 . . . . 0.0 110.912 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.7 m -112.55 65.92 0.85 Allowed Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 110.543 -3.026 . . . . 0.0 113.621 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -51.95 81.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 122.933 2.422 . . . . 0.0 114.686 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.13 6.73 27.59 Favored Glycine 1 N--CA 1.517 4.036 0 O-C-N 122.251 -0.28 . . . . 0.0 113.541 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.68 156.91 35.02 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 124.374 2.035 . . . . 0.0 116.241 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.455 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.98 156.39 27.55 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 119.681 3.215 . . . . 0.0 119.681 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -116.01 147.96 40.66 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-O 116.678 -1.63 . . . . 0.0 107.215 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.56 143.79 41.85 Favored 'General case' 0 N--CA 1.53 3.546 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.9 m -119.99 102.62 8.67 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.52 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.439 ' OG1' HG23 ' A' ' 28' ' ' THR . 49.0 m -94.78 152.15 18.66 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.424 ' N ' HG22 ' A' ' 75' ' ' THR . 89.4 m-85 -107.91 168.29 8.11 Favored Pre-proline 0 N--CA 1.503 2.181 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.089 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -72.36 -174.83 1.54 Allowed 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 121.023 1.149 . . . . 0.0 111.121 161.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.73 19.0 Favored 'General case' 0 N--CA 1.51 2.535 0 CA-C-O 124.34 2.019 . . . . 0.0 107.237 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.17 42.68 0.49 Allowed 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 111.258 -2.701 . . . . 0.0 109.118 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.79 9.78 Favored Pre-proline 0 N--CA 1.5 2.069 0 CA-C-N 113.543 -1.662 . . . . 0.0 113.742 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 38.0 Cg_endo -79.39 178.64 7.18 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 122.817 2.345 . . . . 0.0 112.253 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.594 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.03 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 125.367 1.467 . . . . 0.0 113.24 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.44 125.01 5.63 Favored Glycine 0 N--CA 1.507 3.389 0 N-CA-C 121.787 3.475 . . . . 0.0 121.787 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.8 mt-10 -99.4 61.26 1.19 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.516 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.1 m-85 -62.05 77.75 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 122.95 1.357 . . . . 0.0 113.033 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.6 m -63.52 136.0 57.25 Favored 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.582 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.52 136.5 52.93 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.577 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.6 m-85 -84.62 82.02 8.6 Favored 'General case' 0 N--CA 1.51 2.561 1 N-CA-C 132.655 8.02 . . . . 0.0 132.655 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.9 t -63.86 82.11 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.433 2 CA-C-N 130.371 5.987 . . . . 0.0 114.365 179.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.4 tt0 -20.51 -72.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.582 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.43 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 31.8 Cg_endo -67.04 -3.45 9.72 Favored 'Trans proline' 0 N--CA 1.51 2.489 0 C-N-CA 122.409 2.073 . . . . 0.0 115.367 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -120.85 -14.22 8.54 Favored 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.49 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.3 79.62 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.742 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.61 -34.03 1.73 Allowed Glycine 1 N--CA 1.522 4.381 0 O-C-N 121.597 -0.689 . . . . 0.0 112.617 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.52 68.46 7.86 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.79 26.8 0.05 OUTLIER Glycine 1 N--CA 1.527 4.731 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.563 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 1.8 ttt -108.54 43.85 1.19 Allowed 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 124.485 2.088 . . . . 0.0 113.022 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.97 134.88 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 112.228 -2.26 . . . . 0.0 110.903 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.71 154.86 19.38 Favored Glycine 1 N--CA 1.536 5.356 0 C-N-CA 119.446 -1.359 . . . . 0.0 113.96 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.2 ttpp -118.56 81.95 1.77 Allowed 'General case' 0 N--CA 1.517 2.883 0 CA-C-N 119.372 1.586 . . . . 0.0 115.262 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.71 123.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.667 0 C-N-CA 118.054 -1.458 . . . . 0.0 107.079 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -112.68 88.8 2.91 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.124 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.453 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.8 t -74.12 105.27 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.34 -72.28 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 O-C-N 126.101 2.126 . . . . 0.0 115.95 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.594 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.53 0 O-C-N 125.527 1.767 . . . . 0.0 113.81 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.119 ' CE1' HD21 ' A' ' 64' ' ' LEU . 60.5 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' TRP . . . . . 0.474 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.471 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.0 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.2 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 9.9 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 89.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 54.2 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.529 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 77.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.3 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.839 HG13 HG22 ' B' ' 50' ' ' VAL 0.374 0.1 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.7 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.457 HG13 ' HD2' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.457 ' HD2' HG13 ' B' ' 36' ' ' VAL . 23.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.9 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.667 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 30.2 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 1.118 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.839 HG22 HG13 ' B' ' 34' ' ' VAL . 62.0 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.449 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.449 HG22 ' O ' ' B' ' 55' ' ' ASP . 15.2 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 83.3 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.452 HG12 ' N ' ' B' ' 69' ' ' GLY . 74.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.452 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.555 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.415 HG23 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.2 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 1.049 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 24.7 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 1.049 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 42.5 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.567 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 94' ' ' LEU . 50.3 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.4 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 1.344 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 17.2 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' GLN . . . . . 1.105 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.8 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.8 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.507 HG23 ' N ' ' B' ' 116' ' ' VAL 0.46 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.507 ' N ' HG23 ' B' ' 115' ' ' ILE 0.255 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.614 ' CG ' HD23 ' A' ' 64' ' ' LEU . 36.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.856 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 81.9 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.6 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 85.3 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.508 ' C ' HG12 ' B' ' 131' ' ' VAL . 19.9 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 1.56 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.344 0.5 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' B' ' 142' ' ' ILE . 35.7 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' PRO . . . . . 0.525 ' CG ' ' CZ ' ' B' ' 144' ' ' PHE . 18.1 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.589 ' CG ' ' CG2' ' B' ' 142' ' ' ILE . 44.7 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.737 HD11 HD22 ' B' ' 249' ' ' LEU 0.51 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' B' ' 136' ' ' PRO . 81.3 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 69.0 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' B' ' 149' ' ' VAL . 1.3 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.627 HG11 ' CG2' ' B' ' 34' ' ' VAL . 10.7 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' B' ' 155' ' ' ARG . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' B' ' 157' ' ' ARG . 28.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.683 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.7 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.312 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' PRO . . . . . 0.474 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 17.8 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 97.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.442 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 62.2 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.725 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.9 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 172' ' ' TYR . . . . . 0.725 ' N ' HD23 ' B' ' 171' ' ' LEU . 18.5 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.436 HG22 ' N ' ' B' ' 178' ' ' GLY . 61.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.436 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.3 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 182' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.5 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.428 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 41.2 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.38 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.903 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 199' ' ' ILE . . . . . 0.639 HG13 ' O ' ' B' ' 199' ' ' ILE 0.519 0.3 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.6 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.2 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.0 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' ALA . . . . . 0.488 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 18.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.3 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 86.9 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.403 0.1 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.0 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' B' ' 231' ' ' LEU . 84.2 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' ASN . . . . . 0.545 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.507 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.7 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 19.4 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.737 HD22 HD11 ' B' ' 142' ' ' ILE . 41.4 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 255' ' ' HEC . . . . . 0.608 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.47 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.6 m -61.61 89.7 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.98 162.98 12.64 Favored 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.452 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.0 t -107.68 122.36 46.56 Favored 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.52 98.34 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.41 65.5 0.07 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 113.077 -1.874 . . . . 0.0 114.834 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.804 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -29.51 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.96 0 C-N-CA 126.595 1.958 . . . . 0.0 115.534 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.43 59.11 0.4 Allowed Glycine 0 N--CA 1.509 3.557 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.2 p -1.08 54.03 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 120.344 3.461 . . . . 0.0 120.344 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.61 -60.22 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 119.507 3.151 . . . . 0.0 119.507 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.508 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.47 14.45 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 120.998 -1.064 . . . . 0.0 108.143 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.09 -94.83 1.9 Allowed Glycine 0 N--CA 1.511 3.69 0 N-CA-C 115.553 0.981 . . . . 0.0 115.553 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.556 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 47.1 tp -150.57 -177.16 5.81 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.556 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 15.7 mt -74.68 46.66 0.29 Allowed 'General case' 0 N--CA 1.509 2.478 0 O-C-N 120.608 -1.307 . . . . 0.0 111.296 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.681 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.8 p -113.84 165.67 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.681 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.24 75.38 1.49 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 112.209 -2.269 . . . . 0.0 113.436 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.42 142.44 25.23 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 121.851 -0.531 . . . . 0.0 111.744 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 20' ' ' LYS . 56.8 Cg_endo -86.4 76.1 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.389 0 N-CA-C 116.382 1.647 . . . . 0.0 116.382 -9.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.7 -44.18 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.812 1 N-CA-C 122.24 4.163 . . . . 0.0 122.24 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.65 71.55 0.99 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.446 1.117 . . . . 0.0 113.052 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.841 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.06 111.27 7.15 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.177 -1.577 . . . . 0.0 109.147 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.515 ' N ' HD23 ' A' ' 21' ' ' LEU . 53.8 m -87.48 81.39 7.81 Favored 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.841 HG23 HD22 ' A' ' 21' ' ' LEU . 4.6 pt -79.7 -177.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.708 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.666 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.69 166.6 10.49 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.078 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.5 Cg_endo -52.3 77.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.569 2.263 0 N-CA-C 116.92 1.854 . . . . 0.0 116.92 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.09 -50.39 0.52 Allowed Glycine 1 N--CA 1.522 4.404 0 C-N-CA 119.727 -1.225 . . . . 0.0 115.859 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.68 92.11 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.195 1 N-CA-C 122.092 4.108 . . . . 0.0 122.092 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 28' ' ' THR . 11.3 m -64.12 36.03 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 118.681 2.845 . . . . 0.0 118.681 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.99 147.2 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 CA-C-N 112.861 -1.972 . . . . 0.0 111.529 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.31 154.85 27.29 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 123.936 1.827 . . . . 0.0 115.397 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -107.47 113.9 27.55 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.78 112.48 24.91 Favored 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 120.759 3.614 . . . . 0.0 120.759 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -75.11 84.75 2.34 Favored 'General case' 0 N--CA 1.511 2.611 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.14 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.5 p30 -80.35 -45.08 18.36 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 118.862 2.912 . . . . 0.0 118.862 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.92 -169.26 3.33 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 124.678 1.191 . . . . 0.0 109.143 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HA ' HE22 ' B' ' 104' ' ' GLN . 1.6 m 12.82 70.7 0.11 Allowed Pre-proline 0 N--CA 1.52 3.038 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.221 ' HG2' ' CZ ' ' B' ' 102' ' ' TYR . 59.5 Cg_endo -98.41 177.26 0.41 Allowed 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 123.953 3.102 . . . . 0.0 114.382 -165.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.619 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 58.9 Cg_endo -92.48 165.22 25.07 Favored 'Cis proline' 0 N--CA 1.503 2.082 0 N-CA-C 115.392 1.266 . . . . 0.0 115.392 -7.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.804 ' HB2' HD13 ' A' ' 7' ' ' LEU . 18.1 m-70 -118.83 87.4 2.72 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 117.377 2.362 . . . . 0.0 117.377 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.673 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -103.4 140.28 37.66 Favored 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 122.429 2.377 . . . . 0.0 110.695 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.499 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.4 m -118.1 116.27 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 121.43 3.863 . . . . 0.0 121.43 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.4 m -75.9 165.4 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 102.223 -3.251 . . . . 0.0 102.223 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.022 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.28 130.97 55.5 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.46 93.77 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.188 1 N-CA-C 124.16 4.874 . . . . 0.0 124.16 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.0 6.8 43.34 Favored 'General case' 0 CA--C 1.602 2.965 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.84 -65.63 1.17 Allowed 'General case' 0 CA--C 1.573 1.848 0 C-N-CA 127.537 2.335 . . . . 0.0 112.707 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.684 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.7 mp -86.63 66.58 9.54 Favored 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.38 151.23 0.74 Allowed Pre-proline 0 N--CA 1.523 3.179 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.7 Cg_endo -42.36 -58.26 1.31 Allowed 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 123.398 2.732 . . . . 0.0 115.133 170.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.45 67.36 0.72 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 124.027 1.87 . . . . 0.0 107.067 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.18 53.51 0.99 Allowed 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 112.346 -2.206 . . . . 0.0 108.204 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.87 56.95 0.76 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.671 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.58 -47.91 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 117.252 2.315 . . . . 0.0 117.252 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.08 -30.9 0.16 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.218 -1.551 . . . . 0.0 111.584 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 55' ' ' LEU . 2.9 pp -41.16 -28.53 0.1 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 122.696 1.236 . . . . 0.0 112.478 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.505 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.83 -27.64 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.03 -55.54 0.3 Allowed 'General case' 0 N--CA 1.534 3.748 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.77 -28.91 0.17 Allowed 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.022 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.71 -66.76 0.34 Allowed 'General case' 0 CA--C 1.603 2.984 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.831 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.01 98.32 2.05 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 125.356 1.462 . . . . 0.0 112.803 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.694 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.0 -172.97 3.7 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.694 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.39 155.12 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.59 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.0 tt0 105.55 65.93 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 120.258 3.429 . . . . 0.0 120.258 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.584 HD23 ' CG ' ' B' ' 118' ' ' PRO . 6.0 mp 38.21 84.3 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 120.793 3.627 . . . . 0.0 120.793 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.673 ' N ' HD21 ' A' ' 40' ' ' ASN . 35.0 mt -70.76 82.13 0.63 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.137 -1.602 . . . . 0.0 111.818 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . 1.422 ' CE ' ' O ' ' B' ' 118' ' ' PRO . 42.3 mmm -79.29 62.0 3.53 Favored 'General case' 0 N--CA 1.512 2.647 0 CA-C-O 126.069 2.842 . . . . 0.0 110.886 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.0 m -112.53 65.89 0.84 Allowed Pre-proline 0 C--N 1.284 -2.259 0 CA-C-N 110.53 -3.032 . . . . 0.0 113.667 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HG2' ' OD2' ' B' ' 100' ' ' ASP . 21.7 Cg_endo -51.91 81.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.466 0 C-N-CA 122.932 2.422 . . . . 0.0 114.696 -177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.08 6.58 27.81 Favored Glycine 1 N--CA 1.516 4.03 0 O-C-N 122.18 -0.325 . . . . 0.0 113.613 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.56 156.84 34.97 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 124.366 2.031 . . . . 0.0 116.352 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.438 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -116.95 156.38 27.52 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 119.703 3.223 . . . . 0.0 119.703 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -115.95 147.9 40.64 Favored 'General case' 0 N--CA 1.52 3.07 0 CA-C-O 116.711 -1.614 . . . . 0.0 107.192 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.44 143.67 41.89 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 118.36 2.726 . . . . 0.0 118.36 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.7 m -119.94 102.64 8.7 Favored 'General case' 0 N--CA 1.514 2.772 0 CA-C-N 114.227 -1.351 . . . . 0.0 113.584 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.455 ' OG1' HG23 ' A' ' 28' ' ' THR . 48.8 m -94.7 152.2 18.66 Favored 'General case' 0 N--CA 1.526 3.341 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' N ' HG22 ' A' ' 75' ' ' THR . 90.7 m-85 -107.98 168.33 8.04 Favored Pre-proline 0 N--CA 1.504 2.244 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.037 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.36 -174.78 1.52 Allowed 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 121.023 1.149 . . . . 0.0 111.12 161.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.77 18.97 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 124.364 2.03 . . . . 0.0 107.246 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.09 42.55 0.48 Allowed 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 111.24 -2.709 . . . . 0.0 109.067 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.24 84.81 9.68 Favored Pre-proline 0 N--CA 1.501 2.075 0 CA-C-N 113.658 -1.61 . . . . 0.0 113.768 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 83' ' ' GLY . 47.5 Cg_endo -79.36 178.67 7.16 Favored 'Trans proline' 0 N--CA 1.503 2.085 0 C-N-CA 122.79 2.326 . . . . 0.0 112.276 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.598 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.11 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.86 0 C-N-CA 125.328 1.451 . . . . 0.0 113.291 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.539 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.4 124.92 5.6 Favored Glycine 0 N--CA 1.507 3.393 0 N-CA-C 121.739 3.455 . . . . 0.0 121.739 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.41 61.31 1.19 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.539 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.13 77.81 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.906 1.336 . . . . 0.0 113.006 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.8 m -63.46 135.94 57.25 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.53 136.54 52.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.568 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.71 82.11 8.57 Favored 'General case' 0 N--CA 1.511 2.618 1 N-CA-C 132.562 7.986 . . . . 0.0 132.562 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.94 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.495 2 CA-C-N 130.298 5.953 . . . . 0.0 114.346 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.0 tt0 -20.55 -72.35 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.586 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.417 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 36.8 Cg_endo -67.11 -3.34 9.61 Favored 'Trans proline' 0 N--CA 1.513 2.626 0 C-N-CA 122.359 2.039 . . . . 0.0 115.343 176.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -120.99 -14.12 8.49 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.458 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.35 79.71 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.51 -34.03 1.74 Allowed Glycine 1 N--CA 1.522 4.37 0 O-C-N 121.517 -0.739 . . . . 0.0 112.679 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.57 68.44 7.91 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 39.0 26.68 0.05 OUTLIER Glycine 1 N--CA 1.527 4.721 0 CA-C-N 114.018 -1.446 . . . . 0.0 116.573 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.567 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.57 43.92 1.18 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 124.52 2.105 . . . . 0.0 112.957 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.0 134.85 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 112.271 -2.24 . . . . 0.0 110.928 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.64 154.87 19.34 Favored Glycine 1 N--CA 1.535 5.295 0 CA-C-N 120.118 1.326 . . . . 0.0 114.039 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.57 81.91 1.77 Allowed 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 119.405 1.603 . . . . 0.0 115.246 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.68 123.31 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.737 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.8 m -112.64 88.73 2.89 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.155 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.446 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.2 t -74.02 105.18 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.25 -72.3 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 O-C-N 126.046 2.091 . . . . 0.0 115.929 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.598 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.532 0 O-C-N 125.547 1.78 . . . . 0.0 113.841 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.013 ' CE1' HD21 ' A' ' 64' ' ' LEU . 60.9 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' TRP . . . . . 0.458 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.9 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.448 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.2 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.413 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 55.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.7 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.4 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 52.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.528 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 78.4 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.0 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.738 HG13 HG22 ' B' ' 50' ' ' VAL 0.386 0.2 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.488 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.9 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.613 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.6 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.5 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.974 ' CE1' HG22 ' B' ' 131' ' ' VAL . 51.5 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.738 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.5 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.411 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.1 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.411 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.2 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.8 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.424 HG12 ' N ' ' B' ' 69' ' ' GLY . 80.7 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.424 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.522 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.514 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.8 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.0 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 0.859 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 17.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.859 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 46.4 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.478 HG22 HG11 ' B' ' 114' ' ' VAL 0.491 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.4 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.1 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.544 ' OD2' ' HG2' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.1 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 1.221 ' CZ ' ' HG2' ' A' ' 37' ' ' PRO . 17.3 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' GLN . . . . . 0.58 HE22 ' HA ' ' A' ' 36' ' ' VAL . 11.2 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.448 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 25.0 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.7 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.478 HG11 HG22 ' B' ' 84' ' ' ILE . 16.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.514 HD11 HG23 ' B' ' 75' ' ' VAL 0.526 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.433 ' N ' HG23 ' B' ' 115' ' ' ILE 0.403 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.667 ' C ' ' HE1' ' A' ' 66' ' ' MET . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 1.584 ' CG ' HD23 ' A' ' 64' ' ' LEU . 38.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 66' ' ' MET . 81.3 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.8 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 90.0 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.521 ' C ' HG12 ' B' ' 131' ' ' VAL . 12.8 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 1.549 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.511 0.9 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' PRO . . . . . 0.647 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.4 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.626 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.626 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.469 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' PHE . . . . . 0.647 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.5 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.361 1.5 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' HIS . . . . . 0.413 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.6 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.623 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.475 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.6 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.666 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.3 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.398 0.6 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' PRO . . . . . 0.458 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.1 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.443 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 62.7 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.681 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 172' ' ' TYR . . . . . 0.681 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.2 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.3 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.405 HG22 ' N ' ' B' ' 178' ' ' GLY . 58.0 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.405 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 64.8 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.9 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 182' ' ' LYS . . . . . 0.406 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.406 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.7 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.433 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.822 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 199' ' ' ILE . . . . . 0.4 ' O ' HG13 ' B' ' 199' ' ' ILE 0.464 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.7 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.9 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.8 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.2 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' ALA . . . . . 0.443 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.443 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 12.2 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.3 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.9 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.423 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.8 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.6 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' ASN . . . . . 0.51 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.482 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.1 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.0 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.7 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.597 HD22 HD11 ' B' ' 142' ' ' ILE . 40.8 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.924 -1.036 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 255' ' ' HEC . . . . . 0.607 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.455 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 69.7 m -61.51 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.963 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.408 ' HD2' HD11 ' A' ' 21' ' ' LEU . 10.8 m-85 -99.93 163.03 12.63 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.46 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.2 t -107.74 122.43 46.72 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.9 t -100.56 98.37 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.4 mmmt -67.35 65.37 0.07 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.894 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.807 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.9 mt -29.46 68.22 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 126.61 1.964 . . . . 0.0 115.517 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.45 59.01 0.4 Allowed Glycine 0 N--CA 1.51 3.584 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 11' ' ' LYS . 20.3 p -1.13 54.15 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.284 0 N-CA-C 120.32 3.452 . . . . 0.0 120.32 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.51 -60.23 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 119.539 3.163 . . . . 0.0 119.539 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.87 22.62 14.27 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.858 -1.151 . . . . 0.0 108.189 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.2 -94.81 1.89 Allowed Glycine 0 N--CA 1.512 3.721 0 N-CA-C 115.521 0.969 . . . . 0.0 115.521 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.6 tp -150.56 -177.14 5.8 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.597 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 15.4 mt -74.78 46.76 0.3 Allowed 'General case' 0 N--CA 1.509 2.506 0 O-C-N 120.716 -1.24 . . . . 0.0 111.261 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.727 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.6 p -113.79 165.59 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 118.464 2.764 . . . . 0.0 118.464 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.727 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.3 m-30 -102.22 75.41 1.49 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 112.142 -2.299 . . . . 0.0 113.431 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.343 0.6 OUTLIER -93.46 142.43 25.19 Favored Pre-proline 0 N--CA 1.506 2.347 0 O-C-N 121.805 -0.559 . . . . 0.0 111.754 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' LYS . 46.3 Cg_endo -86.46 76.22 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.39 0 N-CA-C 116.351 1.635 . . . . 0.0 116.351 -9.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.54 -44.17 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.841 1 N-CA-C 122.284 4.179 . . . . 0.0 122.284 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.648 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.61 71.69 1.0 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 122.408 1.099 . . . . 0.0 113.072 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.865 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.19 111.23 7.23 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.237 -1.539 . . . . 0.0 109.1 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.572 ' N ' HD23 ' A' ' 21' ' ' LEU . 46.1 m -87.42 81.41 7.84 Favored 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.865 HG23 HD22 ' A' ' 21' ' ' LEU . 4.4 pt -79.61 -177.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 CA-C-N 114.772 -1.103 . . . . 0.0 112.719 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.706 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -109.7 166.6 10.49 Favored Pre-proline 0 CA--C 1.566 1.569 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.135 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 19.9 Cg_endo -52.26 77.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.288 0 N-CA-C 116.903 1.847 . . . . 0.0 116.903 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.16 -50.59 0.51 Allowed Glycine 1 N--CA 1.522 4.419 0 C-N-CA 119.753 -1.213 . . . . 0.0 115.834 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.61 92.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.171 1 N-CA-C 122.227 4.158 . . . . 0.0 122.227 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 28' ' ' THR . 11.1 m -64.15 36.08 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -52.11 147.23 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 CA-C-N 112.878 -1.965 . . . . 0.0 111.475 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.28 154.87 27.21 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 123.978 1.847 . . . . 0.0 115.356 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.418 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.9 m-85 -107.53 113.83 27.41 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.65 112.49 24.89 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 120.792 3.627 . . . . 0.0 120.792 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -75.12 84.78 2.34 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.164 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 29.7 p30 -80.35 -45.06 18.4 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 118.904 2.928 . . . . 0.0 118.904 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.97 -169.33 3.35 Favored 'General case' 0 N--CA 1.509 2.491 0 C-N-CA 124.596 1.158 . . . . 0.0 109.068 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.815 ' HA ' ' OE1' ' B' ' 104' ' ' GLN . 1.6 m 12.91 70.62 0.11 Allowed Pre-proline 0 N--CA 1.519 3.01 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.328 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 55.3 Cg_endo -98.43 177.28 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.213 0 C-N-CA 123.908 3.072 . . . . 0.0 114.455 -165.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.713 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 52.3 Cg_endo -92.47 165.29 25.09 Favored 'Cis proline' 0 N--CA 1.503 2.069 0 N-CA-C 115.442 1.285 . . . . 0.0 115.442 -7.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.807 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.3 m-70 -118.96 87.46 2.74 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.729 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -103.37 140.2 37.76 Favored 'General case' 0 N--CA 1.516 2.827 0 CA-C-N 122.395 2.362 . . . . 0.0 110.744 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.5 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.3 m -118.11 116.22 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 121.476 3.88 . . . . 0.0 121.476 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.566 HG22 ' CB ' ' A' ' 88' ' ' TYR . 13.3 m -75.87 165.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.049 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.3 130.94 55.51 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.444 ' OD1' HD13 ' A' ' 47' ' ' LEU . 4.2 m-20 -53.4 93.71 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.183 1 N-CA-C 124.2 4.889 . . . . 0.0 124.2 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.98 6.8 43.28 Favored 'General case' 0 CA--C 1.602 2.957 0 N-CA-C 101.23 -3.619 . . . . 0.0 101.23 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -115.83 -65.53 1.18 Allowed 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 127.595 2.358 . . . . 0.0 112.704 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.5 mp -86.72 66.47 9.48 Favored 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 118.966 2.95 . . . . 0.0 118.966 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.43 151.22 0.74 Allowed Pre-proline 0 N--CA 1.522 3.167 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.505 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 17.4 Cg_endo -42.32 -58.31 1.28 Allowed 'Trans proline' 0 N--CA 1.508 2.376 0 C-N-CA 123.408 2.739 . . . . 0.0 115.085 170.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.637 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.48 67.46 0.72 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 124.034 1.873 . . . . 0.0 107.04 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -77.25 53.6 1.02 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 112.333 -2.212 . . . . 0.0 108.331 179.392 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.4 t -115.88 56.96 0.76 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.658 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.57 -47.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.11 -30.87 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.104 -1.622 . . . . 0.0 111.636 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 55' ' ' LEU . 2.9 pp -41.13 -28.5 0.09 Allowed 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 122.801 1.286 . . . . 0.0 112.561 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.86 -27.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.3 tptt 65.15 -55.62 0.31 Allowed 'General case' 0 N--CA 1.533 3.678 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.2 m -41.72 -28.9 0.16 Allowed 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.049 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.2 pp -53.74 -66.71 0.35 Allowed 'General case' 0 CA--C 1.603 3.017 0 N-CA-C 100.723 -3.806 . . . . 0.0 100.723 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.861 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 11.0 p -72.14 98.38 2.12 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.278 1.431 . . . . 0.0 112.816 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.702 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.5 t60 -89.96 -173.01 3.72 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.702 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.39 155.17 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.584 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 26.2 tt0 105.43 66.08 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 120.289 3.44 . . . . 0.0 120.289 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.017 HD21 ' CD1' ' B' ' 1' ' ' TYR . 5.6 mp 38.1 84.27 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 120.803 3.631 . . . . 0.0 120.803 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.729 ' N ' HD21 ' A' ' 40' ' ' ASN . 36.3 mt -70.68 82.12 0.61 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.144 -1.597 . . . . 0.0 111.88 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . 1.27 ' HE2' ' O ' ' B' ' 118' ' ' PRO . 41.4 mmm -79.27 61.92 3.5 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-O 126.096 2.855 . . . . 0.0 110.918 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.524 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.9 m -112.52 65.95 0.84 Allowed Pre-proline 0 N--CA 1.505 2.298 0 CA-C-N 110.47 -3.059 . . . . 0.0 113.601 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.86 ' HG3' ' O ' ' B' ' 100' ' ' ASP . 19.3 Cg_endo -51.94 81.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.522 0 C-N-CA 122.979 2.452 . . . . 0.0 114.633 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.09 6.67 27.71 Favored Glycine 1 N--CA 1.516 4.021 0 O-C-N 122.203 -0.31 . . . . 0.0 113.606 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.66 156.82 35.17 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 124.389 2.042 . . . . 0.0 116.332 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.451 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.91 156.34 27.55 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 119.742 3.238 . . . . 0.0 119.742 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -115.9 147.97 40.52 Favored 'General case' 0 N--CA 1.52 3.048 0 CA-C-O 116.643 -1.646 . . . . 0.0 107.264 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.59 143.76 41.94 Favored 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 76.1 m -119.95 102.64 8.69 Favored 'General case' 0 N--CA 1.514 2.751 0 CA-C-N 114.221 -1.354 . . . . 0.0 113.525 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.443 ' OG1' HG23 ' A' ' 28' ' ' THR . 49.8 m -94.81 152.26 18.56 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.429 ' N ' HG22 ' A' ' 75' ' ' THR . 89.8 m-85 -107.97 168.33 8.05 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.067 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -72.36 -174.76 1.52 Allowed 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 121.009 1.14 . . . . 0.0 111.115 161.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.34 -19.78 18.98 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 124.301 2.001 . . . . 0.0 107.241 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.16 42.64 0.49 Allowed 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 111.246 -2.706 . . . . 0.0 109.059 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.84 9.84 Favored Pre-proline 0 N--CA 1.499 2.023 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.778 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 83' ' ' GLY . 38.0 Cg_endo -79.38 178.6 7.23 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.851 2.367 . . . . 0.0 112.298 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.604 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -15.97 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.889 0 C-N-CA 125.316 1.447 . . . . 0.0 113.262 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.51 125.08 5.64 Favored Glycine 0 N--CA 1.506 3.365 0 N-CA-C 121.703 3.441 . . . . 0.0 121.703 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.5 61.18 1.17 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.525 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.04 77.74 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.873 1.32 . . . . 0.0 113.068 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.4 m -63.36 135.92 57.31 Favored 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.583 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.47 136.55 52.89 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.566 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.6 m-85 -84.63 81.97 8.63 Favored 'General case' 0 N--CA 1.511 2.576 1 N-CA-C 132.625 8.009 . . . . 0.0 132.625 -179.33 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.7 t -63.84 82.21 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.447 2 CA-C-N 130.434 6.016 . . . . 0.0 114.298 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.5 tt0 -20.61 -72.48 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.61 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.838 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 31.7 Cg_endo -66.88 -3.55 9.71 Favored 'Trans proline' 0 N--CA 1.511 2.547 0 C-N-CA 122.419 2.079 . . . . 0.0 115.372 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -120.88 -14.08 8.54 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.501 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.45 79.75 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.53 -34.03 1.74 Allowed Glycine 1 N--CA 1.521 4.309 0 O-C-N 121.571 -0.706 . . . . 0.0 112.621 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.62 68.54 8.01 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.78 26.78 0.05 OUTLIER Glycine 1 N--CA 1.528 4.787 0 CA-C-N 114.004 -1.453 . . . . 0.0 116.636 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.573 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 1.8 ttt -108.53 43.76 1.2 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 124.51 2.1 . . . . 0.0 113.035 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.89 134.89 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 112.216 -2.266 . . . . 0.0 111.007 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.7 154.89 19.38 Favored Glycine 1 N--CA 1.535 5.269 0 C-N-CA 119.486 -1.34 . . . . 0.0 113.986 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.2 ttpp -118.63 81.96 1.78 Allowed 'General case' 0 N--CA 1.518 2.956 0 CA-C-N 119.404 1.602 . . . . 0.0 115.252 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.76 123.24 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -112.56 88.72 2.89 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.196 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.449 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.8 t -73.97 105.21 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.3 -72.3 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 O-C-N 126.051 2.094 . . . . 0.0 115.888 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.486 0 O-C-N 125.579 1.799 . . . . 0.0 113.861 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.017 ' CD1' HD21 ' A' ' 64' ' ' LEU . 60.6 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.838 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 24.1 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' TRP . . . . . 0.474 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.471 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.0 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.2 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 89.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 54.2 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.529 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 77.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.3 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.84 HG13 HG22 ' B' ' 50' ' ' VAL 0.373 0.1 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 58.6 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.458 HG13 ' HD2' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.458 ' HD2' HG13 ' B' ' 36' ' ' VAL . 23.7 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.9 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.668 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 30.2 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 1.112 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.3 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.84 HG22 HG13 ' B' ' 34' ' ' VAL . 62.0 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.449 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.9 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.449 HG22 ' O ' ' B' ' 55' ' ' ASP . 15.1 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 82.9 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.452 HG12 ' N ' ' B' ' 69' ' ' GLY . 74.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.452 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.555 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.416 HG23 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.2 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 1.052 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 24.8 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 1.052 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 43.0 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.568 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 94' ' ' LEU . 50.3 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.86 ' O ' ' HG3' ' A' ' 68' ' ' PRO . 24.3 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 1.328 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 17.2 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' GLN . . . . . 0.815 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 1.8 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.9 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.2 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.513 HG23 ' N ' ' B' ' 116' ' ' VAL 0.454 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.513 ' N ' HG23 ' B' ' 115' ' ' ILE 0.254 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.576 ' C ' ' HE1' ' A' ' 66' ' ' MET . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 1.27 ' O ' ' HE2' ' A' ' 66' ' ' MET . 36.4 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.917 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 81.9 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.5 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 85.3 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.515 ' C ' HG12 ' B' ' 131' ' ' VAL . 19.8 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 1.556 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.348 0.5 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' B' ' 142' ' ' ILE . 35.7 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' PRO . . . . . 0.526 ' CG ' ' CZ ' ' B' ' 144' ' ' PHE . 18.2 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.591 ' CG ' ' CG2' ' B' ' 142' ' ' ILE . 44.7 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.739 HD11 HD22 ' B' ' 249' ' ' LEU 0.511 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' PHE . . . . . 0.526 ' CZ ' ' CG ' ' B' ' 136' ' ' PRO . 81.3 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 69.0 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' B' ' 149' ' ' VAL . 1.3 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.627 HG11 ' CG2' ' B' ' 34' ' ' VAL . 10.7 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' B' ' 155' ' ' ARG . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.458 HH11 ' HD2' ' B' ' 157' ' ' ARG . 28.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.683 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.7 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.31 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' PRO . . . . . 0.474 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 17.8 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 97.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.442 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 62.2 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.725 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.9 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 172' ' ' TYR . . . . . 0.725 ' N ' HD23 ' B' ' 171' ' ' LEU . 18.4 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.436 HG22 ' N ' ' B' ' 178' ' ' GLY . 61.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.436 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.4 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.6 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 183' ' ' ILE . . . . . 0.429 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 41.2 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.381 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.904 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 199' ' ' ILE . . . . . 0.642 HG13 ' O ' ' B' ' 199' ' ' ILE 0.52 0.3 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.6 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.2 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' ALA . . . . . 0.488 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 18.3 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.3 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.1 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.402 0.1 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.0 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' B' ' 231' ' ' LEU . 84.2 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' ASN . . . . . 0.545 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.507 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.6 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 19.4 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.739 HD22 HD11 ' B' ' 142' ' ' ILE . 41.4 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 255' ' ' HEC . . . . . 0.608 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.605 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.488 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.5 m -61.53 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.029 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -99.95 163.08 12.6 Favored 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.83 122.39 46.69 Favored 'General case' 0 N--CA 1.525 3.305 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -100.49 98.38 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.7 mmmt -67.37 65.39 0.07 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 113.121 -1.854 . . . . 0.0 114.847 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.826 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.6 mt -29.59 68.29 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 126.53 1.932 . . . . 0.0 115.501 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.44 58.98 0.4 Allowed Glycine 0 N--CA 1.509 3.54 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.1 p -1.07 54.24 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 N-CA-C 120.187 3.402 . . . . 0.0 120.187 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.44 -60.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 119.513 3.153 . . . . 0.0 119.513 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.76 22.53 14.42 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.858 -1.151 . . . . 0.0 108.183 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.18 -94.77 1.89 Allowed Glycine 0 N--CA 1.512 3.713 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 44.6 tp -150.61 -177.2 5.84 Favored 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.532 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.2 mt -74.78 46.78 0.3 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 120.638 -1.289 . . . . 0.0 111.279 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.624 HG22 ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.85 165.68 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 118.596 2.813 . . . . 0.0 118.596 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.624 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.9 m-30 -102.23 75.42 1.49 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 112.2 -2.273 . . . . 0.0 113.389 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.308 12.3 mt-10 -93.47 142.43 25.2 Favored Pre-proline 0 N--CA 1.505 2.294 0 O-C-N 121.826 -0.546 . . . . 0.0 111.814 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.41 76.15 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.458 0 N-CA-C 116.328 1.626 . . . . 0.0 116.328 -9.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.59 -44.14 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 1 N-CA-C 122.344 4.201 . . . . 0.0 122.344 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.63 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.62 71.62 1.0 Allowed 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 122.364 1.078 . . . . 0.0 113.025 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.787 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.13 111.31 7.25 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.208 -1.557 . . . . 0.0 109.104 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.488 ' N ' HD23 ' A' ' 21' ' ' LEU . 49.4 m -87.49 81.46 7.78 Favored 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.787 HG23 HD22 ' A' ' 21' ' ' LEU . 5.3 pt -79.78 -177.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.692 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.613 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.66 166.51 10.65 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.198 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.6 Cg_endo -52.2 77.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.3 0 N-CA-C 116.91 1.85 . . . . 0.0 116.91 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.09 -50.44 0.52 Allowed Glycine 1 N--CA 1.523 4.449 0 C-N-CA 119.789 -1.196 . . . . 0.0 115.915 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.555 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.64 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.178 1 N-CA-C 122.151 4.13 . . . . 0.0 122.151 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 28' ' ' THR . 11.9 m -64.0 35.98 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.027 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.11 147.21 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 112.906 -1.952 . . . . 0.0 111.418 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 4.1 pt-20 -114.29 154.93 27.11 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 123.925 1.822 . . . . 0.0 115.324 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -107.53 113.79 27.35 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.76 112.57 25.0 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 120.758 3.614 . . . . 0.0 120.758 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -75.16 84.72 2.37 Favored 'General case' 0 N--CA 1.511 2.622 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.13 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.23 -45.11 18.55 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.553 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.93 -169.38 3.36 Favored 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 124.61 1.164 . . . . 0.0 109.086 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.845 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.7 m 12.92 70.63 0.11 Allowed Pre-proline 0 N--CA 1.521 3.098 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.454 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.4 177.28 0.41 Allowed 'Trans proline' 0 CA--C 1.569 2.241 0 C-N-CA 123.939 3.093 . . . . 0.0 114.416 -165.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.4 Cg_endo -92.5 165.31 25.0 Favored 'Cis proline' 0 N--CA 1.503 2.068 0 N-CA-C 115.398 1.268 . . . . 0.0 115.398 -7.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.826 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.89 87.46 2.74 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.64 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 1.0 OUTLIER -103.45 140.22 37.78 Favored 'General case' 0 N--CA 1.515 2.818 0 CA-C-N 122.456 2.389 . . . . 0.0 110.722 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.2 m -118.08 116.31 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.564 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.8 m -75.95 165.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 102.19 -3.263 . . . . 0.0 102.19 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.03 ' HB2' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.3 130.93 55.51 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.32 93.77 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.221 1 N-CA-C 124.182 4.882 . . . . 0.0 124.182 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.4 ' C ' ' HB2' ' A' ' 51' ' ' LYS . . . -91.06 6.74 43.68 Favored 'General case' 0 CA--C 1.602 2.972 0 N-CA-C 101.168 -3.642 . . . . 0.0 101.168 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.8 -65.54 1.18 Allowed 'General case' 0 CA--C 1.573 1.853 0 C-N-CA 127.525 2.33 . . . . 0.0 112.718 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.56 9.53 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 118.915 2.932 . . . . 0.0 118.915 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.46 151.25 0.74 Allowed Pre-proline 0 N--CA 1.522 3.135 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.497 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.8 Cg_endo -42.51 -58.2 1.35 Allowed 'Trans proline' 0 N--CA 1.508 2.371 0 C-N-CA 123.438 2.758 . . . . 0.0 115.04 170.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.52 67.43 0.72 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 124.091 1.901 . . . . 0.0 107.072 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.412 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.28 53.55 1.02 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.256 -2.247 . . . . 0.0 108.222 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.8 56.94 0.76 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.7 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.58 -47.94 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.184 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.12 -30.85 0.16 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.113 -1.617 . . . . 0.0 111.545 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.548 ' HG ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 pp -41.22 -28.54 0.1 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.732 1.253 . . . . 0.0 112.485 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.82 -27.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.3 tptt 64.93 -55.47 0.3 Allowed 'General case' 0 N--CA 1.533 3.715 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -41.78 -28.86 0.17 Allowed 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.03 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.8 pp -53.74 -66.76 0.33 Allowed 'General case' 0 CA--C 1.604 3.022 0 N-CA-C 100.713 -3.81 . . . . 0.0 100.713 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.756 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.11 98.44 2.11 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 125.268 1.427 . . . . 0.0 112.781 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.671 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.3 t60 -90.05 -173.08 3.73 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.671 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.42 155.15 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 28.1 tt0 105.5 66.06 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.755 0 N-CA-C 120.313 3.449 . . . . 0.0 120.313 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.246 HD23 ' CG ' ' B' ' 118' ' ' PRO . 6.1 mp 38.13 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.518 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 36.2 mt -70.67 82.08 0.61 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.197 -1.564 . . . . 0.0 111.906 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.663 ' HE2' HD23 ' B' ' 119' ' ' LEU . 41.4 mmm -79.3 62.0 3.53 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 126.051 2.834 . . . . 0.0 110.867 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.4 m -112.58 65.84 0.85 Allowed Pre-proline 0 C--N 1.283 -2.287 0 CA-C-N 110.474 -3.057 . . . . 0.0 113.558 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HG2' ' OD2' ' B' ' 100' ' ' ASP . 19.5 Cg_endo -51.92 81.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.45 0 C-N-CA 122.959 2.439 . . . . 0.0 114.716 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.66 27.63 Favored Glycine 0 N--CA 1.516 3.991 0 O-C-N 122.131 -0.356 . . . . 0.0 113.603 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.8 tt0 -123.65 156.92 34.97 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 124.384 2.04 . . . . 0.0 116.273 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.435 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.98 156.37 27.58 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 119.722 3.23 . . . . 0.0 119.722 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -115.93 147.95 40.58 Favored 'General case' 0 N--CA 1.52 3.056 0 CA-C-O 116.636 -1.65 . . . . 0.0 107.194 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.46 143.74 41.81 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.2 m -120.02 102.57 8.63 Favored 'General case' 0 N--CA 1.513 2.719 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.532 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.457 ' OG1' HG23 ' A' ' 28' ' ' THR . 44.5 m -94.74 152.22 18.63 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.452 ' N ' HG22 ' A' ' 75' ' ' THR . 89.2 m-85 -107.97 168.27 8.13 Favored Pre-proline 0 N--CA 1.502 2.13 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.135 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.33 -174.77 1.51 Allowed 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.006 1.137 . . . . 0.0 111.122 161.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.45 -19.64 19.01 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-O 124.346 2.022 . . . . 0.0 107.216 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.25 42.72 0.5 Allowed 'General case' 0 CA--C 1.576 1.963 0 CA-C-N 111.249 -2.705 . . . . 0.0 109.036 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.29 84.73 9.68 Favored Pre-proline 0 N--CA 1.5 2.031 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.846 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -79.36 178.68 7.15 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 122.753 2.302 . . . . 0.0 112.226 173.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.604 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.04 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 125.294 1.437 . . . . 0.0 113.3 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.549 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.35 125.01 5.64 Favored Glycine 0 N--CA 1.508 3.472 0 N-CA-C 121.777 3.471 . . . . 0.0 121.777 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.44 61.15 1.18 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.549 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.8 m-85 -62.06 77.79 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 122.9 1.333 . . . . 0.0 112.984 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 6.9 m -63.46 135.91 57.23 Favored 'General case' 0 N--CA 1.51 2.561 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.526 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.43 136.51 52.93 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.564 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.64 81.96 8.63 Favored 'General case' 0 N--CA 1.511 2.617 1 N-CA-C 132.611 8.004 . . . . 0.0 132.611 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.0 t -63.82 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.471 2 CA-C-N 130.384 5.993 . . . . 0.0 114.34 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.6 tt0 -20.5 -72.4 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.62 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 29.6 Cg_endo -67.08 -3.45 9.76 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 122.406 2.071 . . . . 0.0 115.334 176.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -120.93 -14.16 8.51 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.442 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.23 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.782 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.58 -34.1 1.73 Allowed Glycine 1 N--CA 1.521 4.304 0 O-C-N 121.516 -0.74 . . . . 0.0 112.628 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.47 68.42 7.79 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.84 26.81 0.05 OUTLIER Glycine 1 N--CA 1.526 4.648 0 N-CA-C 116.616 1.407 . . . . 0.0 116.616 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.586 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.1 ttt -108.55 43.86 1.19 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 124.482 2.087 . . . . 0.0 112.966 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.03 134.88 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 112.233 -2.258 . . . . 0.0 110.973 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.65 154.86 19.34 Favored Glycine 1 N--CA 1.534 5.228 0 C-N-CA 119.525 -1.321 . . . . 0.0 114.032 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 ttpp -118.63 82.0 1.78 Allowed 'General case' 0 N--CA 1.518 2.925 0 CA-C-N 119.474 1.637 . . . . 0.0 115.188 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.74 123.29 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.5 m -112.67 88.77 2.9 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.197 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.3 t -74.05 105.23 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.35 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 O-C-N 126.066 2.104 . . . . 0.0 115.912 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.438 0 O-C-N 125.478 1.736 . . . . 0.0 113.835 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.853 ' CE1' HD21 ' A' ' 64' ' ' LEU . 61.0 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.28 21.9 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' TRP . . . . . 0.437 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.8 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.308 27.5 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.406 ' HE ' ' CE1' ' B' ' 150' ' ' HIS . 52.9 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.611 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.525 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.638 HG22 HG11 ' B' ' 151' ' ' VAL 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.5 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.557 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.367 22.0 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 33.0 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.786 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.411 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.8 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.418 HG12 ' N ' ' B' ' 69' ' ' GLY . 88.0 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.418 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.506 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 50.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 0.719 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.1 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.719 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.2 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.512 HG22 HG11 ' B' ' 114' ' ' VAL 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' B' ' 130' ' ' PRO . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.5 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 68' ' ' PRO . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 1.454 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 20.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' GLN . . . . . 0.845 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.6 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.512 HG11 HG22 ' B' ' 84' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . 0.592 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 1.246 ' CG ' HD23 ' A' ' 64' ' ' LEU . 36.5 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.663 HD23 ' HE2' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.466 ' HB3' HD21 ' B' ' 94' ' ' LEU . 23.9 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.786 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.442 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' PRO . . . . . 0.691 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.327 23.8 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.556 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.556 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.316 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' PHE . . . . . 0.691 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.418 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 150' ' ' HIS . . . . . 0.406 ' CE1' ' HE ' ' B' ' 14' ' ' ARG . 82.0 m-70 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.638 HG11 HG22 ' B' ' 34' ' ' VAL . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.501 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.526 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' PRO . . . . . 0.437 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 23.0 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.2 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.635 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 172' ' ' TYR . . . . . 0.635 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.363 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.739 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.256 25.7 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.625 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.8 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' ASN . . . . . 0.535 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.52 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 19.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 255' ' ' HEC . . . . . 0.611 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.593 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 82.1 m -61.63 89.63 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.012 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -99.92 163.03 12.63 Favored 'General case' 0 N--CA 1.511 2.617 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.79 122.4 46.69 Favored 'General case' 0 N--CA 1.525 3.301 0 N-CA-C 117.179 2.288 . . . . 0.0 117.179 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.49 98.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.6 mmmt -67.36 65.41 0.07 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 113.144 -1.843 . . . . 0.0 114.828 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.846 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.6 mt -29.48 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 C-N-CA 126.575 1.95 . . . . 0.0 115.508 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.49 59.0 0.4 Allowed Glycine 0 N--CA 1.51 3.62 0 N-CA-C 106.897 -2.481 . . . . 0.0 106.897 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -1.05 54.08 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 120.324 3.453 . . . . 0.0 120.324 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.55 -60.25 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 119.494 3.146 . . . . 0.0 119.494 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.504 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.81 22.53 14.39 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 120.941 -1.099 . . . . 0.0 108.196 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.13 -94.8 1.9 Allowed Glycine 0 N--CA 1.511 3.694 0 N-CA-C 115.511 0.964 . . . . 0.0 115.511 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.496 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 44.4 tp -150.62 -177.16 5.82 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.531 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.2 mt -74.8 46.72 0.3 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 120.677 -1.264 . . . . 0.0 111.271 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.629 HG22 ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.76 165.69 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 118.578 2.807 . . . . 0.0 118.578 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.629 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.9 m-30 -102.26 75.39 1.48 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.364 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.307 12.4 mt-10 -93.45 142.46 25.24 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.81 -0.556 . . . . 0.0 111.746 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.41 76.13 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.459 0 N-CA-C 116.3 1.616 . . . . 0.0 116.3 -9.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.61 -44.19 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.807 1 N-CA-C 122.316 4.191 . . . . 0.0 122.316 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.61 71.62 1.0 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 122.484 1.135 . . . . 0.0 113.061 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.788 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.13 111.28 7.21 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.134 -1.604 . . . . 0.0 109.138 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.489 ' N ' HD23 ' A' ' 21' ' ' LEU . 50.6 m -87.49 81.43 7.79 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.788 HG23 HD22 ' A' ' 21' ' ' LEU . 5.3 pt -79.7 -177.57 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.689 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.623 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.49 10.68 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.133 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.4 Cg_endo -52.16 77.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.314 0 N-CA-C 116.97 1.873 . . . . 0.0 116.97 174.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.19 -50.5 0.51 Allowed Glycine 1 N--CA 1.522 4.403 0 C-N-CA 119.69 -1.243 . . . . 0.0 115.826 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.66 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.171 1 N-CA-C 122.149 4.129 . . . . 0.0 122.149 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 28' ' ' THR . 11.7 m -63.98 35.9 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.977 0 N-CA-C 118.726 2.861 . . . . 0.0 118.726 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.3 t -51.98 147.15 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 112.886 -1.961 . . . . 0.0 111.57 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 4.1 pt-20 -114.2 154.9 27.06 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 123.942 1.83 . . . . 0.0 115.442 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.54 113.84 27.43 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.56 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.79 112.49 24.92 Favored 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 120.686 3.587 . . . . 0.0 120.686 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -75.06 84.6 2.31 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.197 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.27 -45.03 18.62 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 118.919 2.933 . . . . 0.0 118.919 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.96 -169.38 3.36 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 124.619 1.167 . . . . 0.0 109.124 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.871 ' HA ' ' CE2' ' B' ' 102' ' ' TYR . 1.7 m 12.95 70.62 0.11 Allowed Pre-proline 0 N--CA 1.521 3.076 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.489 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.37 177.33 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.224 0 C-N-CA 123.941 3.094 . . . . 0.0 114.395 -165.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.3 Cg_endo -92.38 165.28 25.37 Favored 'Cis proline' 0 N--CA 1.504 2.104 0 N-CA-C 115.453 1.29 . . . . 0.0 115.453 -7.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.846 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.83 87.41 2.73 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 117.346 2.35 . . . . 0.0 117.346 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.707 HD21 ' N ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -103.44 140.25 37.73 Favored 'General case' 0 N--CA 1.516 2.863 0 CA-C-N 122.494 2.406 . . . . 0.0 110.681 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.1 m -118.11 116.26 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 121.386 3.847 . . . . 0.0 121.386 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.566 HG22 ' CB ' ' A' ' 88' ' ' TYR . 15.0 m -75.89 165.35 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 102.238 -3.245 . . . . 0.0 102.238 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.061 ' HB2' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.3 131.02 55.47 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.481 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.53 93.87 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.163 1 N-CA-C 124.149 4.87 . . . . 0.0 124.149 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.08 6.84 43.3 Favored 'General case' 0 CA--C 1.601 2.94 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.85 -65.5 1.18 Allowed 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 127.612 2.365 . . . . 0.0 112.753 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.9 mp -86.78 66.64 9.55 Favored 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 118.885 2.92 . . . . 0.0 118.885 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.48 151.22 0.73 Allowed Pre-proline 0 N--CA 1.522 3.137 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.7 Cg_endo -42.47 -58.24 1.33 Allowed 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 123.403 2.736 . . . . 0.0 115.079 170.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.45 67.34 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 124.063 1.887 . . . . 0.0 107.084 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.8 OUTLIER -77.06 53.39 0.96 Allowed 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.296 -2.229 . . . . 0.0 108.266 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.77 56.89 0.76 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.846 2.535 . . . . 0.0 117.846 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.709 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.49 -48.04 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.171 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.04 -30.93 0.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.098 -1.626 . . . . 0.0 111.584 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.551 ' HG ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 pp -41.08 -28.61 0.09 Allowed 'General case' 0 N--CA 1.509 2.501 0 CA-C-O 122.68 1.229 . . . . 0.0 112.524 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.81 -27.48 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.798 ' HE2' ' OE1' ' B' ' 189' ' ' GLU . 12.3 tptt 65.08 -55.64 0.3 Allowed 'General case' 0 N--CA 1.532 3.66 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.7 m -41.67 -28.93 0.16 Allowed 'General case' 0 N--CA 1.513 2.715 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.061 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.8 pp -53.69 -66.8 0.33 Allowed 'General case' 0 CA--C 1.604 3.038 0 N-CA-C 100.673 -3.825 . . . . 0.0 100.673 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.761 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.16 98.47 2.14 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.248 1.419 . . . . 0.0 112.78 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.685 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.07 -173.05 3.72 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.685 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.39 155.18 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 28.2 tt0 105.44 66.11 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 N-CA-C 120.281 3.437 . . . . 0.0 120.281 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.108 HD21 ' CE1' ' B' ' 1' ' ' TYR . 6.1 mp 38.13 84.23 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 120.789 3.626 . . . . 0.0 120.789 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 65' ' ' LEU . 36.2 mt -70.6 81.99 0.6 Allowed 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.051 -1.655 . . . . 0.0 111.88 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . 1.374 ' CE ' ' HA ' ' B' ' 119' ' ' LEU . 41.2 mmm -79.18 61.94 3.44 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 126.052 2.834 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.0 m -112.55 65.94 0.85 Allowed Pre-proline 0 C--N 1.284 -2.277 0 CA-C-N 110.465 -3.061 . . . . 0.0 113.662 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -52.05 81.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.463 0 C-N-CA 123.001 2.468 . . . . 0.0 114.642 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.06 6.73 27.73 Favored Glycine 1 N--CA 1.516 4.007 0 O-C-N 122.115 -0.366 . . . . 0.0 113.619 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.502 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 36.0 tt0 -123.61 156.85 35.02 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 124.36 2.029 . . . . 0.0 116.326 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.434 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.96 156.37 27.55 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -115.95 147.89 40.67 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-O 116.518 -1.706 . . . . 0.0 107.247 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.45 143.76 41.77 Favored 'General case' 0 N--CA 1.529 3.511 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.0 m -119.95 102.52 8.61 Favored 'General case' 0 N--CA 1.514 2.769 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.546 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.463 ' OG1' HG23 ' A' ' 28' ' ' THR . 44.7 m -94.8 152.24 18.58 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.461 ' N ' HG22 ' A' ' 75' ' ' THR . 89.1 m-85 -107.9 168.33 8.05 Favored Pre-proline 0 N--CA 1.504 2.268 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.076 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.35 -174.84 1.54 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 121.058 1.172 . . . . 0.0 111.073 161.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.36 -19.74 18.99 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 124.289 1.995 . . . . 0.0 107.173 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.15 42.66 0.49 Allowed 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 111.286 -2.688 . . . . 0.0 109.132 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.34 84.83 9.9 Favored Pre-proline 0 N--CA 1.499 2.011 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.723 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.8 Cg_endo -79.45 178.59 7.22 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.83 2.354 . . . . 0.0 112.303 172.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.589 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.03 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 125.432 1.493 . . . . 0.0 113.243 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.546 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.33 124.99 5.63 Favored Glycine 0 N--CA 1.507 3.38 0 N-CA-C 121.792 3.477 . . . . 0.0 121.792 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.46 61.23 1.18 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.546 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.8 m-85 -62.13 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.924 1.345 . . . . 0.0 112.969 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 6.8 m -63.42 135.95 57.28 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.539 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.53 136.53 52.91 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.566 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.69 82.11 8.57 Favored 'General case' 0 N--CA 1.512 2.672 1 N-CA-C 132.536 7.976 . . . . 0.0 132.536 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.0 t -63.91 82.21 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.495 2 CA-C-N 130.343 5.974 . . . . 0.0 114.324 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.5 tt0 -20.6 -72.42 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.6 0 N-CA-C 118.518 2.784 . . . . 0.0 118.518 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.55 ' O ' ' CD2' ' B' ' 3' ' ' PHE . 29.5 Cg_endo -67.04 -3.41 9.65 Favored 'Trans proline' 0 N--CA 1.51 2.473 0 C-N-CA 122.361 2.04 . . . . 0.0 115.383 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -120.85 -14.18 8.54 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.457 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.35 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.55 -33.94 1.74 Allowed Glycine 1 N--CA 1.521 4.343 0 O-C-N 121.491 -0.756 . . . . 0.0 112.645 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.6 68.51 7.98 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.9 26.74 0.05 OUTLIER Glycine 1 N--CA 1.528 4.774 0 CA-C-N 114.0 -1.455 . . . . 0.0 116.631 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.605 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.1 ttm -108.63 43.9 1.19 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 124.539 2.114 . . . . 0.0 112.973 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.02 134.87 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 112.209 -2.269 . . . . 0.0 110.916 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.539 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.62 154.88 19.33 Favored Glycine 1 N--CA 1.536 5.36 0 C-N-CA 119.468 -1.349 . . . . 0.0 114.023 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 ttpp -118.63 81.95 1.77 Allowed 'General case' 0 N--CA 1.516 2.863 0 CA-C-N 119.408 1.604 . . . . 0.0 115.238 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.66 123.22 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.731 0 C-N-CA 118.061 -1.456 . . . . 0.0 107.087 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.5 m -112.59 88.74 2.89 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.177 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.47 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.2 t -74.08 105.15 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.16 -72.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 O-C-N 126.112 2.133 . . . . 0.0 115.93 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.589 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.534 0 O-C-N 125.555 1.785 . . . . 0.0 113.796 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.108 ' CE1' HD21 ' A' ' 64' ' ' LEU . 61.1 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.281 22.0 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.55 ' CD2' ' O ' ' A' ' 91' ' ' PRO . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.7 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.31 27.8 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.405 ' HE ' ' CE1' ' B' ' 150' ' ' HIS . 53.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.611 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.525 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.638 HG22 HG11 ' B' ' 151' ' ' VAL 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.557 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.368 22.4 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 33.0 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.785 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.411 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.418 HG12 ' N ' ' B' ' 69' ' ' GLY . 88.0 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.418 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.506 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 50.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 0.72 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.72 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.2 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.512 HG22 HG11 ' B' ' 114' ' ' VAL 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.3 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' B' ' 130' ' ' PRO . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.7 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 1.489 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 20.7 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' GLN . . . . . 0.854 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.6 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.512 HG11 HG22 ' B' ' 84' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . 0.592 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 1.23 ' O ' ' HE1' ' A' ' 66' ' ' MET . 36.4 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 1.374 ' HA ' ' CE ' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.467 ' HB3' HD21 ' B' ' 94' ' ' LEU . 24.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.442 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' PRO . . . . . 0.693 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.328 23.8 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.556 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.556 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.317 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' PHE . . . . . 0.693 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.418 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 150' ' ' HIS . . . . . 0.405 ' CE1' ' HE ' ' B' ' 14' ' ' ARG . 82.0 m-70 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.638 HG11 HG22 ' B' ' 34' ' ' VAL . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.503 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.0 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.525 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' PRO . . . . . 0.436 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 23.0 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.1 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.635 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' TYR . . . . . 0.635 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 189' ' ' GLU . . . . . 0.798 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.363 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.739 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.8 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.256 25.9 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.627 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' ASN . . . . . 0.537 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 19.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 255' ' ' HEC . . . . . 0.611 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.493 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 82.5 m -61.65 89.68 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.022 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.95 163.01 12.63 Favored 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.462 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.72 122.41 46.68 Favored 'General case' 0 N--CA 1.526 3.326 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.5 t -100.57 98.36 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.7 mmmt -67.27 65.33 0.07 Allowed 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 113.144 -1.844 . . . . 0.0 114.9 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.833 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.7 mt -29.45 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 126.539 1.935 . . . . 0.0 115.531 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.48 59.04 0.4 Allowed Glycine 0 N--CA 1.51 3.576 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -0.95 54.0 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.61 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.84 22.57 14.34 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 120.956 -1.09 . . . . 0.0 108.154 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.22 -94.82 1.89 Allowed Glycine 0 N--CA 1.512 3.715 0 N-CA-C 115.499 0.96 . . . . 0.0 115.499 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.499 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 44.6 tp -150.59 -177.14 5.8 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.1 mt -74.77 46.65 0.3 Allowed 'General case' 0 N--CA 1.509 2.499 0 O-C-N 120.641 -1.287 . . . . 0.0 111.264 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.78 165.6 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.621 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.9 m-30 -102.17 75.43 1.5 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 112.263 -2.244 . . . . 0.0 113.423 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.307 12.4 mt-10 -93.51 142.43 25.18 Favored Pre-proline 0 N--CA 1.506 2.333 0 O-C-N 121.822 -0.549 . . . . 0.0 111.778 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.5 76.22 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.431 0 N-CA-C 116.4 1.654 . . . . 0.0 116.4 -9.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.63 -44.22 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.795 1 N-CA-C 122.319 4.192 . . . . 0.0 122.319 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.631 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.56 71.65 1.0 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 122.388 1.09 . . . . 0.0 113.066 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.804 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.1 111.2 7.13 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.131 -1.606 . . . . 0.0 109.099 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.485 ' N ' HD23 ' A' ' 21' ' ' LEU . 49.7 m -87.46 81.42 7.81 Favored 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.804 HG23 HD22 ' A' ' 21' ' ' LEU . 5.3 pt -79.72 -177.55 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.626 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.623 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.68 166.55 10.58 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-N 113.78 -1.554 . . . . 0.0 108.122 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.4 Cg_endo -52.22 77.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.318 0 N-CA-C 116.866 1.833 . . . . 0.0 116.866 174.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.07 -50.51 0.52 Allowed Glycine 1 N--CA 1.522 4.428 0 C-N-CA 119.717 -1.23 . . . . 0.0 115.879 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.563 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.73 92.11 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.184 1 N-CA-C 122.19 4.144 . . . . 0.0 122.19 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 28' ' ' THR . 11.9 m -64.1 36.07 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.019 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.8 t -52.11 147.17 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 CA-C-N 112.853 -1.976 . . . . 0.0 111.51 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 4.1 pt-20 -114.2 154.88 27.11 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 123.916 1.817 . . . . 0.0 115.38 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.52 113.81 27.39 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.554 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.67 112.6 25.02 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -75.17 84.74 2.37 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.159 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.33 -45.11 18.36 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.92 -169.25 3.33 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 124.662 1.185 . . . . 0.0 109.109 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.921 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.7 m 12.75 70.69 0.11 Allowed Pre-proline 0 N--CA 1.52 3.066 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.235 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.44 177.24 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.219 0 C-N-CA 123.99 3.127 . . . . 0.0 114.424 -165.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.6 Cg_endo -92.44 165.31 25.18 Favored 'Cis proline' 0 N--CA 1.503 2.048 0 N-CA-C 115.399 1.269 . . . . 0.0 115.399 -7.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.833 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.9 87.43 2.73 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -103.36 140.35 37.55 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 122.482 2.401 . . . . 0.0 110.664 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.0 m -118.12 116.24 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 121.438 3.866 . . . . 0.0 121.438 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.562 HG22 ' CB ' ' A' ' 88' ' ' TYR . 15.0 m -75.92 165.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 102.258 -3.238 . . . . 0.0 102.258 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.046 ' HB2' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.32 130.97 55.51 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.483 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.41 93.78 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.168 1 N-CA-C 124.111 4.856 . . . . 0.0 124.111 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.07 6.8 43.47 Favored 'General case' 0 CA--C 1.602 2.967 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.81 -65.55 1.18 Allowed 'General case' 0 CA--C 1.574 1.889 0 C-N-CA 127.549 2.339 . . . . 0.0 112.723 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.71 66.45 9.47 Favored 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.37 151.27 0.75 Allowed Pre-proline 0 N--CA 1.523 3.182 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.8 Cg_endo -42.47 -58.28 1.32 Allowed 'Trans proline' 0 N--CA 1.507 2.324 0 C-N-CA 123.385 2.724 . . . . 0.0 115.079 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.43 67.4 0.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 124.069 1.89 . . . . 0.0 107.038 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.2 53.51 1.0 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 112.275 -2.239 . . . . 0.0 108.249 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.85 56.91 0.76 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.712 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.63 -47.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.244 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.17 -30.83 0.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.174 -1.579 . . . . 0.0 111.558 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.547 ' HG ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 pp -41.13 -28.59 0.1 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 122.693 1.235 . . . . 0.0 112.498 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.8 -27.57 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.628 ' HE2' ' OE1' ' B' ' 189' ' ' GLU . 12.3 tptt 65.06 -55.58 0.3 Allowed 'General case' 0 N--CA 1.532 3.632 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -41.68 -28.93 0.16 Allowed 'General case' 0 N--CA 1.515 2.785 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.046 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.8 pp -53.68 -66.79 0.33 Allowed 'General case' 0 CA--C 1.603 2.999 0 N-CA-C 100.711 -3.811 . . . . 0.0 100.711 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.762 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.14 98.39 2.12 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 125.33 1.452 . . . . 0.0 112.789 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.686 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -89.99 -173.0 3.71 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.686 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.37 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.611 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 28.0 tt0 105.45 65.9 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 120.346 3.462 . . . . 0.0 120.346 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.295 HD21 ' CE1' ' B' ' 1' ' ' TYR . 6.0 mp 38.24 84.26 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 120.762 3.616 . . . . 0.0 120.762 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.495 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 36.2 mt -70.65 82.04 0.6 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.18 -1.575 . . . . 0.0 111.812 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.904 ' HE3' HD23 ' B' ' 119' ' ' LEU . 41.2 mmm -79.28 62.0 3.52 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 126.158 2.885 . . . . 0.0 110.94 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.7 m -112.62 65.94 0.87 Allowed Pre-proline 0 N--CA 1.504 2.267 0 CA-C-N 110.486 -3.052 . . . . 0.0 113.577 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -51.98 81.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.987 2.458 . . . . 0.0 114.674 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.18 6.56 27.65 Favored Glycine 1 N--CA 1.516 4.028 0 O-C-N 122.209 -0.307 . . . . 0.0 113.604 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.9 tt0 -123.54 156.82 34.95 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 124.324 2.011 . . . . 0.0 116.368 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.82 156.35 27.42 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 119.694 3.22 . . . . 0.0 119.694 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -116.0 147.91 40.71 Favored 'General case' 0 N--CA 1.518 2.951 0 CA-C-O 116.59 -1.671 . . . . 0.0 107.222 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.49 143.62 42.03 Favored 'General case' 0 N--CA 1.529 3.515 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.5 m -119.89 102.56 8.65 Favored 'General case' 0 N--CA 1.515 2.8 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.569 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 76' ' ' PHE . 44.1 m -94.73 152.26 18.6 Favored 'General case' 0 N--CA 1.524 3.246 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' N ' HG22 ' A' ' 75' ' ' THR . 89.2 m-85 -107.96 168.4 7.95 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.068 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.41 -174.77 1.53 Allowed 'Trans proline' 0 CA--C 1.558 1.708 0 C-N-CA 121.012 1.141 . . . . 0.0 111.116 161.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.38 -19.75 18.97 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 124.34 2.019 . . . . 0.0 107.222 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.17 42.63 0.49 Allowed 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 111.195 -2.729 . . . . 0.0 109.106 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.18 84.75 9.51 Favored Pre-proline 0 N--CA 1.5 2.028 0 CA-C-N 113.603 -1.635 . . . . 0.0 113.841 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -79.4 178.68 7.13 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.77 2.313 . . . . 0.0 112.354 172.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.588 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.11 77.75 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 C-N-CA 125.367 1.467 . . . . 0.0 113.244 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.54 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.4 125.03 5.64 Favored Glycine 0 N--CA 1.508 3.487 0 N-CA-C 121.694 3.438 . . . . 0.0 121.694 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.8 mt-10 -99.49 61.26 1.17 Allowed 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.54 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.8 m-85 -62.1 77.69 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 122.884 1.326 . . . . 0.0 113.07 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 6.8 m -63.29 135.89 57.33 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.536 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.49 136.58 52.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.562 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.7 82.05 8.59 Favored 'General case' 0 N--CA 1.511 2.607 1 N-CA-C 132.617 8.006 . . . . 0.0 132.617 -179.334 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.1 t -63.93 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.499 2 CA-C-N 130.355 5.98 . . . . 0.0 114.295 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.5 tt0 -20.53 -72.44 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.565 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.562 ' O ' ' CD2' ' B' ' 3' ' ' PHE . 29.5 Cg_endo -66.98 -3.51 9.79 Favored 'Trans proline' 0 N--CA 1.511 2.548 0 C-N-CA 122.467 2.112 . . . . 0.0 115.363 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -120.86 -14.16 8.54 Favored 'General case' 0 N--CA 1.51 2.565 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.34 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.52 -34.0 1.74 Allowed Glycine 1 N--CA 1.52 4.292 0 O-C-N 121.534 -0.729 . . . . 0.0 112.735 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.59 68.41 7.93 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.93 26.73 0.05 OUTLIER Glycine 1 N--CA 1.527 4.733 0 CA-C-N 114.035 -1.439 . . . . 0.0 116.605 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.603 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.1 ttt -108.51 43.81 1.19 Allowed 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 124.406 2.05 . . . . 0.0 113.0 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.01 134.85 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 112.247 -2.251 . . . . 0.0 110.968 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.536 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.68 154.87 19.36 Favored Glycine 1 N--CA 1.535 5.24 0 C-N-CA 119.435 -1.364 . . . . 0.0 114.013 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 ttpp -118.58 81.97 1.77 Allowed 'General case' 0 N--CA 1.517 2.907 0 CA-C-N 119.405 1.602 . . . . 0.0 115.242 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.75 123.28 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.743 0 C-N-CA 118.0 -1.48 . . . . 0.0 107.026 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.5 m -112.57 88.75 2.9 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.228 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.471 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.3 t -74.01 105.19 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.26 -72.37 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.643 0 O-C-N 126.121 2.138 . . . . 0.0 115.885 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.588 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.48 0 O-C-N 125.43 1.706 . . . . 0.0 113.889 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.295 ' CE1' HD21 ' A' ' 64' ' ' LEU . 61.1 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.281 21.7 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 91' ' ' PRO . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' TRP . . . . . 0.437 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.7 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.31 27.6 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.408 ' HE ' ' CE1' ' B' ' 150' ' ' HIS . 52.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.611 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.525 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.638 HG22 HG11 ' B' ' 151' ' ' VAL 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.557 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.369 22.0 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 33.1 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.783 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.41 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.418 HG12 ' N ' ' B' ' 69' ' ' GLY . 87.8 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.418 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.505 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 50.2 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 0.719 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.0 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.719 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.3 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.511 HG22 HG11 ' B' ' 114' ' ' VAL 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' B' ' 130' ' ' PRO . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.6 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 1.235 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 20.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' GLN . . . . . 0.921 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.6 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.511 HG11 HG22 ' B' ' 84' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . 0.591 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 1.2 ' CG ' HD23 ' A' ' 64' ' ' LEU . 36.5 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.904 HD23 ' HE3' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 93.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.467 ' HB3' HD21 ' B' ' 94' ' ' LEU . 24.1 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.783 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.441 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' PRO . . . . . 0.693 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.328 23.5 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.556 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.556 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.316 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' PHE . . . . . 0.693 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.417 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 150' ' ' HIS . . . . . 0.408 ' CE1' ' HE ' ' B' ' 14' ' ' ARG . 82.0 m-70 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.638 HG11 HG22 ' B' ' 34' ' ' VAL . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.502 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.524 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' PRO . . . . . 0.437 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 22.9 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.1 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.634 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 172' ' ' TYR . . . . . 0.634 ' N ' HD23 ' B' ' 171' ' ' LEU . 18.9 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' GLU . . . . . 0.628 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.362 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.739 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.7 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.257 25.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.627 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' ASN . . . . . 0.536 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.521 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.0 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 255' ' ' HEC . . . . . 0.611 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.48 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 91.2 m -61.63 89.73 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.975 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -100.01 162.97 12.64 Favored 'General case' 0 N--CA 1.513 2.683 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.462 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.8 t -107.71 122.49 46.83 Favored 'General case' 0 N--CA 1.526 3.331 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.0 t -100.62 98.38 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.46 65.53 0.08 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.834 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.0 mt -29.67 68.27 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.996 0 C-N-CA 126.54 1.936 . . . . 0.0 115.493 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.46 59.1 0.4 Allowed Glycine 0 N--CA 1.51 3.583 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -1.13 54.15 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.256 0 N-CA-C 120.282 3.438 . . . . 0.0 120.282 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.44 -60.15 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 119.538 3.162 . . . . 0.0 119.538 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.508 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.5 14.42 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.931 -1.106 . . . . 0.0 108.164 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.11 -94.83 1.9 Allowed Glycine 0 N--CA 1.512 3.75 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.3 tp -150.62 -177.16 5.81 Favored 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.554 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.8 mt -74.73 46.7 0.3 Allowed 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.67 -1.269 . . . . 0.0 111.3 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.665 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.74 165.66 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.665 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.22 75.35 1.49 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.402 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.283 7.4 mt-10 -93.46 142.46 25.24 Favored Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 121.825 -0.547 . . . . 0.0 111.753 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 20' ' ' LYS . 53.9 Cg_endo -86.46 76.14 0.09 OUTLIER 'Cis proline' 0 CA--C 1.571 2.364 0 N-CA-C 116.353 1.636 . . . . 0.0 116.353 -9.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.74 -44.26 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 1 N-CA-C 122.241 4.163 . . . . 0.0 122.241 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.636 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.58 71.59 1.0 Allowed 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 122.413 1.101 . . . . 0.0 113.1 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.8 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.16 111.31 7.27 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.199 -1.563 . . . . 0.0 109.111 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.516 ' N ' HD23 ' A' ' 21' ' ' LEU . 55.9 m -87.52 81.47 7.76 Favored 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.8 HG23 HD22 ' A' ' 21' ' ' LEU . 4.9 pt -79.66 -177.55 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.742 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.643 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.51 10.66 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 113.887 -1.506 . . . . 0.0 108.115 179.397 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.0 Cg_endo -52.12 77.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.304 0 N-CA-C 116.934 1.859 . . . . 0.0 116.934 174.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.11 -50.45 0.52 Allowed Glycine 1 N--CA 1.522 4.423 0 C-N-CA 119.706 -1.235 . . . . 0.0 115.857 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.65 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.167 1 N-CA-C 122.08 4.104 . . . . 0.0 122.08 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 28' ' ' THR . 12.6 m -64.09 35.96 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.96 147.21 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 112.862 -1.972 . . . . 0.0 111.51 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.9 pt-20 -114.3 154.86 27.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 123.92 1.819 . . . . 0.0 115.35 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.404 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.7 m-85 -107.46 113.8 27.38 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.69 112.5 24.91 Favored 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 120.728 3.603 . . . . 0.0 120.728 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -75.17 84.73 2.38 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.156 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.6 p30 -80.31 -44.97 18.64 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -150.01 -169.34 3.35 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 124.643 1.177 . . . . 0.0 109.097 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.959 HG12 ' OE1' ' B' ' 104' ' ' GLN . 1.7 m 12.81 70.69 0.11 Allowed Pre-proline 0 N--CA 1.52 3.046 0 N-CA-C 117.168 2.285 . . . . 0.0 117.168 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.561 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 56.3 Cg_endo -98.41 177.19 0.42 Allowed 'Trans proline' 0 CA--C 1.569 2.263 0 C-N-CA 124.041 3.161 . . . . 0.0 114.372 -165.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 56.5 Cg_endo -92.45 165.24 25.16 Favored 'Cis proline' 0 N--CA 1.503 2.063 0 N-CA-C 115.399 1.269 . . . . 0.0 115.399 -7.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.825 ' HB2' HD13 ' A' ' 7' ' ' LEU . 17.5 m-70 -118.88 87.44 2.73 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.993 HD22 ' HA ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -103.34 140.27 37.65 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 122.421 2.373 . . . . 0.0 110.716 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.9 m -118.16 116.31 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 121.431 3.863 . . . . 0.0 121.431 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.558 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.7 m -75.98 165.4 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.027 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.26 130.89 55.52 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.4 93.71 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.208 1 N-CA-C 124.205 4.891 . . . . 0.0 124.205 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.94 6.7 43.57 Favored 'General case' 0 CA--C 1.602 2.959 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.81 -65.54 1.18 Allowed 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 127.501 2.32 . . . . 0.0 112.668 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 47' ' ' LEU . 2.8 mp -86.62 66.46 9.49 Favored 'General case' 0 N--CA 1.518 2.949 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.36 151.28 0.75 Allowed Pre-proline 0 N--CA 1.522 3.158 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.6 Cg_endo -42.51 -58.3 1.32 Allowed 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 123.389 2.726 . . . . 0.0 115.025 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.51 67.47 0.72 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 124.15 1.928 . . . . 0.0 107.056 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.2 53.5 1.0 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 112.267 -2.242 . . . . 0.0 108.219 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.82 56.81 0.76 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.675 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.46 -48.01 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.13 -30.85 0.17 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.127 -1.608 . . . . 0.0 111.606 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD12 ' C ' ' A' ' 55' ' ' LEU . 2.9 pp -41.12 -28.6 0.1 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.649 1.214 . . . . 0.0 112.461 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.76 -27.7 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.14 -55.57 0.31 Allowed 'General case' 0 N--CA 1.534 3.752 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -41.69 -28.94 0.16 Allowed 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.027 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.6 pp -53.68 -66.82 0.32 Allowed 'General case' 0 CA--C 1.604 3.035 0 N-CA-C 100.697 -3.816 . . . . 0.0 100.697 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.802 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.9 p -72.06 98.42 2.09 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 125.267 1.427 . . . . 0.0 112.814 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.673 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.1 t60 -90.02 -173.03 3.72 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.673 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.42 155.2 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.317 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.597 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.1 tt0 105.43 66.02 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 120.309 3.448 . . . . 0.0 120.309 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.349 HD21 ' CE1' ' B' ' 1' ' ' TYR . 6.0 mp 38.19 84.25 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 120.748 3.61 . . . . 0.0 120.748 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.3 mt -70.66 82.04 0.61 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.145 -1.597 . . . . 0.0 111.865 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.982 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 42.2 mmm -79.21 61.94 3.46 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 126.074 2.845 . . . . 0.0 110.965 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.9 m -112.53 65.96 0.85 Allowed Pre-proline 0 C--N 1.284 -2.262 0 CA-C-N 110.464 -3.062 . . . . 0.0 113.601 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.695 ' HB2' ' OD2' ' B' ' 100' ' ' ASP . 21.3 Cg_endo -51.98 81.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.507 0 C-N-CA 122.964 2.442 . . . . 0.0 114.675 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.17 6.69 27.55 Favored Glycine 1 N--CA 1.517 4.056 0 O-C-N 122.238 -0.289 . . . . 0.0 113.513 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.8 tt0 -123.61 156.8 35.11 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 124.34 2.019 . . . . 0.0 116.349 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.439 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.83 156.37 27.4 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 119.716 3.228 . . . . 0.0 119.716 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.7 t -116.06 147.88 40.8 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-O 116.682 -1.628 . . . . 0.0 107.199 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.45 143.72 41.83 Favored 'General case' 0 N--CA 1.529 3.503 0 N-CA-C 118.347 2.721 . . . . 0.0 118.347 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.3 m -119.88 102.62 8.7 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.517 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 28' ' ' THR . 51.7 m -94.85 152.22 18.57 Favored 'General case' 0 N--CA 1.525 3.297 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' N ' HG22 ' A' ' 75' ' ' THR . 90.0 m-85 -107.95 168.28 8.12 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.059 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -72.27 -174.8 1.51 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 121.03 1.153 . . . . 0.0 111.157 161.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.35 -19.76 18.99 Favored 'General case' 0 N--CA 1.509 2.504 0 CA-C-O 124.384 2.04 . . . . 0.0 107.286 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.14 42.72 0.49 Allowed 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 111.225 -2.716 . . . . 0.0 109.111 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.38 84.74 9.88 Favored Pre-proline 0 N--CA 1.499 2.008 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.809 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 83' ' ' GLY . 42.4 Cg_endo -79.39 178.63 7.2 Favored 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 122.753 2.302 . . . . 0.0 112.275 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.596 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -15.99 77.69 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 125.348 1.459 . . . . 0.0 113.264 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.544 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.43 125.01 5.63 Favored Glycine 0 N--CA 1.507 3.417 0 N-CA-C 121.74 3.456 . . . . 0.0 121.74 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.9 mt-10 -99.51 61.25 1.17 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.544 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.9 m-85 -62.05 77.79 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 122.904 1.335 . . . . 0.0 113.032 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 7.2 m -63.42 135.95 57.29 Favored 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.53 136.51 52.92 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.558 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.64 82.07 8.58 Favored 'General case' 0 N--CA 1.512 2.672 1 N-CA-C 132.559 7.985 . . . . 0.0 132.559 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.711 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.6 t -63.85 82.23 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.498 2 CA-C-N 130.329 5.968 . . . . 0.0 114.314 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.1 tt0 -20.57 -72.45 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.56 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.406 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 35.6 Cg_endo -67.04 -3.43 9.69 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.326 2.017 . . . . 0.0 115.401 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -120.84 -14.12 8.56 Favored 'General case' 0 N--CA 1.511 2.585 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.23 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.53 -33.91 1.75 Allowed Glycine 1 N--CA 1.52 4.266 0 O-C-N 121.535 -0.728 . . . . 0.0 112.657 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.64 68.42 7.98 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.92 26.7 0.05 OUTLIER Glycine 1 N--CA 1.526 4.636 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.581 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.5 43.87 1.19 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 124.559 2.123 . . . . 0.0 113.023 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.94 134.91 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 112.19 -2.277 . . . . 0.0 110.902 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.7 154.88 19.38 Favored Glycine 1 N--CA 1.536 5.347 0 C-N-CA 119.489 -1.339 . . . . 0.0 113.978 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.7 82.0 1.78 Allowed 'General case' 0 N--CA 1.518 2.94 0 CA-C-N 119.371 1.585 . . . . 0.0 115.192 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.473 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.69 123.33 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.4 m -112.7 88.75 2.9 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.193 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.456 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.2 t -73.98 105.21 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.35 -72.26 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 O-C-N 126.132 2.145 . . . . 0.0 115.942 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.596 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.486 0 O-C-N 125.49 1.744 . . . . 0.0 113.811 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.349 ' CE1' HD21 ' A' ' 64' ' ' LEU . 60.8 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' TRP . . . . . 0.45 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.9 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.429 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 62.6 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.6 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.442 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 56.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.5 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 55.5 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' CYS . . . . . 0.529 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 77.0 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.5 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.1 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.63 HG22 HG11 ' B' ' 151' ' ' VAL 0.399 1.4 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.6 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 25.8 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.591 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.5 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 86.9 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.969 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.4 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.582 HG22 HG13 ' B' ' 34' ' ' VAL . 61.1 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.3 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.8 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.421 HG12 ' N ' ' B' ' 69' ' ' GLY . 86.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.421 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' LEU . . . . . 0.515 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.505 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.2 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.9 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 0.779 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 19.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.779 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 44.1 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ILE . . . . . 0.58 HG22 HG11 ' B' ' 114' ' ' VAL 0.384 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 37.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 72.6 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 50.4 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.8 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.695 ' OD2' ' HB2' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 1.561 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 19.1 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' GLN . . . . . 0.959 ' OE1' HG12 ' A' ' 36' ' ' VAL . 1.6 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 23.9 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 56.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.58 HG11 HG22 ' B' ' 84' ' ' ILE . 16.5 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.505 HD11 HG23 ' B' ' 75' ' ' VAL 0.727 0.0 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.68 0.1 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' PRO . . . . . 0.839 ' CG ' HD23 ' A' ' 64' ' ' LEU . 38.0 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.982 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 82.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.5 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 94.4 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.969 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.5 1.5 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' PRO . . . . . 0.653 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 13.0 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASP . . . . . 0.629 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.629 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.393 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' PHE . . . . . 0.653 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.0 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.6 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.426 1.2 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' HIS . . . . . 0.442 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.63 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.495 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.666 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.2 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.457 1.3 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' PRO . . . . . 0.45 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 20.2 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.461 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 64.3 t30 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' LEU . . . . . 0.664 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 172' ' ' TYR . . . . . 0.664 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.6 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.4 HG22 ' N ' ' B' ' 178' ' ' GLY . 58.5 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.4 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.8 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.1 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 43.8 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.444 0.9 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.791 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.366 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 81.0 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.8 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 88.3 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.9 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.391 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.6 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' ASN . . . . . 0.501 ' OD1' ' C ' ' B' ' 234' ' ' ASN . 1.4 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' ASN . . . . . 0.475 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 22.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.6 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.2 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' LEU . . . . . 0.436 HD22 HD11 ' B' ' 142' ' ' ILE . 41.0 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 118.159 -0.924 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 255' ' ' HEC . . . . . 0.608 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.602 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.3 m -61.55 89.7 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -99.99 163.04 12.61 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.47 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.82 122.41 46.72 Favored 'General case' 0 N--CA 1.525 3.321 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -100.49 98.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.33 65.38 0.07 Allowed 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 113.14 -1.845 . . . . 0.0 114.855 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.3 mt -29.52 68.27 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 126.521 1.929 . . . . 0.0 115.543 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.44 59.01 0.4 Allowed Glycine 0 N--CA 1.509 3.539 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.1 p -1.0 54.04 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.33 0 N-CA-C 120.242 3.423 . . . . 0.0 120.242 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.53 -60.19 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.49 14.43 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.962 -1.086 . . . . 0.0 108.151 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.06 -94.86 1.91 Allowed Glycine 0 N--CA 1.512 3.75 0 N-CA-C 115.546 0.978 . . . . 0.0 115.546 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.553 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.9 tp -150.64 -177.13 5.8 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.557 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.6 mt -74.8 46.73 0.3 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.654 -1.279 . . . . 0.0 111.244 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.655 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.83 165.64 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 118.503 2.779 . . . . 0.0 118.503 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.655 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.25 75.35 1.48 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 112.187 -2.279 . . . . 0.0 113.356 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.47 142.47 25.25 Favored Pre-proline 0 N--CA 1.507 2.376 0 O-C-N 121.822 -0.549 . . . . 0.0 111.735 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 20' ' ' LYS . 56.3 Cg_endo -86.43 76.09 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.426 0 N-CA-C 116.359 1.638 . . . . 0.0 116.359 -9.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.73 -44.23 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 1 N-CA-C 122.3 4.185 . . . . 0.0 122.3 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.638 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.62 71.66 1.0 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 122.433 1.111 . . . . 0.0 113.092 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.808 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.11 111.27 7.19 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.152 -1.592 . . . . 0.0 109.107 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.524 ' N ' HD23 ' A' ' 21' ' ' LEU . 52.6 m -87.51 81.5 7.76 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.808 HG23 HD22 ' A' ' 21' ' ' LEU . 4.7 pt -79.7 -177.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.652 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.646 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.69 166.58 10.51 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-N 113.769 -1.559 . . . . 0.0 108.067 179.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.4 Cg_endo -52.18 77.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.571 2.326 0 N-CA-C 116.947 1.864 . . . . 0.0 116.947 174.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.13 -50.48 0.52 Allowed Glycine 1 N--CA 1.522 4.414 0 C-N-CA 119.73 -1.224 . . . . 0.0 115.833 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.71 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.151 1 N-CA-C 122.104 4.113 . . . . 0.0 122.104 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 28' ' ' THR . 11.5 m -64.01 35.91 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.012 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.95 147.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 112.863 -1.971 . . . . 0.0 111.517 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.9 pt-20 -114.29 154.93 27.12 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 123.934 1.826 . . . . 0.0 115.359 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.415 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.6 m-85 -107.55 113.86 27.46 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.79 112.57 25.02 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 120.636 3.569 . . . . 0.0 120.636 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -75.13 84.75 2.35 Favored 'General case' 0 N--CA 1.512 2.645 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.18 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.7 p30 -80.26 -45.14 18.44 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.9 -169.29 3.34 Favored 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 124.661 1.184 . . . . 0.0 109.118 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.911 HG12 HE22 ' B' ' 104' ' ' GLN . 1.6 m 12.82 70.7 0.11 Allowed Pre-proline 0 N--CA 1.521 3.079 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.458 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 58.4 Cg_endo -98.4 177.24 0.41 Allowed 'Trans proline' 0 CA--C 1.569 2.261 0 C-N-CA 123.945 3.096 . . . . 0.0 114.422 -165.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.602 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 58.2 Cg_endo -92.41 165.28 25.29 Favored 'Cis proline' 0 N--CA 1.504 2.105 0 N-CA-C 115.402 1.27 . . . . 0.0 115.402 -7.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.818 ' HB2' HD13 ' A' ' 7' ' ' LEU . 17.9 m-70 -118.88 87.44 2.73 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.615 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -103.4 140.29 37.66 Favored 'General case' 0 N--CA 1.516 2.832 0 CA-C-N 122.469 2.395 . . . . 0.0 110.719 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.498 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.5 m -118.11 116.25 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 121.419 3.859 . . . . 0.0 121.419 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.567 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.5 m -75.95 165.35 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.033 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.26 131.02 55.47 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.436 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.47 93.77 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.174 1 N-CA-C 124.148 4.87 . . . . 0.0 124.148 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.98 6.76 43.43 Favored 'General case' 0 CA--C 1.602 2.97 0 N-CA-C 101.23 -3.618 . . . . 0.0 101.23 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.84 -65.57 1.18 Allowed 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 127.526 2.33 . . . . 0.0 112.669 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.681 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.47 9.49 Favored 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.41 151.25 0.74 Allowed Pre-proline 0 N--CA 1.523 3.181 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.0 Cg_endo -42.51 -58.17 1.36 Allowed 'Trans proline' 0 N--CA 1.508 2.359 0 C-N-CA 123.362 2.708 . . . . 0.0 115.102 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.543 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.51 67.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 124.066 1.888 . . . . 0.0 107.062 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.16 53.5 0.99 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 112.275 -2.239 . . . . 0.0 108.208 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.87 56.89 0.76 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.773 2.508 . . . . 0.0 117.773 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.672 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.51 -48.0 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.13 -30.85 0.16 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.106 -1.622 . . . . 0.0 111.571 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.514 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.16 -28.52 0.1 Allowed 'General case' 0 N--CA 1.509 2.501 0 CA-C-O 122.716 1.246 . . . . 0.0 112.475 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.497 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.81 -27.63 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.466 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.04 -55.59 0.3 Allowed 'General case' 0 N--CA 1.533 3.691 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -41.68 -28.93 0.16 Allowed 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.033 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.72 -66.71 0.34 Allowed 'General case' 0 CA--C 1.603 3.019 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.806 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.6 p -72.18 98.47 2.15 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.273 1.429 . . . . 0.0 112.765 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.669 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.03 -173.1 3.74 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.669 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.43 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.365 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.591 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.1 tt0 105.52 65.99 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 120.292 3.441 . . . . 0.0 120.292 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.778 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.9 mp 38.13 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.615 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 35.2 mt -70.64 82.05 0.6 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.101 -1.624 . . . . 0.0 111.886 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 1.312 ' CE ' ' CD2' ' B' ' 119' ' ' LEU . 41.9 mmm -79.23 61.97 3.48 Favored 'General case' 0 N--CA 1.511 2.579 0 CA-C-O 126.021 2.82 . . . . 0.0 110.913 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.6 m -112.61 65.98 0.87 Allowed Pre-proline 0 C--N 1.283 -2.287 0 CA-C-N 110.525 -3.034 . . . . 0.0 113.585 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.679 ' CG ' ' OD2' ' B' ' 100' ' ' ASP . 21.9 Cg_endo -52.03 81.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.461 0 C-N-CA 122.945 2.43 . . . . 0.0 114.699 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.64 27.66 Favored Glycine 0 N--CA 1.516 3.973 0 O-C-N 122.177 -0.327 . . . . 0.0 113.637 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.55 156.94 34.76 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 124.321 2.01 . . . . 0.0 116.367 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -117.05 156.34 27.71 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 119.628 3.195 . . . . 0.0 119.628 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -115.89 147.97 40.5 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-O 116.603 -1.665 . . . . 0.0 107.236 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.5 143.71 41.91 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 118.383 2.734 . . . . 0.0 118.383 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.4 m -119.94 102.54 8.63 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.543 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.451 ' OG1' HG23 ' A' ' 28' ' ' THR . 48.4 m -94.73 152.18 18.66 Favored 'General case' 0 N--CA 1.526 3.334 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.429 ' N ' HG22 ' A' ' 75' ' ' THR . 90.3 m-85 -107.92 168.31 8.08 Favored Pre-proline 0 N--CA 1.503 2.184 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.09 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -72.35 -174.74 1.51 Allowed 'Trans proline' 0 CA--C 1.559 1.747 0 C-N-CA 120.994 1.129 . . . . 0.0 111.149 161.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.77 18.96 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 124.41 2.052 . . . . 0.0 107.235 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.13 42.61 0.49 Allowed 'General case' 0 CA--C 1.577 1.984 0 CA-C-N 111.265 -2.698 . . . . 0.0 109.097 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.27 84.74 9.66 Favored Pre-proline 0 N--CA 1.5 2.032 0 CA-C-N 113.608 -1.633 . . . . 0.0 113.768 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 83' ' ' GLY . 45.9 Cg_endo -79.41 178.68 7.13 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.73 2.287 . . . . 0.0 112.245 172.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.6 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.05 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.91 0 C-N-CA 125.29 1.436 . . . . 0.0 113.333 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.529 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.41 125.01 5.63 Favored Glycine 0 N--CA 1.508 3.456 0 N-CA-C 121.76 3.464 . . . . 0.0 121.76 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.9 mt-10 -99.43 61.2 1.18 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.529 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.07 77.75 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 122.93 1.348 . . . . 0.0 113.013 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.7 m -63.41 135.97 57.31 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.555 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.51 136.52 52.91 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.567 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.61 82.05 8.59 Favored 'General case' 0 N--CA 1.512 2.627 1 N-CA-C 132.634 8.013 . . . . 0.0 132.634 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.94 82.19 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.438 2 CA-C-N 130.343 5.974 . . . . 0.0 114.313 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.1 tt0 -20.52 -72.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.459 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 36.6 Cg_endo -67.07 -3.43 9.72 Favored 'Trans proline' 0 N--CA 1.511 2.517 0 C-N-CA 122.383 2.056 . . . . 0.0 115.356 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -120.91 -14.13 8.52 Favored 'General case' 0 N--CA 1.511 2.594 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.466 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.25 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.64 -34.16 1.72 Allowed Glycine 1 N--CA 1.521 4.324 0 O-C-N 121.518 -0.739 . . . . 0.0 112.643 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.42 68.44 7.75 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.94 26.63 0.05 OUTLIER Glycine 1 N--CA 1.527 4.71 0 N-CA-C 116.665 1.426 . . . . 0.0 116.665 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.558 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.46 43.84 1.19 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 124.524 2.107 . . . . 0.0 113.016 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.96 134.81 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 112.313 -2.221 . . . . 0.0 110.954 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.62 154.9 19.34 Favored Glycine 1 N--CA 1.535 5.289 0 C-N-CA 119.49 -1.338 . . . . 0.0 113.997 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.61 81.91 1.77 Allowed 'General case' 0 N--CA 1.517 2.912 0 CA-C-N 119.488 1.644 . . . . 0.0 115.226 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.463 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.74 123.31 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 C-N-CA 118.03 -1.468 . . . . 0.0 107.044 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.9 m -112.65 88.76 2.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.15 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.442 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.1 t -74.06 105.27 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.39 -72.25 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.627 0 O-C-N 126.095 2.122 . . . . 0.0 115.885 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.6 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.484 0 O-C-N 125.526 1.766 . . . . 0.0 113.84 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 24.3 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' TRP . . . . . 0.455 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . 0.447 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.449 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 53.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.7 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.4 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 52.8 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 78.4 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.698 HG13 HG22 ' B' ' 50' ' ' VAL 0.389 0.4 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.49 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.7 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 25.8 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.605 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.7 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.0 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.963 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.3 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.698 HG22 HG13 ' B' ' 34' ' ' VAL . 61.3 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.403 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.403 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.4 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.424 HG12 ' N ' ' B' ' 69' ' ' GLY . 81.4 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.424 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.519 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.591 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.5 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.9 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' PRO . . . . . 0.825 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 17.9 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.825 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 44.3 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.52 HG22 HG11 ' B' ' 114' ' ' VAL 0.463 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.679 ' OD2' ' CG ' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.1 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 1.458 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 18.4 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' GLN . . . . . 0.911 HE22 HG12 ' A' ' 36' ' ' VAL . 11.2 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' TYR . . . . . 0.447 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 23.3 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.9 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.52 HG11 HG22 ' B' ' 84' ' ' ILE . 16.7 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 1.578 ' CB ' ' CA ' ' B' ' 115' ' ' ILE 0.521 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.444 ' N ' HG23 ' B' ' 115' ' ' ILE 0.463 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.664 ' O ' ' CE ' ' A' ' 66' ' ' MET . 38.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 1.312 ' CD2' ' CE ' ' A' ' 66' ' ' MET . 81.7 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.8 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.494 ' C ' HG12 ' B' ' 131' ' ' VAL . 13.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.963 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.52 0.7 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.9 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.7 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' PRO . . . . . 0.659 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.7 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . 0.636 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.636 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.453 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . 0.659 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.5 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.387 1.5 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' HIS . . . . . 0.449 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.61 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.485 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.6 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.665 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.1 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.417 0.8 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' PRO . . . . . 0.455 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.6 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.44 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.8 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.675 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . 0.675 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.7 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.402 HG22 ' N ' ' B' ' 178' ' ' GLY . 59.2 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.402 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.0 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.401 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.9 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.448 1.7 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.812 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.439 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.6 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . 0.43 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.43 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 12.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.4 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.417 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' ASN . . . . . 0.511 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.481 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 22.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.6 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.1 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.5 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.55 HD22 HD11 ' B' ' 142' ' ' ILE . 40.7 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.596 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 85.4 m -61.52 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.02 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -100.0 163.01 12.62 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.467 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.75 122.44 46.75 Favored 'General case' 0 N--CA 1.525 3.32 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.4 t -100.57 98.32 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.34 65.4 0.07 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 113.096 -1.865 . . . . 0.0 114.893 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.2 mt -29.49 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 126.585 1.954 . . . . 0.0 115.512 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.45 59.09 0.4 Allowed Glycine 0 N--CA 1.51 3.609 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.4 p -1.09 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 120.31 3.448 . . . . 0.0 120.31 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.48 -60.16 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 119.551 3.167 . . . . 0.0 119.551 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.512 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.84 22.46 14.44 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 120.956 -1.09 . . . . 0.0 108.209 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.09 -94.85 1.91 Allowed Glycine 0 N--CA 1.511 3.672 0 N-CA-C 115.528 0.971 . . . . 0.0 115.528 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.543 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.7 tp -150.54 -177.13 5.79 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.558 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.7 mt -74.8 46.66 0.3 Allowed 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.627 -1.295 . . . . 0.0 111.247 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.672 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.74 165.73 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 118.575 2.805 . . . . 0.0 118.575 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.672 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.34 75.45 1.48 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.384 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.274 4.8 mt-10 -93.48 142.37 25.11 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.781 -0.574 . . . . 0.0 111.806 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 20' ' ' LYS . 55.9 Cg_endo -86.47 76.15 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.389 0 N-CA-C 116.352 1.635 . . . . 0.0 116.352 -9.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.68 -44.17 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.737 1 N-CA-C 122.238 4.162 . . . . 0.0 122.238 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.64 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.68 71.6 0.99 Allowed 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.442 1.115 . . . . 0.0 113.049 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.793 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.1 111.3 7.21 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.178 -1.576 . . . . 0.0 109.098 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.522 ' N ' HD23 ' A' ' 21' ' ' LEU . 54.6 m -87.48 81.38 7.81 Favored 'General case' 0 N--CA 1.514 2.728 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.793 HG23 HD22 ' A' ' 21' ' ' LEU . 4.8 pt -79.68 -177.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.675 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.652 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.72 166.54 10.59 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.104 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.5 Cg_endo -52.18 77.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.288 0 N-CA-C 116.921 1.854 . . . . 0.0 116.921 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.16 -50.44 0.52 Allowed Glycine 1 N--CA 1.522 4.414 0 C-N-CA 119.733 -1.222 . . . . 0.0 115.852 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.6 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.174 1 N-CA-C 122.101 4.112 . . . . 0.0 122.101 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 28' ' ' THR . 11.6 m -63.99 35.92 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.049 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.01 147.22 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.501 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.9 pt-20 -114.26 154.9 27.14 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 123.914 1.816 . . . . 0.0 115.41 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.402 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.4 m-85 -107.54 113.87 27.47 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.77 112.54 24.97 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 120.71 3.596 . . . . 0.0 120.71 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -75.2 84.72 2.39 Favored 'General case' 0 N--CA 1.511 2.599 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.18 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.5 p30 -80.18 -45.17 18.54 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.89 -169.29 3.34 Favored 'General case' 0 N--CA 1.508 2.467 0 C-N-CA 124.656 1.183 . . . . 0.0 109.111 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.219 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.6 m 12.89 70.68 0.11 Allowed Pre-proline 0 N--CA 1.52 3.055 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.169 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 57.7 Cg_endo -98.52 177.26 0.4 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 123.92 3.08 . . . . 0.0 114.324 -165.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 57.7 Cg_endo -92.44 165.32 25.18 Favored 'Cis proline' 0 N--CA 1.503 2.071 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 -7.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.81 ' HB2' HD13 ' A' ' 7' ' ' LEU . 17.9 m-70 -118.95 87.35 2.72 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.65 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -103.42 140.28 37.68 Favored 'General case' 0 N--CA 1.516 2.857 0 CA-C-N 122.418 2.372 . . . . 0.0 110.685 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.6 m -118.09 116.25 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 121.445 3.868 . . . . 0.0 121.445 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.564 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.7 m -75.88 165.44 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.033 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.28 130.96 55.5 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 46' ' ' ALA . 4.1 m-20 -53.53 93.82 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.185 1 N-CA-C 124.088 4.847 . . . . 0.0 124.088 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.94 6.74 43.44 Favored 'General case' 0 CA--C 1.602 2.952 0 N-CA-C 101.228 -3.619 . . . . 0.0 101.228 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.88 -65.49 1.18 Allowed 'General case' 0 CA--C 1.573 1.85 0 C-N-CA 127.519 2.328 . . . . 0.0 112.705 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.676 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.48 9.5 Favored 'General case' 0 N--CA 1.52 3.034 0 N-CA-C 118.91 2.93 . . . . 0.0 118.91 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.44 151.24 0.74 Allowed Pre-proline 0 N--CA 1.522 3.151 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.7 Cg_endo -42.42 -58.27 1.31 Allowed 'Trans proline' 0 N--CA 1.509 2.391 0 C-N-CA 123.376 2.717 . . . . 0.0 115.113 170.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.544 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.49 67.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 124.112 1.911 . . . . 0.0 107.04 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.16 53.49 0.99 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.344 -2.207 . . . . 0.0 108.265 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.81 56.96 0.75 Allowed 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.68 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.57 -47.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.14 -30.84 0.17 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.226 -1.546 . . . . 0.0 111.564 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.507 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.18 -28.53 0.1 Allowed 'General case' 0 N--CA 1.508 2.449 0 CA-C-O 122.77 1.272 . . . . 0.0 112.567 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.499 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.77 -27.58 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.01 -55.55 0.3 Allowed 'General case' 0 N--CA 1.533 3.691 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.76 -28.89 0.17 Allowed 'General case' 0 N--CA 1.515 2.818 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.033 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.69 -66.82 0.32 Allowed 'General case' 0 CA--C 1.603 3.013 0 N-CA-C 100.69 -3.819 . . . . 0.0 100.69 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.812 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.14 98.46 2.13 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 125.259 1.424 . . . . 0.0 112.806 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.691 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.1 t60 -90.01 -172.93 3.68 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.691 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.34 155.2 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.353 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.598 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.3 tt0 105.41 66.08 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.778 0 N-CA-C 120.285 3.439 . . . . 0.0 120.285 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.795 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.9 mp 38.16 84.18 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 120.805 3.632 . . . . 0.0 120.805 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.65 ' N ' HD21 ' A' ' 40' ' ' ASN . 36.0 mt -70.59 82.08 0.59 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.225 -1.547 . . . . 0.0 111.876 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.582 ' SD ' ' HG3' ' A' ' 38' ' ' PRO . 42.1 mmm -79.29 62.02 3.54 Favored 'General case' 0 N--CA 1.51 2.536 0 CA-C-O 126.066 2.841 . . . . 0.0 110.945 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.2 m -112.65 65.92 0.87 Allowed Pre-proline 0 C--N 1.283 -2.295 0 CA-C-N 110.482 -3.053 . . . . 0.0 113.601 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -52.0 81.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.444 0 C-N-CA 122.98 2.453 . . . . 0.0 114.698 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.19 6.64 27.56 Favored Glycine 0 N--CA 1.515 3.963 0 O-C-N 122.195 -0.316 . . . . 0.0 113.573 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.4 tt0 -123.59 156.94 34.82 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 124.336 2.017 . . . . 0.0 116.331 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.439 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -117.01 156.32 27.69 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 119.641 3.2 . . . . 0.0 119.641 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.5 t -115.96 148.0 40.56 Favored 'General case' 0 N--CA 1.52 3.043 0 CA-C-O 116.633 -1.651 . . . . 0.0 107.229 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.55 143.78 41.86 Favored 'General case' 0 N--CA 1.529 3.512 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.8 m -119.96 102.57 8.65 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 114.146 -1.388 . . . . 0.0 113.575 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 28' ' ' THR . 48.8 m -94.71 152.19 18.67 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.422 ' N ' HG22 ' A' ' 75' ' ' THR . 90.3 m-85 -107.97 168.29 8.1 Favored Pre-proline 0 N--CA 1.504 2.233 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.114 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.35 -174.81 1.53 Allowed 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 120.989 1.126 . . . . 0.0 111.107 161.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.31 -19.82 18.97 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 124.336 2.017 . . . . 0.0 107.235 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.12 42.68 0.49 Allowed 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 111.285 -2.688 . . . . 0.0 109.097 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.79 9.78 Favored Pre-proline 0 N--CA 1.5 2.04 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.794 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 83' ' ' GLY . 44.6 Cg_endo -79.42 178.7 7.11 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.831 2.354 . . . . 0.0 112.23 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.593 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.17 77.73 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.921 0 C-N-CA 125.31 1.444 . . . . 0.0 113.265 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.44 125.1 5.65 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 121.757 3.463 . . . . 0.0 121.757 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.49 61.23 1.17 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.536 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.02 77.77 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.934 1.349 . . . . 0.0 113.049 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.5 136.0 57.27 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.557 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.5 136.57 52.87 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.564 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.76 82.05 8.6 Favored 'General case' 0 N--CA 1.511 2.587 1 N-CA-C 132.586 7.995 . . . . 0.0 132.586 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.83 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.465 2 CA-C-N 130.301 5.955 . . . . 0.0 114.293 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.0 tt0 -20.55 -72.42 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.605 0 N-CA-C 118.502 2.778 . . . . 0.0 118.502 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 36.4 Cg_endo -67.01 -3.54 9.86 Favored 'Trans proline' 0 N--CA 1.511 2.534 0 C-N-CA 122.382 2.055 . . . . 0.0 115.351 176.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -120.82 -14.14 8.56 Favored 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.446 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.37 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 116.625 2.084 . . . . 0.0 116.625 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.59 -33.95 1.74 Allowed Glycine 1 N--CA 1.52 4.291 0 O-C-N 121.57 -0.706 . . . . 0.0 112.682 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.62 68.47 7.98 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.92 26.71 0.05 OUTLIER Glycine 1 N--CA 1.527 4.7 0 CA-C-N 114.008 -1.451 . . . . 0.0 116.629 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.559 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.55 43.9 1.19 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 124.505 2.098 . . . . 0.0 113.071 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.96 134.92 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 112.193 -2.276 . . . . 0.0 110.943 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.61 154.85 19.32 Favored Glycine 1 N--CA 1.536 5.354 0 C-N-CA 119.484 -1.341 . . . . 0.0 113.977 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.59 81.99 1.78 Allowed 'General case' 0 N--CA 1.518 2.942 0 CA-C-N 119.4 1.6 . . . . 0.0 115.264 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.74 123.26 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.9 m -112.62 88.76 2.9 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.187 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.454 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.1 t -74.05 105.21 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.25 -72.36 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 O-C-N 126.039 2.087 . . . . 0.0 115.967 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.593 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.46 0 O-C-N 125.468 1.73 . . . . 0.0 113.819 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' TRP . . . . . 0.452 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.2 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . 0.442 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.2 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.464 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 51.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.5 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 86.5 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 53.9 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 77.5 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.0 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.67 HG13 HG22 ' B' ' 50' ' ' VAL 0.39 0.7 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.3 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 25.5 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.599 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.6 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.6 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.99 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.5 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.67 HG22 HG13 ' B' ' 34' ' ' VAL . 61.2 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.5 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.422 HG12 ' N ' ' B' ' 69' ' ' GLY . 84.1 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.422 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.517 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.575 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.0 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' PRO . . . . . 0.8 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 18.7 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.8 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 42.4 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.561 HG22 HG11 ' B' ' 114' ' ' VAL 0.427 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.0 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.2 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 1.169 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 19.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' GLN . . . . . 1.219 ' NE2' HG12 ' A' ' 36' ' ' VAL . 11.3 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 56.0 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.561 HG11 HG22 ' B' ' 84' ' ' ILE . 16.7 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 1.571 ' CB ' ' CA ' ' B' ' 115' ' ' ILE 0.687 0.0 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.462 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.414 ' HG2' ' CE ' ' A' ' 66' ' ' MET . 38.2 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 81.8 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.6 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 93.1 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.42 ' C ' HG12 ' B' ' 131' ' ' VAL . 13.6 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.99 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.494 1.1 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' PRO . . . . . 0.66 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.9 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . 0.643 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.643 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.428 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . 0.66 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.7 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.408 1.4 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' HIS . . . . . 0.464 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.616 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.477 HH11 ' HD2' ' B' ' 157' ' ' ARG . 30.4 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.661 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.4 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.428 0.9 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' PRO . . . . . 0.452 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.7 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.7 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.67 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . 0.67 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.3 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.402 HG22 ' N ' ' B' ' 178' ' ' GLY . 58.8 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.402 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.2 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . 0.406 ' HB3' HE21 ' B' ' 186' ' ' GLN . 1.9 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 43.1 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.45 1.5 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.804 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.409 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.0 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.5 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . 0.415 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.415 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 13.0 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.406 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' ASN . . . . . 0.516 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.481 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.6 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.503 HD22 HD11 ' B' ' 142' ' ' ILE . 40.8 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 118.051 -0.976 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.597 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.472 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 79.6 m -61.59 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -99.93 163.02 12.63 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.77 122.34 46.56 Favored 'General case' 0 N--CA 1.525 3.322 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.5 t -100.54 98.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 8' ' ' GLY . 14.0 mmmt -67.39 65.48 0.07 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 113.109 -1.86 . . . . 0.0 114.857 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -29.54 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 126.641 1.976 . . . . 0.0 115.449 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.52 59.02 0.4 Allowed Glycine 0 N--CA 1.51 3.568 0 N-CA-C 106.849 -2.501 . . . . 0.0 106.849 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.2 p -1.15 54.22 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 120.21 3.411 . . . . 0.0 120.21 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.42 -60.19 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.75 22.39 14.56 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 120.917 -1.114 . . . . 0.0 108.193 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.08 -94.77 1.9 Allowed Glycine 0 N--CA 1.511 3.691 0 N-CA-C 115.519 0.968 . . . . 0.0 115.519 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.573 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 47.5 tp -150.63 -177.19 5.83 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.573 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 15.8 mt -74.73 46.71 0.3 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.6 -1.312 . . . . 0.0 111.286 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.693 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.8 p -113.75 165.64 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 118.53 2.789 . . . . 0.0 118.53 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.693 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.21 75.42 1.49 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.363 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.48 142.41 25.16 Favored Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.85 -0.531 . . . . 0.0 111.795 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 20' ' ' LYS . 58.4 Cg_endo -86.43 76.11 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.424 0 N-CA-C 116.365 1.64 . . . . 0.0 116.365 -9.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.7 -44.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 1 N-CA-C 122.319 4.192 . . . . 0.0 122.319 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.627 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.67 71.52 0.99 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 122.484 1.135 . . . . 0.0 113.064 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.817 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.02 111.26 7.11 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.116 -1.615 . . . . 0.0 109.107 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.542 ' N ' HD23 ' A' ' 21' ' ' LEU . 55.1 m -87.52 81.42 7.77 Favored 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.817 HG23 HD22 ' A' ' 21' ' ' LEU . 4.6 pt -79.57 -177.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.72 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.67 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.63 10.43 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.097 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 24.3 Cg_endo -52.33 77.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.287 0 N-CA-C 116.897 1.845 . . . . 0.0 116.897 174.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.17 -50.63 0.51 Allowed Glycine 1 N--CA 1.522 4.382 0 C-N-CA 119.682 -1.247 . . . . 0.0 115.836 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.56 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 1 N-CA-C 122.115 4.116 . . . . 0.0 122.115 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 28' ' ' THR . 11.2 m -64.07 35.96 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.018 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -51.96 147.19 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 112.849 -1.978 . . . . 0.0 111.513 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.24 154.89 27.13 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 124.011 1.862 . . . . 0.0 115.368 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.416 ' HB3' HD11 ' A' ' 7' ' ' LEU . 56.7 m-85 -107.51 113.88 27.5 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.585 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.1 tt -100.85 112.52 24.96 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 120.729 3.603 . . . . 0.0 120.729 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -75.16 84.7 2.37 Favored 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.111 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.7 p30 -80.29 -45.09 18.47 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.96 -169.31 3.34 Favored 'General case' 0 N--CA 1.509 2.522 0 C-N-CA 124.569 1.148 . . . . 0.0 109.048 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.393 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.6 m 12.89 70.61 0.11 Allowed Pre-proline 0 N--CA 1.521 3.11 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.608 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 64.2 Cg_endo -98.35 177.25 0.42 Allowed 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 123.994 3.129 . . . . 0.0 114.441 -165.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 60.9 Cg_endo -92.42 165.3 25.26 Favored 'Cis proline' 0 N--CA 1.503 2.037 0 N-CA-C 115.391 1.266 . . . . 0.0 115.391 -7.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.8 ' HB2' HD13 ' A' ' 7' ' ' LEU . 18.4 m-70 -118.96 87.37 2.72 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.754 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -103.33 140.26 37.66 Favored 'General case' 0 N--CA 1.516 2.868 0 CA-C-N 122.387 2.358 . . . . 0.0 110.675 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.4 m -118.13 116.3 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 121.406 3.854 . . . . 0.0 121.406 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.554 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.4 m -75.98 165.36 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 102.189 -3.263 . . . . 0.0 102.189 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.045 ' HB2' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.27 131.01 55.48 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.0 m-20 -53.42 93.73 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.19 1 N-CA-C 124.142 4.867 . . . . 0.0 124.142 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.97 6.72 43.58 Favored 'General case' 0 CA--C 1.602 2.948 0 N-CA-C 101.19 -3.633 . . . . 0.0 101.19 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.8 -65.48 1.18 Allowed 'General case' 0 CA--C 1.574 1.89 0 C-N-CA 127.592 2.357 . . . . 0.0 112.742 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.7 mp -86.75 66.59 9.53 Favored 'General case' 0 N--CA 1.519 3.023 0 N-CA-C 118.874 2.916 . . . . 0.0 118.874 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.39 151.26 0.75 Allowed Pre-proline 0 N--CA 1.522 3.17 0 N-CA-C 117.487 2.402 . . . . 0.0 117.487 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.1 Cg_endo -42.44 -58.25 1.32 Allowed 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 123.426 2.751 . . . . 0.0 115.088 170.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.54 67.38 0.72 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 124.119 1.914 . . . . 0.0 107.012 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.15 53.53 0.99 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 112.292 -2.231 . . . . 0.0 108.25 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.78 56.93 0.75 Allowed 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 117.8 2.519 . . . . 0.0 117.8 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.661 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.61 -47.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.262 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -41.21 -30.87 0.18 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.082 -1.636 . . . . 0.0 111.587 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.526 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.04 -28.64 0.09 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 122.787 1.279 . . . . 0.0 112.552 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.502 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.72 -27.68 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.481 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.13 -55.58 0.31 Allowed 'General case' 0 N--CA 1.533 3.705 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.7 -28.96 0.16 Allowed 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.045 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.4 pp -53.57 -66.9 0.31 Allowed 'General case' 0 CA--C 1.604 3.026 0 N-CA-C 100.688 -3.819 . . . . 0.0 100.688 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.851 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.09 98.47 2.11 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.227 1.411 . . . . 0.0 112.786 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.698 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.0 t60 -90.06 -173.01 3.7 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.698 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.42 155.23 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 26.5 tt0 105.45 65.97 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 120.315 3.45 . . . . 0.0 120.315 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.282 HD23 ' CG ' ' B' ' 118' ' ' PRO . 5.9 mp 38.26 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 120.769 3.618 . . . . 0.0 120.769 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.754 ' N ' HD21 ' A' ' 40' ' ' ASN . 35.3 mt -70.67 82.04 0.61 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.166 -1.584 . . . . 0.0 111.876 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 1.022 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 42.5 mmm -79.16 61.9 3.41 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-O 126.066 2.841 . . . . 0.0 110.962 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.4 m -112.54 65.88 0.84 Allowed Pre-proline 0 N--CA 1.505 2.307 0 CA-C-N 110.482 -3.054 . . . . 0.0 113.597 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -51.87 81.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 122.985 2.457 . . . . 0.0 114.71 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.63 27.66 Favored Glycine 1 N--CA 1.517 4.07 0 O-C-N 122.209 -0.307 . . . . 0.0 113.579 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.4 tt0 -123.62 156.83 35.1 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 124.404 2.049 . . . . 0.0 116.285 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.437 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -116.87 156.46 27.28 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 119.748 3.24 . . . . 0.0 119.748 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -116.02 147.91 40.72 Favored 'General case' 0 N--CA 1.52 3.029 0 CA-C-O 116.651 -1.642 . . . . 0.0 107.253 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.51 143.63 42.05 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.6 m -119.84 102.54 8.65 Favored 'General case' 0 N--CA 1.514 2.747 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.632 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.452 ' OG1' HG23 ' A' ' 28' ' ' THR . 50.2 m -94.76 152.2 18.63 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.416 ' N ' HG22 ' A' ' 75' ' ' THR . 90.7 m-85 -107.93 168.33 8.06 Favored Pre-proline 0 N--CA 1.503 2.178 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.124 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.35 -174.85 1.54 Allowed 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 121.021 1.147 . . . . 0.0 111.109 161.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.33 -19.66 19.08 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 124.435 2.064 . . . . 0.0 107.334 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.22 42.71 0.5 Allowed 'General case' 0 CA--C 1.576 1.98 0 CA-C-N 111.187 -2.733 . . . . 0.0 109.045 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.68 9.67 Favored Pre-proline 0 N--CA 1.499 2.012 0 CA-C-N 113.675 -1.602 . . . . 0.0 113.761 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 83' ' ' GLY . 53.5 Cg_endo -79.31 178.62 7.23 Favored 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 122.803 2.335 . . . . 0.0 112.304 172.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.606 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.08 77.69 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.92 0 O-C-N 125.018 1.449 . . . . 0.0 113.346 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.37 124.98 5.63 Favored Glycine 0 N--CA 1.508 3.475 0 N-CA-C 121.746 3.459 . . . . 0.0 121.746 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.46 61.24 1.18 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.526 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.1 m-85 -62.0 77.8 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.872 1.32 . . . . 0.0 113.052 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.57 135.95 57.18 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.47 136.49 52.95 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.554 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.64 82.03 8.6 Favored 'General case' 0 N--CA 1.512 2.64 1 N-CA-C 132.637 8.014 . . . . 0.0 132.637 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.1 t -63.9 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.501 2 CA-C-N 130.342 5.974 . . . . 0.0 114.311 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.7 tt0 -20.52 -72.48 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.605 0 N-CA-C 118.468 2.766 . . . . 0.0 118.468 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.59 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 37.6 Cg_endo -66.97 -3.48 9.7 Favored 'Trans proline' 0 N--CA 1.512 2.569 0 C-N-CA 122.39 2.06 . . . . 0.0 115.352 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -120.87 -14.12 8.55 Favored 'General case' 0 N--CA 1.511 2.613 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.477 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.38 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.62 -34.06 1.73 Allowed Glycine 1 N--CA 1.52 4.296 0 O-C-N 121.616 -0.678 . . . . 0.0 112.7 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.56 68.46 7.91 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.86 26.74 0.05 OUTLIER Glycine 1 N--CA 1.526 4.677 0 CA-C-N 114.041 -1.436 . . . . 0.0 116.68 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.559 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 1.9 ttt -108.55 43.83 1.19 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 124.406 2.05 . . . . 0.0 112.957 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.99 134.89 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 112.275 -2.239 . . . . 0.0 110.945 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.66 154.85 19.35 Favored Glycine 1 N--CA 1.534 5.212 0 C-N-CA 119.523 -1.323 . . . . 0.0 114.059 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.56 81.86 1.76 Allowed 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.63 123.3 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.709 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.0 m -112.63 88.7 2.88 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.185 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.444 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.4 t -74.0 105.17 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.31 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 O-C-N 126.064 2.103 . . . . 0.0 115.933 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.606 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.521 0 O-C-N 125.576 1.798 . . . . 0.0 113.812 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.59 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 22.0 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' TRP . . . . . 0.462 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.0 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . 0.459 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.3 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.499 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 88.7 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 50.9 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 79.5 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.1 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.783 HG13 HG22 ' B' ' 50' ' ' VAL 0.375 0.2 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 58.5 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.408 HG13 ' HD2' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.408 ' HD2' HG13 ' B' ' 36' ' ' VAL . 27.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.625 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.4 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.9 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 1.027 ' CE1' HG22 ' B' ' 131' ' ' VAL . 51.7 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.783 HG22 HG13 ' B' ' 34' ' ' VAL . 61.4 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.421 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.6 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.6 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.421 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.1 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.426 HG12 ' N ' ' B' ' 69' ' ' GLY . 79.1 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.426 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.526 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.507 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.3 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.1 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' PRO . . . . . 0.914 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 14.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.914 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 46.6 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.513 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 74.2 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.4 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 17.7 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 1.608 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 17.0 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' GLN . . . . . 1.393 ' NE2' HG12 ' A' ' 36' ' ' VAL . 10.9 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' TYR . . . . . 0.459 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 25.5 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.507 HD11 HG23 ' B' ' 75' ' ' VAL 0.54 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.466 ' N ' HG23 ' B' ' 115' ' ' ILE 0.411 0.1 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 1.282 ' CG ' HD23 ' A' ' 64' ' ' LEU . 38.7 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 1.022 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 81.1 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 57.2 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 90.8 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.481 ' C ' HG12 ' B' ' 131' ' ' VAL . 11.7 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 1.564 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.43 1.6 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.0 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' PRO . . . . . 0.623 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 10.6 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . 0.607 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.66 HD11 HD22 ' B' ' 249' ' ' LEU 0.483 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . 0.623 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.6 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.3 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' B' ' 149' ' ' VAL 0.335 1.7 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.581 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.471 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.661 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.4 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.387 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' PRO . . . . . 0.462 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 18.5 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.8 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.44 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 8.4 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.692 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.8 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . 0.692 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.7 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.408 HG22 ' N ' ' B' ' 178' ' ' GLY . 59.4 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.408 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 64.1 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' LYS . . . . . 0.411 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.411 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.3 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.6 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.414 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.84 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 199' ' ' ILE . . . . . 0.46 ' O ' HG13 ' B' ' 199' ' ' ILE 0.482 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.6 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.3 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.2 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . 0.465 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.465 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 11.2 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 86.4 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.385 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.4 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' ASN . . . . . 0.503 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.472 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.0 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.9 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.66 HD22 HD11 ' B' ' 142' ' ' ILE . 40.5 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.596 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.453 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 70.1 m -61.59 89.67 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.93 163.03 12.62 Favored 'General case' 0 N--CA 1.512 2.653 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.455 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.2 t -107.83 122.43 46.76 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.2 t -100.5 98.39 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.4 mmmt -67.34 65.32 0.07 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 113.086 -1.87 . . . . 0.0 114.888 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.806 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.9 mt -29.47 68.26 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 126.579 1.952 . . . . 0.0 115.459 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.42 59.06 0.4 Allowed Glycine 0 N--CA 1.509 3.552 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 20.3 p -1.12 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.259 0 N-CA-C 120.346 3.462 . . . . 0.0 120.346 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.49 -60.14 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 119.515 3.154 . . . . 0.0 119.515 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.529 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.85 22.48 14.43 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.957 -1.09 . . . . 0.0 108.116 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.07 -94.8 1.9 Allowed Glycine 0 N--CA 1.512 3.711 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.594 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.7 tp -150.66 -177.23 5.86 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.597 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.5 mt -74.72 46.74 0.3 Allowed 'General case' 0 N--CA 1.509 2.516 0 O-C-N 120.7 -1.25 . . . . 0.0 111.236 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.732 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.6 p -113.86 165.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.732 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.3 m-30 -102.12 75.43 1.51 Allowed 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 112.219 -2.264 . . . . 0.0 113.416 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.342 0.6 OUTLIER -93.47 142.39 25.14 Favored Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.853 -0.529 . . . . 0.0 111.746 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 20' ' ' LYS . 46.0 Cg_endo -86.49 76.11 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.466 0 N-CA-C 116.368 1.642 . . . . 0.0 116.368 -9.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.72 -44.22 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.806 1 N-CA-C 122.26 4.17 . . . . 0.0 122.26 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.645 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.65 71.68 1.0 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 122.412 1.101 . . . . 0.0 112.986 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.847 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.14 111.25 7.21 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.148 -1.595 . . . . 0.0 109.159 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.576 ' N ' HD23 ' A' ' 21' ' ' LEU . 47.7 m -87.52 81.53 7.74 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.847 HG23 HD22 ' A' ' 21' ' ' LEU . 4.4 pt -79.71 -177.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 114.75 -1.113 . . . . 0.0 112.699 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.705 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -109.67 166.55 10.58 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.126 179.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 19.9 Cg_endo -52.24 77.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.314 0 N-CA-C 116.833 1.82 . . . . 0.0 116.833 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.13 -50.41 0.52 Allowed Glycine 1 N--CA 1.522 4.42 0 C-N-CA 119.76 -1.209 . . . . 0.0 115.831 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.556 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.71 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 1 N-CA-C 122.11 4.115 . . . . 0.0 122.11 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 28' ' ' THR . 10.8 m -64.03 36.0 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.012 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.5 t -52.0 147.17 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.566 0 CA-C-N 112.821 -1.991 . . . . 0.0 111.5 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.19 154.91 27.05 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 123.923 1.82 . . . . 0.0 115.416 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.433 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.9 m-85 -107.57 113.84 27.42 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.1 tt -100.72 112.53 24.95 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 120.653 3.575 . . . . 0.0 120.653 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -75.13 84.69 2.35 Favored 'General case' 0 N--CA 1.513 2.689 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.162 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 29.9 p30 -80.27 -45.08 18.54 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 118.935 2.939 . . . . 0.0 118.935 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.95 -169.3 3.34 Favored 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 124.671 1.189 . . . . 0.0 109.077 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.255 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.6 m 12.79 70.72 0.11 Allowed Pre-proline 0 N--CA 1.52 3.029 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.344 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 55.3 Cg_endo -98.49 177.29 0.4 Allowed 'Trans proline' 0 CA--C 1.568 2.222 0 C-N-CA 123.984 3.123 . . . . 0.0 114.37 -165.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.717 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 52.2 Cg_endo -92.39 165.33 25.33 Favored 'Cis proline' 0 N--CA 1.502 2.029 0 N-CA-C 115.472 1.297 . . . . 0.0 115.472 -7.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.806 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.5 m-70 -118.96 87.52 2.75 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.738 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -103.5 140.23 37.79 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 122.465 2.393 . . . . 0.0 110.663 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 6.4 m -118.09 116.41 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 121.446 3.869 . . . . 0.0 121.446 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.577 HG22 ' CB ' ' A' ' 88' ' ' TYR . 13.0 m -76.07 165.46 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 102.099 -3.297 . . . . 0.0 102.099 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.066 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.32 130.96 55.51 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.443 ' OD1' HD13 ' A' ' 47' ' ' LEU . 4.1 m-20 -53.45 93.82 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.212 1 N-CA-C 124.16 4.874 . . . . 0.0 124.16 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.09 6.8 43.47 Favored 'General case' 0 CA--C 1.602 2.979 0 N-CA-C 101.212 -3.625 . . . . 0.0 101.212 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.439 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -115.9 -65.43 1.19 Allowed 'General case' 0 CA--C 1.574 1.88 0 C-N-CA 127.445 2.298 . . . . 0.0 112.682 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.753 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.4 mp -86.65 66.53 9.51 Favored 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 118.902 2.927 . . . . 0.0 118.902 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.634 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.4 151.28 0.74 Allowed Pre-proline 0 N--CA 1.522 3.145 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 17.3 Cg_endo -42.41 -58.29 1.3 Allowed 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.405 2.736 . . . . 0.0 115.112 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.634 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.46 67.34 0.72 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 124.102 1.906 . . . . 0.0 107.077 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -77.13 53.6 0.99 Allowed 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.312 -2.222 . . . . 0.0 108.272 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 t -115.9 56.99 0.76 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.664 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.63 -47.99 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.256 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.07 -30.88 0.16 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.06 -1.65 . . . . 0.0 111.578 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.18 -28.53 0.1 Allowed 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 122.755 1.264 . . . . 0.0 112.487 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.83 -27.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 117.727 2.492 . . . . 0.0 117.727 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.479 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.3 tptt 65.05 -55.59 0.3 Allowed 'General case' 0 N--CA 1.533 3.71 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.1 m -41.68 -28.98 0.16 Allowed 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.066 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.2 pp -53.68 -66.82 0.33 Allowed 'General case' 0 CA--C 1.604 3.032 0 N-CA-C 100.71 -3.811 . . . . 0.0 100.71 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.862 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 11.1 p -72.07 98.45 2.1 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 125.259 1.424 . . . . 0.0 112.806 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.706 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.4 t60 -90.08 -173.01 3.7 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.706 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.4 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.591 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 26.0 tt0 105.51 65.97 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 120.303 3.445 . . . . 0.0 120.303 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.859 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.6 mp 38.11 84.33 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 120.745 3.609 . . . . 0.0 120.745 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.738 ' N ' HD21 ' A' ' 40' ' ' ASN . 36.5 mt -70.66 82.1 0.61 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.078 -1.639 . . . . 0.0 111.888 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.856 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 41.0 mmm -79.25 61.93 3.48 Favored 'General case' 0 N--CA 1.51 2.542 0 CA-C-O 126.057 2.837 . . . . 0.0 110.912 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.7 m -112.55 65.92 0.85 Allowed Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 110.543 -3.026 . . . . 0.0 113.621 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -51.95 81.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 122.933 2.422 . . . . 0.0 114.686 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.13 6.73 27.59 Favored Glycine 1 N--CA 1.517 4.036 0 O-C-N 122.251 -0.28 . . . . 0.0 113.541 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.68 156.91 35.02 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 124.374 2.035 . . . . 0.0 116.241 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.455 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.98 156.39 27.55 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 119.681 3.215 . . . . 0.0 119.681 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -116.01 147.96 40.66 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-O 116.678 -1.63 . . . . 0.0 107.215 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.56 143.79 41.85 Favored 'General case' 0 N--CA 1.53 3.546 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.9 m -119.99 102.62 8.67 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.52 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.439 ' OG1' HG23 ' A' ' 28' ' ' THR . 49.0 m -94.78 152.15 18.66 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.424 ' N ' HG22 ' A' ' 75' ' ' THR . 89.4 m-85 -107.91 168.29 8.11 Favored Pre-proline 0 N--CA 1.503 2.181 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.089 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -72.36 -174.83 1.54 Allowed 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 121.023 1.149 . . . . 0.0 111.121 161.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.73 19.0 Favored 'General case' 0 N--CA 1.51 2.535 0 CA-C-O 124.34 2.019 . . . . 0.0 107.237 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.17 42.68 0.49 Allowed 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 111.258 -2.701 . . . . 0.0 109.118 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.79 9.78 Favored Pre-proline 0 N--CA 1.5 2.069 0 CA-C-N 113.543 -1.662 . . . . 0.0 113.742 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 38.0 Cg_endo -79.39 178.64 7.18 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 122.817 2.345 . . . . 0.0 112.253 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.594 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.03 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 125.367 1.467 . . . . 0.0 113.24 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.44 125.01 5.63 Favored Glycine 0 N--CA 1.507 3.389 0 N-CA-C 121.787 3.475 . . . . 0.0 121.787 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.8 mt-10 -99.4 61.26 1.19 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.516 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.1 m-85 -62.05 77.75 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 122.95 1.357 . . . . 0.0 113.033 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.6 m -63.52 136.0 57.25 Favored 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.582 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.52 136.5 52.93 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.577 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.6 m-85 -84.62 82.02 8.6 Favored 'General case' 0 N--CA 1.51 2.561 1 N-CA-C 132.655 8.02 . . . . 0.0 132.655 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.9 t -63.86 82.11 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.433 2 CA-C-N 130.371 5.987 . . . . 0.0 114.365 179.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.4 tt0 -20.51 -72.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.582 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.43 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 31.8 Cg_endo -67.04 -3.45 9.72 Favored 'Trans proline' 0 N--CA 1.51 2.489 0 C-N-CA 122.409 2.073 . . . . 0.0 115.367 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -120.85 -14.22 8.54 Favored 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.49 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.3 79.62 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.742 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.61 -34.03 1.73 Allowed Glycine 1 N--CA 1.522 4.381 0 O-C-N 121.597 -0.689 . . . . 0.0 112.617 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.52 68.46 7.86 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.79 26.8 0.05 OUTLIER Glycine 1 N--CA 1.527 4.731 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.563 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 1.8 ttt -108.54 43.85 1.19 Allowed 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 124.485 2.088 . . . . 0.0 113.022 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.97 134.88 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 112.228 -2.26 . . . . 0.0 110.903 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.71 154.86 19.38 Favored Glycine 1 N--CA 1.536 5.356 0 C-N-CA 119.446 -1.359 . . . . 0.0 113.96 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.2 ttpp -118.56 81.95 1.77 Allowed 'General case' 0 N--CA 1.517 2.883 0 CA-C-N 119.372 1.586 . . . . 0.0 115.262 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.71 123.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.667 0 C-N-CA 118.054 -1.458 . . . . 0.0 107.079 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -112.68 88.8 2.91 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.124 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.453 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.8 t -74.12 105.27 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.34 -72.28 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 O-C-N 126.101 2.126 . . . . 0.0 115.95 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.594 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.53 0 O-C-N 125.527 1.767 . . . . 0.0 113.81 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' TRP . . . . . 0.474 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . 0.471 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.0 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.2 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 9.9 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 89.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 54.2 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 77.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.3 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.839 HG13 HG22 ' B' ' 50' ' ' VAL 0.374 0.1 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 58.7 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.457 HG13 ' HD2' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.457 ' HD2' HG13 ' B' ' 36' ' ' VAL . 23.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.9 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.667 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 30.2 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 1.118 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.839 HG22 HG13 ' B' ' 34' ' ' VAL . 62.0 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.449 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.449 HG22 ' O ' ' B' ' 55' ' ' ASP . 15.2 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 83.3 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.452 HG12 ' N ' ' B' ' 69' ' ' GLY . 74.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.452 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.555 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.415 HG23 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.2 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' PRO . . . . . 1.049 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 24.7 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 1.049 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 42.5 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.567 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 94' ' ' LEU . 50.3 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.4 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 1.344 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 17.2 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' GLN . . . . . 1.255 ' NE2' HG12 ' A' ' 36' ' ' VAL . 11.0 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.8 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.507 HG23 ' N ' ' B' ' 116' ' ' VAL 0.46 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.507 ' N ' HG23 ' B' ' 115' ' ' ILE 0.255 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.614 ' CG ' HD23 ' A' ' 64' ' ' LEU . 36.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.856 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 81.9 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.6 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 85.3 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.508 ' C ' HG12 ' B' ' 131' ' ' VAL . 19.9 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 1.56 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.344 0.5 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' B' ' 142' ' ' ILE . 35.7 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' PRO . . . . . 0.525 ' CG ' ' CZ ' ' B' ' 144' ' ' PHE . 18.1 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . 0.589 ' CG ' ' CG2' ' B' ' 142' ' ' ILE . 44.7 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.737 HD11 HD22 ' B' ' 249' ' ' LEU 0.51 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' B' ' 136' ' ' PRO . 81.3 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 69.0 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' B' ' 149' ' ' VAL . 1.3 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.627 HG11 ' CG2' ' B' ' 34' ' ' VAL . 10.7 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' B' ' 155' ' ' ARG . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' B' ' 157' ' ' ARG . 28.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.683 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.7 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.312 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' PRO . . . . . 0.474 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 17.8 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 97.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.442 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.9 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.725 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.9 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . 0.725 ' N ' HD23 ' B' ' 171' ' ' LEU . 18.5 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.436 HG22 ' N ' ' B' ' 178' ' ' GLY . 61.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.436 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.3 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.5 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.428 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 41.2 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.38 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.903 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 199' ' ' ILE . . . . . 0.639 HG13 ' O ' ' B' ' 199' ' ' ILE 0.519 0.3 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.6 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.2 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.0 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . 0.488 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 18.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.3 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 86.9 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.403 0.1 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.0 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' B' ' 231' ' ' LEU . 84.2 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' ASN . . . . . 0.545 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.507 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.7 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 19.4 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.737 HD22 HD11 ' B' ' 142' ' ' ILE . 41.4 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.588 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.47 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.6 m -61.61 89.7 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.98 162.98 12.64 Favored 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.452 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.0 t -107.68 122.36 46.56 Favored 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.52 98.34 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.41 65.5 0.07 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 113.077 -1.874 . . . . 0.0 114.834 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.804 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -29.51 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.96 0 C-N-CA 126.595 1.958 . . . . 0.0 115.534 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.43 59.11 0.4 Allowed Glycine 0 N--CA 1.509 3.557 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.2 p -1.08 54.03 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 120.344 3.461 . . . . 0.0 120.344 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.61 -60.22 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 119.507 3.151 . . . . 0.0 119.507 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.508 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.47 14.45 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 120.998 -1.064 . . . . 0.0 108.143 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.09 -94.83 1.9 Allowed Glycine 0 N--CA 1.511 3.69 0 N-CA-C 115.553 0.981 . . . . 0.0 115.553 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.556 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 47.1 tp -150.57 -177.16 5.81 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.556 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 15.7 mt -74.68 46.66 0.29 Allowed 'General case' 0 N--CA 1.509 2.478 0 O-C-N 120.608 -1.307 . . . . 0.0 111.296 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.681 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.8 p -113.84 165.67 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.681 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.24 75.38 1.49 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 112.209 -2.269 . . . . 0.0 113.436 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.42 142.44 25.23 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 121.851 -0.531 . . . . 0.0 111.744 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 20' ' ' LYS . 56.8 Cg_endo -86.4 76.1 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.389 0 N-CA-C 116.382 1.647 . . . . 0.0 116.382 -9.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.7 -44.18 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.812 1 N-CA-C 122.24 4.163 . . . . 0.0 122.24 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.65 71.55 0.99 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.446 1.117 . . . . 0.0 113.052 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.841 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.06 111.27 7.15 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.177 -1.577 . . . . 0.0 109.147 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.515 ' N ' HD23 ' A' ' 21' ' ' LEU . 53.8 m -87.48 81.39 7.81 Favored 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.841 HG23 HD22 ' A' ' 21' ' ' LEU . 4.6 pt -79.7 -177.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.708 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.666 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.69 166.6 10.49 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.078 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.5 Cg_endo -52.3 77.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.569 2.263 0 N-CA-C 116.92 1.854 . . . . 0.0 116.92 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.09 -50.39 0.52 Allowed Glycine 1 N--CA 1.522 4.404 0 C-N-CA 119.727 -1.225 . . . . 0.0 115.859 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.68 92.11 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.195 1 N-CA-C 122.092 4.108 . . . . 0.0 122.092 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 28' ' ' THR . 11.3 m -64.12 36.03 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 118.681 2.845 . . . . 0.0 118.681 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.99 147.2 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 CA-C-N 112.861 -1.972 . . . . 0.0 111.529 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.31 154.85 27.29 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 123.936 1.827 . . . . 0.0 115.397 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -107.47 113.9 27.55 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.78 112.48 24.91 Favored 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 120.759 3.614 . . . . 0.0 120.759 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -75.11 84.75 2.34 Favored 'General case' 0 N--CA 1.511 2.611 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.14 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.5 p30 -80.35 -45.08 18.36 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 118.862 2.912 . . . . 0.0 118.862 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.92 -169.26 3.33 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 124.678 1.191 . . . . 0.0 109.143 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HA ' HE22 ' B' ' 104' ' ' GLN . 1.6 m 12.82 70.7 0.11 Allowed Pre-proline 0 N--CA 1.52 3.038 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.221 ' HG2' ' CZ ' ' B' ' 102' ' ' TYR . 59.5 Cg_endo -98.41 177.26 0.41 Allowed 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 123.953 3.102 . . . . 0.0 114.382 -165.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.619 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 58.9 Cg_endo -92.48 165.22 25.07 Favored 'Cis proline' 0 N--CA 1.503 2.082 0 N-CA-C 115.392 1.266 . . . . 0.0 115.392 -7.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.804 ' HB2' HD13 ' A' ' 7' ' ' LEU . 18.1 m-70 -118.83 87.4 2.72 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 117.377 2.362 . . . . 0.0 117.377 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.673 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -103.4 140.28 37.66 Favored 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 122.429 2.377 . . . . 0.0 110.695 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.499 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.4 m -118.1 116.27 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 121.43 3.863 . . . . 0.0 121.43 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.4 m -75.9 165.4 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 102.223 -3.251 . . . . 0.0 102.223 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.022 ' HB2' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.28 130.97 55.5 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.46 93.77 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.188 1 N-CA-C 124.16 4.874 . . . . 0.0 124.16 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.0 6.8 43.34 Favored 'General case' 0 CA--C 1.602 2.965 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.84 -65.63 1.17 Allowed 'General case' 0 CA--C 1.573 1.848 0 C-N-CA 127.537 2.335 . . . . 0.0 112.707 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.7 mp -86.63 66.58 9.54 Favored 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.38 151.23 0.74 Allowed Pre-proline 0 N--CA 1.523 3.179 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.7 Cg_endo -42.36 -58.26 1.31 Allowed 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 123.398 2.732 . . . . 0.0 115.133 170.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.45 67.36 0.72 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 124.027 1.87 . . . . 0.0 107.067 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.18 53.51 0.99 Allowed 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 112.346 -2.206 . . . . 0.0 108.204 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.87 56.95 0.76 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.671 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.58 -47.91 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 117.252 2.315 . . . . 0.0 117.252 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.08 -30.9 0.16 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.218 -1.551 . . . . 0.0 111.584 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.515 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.16 -28.53 0.1 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 122.696 1.236 . . . . 0.0 112.478 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.505 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.83 -27.64 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.48 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.03 -55.54 0.3 Allowed 'General case' 0 N--CA 1.534 3.748 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.77 -28.91 0.17 Allowed 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.022 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.5 pp -53.71 -66.76 0.34 Allowed 'General case' 0 CA--C 1.603 2.984 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.831 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.01 98.32 2.05 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 125.356 1.462 . . . . 0.0 112.803 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.694 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.0 -172.97 3.7 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.694 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.39 155.12 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.59 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.0 tt0 105.55 65.93 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 120.258 3.429 . . . . 0.0 120.258 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.584 HD23 ' CG ' ' B' ' 118' ' ' PRO . 6.0 mp 38.21 84.3 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 120.793 3.627 . . . . 0.0 120.793 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.673 ' N ' HD21 ' A' ' 40' ' ' ASN . 35.0 mt -70.76 82.13 0.63 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.137 -1.602 . . . . 0.0 111.818 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 1.422 ' CE ' ' O ' ' B' ' 118' ' ' PRO . 42.3 mmm -79.29 62.0 3.53 Favored 'General case' 0 N--CA 1.512 2.647 0 CA-C-O 126.069 2.842 . . . . 0.0 110.886 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.0 m -112.53 65.89 0.84 Allowed Pre-proline 0 C--N 1.284 -2.259 0 CA-C-N 110.53 -3.032 . . . . 0.0 113.667 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HG2' ' OD2' ' B' ' 100' ' ' ASP . 21.7 Cg_endo -51.91 81.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.466 0 C-N-CA 122.932 2.422 . . . . 0.0 114.696 -177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.08 6.58 27.81 Favored Glycine 1 N--CA 1.516 4.03 0 O-C-N 122.18 -0.325 . . . . 0.0 113.613 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.56 156.84 34.97 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 124.366 2.031 . . . . 0.0 116.352 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.438 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -116.95 156.38 27.52 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 119.703 3.223 . . . . 0.0 119.703 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -115.95 147.9 40.64 Favored 'General case' 0 N--CA 1.52 3.07 0 CA-C-O 116.711 -1.614 . . . . 0.0 107.192 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.44 143.67 41.89 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 118.36 2.726 . . . . 0.0 118.36 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.7 m -119.94 102.64 8.7 Favored 'General case' 0 N--CA 1.514 2.772 0 CA-C-N 114.227 -1.351 . . . . 0.0 113.584 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.455 ' OG1' HG23 ' A' ' 28' ' ' THR . 48.8 m -94.7 152.2 18.66 Favored 'General case' 0 N--CA 1.526 3.341 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' N ' HG22 ' A' ' 75' ' ' THR . 90.7 m-85 -107.98 168.33 8.04 Favored Pre-proline 0 N--CA 1.504 2.244 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.037 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.36 -174.78 1.52 Allowed 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 121.023 1.149 . . . . 0.0 111.12 161.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.77 18.97 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 124.364 2.03 . . . . 0.0 107.246 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.09 42.55 0.48 Allowed 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 111.24 -2.709 . . . . 0.0 109.067 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.24 84.81 9.68 Favored Pre-proline 0 N--CA 1.501 2.075 0 CA-C-N 113.658 -1.61 . . . . 0.0 113.768 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 83' ' ' GLY . 47.5 Cg_endo -79.36 178.67 7.16 Favored 'Trans proline' 0 N--CA 1.503 2.085 0 C-N-CA 122.79 2.326 . . . . 0.0 112.276 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.598 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.11 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.86 0 C-N-CA 125.328 1.451 . . . . 0.0 113.291 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.539 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.4 124.92 5.6 Favored Glycine 0 N--CA 1.507 3.393 0 N-CA-C 121.739 3.455 . . . . 0.0 121.739 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.41 61.31 1.19 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.539 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.13 77.81 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.906 1.336 . . . . 0.0 113.006 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.8 m -63.46 135.94 57.25 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.53 136.54 52.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.568 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.71 82.11 8.57 Favored 'General case' 0 N--CA 1.511 2.618 1 N-CA-C 132.562 7.986 . . . . 0.0 132.562 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.94 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.495 2 CA-C-N 130.298 5.953 . . . . 0.0 114.346 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.0 tt0 -20.55 -72.35 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.586 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.417 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 36.8 Cg_endo -67.11 -3.34 9.61 Favored 'Trans proline' 0 N--CA 1.513 2.626 0 C-N-CA 122.359 2.039 . . . . 0.0 115.343 176.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -120.99 -14.12 8.49 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.458 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.35 79.71 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.51 -34.03 1.74 Allowed Glycine 1 N--CA 1.522 4.37 0 O-C-N 121.517 -0.739 . . . . 0.0 112.679 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.57 68.44 7.91 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 39.0 26.68 0.05 OUTLIER Glycine 1 N--CA 1.527 4.721 0 CA-C-N 114.018 -1.446 . . . . 0.0 116.573 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.567 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.57 43.92 1.18 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 124.52 2.105 . . . . 0.0 112.957 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.0 134.85 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 112.271 -2.24 . . . . 0.0 110.928 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.64 154.87 19.34 Favored Glycine 1 N--CA 1.535 5.295 0 CA-C-N 120.118 1.326 . . . . 0.0 114.039 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.57 81.91 1.77 Allowed 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 119.405 1.603 . . . . 0.0 115.246 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.68 123.31 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.737 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.8 m -112.64 88.73 2.89 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.155 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.446 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.2 t -74.02 105.18 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.25 -72.3 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 O-C-N 126.046 2.091 . . . . 0.0 115.929 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.598 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.532 0 O-C-N 125.547 1.78 . . . . 0.0 113.841 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' TRP . . . . . 0.458 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.9 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . 0.448 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.2 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.413 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 55.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.7 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.4 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 52.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 78.4 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.0 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.738 HG13 HG22 ' B' ' 50' ' ' VAL 0.386 0.2 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 58.9 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.613 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.6 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.5 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.974 ' CE1' HG22 ' B' ' 131' ' ' VAL . 51.5 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.738 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.5 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.411 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.1 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.411 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.2 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.8 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.424 HG12 ' N ' ' B' ' 69' ' ' GLY . 80.7 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.424 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.522 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.514 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.8 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.0 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' PRO . . . . . 0.859 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 17.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.859 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 46.4 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.478 HG22 HG11 ' B' ' 114' ' ' VAL 0.491 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.4 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.1 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.544 ' OD2' ' HG2' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.1 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 1.221 ' CZ ' ' HG2' ' A' ' 37' ' ' PRO . 17.3 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' GLN . . . . . 0.58 HE22 ' HA ' ' A' ' 36' ' ' VAL . 11.2 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' TYR . . . . . 0.448 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 25.0 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.7 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.478 HG11 HG22 ' B' ' 84' ' ' ILE . 16.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.514 HD11 HG23 ' B' ' 75' ' ' VAL 0.526 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.433 ' N ' HG23 ' B' ' 115' ' ' ILE 0.403 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.667 ' C ' ' HE1' ' A' ' 66' ' ' MET . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 1.584 ' CG ' HD23 ' A' ' 64' ' ' LEU . 38.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 66' ' ' MET . 81.3 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.8 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 90.0 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.521 ' C ' HG12 ' B' ' 131' ' ' VAL . 12.8 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 1.549 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.511 0.9 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' PRO . . . . . 0.647 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.4 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . 0.626 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.626 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.469 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . 0.647 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.5 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.361 1.5 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' HIS . . . . . 0.413 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.6 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.623 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.475 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.6 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.666 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.3 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.398 0.6 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' PRO . . . . . 0.458 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.1 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.443 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.9 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.681 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . 0.681 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.2 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.3 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.405 HG22 ' N ' ' B' ' 178' ' ' GLY . 58.0 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.405 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 64.8 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.9 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' LYS . . . . . 0.406 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.406 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.7 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.433 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.822 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 199' ' ' ILE . . . . . 0.4 ' O ' HG13 ' B' ' 199' ' ' ILE 0.464 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.7 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.9 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.8 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.2 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . 0.443 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.443 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 12.2 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.3 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.9 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.423 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.8 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.6 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' ASN . . . . . 0.51 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.482 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.1 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.0 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.7 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.597 HD22 HD11 ' B' ' 142' ' ' ILE . 40.8 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.924 -1.036 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.594 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.455 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 69.7 m -61.51 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.963 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.408 ' HD2' HD11 ' A' ' 21' ' ' LEU . 10.8 m-85 -99.93 163.03 12.63 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.46 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.2 t -107.74 122.43 46.72 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.9 t -100.56 98.37 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.4 mmmt -67.35 65.37 0.07 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.894 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.807 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.9 mt -29.46 68.22 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 126.61 1.964 . . . . 0.0 115.517 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.45 59.01 0.4 Allowed Glycine 0 N--CA 1.51 3.584 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 11' ' ' LYS . 20.3 p -1.13 54.15 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.284 0 N-CA-C 120.32 3.452 . . . . 0.0 120.32 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.51 -60.23 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 119.539 3.163 . . . . 0.0 119.539 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.527 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.87 22.62 14.27 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.858 -1.151 . . . . 0.0 108.189 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.2 -94.81 1.89 Allowed Glycine 0 N--CA 1.512 3.721 0 N-CA-C 115.521 0.969 . . . . 0.0 115.521 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.6 tp -150.56 -177.14 5.8 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.597 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 15.4 mt -74.78 46.76 0.3 Allowed 'General case' 0 N--CA 1.509 2.506 0 O-C-N 120.716 -1.24 . . . . 0.0 111.261 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.727 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.6 p -113.79 165.59 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 118.464 2.764 . . . . 0.0 118.464 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.727 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.3 m-30 -102.22 75.41 1.49 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 112.142 -2.299 . . . . 0.0 113.431 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.343 0.6 OUTLIER -93.46 142.43 25.19 Favored Pre-proline 0 N--CA 1.506 2.347 0 O-C-N 121.805 -0.559 . . . . 0.0 111.754 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' LYS . 46.3 Cg_endo -86.46 76.22 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.39 0 N-CA-C 116.351 1.635 . . . . 0.0 116.351 -9.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.54 -44.17 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.841 1 N-CA-C 122.284 4.179 . . . . 0.0 122.284 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.648 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.61 71.69 1.0 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 122.408 1.099 . . . . 0.0 113.072 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.865 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.19 111.23 7.23 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.237 -1.539 . . . . 0.0 109.1 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.572 ' N ' HD23 ' A' ' 21' ' ' LEU . 46.1 m -87.42 81.41 7.84 Favored 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.865 HG23 HD22 ' A' ' 21' ' ' LEU . 4.4 pt -79.61 -177.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 CA-C-N 114.772 -1.103 . . . . 0.0 112.719 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.706 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -109.7 166.6 10.49 Favored Pre-proline 0 CA--C 1.566 1.569 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.135 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 19.9 Cg_endo -52.26 77.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.288 0 N-CA-C 116.903 1.847 . . . . 0.0 116.903 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.16 -50.59 0.51 Allowed Glycine 1 N--CA 1.522 4.419 0 C-N-CA 119.753 -1.213 . . . . 0.0 115.834 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.61 92.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.171 1 N-CA-C 122.227 4.158 . . . . 0.0 122.227 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 28' ' ' THR . 11.1 m -64.15 36.08 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -52.11 147.23 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 CA-C-N 112.878 -1.965 . . . . 0.0 111.475 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.28 154.87 27.21 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 123.978 1.847 . . . . 0.0 115.356 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.418 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.9 m-85 -107.53 113.83 27.41 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.65 112.49 24.89 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 120.792 3.627 . . . . 0.0 120.792 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -75.12 84.78 2.34 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.164 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 29.7 p30 -80.35 -45.06 18.4 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 118.904 2.928 . . . . 0.0 118.904 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.97 -169.33 3.35 Favored 'General case' 0 N--CA 1.509 2.491 0 C-N-CA 124.596 1.158 . . . . 0.0 109.068 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.095 ' HA ' HE22 ' B' ' 104' ' ' GLN . 1.6 m 12.91 70.62 0.11 Allowed Pre-proline 0 N--CA 1.519 3.01 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.328 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 55.3 Cg_endo -98.43 177.28 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.213 0 C-N-CA 123.908 3.072 . . . . 0.0 114.455 -165.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.713 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 52.3 Cg_endo -92.47 165.29 25.09 Favored 'Cis proline' 0 N--CA 1.503 2.069 0 N-CA-C 115.442 1.285 . . . . 0.0 115.442 -7.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.807 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.3 m-70 -118.96 87.46 2.74 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.729 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -103.37 140.2 37.76 Favored 'General case' 0 N--CA 1.516 2.827 0 CA-C-N 122.395 2.362 . . . . 0.0 110.744 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.5 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.3 m -118.11 116.22 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 121.476 3.88 . . . . 0.0 121.476 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.566 HG22 ' CB ' ' A' ' 88' ' ' TYR . 13.3 m -75.87 165.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.049 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.3 130.94 55.51 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.444 ' OD1' HD13 ' A' ' 47' ' ' LEU . 4.2 m-20 -53.4 93.71 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.183 1 N-CA-C 124.2 4.889 . . . . 0.0 124.2 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.98 6.8 43.28 Favored 'General case' 0 CA--C 1.602 2.957 0 N-CA-C 101.23 -3.619 . . . . 0.0 101.23 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -115.83 -65.53 1.18 Allowed 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 127.595 2.358 . . . . 0.0 112.704 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.744 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.5 mp -86.72 66.47 9.48 Favored 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 118.966 2.95 . . . . 0.0 118.966 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.43 151.22 0.74 Allowed Pre-proline 0 N--CA 1.522 3.167 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.505 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 17.4 Cg_endo -42.32 -58.31 1.28 Allowed 'Trans proline' 0 N--CA 1.508 2.376 0 C-N-CA 123.408 2.739 . . . . 0.0 115.085 170.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.637 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.48 67.46 0.72 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 124.034 1.873 . . . . 0.0 107.04 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -77.25 53.6 1.02 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 112.333 -2.212 . . . . 0.0 108.331 179.392 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.4 t -115.88 56.96 0.76 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.658 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.57 -47.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.11 -30.87 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.104 -1.622 . . . . 0.0 111.636 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.556 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.13 -28.5 0.09 Allowed 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 122.801 1.286 . . . . 0.0 112.561 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.86 -27.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.48 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.3 tptt 65.15 -55.62 0.31 Allowed 'General case' 0 N--CA 1.533 3.678 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.2 m -41.72 -28.9 0.16 Allowed 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.049 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.2 pp -53.74 -66.71 0.35 Allowed 'General case' 0 CA--C 1.603 3.017 0 N-CA-C 100.723 -3.806 . . . . 0.0 100.723 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.861 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 11.0 p -72.14 98.38 2.12 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.278 1.431 . . . . 0.0 112.816 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.702 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.5 t60 -89.96 -173.01 3.72 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.702 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.39 155.17 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.584 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 26.2 tt0 105.43 66.08 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 120.289 3.44 . . . . 0.0 120.289 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.855 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.6 mp 38.1 84.27 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 120.803 3.631 . . . . 0.0 120.803 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.729 ' N ' HD21 ' A' ' 40' ' ' ASN . 36.3 mt -70.68 82.12 0.61 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.144 -1.597 . . . . 0.0 111.88 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 1.27 ' HE2' ' O ' ' B' ' 118' ' ' PRO . 41.4 mmm -79.27 61.92 3.5 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-O 126.096 2.855 . . . . 0.0 110.918 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.524 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.9 m -112.52 65.95 0.84 Allowed Pre-proline 0 N--CA 1.505 2.298 0 CA-C-N 110.47 -3.059 . . . . 0.0 113.601 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.86 ' HG3' ' O ' ' B' ' 100' ' ' ASP . 19.3 Cg_endo -51.94 81.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.522 0 C-N-CA 122.979 2.452 . . . . 0.0 114.633 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.09 6.67 27.71 Favored Glycine 1 N--CA 1.516 4.021 0 O-C-N 122.203 -0.31 . . . . 0.0 113.606 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.66 156.82 35.17 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 124.389 2.042 . . . . 0.0 116.332 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.451 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.91 156.34 27.55 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 119.742 3.238 . . . . 0.0 119.742 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -115.9 147.97 40.52 Favored 'General case' 0 N--CA 1.52 3.048 0 CA-C-O 116.643 -1.646 . . . . 0.0 107.264 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.59 143.76 41.94 Favored 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 76.1 m -119.95 102.64 8.69 Favored 'General case' 0 N--CA 1.514 2.751 0 CA-C-N 114.221 -1.354 . . . . 0.0 113.525 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.443 ' OG1' HG23 ' A' ' 28' ' ' THR . 49.8 m -94.81 152.26 18.56 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.429 ' N ' HG22 ' A' ' 75' ' ' THR . 89.8 m-85 -107.97 168.33 8.05 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.067 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -72.36 -174.76 1.52 Allowed 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 121.009 1.14 . . . . 0.0 111.115 161.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.34 -19.78 18.98 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 124.301 2.001 . . . . 0.0 107.241 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.16 42.64 0.49 Allowed 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 111.246 -2.706 . . . . 0.0 109.059 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.84 9.84 Favored Pre-proline 0 N--CA 1.499 2.023 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.778 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 83' ' ' GLY . 38.0 Cg_endo -79.38 178.6 7.23 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.851 2.367 . . . . 0.0 112.298 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.604 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -15.97 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.889 0 C-N-CA 125.316 1.447 . . . . 0.0 113.262 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.51 125.08 5.64 Favored Glycine 0 N--CA 1.506 3.365 0 N-CA-C 121.703 3.441 . . . . 0.0 121.703 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.5 61.18 1.17 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.525 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.04 77.74 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.873 1.32 . . . . 0.0 113.068 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.4 m -63.36 135.92 57.31 Favored 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.583 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.47 136.55 52.89 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.566 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.6 m-85 -84.63 81.97 8.63 Favored 'General case' 0 N--CA 1.511 2.576 1 N-CA-C 132.625 8.009 . . . . 0.0 132.625 -179.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.7 t -63.84 82.21 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.447 2 CA-C-N 130.434 6.016 . . . . 0.0 114.298 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.5 tt0 -20.61 -72.48 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.61 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.838 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 31.7 Cg_endo -66.88 -3.55 9.71 Favored 'Trans proline' 0 N--CA 1.511 2.547 0 C-N-CA 122.419 2.079 . . . . 0.0 115.372 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -120.88 -14.08 8.54 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.501 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.45 79.75 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.53 -34.03 1.74 Allowed Glycine 1 N--CA 1.521 4.309 0 O-C-N 121.571 -0.706 . . . . 0.0 112.621 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.62 68.54 8.01 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.78 26.78 0.05 OUTLIER Glycine 1 N--CA 1.528 4.787 0 CA-C-N 114.004 -1.453 . . . . 0.0 116.636 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.573 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 1.8 ttt -108.53 43.76 1.2 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 124.51 2.1 . . . . 0.0 113.035 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.89 134.89 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 112.216 -2.266 . . . . 0.0 111.007 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.7 154.89 19.38 Favored Glycine 1 N--CA 1.535 5.269 0 C-N-CA 119.486 -1.34 . . . . 0.0 113.986 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.2 ttpp -118.63 81.96 1.78 Allowed 'General case' 0 N--CA 1.518 2.956 0 CA-C-N 119.404 1.602 . . . . 0.0 115.252 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.76 123.24 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -112.56 88.72 2.89 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.196 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.449 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.8 t -73.97 105.21 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.3 -72.3 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 O-C-N 126.051 2.094 . . . . 0.0 115.888 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.486 0 O-C-N 125.579 1.799 . . . . 0.0 113.861 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.838 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 24.1 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' TRP . . . . . 0.474 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . 0.471 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.0 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.2 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 89.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 54.2 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 77.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.3 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.84 HG13 HG22 ' B' ' 50' ' ' VAL 0.373 0.1 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 58.6 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.458 HG13 ' HD2' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.458 ' HD2' HG13 ' B' ' 36' ' ' VAL . 23.7 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.9 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.668 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 30.2 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 1.112 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.3 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.84 HG22 HG13 ' B' ' 34' ' ' VAL . 62.0 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.449 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.9 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.449 HG22 ' O ' ' B' ' 55' ' ' ASP . 15.1 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 82.9 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.452 HG12 ' N ' ' B' ' 69' ' ' GLY . 74.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.452 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.555 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.416 HG23 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.2 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' PRO . . . . . 1.052 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 24.8 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 1.052 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 43.0 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.568 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 94' ' ' LEU . 50.3 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.86 ' O ' ' HG3' ' A' ' 68' ' ' PRO . 24.3 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 1.328 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 17.2 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' GLN . . . . . 1.095 HE22 ' HA ' ' A' ' 36' ' ' VAL . 11.0 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.9 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.2 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.513 HG23 ' N ' ' B' ' 116' ' ' VAL 0.454 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . 0.513 ' N ' HG23 ' B' ' 115' ' ' ILE 0.254 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.576 ' C ' ' HE1' ' A' ' 66' ' ' MET . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 1.27 ' O ' ' HE2' ' A' ' 66' ' ' MET . 36.4 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.917 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 81.9 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.5 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 85.3 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.515 ' C ' HG12 ' B' ' 131' ' ' VAL . 19.8 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 1.556 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.348 0.5 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' B' ' 142' ' ' ILE . 35.7 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' PRO . . . . . 0.526 ' CG ' ' CZ ' ' B' ' 144' ' ' PHE . 18.2 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . 0.591 ' CG ' ' CG2' ' B' ' 142' ' ' ILE . 44.7 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.739 HD11 HD22 ' B' ' 249' ' ' LEU 0.511 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . 0.526 ' CZ ' ' CG ' ' B' ' 136' ' ' PRO . 81.3 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 69.0 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' B' ' 149' ' ' VAL . 1.3 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.627 HG11 ' CG2' ' B' ' 34' ' ' VAL . 10.7 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' B' ' 155' ' ' ARG . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.458 HH11 ' HD2' ' B' ' 157' ' ' ARG . 28.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.683 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.7 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.31 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' PRO . . . . . 0.474 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 17.8 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 97.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.442 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.9 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.725 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.9 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . 0.725 ' N ' HD23 ' B' ' 171' ' ' LEU . 18.4 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.436 HG22 ' N ' ' B' ' 178' ' ' GLY . 61.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.436 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.4 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.6 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . 0.429 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 41.2 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.381 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.904 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 199' ' ' ILE . . . . . 0.642 HG13 ' O ' ' B' ' 199' ' ' ILE 0.52 0.3 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.6 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.2 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . 0.488 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 18.3 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.3 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.1 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.402 0.1 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.0 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' B' ' 231' ' ' LEU . 84.2 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' ASN . . . . . 0.545 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.507 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.6 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 19.4 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.739 HD22 HD11 ' B' ' 142' ' ' ILE . 41.4 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.605 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.488 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.5 m -61.53 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.029 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -99.95 163.08 12.6 Favored 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.83 122.39 46.69 Favored 'General case' 0 N--CA 1.525 3.305 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -100.49 98.38 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.7 mmmt -67.37 65.39 0.07 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 113.121 -1.854 . . . . 0.0 114.847 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.826 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.6 mt -29.59 68.29 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 126.53 1.932 . . . . 0.0 115.501 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.44 58.98 0.4 Allowed Glycine 0 N--CA 1.509 3.54 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.1 p -1.07 54.24 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 N-CA-C 120.187 3.402 . . . . 0.0 120.187 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.44 -60.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 119.513 3.153 . . . . 0.0 119.513 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.76 22.53 14.42 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.858 -1.151 . . . . 0.0 108.183 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.18 -94.77 1.89 Allowed Glycine 0 N--CA 1.512 3.713 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 44.6 tp -150.61 -177.2 5.84 Favored 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.532 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.2 mt -74.78 46.78 0.3 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 120.638 -1.289 . . . . 0.0 111.279 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.624 HG22 ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.85 165.68 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 118.596 2.813 . . . . 0.0 118.596 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.624 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.9 m-30 -102.23 75.42 1.49 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 112.2 -2.273 . . . . 0.0 113.389 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.308 12.3 mt-10 -93.47 142.43 25.2 Favored Pre-proline 0 N--CA 1.505 2.294 0 O-C-N 121.826 -0.546 . . . . 0.0 111.814 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.41 76.15 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.458 0 N-CA-C 116.328 1.626 . . . . 0.0 116.328 -9.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.59 -44.14 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 1 N-CA-C 122.344 4.201 . . . . 0.0 122.344 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.63 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.62 71.62 1.0 Allowed 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 122.364 1.078 . . . . 0.0 113.025 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.787 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.13 111.31 7.25 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.208 -1.557 . . . . 0.0 109.104 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.488 ' N ' HD23 ' A' ' 21' ' ' LEU . 49.4 m -87.49 81.46 7.78 Favored 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.787 HG23 HD22 ' A' ' 21' ' ' LEU . 5.3 pt -79.78 -177.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.692 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.613 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.66 166.51 10.65 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.198 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.6 Cg_endo -52.2 77.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.3 0 N-CA-C 116.91 1.85 . . . . 0.0 116.91 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.09 -50.44 0.52 Allowed Glycine 1 N--CA 1.523 4.449 0 C-N-CA 119.789 -1.196 . . . . 0.0 115.915 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.555 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.64 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.178 1 N-CA-C 122.151 4.13 . . . . 0.0 122.151 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.551 ' O ' HG22 ' A' ' 28' ' ' THR . 11.9 m -64.0 35.98 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.027 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.11 147.21 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 112.906 -1.952 . . . . 0.0 111.418 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 4.1 pt-20 -114.29 154.93 27.11 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 123.925 1.822 . . . . 0.0 115.324 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -107.53 113.79 27.35 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.547 ' C ' HD23 ' A' ' 32' ' ' LEU . 7.0 tt -100.76 112.57 25.0 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 120.758 3.614 . . . . 0.0 120.758 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -75.16 84.72 2.37 Favored 'General case' 0 N--CA 1.511 2.622 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.13 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.23 -45.11 18.55 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.553 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.93 -169.38 3.36 Favored 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 124.61 1.164 . . . . 0.0 109.086 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.995 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.7 m 12.92 70.63 0.11 Allowed Pre-proline 0 N--CA 1.521 3.098 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.454 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.4 177.28 0.41 Allowed 'Trans proline' 0 CA--C 1.569 2.241 0 C-N-CA 123.939 3.093 . . . . 0.0 114.416 -165.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.4 Cg_endo -92.5 165.31 25.0 Favored 'Cis proline' 0 N--CA 1.503 2.068 0 N-CA-C 115.398 1.268 . . . . 0.0 115.398 -7.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.826 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.89 87.46 2.74 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.64 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 1.0 OUTLIER -103.45 140.22 37.78 Favored 'General case' 0 N--CA 1.515 2.818 0 CA-C-N 122.456 2.389 . . . . 0.0 110.722 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 41' ' ' VAL . 7.2 m -118.08 116.31 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.564 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.8 m -75.95 165.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 102.19 -3.263 . . . . 0.0 102.19 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.03 ' HB2' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.3 130.93 55.51 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.32 93.77 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.221 1 N-CA-C 124.182 4.882 . . . . 0.0 124.182 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.4 ' C ' ' HB2' ' A' ' 51' ' ' LYS . . . -91.06 6.74 43.68 Favored 'General case' 0 CA--C 1.602 2.972 0 N-CA-C 101.168 -3.642 . . . . 0.0 101.168 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.8 -65.54 1.18 Allowed 'General case' 0 CA--C 1.573 1.853 0 C-N-CA 127.525 2.33 . . . . 0.0 112.718 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.56 9.53 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 118.915 2.932 . . . . 0.0 118.915 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.46 151.25 0.74 Allowed Pre-proline 0 N--CA 1.522 3.135 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.497 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.8 Cg_endo -42.51 -58.2 1.35 Allowed 'Trans proline' 0 N--CA 1.508 2.371 0 C-N-CA 123.438 2.758 . . . . 0.0 115.04 170.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.52 67.43 0.72 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 124.091 1.901 . . . . 0.0 107.072 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.412 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.28 53.55 1.02 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.256 -2.247 . . . . 0.0 108.222 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.8 56.94 0.76 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.7 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.58 -47.94 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.184 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.12 -30.85 0.16 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.113 -1.617 . . . . 0.0 111.545 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.548 ' HG ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 pp -41.22 -28.54 0.1 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.732 1.253 . . . . 0.0 112.485 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.489 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.82 -27.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.3 tptt 64.93 -55.47 0.3 Allowed 'General case' 0 N--CA 1.533 3.715 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -41.78 -28.86 0.17 Allowed 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.03 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.8 pp -53.74 -66.76 0.33 Allowed 'General case' 0 CA--C 1.604 3.022 0 N-CA-C 100.713 -3.81 . . . . 0.0 100.713 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.756 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.11 98.44 2.11 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 125.268 1.427 . . . . 0.0 112.781 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.671 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.3 t60 -90.05 -173.08 3.73 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.671 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.42 155.15 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 28.1 tt0 105.5 66.06 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.755 0 N-CA-C 120.313 3.449 . . . . 0.0 120.313 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.246 HD23 ' CG ' ' B' ' 118' ' ' PRO . 6.1 mp 38.13 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.518 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 36.2 mt -70.67 82.08 0.61 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.197 -1.564 . . . . 0.0 111.906 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.663 ' HE2' HD23 ' B' ' 119' ' ' LEU . 41.4 mmm -79.3 62.0 3.53 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 126.051 2.834 . . . . 0.0 110.867 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.4 m -112.58 65.84 0.85 Allowed Pre-proline 0 C--N 1.283 -2.287 0 CA-C-N 110.474 -3.057 . . . . 0.0 113.558 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HG2' ' OD2' ' B' ' 100' ' ' ASP . 19.5 Cg_endo -51.92 81.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.45 0 C-N-CA 122.959 2.439 . . . . 0.0 114.716 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.66 27.63 Favored Glycine 0 N--CA 1.516 3.991 0 O-C-N 122.131 -0.356 . . . . 0.0 113.603 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.8 tt0 -123.65 156.92 34.97 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 124.384 2.04 . . . . 0.0 116.273 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.435 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.98 156.37 27.58 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 119.722 3.23 . . . . 0.0 119.722 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -115.93 147.95 40.58 Favored 'General case' 0 N--CA 1.52 3.056 0 CA-C-O 116.636 -1.65 . . . . 0.0 107.194 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.46 143.74 41.81 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.2 m -120.02 102.57 8.63 Favored 'General case' 0 N--CA 1.513 2.719 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.532 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.457 ' OG1' HG23 ' A' ' 28' ' ' THR . 44.5 m -94.74 152.22 18.63 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.452 ' N ' HG22 ' A' ' 75' ' ' THR . 89.2 m-85 -107.97 168.27 8.13 Favored Pre-proline 0 N--CA 1.502 2.13 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.135 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.33 -174.77 1.51 Allowed 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.006 1.137 . . . . 0.0 111.122 161.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.45 -19.64 19.01 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-O 124.346 2.022 . . . . 0.0 107.216 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.25 42.72 0.5 Allowed 'General case' 0 CA--C 1.576 1.963 0 CA-C-N 111.249 -2.705 . . . . 0.0 109.036 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.29 84.73 9.68 Favored Pre-proline 0 N--CA 1.5 2.031 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.846 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -79.36 178.68 7.15 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 122.753 2.302 . . . . 0.0 112.226 173.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.604 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.04 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 125.294 1.437 . . . . 0.0 113.3 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.549 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.35 125.01 5.64 Favored Glycine 0 N--CA 1.508 3.472 0 N-CA-C 121.777 3.471 . . . . 0.0 121.777 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.44 61.15 1.18 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.549 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.8 m-85 -62.06 77.79 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 122.9 1.333 . . . . 0.0 112.984 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 6.9 m -63.46 135.91 57.23 Favored 'General case' 0 N--CA 1.51 2.561 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.526 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.43 136.51 52.93 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.564 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.64 81.96 8.63 Favored 'General case' 0 N--CA 1.511 2.617 1 N-CA-C 132.611 8.004 . . . . 0.0 132.611 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.0 t -63.82 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.471 2 CA-C-N 130.384 5.993 . . . . 0.0 114.34 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.6 tt0 -20.5 -72.4 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.62 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 29.6 Cg_endo -67.08 -3.45 9.76 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 122.406 2.071 . . . . 0.0 115.334 176.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -120.93 -14.16 8.51 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.442 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.23 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.782 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.58 -34.1 1.73 Allowed Glycine 1 N--CA 1.521 4.304 0 O-C-N 121.516 -0.74 . . . . 0.0 112.628 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.47 68.42 7.79 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.84 26.81 0.05 OUTLIER Glycine 1 N--CA 1.526 4.648 0 N-CA-C 116.616 1.407 . . . . 0.0 116.616 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.586 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.1 ttt -108.55 43.86 1.19 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 124.482 2.087 . . . . 0.0 112.966 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.03 134.88 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 112.233 -2.258 . . . . 0.0 110.973 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.65 154.86 19.34 Favored Glycine 1 N--CA 1.534 5.228 0 C-N-CA 119.525 -1.321 . . . . 0.0 114.032 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 ttpp -118.63 82.0 1.78 Allowed 'General case' 0 N--CA 1.518 2.925 0 CA-C-N 119.474 1.637 . . . . 0.0 115.188 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.74 123.29 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.5 m -112.67 88.77 2.9 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.197 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.3 t -74.05 105.23 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.35 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 O-C-N 126.066 2.104 . . . . 0.0 115.912 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.438 0 O-C-N 125.478 1.736 . . . . 0.0 113.835 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.28 21.9 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' TRP . . . . . 0.437 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.8 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.308 27.5 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.512 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 52.9 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.638 HG22 HG11 ' B' ' 151' ' ' VAL 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.5 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.557 HD22 ' N ' ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.367 22.0 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 33.0 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.786 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.411 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.8 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.418 HG12 ' N ' ' B' ' 69' ' ' GLY . 88.0 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.418 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.506 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 50.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' PRO . . . . . 0.719 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.1 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.719 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.2 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.512 HG22 HG11 ' B' ' 114' ' ' VAL 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' B' ' 130' ' ' PRO . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.5 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 68' ' ' PRO . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 1.454 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 20.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' GLN . . . . . 0.995 ' NE2' HG12 ' A' ' 36' ' ' VAL . 11.9 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.512 HG11 HG22 ' B' ' 84' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . 0.592 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 1.246 ' CG ' HD23 ' A' ' 64' ' ' LEU . 36.5 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.663 HD23 ' HE2' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.466 ' HB3' HD21 ' B' ' 94' ' ' LEU . 23.9 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.786 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.442 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' PRO . . . . . 0.691 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.327 23.8 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . 0.556 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.556 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.316 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . 0.691 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.418 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' HIS . . . . . 0.512 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.638 HG11 HG22 ' B' ' 34' ' ' VAL . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.501 ' HD2' HH11 ' B' ' 157' ' ' ARG . 31.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.526 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' PRO . . . . . 0.437 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 23.0 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.2 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.635 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . 0.635 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.363 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.739 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.256 25.7 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.625 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.8 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' ASN . . . . . 0.535 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.52 ' C ' ' OD1' ' B' ' 236' ' ' ASN . 19.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.593 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 82.1 m -61.63 89.63 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.012 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -99.92 163.03 12.63 Favored 'General case' 0 N--CA 1.511 2.617 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.79 122.4 46.69 Favored 'General case' 0 N--CA 1.525 3.301 0 N-CA-C 117.179 2.288 . . . . 0.0 117.179 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.49 98.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.6 mmmt -67.36 65.41 0.07 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 113.144 -1.843 . . . . 0.0 114.828 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.846 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.6 mt -29.48 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 C-N-CA 126.575 1.95 . . . . 0.0 115.508 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.49 59.0 0.4 Allowed Glycine 0 N--CA 1.51 3.62 0 N-CA-C 106.897 -2.481 . . . . 0.0 106.897 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -1.05 54.08 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 120.324 3.453 . . . . 0.0 120.324 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.55 -60.25 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 119.494 3.146 . . . . 0.0 119.494 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.504 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.81 22.53 14.39 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 120.941 -1.099 . . . . 0.0 108.196 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.13 -94.8 1.9 Allowed Glycine 0 N--CA 1.511 3.694 0 N-CA-C 115.511 0.964 . . . . 0.0 115.511 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.496 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 44.4 tp -150.62 -177.16 5.82 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.531 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.2 mt -74.8 46.72 0.3 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 120.677 -1.264 . . . . 0.0 111.271 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.629 HG22 ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.76 165.69 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 118.578 2.807 . . . . 0.0 118.578 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.629 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.9 m-30 -102.26 75.39 1.48 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.364 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.307 12.4 mt-10 -93.45 142.46 25.24 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.81 -0.556 . . . . 0.0 111.746 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.41 76.13 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.459 0 N-CA-C 116.3 1.616 . . . . 0.0 116.3 -9.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.61 -44.19 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.807 1 N-CA-C 122.316 4.191 . . . . 0.0 122.316 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.61 71.62 1.0 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 122.484 1.135 . . . . 0.0 113.061 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.788 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.13 111.28 7.21 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.134 -1.604 . . . . 0.0 109.138 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.489 ' N ' HD23 ' A' ' 21' ' ' LEU . 50.6 m -87.49 81.43 7.79 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.788 HG23 HD22 ' A' ' 21' ' ' LEU . 5.3 pt -79.7 -177.57 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.689 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.623 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.49 10.68 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.133 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.4 Cg_endo -52.16 77.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.314 0 N-CA-C 116.97 1.873 . . . . 0.0 116.97 174.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.19 -50.5 0.51 Allowed Glycine 1 N--CA 1.522 4.403 0 C-N-CA 119.69 -1.243 . . . . 0.0 115.826 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.66 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.171 1 N-CA-C 122.149 4.129 . . . . 0.0 122.149 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 28' ' ' THR . 11.7 m -63.98 35.9 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.977 0 N-CA-C 118.726 2.861 . . . . 0.0 118.726 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.3 t -51.98 147.15 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 112.886 -1.961 . . . . 0.0 111.57 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 4.1 pt-20 -114.2 154.9 27.06 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 123.942 1.83 . . . . 0.0 115.442 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.54 113.84 27.43 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.56 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.79 112.49 24.92 Favored 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 120.686 3.587 . . . . 0.0 120.686 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -75.06 84.6 2.31 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.197 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.27 -45.03 18.62 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 118.919 2.933 . . . . 0.0 118.919 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.96 -169.38 3.36 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 124.619 1.167 . . . . 0.0 109.124 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.004 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.7 m 12.95 70.62 0.11 Allowed Pre-proline 0 N--CA 1.521 3.076 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.489 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.37 177.33 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.224 0 C-N-CA 123.941 3.094 . . . . 0.0 114.395 -165.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.3 Cg_endo -92.38 165.28 25.37 Favored 'Cis proline' 0 N--CA 1.504 2.104 0 N-CA-C 115.453 1.29 . . . . 0.0 115.453 -7.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.846 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.83 87.41 2.73 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 117.346 2.35 . . . . 0.0 117.346 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.707 HD21 ' N ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -103.44 140.25 37.73 Favored 'General case' 0 N--CA 1.516 2.863 0 CA-C-N 122.494 2.406 . . . . 0.0 110.681 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.1 m -118.11 116.26 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 121.386 3.847 . . . . 0.0 121.386 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.566 HG22 ' CB ' ' A' ' 88' ' ' TYR . 15.0 m -75.89 165.35 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 102.238 -3.245 . . . . 0.0 102.238 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.061 ' HB2' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.3 131.02 55.47 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.481 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.53 93.87 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.163 1 N-CA-C 124.149 4.87 . . . . 0.0 124.149 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.08 6.84 43.3 Favored 'General case' 0 CA--C 1.601 2.94 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.85 -65.5 1.18 Allowed 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 127.612 2.365 . . . . 0.0 112.753 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.9 mp -86.78 66.64 9.55 Favored 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 118.885 2.92 . . . . 0.0 118.885 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.48 151.22 0.73 Allowed Pre-proline 0 N--CA 1.522 3.137 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.7 Cg_endo -42.47 -58.24 1.33 Allowed 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 123.403 2.736 . . . . 0.0 115.079 170.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.45 67.34 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 124.063 1.887 . . . . 0.0 107.084 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.8 OUTLIER -77.06 53.39 0.96 Allowed 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.296 -2.229 . . . . 0.0 108.266 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.77 56.89 0.76 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.846 2.535 . . . . 0.0 117.846 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.709 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.49 -48.04 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.171 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.04 -30.93 0.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.098 -1.626 . . . . 0.0 111.584 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.551 ' HG ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 pp -41.08 -28.61 0.09 Allowed 'General case' 0 N--CA 1.509 2.501 0 CA-C-O 122.68 1.229 . . . . 0.0 112.524 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.81 -27.48 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.798 ' HE2' ' OE1' ' B' ' 189' ' ' GLU . 12.3 tptt 65.08 -55.64 0.3 Allowed 'General case' 0 N--CA 1.532 3.66 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.7 m -41.67 -28.93 0.16 Allowed 'General case' 0 N--CA 1.513 2.715 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.061 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.8 pp -53.69 -66.8 0.33 Allowed 'General case' 0 CA--C 1.604 3.038 0 N-CA-C 100.673 -3.825 . . . . 0.0 100.673 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.761 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.16 98.47 2.14 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.248 1.419 . . . . 0.0 112.78 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.685 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.07 -173.05 3.72 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.685 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.39 155.18 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 28.2 tt0 105.44 66.11 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 N-CA-C 120.281 3.437 . . . . 0.0 120.281 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.733 ' H ' HD12 ' A' ' 64' ' ' LEU . 6.1 mp 38.13 84.23 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 120.789 3.626 . . . . 0.0 120.789 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 65' ' ' LEU . 36.2 mt -70.6 81.99 0.6 Allowed 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.051 -1.655 . . . . 0.0 111.88 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 1.374 ' CE ' ' HA ' ' B' ' 119' ' ' LEU . 41.2 mmm -79.18 61.94 3.44 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 126.052 2.834 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.0 m -112.55 65.94 0.85 Allowed Pre-proline 0 C--N 1.284 -2.277 0 CA-C-N 110.465 -3.061 . . . . 0.0 113.662 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -52.05 81.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.463 0 C-N-CA 123.001 2.468 . . . . 0.0 114.642 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.06 6.73 27.73 Favored Glycine 1 N--CA 1.516 4.007 0 O-C-N 122.115 -0.366 . . . . 0.0 113.619 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.502 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 36.0 tt0 -123.61 156.85 35.02 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 124.36 2.029 . . . . 0.0 116.326 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.434 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.96 156.37 27.55 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -115.95 147.89 40.67 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-O 116.518 -1.706 . . . . 0.0 107.247 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.45 143.76 41.77 Favored 'General case' 0 N--CA 1.529 3.511 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.0 m -119.95 102.52 8.61 Favored 'General case' 0 N--CA 1.514 2.769 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.546 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.463 ' OG1' HG23 ' A' ' 28' ' ' THR . 44.7 m -94.8 152.24 18.58 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.461 ' N ' HG22 ' A' ' 75' ' ' THR . 89.1 m-85 -107.9 168.33 8.05 Favored Pre-proline 0 N--CA 1.504 2.268 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.076 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.35 -174.84 1.54 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 121.058 1.172 . . . . 0.0 111.073 161.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.36 -19.74 18.99 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 124.289 1.995 . . . . 0.0 107.173 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.15 42.66 0.49 Allowed 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 111.286 -2.688 . . . . 0.0 109.132 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.34 84.83 9.9 Favored Pre-proline 0 N--CA 1.499 2.011 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.723 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.8 Cg_endo -79.45 178.59 7.22 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.83 2.354 . . . . 0.0 112.303 172.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.589 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.03 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 125.432 1.493 . . . . 0.0 113.243 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.546 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.33 124.99 5.63 Favored Glycine 0 N--CA 1.507 3.38 0 N-CA-C 121.792 3.477 . . . . 0.0 121.792 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.46 61.23 1.18 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.546 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.8 m-85 -62.13 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.924 1.345 . . . . 0.0 112.969 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 6.8 m -63.42 135.95 57.28 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.539 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.53 136.53 52.91 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.566 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.69 82.11 8.57 Favored 'General case' 0 N--CA 1.512 2.672 1 N-CA-C 132.536 7.976 . . . . 0.0 132.536 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.0 t -63.91 82.21 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.495 2 CA-C-N 130.343 5.974 . . . . 0.0 114.324 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.5 tt0 -20.6 -72.42 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.6 0 N-CA-C 118.518 2.784 . . . . 0.0 118.518 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.55 ' O ' ' CD2' ' B' ' 3' ' ' PHE . 29.5 Cg_endo -67.04 -3.41 9.65 Favored 'Trans proline' 0 N--CA 1.51 2.473 0 C-N-CA 122.361 2.04 . . . . 0.0 115.383 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -120.85 -14.18 8.54 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.457 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.35 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.55 -33.94 1.74 Allowed Glycine 1 N--CA 1.521 4.343 0 O-C-N 121.491 -0.756 . . . . 0.0 112.645 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.6 68.51 7.98 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.9 26.74 0.05 OUTLIER Glycine 1 N--CA 1.528 4.774 0 CA-C-N 114.0 -1.455 . . . . 0.0 116.631 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.605 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.1 ttm -108.63 43.9 1.19 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 124.539 2.114 . . . . 0.0 112.973 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.02 134.87 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 112.209 -2.269 . . . . 0.0 110.916 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.539 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.62 154.88 19.33 Favored Glycine 1 N--CA 1.536 5.36 0 C-N-CA 119.468 -1.349 . . . . 0.0 114.023 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 ttpp -118.63 81.95 1.77 Allowed 'General case' 0 N--CA 1.516 2.863 0 CA-C-N 119.408 1.604 . . . . 0.0 115.238 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.66 123.22 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.731 0 C-N-CA 118.061 -1.456 . . . . 0.0 107.087 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.5 m -112.59 88.74 2.89 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.177 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.47 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.2 t -74.08 105.15 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.16 -72.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 O-C-N 126.112 2.133 . . . . 0.0 115.93 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.589 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.534 0 O-C-N 125.555 1.785 . . . . 0.0 113.796 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.281 22.0 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.55 ' CD2' ' O ' ' A' ' 91' ' ' PRO . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.7 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.31 27.8 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.512 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 53.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.638 HG22 HG11 ' B' ' 151' ' ' VAL 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.557 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.368 22.4 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 33.0 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.785 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.411 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.418 HG12 ' N ' ' B' ' 69' ' ' GLY . 88.0 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.418 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.506 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 50.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' PRO . . . . . 0.72 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.72 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.2 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.512 HG22 HG11 ' B' ' 114' ' ' VAL 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.3 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' B' ' 130' ' ' PRO . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.7 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 1.489 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 20.7 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' GLN . . . . . 1.004 ' NE2' HG12 ' A' ' 36' ' ' VAL . 11.9 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.512 HG11 HG22 ' B' ' 84' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . 0.592 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 1.23 ' O ' ' HE1' ' A' ' 66' ' ' MET . 36.4 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 1.374 ' HA ' ' CE ' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.467 ' HB3' HD21 ' B' ' 94' ' ' LEU . 24.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.442 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' PRO . . . . . 0.693 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.328 23.8 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . 0.556 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.556 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.317 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . 0.693 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.418 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' HIS . . . . . 0.512 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.638 HG11 HG22 ' B' ' 34' ' ' VAL . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.503 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.0 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.525 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' PRO . . . . . 0.436 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 23.0 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.1 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.635 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . 0.635 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' GLU . . . . . 0.798 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.363 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.739 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.8 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.256 25.9 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.627 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' ASN . . . . . 0.537 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 19.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.493 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 82.5 m -61.65 89.68 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.022 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.95 163.01 12.63 Favored 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.462 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.72 122.41 46.68 Favored 'General case' 0 N--CA 1.526 3.326 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.5 t -100.57 98.36 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.7 mmmt -67.27 65.33 0.07 Allowed 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 113.144 -1.844 . . . . 0.0 114.9 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.833 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.7 mt -29.45 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 126.539 1.935 . . . . 0.0 115.531 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.48 59.04 0.4 Allowed Glycine 0 N--CA 1.51 3.576 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -0.95 54.0 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.61 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.84 22.57 14.34 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 120.956 -1.09 . . . . 0.0 108.154 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.22 -94.82 1.89 Allowed Glycine 0 N--CA 1.512 3.715 0 N-CA-C 115.499 0.96 . . . . 0.0 115.499 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.499 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 44.6 tp -150.59 -177.14 5.8 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.524 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.1 mt -74.77 46.65 0.3 Allowed 'General case' 0 N--CA 1.509 2.499 0 O-C-N 120.641 -1.287 . . . . 0.0 111.264 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.78 165.6 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.621 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.9 m-30 -102.17 75.43 1.5 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 112.263 -2.244 . . . . 0.0 113.423 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.307 12.4 mt-10 -93.51 142.43 25.18 Favored Pre-proline 0 N--CA 1.506 2.333 0 O-C-N 121.822 -0.549 . . . . 0.0 111.778 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.5 76.22 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.431 0 N-CA-C 116.4 1.654 . . . . 0.0 116.4 -9.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.63 -44.22 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.795 1 N-CA-C 122.319 4.192 . . . . 0.0 122.319 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.631 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.56 71.65 1.0 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 122.388 1.09 . . . . 0.0 113.066 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.804 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.1 111.2 7.13 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.131 -1.606 . . . . 0.0 109.099 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.485 ' N ' HD23 ' A' ' 21' ' ' LEU . 49.7 m -87.46 81.42 7.81 Favored 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.804 HG23 HD22 ' A' ' 21' ' ' LEU . 5.3 pt -79.72 -177.55 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.626 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.623 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.68 166.55 10.58 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-N 113.78 -1.554 . . . . 0.0 108.122 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.4 Cg_endo -52.22 77.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.318 0 N-CA-C 116.866 1.833 . . . . 0.0 116.866 174.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.07 -50.51 0.52 Allowed Glycine 1 N--CA 1.522 4.428 0 C-N-CA 119.717 -1.23 . . . . 0.0 115.879 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.563 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.73 92.11 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.184 1 N-CA-C 122.19 4.144 . . . . 0.0 122.19 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.551 ' O ' HG22 ' A' ' 28' ' ' THR . 11.9 m -64.1 36.07 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.019 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.8 t -52.11 147.17 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 CA-C-N 112.853 -1.976 . . . . 0.0 111.51 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 4.1 pt-20 -114.2 154.88 27.11 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 123.916 1.817 . . . . 0.0 115.38 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.52 113.81 27.39 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 32' ' ' LEU . 7.0 tt -100.67 112.6 25.02 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -75.17 84.74 2.37 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.159 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.33 -45.11 18.36 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.92 -169.25 3.33 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 124.662 1.185 . . . . 0.0 109.109 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.054 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.7 m 12.75 70.69 0.11 Allowed Pre-proline 0 N--CA 1.52 3.066 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.235 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.44 177.24 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.219 0 C-N-CA 123.99 3.127 . . . . 0.0 114.424 -165.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.6 Cg_endo -92.44 165.31 25.18 Favored 'Cis proline' 0 N--CA 1.503 2.048 0 N-CA-C 115.399 1.269 . . . . 0.0 115.399 -7.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.833 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.9 87.43 2.73 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -103.36 140.35 37.55 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 122.482 2.401 . . . . 0.0 110.664 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 41' ' ' VAL . 7.0 m -118.12 116.24 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 121.438 3.866 . . . . 0.0 121.438 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.562 HG22 ' CB ' ' A' ' 88' ' ' TYR . 15.0 m -75.92 165.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 102.258 -3.238 . . . . 0.0 102.258 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.046 ' HB2' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.32 130.97 55.51 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.483 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.41 93.78 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.168 1 N-CA-C 124.111 4.856 . . . . 0.0 124.111 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.07 6.8 43.47 Favored 'General case' 0 CA--C 1.602 2.967 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.81 -65.55 1.18 Allowed 'General case' 0 CA--C 1.574 1.889 0 C-N-CA 127.549 2.339 . . . . 0.0 112.723 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.71 66.45 9.47 Favored 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.37 151.27 0.75 Allowed Pre-proline 0 N--CA 1.523 3.182 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.8 Cg_endo -42.47 -58.28 1.32 Allowed 'Trans proline' 0 N--CA 1.507 2.324 0 C-N-CA 123.385 2.724 . . . . 0.0 115.079 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.43 67.4 0.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 124.069 1.89 . . . . 0.0 107.038 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.2 53.51 1.0 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 112.275 -2.239 . . . . 0.0 108.249 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.85 56.91 0.76 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.712 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.63 -47.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.244 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.17 -30.83 0.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.174 -1.579 . . . . 0.0 111.558 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.547 ' HG ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 pp -41.13 -28.59 0.1 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 122.693 1.235 . . . . 0.0 112.498 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.489 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.8 -27.57 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.628 ' HE2' ' OE1' ' B' ' 189' ' ' GLU . 12.3 tptt 65.06 -55.58 0.3 Allowed 'General case' 0 N--CA 1.532 3.632 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -41.68 -28.93 0.16 Allowed 'General case' 0 N--CA 1.515 2.785 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.046 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.8 pp -53.68 -66.79 0.33 Allowed 'General case' 0 CA--C 1.603 2.999 0 N-CA-C 100.711 -3.811 . . . . 0.0 100.711 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.762 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.14 98.39 2.12 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 125.33 1.452 . . . . 0.0 112.789 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.686 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -89.99 -173.0 3.71 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.686 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.37 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.611 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 28.0 tt0 105.45 65.9 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 120.346 3.462 . . . . 0.0 120.346 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.2 HD23 ' CG ' ' B' ' 118' ' ' PRO . 6.0 mp 38.24 84.26 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 120.762 3.616 . . . . 0.0 120.762 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.495 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 36.2 mt -70.65 82.04 0.6 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.18 -1.575 . . . . 0.0 111.812 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.904 ' HE3' HD23 ' B' ' 119' ' ' LEU . 41.2 mmm -79.28 62.0 3.52 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 126.158 2.885 . . . . 0.0 110.94 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.7 m -112.62 65.94 0.87 Allowed Pre-proline 0 N--CA 1.504 2.267 0 CA-C-N 110.486 -3.052 . . . . 0.0 113.577 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -51.98 81.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.987 2.458 . . . . 0.0 114.674 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.18 6.56 27.65 Favored Glycine 1 N--CA 1.516 4.028 0 O-C-N 122.209 -0.307 . . . . 0.0 113.604 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.9 tt0 -123.54 156.82 34.95 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 124.324 2.011 . . . . 0.0 116.368 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.82 156.35 27.42 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 119.694 3.22 . . . . 0.0 119.694 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -116.0 147.91 40.71 Favored 'General case' 0 N--CA 1.518 2.951 0 CA-C-O 116.59 -1.671 . . . . 0.0 107.222 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.49 143.62 42.03 Favored 'General case' 0 N--CA 1.529 3.515 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.5 m -119.89 102.56 8.65 Favored 'General case' 0 N--CA 1.515 2.8 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.569 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 76' ' ' PHE . 44.1 m -94.73 152.26 18.6 Favored 'General case' 0 N--CA 1.524 3.246 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.465 ' N ' HG22 ' A' ' 75' ' ' THR . 89.2 m-85 -107.96 168.4 7.95 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.068 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.41 -174.77 1.53 Allowed 'Trans proline' 0 CA--C 1.558 1.708 0 C-N-CA 121.012 1.141 . . . . 0.0 111.116 161.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.38 -19.75 18.97 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 124.34 2.019 . . . . 0.0 107.222 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.17 42.63 0.49 Allowed 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 111.195 -2.729 . . . . 0.0 109.106 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.18 84.75 9.51 Favored Pre-proline 0 N--CA 1.5 2.028 0 CA-C-N 113.603 -1.635 . . . . 0.0 113.841 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -79.4 178.68 7.13 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.77 2.313 . . . . 0.0 112.354 172.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.588 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.11 77.75 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 C-N-CA 125.367 1.467 . . . . 0.0 113.244 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.54 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.4 125.03 5.64 Favored Glycine 0 N--CA 1.508 3.487 0 N-CA-C 121.694 3.438 . . . . 0.0 121.694 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.8 mt-10 -99.49 61.26 1.17 Allowed 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.54 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.8 m-85 -62.1 77.69 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 122.884 1.326 . . . . 0.0 113.07 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 6.8 m -63.29 135.89 57.33 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.536 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.49 136.58 52.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.562 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.7 82.05 8.59 Favored 'General case' 0 N--CA 1.511 2.607 1 N-CA-C 132.617 8.006 . . . . 0.0 132.617 -179.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.1 t -63.93 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.499 2 CA-C-N 130.355 5.98 . . . . 0.0 114.295 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.5 tt0 -20.53 -72.44 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.565 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.562 ' O ' ' CD2' ' B' ' 3' ' ' PHE . 29.5 Cg_endo -66.98 -3.51 9.79 Favored 'Trans proline' 0 N--CA 1.511 2.548 0 C-N-CA 122.467 2.112 . . . . 0.0 115.363 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -120.86 -14.16 8.54 Favored 'General case' 0 N--CA 1.51 2.565 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.34 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.52 -34.0 1.74 Allowed Glycine 1 N--CA 1.52 4.292 0 O-C-N 121.534 -0.729 . . . . 0.0 112.735 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.59 68.41 7.93 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.93 26.73 0.05 OUTLIER Glycine 1 N--CA 1.527 4.733 0 CA-C-N 114.035 -1.439 . . . . 0.0 116.605 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.603 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.1 ttt -108.51 43.81 1.19 Allowed 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 124.406 2.05 . . . . 0.0 113.0 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.01 134.85 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 112.247 -2.251 . . . . 0.0 110.968 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.536 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.68 154.87 19.36 Favored Glycine 1 N--CA 1.535 5.24 0 C-N-CA 119.435 -1.364 . . . . 0.0 114.013 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 ttpp -118.58 81.97 1.77 Allowed 'General case' 0 N--CA 1.517 2.907 0 CA-C-N 119.405 1.602 . . . . 0.0 115.242 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.75 123.28 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.743 0 C-N-CA 118.0 -1.48 . . . . 0.0 107.026 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.5 m -112.57 88.75 2.9 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.228 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.471 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.3 t -74.01 105.19 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.26 -72.37 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.643 0 O-C-N 126.121 2.138 . . . . 0.0 115.885 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.588 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.48 0 O-C-N 125.43 1.706 . . . . 0.0 113.889 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.281 21.7 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 91' ' ' PRO . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' TRP . . . . . 0.437 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.7 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.31 27.6 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.515 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 52.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.638 HG22 HG11 ' B' ' 151' ' ' VAL 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.557 HD22 ' N ' ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.369 22.0 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 33.1 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.783 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.41 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.418 HG12 ' N ' ' B' ' 69' ' ' GLY . 87.8 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.418 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.505 ' N ' HD12 ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 50.2 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' PRO . . . . . 0.719 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.0 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.719 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.3 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.511 HG22 HG11 ' B' ' 114' ' ' VAL 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' B' ' 130' ' ' PRO . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.6 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 1.235 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 20.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' GLN . . . . . 1.054 ' NE2' HG12 ' A' ' 36' ' ' VAL . 11.9 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.511 HG11 HG22 ' B' ' 84' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . 0.591 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 1.2 ' CG ' HD23 ' A' ' 64' ' ' LEU . 36.5 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.904 HD23 ' HE3' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 93.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.467 ' HB3' HD21 ' B' ' 94' ' ' LEU . 24.1 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.783 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.441 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' PRO . . . . . 0.693 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.328 23.5 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . 0.556 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.556 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.316 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . 0.693 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.417 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' HIS . . . . . 0.515 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.638 HG11 HG22 ' B' ' 34' ' ' VAL . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.502 ' HD2' HH11 ' B' ' 157' ' ' ARG . 31.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.524 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' PRO . . . . . 0.437 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 22.9 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.1 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.634 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . 0.634 ' N ' HD23 ' B' ' 171' ' ' LEU . 18.9 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' GLU . . . . . 0.628 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.362 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.739 HD22 ' C ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.7 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.257 25.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.627 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' ASN . . . . . 0.536 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.521 ' C ' ' OD1' ' B' ' 236' ' ' ASN . 20.0 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLU . . . . . 0.595 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.48 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 91.2 m -61.63 89.73 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.975 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -100.01 162.97 12.64 Favored 'General case' 0 N--CA 1.513 2.683 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.462 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.8 t -107.71 122.49 46.83 Favored 'General case' 0 N--CA 1.526 3.331 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.0 t -100.62 98.38 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.46 65.53 0.08 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.834 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.0 mt -29.67 68.27 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.996 0 C-N-CA 126.54 1.936 . . . . 0.0 115.493 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.46 59.1 0.4 Allowed Glycine 0 N--CA 1.51 3.583 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -1.13 54.15 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.256 0 N-CA-C 120.282 3.438 . . . . 0.0 120.282 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.44 -60.15 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 119.538 3.162 . . . . 0.0 119.538 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.508 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.5 14.42 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.931 -1.106 . . . . 0.0 108.164 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.11 -94.83 1.9 Allowed Glycine 0 N--CA 1.512 3.75 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.3 tp -150.62 -177.16 5.81 Favored 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.554 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.8 mt -74.73 46.7 0.3 Allowed 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.67 -1.269 . . . . 0.0 111.3 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.665 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.74 165.66 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.665 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.22 75.35 1.49 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.402 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.283 7.4 mt-10 -93.46 142.46 25.24 Favored Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 121.825 -0.547 . . . . 0.0 111.753 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 20' ' ' LYS . 53.9 Cg_endo -86.46 76.14 0.09 OUTLIER 'Cis proline' 0 CA--C 1.571 2.364 0 N-CA-C 116.353 1.636 . . . . 0.0 116.353 -9.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.74 -44.26 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 1 N-CA-C 122.241 4.163 . . . . 0.0 122.241 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.636 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.58 71.59 1.0 Allowed 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 122.413 1.101 . . . . 0.0 113.1 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.8 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.16 111.31 7.27 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.199 -1.563 . . . . 0.0 109.111 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.516 ' N ' HD23 ' A' ' 21' ' ' LEU . 55.9 m -87.52 81.47 7.76 Favored 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.8 HG23 HD22 ' A' ' 21' ' ' LEU . 4.9 pt -79.66 -177.55 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.742 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.643 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.51 10.66 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 113.887 -1.506 . . . . 0.0 108.115 179.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.0 Cg_endo -52.12 77.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.304 0 N-CA-C 116.934 1.859 . . . . 0.0 116.934 174.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.11 -50.45 0.52 Allowed Glycine 1 N--CA 1.522 4.423 0 C-N-CA 119.706 -1.235 . . . . 0.0 115.857 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.65 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.167 1 N-CA-C 122.08 4.104 . . . . 0.0 122.08 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 28' ' ' THR . 12.6 m -64.09 35.96 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.96 147.21 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 112.862 -1.972 . . . . 0.0 111.51 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.9 pt-20 -114.3 154.86 27.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 123.92 1.819 . . . . 0.0 115.35 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.404 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.7 m-85 -107.46 113.8 27.38 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.69 112.5 24.91 Favored 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 120.728 3.603 . . . . 0.0 120.728 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -75.17 84.73 2.38 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.156 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.6 p30 -80.31 -44.97 18.64 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -150.01 -169.34 3.35 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 124.643 1.177 . . . . 0.0 109.097 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.109 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.7 m 12.81 70.69 0.11 Allowed Pre-proline 0 N--CA 1.52 3.046 0 N-CA-C 117.168 2.285 . . . . 0.0 117.168 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.561 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 56.3 Cg_endo -98.41 177.19 0.42 Allowed 'Trans proline' 0 CA--C 1.569 2.263 0 C-N-CA 124.041 3.161 . . . . 0.0 114.372 -165.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 56.5 Cg_endo -92.45 165.24 25.16 Favored 'Cis proline' 0 N--CA 1.503 2.063 0 N-CA-C 115.399 1.269 . . . . 0.0 115.399 -7.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.825 ' HB2' HD13 ' A' ' 7' ' ' LEU . 17.5 m-70 -118.88 87.44 2.73 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.572 HD21 ' C ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -103.34 140.27 37.65 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 122.421 2.373 . . . . 0.0 110.716 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.497 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.9 m -118.16 116.31 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 121.431 3.863 . . . . 0.0 121.431 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.558 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.7 m -75.98 165.4 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.027 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.26 130.89 55.52 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.4 93.71 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.208 1 N-CA-C 124.205 4.891 . . . . 0.0 124.205 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.94 6.7 43.57 Favored 'General case' 0 CA--C 1.602 2.959 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.81 -65.54 1.18 Allowed 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 127.501 2.32 . . . . 0.0 112.668 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.677 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.62 66.46 9.49 Favored 'General case' 0 N--CA 1.518 2.949 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.36 151.28 0.75 Allowed Pre-proline 0 N--CA 1.522 3.158 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.6 Cg_endo -42.51 -58.3 1.32 Allowed 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 123.389 2.726 . . . . 0.0 115.025 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.51 67.47 0.72 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 124.15 1.928 . . . . 0.0 107.056 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.2 53.5 1.0 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 112.267 -2.242 . . . . 0.0 108.219 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.82 56.81 0.76 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.675 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.46 -48.01 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.13 -30.85 0.17 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.127 -1.608 . . . . 0.0 111.606 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.12 -28.6 0.1 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.649 1.214 . . . . 0.0 112.461 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.76 -27.7 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.14 -55.57 0.31 Allowed 'General case' 0 N--CA 1.534 3.752 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -41.69 -28.94 0.16 Allowed 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.027 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.6 pp -53.68 -66.82 0.32 Allowed 'General case' 0 CA--C 1.604 3.035 0 N-CA-C 100.697 -3.816 . . . . 0.0 100.697 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.802 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.9 p -72.06 98.42 2.09 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 125.267 1.427 . . . . 0.0 112.814 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.673 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.1 t60 -90.02 -173.03 3.72 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.673 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.42 155.2 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.317 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.597 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.1 tt0 105.43 66.02 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 120.309 3.448 . . . . 0.0 120.309 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.839 HD23 ' CG ' ' B' ' 118' ' ' PRO . 6.0 mp 38.19 84.25 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 120.748 3.61 . . . . 0.0 120.748 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.542 ' N ' HD21 ' A' ' 40' ' ' ASN . 36.3 mt -70.66 82.04 0.61 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.145 -1.597 . . . . 0.0 111.865 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.982 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 42.2 mmm -79.21 61.94 3.46 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 126.074 2.845 . . . . 0.0 110.965 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.9 m -112.53 65.96 0.85 Allowed Pre-proline 0 C--N 1.284 -2.262 0 CA-C-N 110.464 -3.062 . . . . 0.0 113.601 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.695 ' HB2' ' OD2' ' B' ' 100' ' ' ASP . 21.3 Cg_endo -51.98 81.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.507 0 C-N-CA 122.964 2.442 . . . . 0.0 114.675 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.17 6.69 27.55 Favored Glycine 1 N--CA 1.517 4.056 0 O-C-N 122.238 -0.289 . . . . 0.0 113.513 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.8 tt0 -123.61 156.8 35.11 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 124.34 2.019 . . . . 0.0 116.349 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.439 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.83 156.37 27.4 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 119.716 3.228 . . . . 0.0 119.716 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.7 t -116.06 147.88 40.8 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-O 116.682 -1.628 . . . . 0.0 107.199 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.45 143.72 41.83 Favored 'General case' 0 N--CA 1.529 3.503 0 N-CA-C 118.347 2.721 . . . . 0.0 118.347 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.3 m -119.88 102.62 8.7 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.517 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 28' ' ' THR . 51.7 m -94.85 152.22 18.57 Favored 'General case' 0 N--CA 1.525 3.297 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' N ' HG22 ' A' ' 75' ' ' THR . 90.0 m-85 -107.95 168.28 8.12 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.059 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -72.27 -174.8 1.51 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 121.03 1.153 . . . . 0.0 111.157 161.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.35 -19.76 18.99 Favored 'General case' 0 N--CA 1.509 2.504 0 CA-C-O 124.384 2.04 . . . . 0.0 107.286 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.14 42.72 0.49 Allowed 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 111.225 -2.716 . . . . 0.0 109.111 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.38 84.74 9.88 Favored Pre-proline 0 N--CA 1.499 2.008 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.809 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 83' ' ' GLY . 42.4 Cg_endo -79.39 178.63 7.2 Favored 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 122.753 2.302 . . . . 0.0 112.275 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.596 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -15.99 77.69 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 125.348 1.459 . . . . 0.0 113.264 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.544 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.43 125.01 5.63 Favored Glycine 0 N--CA 1.507 3.417 0 N-CA-C 121.74 3.456 . . . . 0.0 121.74 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.9 mt-10 -99.51 61.25 1.17 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.544 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.9 m-85 -62.05 77.79 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 122.904 1.335 . . . . 0.0 113.032 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 7.2 m -63.42 135.95 57.29 Favored 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.53 136.51 52.92 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.558 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.64 82.07 8.58 Favored 'General case' 0 N--CA 1.512 2.672 1 N-CA-C 132.559 7.985 . . . . 0.0 132.559 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.711 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.6 t -63.85 82.23 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.498 2 CA-C-N 130.329 5.968 . . . . 0.0 114.314 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.1 tt0 -20.57 -72.45 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.56 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.406 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 35.6 Cg_endo -67.04 -3.43 9.69 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.326 2.017 . . . . 0.0 115.401 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -120.84 -14.12 8.56 Favored 'General case' 0 N--CA 1.511 2.585 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.23 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.53 -33.91 1.75 Allowed Glycine 1 N--CA 1.52 4.266 0 O-C-N 121.535 -0.728 . . . . 0.0 112.657 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.64 68.42 7.98 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.92 26.7 0.05 OUTLIER Glycine 1 N--CA 1.526 4.636 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.581 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.5 43.87 1.19 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 124.559 2.123 . . . . 0.0 113.023 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.94 134.91 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 112.19 -2.277 . . . . 0.0 110.902 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.7 154.88 19.38 Favored Glycine 1 N--CA 1.536 5.347 0 C-N-CA 119.489 -1.339 . . . . 0.0 113.978 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.7 82.0 1.78 Allowed 'General case' 0 N--CA 1.518 2.94 0 CA-C-N 119.371 1.585 . . . . 0.0 115.192 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.473 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.69 123.33 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.4 m -112.7 88.75 2.9 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.193 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.456 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.2 t -73.98 105.21 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.35 -72.26 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 O-C-N 126.132 2.145 . . . . 0.0 115.942 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.596 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.486 0 O-C-N 125.49 1.744 . . . . 0.0 113.811 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 N--CA 1.456 -0.704 0 CA-C-O 119.41 -0.329 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' TRP . . . . . 0.45 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.9 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . 0.429 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 62.6 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.6 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.442 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 56.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.5 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' CYS . . . . . . . . . . . . . 55.5 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.5 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.1 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.63 HG22 HG11 ' B' ' 151' ' ' VAL 0.399 1.4 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.6 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 25.8 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.591 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.5 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 86.9 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.969 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.4 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.582 HG22 HG13 ' B' ' 34' ' ' VAL . 61.1 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.3 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.8 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.421 HG12 ' N ' ' B' ' 69' ' ' GLY . 86.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.421 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' LEU . . . . . 0.515 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.505 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.2 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.9 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' PRO . . . . . 0.779 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 19.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.779 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 44.1 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ILE . . . . . 0.58 HG22 HG11 ' B' ' 114' ' ' VAL 0.384 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 37.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 72.6 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 50.4 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.8 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.695 ' OD2' ' HB2' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 1.561 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 19.1 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' GLN . . . . . 1.109 ' NE2' HG12 ' A' ' 36' ' ' VAL . 11.1 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 23.9 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 56.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.58 HG11 HG22 ' B' ' 84' ' ' ILE . 16.5 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.505 HD11 HG23 ' B' ' 75' ' ' VAL 0.727 0.0 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.68 0.1 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' PRO . . . . . 0.839 ' CG ' HD23 ' A' ' 64' ' ' LEU . 38.0 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.982 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 82.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.5 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 94.4 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.969 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.5 1.5 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' PRO . . . . . 0.653 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 13.0 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' ASP . . . . . 0.629 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.629 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.393 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' PHE . . . . . 0.653 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.0 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.6 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.426 1.2 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' HIS . . . . . 0.442 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.63 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.495 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.666 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.2 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.457 1.3 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' PRO . . . . . 0.45 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 20.2 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.461 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.8 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' LEU . . . . . 0.664 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' TYR . . . . . 0.664 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.6 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.4 HG22 ' N ' ' B' ' 178' ' ' GLY . 58.5 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.4 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.8 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.1 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . 0.412 ' HB3' HE21 ' B' ' 186' ' ' GLN . 2.1 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 43.8 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.444 0.9 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.791 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.366 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 81.0 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.8 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 88.3 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.9 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.391 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.6 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' ASN . . . . . 0.501 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.4 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . 0.475 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 22.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.6 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.2 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' LEU . . . . . 0.436 HD22 HD11 ' B' ' 142' ' ' ILE . 41.0 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 118.159 -0.924 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.602 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.3 m -61.55 89.7 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -99.99 163.04 12.61 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.47 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.82 122.41 46.72 Favored 'General case' 0 N--CA 1.525 3.321 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.8 t -100.49 98.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.33 65.38 0.07 Allowed 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 113.14 -1.845 . . . . 0.0 114.855 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.3 mt -29.52 68.27 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 126.521 1.929 . . . . 0.0 115.543 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.44 59.01 0.4 Allowed Glycine 0 N--CA 1.509 3.539 0 N-CA-C 106.896 -2.482 . . . . 0.0 106.896 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.1 p -1.0 54.04 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.33 0 N-CA-C 120.242 3.423 . . . . 0.0 120.242 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.53 -60.19 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.49 14.43 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.962 -1.086 . . . . 0.0 108.151 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.06 -94.86 1.91 Allowed Glycine 0 N--CA 1.512 3.75 0 N-CA-C 115.546 0.978 . . . . 0.0 115.546 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.553 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.9 tp -150.64 -177.13 5.8 Favored 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.557 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.6 mt -74.8 46.73 0.3 Allowed 'General case' 0 N--CA 1.508 2.468 0 O-C-N 120.654 -1.279 . . . . 0.0 111.244 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.655 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.83 165.64 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 118.503 2.779 . . . . 0.0 118.503 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.655 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.25 75.35 1.48 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 112.187 -2.279 . . . . 0.0 113.356 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.47 142.47 25.25 Favored Pre-proline 0 N--CA 1.507 2.376 0 O-C-N 121.822 -0.549 . . . . 0.0 111.735 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 20' ' ' LYS . 56.3 Cg_endo -86.43 76.09 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.426 0 N-CA-C 116.359 1.638 . . . . 0.0 116.359 -9.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.73 -44.23 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 1 N-CA-C 122.3 4.185 . . . . 0.0 122.3 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.638 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.62 71.66 1.0 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-O 122.433 1.111 . . . . 0.0 113.092 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.808 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.11 111.27 7.19 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.152 -1.592 . . . . 0.0 109.107 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.524 ' N ' HD23 ' A' ' 21' ' ' LEU . 52.6 m -87.51 81.5 7.76 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.808 HG23 HD22 ' A' ' 21' ' ' LEU . 4.7 pt -79.7 -177.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.652 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.646 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.69 166.58 10.51 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-N 113.769 -1.559 . . . . 0.0 108.067 179.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.4 Cg_endo -52.18 77.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.571 2.326 0 N-CA-C 116.947 1.864 . . . . 0.0 116.947 174.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.13 -50.48 0.52 Allowed Glycine 1 N--CA 1.522 4.414 0 C-N-CA 119.73 -1.224 . . . . 0.0 115.833 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.71 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.151 1 N-CA-C 122.104 4.113 . . . . 0.0 122.104 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 28' ' ' THR . 11.5 m -64.01 35.91 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.012 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.95 147.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 112.863 -1.971 . . . . 0.0 111.517 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.9 pt-20 -114.29 154.93 27.12 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 123.934 1.826 . . . . 0.0 115.359 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.415 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.6 m-85 -107.55 113.86 27.46 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.79 112.57 25.02 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 120.636 3.569 . . . . 0.0 120.636 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -75.13 84.75 2.35 Favored 'General case' 0 N--CA 1.512 2.645 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.18 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.7 p30 -80.26 -45.14 18.44 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.9 -169.29 3.34 Favored 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 124.661 1.184 . . . . 0.0 109.118 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.911 HG12 HE22 ' B' ' 104' ' ' GLN . 1.6 m 12.82 70.7 0.11 Allowed Pre-proline 0 N--CA 1.521 3.079 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.458 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 58.4 Cg_endo -98.4 177.24 0.41 Allowed 'Trans proline' 0 CA--C 1.569 2.261 0 C-N-CA 123.945 3.096 . . . . 0.0 114.422 -165.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.602 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 58.2 Cg_endo -92.41 165.28 25.29 Favored 'Cis proline' 0 N--CA 1.504 2.105 0 N-CA-C 115.402 1.27 . . . . 0.0 115.402 -7.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.818 ' HB2' HD13 ' A' ' 7' ' ' LEU . 17.9 m-70 -118.88 87.44 2.73 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.615 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -103.4 140.29 37.66 Favored 'General case' 0 N--CA 1.516 2.832 0 CA-C-N 122.469 2.395 . . . . 0.0 110.719 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.498 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.5 m -118.11 116.25 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 121.419 3.859 . . . . 0.0 121.419 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.567 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.5 m -75.95 165.35 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.033 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.26 131.02 55.47 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.436 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.47 93.77 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.174 1 N-CA-C 124.148 4.87 . . . . 0.0 124.148 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.98 6.76 43.43 Favored 'General case' 0 CA--C 1.602 2.97 0 N-CA-C 101.23 -3.618 . . . . 0.0 101.23 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.84 -65.57 1.18 Allowed 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 127.526 2.33 . . . . 0.0 112.669 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.681 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.47 9.49 Favored 'General case' 0 N--CA 1.519 3.007 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.41 151.25 0.74 Allowed Pre-proline 0 N--CA 1.523 3.181 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.0 Cg_endo -42.51 -58.17 1.36 Allowed 'Trans proline' 0 N--CA 1.508 2.359 0 C-N-CA 123.362 2.708 . . . . 0.0 115.102 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.543 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.51 67.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 124.066 1.888 . . . . 0.0 107.062 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.16 53.5 0.99 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 112.275 -2.239 . . . . 0.0 108.208 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.87 56.89 0.76 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.773 2.508 . . . . 0.0 117.773 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.672 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.51 -48.0 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.13 -30.85 0.16 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.106 -1.622 . . . . 0.0 111.571 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.514 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.16 -28.52 0.1 Allowed 'General case' 0 N--CA 1.509 2.501 0 CA-C-O 122.716 1.246 . . . . 0.0 112.475 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.497 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.81 -27.63 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.466 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.04 -55.59 0.3 Allowed 'General case' 0 N--CA 1.533 3.691 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -41.68 -28.93 0.16 Allowed 'General case' 0 N--CA 1.515 2.801 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.033 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.72 -66.71 0.34 Allowed 'General case' 0 CA--C 1.603 3.019 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.806 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.6 p -72.18 98.47 2.15 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.273 1.429 . . . . 0.0 112.765 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.669 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.03 -173.1 3.74 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.669 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.43 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.365 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.591 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.1 tt0 105.52 65.99 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 120.292 3.441 . . . . 0.0 120.292 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.778 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.9 mp 38.13 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.615 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 35.2 mt -70.64 82.05 0.6 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.101 -1.624 . . . . 0.0 111.886 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 1.312 ' CE ' ' CD2' ' B' ' 119' ' ' LEU . 41.9 mmm -79.23 61.97 3.48 Favored 'General case' 0 N--CA 1.511 2.579 0 CA-C-O 126.021 2.82 . . . . 0.0 110.913 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.6 m -112.61 65.98 0.87 Allowed Pre-proline 0 C--N 1.283 -2.287 0 CA-C-N 110.525 -3.034 . . . . 0.0 113.585 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.679 ' CG ' ' OD2' ' B' ' 100' ' ' ASP . 21.9 Cg_endo -52.03 81.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.461 0 C-N-CA 122.945 2.43 . . . . 0.0 114.699 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.64 27.66 Favored Glycine 0 N--CA 1.516 3.973 0 O-C-N 122.177 -0.327 . . . . 0.0 113.637 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.55 156.94 34.76 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 124.321 2.01 . . . . 0.0 116.367 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -117.05 156.34 27.71 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 119.628 3.195 . . . . 0.0 119.628 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -115.89 147.97 40.5 Favored 'General case' 0 N--CA 1.52 3.058 0 CA-C-O 116.603 -1.665 . . . . 0.0 107.236 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.5 143.71 41.91 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 118.383 2.734 . . . . 0.0 118.383 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.4 m -119.94 102.54 8.63 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.543 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.451 ' OG1' HG23 ' A' ' 28' ' ' THR . 48.4 m -94.73 152.18 18.66 Favored 'General case' 0 N--CA 1.526 3.334 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.429 ' N ' HG22 ' A' ' 75' ' ' THR . 90.3 m-85 -107.92 168.31 8.08 Favored Pre-proline 0 N--CA 1.503 2.184 0 CA-C-N 114.002 -1.454 . . . . 0.0 111.09 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -72.35 -174.74 1.51 Allowed 'Trans proline' 0 CA--C 1.559 1.747 0 C-N-CA 120.994 1.129 . . . . 0.0 111.149 161.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.77 18.96 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 124.41 2.052 . . . . 0.0 107.235 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.13 42.61 0.49 Allowed 'General case' 0 CA--C 1.577 1.984 0 CA-C-N 111.265 -2.698 . . . . 0.0 109.097 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.27 84.74 9.66 Favored Pre-proline 0 N--CA 1.5 2.032 0 CA-C-N 113.608 -1.633 . . . . 0.0 113.768 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 83' ' ' GLY . 45.9 Cg_endo -79.41 178.68 7.13 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.73 2.287 . . . . 0.0 112.245 172.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.6 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.05 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.91 0 C-N-CA 125.29 1.436 . . . . 0.0 113.333 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.529 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.41 125.01 5.63 Favored Glycine 0 N--CA 1.508 3.456 0 N-CA-C 121.76 3.464 . . . . 0.0 121.76 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.9 mt-10 -99.43 61.2 1.18 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.529 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.07 77.75 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 122.93 1.348 . . . . 0.0 113.013 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.7 m -63.41 135.97 57.31 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.555 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.51 136.52 52.91 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.567 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.61 82.05 8.59 Favored 'General case' 0 N--CA 1.512 2.627 1 N-CA-C 132.634 8.013 . . . . 0.0 132.634 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.94 82.19 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.438 2 CA-C-N 130.343 5.974 . . . . 0.0 114.313 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.1 tt0 -20.52 -72.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.598 0 N-CA-C 118.506 2.78 . . . . 0.0 118.506 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.459 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 36.6 Cg_endo -67.07 -3.43 9.72 Favored 'Trans proline' 0 N--CA 1.511 2.517 0 C-N-CA 122.383 2.056 . . . . 0.0 115.356 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -120.91 -14.13 8.52 Favored 'General case' 0 N--CA 1.511 2.594 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.466 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.25 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.64 -34.16 1.72 Allowed Glycine 1 N--CA 1.521 4.324 0 O-C-N 121.518 -0.739 . . . . 0.0 112.643 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.42 68.44 7.75 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.94 26.63 0.05 OUTLIER Glycine 1 N--CA 1.527 4.71 0 N-CA-C 116.665 1.426 . . . . 0.0 116.665 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.558 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.46 43.84 1.19 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 124.524 2.107 . . . . 0.0 113.016 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.96 134.81 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 112.313 -2.221 . . . . 0.0 110.954 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.62 154.9 19.34 Favored Glycine 1 N--CA 1.535 5.289 0 C-N-CA 119.49 -1.338 . . . . 0.0 113.997 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.61 81.91 1.77 Allowed 'General case' 0 N--CA 1.517 2.912 0 CA-C-N 119.488 1.644 . . . . 0.0 115.226 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.463 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.74 123.31 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 C-N-CA 118.03 -1.468 . . . . 0.0 107.044 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.9 m -112.65 88.76 2.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.15 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.442 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.1 t -74.06 105.27 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.39 -72.25 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.627 0 O-C-N 126.095 2.122 . . . . 0.0 115.885 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.6 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.484 0 O-C-N 125.526 1.766 . . . . 0.0 113.84 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 24.3 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' TRP . . . . . 0.455 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.447 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.449 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 53.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.7 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.4 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.606 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 52.8 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.528 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 78.4 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.2 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.698 HG13 HG22 ' B' ' 50' ' ' VAL 0.389 0.4 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.49 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.7 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 25.8 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.605 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.7 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.0 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.963 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.3 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.698 HG22 HG13 ' B' ' 34' ' ' VAL . 61.3 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.403 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.403 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.4 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.424 HG12 ' N ' ' B' ' 69' ' ' GLY . 81.4 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.424 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.519 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.591 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.5 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.9 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 0.825 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 17.9 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.825 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 44.3 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.52 HG22 HG11 ' B' ' 114' ' ' VAL 0.463 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.2 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.679 ' OD2' ' CG ' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.1 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 1.458 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 18.4 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' GLN . . . . . 0.911 HE22 HG12 ' A' ' 36' ' ' VAL . 11.2 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.447 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 23.3 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.9 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.52 HG11 HG22 ' B' ' 84' ' ' ILE . 16.7 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 1.578 ' CB ' ' CA ' ' B' ' 115' ' ' ILE 0.521 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.444 ' N ' HG23 ' B' ' 115' ' ' ILE 0.463 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.664 ' O ' ' CE ' ' A' ' 66' ' ' MET . 38.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 1.312 ' CD2' ' CE ' ' A' ' 66' ' ' MET . 81.7 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.8 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.494 ' C ' HG12 ' B' ' 131' ' ' VAL . 13.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.963 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.52 0.7 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.9 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.7 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' PRO . . . . . 0.659 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.7 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.636 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.636 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.453 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . 0.659 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.5 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.387 1.5 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' HIS . . . . . 0.449 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.61 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.485 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.6 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.665 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.1 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.417 0.8 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' PRO . . . . . 0.455 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.6 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.44 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.8 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.675 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . 0.675 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.7 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.402 HG22 ' N ' ' B' ' 178' ' ' GLY . 59.2 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.402 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.0 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.401 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.9 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.448 1.7 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.812 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.439 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.6 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . 0.43 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.43 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 12.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.4 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.417 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' ASN . . . . . 0.511 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.481 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 22.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.6 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.1 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.5 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.55 HD22 HD11 ' B' ' 142' ' ' ILE . 40.7 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' HEC . . . . . 0.606 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.596 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 85.4 m -61.52 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.02 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -100.0 163.01 12.62 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.467 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.75 122.44 46.75 Favored 'General case' 0 N--CA 1.525 3.32 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.4 t -100.57 98.32 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.34 65.4 0.07 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 113.096 -1.865 . . . . 0.0 114.893 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.81 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.2 mt -29.49 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.989 0 C-N-CA 126.585 1.954 . . . . 0.0 115.512 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.45 59.09 0.4 Allowed Glycine 0 N--CA 1.51 3.609 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.4 p -1.09 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 120.31 3.448 . . . . 0.0 120.31 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.48 -60.16 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 119.551 3.167 . . . . 0.0 119.551 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.512 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.84 22.46 14.44 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 120.956 -1.09 . . . . 0.0 108.209 179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.09 -94.85 1.91 Allowed Glycine 0 N--CA 1.511 3.672 0 N-CA-C 115.528 0.971 . . . . 0.0 115.528 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.543 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.7 tp -150.54 -177.13 5.79 Favored 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.558 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.7 mt -74.8 46.66 0.3 Allowed 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.627 -1.295 . . . . 0.0 111.247 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.672 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.74 165.73 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 118.575 2.805 . . . . 0.0 118.575 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.672 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.34 75.45 1.48 Allowed 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.384 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.274 4.8 mt-10 -93.48 142.37 25.11 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.781 -0.574 . . . . 0.0 111.806 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 20' ' ' LYS . 55.9 Cg_endo -86.47 76.15 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.389 0 N-CA-C 116.352 1.635 . . . . 0.0 116.352 -9.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.68 -44.17 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.737 1 N-CA-C 122.238 4.162 . . . . 0.0 122.238 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.64 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.68 71.6 0.99 Allowed 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 122.442 1.115 . . . . 0.0 113.049 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.793 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.1 111.3 7.21 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.178 -1.576 . . . . 0.0 109.098 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.522 ' N ' HD23 ' A' ' 21' ' ' LEU . 54.6 m -87.48 81.38 7.81 Favored 'General case' 0 N--CA 1.514 2.728 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.793 HG23 HD22 ' A' ' 21' ' ' LEU . 4.8 pt -79.68 -177.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.675 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.652 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.72 166.54 10.59 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 113.883 -1.508 . . . . 0.0 108.104 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.5 Cg_endo -52.18 77.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.288 0 N-CA-C 116.921 1.854 . . . . 0.0 116.921 174.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.16 -50.44 0.52 Allowed Glycine 1 N--CA 1.522 4.414 0 C-N-CA 119.733 -1.222 . . . . 0.0 115.852 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.6 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.174 1 N-CA-C 122.101 4.112 . . . . 0.0 122.101 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 28' ' ' THR . 11.6 m -63.99 35.92 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.049 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.01 147.22 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 112.926 -1.943 . . . . 0.0 111.501 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.9 pt-20 -114.26 154.9 27.14 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 123.914 1.816 . . . . 0.0 115.41 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.402 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.4 m-85 -107.54 113.87 27.47 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.77 112.54 24.97 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 120.71 3.596 . . . . 0.0 120.71 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -75.2 84.72 2.39 Favored 'General case' 0 N--CA 1.511 2.599 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.18 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.5 p30 -80.18 -45.17 18.54 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 118.933 2.938 . . . . 0.0 118.933 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.89 -169.29 3.34 Favored 'General case' 0 N--CA 1.508 2.467 0 C-N-CA 124.656 1.183 . . . . 0.0 109.111 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.219 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.6 m 12.89 70.68 0.11 Allowed Pre-proline 0 N--CA 1.52 3.055 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.169 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 57.7 Cg_endo -98.52 177.26 0.4 Allowed 'Trans proline' 0 CA--C 1.569 2.234 0 C-N-CA 123.92 3.08 . . . . 0.0 114.324 -165.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 57.7 Cg_endo -92.44 165.32 25.18 Favored 'Cis proline' 0 N--CA 1.503 2.071 0 N-CA-C 115.404 1.271 . . . . 0.0 115.404 -7.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.81 ' HB2' HD13 ' A' ' 7' ' ' LEU . 17.9 m-70 -118.95 87.35 2.72 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.65 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -103.42 140.28 37.68 Favored 'General case' 0 N--CA 1.516 2.857 0 CA-C-N 122.418 2.372 . . . . 0.0 110.685 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.6 m -118.09 116.25 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 121.445 3.868 . . . . 0.0 121.445 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.564 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.7 m -75.88 165.44 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.033 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.28 130.96 55.5 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 46' ' ' ALA . 4.1 m-20 -53.53 93.82 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.185 1 N-CA-C 124.088 4.847 . . . . 0.0 124.088 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.94 6.74 43.44 Favored 'General case' 0 CA--C 1.602 2.952 0 N-CA-C 101.228 -3.619 . . . . 0.0 101.228 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.88 -65.49 1.18 Allowed 'General case' 0 CA--C 1.573 1.85 0 C-N-CA 127.519 2.328 . . . . 0.0 112.705 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.676 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.48 9.5 Favored 'General case' 0 N--CA 1.52 3.034 0 N-CA-C 118.91 2.93 . . . . 0.0 118.91 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.44 151.24 0.74 Allowed Pre-proline 0 N--CA 1.522 3.151 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.7 Cg_endo -42.42 -58.27 1.31 Allowed 'Trans proline' 0 N--CA 1.509 2.391 0 C-N-CA 123.376 2.717 . . . . 0.0 115.113 170.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.544 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.49 67.41 0.72 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 124.112 1.911 . . . . 0.0 107.04 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.16 53.49 0.99 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 112.344 -2.207 . . . . 0.0 108.265 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.81 56.96 0.75 Allowed 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.68 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.57 -47.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.14 -30.84 0.17 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.226 -1.546 . . . . 0.0 111.564 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.507 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.18 -28.53 0.1 Allowed 'General case' 0 N--CA 1.508 2.449 0 CA-C-O 122.77 1.272 . . . . 0.0 112.567 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.77 -27.58 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.01 -55.55 0.3 Allowed 'General case' 0 N--CA 1.533 3.691 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.76 -28.89 0.17 Allowed 'General case' 0 N--CA 1.515 2.818 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.033 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.5 pp -53.69 -66.82 0.32 Allowed 'General case' 0 CA--C 1.603 3.013 0 N-CA-C 100.69 -3.819 . . . . 0.0 100.69 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.812 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.14 98.46 2.13 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 125.259 1.424 . . . . 0.0 112.806 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.691 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.1 t60 -90.01 -172.93 3.68 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.691 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.34 155.2 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.353 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.598 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.3 tt0 105.41 66.08 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.778 0 N-CA-C 120.285 3.439 . . . . 0.0 120.285 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.154 HD21 ' CZ ' ' B' ' 1' ' ' TYR . 5.9 mp 38.16 84.18 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 120.805 3.632 . . . . 0.0 120.805 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.65 ' N ' HD21 ' A' ' 40' ' ' ASN . 36.0 mt -70.59 82.08 0.59 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.225 -1.547 . . . . 0.0 111.876 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.582 ' SD ' ' HG3' ' A' ' 38' ' ' PRO . 42.1 mmm -79.29 62.02 3.54 Favored 'General case' 0 N--CA 1.51 2.536 0 CA-C-O 126.066 2.841 . . . . 0.0 110.945 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.2 m -112.65 65.92 0.87 Allowed Pre-proline 0 C--N 1.283 -2.295 0 CA-C-N 110.482 -3.053 . . . . 0.0 113.601 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -52.0 81.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.444 0 C-N-CA 122.98 2.453 . . . . 0.0 114.698 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.19 6.64 27.56 Favored Glycine 0 N--CA 1.515 3.963 0 O-C-N 122.195 -0.316 . . . . 0.0 113.573 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.4 tt0 -123.59 156.94 34.82 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 124.336 2.017 . . . . 0.0 116.331 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.439 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -117.01 156.32 27.69 Favored 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 119.641 3.2 . . . . 0.0 119.641 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.5 t -115.96 148.0 40.56 Favored 'General case' 0 N--CA 1.52 3.043 0 CA-C-O 116.633 -1.651 . . . . 0.0 107.229 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.55 143.78 41.86 Favored 'General case' 0 N--CA 1.529 3.512 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.8 m -119.96 102.57 8.65 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 114.146 -1.388 . . . . 0.0 113.575 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 28' ' ' THR . 48.8 m -94.71 152.19 18.67 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.422 ' N ' HG22 ' A' ' 75' ' ' THR . 90.3 m-85 -107.97 168.29 8.1 Favored Pre-proline 0 N--CA 1.504 2.233 0 CA-C-N 114.033 -1.44 . . . . 0.0 111.114 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -72.35 -174.81 1.53 Allowed 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 120.989 1.126 . . . . 0.0 111.107 161.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.31 -19.82 18.97 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 124.336 2.017 . . . . 0.0 107.235 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.12 42.68 0.49 Allowed 'General case' 0 CA--C 1.576 1.971 0 CA-C-N 111.285 -2.688 . . . . 0.0 109.097 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.79 9.78 Favored Pre-proline 0 N--CA 1.5 2.04 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.794 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 83' ' ' GLY . 44.6 Cg_endo -79.42 178.7 7.11 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.831 2.354 . . . . 0.0 112.23 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.593 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.17 77.73 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.921 0 C-N-CA 125.31 1.444 . . . . 0.0 113.265 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.44 125.1 5.65 Favored Glycine 0 N--CA 1.508 3.464 0 N-CA-C 121.757 3.463 . . . . 0.0 121.757 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.49 61.23 1.17 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.536 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.02 77.77 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.934 1.349 . . . . 0.0 113.049 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.5 136.0 57.27 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.557 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.5 136.57 52.87 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 116.697 2.11 . . . . 0.0 116.697 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.564 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.76 82.05 8.6 Favored 'General case' 0 N--CA 1.511 2.587 1 N-CA-C 132.586 7.995 . . . . 0.0 132.586 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.83 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.465 2 CA-C-N 130.301 5.955 . . . . 0.0 114.293 179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.0 tt0 -20.55 -72.42 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.605 0 N-CA-C 118.502 2.778 . . . . 0.0 118.502 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 36.4 Cg_endo -67.01 -3.54 9.86 Favored 'Trans proline' 0 N--CA 1.511 2.534 0 C-N-CA 122.382 2.055 . . . . 0.0 115.351 176.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -120.82 -14.14 8.56 Favored 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.446 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.37 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 N-CA-C 116.625 2.084 . . . . 0.0 116.625 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.59 -33.95 1.74 Allowed Glycine 1 N--CA 1.52 4.291 0 O-C-N 121.57 -0.706 . . . . 0.0 112.682 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.62 68.47 7.98 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.92 26.71 0.05 OUTLIER Glycine 1 N--CA 1.527 4.7 0 CA-C-N 114.008 -1.451 . . . . 0.0 116.629 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.559 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.55 43.9 1.19 Allowed 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 124.505 2.098 . . . . 0.0 113.071 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.96 134.92 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 112.193 -2.276 . . . . 0.0 110.943 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.61 154.85 19.32 Favored Glycine 1 N--CA 1.536 5.354 0 C-N-CA 119.484 -1.341 . . . . 0.0 113.977 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.59 81.99 1.78 Allowed 'General case' 0 N--CA 1.518 2.942 0 CA-C-N 119.4 1.6 . . . . 0.0 115.264 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.74 123.26 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.9 m -112.62 88.76 2.9 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.187 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.454 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.1 t -74.05 105.21 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.25 -72.36 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 O-C-N 126.039 2.087 . . . . 0.0 115.967 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.593 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.46 0 O-C-N 125.468 1.73 . . . . 0.0 113.819 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.154 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 60.5 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' TRP . . . . . 0.452 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.2 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.442 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.2 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.464 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 51.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.5 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 86.5 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.606 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 53.9 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.529 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 77.5 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.8 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.0 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.67 HG13 HG22 ' B' ' 50' ' ' VAL 0.39 0.7 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.3 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 25.5 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.599 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.6 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.6 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.99 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.5 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.67 HG22 HG13 ' B' ' 34' ' ' VAL . 61.2 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.5 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.422 HG12 ' N ' ' B' ' 69' ' ' GLY . 84.1 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.422 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.517 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.575 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.0 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 0.8 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 18.7 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.8 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 42.4 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.561 HG22 HG11 ' B' ' 114' ' ' VAL 0.427 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 39.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.0 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.2 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 1.169 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 19.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' GLN . . . . . 1.219 ' NE2' HG12 ' A' ' 36' ' ' VAL . 11.3 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 56.0 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.561 HG11 HG22 ' B' ' 84' ' ' ILE . 16.7 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 1.571 ' CB ' ' CA ' ' B' ' 115' ' ' ILE 0.687 0.0 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.462 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.414 ' HG2' ' CE ' ' A' ' 66' ' ' MET . 38.2 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 81.8 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.6 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 93.1 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.42 ' C ' HG12 ' B' ' 131' ' ' VAL . 13.6 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.99 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.494 1.1 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' PRO . . . . . 0.66 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.9 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.643 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.643 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.428 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . 0.66 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.7 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.408 1.4 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' HIS . . . . . 0.464 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.616 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.477 HH11 ' HD2' ' B' ' 157' ' ' ARG . 30.4 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.661 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.4 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.428 0.9 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' PRO . . . . . 0.452 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.7 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.7 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.67 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . 0.67 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.3 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.402 HG22 ' N ' ' B' ' 178' ' ' GLY . 58.8 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.402 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.2 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . 0.406 ' HB3' HE21 ' B' ' 186' ' ' GLN . 1.9 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 43.1 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.45 1.5 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.804 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.409 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.0 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.5 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . 0.415 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.415 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 13.0 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.406 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' ASN . . . . . 0.516 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.481 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.6 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.7 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.503 HD22 HD11 ' B' ' 142' ' ' ILE . 40.8 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 118.051 -0.976 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' HEC . . . . . 0.606 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.597 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.472 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 79.6 m -61.59 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -99.93 163.02 12.63 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.77 122.34 46.56 Favored 'General case' 0 N--CA 1.525 3.322 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.5 t -100.54 98.36 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 8' ' ' GLY . 14.0 mmmt -67.39 65.48 0.07 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 113.109 -1.86 . . . . 0.0 114.857 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -29.54 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 126.641 1.976 . . . . 0.0 115.449 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.52 59.02 0.4 Allowed Glycine 0 N--CA 1.51 3.568 0 N-CA-C 106.849 -2.501 . . . . 0.0 106.849 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.2 p -1.15 54.22 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 120.21 3.411 . . . . 0.0 120.21 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.42 -60.19 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.75 22.39 14.56 Favored 'General case' 0 N--CA 1.509 2.503 0 O-C-N 120.917 -1.114 . . . . 0.0 108.193 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.08 -94.77 1.9 Allowed Glycine 0 N--CA 1.511 3.691 0 N-CA-C 115.519 0.968 . . . . 0.0 115.519 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.573 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 47.5 tp -150.63 -177.19 5.83 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.573 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 15.8 mt -74.73 46.71 0.3 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.6 -1.312 . . . . 0.0 111.286 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.693 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.8 p -113.75 165.64 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 118.53 2.789 . . . . 0.0 118.53 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.693 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.21 75.42 1.49 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.363 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.48 142.41 25.16 Favored Pre-proline 0 N--CA 1.505 2.289 0 O-C-N 121.85 -0.531 . . . . 0.0 111.795 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 20' ' ' LYS . 58.4 Cg_endo -86.43 76.11 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.424 0 N-CA-C 116.365 1.64 . . . . 0.0 116.365 -9.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.7 -44.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.726 1 N-CA-C 122.319 4.192 . . . . 0.0 122.319 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.627 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.67 71.52 0.99 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 122.484 1.135 . . . . 0.0 113.064 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.817 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.02 111.26 7.11 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.116 -1.615 . . . . 0.0 109.107 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.542 ' N ' HD23 ' A' ' 21' ' ' LEU . 55.1 m -87.52 81.42 7.77 Favored 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.817 HG23 HD22 ' A' ' 21' ' ' LEU . 4.6 pt -79.57 -177.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.72 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.67 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.63 10.43 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.097 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 24.3 Cg_endo -52.33 77.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.287 0 N-CA-C 116.897 1.845 . . . . 0.0 116.897 174.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.17 -50.63 0.51 Allowed Glycine 1 N--CA 1.522 4.382 0 C-N-CA 119.682 -1.247 . . . . 0.0 115.836 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.56 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 1 N-CA-C 122.115 4.116 . . . . 0.0 122.115 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 28' ' ' THR . 11.2 m -64.07 35.96 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.018 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -51.96 147.19 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 112.849 -1.978 . . . . 0.0 111.513 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.454 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.24 154.89 27.13 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 124.011 1.862 . . . . 0.0 115.368 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.416 ' HB3' HD11 ' A' ' 7' ' ' LEU . 56.7 m-85 -107.51 113.88 27.5 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.585 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.1 tt -100.85 112.52 24.96 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 120.729 3.603 . . . . 0.0 120.729 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -75.16 84.7 2.37 Favored 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.111 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.7 p30 -80.29 -45.09 18.47 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.96 -169.31 3.34 Favored 'General case' 0 N--CA 1.509 2.522 0 C-N-CA 124.569 1.148 . . . . 0.0 109.048 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.393 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.6 m 12.89 70.61 0.11 Allowed Pre-proline 0 N--CA 1.521 3.11 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.608 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 64.2 Cg_endo -98.35 177.25 0.42 Allowed 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 123.994 3.129 . . . . 0.0 114.441 -165.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 60.9 Cg_endo -92.42 165.3 25.26 Favored 'Cis proline' 0 N--CA 1.503 2.037 0 N-CA-C 115.391 1.266 . . . . 0.0 115.391 -7.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.8 ' HB2' HD13 ' A' ' 7' ' ' LEU . 18.4 m-70 -118.96 87.37 2.72 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.754 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -103.33 140.26 37.66 Favored 'General case' 0 N--CA 1.516 2.868 0 CA-C-N 122.387 2.358 . . . . 0.0 110.675 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.4 m -118.13 116.3 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 121.406 3.854 . . . . 0.0 121.406 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.554 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.4 m -75.98 165.36 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 102.189 -3.263 . . . . 0.0 102.189 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.045 ' HB2' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.27 131.01 55.48 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.0 m-20 -53.42 93.73 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.19 1 N-CA-C 124.142 4.867 . . . . 0.0 124.142 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.97 6.72 43.58 Favored 'General case' 0 CA--C 1.602 2.948 0 N-CA-C 101.19 -3.633 . . . . 0.0 101.19 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.8 -65.48 1.18 Allowed 'General case' 0 CA--C 1.574 1.89 0 C-N-CA 127.592 2.357 . . . . 0.0 112.742 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.7 mp -86.75 66.59 9.53 Favored 'General case' 0 N--CA 1.519 3.023 0 N-CA-C 118.874 2.916 . . . . 0.0 118.874 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.39 151.26 0.75 Allowed Pre-proline 0 N--CA 1.522 3.17 0 N-CA-C 117.487 2.402 . . . . 0.0 117.487 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.1 Cg_endo -42.44 -58.25 1.32 Allowed 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 123.426 2.751 . . . . 0.0 115.088 170.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.574 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.54 67.38 0.72 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 124.119 1.914 . . . . 0.0 107.012 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.15 53.53 0.99 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 112.292 -2.231 . . . . 0.0 108.25 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.78 56.93 0.75 Allowed 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 117.8 2.519 . . . . 0.0 117.8 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.661 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.61 -47.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.262 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -41.21 -30.87 0.18 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.082 -1.636 . . . . 0.0 111.587 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.526 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.04 -28.64 0.09 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 122.787 1.279 . . . . 0.0 112.552 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.502 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.72 -27.68 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.481 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.13 -55.58 0.31 Allowed 'General case' 0 N--CA 1.533 3.705 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.7 -28.96 0.16 Allowed 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.045 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.4 pp -53.57 -66.9 0.31 Allowed 'General case' 0 CA--C 1.604 3.026 0 N-CA-C 100.688 -3.819 . . . . 0.0 100.688 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.851 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.09 98.47 2.11 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.227 1.411 . . . . 0.0 112.786 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.698 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.0 t60 -90.06 -173.01 3.7 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.698 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.42 155.23 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.583 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 26.5 tt0 105.45 65.97 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.827 0 N-CA-C 120.315 3.45 . . . . 0.0 120.315 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.532 HD21 ' CE1' ' B' ' 1' ' ' TYR . 5.9 mp 38.26 84.22 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 120.769 3.618 . . . . 0.0 120.769 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.754 ' N ' HD21 ' A' ' 40' ' ' ASN . 35.3 mt -70.67 82.04 0.61 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.166 -1.584 . . . . 0.0 111.876 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 1.022 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 42.5 mmm -79.16 61.9 3.41 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-O 126.066 2.841 . . . . 0.0 110.962 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.4 m -112.54 65.88 0.84 Allowed Pre-proline 0 N--CA 1.505 2.307 0 CA-C-N 110.482 -3.054 . . . . 0.0 113.597 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -51.87 81.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 122.985 2.457 . . . . 0.0 114.71 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.63 27.66 Favored Glycine 1 N--CA 1.517 4.07 0 O-C-N 122.209 -0.307 . . . . 0.0 113.579 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.4 tt0 -123.62 156.83 35.1 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 124.404 2.049 . . . . 0.0 116.285 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.437 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -116.87 156.46 27.28 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 119.748 3.24 . . . . 0.0 119.748 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -116.02 147.91 40.72 Favored 'General case' 0 N--CA 1.52 3.029 0 CA-C-O 116.651 -1.642 . . . . 0.0 107.253 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.51 143.63 42.05 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.6 m -119.84 102.54 8.65 Favored 'General case' 0 N--CA 1.514 2.747 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.632 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.452 ' OG1' HG23 ' A' ' 28' ' ' THR . 50.2 m -94.76 152.2 18.63 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.416 ' N ' HG22 ' A' ' 75' ' ' THR . 90.7 m-85 -107.93 168.33 8.06 Favored Pre-proline 0 N--CA 1.503 2.178 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.124 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.35 -174.85 1.54 Allowed 'Trans proline' 0 CA--C 1.558 1.714 0 C-N-CA 121.021 1.147 . . . . 0.0 111.109 161.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.33 -19.66 19.08 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 124.435 2.064 . . . . 0.0 107.334 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.22 42.71 0.5 Allowed 'General case' 0 CA--C 1.576 1.98 0 CA-C-N 111.187 -2.733 . . . . 0.0 109.045 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.68 9.67 Favored Pre-proline 0 N--CA 1.499 2.012 0 CA-C-N 113.675 -1.602 . . . . 0.0 113.761 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 83' ' ' GLY . 53.5 Cg_endo -79.31 178.62 7.23 Favored 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 122.803 2.335 . . . . 0.0 112.304 172.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.606 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.08 77.69 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.92 0 O-C-N 125.018 1.449 . . . . 0.0 113.346 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.37 124.98 5.63 Favored Glycine 0 N--CA 1.508 3.475 0 N-CA-C 121.746 3.459 . . . . 0.0 121.746 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.46 61.24 1.18 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.1 m-85 -62.0 77.8 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.872 1.32 . . . . 0.0 113.052 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.9 m -63.57 135.95 57.18 Favored 'General case' 0 N--CA 1.509 2.485 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.47 136.49 52.95 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.554 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.64 82.03 8.6 Favored 'General case' 0 N--CA 1.512 2.64 1 N-CA-C 132.637 8.014 . . . . 0.0 132.637 -179.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.1 t -63.9 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.501 2 CA-C-N 130.342 5.974 . . . . 0.0 114.311 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.7 tt0 -20.52 -72.48 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.605 0 N-CA-C 118.468 2.766 . . . . 0.0 118.468 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.59 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 37.6 Cg_endo -66.97 -3.48 9.7 Favored 'Trans proline' 0 N--CA 1.512 2.569 0 C-N-CA 122.39 2.06 . . . . 0.0 115.352 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -120.87 -14.12 8.55 Favored 'General case' 0 N--CA 1.511 2.613 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.477 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.38 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.62 -34.06 1.73 Allowed Glycine 1 N--CA 1.52 4.296 0 O-C-N 121.616 -0.678 . . . . 0.0 112.7 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.56 68.46 7.91 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.86 26.74 0.05 OUTLIER Glycine 1 N--CA 1.526 4.677 0 CA-C-N 114.041 -1.436 . . . . 0.0 116.68 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.559 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 1.9 ttt -108.55 43.83 1.19 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 124.406 2.05 . . . . 0.0 112.957 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.9 m -118.99 134.89 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 112.275 -2.239 . . . . 0.0 110.945 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.66 154.85 19.35 Favored Glycine 1 N--CA 1.534 5.212 0 C-N-CA 119.523 -1.323 . . . . 0.0 114.059 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.56 81.86 1.76 Allowed 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.63 123.3 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.709 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.0 m -112.63 88.7 2.88 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.185 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.444 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.4 t -74.0 105.17 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.31 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 O-C-N 126.064 2.103 . . . . 0.0 115.933 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.606 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.521 0 O-C-N 125.576 1.798 . . . . 0.0 113.812 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.532 ' CE1' HD21 ' A' ' 64' ' ' LEU . 60.9 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.59 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 22.0 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' TRP . . . . . 0.462 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.0 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.459 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.3 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.499 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 58.1 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 88.7 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 50.9 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.529 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 79.5 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.1 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.783 HG13 HG22 ' B' ' 50' ' ' VAL 0.375 0.2 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 58.5 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.408 HG13 ' HD2' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.408 ' HD2' HG13 ' B' ' 36' ' ' VAL . 27.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.625 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.4 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.9 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 1.027 ' CE1' HG22 ' B' ' 131' ' ' VAL . 51.7 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.783 HG22 HG13 ' B' ' 34' ' ' VAL . 61.4 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.421 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.6 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.6 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.0 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.421 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.1 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.6 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.426 HG12 ' N ' ' B' ' 69' ' ' GLY . 79.1 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.426 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.526 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.507 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.3 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.1 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 0.914 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 14.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.914 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 46.6 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.513 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 74.2 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.4 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 17.7 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 1.608 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 17.0 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' GLN . . . . . 1.393 ' NE2' HG12 ' A' ' 36' ' ' VAL . 10.9 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.459 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 25.5 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.507 HD11 HG23 ' B' ' 75' ' ' VAL 0.54 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.466 ' N ' HG23 ' B' ' 115' ' ' ILE 0.411 0.1 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 1.282 ' CG ' HD23 ' A' ' 64' ' ' LEU . 38.7 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 1.022 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 81.1 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 57.2 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 90.8 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.481 ' C ' HG12 ' B' ' 131' ' ' VAL . 11.7 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 1.564 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.43 1.6 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.0 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' PRO . . . . . 0.623 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 10.6 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.607 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.66 HD11 HD22 ' B' ' 249' ' ' LEU 0.483 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . 0.623 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.6 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.7 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.3 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' B' ' 149' ' ' VAL 0.335 1.7 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.581 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.471 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.661 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.4 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.387 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' PRO . . . . . 0.462 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 18.5 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.8 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.44 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 8.4 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.692 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.8 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . 0.692 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.7 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.408 HG22 ' N ' ' B' ' 178' ' ' GLY . 59.4 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.408 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 64.1 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' LYS . . . . . 0.411 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.411 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.3 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.6 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.414 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.84 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' ILE . . . . . 0.46 ' O ' HG13 ' B' ' 199' ' ' ILE 0.482 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.6 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.9 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.9 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.3 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.2 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . 0.465 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.465 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 11.2 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 86.4 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.385 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.4 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' ASN . . . . . 0.503 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.472 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.0 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.9 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.66 HD22 HD11 ' B' ' 142' ' ' ILE . 40.5 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' HEC . . . . . 0.607 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.596 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.453 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 70.1 m -61.59 89.67 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.93 163.03 12.62 Favored 'General case' 0 N--CA 1.512 2.653 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.455 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.2 t -107.83 122.43 46.76 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.2 t -100.5 98.39 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.4 mmmt -67.34 65.32 0.07 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 113.086 -1.87 . . . . 0.0 114.888 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.806 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.9 mt -29.47 68.26 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 126.579 1.952 . . . . 0.0 115.459 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.42 59.06 0.4 Allowed Glycine 0 N--CA 1.509 3.552 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 20.3 p -1.12 54.13 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.259 0 N-CA-C 120.346 3.462 . . . . 0.0 120.346 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.49 -60.14 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 119.515 3.154 . . . . 0.0 119.515 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.529 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.85 22.48 14.43 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.957 -1.09 . . . . 0.0 108.116 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.07 -94.8 1.9 Allowed Glycine 0 N--CA 1.512 3.711 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.594 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.7 tp -150.66 -177.23 5.86 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.597 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.5 mt -74.72 46.74 0.3 Allowed 'General case' 0 N--CA 1.509 2.516 0 O-C-N 120.7 -1.25 . . . . 0.0 111.236 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.732 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.6 p -113.86 165.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.732 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.3 m-30 -102.12 75.43 1.51 Allowed 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 112.219 -2.264 . . . . 0.0 113.416 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.342 0.6 OUTLIER -93.47 142.39 25.14 Favored Pre-proline 0 N--CA 1.505 2.311 0 O-C-N 121.853 -0.529 . . . . 0.0 111.746 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 20' ' ' LYS . 46.0 Cg_endo -86.49 76.11 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.466 0 N-CA-C 116.368 1.642 . . . . 0.0 116.368 -9.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.72 -44.22 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.806 1 N-CA-C 122.26 4.17 . . . . 0.0 122.26 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.645 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.65 71.68 1.0 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 122.412 1.101 . . . . 0.0 112.986 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.847 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.14 111.25 7.21 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.148 -1.595 . . . . 0.0 109.159 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.576 ' N ' HD23 ' A' ' 21' ' ' LEU . 47.7 m -87.52 81.53 7.74 Favored 'General case' 0 N--CA 1.514 2.766 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.847 HG23 HD22 ' A' ' 21' ' ' LEU . 4.4 pt -79.71 -177.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 114.75 -1.113 . . . . 0.0 112.699 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.705 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -109.67 166.55 10.58 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.126 179.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 19.9 Cg_endo -52.24 77.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.314 0 N-CA-C 116.833 1.82 . . . . 0.0 116.833 174.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.13 -50.41 0.52 Allowed Glycine 1 N--CA 1.522 4.42 0 C-N-CA 119.76 -1.209 . . . . 0.0 115.831 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.556 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.71 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 1 N-CA-C 122.11 4.115 . . . . 0.0 122.11 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 28' ' ' THR . 10.8 m -64.03 36.0 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.012 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.5 t -52.0 147.17 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.566 0 CA-C-N 112.821 -1.991 . . . . 0.0 111.5 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.19 154.91 27.05 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 123.923 1.82 . . . . 0.0 115.416 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.433 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.9 m-85 -107.57 113.84 27.42 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.1 tt -100.72 112.53 24.95 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 120.653 3.575 . . . . 0.0 120.653 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -75.13 84.69 2.35 Favored 'General case' 0 N--CA 1.513 2.689 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.162 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 29.9 p30 -80.27 -45.08 18.54 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 118.935 2.939 . . . . 0.0 118.935 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.95 -169.3 3.34 Favored 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 124.671 1.189 . . . . 0.0 109.077 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.255 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.6 m 12.79 70.72 0.11 Allowed Pre-proline 0 N--CA 1.52 3.029 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.344 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 55.3 Cg_endo -98.49 177.29 0.4 Allowed 'Trans proline' 0 CA--C 1.568 2.222 0 C-N-CA 123.984 3.123 . . . . 0.0 114.37 -165.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.717 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 52.2 Cg_endo -92.39 165.33 25.33 Favored 'Cis proline' 0 N--CA 1.502 2.029 0 N-CA-C 115.472 1.297 . . . . 0.0 115.472 -7.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.806 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.5 m-70 -118.96 87.52 2.75 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.738 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -103.5 140.23 37.79 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 122.465 2.393 . . . . 0.0 110.663 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 6.4 m -118.09 116.41 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 N-CA-C 121.446 3.869 . . . . 0.0 121.446 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.577 HG22 ' CB ' ' A' ' 88' ' ' TYR . 13.0 m -76.07 165.46 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 102.099 -3.297 . . . . 0.0 102.099 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.066 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.32 130.96 55.51 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.443 ' OD1' HD13 ' A' ' 47' ' ' LEU . 4.1 m-20 -53.45 93.82 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.212 1 N-CA-C 124.16 4.874 . . . . 0.0 124.16 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.09 6.8 43.47 Favored 'General case' 0 CA--C 1.602 2.979 0 N-CA-C 101.212 -3.625 . . . . 0.0 101.212 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.439 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -115.9 -65.43 1.19 Allowed 'General case' 0 CA--C 1.574 1.88 0 C-N-CA 127.445 2.298 . . . . 0.0 112.682 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.753 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.4 mp -86.65 66.53 9.51 Favored 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 118.902 2.927 . . . . 0.0 118.902 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.634 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.4 151.28 0.74 Allowed Pre-proline 0 N--CA 1.522 3.145 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 17.3 Cg_endo -42.41 -58.29 1.3 Allowed 'Trans proline' 0 N--CA 1.507 2.322 0 C-N-CA 123.405 2.736 . . . . 0.0 115.112 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.634 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.46 67.34 0.72 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 124.102 1.906 . . . . 0.0 107.077 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -77.13 53.6 0.99 Allowed 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.312 -2.222 . . . . 0.0 108.272 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 t -115.9 56.99 0.76 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.664 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.63 -47.99 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.256 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.07 -30.88 0.16 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.06 -1.65 . . . . 0.0 111.578 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.18 -28.53 0.1 Allowed 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 122.755 1.264 . . . . 0.0 112.487 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.83 -27.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 117.727 2.492 . . . . 0.0 117.727 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.479 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.3 tptt 65.05 -55.59 0.3 Allowed 'General case' 0 N--CA 1.533 3.71 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.1 m -41.68 -28.98 0.16 Allowed 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.066 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.2 pp -53.68 -66.82 0.33 Allowed 'General case' 0 CA--C 1.604 3.032 0 N-CA-C 100.71 -3.811 . . . . 0.0 100.71 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.862 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 11.1 p -72.07 98.45 2.1 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 125.259 1.424 . . . . 0.0 112.806 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.706 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.4 t60 -90.08 -173.01 3.7 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.706 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.4 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.591 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 26.0 tt0 105.51 65.97 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 120.303 3.445 . . . . 0.0 120.303 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.119 HD21 ' CE1' ' B' ' 1' ' ' TYR . 5.6 mp 38.11 84.33 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 120.745 3.609 . . . . 0.0 120.745 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.738 ' N ' HD21 ' A' ' 40' ' ' ASN . 36.5 mt -70.66 82.1 0.61 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.078 -1.639 . . . . 0.0 111.888 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.856 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 41.0 mmm -79.25 61.93 3.48 Favored 'General case' 0 N--CA 1.51 2.542 0 CA-C-O 126.057 2.837 . . . . 0.0 110.912 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.7 m -112.55 65.92 0.85 Allowed Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 110.543 -3.026 . . . . 0.0 113.621 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -51.95 81.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 122.933 2.422 . . . . 0.0 114.686 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.13 6.73 27.59 Favored Glycine 1 N--CA 1.517 4.036 0 O-C-N 122.251 -0.28 . . . . 0.0 113.541 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.68 156.91 35.02 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 124.374 2.035 . . . . 0.0 116.241 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.455 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.98 156.39 27.55 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 119.681 3.215 . . . . 0.0 119.681 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -116.01 147.96 40.66 Favored 'General case' 0 N--CA 1.522 3.13 0 CA-C-O 116.678 -1.63 . . . . 0.0 107.215 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.56 143.79 41.85 Favored 'General case' 0 N--CA 1.53 3.546 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.9 m -119.99 102.62 8.67 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.52 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.439 ' OG1' HG23 ' A' ' 28' ' ' THR . 49.0 m -94.78 152.15 18.66 Favored 'General case' 0 N--CA 1.525 3.298 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.424 ' N ' HG22 ' A' ' 75' ' ' THR . 89.4 m-85 -107.91 168.29 8.11 Favored Pre-proline 0 N--CA 1.503 2.181 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.089 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -72.36 -174.83 1.54 Allowed 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 121.023 1.149 . . . . 0.0 111.121 161.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.73 19.0 Favored 'General case' 0 N--CA 1.51 2.535 0 CA-C-O 124.34 2.019 . . . . 0.0 107.237 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.17 42.68 0.49 Allowed 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 111.258 -2.701 . . . . 0.0 109.118 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.79 9.78 Favored Pre-proline 0 N--CA 1.5 2.069 0 CA-C-N 113.543 -1.662 . . . . 0.0 113.742 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 38.0 Cg_endo -79.39 178.64 7.18 Favored 'Trans proline' 0 N--CA 1.504 2.109 0 C-N-CA 122.817 2.345 . . . . 0.0 112.253 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.594 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.03 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 125.367 1.467 . . . . 0.0 113.24 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.44 125.01 5.63 Favored Glycine 0 N--CA 1.507 3.389 0 N-CA-C 121.787 3.475 . . . . 0.0 121.787 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.8 mt-10 -99.4 61.26 1.19 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.516 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.1 m-85 -62.05 77.75 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 122.95 1.357 . . . . 0.0 113.033 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.6 m -63.52 136.0 57.25 Favored 'General case' 0 N--CA 1.509 2.491 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.582 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.52 136.5 52.93 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.577 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.6 m-85 -84.62 82.02 8.6 Favored 'General case' 0 N--CA 1.51 2.561 1 N-CA-C 132.655 8.02 . . . . 0.0 132.655 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.9 t -63.86 82.11 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.433 2 CA-C-N 130.371 5.987 . . . . 0.0 114.365 179.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.4 tt0 -20.51 -72.43 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.582 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.43 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 31.8 Cg_endo -67.04 -3.45 9.72 Favored 'Trans proline' 0 N--CA 1.51 2.489 0 C-N-CA 122.409 2.073 . . . . 0.0 115.367 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -120.85 -14.22 8.54 Favored 'General case' 0 N--CA 1.511 2.619 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.49 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.3 79.62 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.742 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.61 -34.03 1.73 Allowed Glycine 1 N--CA 1.522 4.381 0 O-C-N 121.597 -0.689 . . . . 0.0 112.617 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.52 68.46 7.86 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.79 26.8 0.05 OUTLIER Glycine 1 N--CA 1.527 4.731 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.563 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 1.8 ttt -108.54 43.85 1.19 Allowed 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 124.485 2.088 . . . . 0.0 113.022 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.97 134.88 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 112.228 -2.26 . . . . 0.0 110.903 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.582 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.71 154.86 19.38 Favored Glycine 1 N--CA 1.536 5.356 0 C-N-CA 119.446 -1.359 . . . . 0.0 113.96 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.2 ttpp -118.56 81.95 1.77 Allowed 'General case' 0 N--CA 1.517 2.883 0 CA-C-N 119.372 1.586 . . . . 0.0 115.262 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.71 123.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.667 0 C-N-CA 118.054 -1.458 . . . . 0.0 107.079 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -112.68 88.8 2.91 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.124 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.453 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.8 t -74.12 105.27 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.34 -72.28 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 O-C-N 126.101 2.126 . . . . 0.0 115.95 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.594 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.53 0 O-C-N 125.527 1.767 . . . . 0.0 113.81 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.119 ' CE1' HD21 ' A' ' 64' ' ' LEU . 60.5 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' TRP . . . . . 0.474 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.471 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.0 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.2 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 9.9 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.2 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 89.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 54.2 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.529 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 77.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.3 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.839 HG13 HG22 ' B' ' 50' ' ' VAL 0.374 0.1 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 58.7 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.457 HG13 ' HD2' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.457 ' HD2' HG13 ' B' ' 36' ' ' VAL . 23.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.9 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.667 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 30.2 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 1.118 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.839 HG22 HG13 ' B' ' 34' ' ' VAL . 62.0 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.449 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.449 HG22 ' O ' ' B' ' 55' ' ' ASP . 15.2 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 83.3 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.452 HG12 ' N ' ' B' ' 69' ' ' GLY . 74.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.452 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.555 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.415 HG23 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.2 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 1.049 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 24.7 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 1.049 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 42.5 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.567 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 94' ' ' LEU . 50.3 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.4 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 1.344 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 17.2 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' GLN . . . . . 1.255 ' NE2' HG12 ' A' ' 36' ' ' VAL . 11.0 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.8 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.507 HG23 ' N ' ' B' ' 116' ' ' VAL 0.46 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.507 ' N ' HG23 ' B' ' 115' ' ' ILE 0.255 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.614 ' CG ' HD23 ' A' ' 64' ' ' LEU . 36.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.856 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 81.9 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.6 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 85.3 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.508 ' C ' HG12 ' B' ' 131' ' ' VAL . 19.9 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 1.56 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.344 0.5 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' B' ' 142' ' ' ILE . 35.7 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' PRO . . . . . 0.525 ' CG ' ' CZ ' ' B' ' 144' ' ' PHE . 18.1 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.589 ' CG ' ' CG2' ' B' ' 142' ' ' ILE . 44.7 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.737 HD11 HD22 ' B' ' 249' ' ' LEU 0.51 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' B' ' 136' ' ' PRO . 81.3 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 69.0 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' B' ' 149' ' ' VAL . 1.3 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.627 HG11 ' CG2' ' B' ' 34' ' ' VAL . 10.7 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' B' ' 155' ' ' ARG . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' B' ' 157' ' ' ARG . 28.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.683 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.7 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.312 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' PRO . . . . . 0.474 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 17.8 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 97.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.442 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.9 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.725 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.9 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . 0.725 ' N ' HD23 ' B' ' 171' ' ' LEU . 18.5 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.436 HG22 ' N ' ' B' ' 178' ' ' GLY . 61.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.436 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.3 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.5 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.428 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 41.2 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.38 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.903 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' ILE . . . . . 0.639 HG13 ' O ' ' B' ' 199' ' ' ILE 0.519 0.3 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.6 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.2 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.0 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . 0.488 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 18.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.3 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 86.9 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.403 0.1 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.0 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' B' ' 231' ' ' LEU . 84.2 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' ASN . . . . . 0.545 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.507 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.7 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 19.4 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.737 HD22 HD11 ' B' ' 142' ' ' ILE . 41.4 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' HEC . . . . . 0.608 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.588 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.47 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.6 m -61.61 89.7 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -99.98 162.98 12.64 Favored 'General case' 0 N--CA 1.511 2.625 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.452 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.0 t -107.68 122.36 46.56 Favored 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 117.257 2.317 . . . . 0.0 117.257 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.52 98.34 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.41 65.5 0.07 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 113.077 -1.874 . . . . 0.0 114.834 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.804 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -29.51 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.96 0 C-N-CA 126.595 1.958 . . . . 0.0 115.534 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.43 59.11 0.4 Allowed Glycine 0 N--CA 1.509 3.557 0 N-CA-C 106.89 -2.484 . . . . 0.0 106.89 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.2 p -1.08 54.03 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 120.344 3.461 . . . . 0.0 120.344 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.61 -60.22 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 119.507 3.151 . . . . 0.0 119.507 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.508 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.47 14.45 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 120.998 -1.064 . . . . 0.0 108.143 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.09 -94.83 1.9 Allowed Glycine 0 N--CA 1.511 3.69 0 N-CA-C 115.553 0.981 . . . . 0.0 115.553 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.556 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 47.1 tp -150.57 -177.16 5.81 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.556 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 15.7 mt -74.68 46.66 0.29 Allowed 'General case' 0 N--CA 1.509 2.478 0 O-C-N 120.608 -1.307 . . . . 0.0 111.296 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.681 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.8 p -113.84 165.67 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 118.498 2.777 . . . . 0.0 118.498 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.681 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.24 75.38 1.49 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 112.209 -2.269 . . . . 0.0 113.436 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -93.42 142.44 25.23 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 121.851 -0.531 . . . . 0.0 111.744 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 20' ' ' LYS . 56.8 Cg_endo -86.4 76.1 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.389 0 N-CA-C 116.382 1.647 . . . . 0.0 116.382 -9.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.7 -44.18 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.812 1 N-CA-C 122.24 4.163 . . . . 0.0 122.24 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.65 71.55 0.99 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.446 1.117 . . . . 0.0 113.052 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.841 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.06 111.27 7.15 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.177 -1.577 . . . . 0.0 109.147 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.515 ' N ' HD23 ' A' ' 21' ' ' LEU . 53.8 m -87.48 81.39 7.81 Favored 'General case' 0 N--CA 1.515 2.799 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.841 HG23 HD22 ' A' ' 21' ' ' LEU . 4.6 pt -79.7 -177.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.708 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.666 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.69 166.6 10.49 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.078 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.5 Cg_endo -52.3 77.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.569 2.263 0 N-CA-C 116.92 1.854 . . . . 0.0 116.92 174.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.09 -50.39 0.52 Allowed Glycine 1 N--CA 1.522 4.404 0 C-N-CA 119.727 -1.225 . . . . 0.0 115.859 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.68 92.11 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.195 1 N-CA-C 122.092 4.108 . . . . 0.0 122.092 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 28' ' ' THR . 11.3 m -64.12 36.03 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.965 0 N-CA-C 118.681 2.845 . . . . 0.0 118.681 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.99 147.2 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 CA-C-N 112.861 -1.972 . . . . 0.0 111.529 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.31 154.85 27.29 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 123.936 1.827 . . . . 0.0 115.397 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -107.47 113.9 27.55 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.78 112.48 24.91 Favored 'General case' 0 N--CA 1.509 2.484 0 N-CA-C 120.759 3.614 . . . . 0.0 120.759 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -75.11 84.75 2.34 Favored 'General case' 0 N--CA 1.511 2.611 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.14 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 30.5 p30 -80.35 -45.08 18.36 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 118.862 2.912 . . . . 0.0 118.862 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -149.92 -169.26 3.33 Favored 'General case' 0 N--CA 1.508 2.447 0 C-N-CA 124.678 1.191 . . . . 0.0 109.143 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HA ' HE22 ' B' ' 104' ' ' GLN . 1.6 m 12.82 70.7 0.11 Allowed Pre-proline 0 N--CA 1.52 3.038 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.221 ' HG2' ' CZ ' ' B' ' 102' ' ' TYR . 59.5 Cg_endo -98.41 177.26 0.41 Allowed 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 123.953 3.102 . . . . 0.0 114.382 -165.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.619 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 58.9 Cg_endo -92.48 165.22 25.07 Favored 'Cis proline' 0 N--CA 1.503 2.082 0 N-CA-C 115.392 1.266 . . . . 0.0 115.392 -7.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.804 ' HB2' HD13 ' A' ' 7' ' ' LEU . 18.1 m-70 -118.83 87.4 2.72 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 117.377 2.362 . . . . 0.0 117.377 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.673 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -103.4 140.28 37.66 Favored 'General case' 0 N--CA 1.516 2.829 0 CA-C-N 122.429 2.377 . . . . 0.0 110.695 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.499 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.4 m -118.1 116.27 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 121.43 3.863 . . . . 0.0 121.43 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.4 m -75.9 165.4 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 102.223 -3.251 . . . . 0.0 102.223 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.022 ' HB2' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.28 130.97 55.5 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.46 93.77 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.188 1 N-CA-C 124.16 4.874 . . . . 0.0 124.16 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.0 6.8 43.34 Favored 'General case' 0 CA--C 1.602 2.965 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.84 -65.63 1.17 Allowed 'General case' 0 CA--C 1.573 1.848 0 C-N-CA 127.537 2.335 . . . . 0.0 112.707 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.7 mp -86.63 66.58 9.54 Favored 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 118.908 2.929 . . . . 0.0 118.908 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.38 151.23 0.74 Allowed Pre-proline 0 N--CA 1.523 3.179 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.7 Cg_endo -42.36 -58.26 1.31 Allowed 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 123.398 2.732 . . . . 0.0 115.133 170.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.566 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.45 67.36 0.72 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 124.027 1.87 . . . . 0.0 107.067 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.18 53.51 0.99 Allowed 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 112.346 -2.206 . . . . 0.0 108.204 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.87 56.95 0.76 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.671 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.58 -47.91 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.237 0 N-CA-C 117.252 2.315 . . . . 0.0 117.252 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.08 -30.9 0.16 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.218 -1.551 . . . . 0.0 111.584 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.515 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.16 -28.53 0.1 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 122.696 1.236 . . . . 0.0 112.478 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.505 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.83 -27.64 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.03 -55.54 0.3 Allowed 'General case' 0 N--CA 1.534 3.748 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.5 m -41.77 -28.91 0.17 Allowed 'General case' 0 N--CA 1.514 2.77 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.022 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.5 pp -53.71 -66.76 0.34 Allowed 'General case' 0 CA--C 1.603 2.984 0 N-CA-C 100.732 -3.803 . . . . 0.0 100.732 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.831 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.01 98.32 2.05 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 125.356 1.462 . . . . 0.0 112.803 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.694 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.0 -172.97 3.7 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.694 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.39 155.12 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.59 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.0 tt0 105.55 65.93 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 120.258 3.429 . . . . 0.0 120.258 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.584 HD23 ' CG ' ' B' ' 118' ' ' PRO . 6.0 mp 38.21 84.3 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 120.793 3.627 . . . . 0.0 120.793 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.673 ' N ' HD21 ' A' ' 40' ' ' ASN . 35.0 mt -70.76 82.13 0.63 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.137 -1.602 . . . . 0.0 111.818 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 1.422 ' CE ' ' O ' ' B' ' 118' ' ' PRO . 42.3 mmm -79.29 62.0 3.53 Favored 'General case' 0 N--CA 1.512 2.647 0 CA-C-O 126.069 2.842 . . . . 0.0 110.886 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 68.0 m -112.53 65.89 0.84 Allowed Pre-proline 0 C--N 1.284 -2.259 0 CA-C-N 110.53 -3.032 . . . . 0.0 113.667 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HG2' ' OD2' ' B' ' 100' ' ' ASP . 21.7 Cg_endo -51.91 81.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.466 0 C-N-CA 122.932 2.422 . . . . 0.0 114.696 -177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.08 6.58 27.81 Favored Glycine 1 N--CA 1.516 4.03 0 O-C-N 122.18 -0.325 . . . . 0.0 113.613 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.56 156.84 34.97 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 124.366 2.031 . . . . 0.0 116.352 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.438 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.3 m -116.95 156.38 27.52 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 119.703 3.223 . . . . 0.0 119.703 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -115.95 147.9 40.64 Favored 'General case' 0 N--CA 1.52 3.07 0 CA-C-O 116.711 -1.614 . . . . 0.0 107.192 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.44 143.67 41.89 Favored 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 118.36 2.726 . . . . 0.0 118.36 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.7 m -119.94 102.64 8.7 Favored 'General case' 0 N--CA 1.514 2.772 0 CA-C-N 114.227 -1.351 . . . . 0.0 113.584 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.455 ' OG1' HG23 ' A' ' 28' ' ' THR . 48.8 m -94.7 152.2 18.66 Favored 'General case' 0 N--CA 1.526 3.341 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' N ' HG22 ' A' ' 75' ' ' THR . 90.7 m-85 -107.98 168.33 8.04 Favored Pre-proline 0 N--CA 1.504 2.244 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.037 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.36 -174.78 1.52 Allowed 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 121.023 1.149 . . . . 0.0 111.12 161.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.37 -19.77 18.97 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-O 124.364 2.03 . . . . 0.0 107.246 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.09 42.55 0.48 Allowed 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 111.24 -2.709 . . . . 0.0 109.067 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.24 84.81 9.68 Favored Pre-proline 0 N--CA 1.501 2.075 0 CA-C-N 113.658 -1.61 . . . . 0.0 113.768 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 83' ' ' GLY . 47.5 Cg_endo -79.36 178.67 7.16 Favored 'Trans proline' 0 N--CA 1.503 2.085 0 C-N-CA 122.79 2.326 . . . . 0.0 112.276 172.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.598 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.11 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.86 0 C-N-CA 125.328 1.451 . . . . 0.0 113.291 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.539 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.4 124.92 5.6 Favored Glycine 0 N--CA 1.507 3.393 0 N-CA-C 121.739 3.455 . . . . 0.0 121.739 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.41 61.31 1.19 Allowed 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.539 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.13 77.81 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.906 1.336 . . . . 0.0 113.006 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.8 m -63.46 135.94 57.25 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.53 136.54 52.9 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.568 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.71 82.11 8.57 Favored 'General case' 0 N--CA 1.511 2.618 1 N-CA-C 132.562 7.986 . . . . 0.0 132.562 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.0 t -63.94 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.495 2 CA-C-N 130.298 5.953 . . . . 0.0 114.346 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.0 tt0 -20.55 -72.35 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.586 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.417 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 36.8 Cg_endo -67.11 -3.34 9.61 Favored 'Trans proline' 0 N--CA 1.513 2.626 0 C-N-CA 122.359 2.039 . . . . 0.0 115.343 176.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -120.99 -14.12 8.49 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.458 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.35 79.71 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.51 -34.03 1.74 Allowed Glycine 1 N--CA 1.522 4.37 0 O-C-N 121.517 -0.739 . . . . 0.0 112.679 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.57 68.44 7.91 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 39.0 26.68 0.05 OUTLIER Glycine 1 N--CA 1.527 4.721 0 CA-C-N 114.018 -1.446 . . . . 0.0 116.573 -179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.567 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.57 43.92 1.18 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 124.52 2.105 . . . . 0.0 112.957 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.0 m -119.0 134.85 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 112.271 -2.24 . . . . 0.0 110.928 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.64 154.87 19.34 Favored Glycine 1 N--CA 1.535 5.295 0 CA-C-N 120.118 1.326 . . . . 0.0 114.039 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.57 81.91 1.77 Allowed 'General case' 0 N--CA 1.517 2.916 0 CA-C-N 119.405 1.603 . . . . 0.0 115.246 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.68 123.31 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.737 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.8 m -112.64 88.73 2.89 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.155 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.446 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.2 t -74.02 105.18 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 105.804 -1.925 . . . . 0.0 105.804 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.25 -72.3 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 O-C-N 126.046 2.091 . . . . 0.0 115.929 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.598 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.532 0 O-C-N 125.547 1.78 . . . . 0.0 113.841 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.013 ' CE1' HD21 ' A' ' 64' ' ' LEU . 60.9 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' TRP . . . . . 0.458 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.9 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.448 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.2 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.498 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.413 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 55.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.7 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.4 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.607 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 52.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.528 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 78.4 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.1 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.0 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.738 HG13 HG22 ' B' ' 50' ' ' VAL 0.386 0.2 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 58.9 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.6 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.613 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.6 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 87.5 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.974 ' CE1' HG22 ' B' ' 131' ' ' VAL . 51.5 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.738 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.5 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.411 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.8 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.1 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.411 HG22 ' O ' ' B' ' 55' ' ' ASP . 16.2 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.8 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.424 HG12 ' N ' ' B' ' 69' ' ' GLY . 80.7 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.424 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.522 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.514 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.8 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.0 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 0.859 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 17.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.859 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 46.4 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.478 HG22 HG11 ' B' ' 114' ' ' VAL 0.491 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.4 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.1 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.544 ' OD2' ' HG2' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.1 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 1.221 ' CZ ' ' HG2' ' A' ' 37' ' ' PRO . 17.3 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' GLN . . . . . 0.58 HE22 ' HA ' ' A' ' 36' ' ' VAL . 11.2 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.448 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 25.0 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.7 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.478 HG11 HG22 ' B' ' 84' ' ' ILE . 16.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.514 HD11 HG23 ' B' ' 75' ' ' VAL 0.526 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.433 ' N ' HG23 ' B' ' 115' ' ' ILE 0.403 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.667 ' C ' ' HE1' ' A' ' 66' ' ' MET . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 1.584 ' CG ' HD23 ' A' ' 64' ' ' LEU . 38.3 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 66' ' ' MET . 81.3 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.8 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 90.0 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.521 ' C ' HG12 ' B' ' 131' ' ' VAL . 12.8 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 1.549 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.511 0.9 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' PRO . . . . . 0.647 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 11.4 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.626 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.8 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.626 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.469 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . 0.647 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.2 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.5 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.361 1.5 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' HIS . . . . . 0.413 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.6 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.623 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.475 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.6 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.666 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.3 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.398 0.6 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' PRO . . . . . 0.458 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 19.1 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.443 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.9 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.681 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . 0.681 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.2 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.3 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.405 HG22 ' N ' ' B' ' 178' ' ' GLY . 58.0 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.405 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 64.8 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.9 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' LYS . . . . . 0.406 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.9 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.406 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 42.7 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.433 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.822 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' ILE . . . . . 0.4 ' O ' HG13 ' B' ' 199' ' ' ILE 0.464 0.2 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.7 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.9 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.8 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.2 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . 0.443 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.443 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 12.2 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.3 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.9 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.423 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.8 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.6 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' ASN . . . . . 0.51 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.3 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.482 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 23.1 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.5 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.0 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.7 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.597 HD22 HD11 ' B' ' 142' ' ' ILE . 40.8 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.924 -1.036 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' HEC . . . . . 0.607 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.594 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.455 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 69.7 m -61.51 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.963 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.408 ' HD2' HD11 ' A' ' 21' ' ' LEU . 10.8 m-85 -99.93 163.03 12.63 Favored 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.46 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 10.2 t -107.74 122.43 46.72 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.9 t -100.56 98.37 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.4 mmmt -67.35 65.37 0.07 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 113.137 -1.847 . . . . 0.0 114.894 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.807 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.9 mt -29.46 68.22 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.951 0 C-N-CA 126.61 1.964 . . . . 0.0 115.517 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.45 59.01 0.4 Allowed Glycine 0 N--CA 1.51 3.584 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 11' ' ' LYS . 20.3 p -1.13 54.15 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.284 0 N-CA-C 120.32 3.452 . . . . 0.0 120.32 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.51 -60.23 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 119.539 3.163 . . . . 0.0 119.539 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.527 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.87 22.62 14.27 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.858 -1.151 . . . . 0.0 108.189 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.2 -94.81 1.89 Allowed Glycine 0 N--CA 1.512 3.721 0 N-CA-C 115.521 0.969 . . . . 0.0 115.521 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.6 tp -150.56 -177.14 5.8 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.597 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 15.4 mt -74.78 46.76 0.3 Allowed 'General case' 0 N--CA 1.509 2.506 0 O-C-N 120.716 -1.24 . . . . 0.0 111.261 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.727 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.6 p -113.79 165.59 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 118.464 2.764 . . . . 0.0 118.464 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.727 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.3 m-30 -102.22 75.41 1.49 Allowed 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 112.142 -2.299 . . . . 0.0 113.431 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.343 0.6 OUTLIER -93.46 142.43 25.19 Favored Pre-proline 0 N--CA 1.506 2.347 0 O-C-N 121.805 -0.559 . . . . 0.0 111.754 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 20' ' ' LYS . 46.3 Cg_endo -86.46 76.22 0.09 OUTLIER 'Cis proline' 0 CA--C 1.572 2.39 0 N-CA-C 116.351 1.635 . . . . 0.0 116.351 -9.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.54 -44.17 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.841 1 N-CA-C 122.284 4.179 . . . . 0.0 122.284 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.648 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.61 71.69 1.0 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 122.408 1.099 . . . . 0.0 113.072 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.865 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.19 111.23 7.23 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.237 -1.539 . . . . 0.0 109.1 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.572 ' N ' HD23 ' A' ' 21' ' ' LEU . 46.1 m -87.42 81.41 7.84 Favored 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.865 HG23 HD22 ' A' ' 21' ' ' LEU . 4.4 pt -79.61 -177.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 CA-C-N 114.772 -1.103 . . . . 0.0 112.719 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.706 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -109.7 166.6 10.49 Favored Pre-proline 0 CA--C 1.566 1.569 0 CA-C-N 113.834 -1.53 . . . . 0.0 108.135 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 19.9 Cg_endo -52.26 77.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.288 0 N-CA-C 116.903 1.847 . . . . 0.0 116.903 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.16 -50.59 0.51 Allowed Glycine 1 N--CA 1.522 4.419 0 C-N-CA 119.753 -1.213 . . . . 0.0 115.834 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.561 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.61 92.06 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.171 1 N-CA-C 122.227 4.158 . . . . 0.0 122.227 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 28' ' ' THR . 11.1 m -64.15 36.08 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -52.11 147.23 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 CA-C-N 112.878 -1.965 . . . . 0.0 111.475 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.8 pt-20 -114.28 154.87 27.21 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 123.978 1.847 . . . . 0.0 115.356 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.418 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.9 m-85 -107.53 113.83 27.41 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 103.812 -2.662 . . . . 0.0 103.812 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.65 112.49 24.89 Favored 'General case' 0 N--CA 1.509 2.499 0 N-CA-C 120.792 3.627 . . . . 0.0 120.792 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -75.12 84.78 2.34 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.164 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 29.7 p30 -80.35 -45.06 18.4 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 118.904 2.928 . . . . 0.0 118.904 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.97 -169.33 3.35 Favored 'General case' 0 N--CA 1.509 2.491 0 C-N-CA 124.596 1.158 . . . . 0.0 109.068 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.095 ' HA ' HE22 ' B' ' 104' ' ' GLN . 1.6 m 12.91 70.62 0.11 Allowed Pre-proline 0 N--CA 1.519 3.01 0 N-CA-C 117.197 2.295 . . . . 0.0 117.197 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.328 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 55.3 Cg_endo -98.43 177.28 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.213 0 C-N-CA 123.908 3.072 . . . . 0.0 114.455 -165.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.713 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 52.3 Cg_endo -92.47 165.29 25.09 Favored 'Cis proline' 0 N--CA 1.503 2.069 0 N-CA-C 115.442 1.285 . . . . 0.0 115.442 -7.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.807 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.3 m-70 -118.96 87.46 2.74 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.729 HD21 ' N ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -103.37 140.2 37.76 Favored 'General case' 0 N--CA 1.516 2.827 0 CA-C-N 122.395 2.362 . . . . 0.0 110.744 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.5 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.3 m -118.11 116.22 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 121.476 3.88 . . . . 0.0 121.476 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.566 HG22 ' CB ' ' A' ' 88' ' ' TYR . 13.3 m -75.87 165.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.049 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.3 130.94 55.51 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.444 ' OD1' HD13 ' A' ' 47' ' ' LEU . 4.2 m-20 -53.4 93.71 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.183 1 N-CA-C 124.2 4.889 . . . . 0.0 124.2 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.98 6.8 43.28 Favored 'General case' 0 CA--C 1.602 2.957 0 N-CA-C 101.23 -3.619 . . . . 0.0 101.23 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -115.83 -65.53 1.18 Allowed 'General case' 0 CA--C 1.573 1.836 0 C-N-CA 127.595 2.358 . . . . 0.0 112.704 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.744 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.5 mp -86.72 66.47 9.48 Favored 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 118.966 2.95 . . . . 0.0 118.966 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.43 151.22 0.74 Allowed Pre-proline 0 N--CA 1.522 3.167 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.505 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 17.4 Cg_endo -42.32 -58.31 1.28 Allowed 'Trans proline' 0 N--CA 1.508 2.376 0 C-N-CA 123.408 2.739 . . . . 0.0 115.085 170.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.637 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.48 67.46 0.72 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 124.034 1.873 . . . . 0.0 107.04 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -77.25 53.6 1.02 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 112.333 -2.212 . . . . 0.0 108.331 179.392 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.4 t -115.88 56.96 0.76 Allowed 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.658 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.57 -47.96 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.11 -30.87 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.104 -1.622 . . . . 0.0 111.636 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.556 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.13 -28.5 0.09 Allowed 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 122.801 1.286 . . . . 0.0 112.561 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.86 -27.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.3 tptt 65.15 -55.62 0.31 Allowed 'General case' 0 N--CA 1.533 3.678 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.2 m -41.72 -28.9 0.16 Allowed 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.049 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.2 pp -53.74 -66.71 0.35 Allowed 'General case' 0 CA--C 1.603 3.017 0 N-CA-C 100.723 -3.806 . . . . 0.0 100.723 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.861 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 11.0 p -72.14 98.38 2.12 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 125.278 1.431 . . . . 0.0 112.816 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.702 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.5 t60 -89.96 -173.01 3.72 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.702 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.39 155.17 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.584 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 26.2 tt0 105.43 66.08 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 120.289 3.44 . . . . 0.0 120.289 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.017 HD21 ' CD1' ' B' ' 1' ' ' TYR . 5.6 mp 38.1 84.27 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 120.803 3.631 . . . . 0.0 120.803 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.729 ' N ' HD21 ' A' ' 40' ' ' ASN . 36.3 mt -70.68 82.12 0.61 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 120.144 -1.597 . . . . 0.0 111.88 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 1.27 ' HE2' ' O ' ' B' ' 118' ' ' PRO . 41.4 mmm -79.27 61.92 3.5 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-O 126.096 2.855 . . . . 0.0 110.918 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.524 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.9 m -112.52 65.95 0.84 Allowed Pre-proline 0 N--CA 1.505 2.298 0 CA-C-N 110.47 -3.059 . . . . 0.0 113.601 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.86 ' HG3' ' O ' ' B' ' 100' ' ' ASP . 19.3 Cg_endo -51.94 81.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.522 0 C-N-CA 122.979 2.452 . . . . 0.0 114.633 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.09 6.67 27.71 Favored Glycine 1 N--CA 1.516 4.021 0 O-C-N 122.203 -0.31 . . . . 0.0 113.606 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.2 tt0 -123.66 156.82 35.17 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 124.389 2.042 . . . . 0.0 116.332 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.451 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.91 156.34 27.55 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 119.742 3.238 . . . . 0.0 119.742 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.7 t -115.9 147.97 40.52 Favored 'General case' 0 N--CA 1.52 3.048 0 CA-C-O 116.643 -1.646 . . . . 0.0 107.264 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.59 143.76 41.94 Favored 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 76.1 m -119.95 102.64 8.69 Favored 'General case' 0 N--CA 1.514 2.751 0 CA-C-N 114.221 -1.354 . . . . 0.0 113.525 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.443 ' OG1' HG23 ' A' ' 28' ' ' THR . 49.8 m -94.81 152.26 18.56 Favored 'General case' 0 N--CA 1.525 3.288 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.429 ' N ' HG22 ' A' ' 75' ' ' THR . 89.8 m-85 -107.97 168.33 8.05 Favored Pre-proline 0 N--CA 1.502 2.157 0 CA-C-N 114.062 -1.426 . . . . 0.0 111.067 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -72.36 -174.76 1.52 Allowed 'Trans proline' 0 CA--C 1.559 1.732 0 C-N-CA 121.009 1.14 . . . . 0.0 111.115 161.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.34 -19.78 18.98 Favored 'General case' 0 N--CA 1.509 2.517 0 CA-C-O 124.301 2.001 . . . . 0.0 107.241 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.16 42.64 0.49 Allowed 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 111.246 -2.706 . . . . 0.0 109.059 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.3 84.84 9.84 Favored Pre-proline 0 N--CA 1.499 2.023 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.778 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 83' ' ' GLY . 38.0 Cg_endo -79.38 178.6 7.23 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.851 2.367 . . . . 0.0 112.298 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.604 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -15.97 77.72 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.889 0 C-N-CA 125.316 1.447 . . . . 0.0 113.262 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.51 125.08 5.64 Favored Glycine 0 N--CA 1.506 3.365 0 N-CA-C 121.703 3.441 . . . . 0.0 121.703 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.5 61.18 1.17 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.525 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 3.0 m-85 -62.04 77.74 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.873 1.32 . . . . 0.0 113.068 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 99' ' ' GLY . 6.4 m -63.36 135.92 57.31 Favored 'General case' 0 N--CA 1.51 2.545 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.583 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.4 p90 -116.47 136.55 52.89 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.566 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.6 m-85 -84.63 81.97 8.63 Favored 'General case' 0 N--CA 1.511 2.576 1 N-CA-C 132.625 8.009 . . . . 0.0 132.625 -179.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 10.7 t -63.84 82.21 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.447 2 CA-C-N 130.434 6.016 . . . . 0.0 114.298 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 88' ' ' TYR . 24.5 tt0 -20.61 -72.48 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.61 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.838 ' O ' ' CE2' ' B' ' 3' ' ' PHE . 31.7 Cg_endo -66.88 -3.55 9.71 Favored 'Trans proline' 0 N--CA 1.511 2.547 0 C-N-CA 122.419 2.079 . . . . 0.0 115.372 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -120.88 -14.08 8.54 Favored 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.501 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.45 79.75 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 N-CA-C 116.585 2.068 . . . . 0.0 116.585 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.53 -34.03 1.74 Allowed Glycine 1 N--CA 1.521 4.309 0 O-C-N 121.571 -0.706 . . . . 0.0 112.621 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.62 68.54 8.01 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.78 26.78 0.05 OUTLIER Glycine 1 N--CA 1.528 4.787 0 CA-C-N 114.004 -1.453 . . . . 0.0 116.636 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.573 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 1.8 ttt -108.53 43.76 1.2 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 124.51 2.1 . . . . 0.0 113.035 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -118.89 134.89 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 112.216 -2.266 . . . . 0.0 111.007 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.7 154.89 19.38 Favored Glycine 1 N--CA 1.535 5.269 0 C-N-CA 119.486 -1.34 . . . . 0.0 113.986 179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.2 ttpp -118.63 81.96 1.78 Allowed 'General case' 0 N--CA 1.518 2.956 0 CA-C-N 119.404 1.602 . . . . 0.0 115.252 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.76 123.24 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -112.56 88.72 2.89 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.196 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.449 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.8 t -73.97 105.21 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.3 -72.3 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 O-C-N 126.051 2.094 . . . . 0.0 115.888 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.486 0 O-C-N 125.579 1.799 . . . . 0.0 113.861 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.017 ' CD1' HD21 ' A' ' 64' ' ' LEU . 60.6 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.838 ' CE2' ' O ' ' A' ' 91' ' ' PRO . 24.1 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' TRP . . . . . 0.474 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 9.1 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.471 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 63.0 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.541 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.2 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 89.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 54.2 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.529 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 77.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 72.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.3 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.84 HG13 HG22 ' B' ' 50' ' ' VAL 0.373 0.1 OUTLIER -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 58.6 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.458 HG13 ' HD2' ' B' ' 37' ' ' PRO . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.458 ' HD2' HG13 ' B' ' 36' ' ' VAL . 23.7 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.9 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.668 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.4 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 30.2 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 1.112 ' CE1' HG22 ' B' ' 131' ' ' VAL . 49.3 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.84 HG22 HG13 ' B' ' 34' ' ' VAL . 62.0 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 49.8 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.449 ' O ' HG22 ' B' ' 58' ' ' VAL . 13.9 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.449 HG22 ' O ' ' B' ' 55' ' ' ASP . 15.1 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.5 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 82.9 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.452 HG12 ' N ' ' B' ' 69' ' ' GLY . 74.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.452 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.555 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.0 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.416 HG23 ' CD1' ' B' ' 115' ' ' ILE . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 58.2 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 1.052 ' HG2' ' CD1' ' B' ' 82' ' ' PHE . 24.8 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 1.052 ' CD1' ' HG2' ' B' ' 79' ' ' PRO . 43.0 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . . . . . . . . 0.568 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' B' ' 94' ' ' LEU . 50.3 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.0 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.86 ' O ' ' HG3' ' A' ' 68' ' ' PRO . 24.3 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 10.3 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 1.328 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 17.2 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' GLN . . . . . 1.095 HE22 ' HA ' ' A' ' 36' ' ' VAL . 11.0 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 22.9 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.2 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 17.8 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.513 HG23 ' N ' ' B' ' 116' ' ' VAL 0.454 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.513 ' N ' HG23 ' B' ' 115' ' ' ILE 0.254 0.0 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.576 ' C ' ' HE1' ' A' ' 66' ' ' MET . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 1.27 ' O ' ' HE2' ' A' ' 66' ' ' MET . 36.4 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.917 ' CD2' ' HB3' ' A' ' 66' ' ' MET . 81.9 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.5 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 85.3 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.515 ' C ' HG12 ' B' ' 131' ' ' VAL . 19.8 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 1.556 ' CB ' ' CA ' ' B' ' 131' ' ' VAL 0.348 0.5 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 52.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' B' ' 142' ' ' ILE . 35.7 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' PRO . . . . . 0.526 ' CG ' ' CZ ' ' B' ' 144' ' ' PHE . 18.2 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.591 ' CG ' ' CG2' ' B' ' 142' ' ' ILE . 44.7 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.739 HD11 HD22 ' B' ' 249' ' ' LEU 0.511 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . 0.526 ' CZ ' ' CG ' ' B' ' 136' ' ' PRO . 81.3 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 69.0 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' B' ' 149' ' ' VAL . 1.3 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.627 HG11 ' CG2' ' B' ' 34' ' ' VAL . 10.7 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' B' ' 155' ' ' ARG . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.458 HH11 ' HD2' ' B' ' 157' ' ' ARG . 28.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.683 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.7 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.31 0.5 OUTLIER -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' PRO . . . . . 0.474 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 17.8 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 97.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.442 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.9 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.725 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.9 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . 0.725 ' N ' HD23 ' B' ' 171' ' ' LEU . 18.4 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.436 HG22 ' N ' ' B' ' 178' ' ' GLY . 61.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.436 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 63.7 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.4 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' B' ' 183' ' ' ILE . 35.6 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . 0.429 ' N ' ' HG2' ' B' ' 182' ' ' LYS . 2.2 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 41.2 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.381 2.0 m -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.904 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' ILE . . . . . 0.642 HG13 ' O ' ' B' ' 199' ' ' ILE 0.52 0.3 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.6 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.2 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 87.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . 0.488 ' C ' ' HD2' ' B' ' 215' ' ' PRO . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.488 ' HD2' ' C ' ' B' ' 213' ' ' ALA . 18.3 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.3 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 87.1 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.5 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.8 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.402 0.1 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.0 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' B' ' 231' ' ' LEU . 84.2 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.5 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' ASN . . . . . 0.545 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.507 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.6 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.2 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 19.4 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.0 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.739 HD22 HD11 ' B' ' 142' ' ' ILE . 41.4 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.988 -1.006 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' HEC . . . . . 0.608 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.605 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.488 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 80.5 m -61.53 89.65 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.029 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -99.95 163.08 12.6 Favored 'General case' 0 N--CA 1.512 2.658 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.473 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.83 122.39 46.69 Favored 'General case' 0 N--CA 1.525 3.305 0 N-CA-C 117.118 2.266 . . . . 0.0 117.118 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -100.49 98.38 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.7 mmmt -67.37 65.39 0.07 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 113.121 -1.854 . . . . 0.0 114.847 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.826 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.6 mt -29.59 68.29 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 C-N-CA 126.53 1.932 . . . . 0.0 115.501 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.44 58.98 0.4 Allowed Glycine 0 N--CA 1.509 3.54 0 N-CA-C 106.927 -2.469 . . . . 0.0 106.927 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.1 p -1.07 54.24 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 N-CA-C 120.187 3.402 . . . . 0.0 120.187 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.44 -60.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 N-CA-C 119.513 3.153 . . . . 0.0 119.513 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' O ' ' NZ ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.76 22.53 14.42 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.858 -1.151 . . . . 0.0 108.183 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.18 -94.77 1.89 Allowed Glycine 0 N--CA 1.512 3.713 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 44.6 tp -150.61 -177.2 5.84 Favored 'General case' 0 N--CA 1.509 2.506 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.532 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.2 mt -74.78 46.78 0.3 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 120.638 -1.289 . . . . 0.0 111.279 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.624 HG22 ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.85 165.68 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 118.596 2.813 . . . . 0.0 118.596 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.624 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.9 m-30 -102.23 75.42 1.49 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-N 112.2 -2.273 . . . . 0.0 113.389 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.308 12.3 mt-10 -93.47 142.43 25.2 Favored Pre-proline 0 N--CA 1.505 2.294 0 O-C-N 121.826 -0.546 . . . . 0.0 111.814 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.511 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.41 76.15 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.458 0 N-CA-C 116.328 1.626 . . . . 0.0 116.328 -9.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.59 -44.14 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.775 1 N-CA-C 122.344 4.201 . . . . 0.0 122.344 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.63 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.62 71.62 1.0 Allowed 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 122.364 1.078 . . . . 0.0 113.025 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.787 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.13 111.31 7.25 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.208 -1.557 . . . . 0.0 109.104 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.488 ' N ' HD23 ' A' ' 21' ' ' LEU . 49.4 m -87.49 81.46 7.78 Favored 'General case' 0 N--CA 1.514 2.762 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.787 HG23 HD22 ' A' ' 21' ' ' LEU . 5.3 pt -79.78 -177.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.692 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.613 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.66 166.51 10.65 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.198 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.6 Cg_endo -52.2 77.58 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.3 0 N-CA-C 116.91 1.85 . . . . 0.0 116.91 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.09 -50.44 0.52 Allowed Glycine 1 N--CA 1.523 4.449 0 C-N-CA 119.789 -1.196 . . . . 0.0 115.915 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.555 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.64 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.178 1 N-CA-C 122.151 4.13 . . . . 0.0 122.151 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 28' ' ' THR . 11.9 m -64.0 35.98 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.027 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.11 147.21 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 CA-C-N 112.906 -1.952 . . . . 0.0 111.418 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.473 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 4.1 pt-20 -114.29 154.93 27.11 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 123.925 1.822 . . . . 0.0 115.324 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -107.53 113.79 27.35 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.76 112.57 25.0 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 120.758 3.614 . . . . 0.0 120.758 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -75.16 84.72 2.37 Favored 'General case' 0 N--CA 1.511 2.622 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.13 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.23 -45.11 18.55 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.553 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.93 -169.38 3.36 Favored 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 124.61 1.164 . . . . 0.0 109.086 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.995 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.7 m 12.92 70.63 0.11 Allowed Pre-proline 0 N--CA 1.521 3.098 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.454 ' HD2' ' CE2' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.4 177.28 0.41 Allowed 'Trans proline' 0 CA--C 1.569 2.241 0 C-N-CA 123.939 3.093 . . . . 0.0 114.416 -165.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.4 Cg_endo -92.5 165.31 25.0 Favored 'Cis proline' 0 N--CA 1.503 2.068 0 N-CA-C 115.398 1.268 . . . . 0.0 115.398 -7.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.826 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.89 87.46 2.74 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.64 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 1.0 OUTLIER -103.45 140.22 37.78 Favored 'General case' 0 N--CA 1.515 2.818 0 CA-C-N 122.456 2.389 . . . . 0.0 110.722 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.2 m -118.08 116.31 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.564 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.8 m -75.95 165.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 102.19 -3.263 . . . . 0.0 102.19 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.03 ' HB2' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.3 130.93 55.51 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.32 93.77 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.221 1 N-CA-C 124.182 4.882 . . . . 0.0 124.182 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.4 ' C ' ' HB2' ' A' ' 51' ' ' LYS . . . -91.06 6.74 43.68 Favored 'General case' 0 CA--C 1.602 2.972 0 N-CA-C 101.168 -3.642 . . . . 0.0 101.168 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.8 -65.54 1.18 Allowed 'General case' 0 CA--C 1.573 1.853 0 C-N-CA 127.525 2.33 . . . . 0.0 112.718 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.63 66.56 9.53 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 118.915 2.932 . . . . 0.0 118.915 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.46 151.25 0.74 Allowed Pre-proline 0 N--CA 1.522 3.135 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.497 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.8 Cg_endo -42.51 -58.2 1.35 Allowed 'Trans proline' 0 N--CA 1.508 2.371 0 C-N-CA 123.438 2.758 . . . . 0.0 115.04 170.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.52 67.43 0.72 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 124.091 1.901 . . . . 0.0 107.072 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.412 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.28 53.55 1.02 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.256 -2.247 . . . . 0.0 108.222 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.8 56.94 0.76 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.7 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.58 -47.94 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.184 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.12 -30.85 0.16 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.113 -1.617 . . . . 0.0 111.545 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.548 ' HG ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 pp -41.22 -28.54 0.1 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.732 1.253 . . . . 0.0 112.485 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.82 -27.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 117.707 2.484 . . . . 0.0 117.707 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.3 tptt 64.93 -55.47 0.3 Allowed 'General case' 0 N--CA 1.533 3.715 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -41.78 -28.86 0.17 Allowed 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.03 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.8 pp -53.74 -66.76 0.33 Allowed 'General case' 0 CA--C 1.604 3.022 0 N-CA-C 100.713 -3.81 . . . . 0.0 100.713 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.756 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.11 98.44 2.11 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 125.268 1.427 . . . . 0.0 112.781 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.671 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.3 t60 -90.05 -173.08 3.73 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.671 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.42 155.15 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 28.1 tt0 105.5 66.06 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.755 0 N-CA-C 120.313 3.449 . . . . 0.0 120.313 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.246 HD23 ' CG ' ' B' ' 118' ' ' PRO . 6.1 mp 38.13 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 120.732 3.604 . . . . 0.0 120.732 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.518 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 36.2 mt -70.67 82.08 0.61 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.197 -1.564 . . . . 0.0 111.906 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.663 ' HE2' HD23 ' B' ' 119' ' ' LEU . 41.4 mmm -79.3 62.0 3.53 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-O 126.051 2.834 . . . . 0.0 110.867 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.4 m -112.58 65.84 0.85 Allowed Pre-proline 0 C--N 1.283 -2.287 0 CA-C-N 110.474 -3.057 . . . . 0.0 113.558 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HG2' ' OD2' ' B' ' 100' ' ' ASP . 19.5 Cg_endo -51.92 81.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.45 0 C-N-CA 122.959 2.439 . . . . 0.0 114.716 -177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.14 6.66 27.63 Favored Glycine 0 N--CA 1.516 3.991 0 O-C-N 122.131 -0.356 . . . . 0.0 113.603 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.8 tt0 -123.65 156.92 34.97 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 124.384 2.04 . . . . 0.0 116.273 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.435 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.98 156.37 27.58 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 119.722 3.23 . . . . 0.0 119.722 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -115.93 147.95 40.58 Favored 'General case' 0 N--CA 1.52 3.056 0 CA-C-O 116.636 -1.65 . . . . 0.0 107.194 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.46 143.74 41.81 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 85.2 m -120.02 102.57 8.63 Favored 'General case' 0 N--CA 1.513 2.719 0 CA-C-N 114.296 -1.32 . . . . 0.0 113.532 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.457 ' OG1' HG23 ' A' ' 28' ' ' THR . 44.5 m -94.74 152.22 18.63 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.452 ' N ' HG22 ' A' ' 75' ' ' THR . 89.2 m-85 -107.97 168.27 8.13 Favored Pre-proline 0 N--CA 1.502 2.13 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.135 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.33 -174.77 1.51 Allowed 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.006 1.137 . . . . 0.0 111.122 161.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.45 -19.64 19.01 Favored 'General case' 0 N--CA 1.509 2.486 0 CA-C-O 124.346 2.022 . . . . 0.0 107.216 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.25 42.72 0.5 Allowed 'General case' 0 CA--C 1.576 1.963 0 CA-C-N 111.249 -2.705 . . . . 0.0 109.036 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.29 84.73 9.68 Favored Pre-proline 0 N--CA 1.5 2.031 0 CA-C-N 113.619 -1.628 . . . . 0.0 113.846 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -79.36 178.68 7.15 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 122.753 2.302 . . . . 0.0 112.226 173.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.604 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.04 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 C-N-CA 125.294 1.437 . . . . 0.0 113.3 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.549 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.35 125.01 5.64 Favored Glycine 0 N--CA 1.508 3.472 0 N-CA-C 121.777 3.471 . . . . 0.0 121.777 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.44 61.15 1.18 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.549 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.8 m-85 -62.06 77.79 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 CA-C-O 122.9 1.333 . . . . 0.0 112.984 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 6.9 m -63.46 135.91 57.23 Favored 'General case' 0 N--CA 1.51 2.561 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.526 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.43 136.51 52.93 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.564 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.64 81.96 8.63 Favored 'General case' 0 N--CA 1.511 2.617 1 N-CA-C 132.611 8.004 . . . . 0.0 132.611 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.0 t -63.82 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.528 3.471 2 CA-C-N 130.384 5.993 . . . . 0.0 114.34 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.6 tt0 -20.5 -72.4 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.62 0 N-CA-C 118.541 2.793 . . . . 0.0 118.541 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 90' ' ' GLU . 29.6 Cg_endo -67.08 -3.45 9.76 Favored 'Trans proline' 0 N--CA 1.511 2.53 0 C-N-CA 122.406 2.071 . . . . 0.0 115.334 176.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -120.93 -14.16 8.51 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.442 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.23 79.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.782 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.58 -34.1 1.73 Allowed Glycine 1 N--CA 1.521 4.304 0 O-C-N 121.516 -0.74 . . . . 0.0 112.628 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.47 68.42 7.79 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.84 26.81 0.05 OUTLIER Glycine 1 N--CA 1.526 4.648 0 N-CA-C 116.616 1.407 . . . . 0.0 116.616 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.586 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.1 ttt -108.55 43.86 1.19 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 124.482 2.087 . . . . 0.0 112.966 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.03 134.88 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-N 112.233 -2.258 . . . . 0.0 110.973 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.65 154.86 19.34 Favored Glycine 1 N--CA 1.534 5.228 0 C-N-CA 119.525 -1.321 . . . . 0.0 114.032 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 ttpp -118.63 82.0 1.78 Allowed 'General case' 0 N--CA 1.518 2.925 0 CA-C-N 119.474 1.637 . . . . 0.0 115.188 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.74 123.29 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.5 m -112.67 88.77 2.9 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.197 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.3 t -74.05 105.23 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.35 -72.27 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.579 0 O-C-N 126.066 2.104 . . . . 0.0 115.912 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.438 0 O-C-N 125.478 1.736 . . . . 0.0 113.835 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.853 ' CE1' HD21 ' A' ' 64' ' ' LEU . 61.0 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.28 21.9 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' TRP . . . . . 0.437 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.8 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.308 27.5 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.512 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 52.9 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.611 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.525 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.638 HG22 HG11 ' B' ' 151' ' ' VAL 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.5 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.557 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.367 22.0 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 33.0 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.786 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.411 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.8 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.418 HG12 ' N ' ' B' ' 69' ' ' GLY . 88.0 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.418 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.506 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 50.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 0.719 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.1 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.719 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.2 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.512 HG22 HG11 ' B' ' 114' ' ' VAL 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' B' ' 130' ' ' PRO . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.5 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 68' ' ' PRO . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 1.454 ' CE2' ' HD2' ' A' ' 37' ' ' PRO . 20.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' GLN . . . . . 0.995 ' NE2' HG12 ' A' ' 36' ' ' VAL . 11.9 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.512 HG11 HG22 ' B' ' 84' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . 0.592 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 1.246 ' CG ' HD23 ' A' ' 64' ' ' LEU . 36.5 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.663 HD23 ' HE2' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.466 ' HB3' HD21 ' B' ' 94' ' ' LEU . 23.9 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.786 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.442 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' PRO . . . . . 0.691 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.327 23.8 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.556 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.556 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.316 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . 0.691 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.418 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' HIS . . . . . 0.512 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.638 HG11 HG22 ' B' ' 34' ' ' VAL . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.501 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.526 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' PRO . . . . . 0.437 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 23.0 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.2 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.635 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . 0.635 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.363 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.739 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.4 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.256 25.7 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.625 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.8 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' ASN . . . . . 0.535 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.52 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 19.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' HEC . . . . . 0.611 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.593 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 82.1 m -61.63 89.63 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.012 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -99.92 163.03 12.63 Favored 'General case' 0 N--CA 1.511 2.617 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.79 122.4 46.69 Favored 'General case' 0 N--CA 1.525 3.301 0 N-CA-C 117.179 2.288 . . . . 0.0 117.179 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.49 98.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.6 mmmt -67.36 65.41 0.07 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 113.144 -1.843 . . . . 0.0 114.828 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.846 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.6 mt -29.48 68.2 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.037 0 C-N-CA 126.575 1.95 . . . . 0.0 115.508 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.49 59.0 0.4 Allowed Glycine 0 N--CA 1.51 3.62 0 N-CA-C 106.897 -2.481 . . . . 0.0 106.897 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -1.05 54.08 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 120.324 3.453 . . . . 0.0 120.324 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.55 -60.25 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 119.494 3.146 . . . . 0.0 119.494 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.504 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.81 22.53 14.39 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 120.941 -1.099 . . . . 0.0 108.196 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.13 -94.8 1.9 Allowed Glycine 0 N--CA 1.511 3.694 0 N-CA-C 115.511 0.964 . . . . 0.0 115.511 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.496 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 44.4 tp -150.62 -177.16 5.82 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.531 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.2 mt -74.8 46.72 0.3 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 120.677 -1.264 . . . . 0.0 111.271 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.629 HG22 ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.76 165.69 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 118.578 2.807 . . . . 0.0 118.578 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.629 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.9 m-30 -102.26 75.39 1.48 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.364 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.307 12.4 mt-10 -93.45 142.46 25.24 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.81 -0.556 . . . . 0.0 111.746 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.41 76.13 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.459 0 N-CA-C 116.3 1.616 . . . . 0.0 116.3 -9.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.61 -44.19 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.807 1 N-CA-C 122.316 4.191 . . . . 0.0 122.316 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.61 71.62 1.0 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 122.484 1.135 . . . . 0.0 113.061 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.788 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.13 111.28 7.21 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.134 -1.604 . . . . 0.0 109.138 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.489 ' N ' HD23 ' A' ' 21' ' ' LEU . 50.6 m -87.49 81.43 7.79 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.788 HG23 HD22 ' A' ' 21' ' ' LEU . 5.3 pt -79.7 -177.57 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.689 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.623 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.49 10.68 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.133 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.4 Cg_endo -52.16 77.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.314 0 N-CA-C 116.97 1.873 . . . . 0.0 116.97 174.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.19 -50.5 0.51 Allowed Glycine 1 N--CA 1.522 4.403 0 C-N-CA 119.69 -1.243 . . . . 0.0 115.826 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.66 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.171 1 N-CA-C 122.149 4.129 . . . . 0.0 122.149 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 28' ' ' THR . 11.7 m -63.98 35.9 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.977 0 N-CA-C 118.726 2.861 . . . . 0.0 118.726 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.3 t -51.98 147.15 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 112.886 -1.961 . . . . 0.0 111.57 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 4.1 pt-20 -114.2 154.9 27.06 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 123.942 1.83 . . . . 0.0 115.442 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.54 113.84 27.43 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.56 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.79 112.49 24.92 Favored 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 120.686 3.587 . . . . 0.0 120.686 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -75.06 84.6 2.31 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.197 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.27 -45.03 18.62 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 118.919 2.933 . . . . 0.0 118.919 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.96 -169.38 3.36 Favored 'General case' 0 N--CA 1.509 2.506 0 C-N-CA 124.619 1.167 . . . . 0.0 109.124 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.004 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.7 m 12.95 70.62 0.11 Allowed Pre-proline 0 N--CA 1.521 3.076 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.489 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.37 177.33 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.224 0 C-N-CA 123.941 3.094 . . . . 0.0 114.395 -165.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.3 Cg_endo -92.38 165.28 25.37 Favored 'Cis proline' 0 N--CA 1.504 2.104 0 N-CA-C 115.453 1.29 . . . . 0.0 115.453 -7.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.846 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.83 87.41 2.73 Favored 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 117.346 2.35 . . . . 0.0 117.346 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.707 HD21 ' N ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -103.44 140.25 37.73 Favored 'General case' 0 N--CA 1.516 2.863 0 CA-C-N 122.494 2.406 . . . . 0.0 110.681 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.1 m -118.11 116.26 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 121.386 3.847 . . . . 0.0 121.386 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.566 HG22 ' CB ' ' A' ' 88' ' ' TYR . 15.0 m -75.89 165.35 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 102.238 -3.245 . . . . 0.0 102.238 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.061 ' HB2' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.3 131.02 55.47 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.481 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.53 93.87 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.163 1 N-CA-C 124.149 4.87 . . . . 0.0 124.149 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.08 6.84 43.3 Favored 'General case' 0 CA--C 1.601 2.94 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.85 -65.5 1.18 Allowed 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 127.612 2.365 . . . . 0.0 112.753 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.9 mp -86.78 66.64 9.55 Favored 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 118.885 2.92 . . . . 0.0 118.885 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.48 151.22 0.73 Allowed Pre-proline 0 N--CA 1.522 3.137 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.7 Cg_endo -42.47 -58.24 1.33 Allowed 'Trans proline' 0 N--CA 1.508 2.361 0 C-N-CA 123.403 2.736 . . . . 0.0 115.079 170.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.45 67.34 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 124.063 1.887 . . . . 0.0 107.084 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.8 OUTLIER -77.06 53.39 0.96 Allowed 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 112.296 -2.229 . . . . 0.0 108.266 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.77 56.89 0.76 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.846 2.535 . . . . 0.0 117.846 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.709 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.49 -48.04 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.171 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.04 -30.93 0.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.098 -1.626 . . . . 0.0 111.584 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.551 ' HG ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 pp -41.08 -28.61 0.09 Allowed 'General case' 0 N--CA 1.509 2.501 0 CA-C-O 122.68 1.229 . . . . 0.0 112.524 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.81 -27.48 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 117.736 2.495 . . . . 0.0 117.736 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.798 ' HE2' ' OE1' ' B' ' 189' ' ' GLU . 12.3 tptt 65.08 -55.64 0.3 Allowed 'General case' 0 N--CA 1.532 3.66 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.7 m -41.67 -28.93 0.16 Allowed 'General case' 0 N--CA 1.513 2.715 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.061 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.8 pp -53.69 -66.8 0.33 Allowed 'General case' 0 CA--C 1.604 3.038 0 N-CA-C 100.673 -3.825 . . . . 0.0 100.673 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.761 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.7 p -72.16 98.47 2.14 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.248 1.419 . . . . 0.0 112.78 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.685 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -90.07 -173.05 3.72 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.685 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.39 155.18 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.388 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 28.2 tt0 105.44 66.11 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 N-CA-C 120.281 3.437 . . . . 0.0 120.281 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.108 HD21 ' CE1' ' B' ' 1' ' ' TYR . 6.1 mp 38.13 84.23 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 120.789 3.626 . . . . 0.0 120.789 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 65' ' ' LEU . 36.2 mt -70.6 81.99 0.6 Allowed 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.051 -1.655 . . . . 0.0 111.88 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 1.374 ' CE ' ' HA ' ' B' ' 119' ' ' LEU . 41.2 mmm -79.18 61.94 3.44 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 126.052 2.834 . . . . 0.0 110.985 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.0 m -112.55 65.94 0.85 Allowed Pre-proline 0 C--N 1.284 -2.277 0 CA-C-N 110.465 -3.061 . . . . 0.0 113.662 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -52.05 81.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.463 0 C-N-CA 123.001 2.468 . . . . 0.0 114.642 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.06 6.73 27.73 Favored Glycine 1 N--CA 1.516 4.007 0 O-C-N 122.115 -0.366 . . . . 0.0 113.619 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.502 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 36.0 tt0 -123.61 156.85 35.02 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-O 124.36 2.029 . . . . 0.0 116.326 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.434 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.96 156.37 27.55 Favored 'General case' 0 N--CA 1.507 2.38 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -115.95 147.89 40.67 Favored 'General case' 0 N--CA 1.52 3.066 0 CA-C-O 116.518 -1.706 . . . . 0.0 107.247 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.45 143.76 41.77 Favored 'General case' 0 N--CA 1.529 3.511 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.0 m -119.95 102.52 8.61 Favored 'General case' 0 N--CA 1.514 2.769 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.546 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.463 ' OG1' HG23 ' A' ' 28' ' ' THR . 44.7 m -94.8 152.24 18.58 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.461 ' N ' HG22 ' A' ' 75' ' ' THR . 89.1 m-85 -107.9 168.33 8.05 Favored Pre-proline 0 N--CA 1.504 2.268 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.076 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.35 -174.84 1.54 Allowed 'Trans proline' 0 CA--C 1.559 1.739 0 C-N-CA 121.058 1.172 . . . . 0.0 111.073 161.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.36 -19.74 18.99 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 124.289 1.995 . . . . 0.0 107.173 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.15 42.66 0.49 Allowed 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 111.286 -2.688 . . . . 0.0 109.132 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.34 84.83 9.9 Favored Pre-proline 0 N--CA 1.499 2.011 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.723 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.8 Cg_endo -79.45 178.59 7.22 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.83 2.354 . . . . 0.0 112.303 172.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.589 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.03 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.877 0 C-N-CA 125.432 1.493 . . . . 0.0 113.243 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.546 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.33 124.99 5.63 Favored Glycine 0 N--CA 1.507 3.38 0 N-CA-C 121.792 3.477 . . . . 0.0 121.792 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 44.0 mt-10 -99.46 61.23 1.18 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.546 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.8 m-85 -62.13 77.83 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 CA-C-O 122.924 1.345 . . . . 0.0 112.969 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 6.8 m -63.42 135.95 57.28 Favored 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.539 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.53 136.53 52.91 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.566 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.69 82.11 8.57 Favored 'General case' 0 N--CA 1.512 2.672 1 N-CA-C 132.536 7.976 . . . . 0.0 132.536 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.0 t -63.91 82.21 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.495 2 CA-C-N 130.343 5.974 . . . . 0.0 114.324 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.5 tt0 -20.6 -72.42 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.6 0 N-CA-C 118.518 2.784 . . . . 0.0 118.518 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.55 ' O ' ' CD2' ' B' ' 3' ' ' PHE . 29.5 Cg_endo -67.04 -3.41 9.65 Favored 'Trans proline' 0 N--CA 1.51 2.473 0 C-N-CA 122.361 2.04 . . . . 0.0 115.383 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -120.85 -14.18 8.54 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.457 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.35 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.55 -33.94 1.74 Allowed Glycine 1 N--CA 1.521 4.343 0 O-C-N 121.491 -0.756 . . . . 0.0 112.645 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.6 68.51 7.98 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.9 26.74 0.05 OUTLIER Glycine 1 N--CA 1.528 4.774 0 CA-C-N 114.0 -1.455 . . . . 0.0 116.631 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.605 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.1 ttm -108.63 43.9 1.19 Allowed 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 124.539 2.114 . . . . 0.0 112.973 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.02 134.87 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 112.209 -2.269 . . . . 0.0 110.916 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.539 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.62 154.88 19.33 Favored Glycine 1 N--CA 1.536 5.36 0 C-N-CA 119.468 -1.349 . . . . 0.0 114.023 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 ttpp -118.63 81.95 1.77 Allowed 'General case' 0 N--CA 1.516 2.863 0 CA-C-N 119.408 1.604 . . . . 0.0 115.238 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.66 123.22 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.731 0 C-N-CA 118.061 -1.456 . . . . 0.0 107.087 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.5 m -112.59 88.74 2.89 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.177 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.47 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.2 t -74.08 105.15 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.16 -72.4 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 O-C-N 126.112 2.133 . . . . 0.0 115.93 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.589 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.494 2.534 0 O-C-N 125.555 1.785 . . . . 0.0 113.796 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.108 ' CE1' HD21 ' A' ' 64' ' ' LEU . 61.1 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.281 22.0 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.55 ' CD2' ' O ' ' A' ' 91' ' ' PRO . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.7 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.31 27.8 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.512 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 53.0 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.611 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.525 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.638 HG22 HG11 ' B' ' 151' ' ' VAL 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.557 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.368 22.4 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 33.0 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.785 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.411 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.418 HG12 ' N ' ' B' ' 69' ' ' GLY . 88.0 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.418 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.506 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 50.4 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 0.72 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.72 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.2 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.512 HG22 HG11 ' B' ' 114' ' ' VAL 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.3 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' B' ' 130' ' ' PRO . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.7 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 1.489 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 20.7 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' GLN . . . . . 1.004 ' NE2' HG12 ' A' ' 36' ' ' VAL . 11.9 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.512 HG11 HG22 ' B' ' 84' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . 0.592 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 1.23 ' O ' ' HE1' ' A' ' 66' ' ' MET . 36.4 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 1.374 ' HA ' ' CE ' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 92.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.467 ' HB3' HD21 ' B' ' 94' ' ' LEU . 24.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.442 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.6 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' PRO . . . . . 0.693 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.328 23.8 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.556 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.556 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.317 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . 0.693 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.418 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' HIS . . . . . 0.512 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.638 HG11 HG22 ' B' ' 34' ' ' VAL . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.503 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.0 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.525 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' PRO . . . . . 0.436 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 23.0 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.9 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.1 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.635 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . 0.635 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.0 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' GLU . . . . . 0.798 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.363 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.739 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.8 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.256 25.9 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.627 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' ASN . . . . . 0.537 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.522 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 19.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' HEC . . . . . 0.611 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.595 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.493 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 82.5 m -61.65 89.68 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.022 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -99.95 163.01 12.63 Favored 'General case' 0 N--CA 1.513 2.706 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.462 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.9 t -107.72 122.41 46.68 Favored 'General case' 0 N--CA 1.526 3.326 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.5 t -100.57 98.36 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.7 mmmt -67.27 65.33 0.07 Allowed 'General case' 0 N--CA 1.503 2.224 0 CA-C-N 113.144 -1.844 . . . . 0.0 114.9 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.833 HD13 ' HB2' ' A' ' 39' ' ' HIS . 14.7 mt -29.45 68.15 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 126.539 1.935 . . . . 0.0 115.531 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.48 59.04 0.4 Allowed Glycine 0 N--CA 1.51 3.576 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -0.95 54.0 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.363 0 N-CA-C 120.279 3.437 . . . . 0.0 120.279 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.61 -60.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.84 22.57 14.34 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 120.956 -1.09 . . . . 0.0 108.154 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.22 -94.82 1.89 Allowed Glycine 0 N--CA 1.512 3.715 0 N-CA-C 115.499 0.96 . . . . 0.0 115.499 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.499 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 44.6 tp -150.59 -177.14 5.8 Favored 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.524 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.1 mt -74.77 46.65 0.3 Allowed 'General case' 0 N--CA 1.509 2.499 0 O-C-N 120.641 -1.287 . . . . 0.0 111.264 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 16' ' ' PHE . 8.0 p -113.78 165.6 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 118.587 2.81 . . . . 0.0 118.587 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.621 ' N ' HG22 ' A' ' 15' ' ' VAL . 4.9 m-30 -102.17 75.43 1.5 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 112.263 -2.244 . . . . 0.0 113.423 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.307 12.4 mt-10 -93.51 142.43 25.18 Favored Pre-proline 0 N--CA 1.506 2.333 0 O-C-N 121.822 -0.549 . . . . 0.0 111.778 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' LYS . 38.0 Cg_endo -86.5 76.22 0.09 OUTLIER 'Cis proline' 0 CA--C 1.573 2.431 0 N-CA-C 116.4 1.654 . . . . 0.0 116.4 -9.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.63 -44.22 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.795 1 N-CA-C 122.319 4.192 . . . . 0.0 122.319 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.631 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.56 71.65 1.0 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 122.388 1.09 . . . . 0.0 113.066 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.804 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.1 111.2 7.13 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.131 -1.606 . . . . 0.0 109.099 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.485 ' N ' HD23 ' A' ' 21' ' ' LEU . 49.7 m -87.46 81.42 7.81 Favored 'General case' 0 N--CA 1.515 2.787 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.804 HG23 HD22 ' A' ' 21' ' ' LEU . 5.3 pt -79.72 -177.55 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.626 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.623 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.68 166.55 10.58 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-N 113.78 -1.554 . . . . 0.0 108.122 179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 20.4 Cg_endo -52.22 77.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.318 0 N-CA-C 116.866 1.833 . . . . 0.0 116.866 174.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.07 -50.51 0.52 Allowed Glycine 1 N--CA 1.522 4.428 0 C-N-CA 119.717 -1.23 . . . . 0.0 115.879 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.563 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.2 m-20 -6.73 92.11 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.184 1 N-CA-C 122.19 4.144 . . . . 0.0 122.19 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 28' ' ' THR . 11.9 m -64.1 36.07 0.01 OUTLIER 'General case' 1 N--CA 1.539 4.019 0 N-CA-C 118.67 2.841 . . . . 0.0 118.67 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.8 t -52.11 147.17 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.517 0 CA-C-N 112.853 -1.976 . . . . 0.0 111.51 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 4.1 pt-20 -114.2 154.88 27.11 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 123.916 1.817 . . . . 0.0 115.38 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.52 113.81 27.39 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.554 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.67 112.6 25.02 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -75.17 84.74 2.37 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.159 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.3 p30 -80.33 -45.11 18.36 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.7 mptp? -149.92 -169.25 3.33 Favored 'General case' 0 N--CA 1.509 2.484 0 C-N-CA 124.662 1.185 . . . . 0.0 109.109 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.054 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.7 m 12.75 70.69 0.11 Allowed Pre-proline 0 N--CA 1.52 3.066 0 N-CA-C 117.135 2.272 . . . . 0.0 117.135 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.235 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 37.0 Cg_endo -98.44 177.24 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.219 0 C-N-CA 123.99 3.127 . . . . 0.0 114.424 -165.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 38.6 Cg_endo -92.44 165.31 25.18 Favored 'Cis proline' 0 N--CA 1.503 2.048 0 N-CA-C 115.399 1.269 . . . . 0.0 115.399 -7.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.833 ' HB2' HD13 ' A' ' 7' ' ' LEU . 16.2 m-70 -118.9 87.43 2.73 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -103.36 140.35 37.55 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 122.482 2.401 . . . . 0.0 110.664 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 41' ' ' VAL . 7.0 m -118.12 116.24 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 121.438 3.866 . . . . 0.0 121.438 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.562 HG22 ' CB ' ' A' ' 88' ' ' TYR . 15.0 m -75.92 165.39 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 102.258 -3.238 . . . . 0.0 102.258 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.046 ' HB2' HD12 ' A' ' 59' ' ' LEU . 1.9 m-85 -111.32 130.97 55.51 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.483 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.2 m-20 -53.41 93.78 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.168 1 N-CA-C 124.111 4.856 . . . . 0.0 124.111 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.07 6.8 43.47 Favored 'General case' 0 CA--C 1.602 2.967 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 44' ' ' ASP . . . -115.81 -65.55 1.18 Allowed 'General case' 0 CA--C 1.574 1.889 0 C-N-CA 127.549 2.339 . . . . 0.0 112.723 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.71 66.45 9.47 Favored 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -178.37 151.27 0.75 Allowed Pre-proline 0 N--CA 1.523 3.182 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 18.8 Cg_endo -42.47 -58.28 1.32 Allowed 'Trans proline' 0 N--CA 1.507 2.324 0 C-N-CA 123.385 2.724 . . . . 0.0 115.079 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.43 67.4 0.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 124.069 1.89 . . . . 0.0 107.038 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.2 53.51 1.0 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 112.275 -2.239 . . . . 0.0 108.249 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.2 t -115.85 56.91 0.76 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.712 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.63 -47.89 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.244 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.17 -30.83 0.17 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.174 -1.579 . . . . 0.0 111.558 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.547 ' HG ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 pp -41.13 -28.59 0.1 Allowed 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 122.693 1.235 . . . . 0.0 112.498 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.8 -27.57 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 117.719 2.488 . . . . 0.0 117.719 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.628 ' HE2' ' OE1' ' B' ' 189' ' ' GLU . 12.3 tptt 65.06 -55.58 0.3 Allowed 'General case' 0 N--CA 1.532 3.632 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -41.68 -28.93 0.16 Allowed 'General case' 0 N--CA 1.515 2.785 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.046 HD12 ' HB2' ' A' ' 43' ' ' PHE . 1.8 pp -53.68 -66.79 0.33 Allowed 'General case' 0 CA--C 1.603 2.999 0 N-CA-C 100.711 -3.811 . . . . 0.0 100.711 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.762 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.8 p -72.14 98.39 2.12 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 125.33 1.452 . . . . 0.0 112.789 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.686 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.2 t60 -89.99 -173.0 3.71 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.686 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.37 155.19 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.611 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 28.0 tt0 105.45 65.9 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 120.346 3.462 . . . . 0.0 120.346 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.295 HD21 ' CE1' ' B' ' 1' ' ' TYR . 6.0 mp 38.24 84.26 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 120.762 3.616 . . . . 0.0 120.762 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.495 ' HG ' ' ND2' ' A' ' 40' ' ' ASN . 36.2 mt -70.65 82.04 0.6 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.18 -1.575 . . . . 0.0 111.812 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.904 ' HE3' HD23 ' B' ' 119' ' ' LEU . 41.2 mmm -79.28 62.0 3.52 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 126.158 2.885 . . . . 0.0 110.94 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.7 m -112.62 65.94 0.87 Allowed Pre-proline 0 N--CA 1.504 2.267 0 CA-C-N 110.486 -3.052 . . . . 0.0 113.577 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -51.98 81.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.987 2.458 . . . . 0.0 114.674 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.18 6.56 27.65 Favored Glycine 1 N--CA 1.516 4.028 0 O-C-N 122.209 -0.307 . . . . 0.0 113.604 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.9 tt0 -123.54 156.82 34.95 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 124.324 2.011 . . . . 0.0 116.368 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.82 156.35 27.42 Favored 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 119.694 3.22 . . . . 0.0 119.694 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -116.0 147.91 40.71 Favored 'General case' 0 N--CA 1.518 2.951 0 CA-C-O 116.59 -1.671 . . . . 0.0 107.222 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.49 143.62 42.03 Favored 'General case' 0 N--CA 1.529 3.515 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 84.5 m -119.89 102.56 8.65 Favored 'General case' 0 N--CA 1.515 2.8 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.569 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 76' ' ' PHE . 44.1 m -94.73 152.26 18.6 Favored 'General case' 0 N--CA 1.524 3.246 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' N ' HG22 ' A' ' 75' ' ' THR . 89.2 m-85 -107.96 168.4 7.95 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.068 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -72.41 -174.77 1.53 Allowed 'Trans proline' 0 CA--C 1.558 1.708 0 C-N-CA 121.012 1.141 . . . . 0.0 111.116 161.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.38 -19.75 18.97 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 124.34 2.019 . . . . 0.0 107.222 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -79.17 42.63 0.49 Allowed 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 111.195 -2.729 . . . . 0.0 109.106 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.18 84.75 9.51 Favored Pre-proline 0 N--CA 1.5 2.028 0 CA-C-N 113.603 -1.635 . . . . 0.0 113.841 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' O ' ' N ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -79.4 178.68 7.13 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 122.77 2.313 . . . . 0.0 112.354 172.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.588 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -16.11 77.75 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 C-N-CA 125.367 1.467 . . . . 0.0 113.244 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.54 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.4 125.03 5.64 Favored Glycine 0 N--CA 1.508 3.487 0 N-CA-C 121.694 3.438 . . . . 0.0 121.694 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.8 mt-10 -99.49 61.26 1.17 Allowed 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.54 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.8 m-85 -62.1 77.69 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 122.884 1.326 . . . . 0.0 113.07 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 6.8 m -63.29 135.89 57.33 Favored 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.536 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.49 136.58 52.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.562 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.4 m-85 -84.7 82.05 8.59 Favored 'General case' 0 N--CA 1.511 2.607 1 N-CA-C 132.617 8.006 . . . . 0.0 132.617 -179.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.1 t -63.93 82.2 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.499 2 CA-C-N 130.355 5.98 . . . . 0.0 114.295 179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.5 tt0 -20.53 -72.44 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.565 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.562 ' O ' ' CD2' ' B' ' 3' ' ' PHE . 29.5 Cg_endo -66.98 -3.51 9.79 Favored 'Trans proline' 0 N--CA 1.511 2.548 0 C-N-CA 122.467 2.112 . . . . 0.0 115.363 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -120.86 -14.16 8.54 Favored 'General case' 0 N--CA 1.51 2.565 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.34 79.7 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.52 -34.0 1.74 Allowed Glycine 1 N--CA 1.52 4.292 0 O-C-N 121.534 -0.729 . . . . 0.0 112.735 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.59 68.41 7.93 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.93 26.73 0.05 OUTLIER Glycine 1 N--CA 1.527 4.733 0 CA-C-N 114.035 -1.439 . . . . 0.0 116.605 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.603 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.1 ttt -108.51 43.81 1.19 Allowed 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 124.406 2.05 . . . . 0.0 113.0 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.01 134.85 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 112.247 -2.251 . . . . 0.0 110.968 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.536 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.68 154.87 19.36 Favored Glycine 1 N--CA 1.535 5.24 0 C-N-CA 119.435 -1.364 . . . . 0.0 114.013 179.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 ttpp -118.58 81.97 1.77 Allowed 'General case' 0 N--CA 1.517 2.907 0 CA-C-N 119.405 1.602 . . . . 0.0 115.242 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.75 123.28 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.743 0 C-N-CA 118.0 -1.48 . . . . 0.0 107.026 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.5 m -112.57 88.75 2.9 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.228 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.471 ' CG2' HD11 ' A' ' 23' ' ' ILE . 38.3 t -74.01 105.19 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.26 -72.37 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.643 0 O-C-N 126.121 2.138 . . . . 0.0 115.885 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.588 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.48 0 O-C-N 125.43 1.706 . . . . 0.0 113.889 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.295 ' CE1' HD21 ' A' ' 64' ' ' LEU . 61.1 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . 0.281 21.7 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.562 ' CD2' ' O ' ' A' ' 91' ' ' PRO . 26.2 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' TRP . . . . . 0.437 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.7 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.5 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . 0.31 27.6 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.515 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 52.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 27.1 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 82.9 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.611 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 56.4 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.525 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 74.8 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 18.8 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.638 HG22 HG11 ' B' ' 151' ' ' VAL 0.544 2.0 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.2 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.557 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . 0.369 22.0 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 33.1 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.783 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.1 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.41 HG22 HG13 ' B' ' 34' ' ' VAL . 61.5 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 52.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 19.8 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.9 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.418 HG12 ' N ' ' B' ' 69' ' ' GLY . 87.8 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.418 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.505 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 50.2 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.8 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 0.719 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 29.0 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.719 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 43.3 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.511 HG22 HG11 ' B' ' 114' ' ' VAL 0.299 0.5 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 69.5 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' B' ' 130' ' ' PRO . 51.8 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 20.6 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 8.5 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 1.235 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 20.5 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' GLN . . . . . 1.054 ' NE2' HG12 ' A' ' 36' ' ' VAL . 11.9 mm-40 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 57.6 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.511 HG11 HG22 ' B' ' 84' ' ' ILE . 15.4 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . 0.591 0.2 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.633 0.2 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 1.2 ' CG ' HD23 ' A' ' 64' ' ' LEU . 36.5 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.904 HD23 ' HE3' ' A' ' 66' ' ' MET . 83.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 93.5 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.467 ' HB3' HD21 ' B' ' 94' ' ' LEU . 24.1 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.783 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.441 0.8 OUTLIER -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 47.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' PRO . . . . . 0.693 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE 0.328 23.5 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.556 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.556 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.316 0.4 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . 0.693 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 81.7 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.8 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.417 0.8 OUTLIER -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' HIS . . . . . 0.515 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.638 HG11 HG22 ' B' ' 34' ' ' VAL . 10.5 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.502 HH11 ' HD2' ' B' ' 157' ' ' ARG . 31.1 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.681 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.0 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.524 2.0 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' PRO . . . . . 0.437 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 22.9 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.2 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.8 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.463 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 5.1 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.634 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.6 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . 0.634 ' N ' HD23 ' B' ' 171' ' ' LEU . 18.9 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 97.0 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . . . . . . . . . 55.1 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.6 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' GLU . . . . . 0.628 ' OE1' ' HE2' ' A' ' 57' ' ' LYS . 65.6 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 44.3 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.362 1.0 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.739 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.271 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.7 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 80.4 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 44.1 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 90.1 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.1 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . 0.257 25.6 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 90.7 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.2 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.627 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 14.7 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.7 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' ASN . . . . . 0.536 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.1 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.521 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 20.0 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.3 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 17.3 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 117.816 -1.087 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' HEC . . . . . 0.611 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.595 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 1.6 mp0 . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.48 ' OG1' ' HB ' ' A' ' 28' ' ' THR . 91.2 m -61.63 89.73 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.975 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -100.01 162.97 12.64 Favored 'General case' 0 N--CA 1.513 2.683 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.462 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 9.8 t -107.71 122.49 46.83 Favored 'General case' 0 N--CA 1.526 3.331 0 N-CA-C 117.12 2.267 . . . . 0.0 117.12 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.0 t -100.62 98.38 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' GLY . 13.9 mmmt -67.46 65.53 0.08 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.834 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.0 mt -29.67 68.27 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.996 0 C-N-CA 126.54 1.936 . . . . 0.0 115.493 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 6' ' ' LYS . . . 113.46 59.1 0.4 Allowed Glycine 0 N--CA 1.51 3.583 0 N-CA-C 106.832 -2.507 . . . . 0.0 106.832 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 11' ' ' LYS . 19.5 p -1.13 54.15 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.256 0 N-CA-C 120.282 3.438 . . . . 0.0 120.282 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER 25.44 -60.15 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 119.538 3.162 . . . . 0.0 119.538 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.508 ' O ' ' CE ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -112.82 22.5 14.42 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.931 -1.106 . . . . 0.0 108.164 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.11 -94.83 1.9 Allowed Glycine 0 N--CA 1.512 3.75 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 14' ' ' LEU . 46.3 tp -150.62 -177.16 5.81 Favored 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.554 HD21 ' CG2' ' A' ' 36' ' ' VAL . 15.8 mt -74.73 46.7 0.3 Allowed 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.67 -1.269 . . . . 0.0 111.3 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.665 HG22 ' N ' ' A' ' 16' ' ' PHE . 7.9 p -113.74 165.66 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.665 ' N ' HG22 ' A' ' 15' ' ' VAL . 5.1 m-30 -102.22 75.35 1.49 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.402 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.283 7.4 mt-10 -93.46 142.46 25.24 Favored Pre-proline 0 N--CA 1.505 2.293 0 O-C-N 121.825 -0.547 . . . . 0.0 111.753 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 20' ' ' LYS . 53.9 Cg_endo -86.46 76.14 0.09 OUTLIER 'Cis proline' 0 CA--C 1.571 2.364 0 N-CA-C 116.353 1.636 . . . . 0.0 116.353 -9.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 9.74 -44.26 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.799 1 N-CA-C 122.241 4.163 . . . . 0.0 122.241 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.636 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -104.58 71.59 1.0 Allowed 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 122.413 1.101 . . . . 0.0 113.1 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.8 HD22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.16 111.31 7.27 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.199 -1.563 . . . . 0.0 109.111 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.516 ' N ' HD23 ' A' ' 21' ' ' LEU . 55.9 m -87.52 81.47 7.76 Favored 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.8 HG23 HD22 ' A' ' 21' ' ' LEU . 4.9 pt -79.66 -177.55 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.742 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.643 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -109.67 166.51 10.66 Favored Pre-proline 0 C--N 1.301 -1.543 0 CA-C-N 113.887 -1.506 . . . . 0.0 108.115 179.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 23.0 Cg_endo -52.12 77.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.57 2.304 0 N-CA-C 116.934 1.859 . . . . 0.0 116.934 174.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.11 -50.45 0.52 Allowed Glycine 1 N--CA 1.522 4.423 0 C-N-CA 119.706 -1.235 . . . . 0.0 115.857 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.547 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 1.1 m-20 -6.65 92.09 0.01 OUTLIER 'General case' 0 CA--C 1.581 2.167 1 N-CA-C 122.08 4.104 . . . . 0.0 122.08 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 28' ' ' THR . 12.6 m -64.09 35.96 0.01 OUTLIER 'General case' 0 N--CA 1.539 3.989 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.96 147.21 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 CA-C-N 112.862 -1.972 . . . . 0.0 111.51 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 3.9 pt-20 -114.3 154.86 27.25 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 123.92 1.819 . . . . 0.0 115.35 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.404 ' HB3' HD11 ' A' ' 7' ' ' LEU . 55.7 m-85 -107.46 113.8 27.38 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 32' ' ' LEU . 7.0 tt -100.69 112.5 24.91 Favored 'General case' 0 N--CA 1.508 2.442 0 N-CA-C 120.728 3.603 . . . . 0.0 120.728 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -75.17 84.73 2.38 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.156 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 31.6 p30 -80.31 -44.97 18.64 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 118.975 2.954 . . . . 0.0 118.975 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 2.6 mptp? -150.01 -169.34 3.35 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 124.643 1.177 . . . . 0.0 109.097 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.109 HG12 ' NE2' ' B' ' 104' ' ' GLN . 1.7 m 12.81 70.69 0.11 Allowed Pre-proline 0 N--CA 1.52 3.046 0 N-CA-C 117.168 2.285 . . . . 0.0 117.168 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.561 ' HD2' ' CZ ' ' B' ' 102' ' ' TYR . 56.3 Cg_endo -98.41 177.19 0.42 Allowed 'Trans proline' 0 CA--C 1.569 2.263 0 C-N-CA 124.041 3.161 . . . . 0.0 114.372 -165.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HG3' ' SD ' ' A' ' 66' ' ' MET . 56.5 Cg_endo -92.45 165.24 25.16 Favored 'Cis proline' 0 N--CA 1.503 2.063 0 N-CA-C 115.399 1.269 . . . . 0.0 115.399 -7.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.825 ' HB2' HD13 ' A' ' 7' ' ' LEU . 17.5 m-70 -118.88 87.44 2.73 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.572 HD21 ' C ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -103.34 140.27 37.65 Favored 'General case' 0 N--CA 1.515 2.821 0 CA-C-N 122.421 2.373 . . . . 0.0 110.716 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.497 ' HB ' ' N ' ' A' ' 88' ' ' TYR . 6.9 m -118.16 116.31 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 N-CA-C 121.431 3.863 . . . . 0.0 121.431 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.558 HG22 ' CB ' ' A' ' 88' ' ' TYR . 14.7 m -75.98 165.4 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.027 ' CB ' HD12 ' A' ' 59' ' ' LEU . 2.0 m-85 -111.26 130.89 55.52 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.462 ' HB2' ' HB ' ' A' ' 86' ' ' THR . 4.1 m-20 -53.4 93.71 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.208 1 N-CA-C 124.205 4.891 . . . . 0.0 124.205 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.94 6.7 43.57 Favored 'General case' 0 CA--C 1.602 2.959 0 N-CA-C 101.272 -3.603 . . . . 0.0 101.272 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.81 -65.54 1.18 Allowed 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 127.501 2.32 . . . . 0.0 112.668 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.677 ' N ' HD12 ' A' ' 47' ' ' LEU . 2.8 mp -86.62 66.46 9.49 Favored 'General case' 0 N--CA 1.518 2.949 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -178.36 151.28 0.75 Allowed Pre-proline 0 N--CA 1.522 3.158 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HG2' ' HA2' ' A' ' 83' ' ' GLY . 19.6 Cg_endo -42.51 -58.3 1.32 Allowed 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 123.389 2.726 . . . . 0.0 115.025 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . -106.51 67.47 0.72 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 124.15 1.928 . . . . 0.0 107.056 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -77.2 53.5 1.0 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 112.267 -2.242 . . . . 0.0 108.219 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 t -115.82 56.81 0.76 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.675 ' O ' HD21 ' A' ' 59' ' ' LEU . . . -24.46 -48.01 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -41.13 -30.85 0.17 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.127 -1.608 . . . . 0.0 111.606 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.9 pp -41.12 -28.6 0.1 Allowed 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.649 1.214 . . . . 0.0 112.461 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' CB ' HD12 ' A' ' 55' ' ' LEU . . . -166.76 -27.7 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 12.2 tptt 65.14 -55.57 0.31 Allowed 'General case' 0 N--CA 1.534 3.752 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.4 m -41.69 -28.94 0.16 Allowed 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.027 HD12 ' CB ' ' A' ' 43' ' ' PHE . 1.6 pp -53.68 -66.82 0.32 Allowed 'General case' 0 CA--C 1.604 3.035 0 N-CA-C 100.697 -3.816 . . . . 0.0 100.697 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.802 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 10.9 p -72.06 98.42 2.09 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 125.267 1.427 . . . . 0.0 112.814 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.673 ' CG ' ' H ' ' A' ' 62' ' ' LYS . 73.1 t60 -90.02 -173.03 3.72 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.673 ' H ' ' CG ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 152.42 155.2 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.317 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.597 ' HB2' ' NZ ' ' A' ' 62' ' ' LYS . 27.1 tt0 105.43 66.02 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.826 0 N-CA-C 120.309 3.448 . . . . 0.0 120.309 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.349 HD21 ' CE1' ' B' ' 1' ' ' TYR . 6.0 mp 38.19 84.25 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 120.748 3.61 . . . . 0.0 120.748 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.542 ' N ' HD21 ' A' ' 40' ' ' ASN . 36.3 mt -70.66 82.04 0.61 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.145 -1.597 . . . . 0.0 111.865 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.982 ' HE3' ' HA ' ' B' ' 119' ' ' LEU . 42.2 mmm -79.21 61.94 3.46 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 126.074 2.845 . . . . 0.0 110.965 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 70' ' ' GLN . 67.9 m -112.53 65.96 0.85 Allowed Pre-proline 0 C--N 1.284 -2.262 0 CA-C-N 110.464 -3.062 . . . . 0.0 113.601 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.695 ' HB2' ' OD2' ' B' ' 100' ' ' ASP . 21.3 Cg_endo -51.98 81.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.507 0 C-N-CA 122.964 2.442 . . . . 0.0 114.675 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.17 6.69 27.55 Favored Glycine 1 N--CA 1.517 4.056 0 O-C-N 122.238 -0.289 . . . . 0.0 113.513 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 35.8 tt0 -123.61 156.8 35.11 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 124.34 2.019 . . . . 0.0 116.349 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.439 ' OG ' ' CB ' ' A' ' 32' ' ' LEU . 4.2 m -116.83 156.37 27.4 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 119.716 3.228 . . . . 0.0 119.716 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.7 t -116.06 147.88 40.8 Favored 'General case' 0 N--CA 1.519 2.993 0 CA-C-O 116.682 -1.628 . . . . 0.0 107.199 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.9 m -111.45 143.72 41.83 Favored 'General case' 0 N--CA 1.529 3.503 0 N-CA-C 118.347 2.721 . . . . 0.0 118.347 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.3 m -119.88 102.62 8.7 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.517 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.449 ' OG1' HG23 ' A' ' 28' ' ' THR . 51.7 m -94.85 152.22 18.57 Favored 'General case' 0 N--CA 1.525 3.297 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' N ' HG22 ' A' ' 75' ' ' THR . 90.0 m-85 -107.95 168.28 8.12 Favored Pre-proline 0 N--CA 1.503 2.217 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.059 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -72.27 -174.8 1.51 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 121.03 1.153 . . . . 0.0 111.157 161.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -96.35 -19.76 18.99 Favored 'General case' 0 N--CA 1.509 2.504 0 CA-C-O 124.384 2.04 . . . . 0.0 107.286 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.14 42.72 0.49 Allowed 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 111.225 -2.716 . . . . 0.0 109.111 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -114.38 84.74 9.88 Favored Pre-proline 0 N--CA 1.499 2.008 0 CA-C-N 113.55 -1.659 . . . . 0.0 113.809 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 83' ' ' GLY . 42.4 Cg_endo -79.39 178.63 7.2 Favored 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 122.753 2.302 . . . . 0.0 112.275 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.596 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . -15.99 77.69 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 125.348 1.459 . . . . 0.0 113.264 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.544 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -124.43 125.01 5.63 Favored Glycine 0 N--CA 1.507 3.417 0 N-CA-C 121.74 3.456 . . . . 0.0 121.74 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 43.9 mt-10 -99.51 61.25 1.17 Allowed 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.544 ' CE1' ' HA3' ' A' ' 83' ' ' GLY . 2.9 m-85 -62.05 77.79 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 122.904 1.335 . . . . 0.0 113.032 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 44' ' ' ASP . 7.2 m -63.42 135.95 57.29 Favored 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 1.3 p90 -116.53 136.51 52.92 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.558 ' CB ' HG22 ' A' ' 42' ' ' VAL . 3.5 m-85 -84.64 82.07 8.58 Favored 'General case' 0 N--CA 1.512 2.672 1 N-CA-C 132.559 7.985 . . . . 0.0 132.559 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.711 ' SG ' ' HB3' ' A' ' 39' ' ' HIS . 9.6 t -63.85 82.23 0.03 OUTLIER 'General case' 0 N--CA 1.529 3.498 2 CA-C-N 130.329 5.968 . . . . 0.0 114.314 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 88' ' ' TYR . 25.1 tt0 -20.57 -72.45 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.56 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.406 ' HD3' ' CG ' ' A' ' 90' ' ' GLU . 35.6 Cg_endo -67.04 -3.43 9.69 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.326 2.017 . . . . 0.0 115.401 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -120.84 -14.12 8.56 Favored 'General case' 0 N--CA 1.511 2.585 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.437 ' HG3' ' CE2' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -25.23 79.6 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 N-CA-C 116.579 2.066 . . . . 0.0 116.579 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.53 -33.91 1.75 Allowed Glycine 1 N--CA 1.52 4.266 0 O-C-N 121.535 -0.728 . . . . 0.0 112.657 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.64 68.42 7.98 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 38.92 26.7 0.05 OUTLIER Glycine 1 N--CA 1.526 4.636 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.581 ' HG2' ' HB2' ' A' ' 89' ' ' CYS . 2.0 ttt -108.5 43.87 1.19 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 124.559 2.123 . . . . 0.0 113.023 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.94 134.91 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 112.19 -2.277 . . . . 0.0 110.902 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -126.7 154.88 19.38 Favored Glycine 1 N--CA 1.536 5.347 0 C-N-CA 119.489 -1.339 . . . . 0.0 113.978 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.1 ttpp -118.7 82.0 1.78 Allowed 'General case' 0 N--CA 1.518 2.94 0 CA-C-N 119.371 1.585 . . . . 0.0 115.192 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.473 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -55.69 123.33 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.4 m -112.7 88.75 2.9 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.193 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.456 ' CG2' HD11 ' A' ' 23' ' ' ILE . 39.2 t -73.98 105.21 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -12.35 -72.26 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 O-C-N 126.132 2.145 . . . . 0.0 115.942 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.596 ' HA2' ' N ' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.486 0 O-C-N 125.49 1.744 . . . . 0.0 113.811 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.349 ' CE1' HD21 ' A' ' 64' ' ' LEU . 60.8 m-85 . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -53.23 -37.45 80.47 Favored 'Trans proline' 0 C--N 1.359 1.087 0 CA-C-N 122.591 1.961 . . . . 0.0 112.921 169.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -60.04 -38.09 81.74 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.639 -171.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' TRP . . . . . 0.45 ' CD1' ' HG3' ' B' ' 162' ' ' PRO . 8.9 m0 -62.67 -47.15 84.93 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 120.883 1.674 . . . . 0.0 109.318 175.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.56 -42.15 70.66 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.043 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.429 ' HG2' ' CD1' ' B' ' 106' ' ' TYR . 62.6 mt-30 -60.25 -51.47 69.4 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.601 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -57.18 -32.93 66.95 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 116.668 -1.634 . . . . 0.0 112.94 -172.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.497 ' O ' ' OG1' ' B' ' 8' ' ' THR . 1.4 t -131.28 22.35 4.81 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 120.601 1.546 . . . . 0.0 114.679 -173.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -149.69 53.06 1.21 Allowed Pre-proline 0 C--N 1.357 0.918 0 CA-C-O 116.927 -1.511 . . . . 0.0 110.695 163.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.95 -32.73 98.03 Favored 'Trans proline' 0 C--N 1.362 1.241 0 CA-C-N 123.594 2.319 . . . . 0.0 115.674 -172.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -110.74 11.93 22.55 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-O 117.084 -1.436 . . . . 0.0 112.505 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 11.6 m -140.33 54.39 5.07 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-N 120.545 1.52 . . . . 0.0 110.016 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.04 -29.72 4.02 Favored 'Trans proline' 0 C--N 1.36 1.15 0 CA-C-N 121.293 1.497 . . . . 0.0 109.823 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.442 ' HE ' ' CD2' ' B' ' 150' ' ' HIS . 56.6 ttt-85 -102.22 94.15 5.58 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -56.98 154.99 16.79 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 115.947 -1.978 . . . . 0.0 109.306 -175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -56.42 -19.13 27.56 Favored 'Trans proline' 0 C--N 1.362 1.238 0 CA-C-N 123.5 2.286 . . . . 0.0 114.495 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 28.5 p -69.57 -2.93 12.8 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 120.375 1.443 . . . . 0.0 112.152 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.45 -2.64 86.9 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 116.997 -2.002 . . . . 0.0 110.909 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -91.93 156.55 17.39 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 120.351 2.075 . . . . 0.0 107.821 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 86.0 mt -104.18 144.24 14.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -58.6 -28.99 38.21 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 CA-C-O 117.733 -1.127 . . . . 0.0 112.717 -168.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' CYS . . . . . 0.608 ' SG ' ' CAB' ' B' ' 255' ' ' HEC . 55.5 m -40.48 -46.91 2.55 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 119.876 1.216 . . . . 0.0 110.309 173.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.75 -42.29 45.97 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.507 -0.759 . . . . 0.0 111.071 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -42.5 -43.55 3.72 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.366 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' CYS . . . . . 0.529 ' SG ' HBC3 ' B' ' 255' ' ' HEC . 77.0 m -110.53 -46.02 3.45 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.418 -176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -72.8 94.43 1.79 Allowed 'General case' 0 C--N 1.352 0.681 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 71.5 mt -79.81 -47.42 15.21 Favored 'General case' 0 C--N 1.355 0.839 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.314 -169.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.16 154.72 15.45 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 120.144 1.338 . . . . 0.0 110.653 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.08 126.72 55.02 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 116.879 -1.534 . . . . 0.0 109.695 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.34 160.89 60.1 Favored Pre-proline 0 C--N 1.358 0.952 0 CA-C-O 115.738 -2.077 . . . . 0.0 109.303 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.99 148.54 31.7 Favored 'Trans proline' 0 C--N 1.363 1.323 0 CA-C-N 123.931 2.44 . . . . 0.0 114.519 -168.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' THR . . . . . . . . . . . . . 19.1 m -125.3 141.78 51.88 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 115.934 -1.984 . . . . 0.0 105.654 171.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -114.29 157.65 22.47 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-N 121.138 1.79 . . . . 0.0 108.463 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.63 HG22 HG11 ' B' ' 151' ' ' VAL 0.399 1.4 t -149.45 121.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.779 0 CA-C-O 117.467 -1.254 . . . . 0.0 109.697 169.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 35' ' ' GLU . 59.6 mp0 -100.33 149.64 23.4 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -148.95 147.76 25.13 Favored Pre-proline 0 C--N 1.351 0.664 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.59 157.0 53.61 Favored 'Trans proline' 0 C--N 1.356 0.963 0 CA-C-N 123.882 2.422 . . . . 0.0 109.965 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -64.31 -42.6 96.25 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 87.8 p -147.8 161.63 40.87 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 117.879 -1.058 . . . . 0.0 111.463 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 25.8 m -146.14 155.17 12.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-O 118.35 -0.833 . . . . 0.0 109.715 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.591 ' N ' HD22 ' B' ' 41' ' ' LEU . 3.5 mm? -98.85 150.71 36.95 Favored Pre-proline 0 C--N 1.356 0.873 0 CA-C-O 116.144 -1.884 . . . . 0.0 108.632 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -42.09 148.8 0.34 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 47.0 54.98 8.55 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.025 0.828 . . . . 0.0 112.348 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 32.5 p -138.01 149.96 46.54 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 86.9 t -87.77 141.73 13.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.969 ' CE1' HG22 ' B' ' 131' ' ' VAL . 50.4 p90 -140.24 175.77 9.32 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 117.271 -1.347 . . . . 0.0 107.402 173.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.94 124.47 45.0 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 117.658 -1.163 . . . . 0.0 109.224 -175.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.19 105.43 17.37 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 168.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.26 129.94 41.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.902 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.582 HG22 HG13 ' B' ' 34' ' ' VAL . 61.1 t -113.4 141.24 29.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 CA-C-O 115.451 -2.214 . . . . 0.0 106.763 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -118.52 145.04 45.62 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 120.946 1.703 . . . . 0.0 109.459 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ILE . . . . . . . . . . . . . 50.1 mt -137.63 65.43 47.26 Favored Pre-proline 0 C--N 1.354 0.773 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -174.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -79.0 160.82 26.96 Favored 'Trans proline' 0 C--N 1.358 1.062 0 CA-C-N 119.727 0.938 . . . . 0.0 112.318 -167.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -167.4 152.49 7.19 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-O 117.714 -1.136 . . . . 0.0 108.71 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -58.76 109.58 0.84 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 20.3 p -65.29 -25.83 67.81 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.837 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 99.3 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 120.575 1.534 . . . . 0.0 112.491 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 m -59.59 162.55 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.856 0 CA-C-N 120.401 1.455 . . . . 0.0 110.077 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -135.56 156.23 49.21 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -119.31 164.59 15.43 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.097 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.68 126.4 38.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.24 179.36 42.75 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 120.46 1.482 . . . . 0.0 109.547 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.7 75.42 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 119.573 1.686 . . . . 0.0 110.629 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -83.78 -3.96 58.25 Favored 'General case' 0 C--N 1.356 0.849 0 CA-C-O 116.454 -1.736 . . . . 0.0 115.255 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.2 -37.19 3.83 Favored Glycine 0 C--N 1.357 1.722 0 CA-C-N 121.364 1.893 . . . . 0.0 110.861 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 81.8 p -60.64 161.08 8.21 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 117.073 -1.441 . . . . 0.0 109.796 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -97.97 139.56 33.62 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-N 119.716 1.144 . . . . 0.0 109.675 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.421 HG12 ' N ' ' B' ' 69' ' ' GLY . 86.3 t -147.13 161.08 8.65 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 CA-C-O 117.471 -1.252 . . . . 0.0 108.293 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.421 ' N ' HG12 ' B' ' 68' ' ' VAL . . . -63.52 -176.27 3.74 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 120.705 1.593 . . . . 0.0 112.468 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' LEU . . . . . 0.515 HD12 ' N ' ' B' ' 70' ' ' LEU . 10.1 mp -102.77 162.26 13.07 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-N 117.638 0.719 . . . . 0.0 111.158 -173.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -115.44 169.51 9.11 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 169.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 t -133.41 152.81 36.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.716 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.56 176.08 34.0 Favored Glycine 0 C--N 1.356 1.652 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 174.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.51 169.46 15.48 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 119.385 1.593 . . . . 0.0 113.04 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.505 HG23 HD11 ' B' ' 115' ' ' ILE . 2.3 p -133.82 133.99 56.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 53.2 tp -122.64 128.13 50.24 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 57.9 mtt -110.84 118.7 36.82 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 11.9 mt -112.37 164.67 14.71 Favored Pre-proline 0 C--N 1.356 0.861 0 CA-C-O 116.112 -1.899 . . . . 0.0 108.164 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 0.779 ' HG2' ' CE1' ' B' ' 82' ' ' PHE . 19.2 Cg_endo -68.67 169.6 17.08 Favored 'Trans proline' 0 C--N 1.36 1.14 0 CA-C-N 123.628 2.331 . . . . 0.0 111.007 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.41 149.38 50.1 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 -42.35 2.17 Favored Glycine 0 C--N 1.357 1.747 0 CA-C-O 119.042 -0.866 . . . . 0.0 110.995 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.779 ' CE1' ' HG2' ' B' ' 79' ' ' PRO . 44.1 m-85 -78.62 151.97 32.02 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -168.17 171.87 9.1 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.695 1.134 . . . . 0.0 111.221 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ILE . . . . . 0.58 HG22 HG11 ' B' ' 114' ' ' VAL 0.384 0.1 OUTLIER -59.24 138.13 20.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -176.825 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.54 141.99 73.66 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 116.641 -1.647 . . . . 0.0 110.445 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.26 169.78 21.76 Favored 'Trans proline' 0 C--N 1.359 1.119 0 CA-C-N 122.676 1.992 . . . . 0.0 110.81 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -65.05 -44.71 88.11 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.794 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -55.04 -33.91 63.07 Favored 'General case' 0 C--N 1.351 0.644 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.022 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 37.0 mmm-85 -86.81 -3.73 59.09 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 116.847 -1.549 . . . . 0.0 113.232 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 72.6 mt -87.95 112.08 46.8 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 115.219 -2.324 . . . . 0.0 106.998 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -71.38 170.84 17.4 Favored 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 124.569 2.667 . . . . 0.0 111.3 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -67.4 -35.14 78.69 Favored 'General case' 0 C--N 1.353 0.744 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.808 -172.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -60.75 -45.69 93.35 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 50.4 tp -68.53 -36.02 78.27 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.997 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -61.01 -45.06 96.37 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.303 -174.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -65.46 -33.57 76.24 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.797 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -60.02 -43.68 95.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.407 1.458 . . . . 0.0 109.96 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ILE . . . . . . . . . . . . . 18.8 pt -70.15 -6.66 7.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 CA-C-O 117.235 -1.364 . . . . 0.0 111.87 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.66 -121.76 22.97 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.695 ' OD2' ' HB2' ' A' ' 68' ' ' PRO . 24.1 p-10 -140.89 48.68 1.7 Allowed 'General case' 0 C--N 1.355 0.818 0 CA-C-N 119.208 1.504 . . . . 0.0 108.639 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 m -78.32 174.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 1.561 ' CZ ' ' HD2' ' A' ' 37' ' ' PRO . 19.1 p90 -140.82 95.15 2.81 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -71.59 133.69 45.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.241 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' GLN . . . . . 1.109 ' NE2' HG12 ' A' ' 36' ' ' VAL . 11.1 mm100 -108.16 150.75 40.86 Favored Pre-proline 0 C--N 1.357 0.909 0 CA-C-O 115.707 -2.092 . . . . 0.0 106.175 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -73.63 155.81 49.5 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 123.77 2.382 . . . . 0.0 106.12 170.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' B' ' 6' ' ' GLN . 23.9 t80 -62.28 -38.69 90.31 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . -146.65 151.79 24.01 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 106.086 -2.806 . . . . 0.0 106.086 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -52.25 -40.49 61.75 Favored 'General case' 0 C--N 1.351 0.652 0 CA-C-N 120.59 2.195 . . . . 0.0 109.372 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -67.29 -40.76 86.15 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-O 117.825 -1.084 . . . . 0.0 111.736 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -80.4 72.97 7.3 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 120.017 1.28 . . . . 0.0 109.716 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -62.38 -35.97 80.84 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.88 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -70.64 -8.6 53.0 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-O 116.611 -1.661 . . . . 0.0 114.718 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 56.3 mt -110.27 133.09 56.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.58 HG11 HG22 ' B' ' 84' ' ' ILE . 16.5 m -137.9 131.08 41.88 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 117.301 -1.333 . . . . 0.0 108.754 -168.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.505 HD11 HG23 ' B' ' 75' ' ' VAL 0.727 0.0 OUTLIER -121.08 166.86 15.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.098 0 CA-C-N 119.791 1.178 . . . . 0.0 109.318 -171.0 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . 0.68 0.1 OUTLIER -158.86 149.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 CA-C-O 117.076 -1.44 . . . . 0.0 107.736 173.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 125.4 160.32 10.64 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 117.435 -1.758 . . . . 0.0 110.212 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . 0.839 ' CG ' HD23 ' A' ' 64' ' ' LEU . 38.0 Cg_endo -78.79 143.93 72.84 Favored 'Cis proline' 0 C--N 1.357 1.007 0 CA-C-N 120.93 2.365 . . . . 0.0 110.785 -2.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.982 ' HA ' ' HE3' ' A' ' 66' ' ' MET . 82.2 mt -138.06 153.46 73.4 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.906 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.95 144.95 99.41 Favored 'Trans proline' 0 C--N 1.357 1.022 0 CA-C-N 123.944 2.444 . . . . 0.0 111.327 -177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.0 -40.08 15.06 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 118.183 -1.343 . . . . 0.0 110.672 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -43.69 -48.8 7.93 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 118.588 1.194 . . . . 0.0 109.474 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -44.57 34.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.032 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -116.26 50.92 1.0 Allowed 'General case' 0 C--N 1.355 0.845 0 CA-C-O 117.986 -1.007 . . . . 0.0 112.707 -170.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -62.4 -51.77 66.22 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.29 151.62 21.41 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.903 173.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.5 mt -137.95 140.98 39.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' VAL . . . . . . . . . . . . . 94.4 t -113.05 113.42 44.01 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -97.03 112.85 61.86 Favored Pre-proline 0 C--N 1.357 0.93 0 CA-C-O 115.787 -2.054 . . . . 0.0 107.157 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -63.92 148.67 91.66 Favored 'Trans proline' 0 C--N 1.358 1.045 0 CA-C-N 123.903 2.43 . . . . 0.0 108.879 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.969 HG22 ' CE1' ' B' ' 46' ' ' PHE 0.5 1.5 m -144.58 127.44 11.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.211 176.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 50.5 tp -84.28 130.19 34.83 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' SER . . . . . . . . . . . . . 94.8 p -80.06 141.35 54.32 Favored Pre-proline 0 C--N 1.355 0.827 0 CA-C-O 116.786 -1.578 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.05 -177.9 4.21 Favored 'Trans proline' 0 C--N 1.358 1.059 0 CA-C-N 122.258 1.842 . . . . 0.0 111.717 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -129.37 113.9 18.26 Favored Pre-proline 0 C--N 1.358 0.945 0 CA-C-O 115.97 -1.967 . . . . 0.0 109.952 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' PRO . . . . . 0.653 ' HG2' ' CZ ' ' B' ' 144' ' ' PHE . 13.0 Cg_endo -56.47 -37.98 96.22 Favored 'Trans proline' 0 C--N 1.362 1.283 0 CA-C-N 123.652 2.34 . . . . 0.0 113.867 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.51 -40.45 78.71 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.804 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.78 28.45 4.29 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 117.795 -1.098 . . . . 0.0 110.3 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASP . . . . . 0.629 ' CG ' HG23 ' B' ' 142' ' ' ILE . 44.9 t0 -169.16 94.25 0.3 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.301 1.409 . . . . 0.0 108.537 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.87 -50.96 72.04 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.087 -0.958 . . . . 0.0 112.455 -171.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -54.96 -24.46 24.03 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 117.149 -1.405 . . . . 0.0 113.429 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.629 HG23 ' CG ' ' B' ' 139' ' ' ASP 0.393 0.1 OUTLIER -86.07 151.44 3.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 CA-C-N 120.757 1.617 . . . . 0.0 107.891 -178.628 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -144.09 166.28 25.44 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 119.256 0.935 . . . . 0.0 110.872 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' PHE . . . . . 0.653 ' CZ ' ' HG2' ' B' ' 136' ' ' PRO . 82.0 m-85 -77.4 100.54 6.0 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.92 173.0 38.2 Favored Glycine 0 C--N 1.353 1.488 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.812 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -65.94 158.49 27.96 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -153.48 146.12 24.21 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-O 117.358 -1.306 . . . . 0.0 109.625 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 68.6 p -88.33 158.91 18.29 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.28 0.945 . . . . 0.0 110.049 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' VAL . . . . . . . . . . . . 0.426 1.2 m -141.06 102.13 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' HIS . . . . . 0.442 ' CD2' ' HE ' ' B' ' 14' ' ' ARG . 80.7 m80 -86.61 162.62 17.88 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 121.046 1.748 . . . . 0.0 109.019 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.63 HG11 HG22 ' B' ' 34' ' ' VAL . 10.8 p -148.84 152.73 11.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.869 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.176 177.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . -127.85 139.68 11.28 Favored Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.73 118.24 1.72 Allowed Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.339 2.07 . . . . 0.0 109.103 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.88 156.53 19.57 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.656 1.728 . . . . 0.0 111.317 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.74 139.66 31.14 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.41 175.59 37.44 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 119.598 1.09 . . . . 0.0 113.961 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.495 HH11 ' HD2' ' B' ' 157' ' ' ARG . 29.9 mtm180 -80.22 149.39 30.46 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 119.411 -0.328 . . . . 0.0 111.583 -171.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' GLY . . . . . . . . . . . . . . . -88.44 -179.05 46.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.666 ' N ' ' CD ' ' B' ' 159' ' ' GLN . 5.2 mp0 -101.6 -27.27 13.17 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 116.192 -1.861 . . . . 0.0 112.214 -173.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . 0.457 1.3 m -130.89 142.65 43.08 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-N 121.25 1.841 . . . . 0.0 111.337 -172.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -89.2 165.27 27.17 Favored Pre-proline 0 C--N 1.358 0.978 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.455 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' PRO . . . . . 0.45 ' HG3' ' CD1' ' B' ' 4' ' ' TRP . 20.2 Cg_endo -53.74 -28.21 46.36 Favored 'Trans proline' 0 C--N 1.362 1.285 0 CA-C-N 123.677 2.349 . . . . 0.0 114.444 173.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' THR . . . . . . . . . . . . . 40.7 p -75.49 -4.72 41.35 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 120.442 1.473 . . . . 0.0 112.265 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 92.62 -7.58 77.34 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-O 117.425 -1.764 . . . . 0.0 111.784 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -71.83 153.09 42.16 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.482 2.141 . . . . 0.0 108.901 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -80.08 163.18 24.35 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' SER . . . . . . . . . . . . . 98.7 p -110.85 174.71 5.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 117.472 -1.251 . . . . 0.0 108.065 173.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -89.16 33.54 0.8 Allowed 'General case' 0 C--N 1.357 0.924 0 CA-C-N 119.967 1.258 . . . . 0.0 112.095 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.461 ' HB2' ' NH2' ' B' ' 157' ' ' ARG . 7.8 t-20 -123.17 52.6 1.36 Allowed 'General case' 0 C--N 1.357 0.907 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 171.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.32 174.15 11.43 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.619 -0.832 . . . . 0.0 112.725 -172.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . 0.664 HD23 ' N ' ' B' ' 172' ' ' TYR . 5.7 tt -80.44 133.84 35.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 117.343 -1.313 . . . . 0.0 108.511 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' TYR . . . . . 0.664 ' N ' HD23 ' B' ' 171' ' ' LEU . 19.1 m-85 -102.76 95.66 6.34 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 174.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 96.6 p -71.44 166.61 21.35 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.806 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' ALA . . . . . . . . . . . . . . . -74.55 149.57 40.12 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -102.73 33.17 3.3 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 170.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -172.98 145.48 1.39 Allowed 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -171.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.4 HG22 ' N ' ' B' ' 178' ' ' GLY . 58.5 m -85.27 163.2 18.78 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 166.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.4 ' N ' HG22 ' B' ' 177' ' ' THR . . . 147.24 -165.8 28.59 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 121.46 1.936 . . . . 0.0 111.472 172.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -115.02 157.28 23.68 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 170.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' ILE . . . . . . . . . . . . . 65.6 mt -96.05 121.19 46.34 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' SER . . . . . . . . . . . . . 57.8 p -95.21 -16.29 22.63 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 116.946 -1.502 . . . . 0.0 113.391 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -162.13 150.39 14.82 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 121.273 1.851 . . . . 0.0 109.637 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' ILE . . . . . . . . . . . . . 2.1 mt -141.3 153.59 20.09 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 CA-C-O 117.283 -1.341 . . . . 0.0 108.799 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' ALA . . . . . . . . . . . . . . . -165.78 110.09 0.83 Allowed 'General case' 0 C--N 1.36 1.037 0 CA-C-O 117.506 -1.235 . . . . 0.0 111.745 171.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -71.18 132.07 44.46 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 169.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . 0.412 ' HB3' HE21 ' B' ' 186' ' ' GLN . 2.1 mm100 -123.69 159.41 29.42 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-O 116.72 -1.609 . . . . 0.0 107.546 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -104.86 138.64 40.8 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 117.37 -1.3 . . . . 0.0 107.801 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . -112.39 -88.9 1.79 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -134.91 -65.82 0.61 Allowed 'General case' 0 C--N 1.358 0.941 0 CA-C-N 118.556 1.178 . . . . 0.0 108.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -82.97 -40.53 19.92 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-O 118.323 -0.846 . . . . 0.0 109.284 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.5 -177.11 30.3 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.337 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' SER . . . . . . . . . . . . . 43.8 m -72.19 142.49 49.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . 0.444 0.9 OUTLIER -94.87 117.38 38.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.016 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 164.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -88.17 135.52 33.4 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -124.02 150.12 45.26 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-O 117.427 -1.273 . . . . 0.0 109.309 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.791 ' C ' HD22 ' B' ' 196' ' ' LEU . 0.0 OUTLIER -167.8 171.78 9.68 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.448 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.18 158.09 17.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -128.61 142.33 51.08 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 116.799 -1.572 . . . . 0.0 107.092 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' ILE . . . . . . . . . . . . 0.366 0.1 OUTLIER -107.55 104.07 16.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 177.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.8 80.17 0.45 Allowed 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' THR . . . . . . . . . . . . . 32.5 m -54.14 -37.36 64.31 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.402 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.03 -54.41 47.02 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 118.124 -0.941 . . . . 0.0 110.185 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' SER . . . . . . . . . . . . . 81.0 p -94.14 6.38 48.75 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-O 117.426 -1.274 . . . . 0.0 113.217 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' GLY . . . . . . . . . . . . . . . 55.68 61.4 7.46 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 120.839 1.654 . . . . 0.0 110.121 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -151.62 150.76 30.65 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-O 117.428 -1.272 . . . . 0.0 108.635 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 59.4 t -117.98 142.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 117.139 -1.41 . . . . 0.0 107.883 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.84 164.77 33.02 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 CA-C-N 119.682 1.128 . . . . 0.0 108.062 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' SER . . . . . . . . . . . . . 43.8 t -133.88 82.07 1.96 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -58.12 161.34 4.2 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 174.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 89.2 m -131.73 147.24 52.49 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 14.6 mt -126.64 133.44 25.0 Favored Pre-proline 0 C--N 1.354 0.778 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -79.81 -174.83 2.43 Favored 'Trans proline' 0 C--N 1.361 1.188 0 CA-C-N 122.89 2.068 . . . . 0.0 111.326 -173.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -77.71 149.09 34.64 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-O 117.454 -1.26 . . . . 0.0 110.599 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.8 -62.68 0.47 Allowed Glycine 0 C--N 1.356 1.65 0 CA-C-O 117.513 -1.715 . . . . 0.0 110.715 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.81 179.23 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 121.131 2.465 . . . . 0.0 112.271 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.99 152.61 40.43 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' B' ' 217' ' ' LEU . 1.5 mt -75.35 157.52 34.13 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 88.3 mt -97.45 -50.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.275 155.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.0 169.76 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.954 0 CA-C-N 119.917 1.235 . . . . 0.0 113.602 -167.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 22.9 m -134.36 -179.23 5.45 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.358 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -69.97 159.12 34.35 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.418 1.463 . . . . 0.0 109.735 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' GLY . . . . . . . . . . . . . . . 65.04 7.68 31.85 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-O 116.289 -2.395 . . . . 0.0 114.756 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -94.98 138.89 32.11 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 121.242 2.521 . . . . 0.0 108.346 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . -70.66 138.72 50.94 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-O 117.511 -1.233 . . . . 0.0 107.791 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' VAL . . . . . . . . . . . . 0.391 0.0 OUTLIER -129.53 148.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 116.876 -1.535 . . . . 0.0 107.412 -178.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' THR . . . . . . . . . . . . . 13.6 m -107.34 153.43 22.77 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.35 144.35 30.92 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-N 119.299 0.954 . . . . 0.0 109.593 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 76.06 0.49 65.44 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 116.488 -2.285 . . . . 0.0 114.607 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.17 159.1 29.97 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 121.987 2.893 . . . . 0.0 111.481 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.11 111.17 9.02 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.591 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.51 -43.86 46.76 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.181 171.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.6 p -108.79 169.16 8.84 Favored 'General case' 0 C--N 1.357 0.927 0 CA-C-N 119.484 1.038 . . . . 0.0 111.652 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -66.33 166.93 11.29 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 167.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' ASN . . . . . 0.501 ' C ' ' OD1' ' B' ' 234' ' ' ASN . 1.4 t-20 -89.32 113.23 55.6 Favored Pre-proline 0 C--N 1.353 0.743 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -87.35 6.78 5.03 Favored 'Trans proline' 0 C--N 1.36 1.136 0 CA-C-N 123.498 2.285 . . . . 0.0 113.315 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . 0.475 ' OD1' ' C ' ' B' ' 236' ' ' ASN . 22.9 t-20 -71.71 111.89 7.37 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 120.748 1.613 . . . . 0.0 110.131 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' VAL . . . . . . . . . . . . . 18.6 m -102.45 5.38 10.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.978 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.898 174.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' GLY . . . . . . . . . . . . . . . -114.06 -159.55 13.09 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . 171.66 -162.71 35.18 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-N 119.146 1.473 . . . . 0.0 111.771 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -137.8 150.85 47.56 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.155 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' GLY . . . . . . . . . . . . . . . -143.87 165.78 27.19 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -158.11 158.19 34.22 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.994 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 243' ' ' LEU . 15.3 mt -159.92 -178.59 7.14 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -140.8 157.04 45.97 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.231 167.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' ALA . . . . . . . . . . . . . . . -126.61 161.61 27.65 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.7 149.99 28.95 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' ILE . . . . . . . . . . . . . 18.2 tt -137.16 138.7 45.22 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.32 107.11 21.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' LEU . . . . . 0.436 HD22 HD11 ' B' ' 142' ' ' ILE . 41.0 tp -68.9 124.28 23.29 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -116.01 138.81 50.88 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 119.657 1.117 . . . . 0.0 111.264 -163.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -71.67 136.95 47.49 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.87 -38.5 70.23 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 119.393 0.997 . . . . 0.0 109.977 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.05 -177.53 4.94 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 . . . . . 0 C--N 1.355 0.809 0 CA-C-O 118.159 -0.924 . . . . 0.0 108.825 178.581 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' HEC . . . . . 0.608 ' CAB' ' SG ' ' B' ' 22' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_